Citrus Sinensis ID: 017768

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360------
Protein Sequence
MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEEcccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccEEEEcccEEEcccccccccccHHcccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHHHHHcHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEccccEEEEccccEEEcccccHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccHHHccHHHHHHHHHHccccHHHcccHHHHcccHHHccccccccccEcHHHHHHHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mglcftrsrshdipissssdesphhryqplprrtqqdfrptssrppalskqipqtsqigpilgkpyvditTIYDldkelgrgqfgvtylctkkatgrkyacksisrrklvydkdmEDVRREILILQHltgqpnivefegayedkQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMgvihrdlkpenfllaskeedspikatdFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLsgvppfwaeTEKGIFEAILEgnldlqsspwpsisgQAKDLIRKMLTKDPKKRITAAEalehpwlkedgatsdkpidSAVLTRMKQFRAMNKMKKLALKV
Flexible Loop (DISEMBL)
mglcftrsrshdipissssdesphhryqplprrtqqdfrptssrppalskqipqtsqigpilgkpyVDITTIYDLDKELGRGQFGVtylctkkatgrkyacksisrrklvydkdmEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASkeedspikaTDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNldlqsspwpsISGQAKDLIRKMLTKDPKKRITAaealehpwlkedgatsdkpidsAVLTRMKQFramnkmkklalkv
Low Complexity Region (SEG)
MGLCFTrsrshdipissssdesphHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV
Disordered region (IsUnstruct)
*********************************************************IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS*****PIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ*************************************************************************
Disordered Region (DISOPRED)
****************************************************************PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV
Disordered Region (DISEMBL)
****************************PLPRR********************QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV
Disordered Region (DISPRO)
***********************************************************PILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALK*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	366	2.2.26 [Sep-21-2011]
Q8RWL2	534	Calcium-dependent protein	yes	no	0.997	0.683	0.746	1e-158
P53683	533	Calcium-dependent protein	yes	no	0.991	0.681	0.660	1e-145
Q9C6P3	521	Calcium-dependent protein	no	no	0.912	0.641	0.715	1e-145
Q38868	541	Calcium-dependent protein	no	no	0.994	0.672	0.632	1e-144
P49101	513	Calcium-dependent protein	N/A	no	0.836	0.596	0.754	1e-142
P28582	532	Calcium-dependent protein	N/A	no	0.836	0.575	0.745	1e-141
Q9ZSA2	531	Calcium-dependent protein	no	no	0.918	0.632	0.68	1e-137
Q3E9C0	523	Calcium-dependent protein	no	no	0.986	0.690	0.617	1e-134
Q9FMP5	528	Calcium-dependent protein	no	no	0.989	0.685	0.605	1e-134
O49717	554	Calcium-dependent protein	no	no	0.956	0.631	0.624	1e-132

>sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2

 Score =  558 bits (1439), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 282/378 (74%), Positives = 315/378 (83%), Gaps = 13/378 (3%)

Query: 1   MGLCFTR---SRSHDIPISSSSDESPHHRYQPLPRRT---QQDFRPTSSRPPALSK---- 50
           MG CF++   S++H+IPISSSSD SP H YQPLP+ T    Q   PTS+  P        
Sbjct: 1   MGFCFSKFGKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPTSNPQPKPKPAPPP 60

Query: 51  --QIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
                  SQIGPIL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RK
Sbjct: 61  PPSTSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRK 120

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           L+  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG 
Sbjct: 121 LIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGS 180

Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           YSE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE G
Sbjct: 181 YSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEG 240

Query: 229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
           KVY++IVGSAYYVAPEVLH+ YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG
Sbjct: 241 KVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEG 300

Query: 289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
            LDL++SPWP+IS  AKDLIRKML +DPKKRITAAEALEHPW+  D   SDKPI+SAVL 
Sbjct: 301 KLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMT-DTKISDKPINSAVLV 359

Query: 349 RMKQFRAMNKMKKLALKV 366
           RMKQFRAMNK+KKLALKV
Sbjct: 360 RMKQFRAMNKLKKLALKV 377

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2

 Score =  515 bits (1326), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 251/380 (66%), Positives = 296/380 (77%), Gaps = 17/380 (4%)

Query: 1   MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQT----- 55
           MG C +R+ S D     ++     H  Q  P +T   +      PPA  +  P       
Sbjct: 1   MGSCCSRATSPDSGRGGANGYGYSH--QTKPAQTTPSYNHPQPPPPAEVRYTPSAMNPPV 58

Query: 56  ---------SQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISR 106
                         ILGKPY D+ ++Y L KELGRGQFGVTYLCT+ A+G++YACKSIS+
Sbjct: 59  VPPVVAPPKPTPDTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKSISK 118

Query: 107 RKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK 166
           RKLV   D ED+RREI I+QHL+GQ NIVEF GAYEDK N+H+VMELC+GGELFDRIIAK
Sbjct: 119 RKLVSKADKEDIRREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAK 178

Query: 167 GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE 226
           G YSER AA ICR +VNVV+ CHFMGV+HRDLKPENFLLA+KEE++ +KATDFGLSVFIE
Sbjct: 179 GHYSERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSVFIE 238

Query: 227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL 286
            GK+Y++IVGSAYYVAPEVL + YGKEIDVWSAGVILYILLSGVPPFWAETEKGIF+AIL
Sbjct: 239 EGKMYRDIVGSAYYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 298

Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
           +G +D +S PWPSIS  AKDL+RKMLT+DPKKRIT+A+ L+HPWL+ DG  SDKPIDSAV
Sbjct: 299 QGEIDFESQPWPSISESAKDLVRKMLTQDPKKRITSAQVLQHPWLR-DGEASDKPIDSAV 357

Query: 347 LTRMKQFRAMNKMKKLALKV 366
           L+RMKQFRAMNK+KK+ALKV
Sbjct: 358 LSRMKQFRAMNKLKKMALKV 377

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1

 Score =  513 bits (1321), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 242/338 (71%), Positives = 289/338 (85%), Gaps = 4/338 (1%)

Query: 32  RRTQQD---FRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTY 88
           R T QD       +++PP   +   + S    IL KPY D+   Y L KELGRGQFGVTY
Sbjct: 30  RSTHQDPSKISTGTNQPPPW-RNPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTY 88

Query: 89  LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH 148
           LCT+K+TG+++ACKSIS++KLV   D ED+RREI I+QHL+GQPNIVEF+GAYED++ ++
Sbjct: 89  LCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVN 148

Query: 149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK 208
           LVMELC+GGELFDRI+AKG YSER AA++CRQIVNVV+ CHFMGV+HRDLKPENFLL+SK
Sbjct: 149 LVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSK 208

Query: 209 EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLS 268
           +E + IKATDFGLSVFIE G+VYK+IVGSAYYVAPEVL +RYGKEID+WSAG+ILYILLS
Sbjct: 209 DEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLS 268

Query: 269 GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
           GVPPFWAETEKGIF+AILEG +D +S PWPSIS  AKDL+R+MLT+DPK+RI+AAE L+H
Sbjct: 269 GVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKH 328

Query: 329 PWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           PWL+E G  SDKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct: 329 PWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 366

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1

 Score =  510 bits (1313), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 244/386 (63%), Positives = 299/386 (77%), Gaps = 22/386 (5%)

Query: 1   MGLCFTRSR-----------SHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALS 49
           MG CF ++            +  + +  ++ + P   Y P  R TQQ  +P S       
Sbjct: 1   MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPS--YTPQARTTQQPEKPGSVNSQPPP 58

Query: 50  KQI---------PQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYA 100
            +            T++   IL   + D+   Y L KELGRGQFGVTYLCT+ +TG+KYA
Sbjct: 59  WRAAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYA 118

Query: 101 CKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELF 160
           CKSIS++KLV   D +D+RREI I+QHL+GQPNIVEF+GAYED++ ++LVMELC+GGELF
Sbjct: 119 CKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELF 178

Query: 161 DRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG 220
           DRIIAKG Y+ER AA++CRQIVNVV  CHFMGV+HRDLKPENFLL+SK+E + IKATDFG
Sbjct: 179 DRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFG 238

Query: 221 LSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG 280
           LSVFIE GKVY++IVGSAYYVAPEVL +RYGKE+D+WSAG+ILYILLSGVPPFWAETEKG
Sbjct: 239 LSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKG 298

Query: 281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
           IF+AILEG++D +S PWPSIS  AKDL+R+MLT DPK+RI+AA+ L+HPWL+E G  SDK
Sbjct: 299 IFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDK 358

Query: 341 PIDSAVLTRMKQFRAMNKMKKLALKV 366
           PIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct: 359 PIDSAVLSRMKQFRAMNKLKKLALKV 384

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 231/306 (75%), Positives = 269/306 (87%)

Query: 61  ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR 120
           ILGK Y D+ ++Y   KELGRGQFGVTYLCT+ A+GR+YACKSIS+RKLV   D ED+RR
Sbjct: 53  ILGKQYEDVRSVYSFGKELGRGQFGVTYLCTEIASGRQYACKSISKRKLVSKADREDIRR 112

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
           EI I+QHL+GQPNIVEF GAYEDK N+H+VMELC+GGELFDRIIAKG Y+ER AA ICR 
Sbjct: 113 EIQIMQHLSGQPNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYTERAAATICRA 172

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
           +VNVV+ CHFMGV+HRDLKPENFLLA+ EE++ +KATDFGLSVFIE GK+Y++IVGSAYY
Sbjct: 173 VVNVVNICHFMGVMHRDLKPENFLLATMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYY 232

Query: 241 VAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           VAPEVL + YGKEIDVWSAGVILYILLSGVPPFWAE EKGIF+AIL   +D +S PWPSI
Sbjct: 233 VAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSI 292

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           S  AKDL+RKMLT+DPKKR+T+A+ L+H WL+E G  SDKPIDSAVL+RMKQFRAMNK+K
Sbjct: 293 SESAKDLVRKMLTRDPKKRLTSAQVLQHQWLREGGEASDKPIDSAVLSRMKQFRAMNKLK 352

Query: 361 KLALKV 366
           K+ALKV
Sbjct: 353 KMALKV 358

May play a role in signal transduction pathways that involve calcium as a second messenger.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2

 Score =  500 bits (1287), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 228/306 (74%), Positives = 269/306 (87%)

Query: 61  ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR 120
           ILGKP+ DI   Y L KELGRGQFG  Y CT+ ++G+ YACKSI +RKLV   D ED++R
Sbjct: 69  ILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKLVSKNDKEDIKR 128

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
           EI ILQHL+GQPNIVEF+G +ED+Q++HLVMELC+GGELFDRIIA+G YSER AA ICRQ
Sbjct: 129 EIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHYSERAAATICRQ 188

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
           IVNVVH CHFMGV+HRDLKPENFLL+SK++D+ +KATDFGLSVFIE GKVY+ IVGSAYY
Sbjct: 189 IVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGKVYRNIVGSAYY 248

Query: 241 VAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           VAPEVL + YGKEID+WSAGVILYILLSGVPPFWAE EKGIF+AILEG +D +S PWPS+
Sbjct: 249 VAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGVIDFESEPWPSV 308

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           S  AKDL+RKMLT+DP++RIT+A+ L+HPW++E G  SDKPIDSAVL+RMKQFRAMNK+K
Sbjct: 309 SNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSRMKQFRAMNKLK 368

Query: 361 KLALKV 366
           +LALKV
Sbjct: 369 QLALKV 374

May play a role in signal transduction pathways that involve calcium as a second messenger.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1

 Score =  488 bits (1255), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 238/350 (68%), Positives = 280/350 (80%), Gaps = 14/350 (4%)

Query: 23  PHHRY------QPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLD 76
           P HR       +P+ +   Q     SS P  +S + P T     ILGKP+ DI   Y L 
Sbjct: 31  PEHRKPQTPTPKPMTQPIHQQISTPSSNP--VSVRDPDT-----ILGKPFEDIRKFYSLG 83

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELGRGQFG+TY+C +  TG  YACKSI +RKL+  +D EDV+REI I+Q+L+GQPNIVE
Sbjct: 84  KELGRGQFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVE 143

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            +GAYED+Q++HLVMELC+GGELFDRIIA+G YSER AA I R IVNVV  CHFMGV+HR
Sbjct: 144 IKGAYEDRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHR 203

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDV 256
           DLKPENFLL+SKEE++ +KATDFGLSVFIE GKVY++IVGSAYYVAPEVL + YGKEID+
Sbjct: 204 DLKPENFLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDI 263

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WSAGVILYILLSGVPPFWAE EKGIF+ +++G +D  S PWPSIS  AKDL+RKMLTKDP
Sbjct: 264 WSAGVILYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDP 323

Query: 317 KKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           K+RITAA+ LEHPW+K  G   DKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct: 324 KRRITAAQVLEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 372

May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  478 bits (1230), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 226/366 (61%), Positives = 281/366 (76%), Gaps = 5/366 (1%)

Query: 1   MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGP 60
           MG C +  R  D        E+            +    P +S PPA +KQ P    IGP
Sbjct: 1   MGNCCSHGRDSDDNKEEPRPENGGGGVGAAEASVRASKHPPASPPPA-TKQGP----IGP 55

Query: 61  ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR 120
           +LG+P  D+ + Y L KELGRGQFGVT+LCT+KATG ++ACK+I++RKLV  +D+EDVRR
Sbjct: 56  VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
           E+ I+ HLTGQPNIVE +GAYEDK ++HLVMELC+GGELFDRIIAKG YSER AA++ R 
Sbjct: 116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
           IV ++H CH MGVIHRDLKPENFLL SK+E+SP+KATDFGLSVF + G+V+K+IVGSAYY
Sbjct: 176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query: 241 VAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           +APEVL ++YG E D+WS GV+LYILL GVPPFWAE+E GIF AIL G +D  S PWP I
Sbjct: 236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           S QAKDL+RKML  DPK+R+TAA+ L HPW+KEDG   D P+D+AV++R+KQF+AMN  K
Sbjct: 296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355

Query: 361 KLALKV 366
           K+AL+V
Sbjct: 356 KVALRV 361

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  477 bits (1228), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 224/370 (60%), Positives = 284/370 (76%), Gaps = 8/370 (2%)

Query: 1   MGLCFTRSR----SHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTS 56
           MG C +  R    + D   + +S  +  +   P    +    +     PP  +KQ P   
Sbjct: 1   MGNCCSHGRDSADNGDALENGASASNAANSTGPTAEASVPQSKHAPPSPPPATKQGP--- 57

Query: 57  QIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME 116
            IGP+LG+P  D+   Y L KELGRGQFGVT+LCT+KATG ++ACK+I++RKLV  +D+E
Sbjct: 58  -IGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIE 116

Query: 117 DVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN 176
           DVRRE+ I+ HLTGQPNIVE +GAYEDK ++HLVMELC+GGELFDRIIAKG YSER AA+
Sbjct: 117 DVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAAS 176

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG 236
           + R IV +VH CH MGVIHRDLKPENFLL +K+E+SP+KATDFGLSVF + G+V+K+IVG
Sbjct: 177 LLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVG 236

Query: 237 SAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
           SAYY+APEVL ++YG E D+WS GV+LYILL GVPPFWAE+E GIF AIL G++D  S P
Sbjct: 237 SAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDP 296

Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAM 356
           WPSIS QAKDL++KML  DPK+R+TAA+ L HPW+KEDG   D P+D+AV++R+KQF+AM
Sbjct: 297 WPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAM 356

Query: 357 NKMKKLALKV 366
           N  KK+AL+V
Sbjct: 357 NNFKKVALRV 366

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1

 Score =  471 bits (1213), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 223/357 (62%), Positives = 280/357 (78%), Gaps = 7/357 (1%)

Query: 10  SHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDI 69
           S  IP ++ S+       +P+ ++ ++    T    P + ++         ILGKP+ +I
Sbjct: 45  SPQIPTTTQSNHHHQQESKPVNQQIEKKHVLTQPLKPIVFRETE------TILGKPFEEI 98

Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             +Y L KELGRGQFG+TY C + +TG  YACKSI +RKL   +D++DV+REI I+Q+L+
Sbjct: 99  RKLYTLGKELGRGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDVKREIQIMQYLS 158

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
           GQ NIVE +GAYED+Q++HLVMELC G ELFDRIIA+G YSE+ AA + R ++NVV  CH
Sbjct: 159 GQENIVEIKGAYEDRQSIHLVMELCGGSELFDRIIAQGHYSEKAAAGVIRSVLNVVQICH 218

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
           FMGVIHRDLKPENFLLAS +E++ +KATDFGLSVFIE GKVY++IVGSAYYVAPEVL + 
Sbjct: 219 FMGVIHRDLKPENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRS 278

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           YGKEID+WSAG+ILYILL GVPPFW+ETEKGIF  I++G +D  S PWPSIS  AKDL+R
Sbjct: 279 YGKEIDIWSAGIILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWPSISESAKDLVR 338

Query: 310 KMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           K+LTKDPK+RI+AA+ALEHPW++  G   DKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct: 339 KLLTKDPKQRISAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 394

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
255539058	529	calcium-dependent protein kinase, putati	0.986	0.682	0.786	1e-169
224083155	513	calcium dependent protein kinase 27 [Pop	1.0	0.713	0.760	1e-162
359492038	529	PREDICTED: calcium-dependent protein kin	0.983	0.680	0.726	1e-157
359492036	523	PREDICTED: calcium-dependent protein kin	0.983	0.688	0.726	1e-157
79607733	561	calcium-dependent protein kinase 29 [Ara	0.997	0.650	0.746	1e-157
223635142	534	RecName: Full=Calcium-dependent protein	0.997	0.683	0.746	1e-156
6721111	980	T4O12.25 [Arabidopsis thaliana]	0.997	0.372	0.746	1e-156
147778668	548	hypothetical protein VITISV_026712 [Viti	0.983	0.656	0.721	1e-156
356553339	526	PREDICTED: calcium-dependent protein kin	0.980	0.682	0.706	1e-152
297839485	930	T4O12.25 [Arabidopsis lyrata subsp. lyra	0.997	0.392	0.740	1e-151

>gi|255539058|ref|XP_002510594.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223551295|gb|EEF52781.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 298/379 (78%), Positives = 321/379 (84%), Gaps = 18/379 (4%)

Query: 1   MGLCFTR--SRSHDIPISSSSDESPHHRYQPLPRRT-QQDFRP----------TSSRPPA 47
           MGLCFT+  SRSHDI ISS+SD SP H YQ  P+R  QQ +            TS  PP 
Sbjct: 1   MGLCFTKFHSRSHDITISSASD-SPPHPYQSQPKRPPQQRYHNPPPPYNPRPRTSQAPPP 59

Query: 48  LSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRR 107
            S      S IGPILGKPYVDI +IYDLDKELGRGQFG+TYLCT+K TG KYACKSISRR
Sbjct: 60  TS----SASNIGPILGKPYVDIASIYDLDKELGRGQFGITYLCTEKTTGLKYACKSISRR 115

Query: 108 KLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG 167
           KLV DKD+EDVRREILILQHLTGQPNIVEF+GAYED+QNLHLVMELCSGGELFDRIIAKG
Sbjct: 116 KLVNDKDVEDVRREILILQHLTGQPNIVEFKGAYEDRQNLHLVMELCSGGELFDRIIAKG 175

Query: 168 IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET 227
            Y+EREAA I RQIVNVVHACHFMGVIHRDLKPENFLL SK EDSP+KATDFGLSVFIE 
Sbjct: 176 TYTEREAATITRQIVNVVHACHFMGVIHRDLKPENFLLVSKAEDSPLKATDFGLSVFIEE 235

Query: 228 GKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
           G VYK+IVGSAYYVAPEVL++ YGKE+DVWSAG+ILYILLSGVPPFW E EKGIFEAI++
Sbjct: 236 GVVYKDIVGSAYYVAPEVLNRSYGKEVDVWSAGIILYILLSGVPPFWGENEKGIFEAIIK 295

Query: 288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVL 347
           G LDLQSSPWP IS  AKDLIRKML +DPKKRITAAEALEHPWLK  G  S+KPIDSAVL
Sbjct: 296 GQLDLQSSPWPKISASAKDLIRKMLARDPKKRITAAEALEHPWLKVGGEASEKPIDSAVL 355

Query: 348 TRMKQFRAMNKMKKLALKV 366
            R+KQFRAMNK+KKLALKV
Sbjct: 356 RRLKQFRAMNKLKKLALKV 374

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224083155|ref|XP_002306955.1| calcium dependent protein kinase 27 [Populus trichocarpa] gi|222856404|gb|EEE93951.1| calcium dependent protein kinase 27 [Populus trichocarpa]

 Score =  578 bits (1489), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 279/367 (76%), Positives = 311/367 (84%), Gaps = 1/367 (0%)

Query: 1   MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQI-PQTSQIG 59
           MG CF+RS SHDIPISSSSD++ +    P            SS+    S+ I   +S IG
Sbjct: 1   MGKCFSRSCSHDIPISSSSDDAYYQPTPPKRPPLPPTLTTPSSKTSGTSQTIVTSSSNIG 60

Query: 60  PILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR 119
           PILGKPYV+ITTIYDLDKELGRGQFG+TYLCT+KA+GR YACKSISRRKLV  KD+EDV+
Sbjct: 61  PILGKPYVEITTIYDLDKELGRGQFGITYLCTEKASGRMYACKSISRRKLVKVKDIEDVK 120

Query: 120 REILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           REILILQHLTGQPNIVEF+GAYEDKQNLHL+MELCSGGELFDRI+AKG YSE EAA I R
Sbjct: 121 REILILQHLTGQPNIVEFKGAYEDKQNLHLIMELCSGGELFDRILAKGSYSESEAATIIR 180

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           QIVNVVHACHFMGV+HRDLKPENFLLASK+ ++ IKATDFGLSVFIE GKVY +IVGS+Y
Sbjct: 181 QIVNVVHACHFMGVMHRDLKPENFLLASKDPNALIKATDFGLSVFIEEGKVYNDIVGSSY 240

Query: 240 YVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           YVAPEVL + YGKEIDVWSAG+ILYILLSGVPPFWAE EKGI+EAIL GNLDLQS PWP 
Sbjct: 241 YVAPEVLKRSYGKEIDVWSAGIILYILLSGVPPFWAEAEKGIYEAILNGNLDLQSKPWPK 300

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKM 359
           IS  AKDLI+KMLT+DPK RITAA+AL+HPW+K  G  S+  IDS VL RMKQFRAMNK+
Sbjct: 301 ISPSAKDLIKKMLTRDPKSRITAAQALDHPWMKVGGEASNTLIDSVVLIRMKQFRAMNKL 360

Query: 360 KKLALKV 366
           KKLALKV
Sbjct: 361 KKLALKV 367

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492038|ref|XP_003634354.1| PREDICTED: calcium-dependent protein kinase 29-like isoform 2 [Vitis vinifera]

 Score =  560 bits (1443), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 271/373 (72%), Positives = 315/373 (84%), Gaps = 13/373 (3%)

Query: 1   MGLCFTRSRSHDIPISS----SSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQ-- 54
           MG CF+R R  DIPISS      D + HH YQP+P  + ++   +   PP LS  +P+  
Sbjct: 1   MGFCFSRPR--DIPISSSSSSDGDFTNHH-YQPIPISSSKE---SLDIPPPLSMSVPKPP 54

Query: 55  -TSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
            +SQIG +LG+P  +IT+IYD+ KELGRGQFG+TYLCT+K+TG KYACKSIS+RKL   K
Sbjct: 55  TSSQIGTVLGRPLCEITSIYDIGKELGRGQFGITYLCTEKSTGLKYACKSISKRKLKSGK 114

Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE 173
           D+EDV+REILIL+HLTGQPNIVEF+GAYEDKQNLHLVMELCSGGELFDRI AKG YSERE
Sbjct: 115 DIEDVKREILILEHLTGQPNIVEFKGAYEDKQNLHLVMELCSGGELFDRITAKGSYSERE 174

Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
           AA+ICRQIV VVH CHFMGV+HRDLKPENFL+ S+EE+SP+KATDFGLSVFIE  +VYK+
Sbjct: 175 AADICRQIVTVVHVCHFMGVMHRDLKPENFLMVSREENSPLKATDFGLSVFIEDNEVYKD 234

Query: 234 IVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           +VGSAYYVAPEVL + YGKEIDVWSAGVILYILLSGVPPFW E EK IF+A+L+G +D  
Sbjct: 235 VVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWGENEKSIFDAVLQGYVDFD 294

Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF 353
           S+PWPSIS  AKDLI+KML KDPK+RITA++AL HPWL+EDG  SDKPIDSAVL RMKQF
Sbjct: 295 SAPWPSISSSAKDLIKKMLMKDPKRRITASDALNHPWLREDGEASDKPIDSAVLVRMKQF 354

Query: 354 RAMNKMKKLALKV 366
           RAMNK+KKLALKV
Sbjct: 355 RAMNKLKKLALKV 367

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492036|ref|XP_002284750.2| PREDICTED: calcium-dependent protein kinase 29-like isoform 1 [Vitis vinifera] gi|302141719|emb|CBI18922.3| unnamed protein product [Vitis vinifera]

 Score =  560 bits (1443), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 271/373 (72%), Positives = 315/373 (84%), Gaps = 13/373 (3%)

Query: 1   MGLCFTRSRSHDIPISS----SSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQ-- 54
           MG CF+R R  DIPISS      D + HH YQP+P  + ++   +   PP LS  +P+  
Sbjct: 1   MGFCFSRPR--DIPISSSSSSDGDFTNHH-YQPIPISSSKE---SLDIPPPLSMSVPKPP 54

Query: 55  -TSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
            +SQIG +LG+P  +IT+IYD+ KELGRGQFG+TYLCT+K+TG KYACKSIS+RKL   K
Sbjct: 55  TSSQIGTVLGRPLCEITSIYDIGKELGRGQFGITYLCTEKSTGLKYACKSISKRKLKSGK 114

Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE 173
           D+EDV+REILIL+HLTGQPNIVEF+GAYEDKQNLHLVMELCSGGELFDRI AKG YSERE
Sbjct: 115 DIEDVKREILILEHLTGQPNIVEFKGAYEDKQNLHLVMELCSGGELFDRITAKGSYSERE 174

Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
           AA+ICRQIV VVH CHFMGV+HRDLKPENFL+ S+EE+SP+KATDFGLSVFIE  +VYK+
Sbjct: 175 AADICRQIVTVVHVCHFMGVMHRDLKPENFLMVSREENSPLKATDFGLSVFIEDNEVYKD 234

Query: 234 IVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           +VGSAYYVAPEVL + YGKEIDVWSAGVILYILLSGVPPFW E EK IF+A+L+G +D  
Sbjct: 235 VVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWGENEKSIFDAVLQGYVDFD 294

Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF 353
           S+PWPSIS  AKDLI+KML KDPK+RITA++AL HPWL+EDG  SDKPIDSAVL RMKQF
Sbjct: 295 SAPWPSISSSAKDLIKKMLMKDPKRRITASDALNHPWLREDGEASDKPIDSAVLVRMKQF 354

Query: 354 RAMNKMKKLALKV 366
           RAMNK+KKLALKV
Sbjct: 355 RAMNKLKKLALKV 367

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|79607733|ref|NP_974150.2| calcium-dependent protein kinase 29 [Arabidopsis thaliana] gi|332197666|gb|AEE35787.1| calcium-dependent protein kinase 29 [Arabidopsis thaliana]

 Score =  559 bits (1441), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 282/378 (74%), Positives = 315/378 (83%), Gaps = 13/378 (3%)

Query: 1   MGLCFTR---SRSHDIPISSSSDESPHHRYQPLPRRT---QQDFRPTSSRPPALSK---- 50
           MG CF++   S++H+IPISSSSD SP H YQPLP+ T    Q   PTS+  P        
Sbjct: 28  MGFCFSKFGKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPTSNPQPKPKPAPPP 87

Query: 51  --QIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
                  SQIGPIL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RK
Sbjct: 88  PPSTSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRK 147

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           L+  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG 
Sbjct: 148 LIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGS 207

Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           YSE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE G
Sbjct: 208 YSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEG 267

Query: 229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
           KVY++IVGSAYYVAPEVLH+ YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG
Sbjct: 268 KVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEG 327

Query: 289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
            LDL++SPWP+IS  AKDLIRKML +DPKKRITAAEALEHPW+  D   SDKPI+SAVL 
Sbjct: 328 KLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMT-DTKISDKPINSAVLV 386

Query: 349 RMKQFRAMNKMKKLALKV 366
           RMKQFRAMNK+KKLALKV
Sbjct: 387 RMKQFRAMNKLKKLALKV 404

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|223635142|sp|Q8RWL2.2|CDPKT_ARATH RecName: Full=Calcium-dependent protein kinase 29

 Score =  558 bits (1439), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 282/378 (74%), Positives = 315/378 (83%), Gaps = 13/378 (3%)

Query: 1   MGLCFTR---SRSHDIPISSSSDESPHHRYQPLPRRT---QQDFRPTSSRPPALSK---- 50
           MG CF++   S++H+IPISSSSD SP H YQPLP+ T    Q   PTS+  P        
Sbjct: 1   MGFCFSKFGKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPTSNPQPKPKPAPPP 60

Query: 51  --QIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
                  SQIGPIL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RK
Sbjct: 61  PPSTSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRK 120

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           L+  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG 
Sbjct: 121 LIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGS 180

Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           YSE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE G
Sbjct: 181 YSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEG 240

Query: 229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
           KVY++IVGSAYYVAPEVLH+ YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG
Sbjct: 241 KVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEG 300

Query: 289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
            LDL++SPWP+IS  AKDLIRKML +DPKKRITAAEALEHPW+  D   SDKPI+SAVL 
Sbjct: 301 KLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMT-DTKISDKPINSAVLV 359

Query: 349 RMKQFRAMNKMKKLALKV 366
           RMKQFRAMNK+KKLALKV
Sbjct: 360 RMKQFRAMNKLKKLALKV 377

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|6721111|gb|AAF26765.1|AC007396_14 T4O12.25 [Arabidopsis thaliana]

 Score =  558 bits (1439), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 282/378 (74%), Positives = 315/378 (83%), Gaps = 13/378 (3%)

Query: 1   MGLCFTR---SRSHDIPISSSSDESPHHRYQPLPRRT---QQDFRPTSSRPPALSK---- 50
           MG CF++   S++H+IPISSSSD SP H YQPLP+ T    Q   PTS+  P        
Sbjct: 28  MGFCFSKFGKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPTSNPQPKPKPAPPP 87

Query: 51  --QIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
                  SQIGPIL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RK
Sbjct: 88  PPSTSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRK 147

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           L+  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG 
Sbjct: 148 LIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGS 207

Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           YSE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE G
Sbjct: 208 YSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEG 267

Query: 229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
           KVY++IVGSAYYVAPEVLH+ YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG
Sbjct: 268 KVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEG 327

Query: 289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
            LDL++SPWP+IS  AKDLIRKML +DPKKRITAAEALEHPW+  D   SDKPI+SAVL 
Sbjct: 328 KLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMT-DTKISDKPINSAVLV 386

Query: 349 RMKQFRAMNKMKKLALKV 366
           RMKQFRAMNK+KKLALKV
Sbjct: 387 RMKQFRAMNKLKKLALKV 404

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147778668|emb|CAN67210.1| hypothetical protein VITISV_026712 [Vitis vinifera]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 269/373 (72%), Positives = 313/373 (83%), Gaps = 13/373 (3%)

Query: 1   MGLCFTRSRSHDIPISS----SSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQ-- 54
           MG CF+R R  DIPISS      D + HH YQP+P  + ++   +   PP LS  +P+  
Sbjct: 1   MGFCFSRPR--DIPISSSSSSDGDFTNHH-YQPIPISSSKE---SLDIPPPLSMSVPKPP 54

Query: 55  -TSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
            +SQIG +LG+P  +IT+IYD+ KELGRGQFG+TYLCT+K+TG KYACKSIS+RKL   K
Sbjct: 55  TSSQIGTVLGRPLCEITSIYDIGKELGRGQFGITYLCTEKSTGLKYACKSISKRKLKSGK 114

Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE 173
           D+ED +REILIL+HLTGQPNIVEF+GAYEDKQNLHLVMELCSGGELFDRI AKG YSERE
Sbjct: 115 DIEDXKREILILEHLTGQPNIVEFKGAYEDKQNLHLVMELCSGGELFDRITAKGSYSERE 174

Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
           AA+ICRQIV VVH CHFMGV+HRDLKPENFL+ S+EE+SP+KATDFGLSVFIE  +VY +
Sbjct: 175 AADICRQIVTVVHVCHFMGVMHRDLKPENFLMVSREENSPLKATDFGLSVFIEDNEVYTD 234

Query: 234 IVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           +VGSAYYVAPEVL + YGKEIDVWSAGVILYILLSGVPPFW E EK IF+A+L+G +D  
Sbjct: 235 VVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWGENEKSIFDAVLQGYVDFD 294

Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF 353
           S+PWPSIS  AKDLI+KML KDPK+RITA++AL HPWL+EDG  SDKPIDSAVL RMKQF
Sbjct: 295 SAPWPSISSSAKDLIKKMLMKDPKRRITASDALNHPWLREDGEASDKPIDSAVLVRMKQF 354

Query: 354 RAMNKMKKLALKV 366
           RAMNK+KKLALKV
Sbjct: 355 RAMNKLKKLALKV 367

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553339|ref|XP_003545014.1| PREDICTED: calcium-dependent protein kinase 29-like isoform 2 [Glycine max]

 Score =  545 bits (1403), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 265/375 (70%), Positives = 305/375 (81%), Gaps = 16/375 (4%)

Query: 1   MGL-----CFTRSRSHDIPISSSSDESPHH----RYQPLPRRTQQDFRPTSSRPPALSKQ 51
           MGL      F  S+ H+I I+ S D SP H      +P P+       P ++   + +KQ
Sbjct: 1   MGLGMFKALFCCSKPHEIDIADSWDSSPDHTPKQHSKPKPK-------PNAAPTHSNNKQ 53

Query: 52  IPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY 111
              ++QIG ILGKPYV+I  +Y++ KELG GQ GVTYLC +K T R+YACKSISR KL+ 
Sbjct: 54  TTTSTQIGAILGKPYVNIHQMYEMKKELGSGQSGVTYLCVEKTTKREYACKSISRSKLLS 113

Query: 112 DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE 171
            +++EDVRRE++ILQHL+GQPNIVEF GAYEDKQN+HLVMELCSGGELFDRIIAKG YSE
Sbjct: 114 TQEIEDVRREVMILQHLSGQPNIVEFRGAYEDKQNVHLVMELCSGGELFDRIIAKGNYSE 173

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           REAA + RQIVNVVHACHFMGV+HRDLKPENFLLA+K+  +P+KATDFGLSVFIE G VY
Sbjct: 174 REAATVMRQIVNVVHACHFMGVMHRDLKPENFLLANKDPKAPLKATDFGLSVFIEEGIVY 233

Query: 232 KEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD 291
           +EIVGSAYYVAPEVL + YGKEIDVWSAG+ILYILLSGVPPFW E E+ IFEAIL G LD
Sbjct: 234 REIVGSAYYVAPEVLKRNYGKEIDVWSAGIILYILLSGVPPFWGENERSIFEAILGGKLD 293

Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMK 351
           L+S+PWPSIS  AKDLIRKML  DPKKRITAAEALEHPW+KE G  SDKP+D+AVLTRMK
Sbjct: 294 LESAPWPSISAAAKDLIRKMLNNDPKKRITAAEALEHPWMKEGGEASDKPLDNAVLTRMK 353

Query: 352 QFRAMNKMKKLALKV 366
           QFRAMNKMKKLALKV
Sbjct: 354 QFRAMNKMKKLALKV 368

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297839485|ref|XP_002887624.1| T4O12.25 [Arabidopsis lyrata subsp. lyrata] gi|297333465|gb|EFH63883.1| T4O12.25 [Arabidopsis lyrata subsp. lyrata]

 Score =  541 bits (1395), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 279/377 (74%), Positives = 311/377 (82%), Gaps = 12/377 (3%)

Query: 1   MGLCFTR---SRSHDIPISSSSDESPHHRYQPLPRRT---QQDFRPTSSRPPALSKQIPQ 54
           MG CF++   S++H+IPISSSSD SP H YQPLP+ T    Q   P S+  P      P 
Sbjct: 1   MGFCFSKFCKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPASNPQPKPKPAPPP 60

Query: 55  TSQIGP-----ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL 109
            S         IL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RKL
Sbjct: 61  PSSSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKL 120

Query: 110 VYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY 169
           +  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG Y
Sbjct: 121 IRRKDIEDVRREVIILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSY 180

Query: 170 SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK 229
           SE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE GK
Sbjct: 181 SEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGK 240

Query: 230 VYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN 289
           VY++IVGSAYYVAPEVL + YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG 
Sbjct: 241 VYRDIVGSAYYVAPEVLQRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGK 300

Query: 290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTR 349
           LDL++SPWP+IS  AKDLIRKMLT+DPKKRITAAEALEHPW+  D   SDKPIDSAVL R
Sbjct: 301 LDLETSPWPTISESAKDLIRKMLTRDPKKRITAAEALEHPWMT-DIKISDKPIDSAVLIR 359

Query: 350 MKQFRAMNKMKKLALKV 366
           MKQFRAMNK+KKLALKV
Sbjct: 360 MKQFRAMNKLKKLALKV 376

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	366
TAIR|locus:2204340	561	CPK29 "calcium-dependent prote	0.997	0.650	0.719	4.3e-141
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.912	0.641	0.718	5.7e-130
TAIR|locus:2092399	541	CPK9 "calmodulin-domain protei	0.928	0.628	0.699	1.5e-129
TAIR|locus:2138897	531	CPK21 "calcium-dependent prote	0.904	0.623	0.693	1.9e-124
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.879	0.615	0.672	1.7e-121
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.890	0.617	0.662	2.8e-121
TAIR|locus:2036783	551	CPK19 "calcium-dependent prote	0.907	0.602	0.653	1.8e-117
TAIR|locus:2128409	529	CDPK6 "calcium-dependent prote	0.868	0.601	0.654	9.1e-116
TAIR|locus:2075885	646	CPK2 "calmodulin-domain protei	0.909	0.515	0.596	4.3e-111
TAIR|locus:2175503	610	CPK1 "calcium dependent protei	0.926	0.555	0.583	3e-108

TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1380 (490.8 bits), Expect = 4.3e-141, P = 4.3e-141
 Identities = 272/378 (71%), Positives = 302/378 (79%)

Query:     1 MGLCFTXXXXXXXXXXXXXXXXXX---HRYQPLPRRTQ---QDFRPTSS---RPPALSKQ 51
             MG CF+                     H YQPLP+ T    Q   PTS+   +P      
Sbjct:    28 MGFCFSKFGKSQTHEIPISSSSDSSPPHHYQPLPKPTVSQGQTSNPTSNPQPKPKPAPPP 87

Query:    52 IPQTS---QIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
              P TS   QIGPIL +P +D++ +YDL KELGRGQFG+TY CT K+ GR+YACKSIS+RK
Sbjct:    88 PPSTSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRK 147

Query:   109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
             L+  KD+EDVRRE++ILQHLTGQPNIVEF GAYEDK NLHLVMELCSGGELFDRII KG 
Sbjct:   148 LIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGS 207

Query:   169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
             YSE+EAANI RQIVNVVH CHFMGV+HRDLKPENFLL S EEDSPIKATDFGLSVFIE G
Sbjct:   208 YSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEG 267

Query:   229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
             KVY++IVGSAYYVAPEVLH+ YGKEIDVWSAGV+LYILLSGVPPFW ETEK IFEAILEG
Sbjct:   268 KVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEG 327

Query:   289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
              LDL++SPWP+IS  AKDLIRKML +DPKKRITAAEALEHPW+  D   SDKPI+SAVL 
Sbjct:   328 KLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMT-DTKISDKPINSAVLV 386

Query:   349 RMKQFRAMNKMKKLALKV 366
             RMKQFRAMNK+KKLALKV
Sbjct:   387 RMKQFRAMNKLKKLALKV 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
 Identities = 243/338 (71%), Positives = 289/338 (85%)

Query:    32 RRTQQDFRPTSS---RPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTY 88
             R T QD    S+   +PP   +   + S    IL KPY D+   Y L KELGRGQFGVTY
Sbjct:    30 RSTHQDPSKISTGTNQPPPW-RNPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTY 88

Query:    89 LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH 148
             LCT+K+TG+++ACKSIS++KLV   D ED+RREI I+QHL+GQPNIVEF+GAYED++ ++
Sbjct:    89 LCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVN 148

Query:   149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK 208
             LVMELC+GGELFDRI+AKG YSER AA++CRQIVNVV+ CHFMGV+HRDLKPENFLL+SK
Sbjct:   149 LVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSK 208

Query:   209 EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLS 268
             +E + IKATDFGLSVFIE G+VYK+IVGSAYYVAPEVL +RYGKEID+WSAG+ILYILLS
Sbjct:   209 DEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLS 268

Query:   269 GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
             GVPPFWAETEKGIF+AILEG +D +S PWPSIS  AKDL+R+MLT+DPK+RI+AAE L+H
Sbjct:   269 GVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKH 328

Query:   329 PWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             PWL+E G  SDKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct:   329 PWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
 Identities = 244/349 (69%), Positives = 294/349 (84%)

Query:    27 YQPLPRRTQQDFRPTS--SRPP-----ALSKQI-PQTS-QIGPILGKPYVDITTIYDLDK 77
             Y P  R TQQ  +P S  S+PP     A +  + P+T+ +   IL   + D+   Y L K
Sbjct:    36 YTPQARTTQQPEKPGSVNSQPPPWRAAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGK 95

Query:    78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
             ELGRGQFGVTYLCT+ +TG+KYACKSIS++KLV   D +D+RREI I+QHL+GQPNIVEF
Sbjct:    96 ELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEF 155

Query:   138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +GAYED++ ++LVMELC+GGELFDRIIAKG Y+ER AA++CRQIVNVV  CHFMGV+HRD
Sbjct:   156 KGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRD 215

Query:   198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVW 257
             LKPENFLL+SK+E + IKATDFGLSVFIE GKVY++IVGSAYYVAPEVL +RYGKE+D+W
Sbjct:   216 LKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIW 275

Query:   258 SAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPK 317
             SAG+ILYILLSGVPPFWAETEKGIF+AILEG++D +S PWPSIS  AKDL+R+MLT DPK
Sbjct:   276 SAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPK 335

Query:   318 KRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             +RI+AA+ L+HPWL+E G  SDKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct:   336 RRISAADVLQHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 1223 (435.6 bits), Expect = 1.9e-124, P = 1.9e-124
 Identities = 235/339 (69%), Positives = 277/339 (81%)

Query:    28 QPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVT 87
             +P+ +   Q     SS P  +S + P T     ILGKP+ DI   Y L KELGRGQFG+T
Sbjct:    42 KPMTQPIHQQISTPSSNP--VSVRDPDT-----ILGKPFEDIRKFYSLGKELGRGQFGIT 94

Query:    88 YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL 147
             Y+C +  TG  YACKSI +RKL+  +D EDV+REI I+Q+L+GQPNIVE +GAYED+Q++
Sbjct:    95 YMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSI 154

Query:   148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS 207
             HLVMELC+GGELFDRIIA+G YSER AA I R IVNVV  CHFMGV+HRDLKPENFLL+S
Sbjct:   155 HLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSS 214

Query:   208 KEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILL 267
             KEE++ +KATDFGLSVFIE GKVY++IVGSAYYVAPEVL + YGKEID+WSAGVILYILL
Sbjct:   215 KEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILL 274

Query:   268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
             SGVPPFWAE EKGIF+ +++G +D  S PWPSIS  AKDL+RKMLTKDPK+RITAA+ LE
Sbjct:   275 SGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLE 334

Query:   328 HPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             HPW+K  G   DKPIDSAVL+RMKQFRAMNK+KKLALKV
Sbjct:   335 HPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 372

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1195 (425.7 bits), Expect = 1.7e-121, P = 1.7e-121
 Identities = 220/327 (67%), Positives = 272/327 (83%)

Query:    40 PTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKY 99
             P +S PPA +KQ P    IGP+LG+P  D+ + Y L KELGRGQFGVT+LCT+KATG ++
Sbjct:    40 PPASPPPA-TKQGP----IGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQF 94

Query:   100 ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL 159
             ACK+I++RKLV  +D+EDVRRE+ I+ HLTGQPNIVE +GAYEDK ++HLVMELC+GGEL
Sbjct:    95 ACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGEL 154

Query:   160 FDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF 219
             FDRIIAKG YSER AA++ R IV ++H CH MGVIHRDLKPENFLL SK+E+SP+KATDF
Sbjct:   155 FDRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDF 214

Query:   220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEK 279
             GLSVF + G+V+K+IVGSAYY+APEVL ++YG E D+WS GV+LYILL GVPPFWAE+E 
Sbjct:   215 GLSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESEN 274

Query:   280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
             GIF AIL G +D  S PWP IS QAKDL+RKML  DPK+R+TAA+ L HPW+KEDG   D
Sbjct:   275 GIFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 334

Query:   340 KPIDSAVLTRMKQFRAMNKMKKLALKV 366
              P+D+AV++R+KQF+AMN  KK+AL+V
Sbjct:   335 VPLDNAVMSRLKQFKAMNNFKKVALRV 361

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
 Identities = 220/332 (66%), Positives = 272/332 (81%)

Query:    35 QQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKA 94
             Q    P S  PP  +KQ P    IGP+LG+P  D+   Y L KELGRGQFGVT+LCT+KA
Sbjct:    41 QSKHAPPS--PPPATKQGP----IGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKA 94

Query:    95 TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC 154
             TG ++ACK+I++RKLV  +D+EDVRRE+ I+ HLTGQPNIVE +GAYEDK ++HLVMELC
Sbjct:    95 TGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELC 154

Query:   155 SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI 214
             +GGELFDRIIAKG YSER AA++ R IV +VH CH MGVIHRDLKPENFLL +K+E+SP+
Sbjct:   155 AGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPL 214

Query:   215 KATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFW 274
             KATDFGLSVF + G+V+K+IVGSAYY+APEVL ++YG E D+WS GV+LYILL GVPPFW
Sbjct:   215 KATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFW 274

Query:   275 AETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
             AE+E GIF AIL G++D  S PWPSIS QAKDL++KML  DPK+R+TAA+ L HPW+KED
Sbjct:   275 AESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKED 334

Query:   335 GATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             G   D P+D+AV++R+KQF+AMN  KK+AL+V
Sbjct:   335 GEAPDVPLDNAVMSRLKQFKAMNNFKKVALRV 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1157 (412.3 bits), Expect = 1.8e-117, P = 1.8e-117
 Identities = 221/338 (65%), Positives = 266/338 (78%)

Query:    29 PLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTY 88
             PLP    Q+ +   +     + Q P+     PILG+P+ DI   Y L +ELGRGQFG+TY
Sbjct:    59 PLPLPQPQEKQKLINHQKQSTLQQPE-----PILGRPFEDIKEKYSLGRELGRGQFGITY 113

Query:    89 LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH 148
             +CT+ ++G+ +ACKSI +RKL+  KD EDVRREI I+ +L+GQPNIVE +GAYED+Q++H
Sbjct:   114 ICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSVH 173

Query:   149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK 208
             LVMELC GGELFD+I  +G YSE+ AA I R +V VV  CHFMGVIHRDLKPENFLL+SK
Sbjct:   174 LVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSSK 233

Query:   209 EE-DSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILL 267
             +E  S +KATDFG+SVFIE GKVY++IVGSAYYVAPEVL + YGK ID+WSAGVILYILL
Sbjct:   234 DEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYILL 293

Query:   268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
              G PPFWAET+KGIFE IL G +D +S PWPSIS  AKDL+R ML  DPKKR TAA+ LE
Sbjct:   294 CGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVLE 353

Query:   328 HPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALK 365
             HPW++E G  SDKPIDSAVL+RMKQ RAMNK+KKLA K
Sbjct:   354 HPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFK 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
 Identities = 208/318 (65%), Positives = 259/318 (81%)

Query:    49 SKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
             S+    T Q G ILG+P  ++   Y+  +ELGRGQFGVTYL T K T ++ ACKSI  R+
Sbjct:    54 SRSTTSTQQNGRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRR 113

Query:   109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
             LV+  D+EDVRRE+ I+ HL+G  NIV+ +GAYED+ +++L+MELC GGELFDRII+KG+
Sbjct:   114 LVHKDDIEDVRREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGL 173

Query:   169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
             YSER AA++CRQ+V VVH+CH MGV+HRDLKPENFL  SK+E+SP+KATDFGLSVF + G
Sbjct:   174 YSERAAADLCRQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPG 233

Query:   229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
               +K++VGSAYYVAPEVL + YG E D+WSAGVILYILLSGVPPFW E E GIF+AIL+G
Sbjct:   234 DKFKDLVGSAYYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQG 293

Query:   289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
              LD  + PWP++S  AKDL+RKML  DPK R+TAAE L HPW++EDG  SDKP+D+AVL+
Sbjct:   294 QLDFSADPWPALSDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLS 353

Query:   349 RMKQFRAMNKMKKLALKV 366
             RMKQFRAMNK+KK+ALKV
Sbjct:   354 RMKQFRAMNKLKKMALKV 371

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0009651 "response to salt stress" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1079 (384.9 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
 Identities = 201/337 (59%), Positives = 255/337 (75%)

Query:    34 TQQDFRPTSSRPPALSKQIPQTSQIG----PILGKPYVDITTIYDLDKELGRGQFGVTYL 89
             T  + +P +   P   K + + S  G     +L +   +    Y L ++LG+GQFG T+L
Sbjct:   143 TTSETKPETKAEPQKPKHMRRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQFGTTFL 202

Query:    90 CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL 149
             C +K TG +YACKSIS+RKL+ D+D+EDVRREI I+ HL G PN++  +GAYED   +HL
Sbjct:   203 CLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHL 262

Query:   150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE 209
             VMELCSGGELFDRII +G Y+ER+AA + R IV V+ ACH +GV+HRDLKPENFL  S+E
Sbjct:   263 VMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSRE 322

Query:   210 EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSG 269
             EDS +K  DFGLS+F +  +V+ ++VGS YYVAPEVL +RYG E DVWSAGVI+YILLSG
Sbjct:   323 EDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSG 382

Query:   270 VPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
             VPPFWAETE+GIFE +L G+LD  S PWPSIS  AKDL+RKML +DPK+R+TA + L HP
Sbjct:   383 VPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLCHP 442

Query:   330 WLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             W++ DG   DKP+DSAVL+RMKQF AMNK KK+AL+V
Sbjct:   443 WVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRV 479

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 200/343 (58%), Positives = 254/343 (74%)

Query:    28 QPLPRRTQQDFRPTSSRPPALSKQIPQTSQIG----PILGKPYVDITTIYDLDKELGRGQ 83
             Q     T+ + +P     P   K + + S  G     +L +   +    Y L ++LG+GQ
Sbjct:   101 QETKSETKPESKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQ 160

Query:    84 FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED 143
             FG T+LC +K TG+++ACKSI++RKL+ D+D+EDVRREI I+ HL G PN++  +GAYED
Sbjct:   161 FGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 220

Query:   144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF 203
                +HLVME C+GGELFDRII +G Y+ER+AA + R IV VV ACH +GV+HRDLKPENF
Sbjct:   221 VVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVMHRDLKPENF 280

Query:   204 LLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVIL 263
             L  SK EDS +K  DFGLS+F +   V+ ++VGS YYVAPEVL +RYG E DVWSAGVI+
Sbjct:   281 LFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEADVWSAGVIV 340

Query:   264 YILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
             YILLSGVPPFWAETE+GIFE +L G+LD  S PWPSIS  AKDL+RKML +DPKKR+TA 
Sbjct:   341 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKKRLTAH 400

Query:   324 EALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
             + L HPW++ DG   DKP+DSAVL+RMKQF AMNK KK+AL+V
Sbjct:   401 QVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRV 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8RWL2	CDPKT_ARATH	2, ., 7, ., 1, 1, ., 1	0.7460	0.9972	0.6835	yes	no
P53683	CDPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6605	0.9918	0.6810	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.II.2223.1 annotation not avaliable (462 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	366
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-107
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-96
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-71
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-67
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-63
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-62
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-62
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-54
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-52
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-52
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-51
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-50
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-49
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-48
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-48
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-48
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-45
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-44
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-43
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-43
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-43
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-43
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-42
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-42
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-41
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-41
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-40
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-40
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-40
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-39
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-39
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-39
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-39
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-38
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-38
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-38
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-38
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-37
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-37
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-37
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-36
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-36
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-36
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-35
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-34
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-34
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-34
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-34
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-34
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-34
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-34
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-34
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-33
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-33
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-33
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-33
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-33
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-33
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-33
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-33
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-33
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-32
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-32
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-32
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-32
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-32
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-32
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-31
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-31
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-31
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-31
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-31
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-31
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-30
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-30
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-30
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-30
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-30
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-30
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-30
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-29
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-29
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-28
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-28
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-28
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-28
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-27
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-27
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-27
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-27
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-26
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-26
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-26
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-26
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-25
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-24
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-24
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-24
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-23
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-22
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-22
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-22
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-18
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-17
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  314 bits (806), Expect = e-107
 Identities = 119/261 (45%), Positives = 162/261 (62%), Gaps = 9/261 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ ++LG G FG  YL   K TG+  A K I ++K+   KD E + REI IL+ L   P
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV     +ED+  L+LVME C GG+LFD +  +G  SE EA    RQI++ +   H  G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYG 251
           ++HRDLKPEN LL   +ED  +K  DFGL+  ++ G+     VG+  Y+APEVL  + YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 252 KEIDVWSAGVILYILLSGVPPFWA-ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           K +D+WS GVILY LL+G PPF   +    +F+ I +         W  IS +AKDLIRK
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRK 233

Query: 311 MLTKDPKKRITAAEALEHPWL 331
           +L KDP+KR+TA EAL+HP+ 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  285 bits (732), Expect = 9e-96
 Identities = 119/265 (44%), Positives = 151/265 (56%), Gaps = 11/265 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L ++LG G FG  Y    K TG+  A K + +R     KD    RREI IL+ L+  P
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRLSH-P 58

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV    A+EDK +L+LVME C GG+LFD +   G  SE EA  I  QI+  +   H  G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQR 249
           +IHRDLKPEN LL        +K  DFGL+   +++       VG+ +Y+APEVL     
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFEAILEGNLDLQSSPWPSISGQAKD 306
           YG ++DVWS GVILY LL+G PPF  E       +   IL   L+     W S S +AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 307 LIRKMLTKDPKKRITAAEALEHPWL 331
           LI+K L KDP KR TA E L+HPW 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  221 bits (566), Expect = 6e-71
 Identities = 105/257 (40%), Positives = 149/257 (57%), Gaps = 13/257 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  KK TG+ YA K + ++K++  K++E    E  IL  +   P IV+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
            A++ ++ L+LV+E   GGELF  +  +G +SE  A     +IV  +   H +G+I+RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 199 KPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDV 256
           KPEN LL   + D  IK TDFGL+      G       G+  Y+APEVL  + YGK +D 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS GV+LY +L+G PPF+AE  K I+E IL+  L     P   +S +A+DLI  +L KDP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232

Query: 317 KKRITAAEALE---HPW 330
            KR+ +  A E   HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  210 bits (536), Expect = 5e-67
 Identities = 102/255 (40%), Positives = 131/255 (51%), Gaps = 44/255 (17%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG G FG  YL   K TG+K A K I +        +E++ REI IL+ L   PNIV+  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLNH-PNIVKLY 57

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRD 197
           G +ED+ +L+LVME C GG L D +    G  SE E   I  QI+  +   H  G+IHRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVLHQR--YGKEI 254
           LKPEN LL    ++  +K  DFGLS  +     + K IVG+  Y+APEVL  +  Y ++ 
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D+WS GVILY L                                    + KDLIRKML K
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 315 DPKKRITAAEALEHP 329
           DP+KR +A E LEH 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  202 bits (515), Expect = 4e-63
 Identities = 101/274 (36%), Positives = 142/274 (51%), Gaps = 31/274 (11%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED---VRREILILQHLTGQPNIV 135
           + +G +G  +L  KK+TG  YA K I +  ++  K+  D     R+IL        P +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQ---SPYVV 56

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
           +   +++ K+NL+LVME   GG+L   +   G   E  A     +IV  +   H  G+IH
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---------KEIVGSAYYVAPEV- 245
           RDLKP+N L+ S   +  +K TDFGLS      +           K IVG+  Y+APEV 
Sbjct: 117 RDLKPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 246 LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS---ISG 302
           L Q + K +D WS G ILY  L G+PPF  ET + IF+ IL G +      WP    +S 
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-----EWPEDVEVSD 228

Query: 303 QAKDLIRKMLTKDPKKRITAAEALE---HPWLKE 333
           +A DLI K+L  DP+KR+ A    E   HP+ K 
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  200 bits (512), Expect = 1e-62
 Identities = 86/264 (32%), Positives = 143/264 (54%), Gaps = 16/264 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K++G+G FG  YL  +K+ G+ Y  K I    +  +K+ ED   E+ IL+ L   P
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-HP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI---IAKGIY-SEREAANICRQIVNVVHAC 188
           NI+++  ++E+K  L +VME   GG+L  +I     +G    E +  +   Q+   +   
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL- 246
           H   ++HRD+KP+N  L S      +K  DFG+S V   T  + K +VG+ YY++PE+  
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI-SGQAK 305
           ++ Y  + D+WS G +LY L +   PF  E    +   IL+G       P PS  S + +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----PIPSQYSSELR 232

Query: 306 DLIRKMLTKDPKKRITAAEALEHP 329
           +L+  +L KDP++R + A+ L+ P
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  199 bits (509), Expect = 5e-62
 Identities = 93/284 (32%), Positives = 138/284 (48%), Gaps = 33/284 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K +G G F    L  +K T ++YA K + +R+L+ +K ++ V+ E  +L  L G P
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I++    ++D++NL+ V+E    GEL   I   G   E+       +I+  +   H  G
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFG-------LSVFIETGKVYKEI----------- 234
           +IHRDLKPEN LL    +D  IK TDFG        S           I           
Sbjct: 123 IIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 235 ---VGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
              VG+A YV+PE+L  +  GK  D+W+ G I+Y +L+G PPF    E   F+ IL+   
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239

Query: 291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE----HPW 330
                P P+    AKDLI K+L  DP+ R+   E  +    HP+
Sbjct: 240 SF---P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  185 bits (471), Expect = 3e-56
 Identities = 100/268 (37%), Positives = 145/268 (54%), Gaps = 18/268 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++  K LG G FG   L   K +G+ YA K +S+ K+V  K +E V  E  ILQ +   P
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V   G+++D  NL+LVME   GGELF  +   G + E  A     Q+V  +   H + 
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRYG 251
           +++RDLKPEN LL S   D  IK TDFG +  ++       + G+  Y+APE+ L + YG
Sbjct: 122 IVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILSKGYG 176

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRK 310
           K +D W+ G+++Y +L+G PPF+ +    I+E ILEG +      +PS  S  AKDLIR 
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-----FPSFFSPDAKDLIRN 231

Query: 311 MLTKDPKKRI-----TAAEALEHPWLKE 333
           +L  D  KR+        +   HPW   
Sbjct: 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  179 bits (457), Expect = 2e-54
 Identities = 89/262 (33%), Positives = 135/262 (51%), Gaps = 14/262 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           + LGRG FG  YL   K TG   A KS+       ++++E + REI IL  L   PNIV 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQ-HPNIVR 63

Query: 137 FEGAYEDKQ--NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           + G+  D++   L++ +E  SGG L   +   G   E       RQI+  +   H  G++
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE---IVGSAYYVAPEVLHQ-RY 250
           HRD+K  N L+ S      +K  DFG +  +   +  +    + G+ Y++APEV+    Y
Sbjct: 124 HRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIR 309
           G+  D+WS G  +  + +G PP W+E       A+ +     +    P  +S +AKD +R
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 310 KMLTKDPKKRITAAEALEHPWL 331
           K L +DPKKR TA E L+HP+L
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  176 bits (448), Expect = 3e-53
 Identities = 91/262 (34%), Positives = 142/262 (54%), Gaps = 12/262 (4%)

Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++++ +++G+G FG  Y    K TG++ A K I   KL   +  E +  EI IL+     
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-H 56

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHF 190
           PNIV++ G+Y  K  L +VME CSGG L D +       +E + A +C++++  +   H 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-R 249
            G+IHRD+K  N LL S  E   +K  DFGLS  +   K    +VG+ Y++APEV++   
Sbjct: 117 NGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
           Y  + D+WS G+    L  G PP+      K +F+    G   L++    S     KD +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE--FKDFL 231

Query: 309 RKMLTKDPKKRITAAEALEHPW 330
           +K L K+P+KR TA + L+HP+
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (450), Expect = 2e-52
 Identities = 98/284 (34%), Positives = 141/284 (49%), Gaps = 28/284 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + ++LG G FG  YL   +   +  A K ++++     K++E   REI IL  L   P
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI---IAKGIYSEREAANICRQIVNVVHACH 189
           NIV+    ++D+ +L+LVME   GG L D +     KG  SE EA  I  QI++ +   H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-------YKEIVGSAYYVA 242
             G+IHRD+KPEN LL    +   +K  DFGL+  +                VG+  Y+A
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 243 PEVLH----QRYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAILEGNLDLQS 294
           PEVL            D+WS G+ LY LL+G+PPF     +       + ILE      +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 295 SPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           SP        IS  A DL++K+L KDPK R++++  L H  L  
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280

Length = 384

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  173 bits (441), Expect = 4e-52
 Identities = 87/261 (33%), Positives = 141/261 (54%), Gaps = 16/261 (6%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG G FG   L   K+  R +A K + +R +V     E +  E  IL+     P IV+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLY 59

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++DK+ ++++ME C GGEL+  +  +G++ E  A      +V      H  G+I+RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVW 257
           KPEN LL S      +K  DFG +  +++G+      G+  YVAPE++  + Y   +D W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 258 SAGVILYILLSGVPPFWAETEK--GIFEAILEGNLDLQSSPWPSISGQ-AKDLIRKMLTK 314
           S G++LY LL+G PPF  + E    I+  IL+GN  L+   +P+   + AKDLI+++L +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233

Query: 315 DPKKRI-----TAAEALEHPW 330
           +P++R+        +  +H W
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 8e-51
 Identities = 86/260 (33%), Positives = 131/260 (50%), Gaps = 10/260 (3%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K + +G FG  YL  K++TG  +A K + +  ++    + +V+ E  I+      P + +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++ K  L+LVME  +GG+    I   G   E  A     ++V  V   H  G+IHR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYG-KEID 255
           D+KPEN L+   ++   +K TDFGLS     G   K+ VG+  Y+APE +      K  D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            WS G +++  L G PPF AET   +F+ IL   ++         S +A DLI ++L  D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 316 PKKRITA---AEALEHPWLK 332
           P KR+ A    E   HP+ K
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 8e-50
 Identities = 94/288 (32%), Positives = 142/288 (49%), Gaps = 37/288 (12%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +GRG FG  +L   K TG+ YA K + +  ++    +  VR E  IL      P IV+
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++D+++L+LVME   GG+L + +I K ++ E  A     ++V  + + H +G IHR
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKE---------------------- 233
           D+KP+N L+     D  IK  DFGL     +                             
Sbjct: 126 DIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 234 -------IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI 285
                   VG+  Y+APEVL    YG E D WS GVILY +L G PPF+++T +  +  I
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242

Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE-ALEHPWLK 332
           +     L+  P P +S +A DLI ++L  DP+ R+ + E    HP+ K
Sbjct: 243 INWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  165 bits (421), Expect = 3e-49
 Identities = 84/262 (32%), Positives = 130/262 (49%), Gaps = 12/262 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   +GRG FGV Y      TG   A K IS  K+  +  ++ + +EI +L++L   P
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNLK-HP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV++ G+ E   +L++++E    G L   I   G + E   A    Q++  +   H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVLHQRYG 251
           VIHRD+K  N L     +D  +K  DFG++    +  K    +VG+ Y++APEV+     
Sbjct: 120 VIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 252 KEI-DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIR 309
               D+WS G  +  LL+G PP++          I++        P P  IS + KD + 
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----DDHPPLPEGISPELKDFLM 232

Query: 310 KMLTKDPKKRITAAEALEHPWL 331
           +   KDP  R TA + L+HPW+
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  164 bits (419), Expect = 1e-48
 Identities = 90/299 (30%), Positives = 139/299 (46%), Gaps = 57/299 (19%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD------MEDVRREILILQ 126
           Y+  ++LG G +GV Y    K TG   A K I   +L  +++      +    REI +L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTAL----REISLLK 53

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAK--GIYSEREAANICRQIV 182
            L   PNIV+       ++ L+LV E C      D  + + K  G  S     +I  Q++
Sbjct: 54  ELK-HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLL 108

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVY-KEIVGSAYY 240
             +  CH   ++HRDLKP+N L+        +K  DFGL+  F    + Y  E+V + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVV-TLWY 164

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAIL-----EGN 289
            APE+L   + Y   +D+WS G I   +++G P F  ++E      IF+ IL     E  
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESW 223

Query: 290 LDLQSSPW-----------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             +   P                  P +  +  DL+ KML  +P KRI+A EAL+HP+ 
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  162 bits (412), Expect = 7e-48
 Identities = 88/265 (33%), Positives = 130/265 (49%), Gaps = 18/265 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILILQHLTGQPNIV 135
           K LG+G  GV Y    K TG+ YA K I    +  D++    + RE+  L      P +V
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTL-RSCESPYVV 62

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN---VVHACHFMG 192
           +  GA+  +  + +V+E   GG L D +   G   E   A I RQI+     +H    + 
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI- 121

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-EIVGSAYYVAPEVLH-QRY 250
            IHRD+KP N L+ SK E   +K  DFG+S  +E         VG+  Y++PE +  + Y
Sbjct: 122 -IHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS--ISGQAKDLI 308
               D+WS G+ L     G  PF    +   FE +++   D      P+   S + +D I
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-LMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 309 RKMLTKDPKKRITAAEALEHPWLKE 333
              L KDPKKR +AAE L+HP++K+
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  163 bits (414), Expect = 8e-48
 Identities = 89/276 (32%), Positives = 145/276 (52%), Gaps = 14/276 (5%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   +Y   +++G G  G  Y  T +ATG++ A K +  RK    ++ E +  EILI++ 
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIINEILIMKD 71

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVH 186
               PNIV++  +Y     L +VME   GG L D I    +  +E + A +CR+++  + 
Sbjct: 72  CK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSAYYVAPEV 245
             H   VIHRD+K +N LL+       +K  DFG +  +   K     +VG+ Y++APEV
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 246 -LHQRYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLDLQSSPWPSISGQ 303
              + YG ++D+WS G++   +  G PP+  E   + +F    +G   L++      S +
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPE--KWSPE 245

Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
            KD + K L KDP+KR +A E L+HP+LK+     +
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 7e-45
 Identities = 82/274 (29%), Positives = 138/274 (50%), Gaps = 32/274 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            +  K +G G FG  +L   + +   YA K ++  +++  K  + V  E  +L+ ++  P
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HP 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I+       D++ L+++ME   GGELF  +   G +S         +IV  +   H   
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV-------GSAYYVAPEV 245
           +++RDLKPEN LL   +++  IK TDFG +         K++        G+  Y+APEV
Sbjct: 122 IVYRDLKPENILL---DKEGHIKLTDFGFA---------KKLRDRTWTLCGTPEYLAPEV 169

Query: 246 LHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQ 303
           +  + + K +D W+ G+++Y +L G PPF+ +   GI+E IL G L+     +P  +   
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-----FPRHLDLY 224

Query: 304 AKDLIRKMLTKDPKKRI-----TAAEALEHPWLK 332
           AKDLI+K+L  D  +R+      A +   H W K
Sbjct: 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  154 bits (392), Expect = 2e-44
 Identities = 92/294 (31%), Positives = 136/294 (46%), Gaps = 39/294 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSI--SRRKLVYDKDMEDVRREILILQHLTG 130
           Y+  K+LG G + V Y    K TGR  A K I    RK   D       REI +LQ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK- 60

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSG---GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            PNI+     +  K N++LV E         + D+ I   + +  +  +     +  +  
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL 246
            H   ++HRDLKP N L+AS      +K  DFGL+  F    +     V + +Y APE+L
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Query: 247 H--QRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAI-------------LE 287
              + YG  +D+WS G I   LL  VP    +++      IFEA+             L 
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234

Query: 288 GNLDLQSSP-------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
             ++ +  P       +P+ S  A DL++++LT +P KRITA +ALEHP+   D
Sbjct: 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  153 bits (389), Expect = 2e-44
 Identities = 86/273 (31%), Positives = 135/273 (49%), Gaps = 27/273 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ + +G+G FG      +K+ G+    K I    +  +K+ + +  E+ IL+ L   P
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELK-HP 59

Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIAKGI-----YSEREAANICRQIVNVV 185
           NIV +     D+ N  L++VME C GG+L  ++I K         E     I  Q++  +
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 186 HACHF-----MGVIHRDLKPEN-FLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSA 238
           + CH        V+HRDLKP N FL A+      +K  DFGL+  +     + K  VG+ 
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           YY++PE L H  Y ++ D+WS G ++Y L +  PPF A  +  +   I EG         
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----RI 230

Query: 298 PSI-SGQAKDLIRKMLTKDPKKRITAAEALEHP 329
           P   S +  ++I+ ML  DP KR +  E L+ P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  151 bits (384), Expect = 1e-43
 Identities = 80/264 (30%), Positives = 134/264 (50%), Gaps = 12/264 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++L + +G+G FG   +  K+ T + +A K ++++K V    + +V  E  ILQ L   P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V    +++D++N++LV++L  GG+L   +  K  +SE +      +IV  +   H  G
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYG 251
           +IHRD+KP+N LL   +E   +  TDF ++  +    +     G+  Y+APEVL  Q Y 
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGI--FEAILEGNLDLQSSPWPSISGQAKDLIR 309
             +D WS GV  Y  L G  P+   +        A  E    L  + W +   +A D I 
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST---EAIDAIN 234

Query: 310 KMLTKDPKKRI--TAAEALEHPWL 331
           K+L +DP+KR+     +   HP+ 
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 1e-43
 Identities = 94/267 (35%), Positives = 136/267 (50%), Gaps = 13/267 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + +  ++G+G +G  +L  KK TG   A K + +  L    ++  V  E  IL   T   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L+L ME   GG+    +   G+ SE  A     ++   V A H +G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
            IHRDLKPENFL+ +      IK TDFGLS  I T      +VGS  Y+APEVL  + Y 
Sbjct: 122 YIHRDLKPENFLIDA---SGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYD 176

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ----SSPWPSISGQAKDL 307
             +D WS G +LY  L G PPF   T    +E +      LQ      P  ++S +A DL
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236

Query: 308 IRKMLTKDPKKRITAAEALE-HPWLKE 333
           I K++  DP +R  + E ++ HP+ KE
Sbjct: 237 ITKLIN-DPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  150 bits (381), Expect = 2e-43
 Identities = 81/271 (29%), Positives = 139/271 (51%), Gaps = 27/271 (9%)

Query: 71  TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
            ++D+ ++LG G +G  Y    K TG+  A K +       ++D++++ +EI IL+    
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CD 56

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHAC 188
            P IV++ G+Y    +L +VME C  G + D  +I  K + +E E A I  Q +  +   
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-TEEEIAAILYQTLKGLEYL 115

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL- 246
           H    IHRD+K  N LL    E+   K  DFG+S    +T      ++G+ +++APEV+ 
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK- 305
              Y  + D+WS G+    +  G PP+   ++     AI      + + P P++S   K 
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFM----IPNKPPPTLSDPEKW 225

Query: 306 -----DLIRKMLTKDPKKRITAAEALEHPWL 331
                D ++K L KDP++R +A + L+HP++
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  151 bits (384), Expect = 6e-43
 Identities = 103/316 (32%), Positives = 142/316 (44%), Gaps = 60/316 (18%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR---REILILQHLT 129
           Y+L K +G G +GV      K TGRK A K IS        D+ D +   REI +L+HL 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHL- 56

Query: 130 GQPNIVEFE-----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN--ICR--- 179
              NI+         + ED  ++++V EL       +  + K I S +   +  I     
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTEL------METDLHKVIKSPQPLTDDHIQYFLY 110

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----V 235
           QI+  +   H   VIHRDLKP N +L +   D  +K  DFGL+  ++  +  K      V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 236 GSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAI---- 285
            + +Y APE+L    RY K ID+WS G I   LL+  P F           I E +    
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227

Query: 286 LEGNLDLQSS---------------PW----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            E    + S                P     P  S +A DL+ KML  DPKKRITA EAL
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287

Query: 327 EHPWLKEDGATSDKPI 342
            HP+L +     D+P+
Sbjct: 288 AHPYLAQLHDPEDEPV 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  148 bits (377), Expect = 2e-42
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 37/290 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y +   +G G  G+ +    + TG   A K ++ R+L          REI  LQ     P
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQAC-QHP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFM 191
            +V+    +       LVME     +L + +   +    E +  +  R ++  V   H  
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSV--FIETGKVYKEIVGSAYYVAPEVLH-- 247
           G++HRDLKP N L+++      +K  DFGL+     E  ++Y   V + +Y APE+L+  
Sbjct: 119 GIMHRDLKPANLLISADGV---LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLDLQS----------- 294
           ++Y   +D+W+ G I   LL+G P F  E +      +    G  + ++           
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 295 ---------SPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                     P     P  S +A DL++ +L  DP KR++AAEAL HP+ 
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  148 bits (376), Expect = 7e-42
 Identities = 94/267 (35%), Positives = 147/267 (55%), Gaps = 19/267 (7%)

Query: 77  KELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYD-KDMEDVRREILILQHLTGQP 132
           K LG+G +G  +   K     TG+ +A K + +  +V + KD    + E  IL+ +   P
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            IV+   A++    L+L++E  SGGELF  +  +GI+ E  A     +I   +   H  G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           +I+RDLKPEN LL ++     +K TDFGL    I  G V     G+  Y+APE+L +  +
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           GK +D WS G ++Y +L+G PPF AE  K   + IL+G L+L     P ++ +A+DL++K
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK 233

Query: 311 MLTKDPKKRI-----TAAEALEHPWLK 332
           +L ++P  R+      AAE   HP+ +
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  148 bits (375), Expect = 1e-41
 Identities = 82/249 (32%), Positives = 137/249 (55%), Gaps = 11/249 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG G FG   +   K TG  YA K + +R+++  K ++ V +E  IL  L+  P
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HP 78

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            IV    +++D+  ++ ++E   GGELF  +   G +    A     ++V      H   
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           +I+RDLKPEN LL +K     +K TDFG +  +   + +  + G+  Y+APEV+  + +G
Sbjct: 139 IIYRDLKPENLLLDNKGH---VKVTDFGFAKKV-PDRTFT-LCGTPEYLAPEVIQSKGHG 193

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV+LY  ++G PPF+ +T   I+E IL G L   +  W    G+A+DL++ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249

Query: 312 LTKDPKKRI 320
           L  D  KR+
Sbjct: 250 LQTDHTKRL 258

Length = 329

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 1e-41
 Identities = 85/288 (29%), Positives = 124/288 (43%), Gaps = 42/288 (14%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTGQPNI 134
            ++G G +GV Y    K TG   A K I  R   ++ +       REI +L+ L   PNI
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELN-HPNI 60

Query: 135 VEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           ++    +  K +L+LV E       +L      +    E    +   Q++  +  CH  G
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQR 249
           ++HRDLKPEN L+     +  +K  DFGL+  F    + Y   V + +Y APE+L   + 
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE-------------------KGIFEAILEGNL 290
           Y   +D+WS G I   LLS  P F  ++E                               
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 291 DLQS---SPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                   P     P+ S QA DL+ +ML  DP KRITA +AL HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  145 bits (367), Expect = 6e-41
 Identities = 87/277 (31%), Positives = 142/277 (51%), Gaps = 25/277 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L + LG G +G  +L  K      G+ YA K + +  +V   K  E  R E  +L+ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V    A++    LHL+++  +GGELF  +  +  ++E E      +IV  +   
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVL 246
           H +G+I+RD+K EN LL   + +  +  TDFGLS      +  +     G+  Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 247 HQR---YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLDLQSSPWP- 298
                 + K +D WS GV+ + LL+G  PF  + E+     I   IL+        P+P 
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-----SKPPFPK 233

Query: 299 SISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLK 332
           ++S +A+D I+K+L KDPKKR+    A E   HP+ +
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  143 bits (362), Expect = 3e-40
 Identities = 92/285 (32%), Positives = 149/285 (52%), Gaps = 43/285 (15%)

Query: 73  YDLD--KELGRGQFGVTYLCTKKATGRKYACKSIS-----RRKLVYDKDMEDVRREILIL 125
             LD   ++G G  G+  + T K+TGR+ A K +      RR+L+++        E++I+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--------EVVIM 70

Query: 126 ---QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
              QH    PNIVE   +Y     L +VME   GG L D I+     +E + A +C  ++
Sbjct: 71  RDYQH----PNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL--SVFIETGKVYKEIVGSAYY 240
             +   H  GVIHRD+K ++ LL S   D  +K +DFG    V  E  +  K +VG+ Y+
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYW 181

Query: 241 VAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP- 298
           +APEV+ +  YG E+D+WS G+++  ++ G PP++ E         L+    ++ +  P 
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPK 234

Query: 299 -----SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
                 +S + +  + +ML +DP +R TAAE L HP+L + G  S
Sbjct: 235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  142 bits (360), Expect = 4e-40
 Identities = 79/270 (29%), Positives = 122/270 (45%), Gaps = 20/270 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L + +G G   V Y         K A K I   K      ++++R+E+  +      P
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMS-QCNHP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFD---RIIAKGIYSEREAANICRQIVNVVHACH 189
           N+V++  ++     L LVM   SGG L D       +G   E   A + ++++  +   H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-----KVYKEIVGSAYYVAPE 244
             G IHRD+K  N LL    ED  +K  DFG+S  +  G     KV K  VG+  ++APE
Sbjct: 120 SNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 245 VLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN---LDLQSSPWPS 299
           V+ Q   Y  + D+WS G+    L +G  P+       +    L+ +   L+  +     
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK- 235

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
            S   + +I   L KDP KR TA E L+H 
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  144 bits (366), Expect = 5e-40
 Identities = 94/276 (34%), Positives = 139/276 (50%), Gaps = 14/276 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ K +GRG FG   L   K++ + YA K +S+ +++   D      E  I+ H     
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSE 103

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            IV+   A++D + L++VME   GG+L + +    I  E+ A     ++V  + A H MG
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSMG 162

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEI-VGSAYYVAPEVL---- 246
            IHRD+KP+N LL        +K  DFG  + ++  G V  +  VG+  Y++PEVL    
Sbjct: 163 FIHRDVKPDNMLLDK---SGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I++    L       IS QAK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279

Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKEDGATSD 339
           DLI   LT    +  R    E   HP+ K D  T D
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFD 315

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  143 bits (363), Expect = 5e-40
 Identities = 88/261 (33%), Positives = 139/261 (53%), Gaps = 15/261 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATG+ YA K + +  ++   ++     E  +LQ+ T  P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H   V++R
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEI 254
           DLK EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  GV++Y ++ G  PF+ +  + +FE IL   +        ++S +AK L+  +L K
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232

Query: 315 DPKKRI-----TAAEALEHPW 330
           DPK+R+      A E +EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 1e-39
 Identities = 93/297 (31%), Positives = 133/297 (44%), Gaps = 52/297 (17%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTG 130
           Y + K+LG G FG  YL   K TG   A K + ++K       E+    RE+  L+ L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF---YSWEECMNLREVKSLRKLNE 56

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIY-SEREAANICRQIVNVVHAC 188
            PNIV+ +  + +   L+ V E   G  L+  +   KG   SE    +I  QI+  +   
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-- 246
           H  G  HRDLKPEN L++  E    +K  DFGL+  I +   Y + V + +Y APE+L  
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPF-----------------------WAETEKGIFE 283
              Y   +D+W+ G I+  L +  P F                       W E  K    
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK---- 228

Query: 284 AILEGNLDLQ---------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             L   L  +             P+ S +A DLI+ ML  DPKKR TA++AL+HP+ 
Sbjct: 229 --LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  141 bits (357), Expect = 4e-39
 Identities = 94/274 (34%), Positives = 148/274 (54%), Gaps = 18/274 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVY-DKDMEDVRREILILQHL 128
           ++L K LG G +G  +L  K     TG+ YA K + +  LV   K +E  R E  +L+H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V    A++ +  LHL+++  SGGE+F  +  +  +SE E      +I+  +   
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYK-EIVGSAYYVAPEVL 246
           H +G+++RD+K EN LL S   +  +  TDFGLS  F+   K       G+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 247 HQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG-Q 303
             +  +GK +D WS G++++ LL+G  PF  E E+     +    L     P+PS  G +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-DPPFPSFIGPE 237

Query: 304 AKDLIRKMLTKDPKKRITAA-----EALEHPWLK 332
           A+DL+ K+L KDPKKR+ A      E  EHP+ K
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 5e-39
 Identities = 87/293 (29%), Positives = 133/293 (45%), Gaps = 43/293 (14%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G  G  +L   K TG+ +A K + +++++    ++ V  E  IL      P +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA-TLDHPFLPT 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
              +++ +  L LVM+ C GGELF   +       SE  A     +++  +   H +G++
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSV--------------FIETGKVYKEI------ 234
           +RDLKPEN LL    E   I  +DF LS                         I      
Sbjct: 126 YRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 235 ----------VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
                     VG+  Y+APEV+    +G  +D W+ G++LY +L G  PF        F 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242

Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI----TAAEALEHPWLK 332
            IL+  +    S  P +S  A+DLIRK+L KDP KR+     AAE  +HP+ +
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 6e-39
 Identities = 89/299 (29%), Positives = 139/299 (46%), Gaps = 48/299 (16%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +GRG FG   L  KK TG  YA K + + +++  + +  VR E  IL      P +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++D+  L+L+ME   GG++   ++ K  ++E E      + +  + + H +G IHR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGL------------------------SVFIETGKVYK 232
           D+KP+N LL +K     IK +DFGL                          FI      K
Sbjct: 126 DIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 233 E---------------IVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAE 276
                            VG+  Y+APEV  Q  Y KE D WS GVI+Y +L G PPF ++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 277 TEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLK 332
             +  +  I+     LQ      +S +AKDLI+++   + ++R+      E   HP+ K
Sbjct: 243 NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  139 bits (352), Expect = 2e-38
 Identities = 87/265 (32%), Positives = 134/265 (50%), Gaps = 16/265 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L   K T   YA K + +  ++ D D+E    E  +L      P + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               ++ K  L  VME  +GG+L   I   G + E  A     +IV  +   H  G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL-HQRYGKEI 254
           DLK +N LL S   +  IK  DFG+    I  G       G+  Y+APE+L +Q YG  +
Sbjct: 121 DLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKMLT 313
           D W+ GV+LY +L+G  PF  + E  +F++ILE  +      +P  +S +AK +++  LT
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-----RYPRWLSKEAKSILKSFLT 232

Query: 314 KDPKKRITA-----AEALEHPWLKE 333
           K+P+KR+        +   HP+ +E
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 3e-38
 Identities = 93/277 (33%), Positives = 133/277 (48%), Gaps = 36/277 (12%)

Query: 71  TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
             Y+L + +G G +G  Y     ATG   A K I   KL    D E +++EI +L+    
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR- 58

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-------SEREAANICRQIVN 183
            PNIV + G+Y  +  L +VME C GG L D      IY       SE + A +CR+ + 
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD------IYQVTRGPLSELQIAYVCRETLK 112

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVA 242
            +   H  G IHRD+K  N LL    ED  +K  DFG+S  +  T    K  +G+ Y++A
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169

Query: 243 PEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           PEV        Y  + D+W+ G+    L    PP +   +     A+    +   + P P
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFL--ISKSNFPPP 224

Query: 299 SISGQAK------DLIRKMLTKDPKKRITAAEALEHP 329
            +  + K      D I+K LTKDPKKR TA + L+HP
Sbjct: 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  137 bits (347), Expect = 4e-38
 Identities = 91/277 (32%), Positives = 146/277 (52%), Gaps = 21/277 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L K LG G +G  +L  K +   +G+ YA K + +  +V   K  E  R E  +L+H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V    A++    LHL+++  +GGELF  +  +  + E+E      +IV  +   
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS---VFIETGKVYKEIVGSAYYVAPEV 245
           H +G+I+RD+K EN LL S   +  +  TDFGLS      E  + Y    G+  Y+AP++
Sbjct: 122 HKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAY-SFCGTIEYMAPDI 177

Query: 246 LH---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-IS 301
           +      + K +D WS GV++Y LL+G  PF  + EK     I    L     P+P  +S
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236

Query: 302 GQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
             AKD+I+++L KDPKKR+      A E  +HP+ ++
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 4e-38
 Identities = 84/264 (31%), Positives = 137/264 (51%), Gaps = 15/264 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV--RREILILQHLTGQPNIVE 136
           +G+G FG  Y   KK T R YA K +S++++V  K++      R IL+   L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            + +++   +L+LV +  SGGELF  +  +G +SE  A     ++V  +   H   +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQRYGKE 253
           DLKPEN LL   +    I   DFGLS   +   K      G+  Y+APEVL   + Y K 
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           +D WS GV+++ +  G  PF+AE  + ++  I  G +     P   +S + +  ++ +L 
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLLN 234

Query: 314 KDPKKRI----TAAEALEHPWLKE 333
           ++P+ R+     A E  EHP+  +
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 6e-38
 Identities = 91/298 (30%), Positives = 128/298 (42%), Gaps = 50/298 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ- 131
           Y+   E+G G +G  Y      TGR  A K + R  L  +       REI +L+ L    
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59

Query: 132 -PNIVE----FEGAYEDKQ-NLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVN 183
            PNIV       G   D++  L LV E           +    G+       ++ RQ++ 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGL-PPETIKDLMRQLLR 118

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK------EIVGS 237
            V   H   ++HRDLKP+N L+ S   D  +K  DFGL+      ++Y        +V +
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLA------RIYSFEMALTSVVVT 169

Query: 238 AYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAI---LEGN 289
            +Y APEVL Q  Y   +D+WS G I   L    P F   +E      IF+ I    E  
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229

Query: 290 LDLQSS-PW---------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                S P                P I  +  DL++KMLT +P KRI+A EAL+HP+ 
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  136 bits (344), Expect = 9e-38
 Identities = 90/264 (34%), Positives = 135/264 (51%), Gaps = 16/264 (6%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK--DMEDVRREILILQHLTGQPNIVE 136
           LG+G FG    C  KATG+ YACK + +++L   K   M    ++IL          IV 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS---SRFIVS 57

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFMGVI 194
              A+E K +L LVM L +GG+L   I  + +  + E  A     QI+  +   H   ++
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKE 253
           +RDLKPEN LL   ++   ++ +D GL+V ++ GK  K   G+  Y+APEVL  + Y   
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           +D ++ G  LY +++G  PF    EK   E +    L++        S +AKDL   +L 
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234

Query: 314 KDPKKRI-----TAAEALEHPWLK 332
           KDP+KR+     +A E  EHP  K
Sbjct: 235 KDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 1e-37
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 70/307 (22%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--------REILI 124
           Y+   ++G G +G  Y    K TG   A K I          ME+ +        REI +
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51

Query: 125 LQHLTGQPNIVEFEGAYEDKQ--NLHLVMELCSGGELFD--RIIAKGIY--SEREAANIC 178
           LQ L   PNIV  +     K   ++++V E        D   ++       +E +     
Sbjct: 52  LQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYM 106

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKEIVG 236
           +Q++  +   H  G++HRD+K  N L+ +      +K  DFGL+          Y   V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVI 163

Query: 237 SAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS 294
           + +Y  PE+L    RYG E+D+WS G IL  L  G P F   TE    E I E    L  
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE----LCG 219

Query: 295 SP----WPS---------------------------ISGQAKDLIRKMLTKDPKKRITAA 323
           SP    WP                            I   A DL+ K+LT DPKKRI+A 
Sbjct: 220 SPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD 279

Query: 324 EALEHPW 330
           +AL+H +
Sbjct: 280 QALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 1e-37
 Identities = 85/290 (29%), Positives = 139/290 (47%), Gaps = 27/290 (9%)

Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++ L + +G+G FG  Y    K T +  A K I   +   + ++ED+++EI  L      
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-S 58

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           P I ++ G++     L ++ME C GG   D ++  G   E   A I R+++  +   H  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVL-HQR 249
           G IHRD+K  N LL+   E+  +K  DFG+S  +  T       VG+ +++APEV+    
Sbjct: 118 GKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAI------LEGNLDLQSSPWPSIS 301
           Y ++ D+WS G+    L  G PP  ++    + +F         LEGN           S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPL-SDLHPMRVLFLIPKNNPPSLEGN---------KFS 224

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMK 351
              KD +   L KDPK+R +A E L+H ++K+   TS   +    + + K
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  136 bits (344), Expect = 2e-37
 Identities = 83/244 (34%), Positives = 129/244 (52%), Gaps = 9/244 (3%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L      P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L+ VME  +GG+L   I   G + E  A     +I   +   H  G+I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEIDV 256
           K +N +L   + +  IK  DFG+    I  GK  +   G+  Y+APE + +Q YGK +D 
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L+G PPF  E E  +F++I+E N+   S P  S+S +A  + + +LTK P
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYP-KSLSKEAVSICKGLLTKHP 240

Query: 317 KKRI 320
            KR+
Sbjct: 241 AKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  135 bits (341), Expect = 5e-37
 Identities = 85/287 (29%), Positives = 142/287 (49%), Gaps = 37/287 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV--RREILILQHLTG 130
           ++  K +  G +G  YL   K T +++A K I+++ L+    ++ V   R+IL       
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--- 59

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P +V    ++E K++L +VME   GG+    +   G      A     + V  +   H 
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS---VFIETGKVY-------------KEI 234
            G++HRDLKP+N L+ S      IK TDFGLS   +   T  +Y             K++
Sbjct: 120 YGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 235 VGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
            G+  Y+APEV L Q YGK +D W+ G+ILY  L G  PF+ +T + +F  ++  +++  
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-- 234

Query: 294 SSPWP----SISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKE 333
              WP    ++   A+DLI ++L ++P +R+    A E  +H +   
Sbjct: 235 ---WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  135 bits (340), Expect = 1e-36
 Identities = 89/260 (34%), Positives = 141/260 (54%), Gaps = 17/260 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   V++R
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEI 254
           D+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    YG+ +
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKMLT 313
           D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+  +L 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLAGLLK 231

Query: 314 KDPKKRI-----TAAEALEH 328
           KDPK+R+      A E +EH
Sbjct: 232 KDPKQRLGGGPSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  132 bits (334), Expect = 3e-36
 Identities = 87/262 (33%), Positives = 133/262 (50%), Gaps = 12/262 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +  Q  +V   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ + +GG+L   I   G   + E  A     +I+  +   H    ++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V I  G+  +  VG+  Y+APEVL +QRY    D
Sbjct: 127 DLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W  G ++Y ++ G  PF    EK   E +    L+ +       S +AK + + +LTKD
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243

Query: 316 PKKRI-----TAAEALEHPWLK 332
           PK+R+      A E   HP+ +
Sbjct: 244 PKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 7e-36
 Identities = 95/293 (32%), Positives = 139/293 (47%), Gaps = 36/293 (12%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           V+   I+++  ELG G FG  Y    K TG   A K I   ++  ++++ED   EI IL 
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILS 57

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNV 184
                PNIV    AY  +  L +++E C GG L D I+ +     +E +   +CRQ++  
Sbjct: 58  ECK-HPNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI------VGSA 238
           ++  H   VIHRDLK  N LL     D  +K  DFG+S      K    +      +G+ 
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVS-----AKNKSTLQKRDTFIGTP 167

Query: 239 YYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--- 289
           Y++APEV+         Y  + D+WS G+ L  L    PP        +   IL+     
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227

Query: 290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           LD Q S W   S    D ++  L KDP  R TAAE L+HP++ +   + +K I
Sbjct: 228 LD-QPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD--QSDNKAI 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  131 bits (330), Expect = 2e-35
 Identities = 83/266 (31%), Positives = 132/266 (49%), Gaps = 16/266 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L   K T   YA K + +  ++ D D++    E  IL      P +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               ++ K  L  VME  +GG+L  +I     + E  +     ++   +   H  GVI+R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEI 254
           DLK +N LL   + +   K  DFG+    I  G       G+  Y+APE+L    YG  +
Sbjct: 121 DLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W+ GV++Y +++G PPF A+ E  +FE+IL  + D+    W  +S +A  +++  +TK
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVW--LSKEAVSILKAFMTK 233

Query: 315 DPKKRI--TAAEALE-----HPWLKE 333
           +P KR+   A++  E     HP+ KE
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  130 bits (328), Expect = 5e-35
 Identities = 87/263 (33%), Positives = 130/263 (49%), Gaps = 15/263 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L   K +GR YA K + +  ++ D D+E    E  IL      P + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L  VME  +GG+L   I     + E  A     +I + +   H  G+I+RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K +N LL   + +   K  DFG+    I  GK      G+  Y+APE+L +  YG  +D 
Sbjct: 123 KLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L G  PF AE E  +FEAIL  N ++    W  +S  A D+++  +TK+P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTW--LSQDAVDILKAFMTKNP 235

Query: 317 KKRITAAE------ALEHPWLKE 333
             R+ +         L HP+ KE
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 1e-34
 Identities = 85/263 (32%), Positives = 133/263 (50%), Gaps = 19/263 (7%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD--KDMEDVRREILILQHLTGQPNI 134
           K LG+G FG  YLC    TGR+ A K +       +  K++  +  EI +L++L     I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERI 66

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           V++ G   D + L + ME   GG + D++ A G  +E       RQI+  V   H   ++
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIET----GKVYKEIVGSAYYVAPEVLH-QR 249
           HRD+K  N L   ++    +K  DFG S  ++T    G   K + G+ Y+++PEV+  + 
Sbjct: 127 HRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFE-AILEGNLDLQSSPWPSISGQAKD 306
           YG++ DVWS G  +  +L+  PP WAE E    IF+ A    N  L       +S  A++
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQPTNPQLP----SHVSPDARN 238

Query: 307 LIRKMLTKDPKKRITAAEALEHP 329
            +R+   ++ KKR +A E L H 
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (321), Expect = 2e-34
 Identities = 86/275 (31%), Positives = 133/275 (48%), Gaps = 31/275 (11%)

Query: 74  DLD--KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL----ILQH 127
           DL+   ELG G  GV      + TG+  A       K +  +  E ++++IL    IL  
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMA------VKTIRLEINEAIQKQILRELDILHK 55

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII--AKGIYSEREAANICRQIVN-V 184
               P IV F GA+ +  ++ + ME   GG L D+I+   +G   ER    I   ++  +
Sbjct: 56  CN-SPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGL 113

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
            +      +IHRD+KP N L+ S+ +   IK  DFG+S  +    + K  VG++ Y+APE
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQL-VNSLAKTFVGTSSYMAPE 169

Query: 245 VLH-QRYGKEIDVWSAGVILYILLSG-VP-PFWAETEKGIFE---AILEGNLD-LQSSPW 297
            +    Y  + D+WS G+ L  L +G  P P   +   GIFE    I+      L S  +
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
              S   +D +   L KDP++R +  E LEHP++K
Sbjct: 230 ---SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 61/299 (20%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM-EDVRREILILQ 126
           D T I++L + +G G +G  Y    K TG+  A K +        +D  E+++ E  IL+
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-----IIEDEEEEIKEEYNILR 57

Query: 127 HLTGQPNIVEFEGAY-------EDKQNLHLVMELCSGG---ELFDRIIAKG-IYSEREAA 175
             +  PNI  F GA+        D Q L LVMELC GG   +L   +  KG    E   A
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-- 233
            I R+ +  +   H   VIHRD+K +N LL    +++ +K  DFG+S  +++  + +   
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDS-TLGRRNT 172

Query: 234 IVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
            +G+ Y++APEV+         Y    DVWS G+    L  G PP               
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------------- 218

Query: 288 GNLDLQ---------SSPWPSISGQAK------DLIRKMLTKDPKKRITAAEALEHPWL 331
              D+           +P P++           D I + L K+ ++R    E LEHP++
Sbjct: 219 --CDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  129 bits (326), Expect = 2e-34
 Identities = 90/271 (33%), Positives = 143/271 (52%), Gaps = 14/271 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ K +GRG FG   L   K++ + YA K +S+ +++   D      E  I+      P
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEI-VGSAYYVAPEVLHQR- 249
           +IHRD+KP+N LL   ++   +K  DFG  + + ETG V  +  VG+  Y++PEVL  + 
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV L+ +L G  PF+A++  G +  I++    L       IS  AK
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279

Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKED 334
           +LI   LT    +  R    E  +HP+ K D
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  128 bits (323), Expect = 3e-34
 Identities = 89/261 (34%), Positives = 142/261 (54%), Gaps = 18/261 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATGR YA K + +  +V   ++     E  +LQ+ +  P +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIH 195
            + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H    V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 196 RDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKE 253
           RDLK EN +L   ++D  IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ 
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKML 312
           +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+  +L
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLSPEAKSLLSGLL 231

Query: 313 TKDPKKRI-----TAAEALEH 328
            KDPK+R+      A E ++H
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  128 bits (322), Expect = 3e-34
 Identities = 81/244 (33%), Positives = 130/244 (53%), Gaps = 9/244 (3%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L      P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L+ VME  +GG+L   I   G + E +A     +I   +   H  G+I+RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDV 256
           K +N +L S   +  IK  DFG+    +  G   +   G+  Y+APE++ +Q YGK +D 
Sbjct: 128 KLDNVMLDS---EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L+G PPF  E E  +F++I+E N+   S P  S+S +A  + + ++TK P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYP-KSLSKEAVSICKGLMTKHP 240

Query: 317 KKRI 320
            KR+
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  128 bits (322), Expect = 4e-34
 Identities = 87/271 (32%), Positives = 132/271 (48%), Gaps = 15/271 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+   +GRG FG   +  +KATG  YA K + +  L+  + +     E  IL  ++  P
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSP 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
            I + + A++DK NL+LVME   GG+L   +   +  + E  A     ++V  +H+ H M
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--VYKEIVGSAYYVAPEVL--- 246
           G +HRD+KPEN L+   +    IK  DFG +  +   K    K  VG+  Y+APEVL   
Sbjct: 122 GYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 247 ----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
                  YG E D WS GVI Y ++ G  PF   T    +  I+     L+    P +S 
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
              DLI+ +L    K+R+       HP+  +
Sbjct: 239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  127 bits (320), Expect = 4e-34
 Identities = 83/266 (31%), Positives = 147/266 (55%), Gaps = 23/266 (8%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  +  +K +GR+ A K +  RK    +  E +  E++I++    Q N+VE 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQ-NVVEM 83

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y   + L ++ME   GG L D I+++   +E + A +C  ++  +   H  GVIHRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQR-YGKEID 255
           +K ++ LL     D  +K +DFG    I       K +VG+ Y++APEV+ +  YG E+D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS------ISGQAKDLIR 309
           +WS G+++  ++ G PP+++++        ++    L+ SP P       IS   +D + 
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252

Query: 310 KMLTKDPKKRITAAEALEHPWLKEDG 335
           +MLT++P++R TA E L+HP+L + G
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  127 bits (320), Expect = 8e-34
 Identities = 81/250 (32%), Positives = 131/250 (52%), Gaps = 9/250 (3%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G+G FG   L   KA G+ YA K + ++ ++  K+ + +  E  +L      P +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++    L+ V++  +GGELF  +  +  + E  A     +I + +   H + +I+R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEI 254
           DLKPEN LL S+     +  TDFGL    IE  K      G+  Y+APEVL  Q Y + +
Sbjct: 121 DLKPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  G +LY +L G+PPF++     +++ IL   L L+    P+IS  A+ L+  +L K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQK 233

Query: 315 DPKKRITAAE 324
           D  KR+ A +
Sbjct: 234 DRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 9e-34
 Identities = 88/297 (29%), Positives = 131/297 (44%), Gaps = 49/297 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHL 128
           Y++   +G G +GV   C  KATG   A K     K    +D EDV+    RE+ +L+ L
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL 57

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVH 186
               NIV  + A+  K  L+LV E       EL +   + G        +   Q++  + 
Sbjct: 58  R-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--VYKEIVGSAYYVAPE 244
            CH   +IHRD+KPEN L+    E   +K  DFG +  +         + V + +Y APE
Sbjct: 115 YCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD------LQS 294
           +L     YGK +DVW+ G I+  LL G P F  +++      I +  G L         S
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 295 SP------WPSI--------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           +P      +P                S  A D ++  L  DPK+R+T  E L+HP+ 
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  127 bits (319), Expect = 9e-34
 Identities = 83/262 (31%), Positives = 136/262 (51%), Gaps = 15/262 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KA+G+ YA K + +  ++   ++     E  +L++ T  P +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            + +++ K  L  VME  +GGELF  +  + ++SE        +IV+ +   H   +++R
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEI 254
           DLK EN +L   ++D  IK TDFGL    I      K   G+  Y+APEVL    YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  GV++Y ++ G  PF+ +  + +FE IL  ++        ++S  AK L+  +L K
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232

Query: 315 DPKKRI-----TAAEALEHPWL 331
           DP KR+      A E + H + 
Sbjct: 233 DPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  125 bits (315), Expect = 1e-33
 Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 32/273 (11%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSI----SRRKLVYDKDMEDVRREILILQHLTGQP 132
            ++G G FG  Y      TG   A K I    +  K +     +++  E+ +L+ L   P
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLK-HP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V++ G    ++ +++ ME CSGG L + +    I  E        Q++  +   H  G
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE----IVGSAYYVAPEVL- 246
           ++HRD+KP N  L        IK  DFG +V +        E    + G+  Y+APEV+ 
Sbjct: 120 IVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE--TEKGIFEAILEGNLDLQSSPWP--- 298
               + +G+  D+WS G ++  + +G  P W+E   E  I   +  G       P P   
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAG----HKPPIPDSL 231

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            +S + KD + + L  DPKKR TA+E L+HP++
Sbjct: 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (314), Expect = 1e-33
 Identities = 83/258 (32%), Positives = 129/258 (50%), Gaps = 12/258 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACK--SISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           LG G FG  Y       G  +A K  S++       + ++ + +EI +L  L   PNIV+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQ 66

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G   ++ NL++ +EL  GG L   +   G + E       RQI+  +   H    +HR
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR--YGKEI 254
           D+K  N L+ +      +K  DFG++  +      K   GS Y++APEV+ Q+  YG   
Sbjct: 127 DIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKMLT 313
           D+WS G  +  + +G PP W++ E     A+ +     +  P P  +S +AKD I K L 
Sbjct: 184 DIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 314 KDPKKRITAAEALEHPWL 331
           +DP  R TAAE LEHP++
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  124 bits (314), Expect = 1e-33
 Identities = 80/257 (31%), Positives = 127/257 (49%), Gaps = 12/257 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +         K ++  +L  +K+  D   EI+IL  L   PNI+ + 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQ-HPNIIAYY 65

Query: 139 GAYEDKQNLHLVMELCSGGELFDRII--AKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
             + D   L + ME  +GG L+D+I+     ++ E        QIV+ V   H  G++HR
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLH-QRYGKEI 254
           D+K  N  L    +   IK  DFG+S  + +     E +VG+ YY++PE+    +Y  + 
Sbjct: 126 DIKTLNIFLT---KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D+W+ G +LY LL+    F A     +   I++GN     S +   S +   L+  +L +
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSLLQQ 239

Query: 315 DPKKRITAAEALEHPWL 331
           DP+KR TA E L+ P L
Sbjct: 240 DPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  125 bits (316), Expect = 3e-33
 Identities = 79/250 (31%), Positives = 130/250 (52%), Gaps = 9/250 (3%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G+G FG   L   KA  + YA K + ++ ++  K+ + +  E  +L      P +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++    L+ V++  +GGELF  +  +  + E  A     +I + +   H + +++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEI 254
           DLKPEN LL S+     I  TDFGL    IE         G+  Y+APEVLH Q Y + +
Sbjct: 121 DLKPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  G +LY +L G+PPF++     +++ IL   L L+    P+I+  A+ L+  +L K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQK 233

Query: 315 DPKKRITAAE 324
           D  KR+ A +
Sbjct: 234 DRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  123 bits (311), Expect = 3e-33
 Identities = 76/259 (29%), Positives = 143/259 (55%), Gaps = 12/259 (4%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K++G G FG   L   K  G++Y  K I+  K+   K+ E+ R+E+ +L ++   PNIV+
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQ 63

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIA-KGI-YSEREAANICRQIVNVVHACHFMGVI 194
           ++ ++E+  NL++VM+ C GG+L+ +I A +G+ + E +  +   QI   +   H   ++
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR-YGK 252
           HRD+K +N  L    +D  IK  DFG++ V   T ++ +  +G+ YY++PE+   R Y  
Sbjct: 124 HRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + D+W+ G +LY + +    F A   K +   I+ G+    SS +   S   ++L+ ++ 
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY---SYDLRNLVSQLF 237

Query: 313 TKDPKKRITAAEALEHPWL 331
            ++P+ R +    LE  ++
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  124 bits (312), Expect = 5e-33
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 12/262 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +     +V   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 66

Query: 139 GAYEDKQNLHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ L +GG+L   I  +    + E  A     +I   +   H   +++R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V I  G+  +  VG+  Y+APEV+ ++RY    D
Sbjct: 127 DLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W  G ++Y ++ G  PF    EK   E +     + Q       S  A+ + R++LTKD
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD 243

Query: 316 PKKRI-----TAAEALEHPWLK 332
           P  R+      A E   HP+ +
Sbjct: 244 PGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  124 bits (312), Expect = 5e-33
 Identities = 81/263 (30%), Positives = 140/263 (53%), Gaps = 11/263 (4%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T K++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 82

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQ-RYGKEID 255
           +K ++ LL     D  +K +DFG    +       K +VG+ Y++APE++ +  YG E+D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
           +WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + ++L +D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 316 PKKRITAAEALEHPWLKEDGATS 338
           P +R TAAE L+HP+L + G  S
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  123 bits (311), Expect = 7e-33
 Identities = 89/280 (31%), Positives = 147/280 (52%), Gaps = 19/280 (6%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T+K TG++ A K +  RK    +  E +  E++I++      N+V+ 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDM 84

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 198 LKPENFLLASKEEDSPIKATDFGL--SVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEI 254
           +K ++ LL S   D  IK +DFG    V  E  K  K +VG+ Y++APEV+ +  YG E+
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D+WS G+++  ++ G PP++ E        I + NL  +      +S   +  +  ML +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLMLVR 258

Query: 315 DPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFR 354
           +P +R TA E L+HP+LK  G        S ++  M+Q+R
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPP------SCIVPLMRQYR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  124 bits (311), Expect = 7e-33
 Identities = 83/263 (31%), Positives = 141/263 (53%), Gaps = 13/263 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   +++G+G  G  +     ATG++ A K I+ +K       E +  EIL+++ L   P
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NP 76

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV F  ++     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-Y 250
           VIHRD+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ Y
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           G ++D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSPIFRDFLN 250

Query: 310 KMLTKDPKKRITAAEALEHPWLK 332
           + L  D +KR +A E L+HP+LK
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  123 bits (311), Expect = 7e-33
 Identities = 87/273 (31%), Positives = 132/273 (48%), Gaps = 26/273 (9%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELG+G +G  Y    + TG   A K I  R  + +     +  E+ IL H    P IV+F
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDIL-HKAVSPYIVDF 64

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN-VVHACHFM----G 192
            GA+  +  +++ ME    G L D++ A G+ +E    ++ R+I   VV    F+     
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ---- 248
           +IHRD+KP N L+    +   +K  DFG+S  +    + K  +G   Y+APE +      
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIKSGGPN 179

Query: 249 ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF---EAILEGNLDLQSSPWPSISG 302
               Y  + DVWS G+ +  +  G  P+  ET   IF    AI++G  D  + P    S 
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPTLP-SGYSD 236

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            A+D + K L K P +R T A+ LEHPWL +  
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  125 bits (315), Expect = 8e-33
 Identities = 92/296 (31%), Positives = 140/296 (47%), Gaps = 45/296 (15%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +GRG FG   L  KK TG  YA K + +  ++  + +  +R E  IL    G   +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++DK+NL+L+ME   GG++   ++ K   SE        + V  + A H +G IHR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEI------------------- 234
           D+KP+N LL +K     +K +DFGL   ++     + Y+ +                   
Sbjct: 126 DIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 235 --------------VGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEK 279
                         VG+  Y+APEV  Q  Y K  D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAA---EALEHPWLK 332
             +  ++     L   P   IS +AKDLI +  T D + RI +    E   HP+ +
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  124 bits (313), Expect = 8e-33
 Identities = 99/346 (28%), Positives = 142/346 (41%), Gaps = 79/346 (22%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVR--REILILQ 126
           Y+L KELG+G +G+  +C+ +          A K I+    V+ K +   R  RE+ +L+
Sbjct: 2   YELIKELGQGAYGI--VCSARNAETSEEETVAIKKITN---VFSKKILAKRALRELKLLR 56

Query: 127 HLTGQPNIVE-------FEGAYEDKQNLHLVMELC---------SGGELFDRIIAKGIYS 170
           H  G  NI         F G + +   L+L  EL          SG  L D      IY 
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNE---LYLYEELMEADLHQIIRSGQPLTDAHFQSFIY- 112

Query: 171 EREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
                    QI+  +   H   V+HRDLKP N L+ +   D  +K  DFGL+        
Sbjct: 113 ---------QILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPG 160

Query: 231 -----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
                  E V + +Y APE++   Q Y K IDVWS G IL  LL   P F  +       
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220

Query: 284 AILE-------------------------GNLDLQSSPW--PSISGQAKDLIRKMLTKDP 316
            IL+                          N+  +      P+ +  A DL+ K+L  DP
Sbjct: 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP 280

Query: 317 KKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL 362
            KRI+  EALEHP+L       D+P+          F + + M++L
Sbjct: 281 TKRISVEEALEHPYLAIWHDPDDEPVCQKPFD--FSFESEDSMEEL 324

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  124 bits (314), Expect = 9e-33
 Identities = 95/309 (30%), Positives = 141/309 (45%), Gaps = 57/309 (18%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREIL 123
           I   Y++ ++LG+G +G+ +    + T    A K I      +D      D +   REI+
Sbjct: 5   ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI------FDAFRNATDAQRTFREIM 58

Query: 124 ILQHLTGQPNIVEFEGAY--EDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICR 179
            LQ L   PNIV+       E+ ++++LV E        D   +I   I  +     I  
Sbjct: 59  FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET----DLHAVIRANILEDVHKRYIMY 114

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----- 234
           Q++  +   H   VIHRDLKP N LL S   D  +K  DFGL+  +   +   E      
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 235 -VGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG--- 288
            V + +Y APE+L    RY K +D+WS G IL  +L G P F   +     E I+E    
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 289 --NLDLQS--SPW--------------------PSISGQAKDLIRKMLTKDPKKRITAAE 324
               D++S  SP+                    P  S  A DL++K+L  +P KR+TA E
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Query: 325 ALEHPWLKE 333
           ALEHP++ +
Sbjct: 292 ALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  123 bits (311), Expect = 1e-32
 Identities = 87/264 (32%), Positives = 134/264 (50%), Gaps = 18/264 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED--VRREILILQHLTGQPNI 134
           K LG+G FG   L   K T   +A K++ +  ++ D D+E   V R +L L      P +
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA--WEHPFL 58

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
                 ++ K++L  VME  +GG+L   I + G + E  A     +I+  +   H  G+I
Sbjct: 59  THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLH-QRYGK 252
           +RDLK +N LL   ++D  IK  DFG+      G        G+  Y+APE+L  Q+Y +
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW-PS-ISGQAKDLIRK 310
            +D WS GV+LY +L G  PF  E E  +F++IL         P  P  IS +AKD + K
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------PHFPRWISKEAKDCLSK 229

Query: 311 MLTKDPKKRI-TAAEALEHPWLKE 333
           +  +DP KR+    +  +HP+ + 
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  123 bits (309), Expect = 1e-32
 Identities = 86/263 (32%), Positives = 134/263 (50%), Gaps = 12/263 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +  +  +V   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ L +GG+L   I   G   + E  A     +I   +   H   +++R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V +  G+  K  VG+  Y+APEV+ ++RY    D
Sbjct: 127 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ G +LY +++G  PF    +K   E +     ++Q       S  A+ L + +L KD
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243

Query: 316 PKKRI-----TAAEALEHPWLKE 333
           PK+R+      A E  EHP  K+
Sbjct: 244 PKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  123 bits (311), Expect = 1e-32
 Identities = 82/245 (33%), Positives = 133/245 (54%), Gaps = 11/245 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-IVEF 137
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L  L+G+P  + + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
              ++    L+ VME  +GG+L  +I   G + E  A     +I   +   H  G+I+RD
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126

Query: 198 LKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           LK +N +L S   +  IK  DFG+    +  G   K   G+  Y+APE++ +Q YGK +D
Sbjct: 127 LKLDNVMLDS---EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV+LY +L+G  PF  E E  +F++I+E N+   + P  S+S +A  + + ++TK 
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---AYP-KSMSKEAVAICKGLMTKH 239

Query: 316 PKKRI 320
           P KR+
Sbjct: 240 PGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  122 bits (308), Expect = 2e-32
 Identities = 80/259 (30%), Positives = 139/259 (53%), Gaps = 13/259 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A K ++ ++       E +  EIL+++     PNIV 
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVN 80

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 139

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 140 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLE 254

Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E L+HP+LK
Sbjct: 255 MDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  124 bits (313), Expect = 2e-32
 Identities = 86/304 (28%), Positives = 131/304 (43%), Gaps = 53/304 (17%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G FG   L  K  T   YA K++ +  ++       V+ E  IL        +V+
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++DK NL+ VM+   GG++   +I  GI+ E  A     ++   + + H MG IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKE-------------------- 233
           D+KP+N L+   + D  IK TDFGL     +    K Y++                    
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 234 ---------------------IVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVP 271
                                +VG+  Y+APEVL +  Y +  D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEH 328
           PF A+T       ++     L       +S +A DLI ++     + R+    A E   H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301

Query: 329 PWLK 332
           P+ K
Sbjct: 302 PFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  121 bits (305), Expect = 2e-32
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 12/263 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++  ++G+G FGV +   +KA  R YA K I   K+   ++ E+   E  +L  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SS 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHF 190
            I+ +  ++ DK  L++VME    G+L   +         E +      QI+  +   H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSAYYVAPEVLHQR 249
             ++HRD+K  N  L   +    +K  D G++  +     +   IVG+ YY++PE+   +
Sbjct: 120 KKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 250 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y ++ DVW+ GV+LY   +G  PF A  +  +   I+ G     S  +   S Q   LI
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLI 233

Query: 309 RKMLTKDPKKRITAAEALEHPWL 331
            + LTKD ++R    + L +P L
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  123 bits (310), Expect = 3e-32
 Identities = 84/266 (31%), Positives = 132/266 (49%), Gaps = 17/266 (6%)

Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++  + LG G FG   L T K       A K   + K++  K ++ V  E  IL ++   
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-H 90

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           P  V   G+++D+  L+LV+E   GGE F  +     +          QIV +      +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
            +++RDLKPEN LL   ++D  IK TDFG +  ++T + Y  + G+  Y+APE+L +  +
Sbjct: 151 NIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILLNVGH 205

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           GK  D W+ G+ +Y +L G PPF+A     I++ ILEG +         +    K L++K
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKK 261

Query: 311 MLTKDPKKRI-----TAAEALEHPWL 331
           +L+ D  KR       A    EHPW 
Sbjct: 262 LLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (309), Expect = 8e-32
 Identities = 89/308 (28%), Positives = 140/308 (45%), Gaps = 57/308 (18%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G+G FG   L  KK TG+ YA K++ + ++     +  V+ E  +L   +  P +V 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVS 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++D Q L+L+ME   GG+L   +I    +SE        + V  + A H +G IHR
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSV-F------------------------------- 224
           D+KP+N L+   +    IK +DFGLS  F                               
Sbjct: 126 DIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 225 -----------IETGKVYKEI-----VGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILL 267
                      I T K  + +     VG+  Y+APE+ L Q YG+E D WS G I++  L
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAE 324
            G PPF +E     +  I+     L       +S +A+DLIR+++T + + R+    A E
Sbjct: 243 IGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301

Query: 325 ALEHPWLK 332
              HP+ +
Sbjct: 302 IKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  120 bits (302), Expect = 2e-31
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 13/259 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     PNIV 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNPNIVN 81

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-EIVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 141 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLD 255

Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E L+H +LK
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 80/275 (29%), Positives = 138/275 (50%), Gaps = 35/275 (12%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL--TGQPNIVE 136
           +GRG +G  Y      TGR  A K I+      D D+ D++RE+ +L  L  +  PNI +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIH 195
           + G+Y     L ++ME   GG +  R + K G  +E+  + I R+++  +   H +GVIH
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLH--QRYGK 252
           RD+K  N L+ +      +K  DFG++  +      +   VG+ Y++APEV+   + Y  
Sbjct: 125 RDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAI----------LEGNLDLQSSPWPSISG 302
           + D+WS G+ +Y + +G PP+ ++ +   F A+          LE N           S 
Sbjct: 182 KADIWSLGITIYEMATGNPPY-SDVDA--FRAMMLIPKSKPPRLEDN---------GYSK 229

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT 337
             ++ +   L ++PK+R++A E L+  W+K    T
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  120 bits (301), Expect = 2e-31
 Identities = 80/259 (30%), Positives = 137/259 (52%), Gaps = 13/259 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A K ++   L      E +  EIL+++     PNIV 
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-NKNPNIVN 80

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 140 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--ERLSAVFRDFLNRCLE 254

Query: 314 KDPKKRITAAEALEHPWLK 332
            D  +R +A E L+HP+LK
Sbjct: 255 MDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  118 bits (297), Expect = 3e-31
 Identities = 81/259 (31%), Positives = 132/259 (50%), Gaps = 15/259 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ + +G G FG   L     + +KYA K I  R       +ED R+E ++L  +   P
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKG-IYSEREAANICRQIVNVVHACHF 190
           NIV F+ ++E   +L++VME C GG+L  +I + +G ++ E        Q+   V   H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-EIVGSAYYVAPEVLHQR 249
             V+HRD+K +N  L    ++  +K  DFG +  + +   Y    VG+ YYV PE+    
Sbjct: 119 KRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 250 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDL 307
            Y  + D+WS G ILY L +   PF A + K +   + +G+      P PS  S + + L
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----KPLPSHYSYELRSL 231

Query: 308 IRKMLTKDPKKRITAAEAL 326
           I++M  ++P+ R +A   L
Sbjct: 232 IKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  118 bits (298), Expect = 3e-31
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 40/273 (14%)

Query: 75  LDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
           L K+LG G FG  Y             + A K++       ++ +E+  RE  I   L H
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLDH 60

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVH 186
               PN+V+  G   +++ L++VME   GG+L   +   +   S  +  +   QI     
Sbjct: 61  ----PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI----- 111

Query: 187 AC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA--Y 239
           A           IHRDL   N L+        +K +DFGLS  +     Y++  G     
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           ++APE L   ++  + DVWS GV+L+ + + G  P+   + + + E +  G    Q    
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228

Query: 298 PSISGQAKDLIRKMLT---KDPKKRITAAEALE 327
           P       +L   ML    +DP+ R T +E +E
Sbjct: 229 PP------ELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  120 bits (301), Expect = 3e-31
 Identities = 79/260 (30%), Positives = 130/260 (50%), Gaps = 13/260 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G+G FG      K+ T R YA K+I +  +V   ++     E  +L  +   P IV  +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
            +++  + L+LV+   +GGELF  +  +G +    A     +++  +   H   VI+RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDV 256
           KPEN LL   +    I   DFGL  + ++         G+  Y+APE+L    Y K +D 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L+G+PPF+ E    ++  IL+  L             AKDL+  +L++DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232

Query: 317 KKRI---TAAEALEHPWLKE 333
            +R+    A E   HP+  +
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  119 bits (299), Expect = 7e-31
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 16/262 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L   K  G  +A K++ +  ++ D D+E    E  +L      P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               ++ K++L  VME  +GG+L   I  KG +    A     +IV  +   H  G+I+R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL---SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGK 252
           DLK +N +L   + D  IK  DFG+   +VF +         G+  Y+APE+L   +Y  
Sbjct: 121 DLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-WPSISGQAKDLIRKM 311
            +D WS GV+LY +L G  PF  + E  +FE+I    +D    P W  I+ ++KD++ K+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKL 230

Query: 312 LTKDPKKRITAAEALE-HPWLK 332
             +DP +R+     +  HP+ K
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  117 bits (295), Expect = 8e-31
 Identities = 79/259 (30%), Positives = 126/259 (48%), Gaps = 16/259 (6%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K+LG+G +G  Y   + +  + YA K +    +   K+ ED   EI IL  +   PNI+ 
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIIS 63

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNVVHACHFMG 192
           ++ A+ D   L +VME    G+L   I      + +  E+E   I  Q++  + A H   
Sbjct: 64  YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++HRDLK  N LL + +    +K  D G+S  +    + K  +G+ +Y+APEV   R Y 
Sbjct: 124 ILHRDLKSANILLVANDL---VKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI-SGQAKDLIRK 310
            + D+WS G +LY + +  PPF A + + +   +  G    +  P P I S   ++ IR 
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQNFIRS 235

Query: 311 MLTKDPKKRITAAEALEHP 329
           ML   PK R    + L  P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  120 bits (301), Expect = 8e-31
 Identities = 87/282 (30%), Positives = 140/282 (49%), Gaps = 14/282 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K +GRG FG   L   K+T + YA K +S+ +++   D      E  I+      P
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQR- 249
            IHRD+KP+N LL   ++   +K  DFG  + +    + +    VG+  Y++PEVL  + 
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I+     L       IS +AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279

Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKEDGATSDKPIDSA 345
           +LI   LT    +  R    E   H + K D    +   D+ 
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 321

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (294), Expect = 1e-30
 Identities = 75/274 (27%), Positives = 117/274 (42%), Gaps = 41/274 (14%)

Query: 75  LDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
           L K+LG G FG  Y  T          + A K++       ++ +E+  RE  I   L H
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS--EQQIEEFLREARIMRKLDH 60

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY--SEREAANICRQIVNVV 185
               PNIV+  G   +++ L +VME   GG+L D +        S  +  +   QI    
Sbjct: 61  ----PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI---- 112

Query: 186 HAC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA-- 238
            A           IHRDL   N L+        +K +DFGLS  +     YK   G    
Sbjct: 113 -ARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPI 168

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSP 296
            ++APE L   ++  + DVWS GV+L+ + + G  P+   +   + E + +G    +   
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPN 228

Query: 297 WPSISGQAKDLIRKMLT---KDPKKRITAAEALE 327
            P       +L + ML    +DP+ R T +E +E
Sbjct: 229 CPP------ELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  117 bits (296), Expect = 1e-30
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 39/289 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQ 131
           Y +  ++G G F        + TG+ YA K     K  +    +    REI  L+ L+  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIK---CMKKHFKSLEQVNNLREIQALRRLSPH 57

Query: 132 PNIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHAC 188
           PNI+       D++   L LV EL     L++ I  +     E+   +   Q++  +   
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-- 246
           H  G+ HRD+KPEN L+        +K  DFG    I +   Y E + + +Y APE L  
Sbjct: 117 HRNGIFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE------------------KGIFEAILEG 288
              YG ++D+W+ G + + +LS  P F    E                     F      
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232

Query: 289 NLDLQSS-----PW--PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           N +  S          P+ S +  DL++K+L  DP +RITA +AL HP+
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  117 bits (295), Expect = 2e-30
 Identities = 79/261 (30%), Positives = 134/261 (51%), Gaps = 12/261 (4%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG  +L   K T + +A K++ +  ++ D D+E    E  +L      P +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               ++ K+NL  VME  +GG+L   I +   +    A     +I+  +   H  G+++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-EIVGSAYYVAPEV-LHQRYGKEI 254
           DLK +N LL   + D  IK  DFG+      G        G+  Y+APE+ L Q+Y   +
Sbjct: 121 DLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-WPSISGQAKDLIRKMLT 313
           D WS GV+LY +L G  PF    E+ +F++I    +D    P W  ++ +AKD++ K+  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSI---RMDNPCYPRW--LTREAKDILVKLFV 232

Query: 314 KDPKKRI-TAAEALEHPWLKE 333
           ++P++R+    +  +HP+ +E
Sbjct: 233 REPERRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  117 bits (294), Expect = 3e-30
 Identities = 76/254 (29%), Positives = 131/254 (51%), Gaps = 10/254 (3%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G+G FG   L  +K+ G  YA K + ++ ++  K+   +  E  +L      P +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++  + L+ V++  +GGELF  +  +  + E  A     ++ + +   H + +I+R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEI 254
           DLKPEN LL S+     +  TDFGL    +E  +      G+  Y+APEVL  + Y + +
Sbjct: 121 DLKPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  G +LY +L G+PPF++     +++ IL   L L        +  A DL+  +L K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHK 233

Query: 315 DPKKRITA-AEALE 327
           D ++R+ A A+ LE
Sbjct: 234 DQRRRLGAKADFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  116 bits (292), Expect = 6e-30
 Identities = 94/296 (31%), Positives = 137/296 (46%), Gaps = 66/296 (22%)

Query: 82  GQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REI---LILQHLTGQPNI 134
           G +GV Y    K TG   A K     KL  +K+ E       REI   L LQH    PNI
Sbjct: 16  GTYGVVYRARDKKTGEIVALK-----KLKMEKEKEGFPITSLREINILLKLQH----PNI 66

Query: 135 VEFE----GAYEDKQNLHLVME-----LCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           V  +    G+  DK  +++VME     L S   L + +  K  + + E   +  Q+++ V
Sbjct: 67  VTVKEVVVGSNLDK--IYMVMEYVEHDLKS---LMETM--KQPFLQSEVKCLMLQLLSGV 119

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPE 244
              H   ++HRDLK  N LL ++     +K  DFGL+  +    K Y ++V + +Y APE
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176

Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIF-------EAILEGNLD 291
           +L   + Y   ID+WS G I   LL+  P F  ++E      IF       E I  G  +
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236

Query: 292 LQSS-----------------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           L  +                 P  S+S    DL+ ++LT DP KRI+A +AL+HP+
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  116 bits (291), Expect = 9e-30
 Identities = 81/255 (31%), Positives = 137/255 (53%), Gaps = 18/255 (7%)

Query: 77  KELGRGQFGVTYLCTK---KATGRKYACKSISRRKL-VYDKDMEDVRREILI-LQHLTGQ 131
           K LG+G FG  +L  K      G+ YA K + +  L V D+    + R+IL  + H    
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH---- 57

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           P IV+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +   H +
Sbjct: 58  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           G+I+RDLKPEN LL   +E+  IK TDFGLS   I+  K      G+  Y+APEV+++R 
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           + +  D WS GV+++ +L+G  PF  +  K     IL+  L +       +S +A+ L+R
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 230

Query: 310 KMLTKDPKKRITAAE 324
            +  ++P  R+ A  
Sbjct: 231 ALFKRNPANRLGAGP 245

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  116 bits (291), Expect = 9e-30
 Identities = 77/262 (29%), Positives = 132/262 (50%), Gaps = 13/262 (4%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G+G FG   L  +K  G+ YA K + ++ ++  K+ + +  E  +L      P +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++  + L+ V++  +GGELF  +  +  + E  A     +I + +   H + +++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 197 DLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEI 254
           DLKPEN LL S+     +  TDFGL    I          G+  Y+APEV+  Q Y   +
Sbjct: 121 DLKPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D W  G +LY +L G+PPF+      +++ IL   L L+    P  S  A  ++ ++L K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEK 233

Query: 315 DPKKRITAAEAL----EHPWLK 332
           D ++R+ A E      EHP+ +
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  117 bits (293), Expect = 9e-30
 Identities = 84/269 (31%), Positives = 128/269 (47%), Gaps = 41/269 (15%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +GRG FG   L  KK TG  YA K + +  ++  + +  +R E  IL        +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++DK NL+L+ME   GG++   ++ K   +E E      + V  + + H +G IHR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEI------------------- 234
           D+KP+N LL SK     +K +DFGL   ++     + Y+ +                   
Sbjct: 126 DIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 235 --------------VGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEK 279
                         VG+  Y+APEV  Q  Y K  D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 280 GIFEAILEGNLDLQSSPWPSISGQAKDLI 308
             ++ ++     L   P   IS +AKDLI
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  116 bits (291), Expect = 1e-29
 Identities = 93/314 (29%), Positives = 141/314 (44%), Gaps = 49/314 (15%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILIL 125
           +IT  Y   + +G G FG+      + TG+  A K I +     V  K      RE+ +L
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT---YRELKLL 63

Query: 126 QHLTGQPNIVEFEGAY-EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +HL  + NI+     +    ++++ V EL   G    R++      ++       QI+  
Sbjct: 64  KHLRHE-NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYV 241
           +   H  GV+HRDLKP N L+    E+  +K  DFGL+   +   TG      V + YY 
Sbjct: 121 LKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQMTG-----YVSTRYYR 172

Query: 242 APEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD------ 291
           APE++   Q+Y  E+D+WSAG I   +L G P F  +     F  I +  G         
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232

Query: 292 ---------LQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                    +QS P          + +    A DL+ KML  DP+KRI+AAEAL HP+L 
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Query: 333 EDGATSDKPIDSAV 346
                +D+P+    
Sbjct: 293 PYHDPTDEPVAEEK 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (286), Expect = 1e-29
 Identities = 78/261 (29%), Positives = 127/261 (48%), Gaps = 12/261 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+  + +GRG FG+ +LC +KA  +    K I   ++  D+ +   + E  +L+ L+  P
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLS-HP 59

Query: 133 NIVEF-EGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACH 189
           NI+E+ E   EDK  L +VME   GG L + I  +   +  E    +   QI+  +H  H
Sbjct: 60  NIIEYYENFLEDKA-LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
              ++HRDLK +N LL   +    +K  DFG+S  + +      +VG+  Y++PE+   +
Sbjct: 119 TKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176

Query: 250 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y ++ D+W+ G +LY L S    F A     +   I+ G     S      S   + LI
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLI 233

Query: 309 RKMLTKDPKKRITAAEALEHP 329
             ML  DP KR   ++ +  P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  114 bits (287), Expect = 1e-29
 Identities = 81/263 (30%), Positives = 131/263 (49%), Gaps = 12/263 (4%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +  +  +V   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLA 66

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ + +GG+L   I   G   + E+ A     ++   +       +++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V I  G+  +  VG+  Y+APEV+ +++Y    D
Sbjct: 127 DLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPD 183

Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W  G ++Y ++ G  PF    E+   E +     + Q       S  AK + R +LTK+
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243

Query: 316 PKKRI-----TAAEALEHPWLKE 333
           PK+R+      AA   +HP  K 
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 3e-29
 Identities = 86/267 (32%), Positives = 135/267 (50%), Gaps = 21/267 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACK-----SISRRKLVYDKDMED-VRREILILQHLTGQP 132
           +G G FG  YL    ++G   A K     S+S       + M D + REI +L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HE 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV++ G+  D  +L++ +E   GG +   +   G + E    N  RQI+  ++  H  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-------TGKVYKEIVGSAYYVAPEV 245
           +IHRD+K  N L+ +K     IK +DFG+S  +E       T      + GS +++APEV
Sbjct: 127 IIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 246 LHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + Q  Y ++ D+WS G ++  +L+G  PF   T+    +AI +   +       +IS +A
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPSNISSEA 240

Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWL 331
            D + K    D  KR TAAE L+HP+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  114 bits (286), Expect = 3e-29
 Identities = 91/292 (31%), Positives = 143/292 (48%), Gaps = 26/292 (8%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D   ++++  ELG G FG  Y    K TG   A K I  +    ++++ED   EI IL 
Sbjct: 8   LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILA 64

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI---IAKGIYSEREAANICRQIVN 183
                P IV+  GA+     L +++E C GG + D I   + +G+ +E +   ICRQ++ 
Sbjct: 65  T-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVICRQMLE 121

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVA 242
            +   H M +IHRDLK  N LL     D  IK  DFG+S   ++T +     +G+ Y++A
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178

Query: 243 PEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
           PEV+         Y  + D+WS G+ L  +    PP        +   I +      S P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238

Query: 297 --WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
             W   S + +D ++  L K P+ R +AA+ LEHP++     TS++P+   V
Sbjct: 239 SKW---SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS--VTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  115 bits (290), Expect = 4e-29
 Identities = 94/315 (29%), Positives = 141/315 (44%), Gaps = 57/315 (18%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L  K  T   YA K++ ++ ++    +  V+ E  IL     +  +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVR 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++DK NL+ VM+   GG++   +I  GI+ E  A     ++   V + H MG IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGL---------SVFIETGKVYKE-------------- 233
           D+KP+N L+   + D  IK TDFGL         S + ++G   ++              
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 234 -------------------------IVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILL 267
                                    +VG+  Y+APEVL +  Y +  D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAE 324
            G PPF A+T       ++     L   P   +S +A DLI K L + P+ R+    A E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301

Query: 325 ALEHPWLKEDGATSD 339
              HP+ K    +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  111 bits (280), Expect = 1e-28
 Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 21/262 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVY-------DKDMEDVRREILI 124
           Y + + LG G FG  Y   KK  G+   A K I+     +       DK + D+  E+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQ 180
           ++     PNIV +   + +   L++VM+L  G  L +   +    K  ++E    NI  Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 181 IVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +V  +   H    ++HRDL P N +L    ED  +  TDFGL+   +       +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 240 YVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD-LQSSPW 297
           Y  PE++    YG++ DVW+ G ILY + +  PPF++     +   I+E   + L    +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 298 PSISGQAKDLIRKMLTKDPKKR 319
              S    D+I   LT D + R
Sbjct: 239 ---SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  111 bits (280), Expect = 4e-28
 Identities = 70/254 (27%), Positives = 128/254 (50%), Gaps = 20/254 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE--ILILQHLTGQPNIVE 136
           LGRG FG   L   K TG  YA K++ +  ++   ++E +  E  I    +    P +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               ++ + ++  VME  +GG+L    I   ++SE  A      +V  +   H   +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE----IVGSAYYVAPEVL-HQRYG 251
           DLK +N LL +   +  +K  DFGL    + G  + +      G+  ++APEVL    Y 
Sbjct: 126 DLKLDNLLLDT---EGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRK 310
           + +D W  GV++Y +L G  PF  + E+ +F++I+          +P  +S +A  ++R+
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234

Query: 311 MLTKDPKKRITAAE 324
           +L ++P++R+ + E
Sbjct: 235 LLRRNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  110 bits (276), Expect = 4e-28
 Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 28/269 (10%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE-------ILILQHLT 129
           K LG+G FG  YLC    TGR+ A K +      +D +  +  +E       I +L++L 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQ-----FDPESPETSKEVSALECEIQLLKNLQ 62

Query: 130 GQPNIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            +  IV++ G   D+  + L + ME   GG + D++ A G  +E       RQI+  +  
Sbjct: 63  HE-RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET----GKVYKEIVGSAYYVAP 243
            H   ++HRD+K  N L   ++    +K  DFG S  ++T    G   + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 244 EVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-IS 301
           EV+  + YG++ DVWS G  +  +L+  PP WAE E     AI +      +   PS IS
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHIS 235

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPW 330
             A+D +  +   + + R +A E L HP+
Sbjct: 236 EHARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  111 bits (279), Expect = 4e-28
 Identities = 86/296 (29%), Positives = 123/296 (41%), Gaps = 56/296 (18%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--------REILILQHLTG 130
           +G G +G+ Y      +G   A K +          M++ R        REI +L +L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVR---------MDNERDGIPISSLREITLLLNLR- 64

Query: 131 QPNIVEFEGAYEDKQ--NLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVH 186
            PNIVE +     K   ++ LVME C      L D +     +SE +   +  Q++  + 
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQ 122

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
             H   +IHRDLK  N LL  K     +K  DFGL+  +    K     V + +Y APE+
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179

Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI------------------ 285
           L     Y   ID+W+ G IL  LL+  P    ++E    + I                  
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239

Query: 286 -LEGNLDLQSSPW-------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            L G   L   P+       P +S     L+  +L  DPKKR TA EALE  + KE
Sbjct: 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  110 bits (275), Expect = 5e-28
 Identities = 84/270 (31%), Positives = 134/270 (49%), Gaps = 22/270 (8%)

Query: 71  TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI--SRRKLVYDKDMEDVRREILILQHL 128
           T + L K LG+G FG  YLC    TGR+ A K +          K++  +  EI +L++L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 129 TGQPNIVEFEGAYEDKQ--NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
             +  IV++ G   D     L + ME   GG + D++ + G  +E       RQI+  V 
Sbjct: 62  LHE-RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET----GKVYKEIVGSAYYVA 242
             H   ++HRD+K  N L   ++    +K  DFG S  ++T    G   K + G+ Y+++
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 243 PEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFE-AILEGNLDLQSSPWP 298
           PEV+  + YG++ D+WS G  +  +L+  PP WAE E    IF+ A    N  L     P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQPTNPVLP----P 232

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEH 328
            +S   +D ++++   + K R +A E L H
Sbjct: 233 HVSDHCRDFLKRIFV-EAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  110 bits (276), Expect = 5e-28
 Identities = 80/258 (31%), Positives = 130/258 (50%), Gaps = 14/258 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD--KDMEDVRREILILQHLTGQPNIVE 136
           LG+G FG       K TG+ YACK + +++L     + M  + +EIL        P IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL---EKVNSPFIVN 57

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII---AKGIYSEREAANICRQIVNVVHACHFMGV 193
              A+E K +L LVM L +GG+L   I     +G+  ER   +   QI   +   H M +
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER-VIHYSAQITCGILHLHSMDI 116

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YGK 252
           ++RD+KPEN LL   ++    + +D GL+V ++ GK   +  G+  Y+APE+L +  Y  
Sbjct: 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-DLQSSPWPSISGQAKDLIRKM 311
            +D ++ G  +Y +++G  PF    EK   E +    L D       + + ++KD+ R  
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233

Query: 312 LTKDPKKRITAAEALEHP 329
           L K P+ R+ + E  + P
Sbjct: 234 LAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  110 bits (276), Expect = 6e-28
 Identities = 80/266 (30%), Positives = 132/266 (49%), Gaps = 15/266 (5%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK +++++L   K  E    E  IL  +  +  IV   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR-FIVSLA 59

Query: 139 GAYEDKQNLHLVMELCSGGELFDRII----AKGIYSEREAANICRQIVNVVHACHFMGVI 194
            A++ K +L LVM + +GG+L   I         + E  A     QI++ +   H   +I
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPEVLH-QRYGK 252
           +RDLKPEN LL   + D  ++ +D GL+V ++ G+   K   G+  ++APE+L  + Y  
Sbjct: 120 YRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
            +D ++ GV LY +++   PF A  EK   + + +  L+   +     S  +K     +L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 313 TKDPKKRI-----TAAEALEHPWLKE 333
            KDP+KR+            HP  ++
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  109 bits (274), Expect = 9e-28
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 29/272 (10%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACK------SISRRKLVYDKDM-EDVRREILILQHLTGQ 131
           +G+G +G  YL     TG   A K      +I+ R     KDM + +R EI  L+ L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-H 67

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            NIV++ G    ++ L + +E   GG +   +   G + E+       Q++  +   H  
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-----IVGSAYYVAPEVL 246
           G++HRDLK +N L+   + D   K +DFG+S   ++  +Y       + GS +++APEV+
Sbjct: 128 GILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 247 H---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS---- 299
           H   Q Y  ++D+WS G ++  + +G  P W++ E     A+ +      + P P     
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEE--AIAAMFKLGNKRSAPPIPPDVSM 239

Query: 300 -ISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            +S  A D +    T +P  R TA E L+HP+
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 26/269 (9%)

Query: 77  KELGRGQFGVTYLCT---KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           K+LG G FG  Y      K     + A K++       +++ +D  +E  +++ L G PN
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKL-GHPN 57

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY---------SEREAANICRQIVNV 184
           +V   G   +++ L+LV+E   GG+L D +               S ++  +   QI   
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV--- 241
           +        +HRDL   N L+    ED  +K +DFGLS  +     Y++  G    +   
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 242 APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           APE L    +  + DVWS GV+L+ + + G  P+   + + + E + +G    +      
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP---EY 231

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEH 328
              +  +L+      DP+ R T +E +E 
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (275), Expect = 1e-27
 Identities = 85/271 (31%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG G  G    C  K TG  +A K+I+          + + RE+ I +     P IV++ 
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKS-CKSPYIVKYY 65

Query: 139 GAYEDKQ--NLHLVMELCSGGELFDRIIAK-----GIYSEREAANICRQIVNVVHACHFM 191
           GA+ D+   ++ + ME C GG L D I  K     G   E+    I   ++  +   H  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPE-VLHQR 249
            +IHRD+KP N LL  K +   +K  DFG+S   +    +     G+++Y+APE +  + 
Sbjct: 125 KIIHRDIKPSNILLTRKGQ---VKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQGKP 179

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKG-----IFEAILEG-NLDLQSSPWPSI--S 301
           Y    DVWS G+ L  +     PF  E E       +   I+   N +L+  P   I  S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            + KD I++ L KDP +R T  + LEHPW+K
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  109 bits (273), Expect = 1e-27
 Identities = 82/270 (30%), Positives = 129/270 (47%), Gaps = 25/270 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++L + +G G +G  Y      TG   A K I   KL   +D   V++EI++++      
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCK-HS 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV + G+Y  +  L + ME C GG L D     G  SE + A + R+ +  ++  H  G
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-- 249
            +HRD+K  N LL    ++  +K  DFG+S  I  T    K  +G+ Y++APEV      
Sbjct: 127 KMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 250 --YGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAK- 305
             Y +  D+W+ G+    L    PP F     + +F   L    + Q    P +  + K 
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP---PKLKDKMKW 237

Query: 306 -----DLIRKMLTKDPKKRITAAEALEHPW 330
                  ++  LTK+PKKR TA + L+HP+
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  109 bits (273), Expect = 2e-27
 Identities = 93/297 (31%), Positives = 133/297 (44%), Gaps = 59/297 (19%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG+  A K     K+  + + E V     REI +L+ L   P
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQ-HP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFD-----RIIAKGIYSERE-AANICRQIVNVVH 186
           NIV  +     +  L+L+ E  S     D       + KG Y + E   +   QI+  + 
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   V+HRDLKP+N L+ +K     IK  DFGL+  F    +VY   V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLDLQSSPWP- 298
           L    RY   +D+WS G I   + +  P F  ++E      IF  +     D+    WP 
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV----WPG 228

Query: 299 -----------------SISGQAK-------DLIRKMLTKDPKKRITAAEALEHPWL 331
                            S+    K       DL+ KML  DP KRI+A +AL HP+ 
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  108 bits (271), Expect = 2e-27
 Identities = 76/263 (28%), Positives = 131/263 (49%), Gaps = 11/263 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K++G G FG  YL   K+       K I   K+   K+ E  ++E+++L  +   P
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HP 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGI-YSEREAANICRQIVNVVHACHF 190
           NIV F  ++++   L +VME C GG+L  RI   +G+ +SE +  +   QI   +   H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR 249
             ++HRD+K +N  L+     +  K  DFG++    ++ ++    VG+ YY++PE+   R
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177

Query: 250 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y  + D+WS G +LY L +   PF       +   I +G     S   P+ S   + LI
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSLI 234

Query: 309 RKMLTKDPKKRITAAEALEHPWL 331
            ++    P+ R +    L+ P+L
Sbjct: 235 SQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 3e-27
 Identities = 90/319 (28%), Positives = 144/319 (45%), Gaps = 58/319 (18%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           D+   Y     +G G +G+    T K TG K A K IS     ++      R  REI IL
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP----FEHQTFCQRTLREIKIL 57

Query: 126 QHLTGQPNIVEF-----EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR- 179
           +    + NI+         ++E   ++++V EL       +  + K I ++  + +  + 
Sbjct: 58  RRFKHE-NIIGILDIIRPPSFESFNDVYIVQEL------METDLYKLIKTQHLSNDHIQY 110

Query: 180 ---QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---- 232
              QI+  +   H   V+HRDLKP N LL +   +  +K  DFGL+   +    +     
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLT 167

Query: 233 EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAIL 286
           E V + +Y APE++   + Y K ID+WS G IL  +LS  P F  +        I   + 
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227

Query: 287 EGNLD-------------LQSSPW----------PSISGQAKDLIRKMLTKDPKKRITAA 323
             + +             ++S P+          P+   +A DL+ KMLT +P KRIT  
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287

Query: 324 EALEHPWLKEDGATSDKPI 342
           EAL HP+L++    SD+P+
Sbjct: 288 EALAHPYLEQYHDPSDEPV 306

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  108 bits (272), Expect = 3e-27
 Identities = 97/311 (31%), Positives = 131/311 (42%), Gaps = 65/311 (20%)

Query: 71  TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRREILILQ 126
             +D+  ++G G +G  Y    K TG   A K     K+  D + E       REI IL+
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILR 61

Query: 127 HLTGQPNIVEFEGAYEDKQ----------NLHLVMELCSGGELFDRIIAKGI--YSEREA 174
            L    NIV  +    DKQ            +LV E     +L   ++  G+  +SE   
Sbjct: 62  QLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHI 118

Query: 175 ANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYK 232
            +  +Q++  ++ CH    +HRD+K  N LL +K +   IK  DFGL+    +   + Y 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYT 175

Query: 233 EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
             V + +Y  PE+L   +RYG  IDVWS G IL  L +  P F A  E    E I     
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR--- 232

Query: 291 DLQSSP----WPS--------------------------ISGQAKDLIRKMLTKDPKKRI 320
            L  SP    WP                           I   A DL+  MLT DP KR 
Sbjct: 233 -LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291

Query: 321 TAAEALEHPWL 331
           TA EAL  PWL
Sbjct: 292 TAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 6e-27
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 26/271 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ------ 126
           + L K LGRG FG  YLC    TGR+ A K +      +D D ++  +E+  L+      
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVP-----FDPDSQETSKEVNALECEIQLL 58

Query: 127 HLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
                  IV++ G   D  ++ L + +E   GG + D++ A G  +E       RQI+  
Sbjct: 59  KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET----GKVYKEIVGSAYY 240
           V   H   ++HRD+K  N L   ++    +K  DFG S  I+T    G   K + G+ Y+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 241 VAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP- 298
           ++PEV+  + YG++ DVWS    +  +L+  PP WAE E     AI +          P 
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTKPMLPD 232

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
            +S   +D ++++  ++ K+R TA   L HP
Sbjct: 233 GVSDACRDFLKQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  107 bits (269), Expect = 6e-27
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 47/288 (16%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNI 134
           +G G +GV + C  + TG+  A K     K V  +D   ++    REI +L+ L   PN+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62

Query: 135 VEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           V     +  K+ LHLV E C    L   ++   +G+  E     I  Q +  V+ CH   
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGV-PEHLIKKIIWQTLQAVNFCHKHN 120

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVL--HQR 249
            IHRD+KPEN L+    +   IK  DFG +  +   G  Y + V + +Y APE+L    +
Sbjct: 121 CIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE------------------KGIFEA--ILEG- 288
           YG  +DVW+ G +   LL+G P +  +++                  + IF      +G 
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 289 ------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                   +   S +P+IS  A   ++  L  DP +R++  E LEHP+
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  109 bits (273), Expect = 8e-27
 Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 55/314 (17%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L  K  T   YA K++ ++ ++    +  V+ E  IL     +  +V+
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW-VVK 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +++DK NL+ VM+   GG++   +I   ++ E  A     ++   + + H MG IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKE-------------------- 233
           D+KP+N L+   + D  IK TDFGL     +    K Y++                    
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 234 -------------------------IVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILL 267
                                    +VG+  Y+APEVL ++ Y +  D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML--TKDPKKRITAAEA 325
            G PPF A T       ++     L   P   +S +A DLI K+    ++   R  A + 
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302

Query: 326 LEHPWLKEDGATSD 339
             HP+  E   +SD
Sbjct: 303 KAHPFFSEVDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  106 bits (265), Expect = 1e-26
 Identities = 67/263 (25%), Positives = 123/263 (46%), Gaps = 13/263 (4%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSIS---RRKLVYDKDMEDVRREILILQHLTGQPN 133
           ++LG G F   Y      TG   A K ++         ++ +E +R+EI ++  L   P+
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPH 64

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+   GA  +  + +L +E  +GG +   +   G + E    N   Q++  +   H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVLH- 247
           IHRD+K  N L+ S  +   ++  DFG +  +       G+   +++G+  ++APEVL  
Sbjct: 125 IHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKD 306
           ++YG+  DVWS G ++  + +  PP+ AE        I +      +   P  +S   +D
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242

Query: 307 LIRKMLTKDPKKRITAAEALEHP 329
           +  + L   P+ R  + E L+HP
Sbjct: 243 VTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  106 bits (266), Expect = 2e-26
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)

Query: 60  PILGKPYV-----DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD 114
           P+ GK  +     D +  +++ + +G+G +G  +    K  G K A K +     ++D D
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IHDID 58

Query: 115 MEDVRREILILQHLTGQPNIVEFEGAY--EDKQN---LHLVMELCSGGELFDRIIAKGI- 168
            E++  E  IL+ L+  PN+V+F G Y  +D +N   L LV+ELC+GG + D  + KG  
Sbjct: 59  -EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFL 115

Query: 169 -----YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
                  E   A I  + +  +   H    IHRD+K  N LL +   +  +K  DFG+S 
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSA 172

Query: 224 FIETGKVYKEI-VGSAYYVAPEV------LHQRYGKEIDVWSAGVILYILLSGVPPFWAE 276
            + + ++ +   VG+ +++APEV      L   Y    DVWS G+    L  G PP  A+
Sbjct: 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-AD 231

Query: 277 TEKGIFEAILEGNLDLQSSPWPSI------SGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                    +     +  +P P++      S +  D IRK LTKD +KR T ++ L+H +
Sbjct: 232 LHP------MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Query: 331 L 331
           +
Sbjct: 286 I 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 80/275 (29%), Positives = 146/275 (53%), Gaps = 26/275 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K TG+ YA K +++ +++   +    R E  +L +   + 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHAC 188
            I     A++D+ NL+LVM+   GG+L   +++K  + +R   ++ R    ++V  + + 
Sbjct: 63  -ITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVLAIDSV 118

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEI-VGSAYYVAPEVL 246
           H +G +HRD+KP+N LL   +++  I+  DFG  + +   G V   + VG+  Y++PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 247 HQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL--EGNLDLQSSPWP 298
                   RYG E D WS GV +Y +L G  PF+AE+    +  I+  + +         
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-T 234

Query: 299 SISGQAKDLIRKMLTKDPKKRI---TAAEALEHPW 330
            +S +AKDLIR+++   P+ R+      +  +HP+
Sbjct: 235 DVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  106 bits (266), Expect = 3e-26
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 24/271 (8%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +GRG +    L   K T R YA K + +  +  D+D++ V+ E  + +  +  P +V   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G+I+RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDV 256
           K +N LL S   +  IK TD+G+    +  G       G+  Y+APE+L  + YG  +D 
Sbjct: 123 KLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 257 WSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S +A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 235

Query: 308 IRKMLTKDPKKRITA------AEALEHPWLK 332
           ++  L KDPK+R+        A+   HP+ +
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  106 bits (267), Expect = 3e-26
 Identities = 94/315 (29%), Positives = 136/315 (43%), Gaps = 51/315 (16%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           ++ T Y   K +GRG +G+        T  K A K I+     +D  ++  R  REI +L
Sbjct: 2   EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLL 58

Query: 126 QHLTGQPNIVEFEG--------AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI 177
           +HL  + N++  +         A+ D   +++V EL    +L   I +    S+      
Sbjct: 59  RHLDHE-NVIAIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVG 236
             Q++  +   H   V+HRDLKP N LL     +  +K  DFGL+    E G    E V 
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVV 170

Query: 237 SAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAI---LE 287
           + +Y APE+L     Y   IDVWS G I   LL   P F    +    K I E +    E
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230

Query: 288 GNLDLQSSP--------------------WPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            +L    +                     +P  +  A DL+ KML  DP KRIT  EAL 
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Query: 328 HPWLKEDGATSDKPI 342
           HP+L      SD+P+
Sbjct: 291 HPYLASLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  106 bits (267), Expect = 4e-26
 Identities = 94/310 (30%), Positives = 137/310 (44%), Gaps = 64/310 (20%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR-------RKLVYDKDMEDVRREILILQHLTGQ 131
           +G G +G         TGRK A K +SR        K  Y        RE+ +L+H+   
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--------RELRLLKHMD-H 73

Query: 132 PNIVEFEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
            N++     +      ED Q+++LV  L  G +L + I+     S+     +  QI+  +
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQILRGL 131

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVA 242
              H  G+IHRDLKP N  +    ED  +K  DFGL+   +   TG  Y   V + +Y A
Sbjct: 132 KYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDEMTG--Y---VATRWYRA 183

Query: 243 PEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD------- 291
           PE++     Y + +D+WS G I+  LL+G   F         + I+   G  D       
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 292 --------LQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                   +QS P          +   +  A DL+ KML  DP KRITAAEAL HP+L E
Sbjct: 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 334 DGATSDKPID 343
                D+P+ 
Sbjct: 304 YHDPEDEPVA 313

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  105 bits (264), Expect = 4e-26
 Identities = 90/300 (30%), Positives = 130/300 (43%), Gaps = 51/300 (17%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHL 128
           Y+  +++G G +G  Y    K TG+  A K     K   + D E +     REI +LQ L
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQML 57

Query: 129 TGQPNIVEF---EGAYED--KQNLHLVME-----LCSGGELFDRIIAKGIYSEREAANIC 178
           +    IV     E   E   K +L+LV E     L    +   R   + +   +   +  
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPL-PAKTIKSFM 116

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVG 236
            Q++  V  CH  GV+HRDLKP+N L+   ++   +K  D GL     I       EIV 
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173

Query: 237 SAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIF-------E 283
           + +Y APEVL     Y   +D+WS G I   +    P F  ++E      IF       E
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 284 AILEGNLDLQ-------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            +  G   L+             S   P +S +  DL++KML  DP KRI+A  AL HP+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (261), Expect = 7e-26
 Identities = 71/267 (26%), Positives = 135/267 (50%), Gaps = 22/267 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + ++K++G+GQF V Y       GR  A K +   +++  K  +D  +EI +L+ L   P
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-----KGIYSEREAANICRQIVNVVHA 187
           N++++  ++ +   L++V+EL   G+L  R+I      K +  ER       Q+ + +  
Sbjct: 63  NVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKEIVGSAYYVAPEV 245
            H   ++HRD+KP N  + +      +K  D GL  F   +T   +  +VG+ YY++PE 
Sbjct: 122 MHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPER 177

Query: 246 LHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEK--GIFEAILEGNLDLQSSPWPS--I 300
           +H+  Y  + D+WS G +LY + +   PF+ +      + + I + +      P P+   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----PPLPADHY 233

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALE 327
           S + +DL+ + +  DP+KR   +  L+
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  106 bits (265), Expect = 8e-26
 Identities = 87/320 (27%), Positives = 141/320 (44%), Gaps = 38/320 (11%)

Query: 29  PLPRRTQQ-----DFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQ 83
           PLP+R           P SS   + S      S   P   K   ++  +      +G G 
Sbjct: 33  PLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSA--PSAAKSLSELERV----NRIGSGA 86

Query: 84  FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNIVEFEG 139
            G  Y    + TGR YA K I      Y    + VR    REI IL+ +   PN+V+   
Sbjct: 87  GGTVYKVIHRPTGRLYALKVI------YGNHEDTVRRQICREIEILRDVN-HPNVVKCHD 139

Query: 140 AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLK 199
            ++    + +++E   GG L    IA     E+  A++ RQI++ +   H   ++HRD+K
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIK 195

Query: 200 PENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-----HQRY-GK 252
           P N L+ S +    +K  DFG+S +  +T       VG+  Y++PE +     H  Y G 
Sbjct: 196 PSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-SPWPSISGQAKDLIRKM 311
             D+WS GV +     G  PF     +G + +++      Q      + S + +  I   
Sbjct: 253 AGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCC 311

Query: 312 LTKDPKKRITAAEALEHPWL 331
           L ++P KR +A + L+HP++
Sbjct: 312 LQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  103 bits (257), Expect = 2e-25
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTG 130
           Y L + LG+G FG  YL   K    +   K +    +      E V+  +E  +L  L  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD- 60

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNVVH 186
            P IV+F  ++ ++    ++ E C G +L  ++          SE +      Q++  VH
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEV 245
             H   ++HRDLK +N  L    +++ +K  DFG+S  +  +  +     G+ YY++PE 
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 246 L-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI---- 300
           L HQ Y  + D+WS G ILY +      F  +    +   I+EG       P PS+    
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------PTPSLPETY 229

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           S Q   +++ ML KDP  R +AAE L +P++
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  104 bits (260), Expect = 2e-25
 Identities = 70/251 (27%), Positives = 124/251 (49%), Gaps = 16/251 (6%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +GRG +    L   K   + YA K + +  +  D+D++ V+ E  + +  +  P +V   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L LV+E  +GG+L   +  +    E  A     +I   ++  H  G+I+RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDV 256
           K +N LL   + D  IK TD+G+    +  G       G+  Y+APE+L  + YG  +D 
Sbjct: 123 KLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 257 WSAGVILYILLSGVPPF-------WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           W+ GV+++ +++G  PF          TE  +F+ ILE  + +       +S +A  +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHVLK 235

Query: 310 KMLTKDPKKRI 320
             L KDPK+R+
Sbjct: 236 GFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  102 bits (257), Expect = 3e-25
 Identities = 85/297 (28%), Positives = 128/297 (43%), Gaps = 62/297 (20%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K     K+  D + E V     REI +L+ L   P
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HP 59

Query: 133 NIVEFEGAYEDKQNLHLV-----------MELCSGGELFDRIIAKGIYSEREAANICRQI 181
           NIV+       +  L+LV           M+      +   +I   ++          Q+
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF----------QL 109

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYY 240
           +  +  CH   V+HRDLKP+N L+     +  IK  DFGL+  F    + Y   V + +Y
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 166

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILE 287
            APE+L   + Y   +D+WS G I   +++    F  ++E      IF       E +  
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226

Query: 288 GNLDLQ----SSP-W---------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           G   L     S P W         P +    +DL+ +ML  DP KRI+A  AL HP+
Sbjct: 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  103 bits (258), Expect = 3e-25
 Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 19/265 (7%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y      T    A K +S      ++  +D+ +E+  LQ L   PN +E
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79

Query: 137 FEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           ++G Y  +    LVME C  S  ++ +  + K    E E A IC   +  +   H    I
Sbjct: 80  YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRY 250
           HRD+K  N LL    E   +K  DFG +  +     +   VG+ Y++APEV+      +Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-DLQSSPWPSISGQAKDLIR 309
             ++DVWS G+    L    PP +          I + +   L S+ W   S   ++ + 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVD 248

Query: 310 KMLTKDPKKRITAAEALEHPWLKED 334
             L K P+ R ++ E L+H ++  +
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  103 bits (258), Expect = 5e-25
 Identities = 76/271 (28%), Positives = 131/271 (48%), Gaps = 24/271 (8%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +GRG +    L   K T R YA K I +  +  D+D++ V+ E  + +  +  P +V   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++ +  L  V+E  SGG+L   +  +    E  A     +I   ++  H  G+I+RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 199 KPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDV 256
           K +N LL +   +  IK TD+G+    I  G       G+  Y+APE+L  + YG  +D 
Sbjct: 123 KLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 257 WSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S +A  +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKASSV 235

Query: 308 IRKMLTKDPKKRITA------AEALEHPWLK 332
           ++  L KDPK+R+         +   HP+ +
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  101 bits (253), Expect = 9e-25
 Identities = 85/281 (30%), Positives = 134/281 (47%), Gaps = 25/281 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++  ELG G FG  Y    K TG   A K I  +    ++++ED   EI IL      P
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDHP 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHF 190
           NIV+   A+  + NL +++E C+GG + D ++ +     +E +   +C+Q +  ++  H 
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL--- 246
             +IHRDLK  N L      D  IK  DFG+S     T +     +G+ Y++APEV+   
Sbjct: 122 NKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--QSSPWPSIS 301
               + Y  + DVWS G+ L  +    PP        +   I +       Q S W   S
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---S 235

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
            + KD ++K L K+   R T  + L+HP++      S+KPI
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVT---VNSNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  101 bits (252), Expect = 1e-24
 Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 16/265 (6%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--PNIVE 136
           +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  ++    P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              A+     L  +++L +GG+L   +   G++SE E      +I+  +   H   V++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEI 254
           DLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +   Y    
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSA 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKMLT 313
           D +S G +L+ LL G  PF     K   E  ++      +   P S S + + L+  +L 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 314 KDPKKRI-----TAAEALEHPWLKE 333
           +D  +R+      A E  EHP+ + 
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 85/296 (28%), Positives = 126/296 (42%), Gaps = 62/296 (20%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNI 134
           +G G +GV Y    K TG   A K I       + + E V     REI +L+ L   PNI
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELN-HPNI 60

Query: 135 VEFEGAYEDKQNLHLV-----------MELCSGGELFDRIIAKGIYSEREAANICRQIVN 183
           V        +  L+LV           M+      L   +I   +Y          Q++ 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY----------QLLQ 110

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVA 242
            +  CH   V+HRDLKP+N L+   + +  +K  DFGL+  F    + Y   V + +Y A
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 243 PEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILEGN 289
           PE+L   ++Y   +D+WS G I   +++  P F  ++E      IF       E +  G 
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 290 LDLQ--------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             L               S   P++     DL+ KML  DP KRI+A  AL+HP+ 
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  102 bits (255), Expect = 1e-24
 Identities = 84/321 (26%), Positives = 123/321 (38%), Gaps = 88/321 (27%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSIS---------RRKLVYDKDMEDVRREIL 123
           Y   + +G G +GV        +G+K A K I          +R L          RE+ 
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----------RELK 56

Query: 124 ILQHLTGQPNIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           IL+H     NI+           D +++++VM+L         II               
Sbjct: 57  ILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIH------------SD 101

Query: 180 QIVNVVHACHFM-------------GVIHRDLKPENFLLASKEEDSPIKATDFGL----- 221
           Q +   H  +F+              VIHRDLKP N L+    ED  ++  DFG+     
Sbjct: 102 QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLS 158

Query: 222 SVFIETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVI----------------- 262
           S   E      E V + +Y APE+L     Y   ID+WS G I                 
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218

Query: 263 --LYILLS--GVPP--FWAETEKGIFEAILEGNLDLQSSPW----PSISGQAKDLIRKML 312
             L ++LS  G P                ++     Q  PW    P  S +A DL+ +ML
Sbjct: 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML 278

Query: 313 TKDPKKRITAAEALEHPWLKE 333
             DP++RIT  +AL+HP+L +
Sbjct: 279 QFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  100 bits (251), Expect = 2e-24
 Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 21/266 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSI---SRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           LG+G +G  Y C     G+  A K +   +   L  +K+ E ++ E+ +L+ L    NIV
Sbjct: 8   LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIV 65

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
           ++ G   D   + + ME   GG +   +   G   E       +QI++ V   H   V+H
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 196 RDLKPENFLLASKEEDSPIKATDFG-------LSVFIETGKVYKEIVGSAYYVAPEVLHQ 248
           RD+K  N +L     +  IK  DFG       + +      + K + G+ Y++APEV+++
Sbjct: 126 RDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 249 R-YGKEIDVWSAGVILYILLSGVPPFWAETEK--GIFEAILEGNLDLQSSPWPSISGQAK 305
             YG++ D+WS G  ++ + +G PP  A  ++   +F  I      +   P  S S  A 
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF-YIGAHRGLMPRLP-DSFSAAAI 239

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
           D +   LT+D  +R +A + L H +L
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  100 bits (251), Expect = 2e-24
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 43/286 (15%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNI 134
           +G G +G+   C  K TG+  A K     K +  +D + V+    REI +L+ L  + N+
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLRHE-NL 62

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           V     +  K+ L+LV E      L D         E        QI+  +  CH   +I
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVL--HQRYG 251
           HRD+KPEN L++   +   +K  DFG +  +   G+VY + V + +Y APE+L    +YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD------LQSSP------- 296
           + +D+W+ G ++  +L+G P F  +++      I++  GNL        Q +P       
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 297 ------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                       +P +SG   DL ++ L  DP  R ++++ L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  101 bits (252), Expect = 2e-24
 Identities = 76/262 (29%), Positives = 117/262 (44%), Gaps = 15/262 (5%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           E+G G FG  Y  T   T    A K +S      ++  +D+ +E+  LQ L   PN +E+
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEY 86

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
           +G Y  +    LVME C G       + K    E E A I    +  +   H   +IHRD
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRYGKE 253
           +K  N LL    E   +K  DFG +        +   VG+ Y++APEV+      +Y  +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200

Query: 254 IDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           +DVWS G+    L    PP F       ++      +  LQS+ W   +   +  +   L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257

Query: 313 TKDPKKRITAAEALEHPWLKED 334
            K P++R  +AE L H +++ D
Sbjct: 258 QKIPQERPASAELLRHDFVRRD 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 81/268 (30%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L + +G G +G  Y      TG   A K I   KL    D   +++EI +++      
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HC 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV + G+Y  ++ L + ME C GG L D     G  SE + A +CR+ +  +   H  G
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVL----H 247
            +HRD+K  N LL    ++  +K  DFG++  I  T    K  +G+ Y++APEV     +
Sbjct: 127 KMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 248 QRYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAK- 305
             Y +  D+W+ G+    L    PP F     + +F   L    + Q    P +  + K 
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP---PKLKDKTKW 237

Query: 306 -----DLIRKMLTKDPKKRITAAEALEH 328
                + ++  LTK+PKKR TA   L H
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  100 bits (251), Expect = 4e-24
 Identities = 77/256 (30%), Positives = 136/256 (53%), Gaps = 26/256 (10%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K T R YA K +++ +++   +    R E  +L +   Q 
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHAC 188
            I     A++D+  L+LVM+   GG+L   +++K  + +R   ++ R    ++V  +H+ 
Sbjct: 63  -ITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYIAEMVLAIHSI 118

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEI-VGSAYYVAPEVL 246
           H +  +HRD+KP+N LL   + +  I+  DFG  +   + G V   + VG+  Y++PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 247 HQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS- 299
                   +YG E D WS GV +Y +L G  PF+AE+    +  I+      Q   +PS 
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSH 232

Query: 300 ---ISGQAKDLIRKML 312
              +S +AKDLI++++
Sbjct: 233 ITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 99.1 bits (248), Expect = 5e-24
 Identities = 70/274 (25%), Positives = 116/274 (42%), Gaps = 47/274 (17%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           L K+LG G FG  Y  T K  G       A K++  ++   +++ E+   E  I++ L  
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL-S 59

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHAC- 188
            PNIV   G     + L++V E   GG+L D +   G   + ++   +  QI     A  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI-----AKG 114

Query: 189 ----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV--- 241
                    +HRDL   N L+        +K +DFGLS         ++I    YY    
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYYRKRG 162

Query: 242 ---------APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNL 290
                    APE L   ++  + DVWS GV+L+ + + G  P+   + + + E + +G  
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222

Query: 291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
             +    P    +  +L+ +    DP+ R T +E
Sbjct: 223 LPRPENCPD---ELYELMLQCWAYDPEDRPTFSE 253

Length = 258

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 99.8 bits (248), Expect = 9e-24
 Identities = 73/254 (28%), Positives = 133/254 (52%), Gaps = 22/254 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K   + +A K +++ +++   +    R E  +L  + G  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDN 60

Query: 133 N-IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHA 187
             I     A++D+ NL+LVM+   GG+L   +++K  + +R   ++ R    ++V  + +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVIAIDS 117

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEI-VGSAYYVAPEV 245
            H +  +HRD+KP+N L+   + +  I+  DFG  +  +E G V   + VG+  Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 246 LHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWP 298
           L        +YG E D WS GV +Y +L G  PF+AE+    +  I+      Q  +   
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234

Query: 299 SISGQAKDLIRKML 312
            +S  AKDLIR+++
Sbjct: 235 DVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 98.5 bits (245), Expect = 1e-23
 Identities = 82/266 (30%), Positives = 128/266 (48%), Gaps = 20/266 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQ-PNIVE 136
           +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  + TG  P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              A+     L  +++L +GG+L   +   G++SE+E      +I+  +   H   V++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEI 254
           DLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +   Y    
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSA 177

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFE---AILEGNLDLQSSPWPSISGQAKDLIRKM 311
           D +S G +L+ LL G  PF     K   E     L  N++L  S  P +    K L+  +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL----KSLLEGL 233

Query: 312 LTKDPKKRI-----TAAEALEHPWLK 332
           L +D  KR+      A E  EH + K
Sbjct: 234 LQRDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  102 bits (254), Expect = 1e-23
 Identities = 89/297 (29%), Positives = 144/297 (48%), Gaps = 43/297 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K++G G+FG  +L   K T   +  K+IS R L  +++   +  E+ +++ L    
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HK 72

Query: 133 NIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAK-----GIYSEREAANICRQIVNVV 185
           NIV +   + +K  Q L+++ME C  G+L  R I K     G   E    +I RQ+++ +
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 186 HACHFMG-------VIHRDLKPENFLL-------------ASKEEDSPI-KATDFGLSVF 224
             CH +        V+HRDLKP+N  L             A+     PI K  DFGLS  
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 225 IETGKVYKEIVGSAYYVAPEVL---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 281
           I    +    VG+ YY +PE+L    + Y  + D+W+ G I+Y L SG  PF        
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248

Query: 282 FEAILEGNLDLQSSPWPSISGQAKD---LIRKMLTKDPKKRITAAEALEHPWLKEDG 335
           F  ++    +L+  P   I G++K+   LI+ +L    K+R +A + L +  +K  G
Sbjct: 249 FSQLIS---ELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 94/329 (28%), Positives = 135/329 (41%), Gaps = 84/329 (25%)

Query: 72  IYDLDKELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
            Y+++  +GRG +G  Y   +K    G++YA K     K  Y    +   REI +L+ L 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-------RII-----AKGIY-SEREAAN 176
              N+V     + +  +  + +       LFD       +II     AK +        +
Sbjct: 61  -HENVVSLVEVFLEHADKSVYL-------LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGLS-VFIETGKVYKE- 233
           +  QI+N VH  H   V+HRDLKP N L+  +  E   +K  D GL+ +F    K   + 
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 234 --IVGSAYYVAPEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-------- 279
             +V + +Y APE+L    H  Y K ID+W+ G I   LL+  P F     K        
Sbjct: 173 DPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230

Query: 280 -----GIFEAILEGNLDLQSSPWPSI---------------------------------S 301
                 IFE  + G    +   WP I                                  
Sbjct: 231 RDQLERIFE--VLGTPTEKD--WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            Q  DL+RK+L  DP KRITA EALEHP+
Sbjct: 287 SQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 97.6 bits (244), Expect = 2e-23
 Identities = 73/257 (28%), Positives = 118/257 (45%), Gaps = 23/257 (8%)

Query: 82  GQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY 141
           G+FG   +   K T + +  K I  +   ++        E ++ Q +   PN ++   + 
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKN--FNAI------EPMVHQLMKDNPNFIKLYYSV 78

Query: 142 EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPE 201
              +   L+M+    G+LFD +  +G  SE E   I RQ+V  ++  H   +IH D+K E
Sbjct: 79  TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138

Query: 202 NFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEIDVWSAG 260
           N +L  + +D  I   D+GL   I T   Y    G+  Y +PE +    Y    D W+ G
Sbjct: 139 N-VLYDRAKDR-IYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWAVG 193

Query: 261 VILYILLSGVPPFWAETEKGIFEAI-LEGNLDLQSSPWP---SISGQAKDLIRKMLTKDP 316
           V+ Y LL+G  PF    ++   E + LE  L  Q    P   ++S  A D ++ ML  + 
Sbjct: 194 VLTYELLTGKHPF----KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNI 249

Query: 317 KKR-ITAAEALEHPWLK 332
             R     E ++HP+LK
Sbjct: 250 NYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 77/259 (29%), Positives = 124/259 (47%), Gaps = 20/259 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G+G FG  Y      T    A K I   +   + ++ED+++EI +L      P I  + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQ-CDSPYITRYY 68

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G+Y     L ++ME   GG   D ++  G   E   A I R+I+  +   H    IHRD+
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127

Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + D+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA----KDLIRKML 312
           WS G+    L  G PP        +   I       ++SP P++ GQ     K+ +   L
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIP------KNSP-PTLEGQYSKPFKEFVEACL 237

Query: 313 TKDPKKRITAAEALEHPWL 331
            KDP+ R TA E L+H ++
Sbjct: 238 NKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 84/315 (26%), Positives = 127/315 (40%), Gaps = 60/315 (19%)

Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRR 120
           P+ D  + Y+   ++G+G FG  +    K T +  A K     K++ + + E       R
Sbjct: 6   PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALR 60

Query: 121 EILILQHLTGQPNIVEF--------EGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYS 170
           EI ILQ L    N+V                K + +LV E C      L      K  ++
Sbjct: 61  EIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--FT 117

Query: 171 EREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
             E   + + ++N ++  H   ++HRD+K  N L+    +D  +K  DFGL+      K 
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKN 174

Query: 231 -----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
                Y   V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+    
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234

Query: 284 AI--LEG-----------NLDLQSS---P-----------WPSISGQ-AKDLIRKMLTKD 315
            I  L G            L+L      P            P +    A DLI K+L  D
Sbjct: 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD 294

Query: 316 PKKRITAAEALEHPW 330
           P KRI A  AL H +
Sbjct: 295 PAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 70/259 (27%), Positives = 127/259 (49%), Gaps = 20/259 (7%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G+G FG  +      T +  A K I   +   + ++ED+++EI +L      P + ++ 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQ-CDSPYVTKYY 68

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G+Y     L ++ME   GG   D ++  G + E + A + ++I+  +   H    IHRD+
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127

Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + D+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRKML 312
           WS G+    L  G PP    ++      +      +  +  P+++G+     K+ I   L
Sbjct: 185 WSLGITAIELAKGEPP---NSDMHPMRVLFL----IPKNNPPTLTGEFSKPFKEFIDACL 237

Query: 313 TKDPKKRITAAEALEHPWL 331
            KDP  R TA E L+H ++
Sbjct: 238 NKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 39/292 (13%)

Query: 61  ILGKPYVDITTIYDLDK--ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           I G+ Y     + DL+   E+G G  G  Y    K TG   A K + R       + E+ 
Sbjct: 5   IDGQKYP--ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR-----TGNKEEN 57

Query: 119 RR-----EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSE 171
           +R     ++++  H    P IV+  G +    ++ + MEL S    +L  RI  +G   E
Sbjct: 58  KRILMDLDVVLKSHDC--PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPE 113

Query: 172 REAANICRQIVNVVHACHFM----GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET 227
                +    V +V A H++    GVIHRD+KP N LL   +    +K  DFG+S  +  
Sbjct: 114 DILGKM---TVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD 167

Query: 228 GKVYKEIVGSAYYVAPEVL-----HQRYGKEIDVWSAGVILYILLSGVPPF-WAETEKGI 281
            K      G A Y+APE +     + +Y    DVWS G+ L  L +G  P+   +TE  +
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227

Query: 282 FEAILEGNLDLQS-SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
              IL    +  S  P    S      +   LTKD +KR    E L+HP+++
Sbjct: 228 LTKIL--QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 68/254 (26%), Positives = 121/254 (47%), Gaps = 12/254 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + ++K++GRGQF   Y  T     +  A K +   +++  K  +D  +EI +L+ L   P
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HP 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII----AKGIYSEREAANICRQIVNVVHAC 188
           N++++  ++ +   L++V+EL   G+L   I      K +  ER       Q+ + V   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 189 HFMGVIHRDLKPEN-FLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVL 246
           H   V+HRD+KP N F+ A+      +K  D GL  F  +       +VG+ YY++PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           H+  Y  + D+WS G +LY + +   PF+ +              D    P    S + +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238

Query: 306 DLIRKMLTKDPKKR 319
           +L+   +  DP +R
Sbjct: 239 ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 82/314 (26%), Positives = 126/314 (40%), Gaps = 61/314 (19%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-------------RE 121
               LG G +G         TG+  A K +   +     D+   R             RE
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIE--ISNDVTKDRQLVGMCGIHFTTLRE 70

Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           + I+  +    NI+     Y +   ++LVM++ +  +L   +  K   +E +   I  QI
Sbjct: 71  LKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-------VFIETGKV---- 230
           +N ++  H    +HRDL P N  + SK      K  DFGL+             K     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 231 ----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KG 280
                   V + +Y APE+L   ++Y   +D+WS G I   LL+G P F  E E      
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245

Query: 281 IFEAI---------LEGNLDL-----QSSP------WPSISGQAKDLIRKMLTKDPKKRI 320
           IFE +             L L        P      +P+ S  A DL++ +L  +P +RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305

Query: 321 TAAEALEHPWLKED 334
           +A EAL+H + K D
Sbjct: 306 SAKEALKHEYFKSD 319

Length = 335

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 38/288 (13%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D T  +++ + +G+G +G  Y  T K  G   A K +     + D D E++  E  ILQ 
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVD-EEIEAEYNILQS 74

Query: 128 LTGQPNIVEFEGAYEDKQN-----LHLVMELCSGG---ELFDRIIAKGI-YSEREAANIC 178
           L   PN+V+F G +          L LV+ELC+GG   EL   ++  G    E   + I 
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-VGS 237
              +  +   H   +IHRD+K  N LL +   +  +K  DFG+S  + + ++ +   VG+
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGT 191

Query: 238 AYYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNL 290
            +++APEV+         Y    DVWS G+    L  G PP F     K +F+       
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK------- 244

Query: 291 DLQSSPWPSISGQAK------DLIRKMLTKDPKKRITAAEALEHPWLK 332
            +  +P P++    K        I + L KD + R +    LEHP++K
Sbjct: 245 -IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.5 bits (237), Expect = 3e-22
 Identities = 74/257 (28%), Positives = 114/257 (44%), Gaps = 15/257 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y      T    A K +S      ++  +D+ +E+  LQ +   PN +E
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE 89

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           ++G Y  +    LVME C G       + K    E E A I    +  +   H   +IHR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRYGK 252
           D+K  N LL    E   +K  DFG +        +   VG+ Y++APEV+      +Y  
Sbjct: 150 DIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDG 203

Query: 253 EIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           ++DVWS G+    L    PP F       ++      +  LQS+ W   S   ++ +   
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDSC 260

Query: 312 LTKDPKKRITAAEALEH 328
           L K P+ R T+ E L+H
Sbjct: 261 LQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 15/265 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   + +G+G +G   L   +  G++Y  K ++ R     ++ +   +E  +L  L   P
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLK-HP 59

Query: 133 NIVEFEGAYEDKQN-LHLVMELCSGGELFDRII-AKG-IYSEREAANICRQIVNVVHACH 189
           NIV +  ++E +   L++VM  C GG+L+ ++   KG +  E +      QI   +   H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQ 248
              ++HRDLK +N  L      + IK  D G++  +E    +   ++G+ YY++PE+   
Sbjct: 120 EKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 249 R-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKD 306
           + Y  + DVW+ G  +Y + +    F A+    +   I+EG L     P P   S +  +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232

Query: 307 LIRKMLTKDPKKRITAAEALEHPWL 331
           LI  ML+K P+KR +    L  P++
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 94.4 bits (234), Expect = 3e-22
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 26/280 (9%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   I++L + +G G +G  Y      TG+  A K +     V   + E++++EI +L+ 
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKK 58

Query: 128 LTGQPNIVEFEGAYEDKQ------NLHLVMELCSGGELFDRII-AKG-IYSEREAANICR 179
            +   NI  + GA+  K        L LVME C  G + D I   KG    E   A ICR
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSA 238
           +I+  +   H   VIHRD+K +N LL    E++ +K  DFG+S  ++ T       +G+ 
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175

Query: 239 YYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLD 291
           Y++APEV+         Y  + D+WS G+    +  G PP       + +F         
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235

Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           L+S  W   S + +  I   L K+  +R T  + ++HP++
Sbjct: 236 LKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 48/288 (16%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNI 134
           +G G +GV   C  K T    A K     K    ++ E+V+    RE+ +L+ L  Q NI
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIK-----KFKDSEENEEVKETTLRELKMLRTLK-QENI 62

Query: 135 VEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           VE + A+  +  L+LV E       EL + +   G+  E+  + I  Q++  +H CH   
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYI-YQLIKAIHWCHKND 120

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--VYKEIVGSAYYVAPE-VLHQR 249
           ++HRD+KPEN L++    +  +K  DFG +  +  G    Y E V + +Y +PE +L   
Sbjct: 121 IVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL-QSSP----- 296
           YGK +D+WS G IL  L  G P F  E+E       + +   +    + L  S+P     
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237

Query: 297 -WPS--------------ISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
            +P+              +SG   DL++ +L  +P  R    + L HP
Sbjct: 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 56/294 (19%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-----VRREILILQHLTGQ 131
           ++LG G +   Y    + TG   A K I    L    D E+       REI +++ L   
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEI---HL----DAEEGTPSTAIREISLMKELK-H 57

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
            NIV        +  L LV E       +  D    +G        +   Q++  +  CH
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGL--SVFIETGKVYKEIVGSAYYVAPEVL- 246
              V+HRDLKP+N L+  + E   +K  DFGL  +  I       E+V + +Y AP+VL 
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP----WPSIS 301
             + Y   ID+WS G I+  +++G P F     +     I      +  +P    WP IS
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI----FRIMGTPTESTWPGIS 229

Query: 302 -------------------------GQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                                        DL+ ++L  +P+ RI+A +AL+HPW
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 85/325 (26%), Positives = 138/325 (42%), Gaps = 57/325 (17%)

Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           LG  Y+D+       + LG G  G+ +        ++ A K I    L   + ++   RE
Sbjct: 3   LGSRYMDL-------RPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALRE 52

Query: 122 ILILQHLTGQPNIVEFEGAY--------EDKQNLHLVMELCSGGELFD----RIIAKGIY 169
           I I++ L    NIV+             ED  +L  +  +    E  +     ++ +G  
Sbjct: 53  IKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL 111

Query: 170 SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK 229
           SE  A     Q++  +   H   V+HRDLKP N  + +  ED  +K  DFGL+  ++   
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPHY 169

Query: 230 VYK----EIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
            +K    E + + +Y +P +L     Y K ID+W+AG I   +L+G P F    E    +
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229

Query: 284 AILEG---------NLDLQSSPW-----------------PSISGQAKDLIRKMLTKDPK 317
            ILE          N  L   P                  P ++ +A D + ++LT +P 
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289

Query: 318 KRITAAEALEHPWLKEDGATSDKPI 342
            R+TA EAL HP++       D+P+
Sbjct: 290 DRLTAEEALMHPYMSCYSCPFDEPV 314

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.0 bits (233), Expect = 6e-22
 Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  +      T +  A K I   +   + ++ED+++EI +L      P + +
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQ-CDSPYVTK 66

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +   H    IHR
Sbjct: 67  YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + 
Sbjct: 126 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRK 310
           D+WS G+    L  G PP        +   I + N        P++ G      K+ +  
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 235

Query: 311 MLTKDPKKRITAAEALEHPWL 331
            L K+P  R TA E L+H ++
Sbjct: 236 CLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.5 bits (232), Expect = 6e-22
 Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 16/256 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + ++K++GRGQF   Y  T    G   A K +    L+  K   D  +EI +L+ L   P
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII-----AKGIYSEREAANICRQIVNVVHA 187
           N++++  ++ +   L++V+EL   G+L  R+I      K +  E+       Q+ + +  
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVL 246
            H   V+HRD+KP N  + +      +K  D GL  F  +       +VG+ YY++PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS--ISGQ 303
           H+  Y  + D+WS G +LY + +   PF+   +K    ++ +        P PS   S +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 304 AKDLIRKMLTKDPKKR 319
            + L+   +  DP+KR
Sbjct: 237 LRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 92.6 bits (230), Expect = 1e-21
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 23/273 (8%)

Query: 73  YDLDKE-----LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           Y+ D+      LG+G +G+ Y     +T  + A K I  R     + ++ +  EI +  +
Sbjct: 5   YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSY 61

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANI--CRQIVNV 184
           L    NIV++ G+  +     + ME   GG L   + +K G   + E   I   +QI+  
Sbjct: 62  LK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAP 243
           +   H   ++HRD+K +N L+ +      +K +DFG S  +       +   G+  Y+AP
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178

Query: 244 EVLHQR---YGKEIDVWSAGVILYILLSGVPPFW--AETEKGIFEAILEGNLDLQSSPWP 298
           EV+ +    YG   D+WS G  +  + +G PPF    E +  +F+    G   +      
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFKIHPEIPE 235

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           S+S +AK+ I +    DP KR +A + L+ P+L
Sbjct: 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 81/280 (28%), Positives = 129/280 (46%), Gaps = 26/280 (9%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   I++L + +G G +G  Y      TG+  A K +     V + + E+++ EI +L+ 
Sbjct: 13  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKK 68

Query: 128 LTGQPNIVEFEGAYEDKQ------NLHLVMELCSGGELFDRII-AKG-IYSEREAANICR 179
            +   NI  + GA+  K        L LVME C  G + D +   KG    E   A ICR
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSA 238
           +I+  +   H   VIHRD+K +N LL    E++ +K  DFG+S  ++ T       +G+ 
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 185

Query: 239 YYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLD 291
           Y++APEV+         Y    D+WS G+    +  G PP       + +F         
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245

Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           L+S  W   S +  D I   L K+   R +  + L+HP++
Sbjct: 246 LKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 66/213 (30%), Positives = 92/213 (43%), Gaps = 36/213 (16%)

Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K+LG G FG   LC        TG + A KS++      ++   D  REI IL+ L    
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HE 66

Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR--------QIV 182
           NIV+++G  E    ++L L+ME    G L D       Y +R    I          QI 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD-------YLQRHRDQINLKRLLLFSSQIC 119

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY------KEIVG 236
             +        IHRDL   N L+   E +  +K +DFGL+  +   K Y       E   
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGES-- 174

Query: 237 SAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS 268
             ++ APE L   ++    DVWS GV LY L +
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.7 bits (227), Expect = 6e-21
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 15/263 (5%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y           A K +S      ++  +D+ +E+  LQ L   PN ++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G Y  +    LVME C G       + K    E E A +    +  +   H   +IHR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRYGK 252
           D+K  N LL+   E   +K  DFG +  +     +   VG+ Y++APEV+      +Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193

Query: 253 EIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           ++DVWS G+    L    PP F       ++      +  LQS  W   S   ++ +   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250

Query: 312 LTKDPKKRITAAEALEHPWLKED 334
           L K P+ R T+   L+H ++  +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 91.0 bits (226), Expect = 8e-21
 Identities = 86/302 (28%), Positives = 140/302 (46%), Gaps = 57/302 (18%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHL 128
           Y+  +++G G +GV Y    KA  R    ++I+ +K+  +++ E V     REI +L+ +
Sbjct: 4   YEKVEKIGEGTYGVVY----KARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM 58

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR-------QI 181
               NIV  +     ++ L+LV E        D  + K + S  + A   R       QI
Sbjct: 59  Q-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYY 240
           +  +  CH   V+HRDLKP+N L+  +   + +K  DFGL+  F    + +   V + +Y
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEVVTLWY 169

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLDLQS 294
            APE+L   + Y   +D+WS G I   +++  P F  ++E      IF   + G  + ++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR--ILGTPNEET 227

Query: 295 SP--------------W---------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            P              W         P++     DL+ KML  DP KRITA  ALEH + 
Sbjct: 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Query: 332 KE 333
           K+
Sbjct: 288 KD 289

Length = 294

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.2 bits (231), Expect = 8e-21
 Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 22/211 (10%)

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELF----DRIIAKGIYSEREAANICRQIVNVVHACH 189
           IV+    ++    L L+ME  SGG+L      R+     + E E   +  QIV  +   H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLS------VFIETGKVYKEIVGSAYYVAP 243
              ++HRDLK  N  L        IK  DFG S      V ++    +    G+ YY+AP
Sbjct: 187 SRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDVASSF---CGTPYYLAP 240

Query: 244 EVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SIS 301
           E+   +RY K+ D+WS GVILY LL+   PF   +++ I + +L G  D    P+P  +S
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPCPVS 296

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
              K L+  +L+K+P  R T  + L   +LK
Sbjct: 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 22/208 (10%)

Query: 140 AYEDKQN------LHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACH 189
           A +D +N      + LV++  + G+L   I ++      + E EA  +  Q++  VH  H
Sbjct: 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH 160

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEVL 246
              +IHRD+K  N LL S   +  +K  DFG S       +  V +   G+ YYVAPE+ 
Sbjct: 161 SKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQA 304
            ++ Y K+ D++S GV+LY LL+   PF  E  + +    L G  D    P P SIS + 
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD----PLPPSISPEM 273

Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLK 332
           ++++  +L+ DPK+R ++++ L  P  K
Sbjct: 274 QEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHL 128
           Y+  +++G G +G  +    + T    A K +       D D E V     REI +L+ L
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKEL 56

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREA--ANICR----QIV 182
               NIV         + L LV E C      D+ + K   S        I +    Q++
Sbjct: 57  K-HKNIVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLL 109

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYV 241
             +  CH   V+HRDLKP+N L+    E   +K  DFGL+  F    + Y   V + +Y 
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYR 166

Query: 242 APEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFEAILEGNLDLQS 294
            P+VL   + Y   ID+WSAG I   L +   P +   +     K IF  +  G    +S
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEES 224

Query: 295 SP-------------------W----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            P                        P ++   +DL++ +L  +P +RI+A EAL+HP+
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 87.3 bits (216), Expect = 1e-19
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 38/292 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-- 130
           Y+   E+G G +G  Y      +G   A KS+ R +   D       RE+ +L+ L    
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 131 QPNIVEF----EGAYEDKQ-NLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVN 183
            PNIV        +  D++  + LV E          D++   G+ +E    ++ RQ + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-IKDLMRQFLR 119

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   ++HRDLKPEN L+ S  +   +K  DFGL+           +V + +Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAI------------- 285
           EVL Q  Y   +D+WS G I   +    P F   +E      IF+ I             
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236

Query: 286 -LEGNLDLQS-----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              G    +      S  P I      L+ +MLT +P KRI+A  AL+HP+ 
Sbjct: 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 81/301 (26%), Positives = 131/301 (43%), Gaps = 46/301 (15%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHL-----T 129
           K++G G +G       + TG K A K + R    +  ++   R  RE+ +L+H+      
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMKHENVI 77

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
           G  ++   + + +   + +LVM     G    +++     SE     +  Q++  +   H
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--H 247
             G+IHRDLKP N  +    ED  +K  DFGL+   +T       V + +Y APEV+   
Sbjct: 136 AAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNW 190

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL--------EGNLDLQS----- 294
             Y + +D+WS G I+  +L+G P F           I+        E    LQS     
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250

Query: 295 --------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
                         S  P+ +  A +++ KML  D + RITAAEAL HP+ +E     D+
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310

Query: 341 P 341
            
Sbjct: 311 T 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 49/288 (17%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL----ILQHLTGQP 132
            +LG G  G         TG      ++  +K+V+      VR++IL    I+ H    P
Sbjct: 11  SDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRELQIM-HECRSP 63

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN-VVHACHFM 191
            IV F GA+ ++ N+ + ME    G L DRI  KG     E   I  +I   VV    ++
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVE---ILGKIAVAVVEGLTYL 119

Query: 192 ----GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----VGSAYYVAP 243
                ++HRD+KP N L+ S+ +   IK  DFG+S     G++   I    VG++ Y++P
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSP 171

Query: 244 EVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD----------- 291
           E +   +Y  + DVWS G+ +  L  G  PF         +    G LD           
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231

Query: 292 -LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE-HPWLKEDGAT 337
            L SS +P      +D +   L KDP +R T  +     P+++   A+
Sbjct: 232 RLPSSDFPED---LRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 86/316 (27%), Positives = 132/316 (41%), Gaps = 55/316 (17%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G  G+         G   A K +SR         +   RE+++L+      
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLK-CVNHK 80

Query: 133 NIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           NI+        + + E+ Q+++LVMEL        ++I   +  ER +  + + +  + H
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 138

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV- 245
             H  G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV 
Sbjct: 139 -LHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 246 LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------------G 288
           L   Y + +D+WS G I+  L+ G   F        +  ++E                  
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254

Query: 289 NLDLQSSPWPSIS---------------------GQAKDLIRKMLTKDPKKRITAAEALE 327
           N       +P IS                      QA+DL+ KML  DP KRI+  EAL 
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314

Query: 328 HPWLK--EDGATSDKP 341
           HP++    D A ++ P
Sbjct: 315 HPYITVWYDPAEAEAP 330

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 89/316 (28%), Positives = 140/316 (44%), Gaps = 65/316 (20%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----T 129
           K++G G +G       K TG K A K +SR  +  ++ K      RE+ +L+H+      
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR---AYRELTLLKHMQHENVI 77

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI----YSEREAANICRQIVNVV 185
           G  ++     + ++ Q+ +LVM        + +   + I     SE +   +  Q++  +
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMP-------YMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVA 242
              H  G+IHRDLKP N  +    ED  +K  DFGL+   +   TG V      + +Y A
Sbjct: 131 KYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGYVV-----TRWYRA 182

Query: 243 PEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE----------GNL 290
           PEV+     Y + +D+WS G I+  +L+G   F  +        IL+            L
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 291 D-------LQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           +       ++S P          +P  S QA DL+ KML  D  KR+TA EALEHP+   
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 334 ----DGATSDKPIDSA 345
               D  T  +P D +
Sbjct: 303 FRDADEETEQQPYDDS 318

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 71/310 (22%)

Query: 74  DLDK--ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQH 127
           D +K  ELG G  GV      + +G       I  RKL++ +    +R    RE+ +L H
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSG------LIMARKLIHLEIKPAIRNQIIRELKVL-H 54

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               P IV F GA+     + + ME   GG L D+++       ++A  I   I+  +  
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL-------KKAGRIPENILGKISI 106

Query: 188 CHFMG---------VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGS 237
               G         ++HRD+KP N L+ S+ E   IK  DFG+S   I++  +    VG+
Sbjct: 107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS--MANSFVGT 161

Query: 238 AYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI-------FEAILEGN 289
             Y++PE L    Y  + D+WS G+ L  +  G  P      K +               
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221

Query: 290 LDLQSSPWPSISGQA---------------------------KDLIRKMLTKDPKKRITA 322
                S  P  S +                            +D + K L K+PK+R   
Sbjct: 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281

Query: 323 AEALEHPWLK 332
            E  +HP++K
Sbjct: 282 KELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 54/304 (17%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 81

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 82  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQR 249
            +IHRDLKP N  +    ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 140 DIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI--------- 300
           Y + +D+WS G I+  LL+G   F         + IL     L  +P   +         
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAELLKKISSESA 250

Query: 301 ----------------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
                                 +  A DL+ KML  D  KRITAA+AL H +  +     
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Query: 339 DKPI 342
           D+P+
Sbjct: 311 DEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 77/326 (23%)

Query: 66  YVDITTI--YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-KDMEDVR--R 120
           +   + +  Y++  +LG G FG  Y   +  TGR  A K I    L+++ KD   +   R
Sbjct: 1   FYGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALR 56

Query: 121 EILILQHLTGQPNIVEF-EGAYE---DKQNLHLVM---------ELCSGGELFDRIIAKG 167
           EI IL+ L   PN+V   + A E     +     +         +L   G L +  +   
Sbjct: 57  EIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSVK-- 111

Query: 168 IYSEREAANICRQI---VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
             +E +      Q+   +N +H  H +   HRD+K  N L+ ++     +K  DFGL+  
Sbjct: 112 -LTESQIKCYMLQLLEGINYLHENHIL---HRDIKAANILIDNQ---GILKIADFGLARP 164

Query: 225 I------------ETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGV 270
                           + Y  +V + +Y  PE+L   +RY   +D+W  G +   + +  
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Query: 271 PPFWAETEKGIFEAI--LEGNLDLQSSP-WPSISG-----------------------QA 304
           P    +++      I  L G    ++ P W S+ G                       + 
Sbjct: 225 PILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEG 284

Query: 305 KDLIRKMLTKDPKKRITAAEALEHPW 330
            DL+ K+L+ DP KR+TA++ALEHP+
Sbjct: 285 LDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 87/307 (28%), Positives = 129/307 (42%), Gaps = 65/307 (21%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYA-------------CKSISRR-KLVYDKDMEDVRR 120
            D+ +G G FGV +  T    G++ A             CK + R  K++     ++V  
Sbjct: 4   PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
            + ILQ     P+I  FE  Y       +V EL    +L   I++    S         Q
Sbjct: 64  ALDILQ----PPHIDPFEEIY-------VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQ 111

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGS 237
           I+  +   H  G++HRD+KP N L+ S   +  +K  DFGL+      E+  + +E+V +
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-T 167

Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWA-------------------E 276
            YY APE+L   + Y   +D+WS G I   LL     F A                   E
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227

Query: 277 TEKGIFEAILEGNLDLQSSPWPSISG----------QAKDLIRKMLTKDPKKRITAAEAL 326
             +   E      L     P PS+            +A  L+ +ML  DP KRI+AA+AL
Sbjct: 228 AMRSACEGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 327 EHPWLKE 333
            HP+L E
Sbjct: 287 AHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 81/301 (26%), Positives = 131/301 (43%), Gaps = 49/301 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD--KDMEDVRREILILQHLTG 130
           Y + + +G+G +GV        TG K A K I+    V++   D   + REI +L+ L  
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND---VFEHVSDATRILREIKLLRLLR- 57

Query: 131 QPNIVEFEG-----AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
            P+IVE +      +  + +++++V EL    +L   I A    +         Q++  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKV--YKEIVGSAYYV 241
              H   V HRDLKP+N L  +   D  +K  DFGL+   F +T     + + V + +Y 
Sbjct: 117 KYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 242 APEV---LHQRYGKEIDVWSAGVILYILLSGVPPF-------------------WAETEK 279
           APE+      +Y   ID+WS G I   +L+G P F                     ET  
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 280 GI-------FEAILEGNLDLQ-SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            +       + + +     +  S  +P+    A  L+ ++L  DPK R TA EAL  P+ 
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 332 K 332
           K
Sbjct: 294 K 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 86/309 (27%), Positives = 130/309 (42%), Gaps = 68/309 (22%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISR-------RKLVYDKDMEDVRREILILQHLT 129
           K +G G  G+        TG+  A K +SR        K  Y        RE L+L  L 
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--------RE-LVLMKLV 72

Query: 130 GQPNIVEFEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN 183
              NI+     +      E+ Q+++LVMEL        ++I   +  ER +  + + +  
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLCG 130

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           + H  H  G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY AP
Sbjct: 131 IKH-LHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186

Query: 244 EV-LHQRYGKEIDVWSAGVIL---------------------YILLSGVPP--FWAETEK 279
           EV L   Y + +D+WS G I+                      I   G P   F +  + 
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246

Query: 280 GI--------------FEAILEGNLDLQSSPWPS--ISGQAKDLIRKMLTKDPKKRITAA 323
            +              FE +    L    S   +   + QA+DL+ KML  DP+KRI+  
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306

Query: 324 EALEHPWLK 332
           +AL+HP++ 
Sbjct: 307 DALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 82.1 bits (202), Expect = 2e-17
 Identities = 83/300 (27%), Positives = 126/300 (42%), Gaps = 53/300 (17%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 80

Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 137

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  EAL+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 78/299 (26%), Positives = 130/299 (43%), Gaps = 51/299 (17%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202

Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 34/275 (12%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           E+GRG FG       K +G   A K I  R  V +K+ + +  ++ ++   +  P IV+F
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 138 EGAYEDKQNLHLVMELCSGG-ELFDRIIAKGIYSEREAANICRQI-----VNVVHACHFM 191
            GA   + +  + MEL     + F + +      E   + I  +I     V  V A +++
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYV-----YEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 192 ----GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
                +IHRD+KP N LL   + +  IK  DFG+S  +          G   Y+APE + 
Sbjct: 124 KEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 247 -HQRYGKEI--DVWSAGVILYILLSGVPPF--WAETEKGIFEAILE---GNLD-LQSSPW 297
              R G ++  DVWS G+ LY + +G  P+  W      +F+ + +   G+   L +S  
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQLTQVVKGDPPILSNSEE 236

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
              S    + I   L KD  KR    E LEHP++K
Sbjct: 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 31/273 (11%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELGRG +GV        TG   A K I  R  V  ++ + +  ++ I       P  V F
Sbjct: 8   ELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 138 EGAYEDKQNLHLVMEL--CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---- 191
            GA   + ++ + ME+   S  + + ++  KG+    +   + +  V++V A  ++    
Sbjct: 66  YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDI--LGKIAVSIVKALEYLHSKL 123

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-VGSAYYVAPEVL---- 246
            VIHRD+KP N L+     +  +K  DFG+S ++    V K I  G   Y+APE +    
Sbjct: 124 SVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPEL 179

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI----- 300
             + Y  + DVWS G+ +  L +G  P+  ++ K  F+ + +    +   P P +     
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQ----VVEEPSPQLPAEKF 233

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           S + +D + K L K+ K+R    E L+HP+ + 
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 46/299 (15%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLT-----GQ 131
           +G G +G           +K A K +SR  + L++ +      RE+ +L+H+      G 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHMKHENVIGL 79

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+   ++LV  L   G   + I+     S+     +  Q++  +   H  
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQR 249
           G+IHRDLKP N  +    ED  ++  DFGL+   +        V + +Y APE++     
Sbjct: 138 GIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWMH 192

Query: 250 YGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAILEGNLDL------------- 292
           Y + +D+WS G I+  LL G   F    + +  K I E +   + ++             
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252

Query: 293 QSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           QS P          +   +  A DL+ KML  D  KRI+A+EAL HP+  +     D+P
Sbjct: 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 17/220 (7%)

Query: 119 RREILILQHLTGQPNIVEF--EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN 176
           RRE  +   L   PNIV     G       L  V E   G  L + + A G     E   
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAGETGR 83

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--------ETG 228
           +  Q+++ +   H  G++HRDLKP+N +++        K  DFG+   +         T 
Sbjct: 84  LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143

Query: 229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
               E++G+  Y APE L  +      D+++ G+I    L+G       +   I    L 
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL- 202

Query: 288 GNLDLQSSPWPSISGQA-KDLIRKMLTKDPKKRITAAEAL 326
             +D+   PW  I+G     ++RK L KDP++R  +A AL
Sbjct: 203 SPVDVSLPPW--IAGHPLGQVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV +L   +      A K I    +  D  +E+ +  ++ L H    PN+V+
Sbjct: 10  KELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFIEEAKV-MMKLSH----PNLVQ 63

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + +V E  + G L + +   KG        ++C  +   +      G IH
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL-HQRYG 251
           RDL   N L+    ED+ +K +DFGL+ ++   + Y    G+ + V    PEV  + R+ 
Sbjct: 124 RDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E++  G
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 52/304 (17%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQH 127
           + T   LDK LG G +   Y    K T    A K I   +L +++       RE+ +L+ 
Sbjct: 5   LETYIKLDK-LGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKD 60

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR------QI 181
           L    NIV        +++L LV E        D+ + + +     + N+        Q+
Sbjct: 61  LK-HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHNVKLFLFQL 113

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL--SVFIETGKVYKEIVGSAY 239
           +  ++ CH   V+HRDLKP+N L+  + E   +K  DFGL  +  I T K Y   V + +
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT-KTYSNEVVTLW 169

Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           Y  P++L     Y  +ID+W  G I Y + +G P F   T +     I           W
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229

Query: 298 PSISGQAK--------------------------DLIRKMLTKDPKKRITAAEALEHPWL 331
           P I    +                          +L+ K+L  + +KRI+A EA++HP+ 
Sbjct: 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Query: 332 KEDG 335
              G
Sbjct: 290 HCLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 50/147 (34%), Positives = 77/147 (52%), Gaps = 6/147 (4%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM-EDVRREILILQHLTGQPNIV 135
           K + RG FG  YL  KK   + YA K + +  ++ +K+M   V+ E   L  L+  P IV
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALA-LSKSPFIV 67

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
               + +   N++LVME   GG++   +   G + E  A     ++   +   H  G+IH
Sbjct: 68  HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLS 222
           RDLKP+N L++++     IK TDFGLS
Sbjct: 128 RDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 69/267 (25%), Positives = 104/267 (38%), Gaps = 36/267 (13%)

Query: 77  KELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           K+LG G FGV        +G K    A K +   KL     M+D  +E  I+  L    N
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HEN 57

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFM 191
           ++   G       L +V EL   G L DR+   A G +      +   QI N +      
Sbjct: 58  LIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---------- 241
             IHRDL   N LLAS ++   +K  DFGL   +   +         +YV          
Sbjct: 117 RFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNE--------DHYVMEEHLKVPFA 165

Query: 242 --APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
             APE L  + +    DVW  GV L+ + + G  P+   +   I + I +   +    P 
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGERLERP- 223

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAE 324
            +      +++ +    +P  R T A 
Sbjct: 224 EACPQDIYNVMLQCWAHNPADRPTFAA 250

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 41/179 (22%)

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAP 243
           CH   V+HRDLKP+N L++ + E   +K  DFGL    SV  +T   Y   V + +Y  P
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKT---YSNEVVTLWYRPP 172

Query: 244 EVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFEAILEGNLD----L 292
           +VL     Y   +D+W  G I Y + +G P F   T+       IF  +     +    +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 293 QSSP------------------WPSISG--QAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            S+P                   P +      ++L  K L  +PKKRI+AAEA++HP+ 
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 16/219 (7%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV +L   +A   K A K+I+   +  +  +E+ +    ++  L+  P +V+
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIEEAK----VMMKLS-HPKLVQ 63

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ L++V E    G L + +  + G  S+    ++C+ +   +        IH
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVLH-QRYG 251
           RDL   N L++S      +K +DFG++ ++   + Y    G+ + V    PEV +  +Y 
Sbjct: 124 RDLAARNCLVSST---GVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 252 KEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
            + DVWS GV+++ +   G  PF  ++   + E I  G 
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 80/303 (26%), Positives = 121/303 (39%), Gaps = 50/303 (16%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQH 127
           + T   L+K LG G +   +    K T    A K I   +L +++       RE+ +L+ 
Sbjct: 5   METYIKLEK-LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKD 60

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK------GIYSEREAANICRQI 181
           L    NIV         ++L LV E        D+ + +       I S         QI
Sbjct: 61  LK-HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQI 113

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYY 240
           +  +  CH   V+HRDLKP+N L+  + E   +K  DFGL+       K Y   V + +Y
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWY 170

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
             P+VL     Y  +ID+W  G I + + SG P F   T +     I           WP
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230

Query: 299 SISG--------------------------QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            IS                           +  +L+ K L  + KKRI+A EA++H + +
Sbjct: 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290

Query: 333 EDG 335
             G
Sbjct: 291 SLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 80/299 (26%), Positives = 118/299 (39%), Gaps = 50/299 (16%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQH 127
           + T   LDK LG G +   +    K T    A K I   +L +++       RE+ +L++
Sbjct: 4   LETYVKLDK-LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKN 59

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVV 185
           L    NIV        ++ L LV E       +  D      + S         Q++  +
Sbjct: 60  LK-HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDN--CGNLMSMHNVKIFMFQLLRGL 116

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPE 244
             CH   ++HRDLKP+N L+  K E   +K  DFGL+       K Y   V + +Y  P+
Sbjct: 117 SYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP----WP 298
           VL     Y   ID+W  G ILY + +G P F   T K     I      L  +P    WP
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR----LLGTPTEETWP 229

Query: 299 SISGQAK--------------------------DLIRKMLTKDPKKRITAAEALEHPWL 331
            I+   +                          DL+  +L  + K RI+A  AL H + 
Sbjct: 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 65/267 (24%), Positives = 102/267 (38%), Gaps = 36/267 (13%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--- 131
           L + +G GQFG  Y    +        + I+              RE  + +    +   
Sbjct: 10  LGRCIGEGQFGDVY----QGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--------CRQIV 182
            P+IV+  G   +   + +VMEL   GEL         Y +    ++          Q+ 
Sbjct: 66  HPHIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYY 240
             +        +HRD+   N L++S +    +K  DFGLS ++E    YK   G     +
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 241 VAPEVLH-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           +APE ++ +R+    DVW  GV ++ IL+ GV PF       +   I  G       P P
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----RLPMP 230

Query: 299 SISGQA-KDLIRKMLTKDPKKRITAAE 324
                    L+ K    DP KR    E
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.1 bits (179), Expect = 9e-15
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 16/220 (7%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L +E+G GQFG+ +L       RK A K+I R   + ++D  +  + ++ L H    P +
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSEEDFIEEAQVMMKLSH----PKL 61

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGV 193
           V+  G   ++  + LV E    G L D + A +G +S+     +C  +   +       V
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL-HQR 249
           IHRDL   N L+    E+  +K +DFG++ F+   + Y    G+ + V   +PEV    +
Sbjct: 122 IHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSK 177

Query: 250 YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           Y  + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 32/211 (15%)

Query: 77  KELGRGQFGVTYLCTKKA----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG G FG   LC        TG + A KS+          + D+++EI IL++L  + 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 66

Query: 133 NIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYSEREAA--NICRQIVNVVHAC 188
           NIV+++G   +     + L+ME    G L +       Y  R     N+ +Q+   V  C
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119

Query: 189 HFMGV------IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY----KEIVGSA 238
             M        +HRDL   N L+   E +  +K  DFGL+  IET K Y     ++    
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLS 268
           ++ APE L   ++    DVWS GV LY LL+
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 19/233 (8%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D + I  ++K +G G+FG       K  G++    +I   K  Y    E  RR+ L   
Sbjct: 1   IDASCI-KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEA 56

Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K  G ++  +   + R I
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGI 115

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGS-- 237
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 238 AYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + APE + ++++    DVWS G++++ ++S G  P+W  + + + +AI EG
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 39/268 (14%)

Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK--DMEDVRREILILQHLTGQ 131
            L   +G+G+FG   L   +  G+K A K +               V   +  L+H    
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASV---MTTLRH---- 59

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           PN+V+  G       L++V E  + G L D + ++G    R    + +Q+   +  C  M
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGM 115

Query: 192 ------GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYV 241
                   +HRDL   N L++   ED   K +DFGL    S   ++GK+         + 
Sbjct: 116 EYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQGQDSGKL------PVKWT 166

Query: 242 APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           APE L  +++  + DVWS G++L+ + S G  P+     K +   + +G    +      
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEG 223

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALE 327
              +   +++     DP KR T  +  E
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           + +GRG FG  +    +A     A KS  R  L   +  K +++ R    IL+  +  PN
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEAR----ILKQYS-HPN 54

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG- 192
           IV   G    KQ +++VMEL  GG+    +  +G     +   + + + N      ++  
Sbjct: 55  IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLES 112

Query: 193 --VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG----SAYYVAPEVL 246
              IHRDL   N L+  K   + +K +DFG+S   E G VY    G       + APE L
Sbjct: 113 KHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEAL 168

Query: 247 -HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + RY  E DVWS G++L+   S G  P+   + +   EAI +G
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  Y    K    + A K+   R  +         +E  IL+     PNIV+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNT-EVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-CRQIVN-VVHACHFM--- 191
             G    KQ +++VMEL  GG L         +  ++   +  ++++   + A   M   
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 192 ---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY------KEIVGSAYYVA 242
                IHRDL   N L+    E++ +K +DFG+S   E G +Y      K+I     + A
Sbjct: 110 ESKNCIHRDLAARNCLVG---ENNVLKISDFGMSR-EEEGGIYTVSDGLKQI--PIKWTA 163

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
           PE L + RY  E DVWS G++L+   S G  P+
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 76/250 (30%), Positives = 119/250 (47%), Gaps = 39/250 (15%)

Query: 74  DLDK--ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHL 128
           D +K  ELG G  GV +  + K +G       I  RKL++ +    +R +I   L + H 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHE 59

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P IV F GA+     + + ME   GG L D+++ K       A  I  QI+  V   
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIA 111

Query: 189 HFMG---------VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSA 238
              G         ++HRD+KP N L+ S+ E   IK  DFG+S   I++  +    VG+ 
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS--MANSFVGTR 166

Query: 239 YYVAPEVLH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN-LDLQ 293
            Y++PE L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+  + +
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226

Query: 294 SSPWPSISGQ 303
           +SP P   G+
Sbjct: 227 TSPRPRPPGR 236

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 33/232 (14%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQ-- 131
           ++K +G G+FG       K  G+K    +I   K    DK   D   E  I+    GQ  
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM----GQFD 63

Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHAC 188
            PNI+  EG     + + ++ E    G L  F R        E +      Q+V ++   
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGI 115

Query: 189 HF-------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG---SA 238
                    M  +HRDL   N L+ S   +   K +DFGLS  +E  +      G     
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + APE + ++++    DVWS G++++ ++S G  P+W  + + + +A+ +G
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 26/225 (11%)

Query: 77  KELGRGQFG-VTYLC---TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + LG G FG V+  C       TG   A K++ R      ++    ++EI IL+ L  + 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHE- 66

Query: 133 NIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYSERE---AANICRQIVNVVHA 187
           NIV+++G   ++  + L L+ME    G L D +    +   +    A  IC  +   +H+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA-YLHS 125

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV----GSAYYVAP 243
            H+   IHRDL   N LL   + D  +K  DFGL+  +  G  Y  +        ++ A 
Sbjct: 126 QHY---IHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 244 EVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
           E L + ++    DVWS GV LY LL+      +  +K  FE ++ 
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIG 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 77  KELGRGQFGVT---YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           KELG G FG         K     + A K++ +  +   K   +  RE  ++  L   P 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLD-HPC 57

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI---VNVVHACHF 190
           IV   G  + +  L LVMEL   G L   +  +      +   +  Q+   +  + + HF
Sbjct: 58  IVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYV---APEVL 246
              +HRDL   N LL ++ +    K +DFG+S  +  G   Y+      + +   APE +
Sbjct: 117 ---VHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 247 HQRYGK---EIDVWSAGVILYILLS-GVPPF 273
           +  YGK   + DVWS GV L+   S G  P+
Sbjct: 171 N--YGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 8e-14
 Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D++ +  +++ +G G+FG       K  G++    +I   K  Y    E  RR+ L   
Sbjct: 1   IDVSCV-KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEA 56

Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + ++ E    G L  F R    G ++  +   + R I
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGI 115

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSA 238
              +     M  +HRDL   N L+ S   +   K +DFGLS F+E       Y   +G  
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 239 Y---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
               + APE + ++++    DVWS G++++ ++S G  P+W  + + +  AI
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.3 bits (172), Expect = 9e-14
 Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 56/278 (20%)

Query: 79  LGRGQFGVTYLCTKK-----ATG-RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ- 131
           LG G FG  Y  T        +G  + A K++ +     +K      +E L   HL    
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK------KEFLKEAHLMSNF 56

Query: 132 --PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-------GIYSEREAANICRQIV 182
             PNIV+  G     +  +++MEL  GG+L   +           + + +E  +IC   +
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC---L 113

Query: 183 NVVHACHF---MGVIHRDLKPENFLLASKEEDSP--IKATDFGLSVFIETGKVYKEIVGS 237
           +V   C +   M  IHRDL   N L++ K  D+   +K  DFGL+         ++I  S
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKS 164

Query: 238 AYY------------VAPEVLHQ-RYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFE 283
            YY            +APE L   ++  + DVWS GV+++ IL  G  P+ A   + + +
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224

Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT 321
            +  G   LQ     +   +   L+     +DP +R T
Sbjct: 225 HVTAGG-RLQKP--ENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   LC     +  TG   A K +        + + D  REI IL+ L    
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD- 65

Query: 133 NIVEFEG-AYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+++G  Y   ++NL LVME    G L D +        RE  +  + ++     C  
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-----KHRERLDHRKLLLYASQICKG 120

Query: 191 MG------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSA-YY 240
           M        +HRDL   N L+ S   ++ +K  DFGL+  +   K Y   +E   S  ++
Sbjct: 121 MEYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 241 VAPEVLHQ-RYGKEIDVWSAGVILYILLS 268
            APE L + ++    DVWS GV+LY L +
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 81/293 (27%), Positives = 125/293 (42%), Gaps = 41/293 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTK-KATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTG 130
           Y+   E+G G +G  +     K  GR  A K +  R    ++ M     RE+ +L+HL  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLET 60

Query: 131 --QPNIVEF----EGAYEDKQN-LHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQI 181
              PN+V        +  D++  L LV E          D++   G+ +E    ++  Q+
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQL 119

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV 241
           +  +   H   V+HRDLKP+N L+ S  +   IK  DFGL+           +V + +Y 
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYR 176

Query: 242 APEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAI-------LEGN 289
           APEVL Q  Y   +D+WS G I   +    P F   ++      I + I          +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236

Query: 290 LDLQSSPW------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           + L    +              I    KDL+ K LT +P KRI+A  AL HP+
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 82/313 (26%), Positives = 117/313 (37%), Gaps = 90/313 (28%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           ++LG G +   Y    +  G+  A K IS       K  E V     RE  +L+ L    
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISM------KTEEGVPFTAIREASLLKGLK-HA 63

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC---- 188
           NIV        K+ L  V E                Y   + A    Q    +H      
Sbjct: 64  NIVLLHDIIHTKETLTFVFE----------------YMHTDLAQYMIQHPGGLHPYNVRL 107

Query: 189 ------------HFMGVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYK 232
                       H   ++HRDLKP+N L++   E   +K  DFGL    S+  +T   Y 
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQT---YS 161

Query: 233 EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
             V + +Y  P+VL     Y   +D+W AG I   +L G P F   ++  +FE  LE   
Sbjct: 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQ-LEKIW 218

Query: 291 DLQSSP----WPSISG----------------------------QAKDLIRKMLTKDPKK 318
            +   P    WP +S                             +A+DL  +ML   PK 
Sbjct: 219 TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKD 278

Query: 319 RITAAEALEHPWL 331
           RI+A +AL HP+ 
Sbjct: 279 RISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV      K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++       +EA  I  +I+  V      G  
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSL-DQVL-------KEAKRIPEEILGKVSIAVLRGLA 117

Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPE 244
                  ++HRD+KP N L+ S+ E   IK  DFG+S   I++  +    VG+  Y++PE
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 172

Query: 245 VLH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIF 282
            L    Y  + D+WS G+ L  L  G   +PP  A+  + IF
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 10/101 (9%)

Query: 234 IVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL 292
           I+G+  Y+APE+L  + +G  +D W+ GV L+  L+G+PPF  ET + +F+ IL  ++  
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597

Query: 293 QSSPWP----SISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
              PWP     +S  A++ I  +LT DP KR    E  +HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 31/273 (11%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNIV 135
           LG G  G  Y      T R  A K I       D  +E ++++I   L + +    P I+
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP-----LDITVE-LQKQIMSELEILYKCDSPYII 62

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---G 192
            F GA+  +  + +  E   GG L        +Y +     + R  V VV    ++    
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           ++HRD+KP N L+ ++ +   +K  DFG+S  +    + K  VG+  Y+APE +  ++YG
Sbjct: 116 ILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 252 KEIDVWSAGVILYILLSGVPPF-WAETEKGIFEAI--LEGNLDLQSSPWP--SISGQAKD 306
              DVWS G+    L  G  P+   +  +G    +  L+  +D      P    S +   
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKE--DGAT 337
            I + + K PK+R      ++HP++ +  DG  
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 14/222 (6%)

Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNI 134
            K +G G+FG  +    K  GRK    +I   K  Y +K  +D   E  I+   +   NI
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NI 68

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMG 192
           +  EG     +   ++ E    G L D+ +    G +S  +   + R I   +     M 
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--VYKEIVGS--AYYVAPEVL-H 247
            +HRDL   N L+ S  E    K +DFGLS  +E      Y    G     + APE + +
Sbjct: 128 YVHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           +++    DVWS G++++ ++S G  P+W  +   + +AI +G
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 64/282 (22%), Positives = 105/282 (37%), Gaps = 45/282 (15%)

Query: 75  LDKELGRGQFGVTYLCT---KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L + LG G FG  Y      +     +      +  +   ++D  D   E LI+      
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-H 68

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFD-------RIIAKGIYSEREAANICRQIVNV 184
            NIV   G   ++    +++EL +GG+L         R       + ++     R +   
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK- 127

Query: 185 VHACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY- 240
              C ++     IHRD+   N LL  K      K  DFG++         ++I  ++YY 
Sbjct: 128 --GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYR 176

Query: 241 -----------VAPEV-LHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE 287
                      + PE  L   +  + DVWS GV+L+ + S G  P+   T + + E +  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 288 G-NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
           G  LD    P     G    ++       P+ R   A  LE 
Sbjct: 237 GGRLD----PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 66/310 (21%), Positives = 122/310 (39%), Gaps = 60/310 (19%)

Query: 74  DLDKELGRG--QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHL 128
           +L   +G+      + +L   K T    A K I+    +     ED++    EI+  + L
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN----LDSCSKEDLKLLQQEIITSRQL 56

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGG---ELFDRIIAKGIYSEREAANICRQIVNVV 185
              PNI+ +  ++     L++V  L + G   +L      +G   E   A I + ++N +
Sbjct: 57  Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNAL 114

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSA------ 238
              H  G IHR +K  + LL+    D  +  +    SV  I+ GK  + +          
Sbjct: 115 DYIHSKGFIHRSVKASHILLSG---DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 239 -YYVAPEVLHQR---YGKEIDVWSAGVILYILLSGVPPFWAETE---------KGIFEAI 285
             +++PEVL Q    Y ++ D++S G+    L +G  PF  +           +G    +
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPCL 230

Query: 286 L--------EGNL--DLQSSPWPSISGQAKDLIRKM------------LTKDPKKRITAA 323
           L        E ++     S+  P+          +             L +DP+ R +A+
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290

Query: 324 EALEHPWLKE 333
           + L H + K+
Sbjct: 291 QLLNHSFFKQ 300

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 40/239 (16%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSI---SRRKLVYDKDMEDVRREILI---LQHLTG 130
           +ELG G FG  Y         + +  S+   + ++    K  ++ R+E  +   LQH   
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH--- 67

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAA--------------- 175
            PNIV   G    +Q   ++ E  + G+L + ++    +S+  A                
Sbjct: 68  -PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 176 -NICRQIV---NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
            +I  QI      + + HF   +HRDL   N L+    E   +K +DFGLS  I +   Y
Sbjct: 127 LHIAIQIAAGMEYLSSHHF---VHRDLAARNCLVG---EGLTVKISDFGLSRDIYSADYY 180

Query: 232 KEIVGSAY---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
           +    S     ++ PE +L+ ++  E D+WS GV+L+ + S G+ P++  + + + E I
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 27/231 (11%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G K        ++   + D  D   E+ +L  L   PNI+   
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 139 GAYEDKQNLHLVMELCSGGELFD-----RIIAK--------GIYSEREAANICRQIVNVV 185
           GA E++  L++ +E    G L D     R++          G  S   +  + +   +V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHRDL   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS---RGEEVYVKKTMGRLPVR 183

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++A E L +  Y  + DVWS GV+L+ ++S G  P+   T   ++E + +G
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQPNIVEF 137
           LG+G FG  +    K T +     ++   K    ++++     E  IL+     PNIV+ 
Sbjct: 3   LGKGNFGEVF----KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKL 57

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---GVI 194
            G    +Q +++VMEL  GG+    +  K    E +   + +  ++      ++     I
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-----KEIVGSAYYVAPEVL-HQ 248
           HRDL   N L+    E++ +K +DFG+S   E   +Y     K+I     + APE L + 
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSR-QEDDGIYSSSGLKQI--PIKWTAPEALNYG 169

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           RY  E DVWS G++L+   S GV P+   T +   E + +G
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 61.8 bits (150), Expect = 6e-11
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 20/220 (9%)

Query: 77  KELGRGQFGVTYLCTKKATGR-KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           KELG GQFGV      K  G+   A K I    +  D+ +E+  + ++ L H      +V
Sbjct: 10  KELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMKLSH----EKLV 62

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           +  G    ++ +++V E  S G L +  R   K  +   +   +C+ +   +        
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVLH-QR 249
           IHRDL   N L+   ++   +K +DFGLS ++   + Y   VGS + V    PEVL   +
Sbjct: 122 IHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSK 177

Query: 250 YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           +  + DVW+ GV+++ + S G  P+         E + +G
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 9e-11
 Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 37/257 (14%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G G+FG       + TG+K A K+I       D   +    E  ++  L  + N+
Sbjct: 10  LGEIIGEGEFGAVL--QGEYTGQKVAVKNIK-----CDVTAQAFLEETAVMTKLHHK-NL 61

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--- 191
           V   G       L++VMEL S G L + +  +G    R   ++ + +   +     M   
Sbjct: 62  VRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116

Query: 192 ---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY----YVAPE 244
               ++HRDL   N L++   ED   K +DFGL+      +V    V ++     + APE
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLA------RVGSMGVDNSKLPVKWTAPE 167

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
            L H+++  + DVWS GV+L+ + S G  P+   + K + E + +G    +  P      
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPA 224

Query: 303 QAKDLIRKMLTKDPKKR 319
               L+      +PKKR
Sbjct: 225 DVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 46/290 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTG 130
           YD+ + +G+G  G  YL       R+ A K I  R+ + +  +   R  RE  I   L  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI--REDLSENPLLKKRFLREAKIAADLI- 60

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY---------SEREAA----NI 177
            P IV       D   ++  M    G  L  + + K ++         +E+ +     +I
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTL--KSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE----------- 226
             +I   +   H  GV+HRDLKP+N LL    E   +   D+G ++F +           
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWGAAIFKKLEEEDLLDIDV 175

Query: 227 --TGKVYKE------IVGSAYYVAPEVLHQRYGKE-IDVWSAGVILYILLSGVPPFWAET 277
                 Y        IVG+  Y+APE L      E  D+++ GVILY +L+   P+  + 
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Query: 278 EKGI-FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            + I +  ++   +++  +P+  I      +  K L  DP +R ++ + L
Sbjct: 236 GRKISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 66/308 (21%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   +G G FGV Y      T  K A K +        +D +   RE+LI+++L    
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-------QDPQYKNRELLIMKNLN-HI 119

Query: 133 NIVEFEGAY------EDKQN--LHLVMEL------------CSGGELFDRIIAKGIYSER 172
           NI+  +  Y      ++++N  L++VME                       + K +YS +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK-LYSYQ 178

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
               +CR +  +    H   + HRDLKP+N L+        +K  DFG +  +  G+   
Sbjct: 179 ----LCRALAYI----HSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSV 228

Query: 233 EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL---- 286
             + S +Y APE++     Y   ID+WS G I+  ++ G P F  ++       I+    
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288

Query: 287 --------EGNLDLQSSPWPSISGQ-------------AKDLIRKMLTKDPKKRITAAEA 325
                   E N +     +P +  +             A + I + L  +P KR+   EA
Sbjct: 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348

Query: 326 LEHPWLKE 333
           L  P+  +
Sbjct: 349 LADPFFDD 356

Length = 440

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 29/241 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSIS-----RRKLVYDKDMEDVRREILILQHLT 129
           L K LG G FG   +       +    K ++      +    DKD+ D+  E+ +++ + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GIYSEREAANI------CRQ 180
              NI+   GA      L++++E  S G L + + A+   G+    +   +       + 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 181 IVN----VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
           +V+    V     ++     IHRDL   N L+    ED+ +K  DFGL+  +     YK+
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYYKK 192

Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + EG
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252

Query: 289 N 289
           +
Sbjct: 253 H 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 14/143 (9%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPE-VLHQR 249
           +HRDL   N L+    E+  +K  DFGLS  I +   YK     A    ++ PE + + R
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208

Query: 250 YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
           Y  E DVW+ GV+L+ + S G+ P++    + +   + +GN+       P    +  +L+
Sbjct: 209 YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPL---ELYNLM 265

Query: 309 RKMLTKDPKKRITAAE---ALEH 328
           R   +K P  R + A     L+ 
Sbjct: 266 RLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 24/236 (10%)

Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L +ELG G FG  +L  C      +     ++   K   D   +D  RE  +L +L  + 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE- 67

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-------------YSEREAANICR 179
           +IV+F G   +   L +V E    G+L   + A G               ++ +  +I +
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EIVG 236
           QI   +        +HRDL   N L+    E+  +K  DFG+S  + +   Y+     + 
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 237 SAYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNL 290
              ++ PE ++++++  E DVWS GV+L+ I   G  P++  +   + E I +G +
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 43/282 (15%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM------EDVRREILILQHL 128
           L +ELG G FG  +L        +   + ++ + L   K+       +D  RE  +L + 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDARKDFEREAELLTNF 65

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGEL----------FDRII----AKGIYSEREA 174
               NIV+F G   +     +V E    G+L             +       G  +  + 
Sbjct: 66  -QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 175 ANICRQI---VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
             I  QI   +  + + HF   +HRDL   N L+     D  +K  DFG+S  + T   Y
Sbjct: 125 LQIAVQIASGMVYLASQHF---VHRDLATRNCLVG---YDLVVKIGDFGMSRDVYTTDYY 178

Query: 232 KEIVGSAY----YVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAI 285
           + + G       ++ PE ++++++  E DVWS GV+L+ I   G  P++  + + + E I
Sbjct: 179 R-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237

Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            +G L  +    PS   +  D++     +DP++RI   +  E
Sbjct: 238 TQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G +        ++     D  D   E+ +L  L   PNI+   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 139 GAYEDKQNLHLVMELCSGGELFD-----RIIAK--------GIYSEREAANICRQIVNVV 185
           GA E +  L+L +E    G L D     R++             S   +  +     +V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHRDL   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 176

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 75  LDKELGRGQFGVTYL-----CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+      V +      R E L    + 
Sbjct: 10  LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT------VNENASMRERIEFLNEASVM 63

Query: 130 GQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----------GIYSEREAAN 176
            +    ++V   G     Q   +VMEL + G+L   + ++          G  + ++   
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 177 ICRQI---VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
           +  +I   +  + A  F   +HRDL   N ++A   ED  +K  DFG++  I     Y++
Sbjct: 124 MAAEIADGMAYLAAKKF---VHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177

Query: 234 IVGSAYYV---APEVLHQ-RYGKEIDVWSAGVILY 264
                  V   APE L    +  + DVWS GV+L+
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 76/298 (25%), Positives = 117/298 (39%), Gaps = 48/298 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+  ++LG G +   Y    K  G+  A K I  ++   +       RE  +L+ L    
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK-HA 63

Query: 133 NIVEFEGAYEDKQNLHLVME-----LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           NIV        K+ L LV E     LC   +  D+    G            Q++  +  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDK--HPGGLHPENVKLFLFQLLRGLSY 118

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVL 246
            H   ++HRDLKP+N L++   E   +K  DFGL+         Y   V + +Y  P+VL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 247 --HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFEAILEGNLD----LQSS 295
                Y   +D+W  G I   ++ GV  F    +     + IF  +   N D    + S 
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 296 P------------------WPSIS--GQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           P                  W  +S    A+DL  K+L   PK R++A  AL H +  +
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 39/272 (14%)

Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L  ELG G FG  +L  C      +     ++   K   +   +D +RE  +L  L  Q 
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ- 67

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----IYSEREAA-----------NI 177
           +IV F G   + + L +V E    G+L   + + G    I +  E              I
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 178 CRQIVN---VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI 234
             QI +    + + HF   +HRDL   N L+    +   +K  DFG+S  I +   Y+  
Sbjct: 128 ASQIASGMVYLASLHF---VHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYR-- 179

Query: 235 VGS-----AYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILE 287
           VG        ++ PE +L++++  E D+WS GV+L+ I   G  P++  +     E I +
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239

Query: 288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR 319
           G    +    P    +   +++    ++P++R
Sbjct: 240 GRELERPRTCPP---EVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 28/160 (17%)

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
            +A  I +QI+  +   H   +IHRD+K EN  +    +   +   D G + F      +
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAF 213

Query: 232 KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
             + G+    APEVL + +Y  + D+WSAG++L+ +L+            IFE       
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--------YPSTIFE------- 258

Query: 291 DLQSSPW-PSISG--QAKDLIRKM------LTKDPKKRIT 321
           D  S+P     S       +I  +        +DP  R+ 
Sbjct: 259 DPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298

Length = 357

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 33/243 (13%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGR--KYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   +       K+   R  K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 79

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----------------GIYSE 171
           +    NI+   GA      L++++E  S G L + + A+                   S 
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           ++  +   Q+   +        IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196

Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256

Query: 287 EGN 289
           EG+
Sbjct: 257 EGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 75/316 (23%), Positives = 129/316 (40%), Gaps = 68/316 (21%)

Query: 78  ELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           ++GRG +G  Y   +K     ++YA K I    +          REI +L+ L   PN++
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELK-HPNVI 61

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIA--KGIYSEREAANICR--------QIVNVV 185
             +  +    +  + +           II   +   + ++   + R        QI++ +
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 186 HACHFMGVIHRDLKPENFL-LASKEEDSPIKATDFGLS-VFIETGKVYKE---IVGSAYY 240
           H  H   V+HRDLKP N L +    E   +K  D G + +F    K   +   +V + +Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVP-------------PFWAETEKGIFEAI 285
            APE+L   + Y K ID+W+ G I   LL+  P             PF  +    IF  +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 286 ----LEGNLDLQSSP-WPSISGQAKD-------------------------LIRKMLTKD 315
                +   D++  P +P++    +                          L++K+LT D
Sbjct: 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301

Query: 316 PKKRITAAEALEHPWL 331
           P KRIT+ +AL+ P+ 
Sbjct: 302 PTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 72/318 (22%)

Query: 78  ELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           ++GRG +G  Y   +K     R YA K I    +          REI +L+ L   PN++
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELK-HPNVI 61

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIA--KGIYSEREAANICR--------QIVNVV 185
             +  +    +  + +           II   +   + ++   + R        QI++ +
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 186 HACHFMGVIHRDLKPENFL-LASKEEDSPIKATDFGLS-VFIETGKVYKE---IVGSAYY 240
           H  H   V+HRDLKP N L +    E   +K  D G + +F    K   +   +V + +Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 241 VAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPF------------------------- 273
            APE+L   + Y K ID+W+ G I   LL+  P F                         
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 274 -------WAETEKGIFEAILEGNLDLQSSPWPSIS-------------GQAKDLIRKMLT 313
                  W + +K    + L    D + + + + S              +A  L++K+LT
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMK--DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299

Query: 314 KDPKKRITAAEALEHPWL 331
            DP KRIT+ +A++ P+ 
Sbjct: 300 MDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  +     YK+
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKK 195

Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255

Query: 289 N 289
           +
Sbjct: 256 H 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 46/281 (16%)

Query: 75  LDKELGRGQFGVTYL--CTKKATGRK---YACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG G FG  +L  C   +  +     A K++    L   KD +     +  LQH  
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-- 66

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELF--------DRII--------AKGIYSERE 173
              +IV+F G   D   L +V E    G+L         D +I        AKG     +
Sbjct: 67  --EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 174 AANICRQIVN---VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
             +I  QI +    + + HF   +HRDL   N L+ +   +  +K  DFG+S  + +   
Sbjct: 125 MLHIASQIASGMVYLASQHF---VHRDLATRNCLVGA---NLLVKIGDFGMSRDVYSTDY 178

Query: 231 YKEIVGS-----AYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFE 283
           Y+  VG        ++ PE ++++++  E DVWS GVIL+ I   G  P++  +   + E
Sbjct: 179 YR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236

Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
            I +G +  +    P    +  D++     ++P++R+   E
Sbjct: 237 CITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKE 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 29/257 (11%)

Query: 77  KELGRGQFGVT---YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL----ILQHLT 129
            ELG G FG         KK+       K+++ + L  D +   ++ E+L    ++Q L 
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSE------KTVAVKILKNDNNDPALKDELLREANVMQQLD 54

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHAC 188
             P IV   G  E  ++  LVMEL   G L ++ + K  + +E+    +  Q+   +   
Sbjct: 55  -NPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYL 111

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY----VAPE 244
                +HRDL   N LL ++      K +DFGLS  +   + Y +      +     APE
Sbjct: 112 EETNFVHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
            + + ++  + DVWS GV+++   S G  P+       + + I  G  +    P      
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--ERMECP-QRCPP 225

Query: 303 QAKDLIRKMLTKDPKKR 319
           +  DL++   T    +R
Sbjct: 226 EMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQPNI 134
           ELG G FG    C KK   +    +     K++ +++ + VR E++    + H    P I
Sbjct: 2   ELGSGNFG----CVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--- 191
           V   G  E  + L LVME+ SGG L   +  K    E   +N+   +  V     ++   
Sbjct: 58  VRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK 114

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAY---YVAPEVLH 247
             +HRDL   N LL ++      K +DFGLS         YK      +   + APE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 248 -QRYGKEIDVWSAGVILYILLS-GVPPF 273
            +++    DVWS G+ ++   S G  P+
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++ +   PN+V+ 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQL 67

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---GVI 194
            G    +   +++ E  + G L D +       E  A  +      +  A  ++     I
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRY 250
           HRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + APE L + ++
Sbjct: 127 HRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 251 GKEIDVWSAGVILY-ILLSGVPPF 273
             + DVW+ GV+L+ I   G+ P+
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 65/255 (25%), Positives = 120/255 (47%), Gaps = 23/255 (9%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           LD +LG+G FG  ++ T   T  K A K++    ++ +  +++ +    I++ L     +
Sbjct: 10  LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQ----IMKKLRHDKLV 64

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSE-REAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E    G L D +    G Y +  +  ++  QI + +     M 
Sbjct: 65  PLY--AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN 122

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPE-VLHQ 248
            IHRDL+  N L+    ++   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 123 YIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 178

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA-KD 306
           R+  + DVWS G++L  L++ G  P+     + + E +  G       P P    ++  +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCPESLHE 234

Query: 307 LIRKMLTKDPKKRIT 321
           L++    KDP +R T
Sbjct: 235 LMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 25/201 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           Y++   L  G  G  ++CTK      +K   K+++  K           REI IL+ ++ 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS- 144

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
              I+    AY  K  + +VM      +LF  +   G     +A  I R+++  +   H 
Sbjct: 145 HRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG 203

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKAT--DFG----LSVFIETGKVYKEIVGSAYYVAPE 244
            G+IHRD+K EN  L     D P  A   DFG    L    +T + Y    G+    +PE
Sbjct: 204 RGIIHRDVKTENIFL-----DEPENAVLGDFGAACKLDAHPDTPQCYG-WSGTLETNSPE 257

Query: 245 VLH-QRYGKEIDVWSAGVILY 264
           +L    Y  + D+WSAG++L+
Sbjct: 258 LLALDPYCAKTDIWSAGLVLF 278

Length = 392

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 52/279 (18%)

Query: 77  KELGRGQFGVTYLCTKKAT--GRKYA---CKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
             LGRG+FG  +L   K             K++ + K   +    + RRE+ + + L+  
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLS-H 67

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHA-C 188
            N+V   G   + +  ++++E    G+L  F R         +      +Q V +     
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 189 HFMG------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY-- 240
             M        +HRDL   N L++S+ E   +K +   LS         K++  S YY  
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYYKL 175

Query: 241 ---------VAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
                    +APE V    +  + DVWS GV+++ +   G  PF+  +++ +   +  G 
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235

Query: 290 LDLQSSPWPSISGQAKDLIRKMLTK----DPKKRITAAE 324
           L+      P   G    L  K++T+    +PK R + +E
Sbjct: 236 LE-----LPVPEGCPSRL-YKLMTRCWAVNPKDRPSFSE 268

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 7/96 (7%)

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGK 229
           +   + RQ+++ +   H  G+IHRD+K EN L+   E+   I   DFG + F     +  
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTP 317

Query: 230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILY 264
            +  I G+    APEVL    Y   +D+WSAG++++
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 28/222 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LG G FG                 +++ + L     +KD+ D+  E+ +++ +   
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV--------- 182
            NI+   G    +  L++V+E  + G L D + A+    E  + +  R            
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 183 ----NVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
                V     F+     IHRDL   N L+    ED  +K  DFGL+  I     Y++  
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 236 GS---AYYVAPEVLHQR-YGKEIDVWSAGVILY--ILLSGVP 271
                  ++APE L  R Y  + DVWS GV+L+    L G P
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 17/211 (8%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
             K LG G FG     T     +  A   ++ + L    +  + E +  E+ I+ HL   
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACH 189
            NIV   GA      + ++ E C  G+L +  R   +   +  +  +   Q+   +    
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV-GSAY----YVAPE 244
               IHRDL   N LL        +K  DFGL+  I     Y  +V G+A     ++APE
Sbjct: 159 SKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDSNY--VVKGNARLPVKWMAPE 213

Query: 245 -VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
            + +  Y  E DVWS G++L+ + S G  P+
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G +        ++     D  D   E+ +L  L   PNI+   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 139 GAYEDKQNLHLVMELCSGGELFDRI-------------IAKGIYSEREAANICRQIVNVV 185
           GA E +  L+L +E    G L D +             IA    S   +  +     +V 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHRDL   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 188

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 27/203 (13%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    N+
Sbjct: 10  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNL 61

Query: 135 VEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-- 191
           V+  G   E+K  L++V E  + G L D + ++G  S      + +  ++V  A  ++  
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 192 -GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAPEVL 246
              +HRDL   N L++   ED+  K +DFGL    S   +TGK+         + APE L
Sbjct: 121 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEAL 171

Query: 247 HQ-RYGKEIDVWSAGVILYILLS 268
            + ++  + DVWS G++L+ + S
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 34/236 (14%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM---EDVRREILI---LQHLTG 130
           +ELG  +FG  Y      T      ++++ + L    +    E+ + E ++   LQH   
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH--- 67

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-------------KGIYSEREAANI 177
            PNIV   G    +Q L ++   CS  +L + ++              K + S  E A+ 
Sbjct: 68  -PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126

Query: 178 CRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI 234
              +  +     F+    V+H+DL   N L+  K     +K +D GL   +     YK +
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLFREVYAADYYKLM 183

Query: 235 VGSAY---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
             S     +++PE +++ ++  + D+WS GV+L+ + S G+ P+   + + + E I
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 34/280 (12%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK-DMEDVRREILIL 125
           +D T+I  L ++LG GQFG  +       G       ++ + L     D +D   E  I+
Sbjct: 3   IDRTSI-QLLRKLGAGQFGEVW------EGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIM 55

Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVN 183
           + L   P +++       ++ +++V EL   G L +  +  A       +  ++  Q+ +
Sbjct: 56  KKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAY--- 239
            +        IHRDL   N L+    E++  K  DFGL+ V  E   +Y+   G+ +   
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKE--DIYEAREGAKFPIK 169

Query: 240 YVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           + APE  L+ R+  + DVWS G++L  I+  G  P+   T   + + + +G       P 
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----YRMPC 225

Query: 298 PSISGQAKDLIRKML---TKDPKKRITAAEALEHPWLKED 334
           P   G  K+L   ML    +DP  R T  E L+  W  ED
Sbjct: 226 P--PGCPKELYDIMLDCWKEDPDDRPT-FETLQ--WKLED 260

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 9/134 (6%)

Query: 146 NLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL 204
           +L LV +L   G L D +   +     +   N C QI   ++      ++HR+L   N L
Sbjct: 82  SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141

Query: 205 LASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAG 260
           L S   DS ++  DFG++  +   +    Y E      ++A E +   RY  + DVWS G
Sbjct: 142 LKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198

Query: 261 VILYILLS-GVPPF 273
           V ++ ++S G  P+
Sbjct: 199 VTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 24/199 (12%)

Query: 112 DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----- 166
           DKD+ D+  E+ +++ +    NI+   G    +  L++++E  + G L + + A+     
Sbjct: 58  DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 167 -----------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK 215
                         S ++  +   Q+   +        IHRDL   N L+    ED+ +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMK 174

Query: 216 ATDFGLSVFIETGKVYKEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGV 270
             DFGL+  +     YK+         ++APE L  R Y  + DVWS G++++ I   G 
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234

Query: 271 PPFWAETEKGIFEAILEGN 289
            P+     + +F+ + EG+
Sbjct: 235 SPYPGIPVEELFKLLREGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 34/223 (15%)

Query: 75  LDKELGRGQFGVTYLCTKKA------------TGRKYACKSISRRKLVYDKDMEDVRREI 122
           L ++LG GQFG  +LC  +              G+         R  V      D  +EI
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ 176
            I+  L   PNI+   G       L ++ E    G+L   +  + I S    AN      
Sbjct: 69  KIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 177 ------ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
                 +  QI + +     +  +HRDL   N L+ +      IK  DFG+S  + +G  
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLYSGDY 184

Query: 231 YKEIVGSAY----YVAPE-VLHQRYGKEIDVWSAGVILYILLS 268
           Y+ I G A     ++A E +L  ++    DVW+ GV L+ + +
Sbjct: 185 YR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 65/257 (25%), Positives = 119/257 (46%), Gaps = 27/257 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 10  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 64

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER----EAANICRQIVNVVHACHF 190
             +  A   ++ +++V E  S G L D +  KG   +     +  ++  QI + +     
Sbjct: 65  QLY--AVVSEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-L 246
           M  +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L
Sbjct: 121 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL 176

Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA- 304
           + R+  + DVWS G++L  L + G  P+     + + + +  G       P P    ++ 
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECPESL 232

Query: 305 KDLIRKMLTKDPKKRIT 321
            DL+ +   K+P++R T
Sbjct: 233 HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 63/267 (23%), Positives = 114/267 (42%), Gaps = 28/267 (10%)

Query: 73  YDLDKELGRGQFGV---TYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           + L + LG+G+FG      L ++  + +K A K + +  +    D+E+  RE   ++   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 130 GQPNIVEFEGAY---EDKQNLHLVM---ELCSGGELFDRIIAKGIYSER---EAANICRQ 180
             PN+++  G       K  L + M        G+L   ++   I  E        + R 
Sbjct: 60  -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 181 IVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
           ++++     ++     IHRDL   N +L    E+  +   DFGLS  I +G  Y++   S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 238 AY---YVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDL 292
                ++A E L    Y    DVW+ GV ++ I+  G  P+       I+  +++GN   
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235

Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKR 319
           Q    P       +L+ +  + +PK R
Sbjct: 236 QP---PDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 20/214 (9%)

Query: 77  KELGRGQFGVTYLCTKKATGRK----YACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASV-DHP 69

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++V   G     Q + L+ +L   G L D +   K     +   N C QI   +      
Sbjct: 70  HVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSA--YYVAPEVLHQ 248
            ++HRDL   N L+ + +    +K TDFGL+  ++   K Y    G     ++A E +  
Sbjct: 129 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 249 R-YGKEIDVWSAGVILYILLSGVPPFWAETEKGI 281
           R Y  + DVWS GV ++ L++    F A+  +GI
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT----FGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 29/241 (12%)

Query: 89  LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH 148
           L     T + +  K + +            R  + I+ H    PN+V        + ++ 
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEY-------SRERLTIIPH--CVPNMVCLHKYIVSEDSVF 61

Query: 149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK 208
           LV++   GG+L+  I       E        ++V  + A H  G++ RDL P N LL   
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118

Query: 209 EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKE-IDVWSAGVILYILL 267
           ++   I+ T F     +E     + +     Y APEV       E  D WS G IL+ LL
Sbjct: 119 DDRGHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 268 SGVPPFWAETEKGIFE---AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
           +G         K + E   + +  +  L    W  +S +A+ L++++L  +P +R+ A  
Sbjct: 177 TG---------KTLVECHPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGV 225

Query: 325 A 325
           A
Sbjct: 226 A 226

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 29/265 (10%)

Query: 84  FGVTYLCTKKATGRKYACKSISRRKLVYDK--DMEDVRREILILQHLTGQPNIVEFEGAY 141
           F +    T  A G  +AC      + V  K         E  IL+ +   P+I++ +G +
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAIN-HPSIIQLKGTF 152

Query: 142 EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPE 201
              +   L++      +L+  + AK   +  +   I R ++  +   H   +IHRD+K E
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211

Query: 202 NFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVW 257
           N  +        +   DFG + F   I   K Y    G+    APE+L +  YG  +D+W
Sbjct: 212 NIFI---NHPGDVCLGDFGAACFPVDINANKYYG-WAGTIATNAPELLARDPYGPAVDIW 267

Query: 258 SAGVILYILLSGVPPFWAETEKGIFEAI-LEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           SAG++L+ + +            +FE   L+G+ D           Q K +IR+  T   
Sbjct: 268 SAGIVLFEMATC--------HDSLFEKDGLDGDCDSDR--------QIKLIIRRSGTHPN 311

Query: 317 KKRITAAEALEHPWLKEDGATSDKP 341
           +  I A   L+  ++     +S KP
Sbjct: 312 EFPIDAQANLDEIYIGLAKKSSRKP 336

Length = 391

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 46/242 (19%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV---------RREILILQH 127
           +ELG   FG  Y       G  +A       +LV  K ++D+         ++E  ++  
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHA-------QLVAIKTLKDINNPQQWGEFQQEASLMAE 63

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN----------- 176
           L   PNIV   G    +Q + ++ E  + G+L + +I +  +S+   ++           
Sbjct: 64  LH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 177 ------ICRQIVNVVH--ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
                 I  QI   +   + HF   +H+DL   N L+    E   +K +D GLS  I + 
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFF--VHKDLAARNILIG---EQLHVKISDLGLSREIYSA 177

Query: 229 KVYKEIVGSAY---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFE 283
             Y+    S     ++ PE +++ ++  + D+WS GV+L+ + S G+ P++  + + + E
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237

Query: 284 AI 285
            +
Sbjct: 238 MV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 25/227 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L+++LG G FG  +    K    + A K +    L+     +D ++E+  L+ L    
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLL---KQQDFQKEVQALKRLR-HK 62

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           +++         + ++++ EL   G L  F R     +       ++  Q+   +     
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY-------YVAP 243
              IHRDL   N L+    ED   K  DFGL+      ++ KE V  +        + AP
Sbjct: 123 QNSIHRDLAARNILVG---EDLVCKVADFGLA------RLIKEDVYLSSDKKIPYKWTAP 173

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           E   H  +  + DVWS G++LY + + G  P+       +++ I  G
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 66/255 (25%), Positives = 117/255 (45%), Gaps = 23/255 (9%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K+LG GQFG  ++ T      K A K++    +  +  +E+ +    I++ L     +
Sbjct: 10  LIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQ----IMKKLR-HDKL 63

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSE-REAANICRQIVNVVHACHFMG 192
           V+   A   ++ +++V E  S G L D +   +G   +     ++  Q+   +     M 
Sbjct: 64  VQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPE-VLHQ 248
            IHRDL+  N L+    +    K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 123 YIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 178

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA-KD 306
           R+  + DVWS G++L  L++ G  P+     + + E +  G       P P     +  +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPISLHE 234

Query: 307 LIRKMLTKDPKKRIT 321
           L+ +   KDP++R T
Sbjct: 235 LMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 58/217 (26%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L+++LG GQFG  ++ T   T  K A K++    +      E   +E  I   L+H    
Sbjct: 10  LERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLRH---- 60

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-------------------IAKGI-YSE 171
             +V+      +++ +++V E  S G L D +                   IA+G+ Y E
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                                 IHRDL   N L+    E+   K  DFGL+  IE    Y
Sbjct: 121 S------------------RNYIHRDLAARNILVG---ENLVCKIADFGLARLIED-DEY 158

Query: 232 KEIVGSAY---YVAPE-VLHQRYGKEIDVWSAGVILY 264
               G+ +   + APE   + R+  + DVWS G++L 
Sbjct: 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 9/133 (6%)

Query: 147 LHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL 205
           + LV +L   G L D +   K     ++  N C QI   +     + ++HRDL   N L+
Sbjct: 83  VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142

Query: 206 ASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA----YYVAPEVLHQRYGKEIDVWSAGV 261
            S      +K TDFGL+  ++  +      G      +     +LH+R+  + DVWS GV
Sbjct: 143 KSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199

Query: 262 ILYILLS-GVPPF 273
            ++ L++ G  P+
Sbjct: 200 TVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 12/221 (5%)

Query: 75  LDKELGRGQFG-VTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           +++ LG G+FG +   C K  + R+      + R    DK       E L L       N
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSN 67

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM 191
           IV  EG       + +V E  S G L D  + K  G     +   +   + + +     M
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL-HQ 248
           G +H+ L     L+ S   D   K + F      ++  +Y  + G     + APE + + 
Sbjct: 127 GYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            +    DVWS G++++ ++S G  P+W  + + + +A+ +G
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 63/274 (22%), Positives = 109/274 (39%), Gaps = 28/274 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L K LG G+FG            +  K A K++      Y  ++E+   E   ++     
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFD-H 60

Query: 132 PNIVEFEGA---YEDKQNLH---LVMELCSGGELFDRIIAKGIYSERE---AANICRQIV 182
           PN+++  G        Q +    +++     G+L   ++   +    E      + + +V
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 183 NVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           ++     ++     IHRDL   N +L    ED  +   DFGLS  I +G  Y++   +  
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 240 ---YVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQS 294
              ++A E L  R Y  + DVW+ GV ++ I   G  P+       I++ +  GN   Q 
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237

Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
                   +  DL+      DPK R T  +  E 
Sbjct: 238 EDCLD---ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 52/224 (23%)

Query: 79  LGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVR---REILILQHLTGQP 132
           +G+G FG  Y   L          A KS++R       D+E+V    +E +I++  +  P
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-----DLEEVEQFLKEGIIMKDFS-HP 56

Query: 133 NIVEFEGAYEDKQNL-HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           N++   G     +    +V+     G+L + I      SE     +   I   +     M
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGM 111

Query: 192 ------GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY----- 240
                   +HRDL   N +L   +E   +K  DFGL+         ++I    YY     
Sbjct: 112 EYLASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNH 159

Query: 241 ---------VAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPF 273
                    +A E L  Q++  + DVWS GV+L+ L++ G PP+
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 21/221 (9%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K+LG GQFG  ++     +  K A K++    +     +E+    +  LQH      +V 
Sbjct: 12  KKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMSVQAFLEEANL-MKTLQH----DKLVR 65

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVI 194
                  ++ ++++ E  + G L D + +   G     +  +   QI   +        I
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLHQRYG 251
           HRDL+  N L++   E    K  DFGL+  IE  + Y    G+ +   + APE ++  +G
Sbjct: 126 HRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN--FG 179

Query: 252 K---EIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
               + DVWS G++LY I+  G  P+   +   +  A+  G
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
            + RQ++  +   H +G++HRD+KPEN L+     D  +K  DFG +V + TG  +  + 
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLY 369

Query: 236 G--SAYYVAPEVL 246
           G     Y  PE L
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 5/104 (4%)

Query: 107 RKLVYDKDMEDVRREILILQHLTGQPNIVEF-EGAYEDKQNLHLVMELCSGGELFDRIIA 165
           +     +   D  RE+ ILQ L  +   V     + E     +L+ME   G  L +    
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEE 86

Query: 166 KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE 209
           +      + A +  ++    H    + + H DL P N L+   +
Sbjct: 87  EKEDIAEQLAELLAKL----HQLPLLVLCHGDLHPGNILVDDGK 126

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 47/232 (20%)

Query: 77  KELGRGQFGVTYLC----------------TKKATGRKYACKSISRRKLVYDKDMEDVRR 120
           ++LG GQFG  +LC                 +K      A K +  R         D  +
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL--RPDANKNARNDFLK 68

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL--------FDRIIAKGIYSER 172
           E+ IL  L   PNI+   G   D+  L ++ E    G+L         D     G  +  
Sbjct: 69  EVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 173 EAA-----------NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL 221
            A            ++  QI + +     +  +HRDL   N L+    E+  IK  DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIADFGM 184

Query: 222 SVFIETGKVYKEIVGSAY----YVAPE-VLHQRYGKEIDVWSAGVILYILLS 268
           S  +  G  Y+ I G A     ++A E +L  ++    DVW+ GV L+ +L 
Sbjct: 185 SRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 39/224 (17%)

Query: 77  KELGRGQFGVTYLCT-----------KKATGRKYACKSISRRKL---VYDKDMEDVRREI 122
           ++LG GQFG  +LC                    A   ++ + L     D   ED  +E+
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL---------FDRIIAKGIYSERE 173
            IL  L+  PNI    G       L ++ME    G+L             +A    S   
Sbjct: 71  KILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 174 AA--NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           +    +  QI + +     +  +HRDL   N L+        IK  DFG+S  + +   Y
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMSRNLYSSDYY 186

Query: 232 KEIVGSAYYVAP-------EVLHQRYGKEIDVWSAGVILYILLS 268
           + + G A    P        VL  ++  + DVW+ GV L+ +L+
Sbjct: 187 R-VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 14/88 (15%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVGSAY----YVAPE-VL 246
           IHRDL   N LL+   E++ +K  DFGL+  ++ +   V K   GSA     ++APE + 
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK---GSARLPLKWMAPESIF 249

Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            + Y  + DVWS GV+L+ + S G  P+
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 86/366 (23%), Positives = 127/366 (34%), Gaps = 119/366 (32%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-GQPN 133
           L K+LG G FGV Y    KA+      +S    K V  K  E    EI + + +    PN
Sbjct: 136 LGKKLGEGAFGVVY----KASLVNK--QSKKEGKYVLKKATEYGAVEIWMNERVRRACPN 189

Query: 134 -IVEFEGAY------EDKQNLHLVMELCSGGELFDRIIAKGI-Y---------------- 169
              +F   +      + +    LV        L D + +K   Y                
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249

Query: 170 SEREAA---NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE 226
            ERE      I RQI+  +   H  G++HRD+KP+N + +  E     K  D G +  + 
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLR 307

Query: 227 TGKVY--KEIVGSAYYVAPE----------------------VLHQ-----RYGKEIDVW 257
            G  Y  KE +    Y APE                      VL Q     R+    D++
Sbjct: 308 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF----DIY 363

Query: 258 SAGVI-LYILLSG---------------------------VPP-FWAETEKGIFEAILEG 288
           SAG+I L +                               V P    +  +G FE     
Sbjct: 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRG-FEV---- 418

Query: 289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
            LDL         G   +L++ M+    ++RI+A  AL HP+   +G           L+
Sbjct: 419 -LDLD-------GGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG--------LLGLS 462

Query: 349 RMKQFR 354
            M+  R
Sbjct: 463 VMQNLR 468

Length = 566

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 38/219 (17%)

Query: 78  ELGRGQFGVTYLCTKKAT--------GRKYACKSISRRKLVYDKDMEDVRR-------EI 122
           +L  G FG  ++C  +A+        G     +   + + +  K ++   R       EI
Sbjct: 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEI 214

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------R 172
           L L  L  + NI++ E     + N +++ +       +D  +   +Y E          +
Sbjct: 215 LALGRLNHE-NILKIEEILRSEANTYMITQK------YDFDLYSFMYDEAFDWKDRPLLK 267

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
           +   I +Q++  V   H   +IHRD+K EN  L     D  I   DFG ++  E  +   
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFEKEREAF 324

Query: 233 EI--VGSAYYVAPEVLHQRYGKEI-DVWSAGVILYILLS 268
           +   VG+    +PE+L      EI D+WS G+IL  +LS
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 56/290 (19%), Positives = 104/290 (35%), Gaps = 67/290 (23%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
            E+G G FG   L      G  +   S +R  +   +       ++L LQ          
Sbjct: 1   DEIGNGWFGKVLL------GEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH 54

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGEL-----FDRIIAKGIYSEREAANICRQIVNVVH 186
           PN+++  G   +     LV+E C  G+L      +R +   +  +     +  ++ + + 
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV------FIETGKVYKEIVGSAYY 240
             H    IH DL   N  L +   D  +K  D+GL++      +  T            +
Sbjct: 115 WLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITK---DCHAVPLRW 168

Query: 241 VAPEVLHQRYG--------KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL 292
           +APE++  R          K+ ++WS GV ++ L                          
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL-----------------------FTA 205

Query: 293 QSSPWPSISGQA--KDLIRKMLTKDPKKRITAA------EALEHPWLKED 334
              P+P +S +   K ++R+   K PK ++         E ++  WL  +
Sbjct: 206 ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPE 255

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 22/146 (15%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVGSAY----YVAPEVLH 247
           IHRDL   N LL+   E++ +K  DFGL+  ++ +   V K   G A     ++APE + 
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK---GDARLPLKWMAPETIF 254

Query: 248 QR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            R Y  + DVWS GV+L+ + S G  P+        F   L+    +++  + +      
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT-----P 309

Query: 306 DLIRKMLT---KDPKKRITAAEALEH 328
           ++ + ML     +P +R T +E +EH
Sbjct: 310 EMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 8/101 (7%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLHQR- 249
           IHRDL   N +L    E+  +   DFGLS  I  G  Y++   +     ++A E L  R 
Sbjct: 134 IHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV 190

Query: 250 YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
           Y  + DVWS GV ++ I   G  P+       I++ + +GN
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 8/103 (7%)

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEI 234
           N C QI   ++      ++HRDL   N L+ + +    +K TDFGL+  +    K Y   
Sbjct: 113 NWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAE 169

Query: 235 VGSA---YYVAPEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
            G     +     +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 40/169 (23%), Positives = 64/169 (37%), Gaps = 26/169 (15%)

Query: 170 SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ET 227
           +E E   +C Q +  +   H        L   + LL              G   F   E 
Sbjct: 15  NEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----------DGSVAFKTPEQ 63

Query: 228 GKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAI 285
            +         Y++APEV+  Q Y ++ D++S G+ LY  L    P+  E E   I E +
Sbjct: 64  SRP------DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117

Query: 286 LEG--NLDLQSSPWP-SISG--QAKDLIRKMLTKDPKKRITAAEALEHP 329
           L G    D +       +S     +D +R   ++ P++R  A   L H 
Sbjct: 118 LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 44/237 (18%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LG G+FG     T      +    +++ + L       ++ D+  E  +L+ +   
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-H 62

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAK----GIYS------------ERE 173
           P++++  GA      L L++E    G L  F R   K     + S            +  
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 174 AANI------CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS--VFI 225
           A  +        QI   +     M ++HRDL   N L+A   E   +K +DFGLS  V+ 
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRDVYE 179

Query: 226 ETGKVYKEIVGS--AYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-------GVPP 272
           E   V K   G     ++A E L    Y  + DVWS GV+L+ +++       G+ P
Sbjct: 180 EDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 21/197 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K+LG GQFG  ++        K A KS+ +  +  +  + +    +  LQH    P +
Sbjct: 10  LVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSPEAFLAEANL-MKQLQH----PRL 63

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGI-YSEREAANICRQIVNVVHACHFMG 192
           V    A   ++ ++++ E    G L D +   +GI  +  +  ++  QI   +       
Sbjct: 64  VRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLHQR 249
            IHRDL+  N L++   E    K  DFGL+  IE  + Y    G+ +   + APE ++  
Sbjct: 123 YIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAIN-- 176

Query: 250 YGK---EIDVWSAGVIL 263
           YG    + DVWS G++L
Sbjct: 177 YGTFTIKSDVWSFGILL 193

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 29/263 (11%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN--- 133
           +ELG+G FG+ Y    K   +      ++ + +     M + R E L    +  + N   
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHH 70

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAA------------NICRQI 181
           +V   G     Q   ++MEL + G+L   +  + +  E E               +  +I
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVG--SA 238
            + +   +    +HRDL   N ++A   ED  +K  DFG++  I ET    K   G    
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 239 YYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
            +++PE L    +    DVWS GV+L+ I      P+   + + +   ++EG L  +   
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDN 245

Query: 297 WPSISGQAKDLIRKMLTKDPKKR 319
            P +     +L+R     +PK R
Sbjct: 246 CPDM---LFELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 24/224 (10%)

Query: 75  LDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           L+K+LG GQFG  ++ T  K T  K A K++    +  +  + +    +  LQH      
Sbjct: 10  LEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANV-MKTLQH----DK 62

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER--EAANICRQIVNVVHACHFM 191
           +V+   A   K+ ++++ E  + G L D + +     +   +  +   QI   +      
Sbjct: 63  LVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLHQ 248
             IHRDL+  N L+++       K  DFGL+  IE  + Y    G+ +   + APE ++ 
Sbjct: 122 NYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN- 176

Query: 249 RYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            +G    + DVWS G++L  +++ G  P+   +   +  A+  G
Sbjct: 177 -FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 14/88 (15%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVGSAY----YVAPEVLH 247
           IHRDL   N LL+   E++ +K  DFGL+  ++ +   V K   G A     ++APE + 
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK---GDARLPLKWMAPESIF 248

Query: 248 QR-YGKEIDVWSAGVILYILLS-GVPPF 273
            + Y  + DVWS GV+L+ + S G  P+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 14/141 (9%)

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY----YVAPE-VLHQ 248
           IHRDL   N LL         K  DFGL+  I     Y  + G+A     ++APE + + 
Sbjct: 236 IHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESIFNC 291

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPF-WAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            Y  E DVWS G++L+ + S G  P+     +   ++ I EG   L     PS   +  D
Sbjct: 292 VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS---EMYD 348

Query: 307 LIRKMLTKDPKKRITAAEALE 327
           +++     DP KR T  + ++
Sbjct: 349 IMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 39/224 (17%)

Query: 77  KELGRGQFGVTYLC--------TKKATGRKYACKS---ISRRKLVYDKDM---EDVRREI 122
           ++LG GQFG  +LC          K      +      ++ + L  D +     D  +EI
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL---FDRIIAKGIYSEREAA---- 175
            I+  L   PNI+           L ++ E    G+L     R   +    + +      
Sbjct: 71  KIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 176 ----NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                +  QI + +     +  +HRDL   N L+    ++  IK  DFG+S  + +G  Y
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSGDYY 186

Query: 232 KEIVGSAYYVAP-------EVLHQRYGKEIDVWSAGVILYILLS 268
           + I G A  V P        +L  ++    DVW+ GV L+ +L+
Sbjct: 187 R-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEI 234
           N C QI   +       ++HRDL   N L+ S      +K TDFGL+  +E   K Y   
Sbjct: 113 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNAD 169

Query: 235 VGSA--YYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
            G     ++A E +H R +  + DVWS GV ++ L++ G  P+
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 65/278 (23%), Positives = 121/278 (43%), Gaps = 31/278 (11%)

Query: 77  KELGRGQFGVTYLCTKKATGR-----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           +ELG+G FG+ Y    +   +     + A K+++    +  ++  +   E  +++  T  
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCH 69

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICRQI 181
            ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  +I
Sbjct: 70  -HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVG--SA 238
            + +   +    +HRDL   N ++A    D  +K  DFG++  I ET    K   G    
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 239 YYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSP 296
            ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q   
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDN 245

Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
            P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 246 CPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 35/126 (27%), Positives = 55/126 (43%), Gaps = 17/126 (13%)

Query: 159 LFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKE-------- 209
           L D I+  G +S R  A I  Q    +   H  + ++H DLKPEN L+ + +        
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277

Query: 210 -----EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVIL 263
                +   ++  D G     +       IV + +Y +PEV L   +    D+WS G I+
Sbjct: 278 RALPPDPCRVRICDLGGCC--DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335

Query: 264 YILLSG 269
           Y L +G
Sbjct: 336 YELYTG 341

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	366
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
smart00090	237	RIO RIO-like kinase.	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.63
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.53
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.52
KOG3087	229	consensus Serine/threonine protein kinase [General	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.48
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.25
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.2
COG4248	637	Uncharacterized protein with protein kinase and he	99.2
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.17
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.08
PRK09902	216	hypothetical protein; Provisional	98.93
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.89
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.79
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.73
PF01636	239	APH: Phosphotransferase enzyme family This family	98.68
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.67
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.62
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.57
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.52
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.49
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.48
PLN02876	822	acyl-CoA dehydrogenase	98.42
KOG2270	520	consensus Serine/threonine protein kinase involved	98.28
PRK10593	297	hypothetical protein; Provisional	98.21
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.21
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.19
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.09
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.08
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.04
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.73
PRK05231	319	homoserine kinase; Provisional	97.73
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.59
PLN02236	344	choline kinase	97.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.46
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.43
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.42
PLN02756	418	S-methyl-5-thioribose kinase	97.39
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.03
PRK12396	409	5-methylribose kinase; Reviewed	96.88
PTZ00384	383	choline kinase; Provisional	96.86
PRK11768	325	serine/threonine protein kinase; Provisional	96.72
COG2334	331	Putative homoserine kinase type II (protein kinase	96.58
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.47
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.37
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.25
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.2
PRK06148	1013	hypothetical protein; Provisional	96.16
PTZ00296	442	choline kinase; Provisional	95.67

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-63  Score=438.98  Aligned_cols=270  Identities=40%  Similarity=0.673  Sum_probs=248.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccc----cHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK----DMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.++......    ....+.+|+++|++|+ |||||+++++|+.
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEV  247 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeec
Confidence            4667799999999999999999999999999999999876654422    3445789999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      .+..|+||||++||+|++.+..++.+.+..-+.+++||+.|+.|||+.||+||||||+|||++.+.++-.+||+|||+|+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999877677889999999999


Q ss_pred             cccCCCceecccCCCCCCcccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  298 (366)
                      .........+.+||+.|.|||++...    +..++|+||+|||||-+++|.+||.+..... ..+++..+.+.+-...|.
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            99888888999999999999998632    4568999999999999999999998876666 889999999999999999


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      .++++..+||.+||..||++|||+.|+|+||||+.....+
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            9999999999999999999999999999999999887665

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-59  Score=431.04  Aligned_cols=264  Identities=37%  Similarity=0.593  Sum_probs=246.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      .+|...+.||+|+|+.||.+++..+|+.||+|++.+.........+.+.+|+++.+.|. |||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            56999999999999999999998999999999999888877888999999999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-C
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-K  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~  229 (366)
                      +|+|+.++|.++++..+.++|.+++.+++||+.||.|||+++|+|||||..|+|+   +++.+|||+|||+|.....+ .
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999988899999999999999999999999999999999999999   67888999999999988744 5


Q ss_pred             ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ...+.+||+.|.|||++.+ ..+..+||||+|||||.||.|++||+..+-++....+....+..+.    .++.++.+||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            6678899999999999874 5899999999999999999999999999999999999998888776    5799999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      .++|..||.+|||+++||.|+||++...+...+.
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS  283 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence            9999999999999999999999977666655443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-59  Score=385.74  Aligned_cols=292  Identities=41%  Similarity=0.771  Sum_probs=262.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.+.|++.+.||+|.|+.||++.+..+|+.+|+|++....+.. ...+++.+|+++-+.|+ ||||+++++.+.+.+.
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF   84 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhcccce
Confidence            346778999999999999999999999999999999998776543 37888999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .|+|+|+++|++|..-+.....+++..+-..++||+++|.|+|.+||||||+||+|+++.+.+...-+||+|||+|....
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999999999998888777778999999999999999999999999999999999999988888889999999999998


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .+......+|||.|||||++. .+++.++|||+.|||||-|+.|.+||++.+...+.+.+..+....+.+.|+.++++++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak  244 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK  244 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence            777888899999999999987 4699999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC-CCCchHHHHHHHHHHHHhHHHH
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD-KPIDSAVLTRMKQFRAMNKMKK  361 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  361 (366)
                      +||++||..||.+|+|+.|+|+|||+.+...-+. .+. -.....|+.|-+-+|+|.
T Consensus       245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~-~dtvd~lrkfNarRKLKg  300 (355)
T KOG0033|consen  245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHR-QDTVDCLKKFNARRKLKG  300 (355)
T ss_pred             HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhh-HHHHHHHHHhhHHHHHHH
Confidence            9999999999999999999999999987655333 333 233445555656666653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-56  Score=391.65  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=227.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-eEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-NLHLV  150 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv  150 (366)
                      ..+.++.||+|+.|+||+++++.+++.+|+|.+...  .......++.+|++++++++ +|+||.+|+.|...+ .++|+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEee
Confidence            456678899999999999999999999999999432  34566788999999999995 999999999999999 59999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||++|+|..++...+++++..+..++.++++||.|||+ ++||||||||+|||+   +..|.|||||||.+..+.+. 
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-
Confidence            9999999999999988899999999999999999999996 999999999999999   56777999999999887666 


Q ss_pred             ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAE-----TEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ..++.+||..|||||.+.+ .|+.++||||||++++|+.+|+.||...     ..-+.+..|..+........  .++++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~e  310 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EFSPE  310 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cCCHH
Confidence            5678899999999998875 6999999999999999999999999764     45567777777544333221  47999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +++||..||.+||.+|||+.|+++|||+++.....
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            99999999999999999999999999998766543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-57  Score=396.13  Aligned_cols=260  Identities=37%  Similarity=0.661  Sum_probs=240.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||+|+||+||+++.+.+++.+|+|++.++......+.+....|..+|.+++ ||.||.++..|++.+.+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence            356999999999999999999999999999999999988887788999999999999987 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~  228 (366)
                      |+||+.||.|+..|+.++.+++..++.++.+|+.||.|||++|||||||||+|||+   +.+|+++|+|||+++.. ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   78999999999999854 444


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ....+.+||+-|||||++. ..++..+|+||||+++|+|++|..||.+.+..+..+.+..+.......   .++.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence            5666789999999999876 569999999999999999999999999999999999999988443332   378999999


Q ss_pred             HHHhcccCcCCCC----CHHHHhcCCCcccCCC
Q 017768          308 IRKMLTKDPKKRI----TAAEALEHPWLKEDGA  336 (366)
Q Consensus       308 i~~~l~~dp~~Rp----t~~~~l~hp~f~~~~~  336 (366)
                      |+++|+.||++|.    ++.++-+||||.+.++
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW  289 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW  289 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence            9999999999996    7999999999988665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-56  Score=405.80  Aligned_cols=262  Identities=35%  Similarity=0.617  Sum_probs=241.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      -..+|..++.||.|+|++|++|+.+.+++.||||++.++.+..+...+.+..|-.+|.+|.+||.|++++..|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34569999999999999999999999999999999998888888888899999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|+||+++|+|.+++++.+.|++..++.++.+|++||+|||++|||||||||+|||+   +.+++++|+|||.|+.+...
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence            999999999999999999999999999999999999999999999999999999999   78999999999999876432


Q ss_pred             Cc--------------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC
Q 017768          229 KV--------------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       229 ~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  293 (366)
                      ..              ...++||..|.+||++.. ..+..+|||+||||+|.|+.|.+||.+.++-..++.|..-.+.++
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11              134799999999999874 578999999999999999999999999999999999988877776


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .    ++++.+++||+++|..||.+|+|+.+|.+||||.+..+.
T Consensus       308 ~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  308 E----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             C----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence            5    678999999999999999999999999999999987664

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-55  Score=406.37  Aligned_cols=298  Identities=60%  Similarity=1.013  Sum_probs=277.7

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+...|++.+.||.|.||.||+++.+.+|+.+|+|.+.+.........+.+.+|+.+|+++.+||||+.++++|++.+.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            45667899999999999999999999999999999999888776666778999999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a~~~  225 (366)
                      .++|||+|.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+....+ ++.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999999887 4999999999999999999999999999999999999987654 458999999999998


Q ss_pred             cCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..+......+||+.|+|||++. ..++..+|+||+|+++|.|+.|..||++.+.......+..+.+.+....|+.++..+
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a  269 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA  269 (382)
T ss_pred             cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence            8877788899999999999998 679999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHhhhc
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALK  365 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (366)
                      .++|+.||..||.+|+|+.++|+|||++........+....+..+.+++..+++++|++++
T Consensus       270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (382)
T KOG0032|consen  270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALR  330 (382)
T ss_pred             HHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998888888888888888888888888887654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-55  Score=389.55  Aligned_cols=264  Identities=37%  Similarity=0.646  Sum_probs=238.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|.+.+.||.|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++ |||||.++++...++.+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEE
Confidence            4469999999999999999999999999999999987654 4567788899999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC---CCEEEeecCCccccc
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED---SPIKATDFGLSVFIE  226 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~---~~vkl~Dfg~a~~~~  226 (366)
                      |||||+||+|.++++..+.+++..++.++.||+.||++||+++||||||||.|||++....+   ..+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875333   579999999999999


Q ss_pred             CCCceecccCCCCCCccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .+....+.+|++.|||||++ .++|+-|+|+||+|+|+|++++|+.||...+..+.+..+..+....+... ..++..+.
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~  245 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLR  245 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchh
Confidence            88888899999999999998 47899999999999999999999999999999999888877765444332 23566777


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +++...+..++.+|.+..+-+.|+++.....
T Consensus       246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  246 ELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             hhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence            9999999999999999999999999977653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-54  Score=403.70  Aligned_cols=255  Identities=41%  Similarity=0.703  Sum_probs=240.0

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++++.||+|+-|.|-+|++..+|+.+|||++.++....+.....+.+|+.+|+.+. ||||+++|++|+...++|+|+|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEEEE
Confidence            999999999999999999999999999999998775555666778999999999998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCcee
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK  232 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~  232 (366)
                      |++||.|++++..++++++.++.+++.||+.|+.|+|..+|+||||||+|+|+   +...++||+|||+|..-..+..+.
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999   556669999999999988888899


Q ss_pred             cccCCCCCCcccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          233 EIVGSAYYVAPEVLHQR-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       233 ~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      +.||++.|.+||++.+. | +.++||||+|||||.||+|+.||.+++.+.++.++..|.+..+.    .++.++++||++
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLLr~  245 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLLRR  245 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHHHH
Confidence            99999999999998764 4 78999999999999999999999999999999999999998885    579999999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCcccCC
Q 017768          311 MLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ||..||++|+|.+||++|||+..-.
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999997743

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-55  Score=373.63  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=220.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|+...++|+|+||+||+|+++.+|+.||||++.... .+....+-..+|+++|+++. |+|+|.++.+|.....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            46888889999999999999999999999999985432 23344556789999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~  229 (366)
                      +|||+..-|.++-.....++...+..++.|++.|+.|+|+++++||||||+|||+   ..++.+||||||+|+... .+.
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcc
Confidence            9999885454444445569999999999999999999999999999999999999   577889999999999876 777


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-------------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG-------------------  288 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~-------------------  288 (366)
                      .++.++.|.+|+|||.+-+  +|++++||||+||++.||++|...|.+...-+++-.|...                   
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            8889999999999998754  6999999999999999999999999988777666555321                   


Q ss_pred             --------CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          289 --------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       289 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                              .....+...|.++.-+.+++.+||+.||++|++.+++|.||||++
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                    011112234567888999999999999999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.8e-54  Score=393.38  Aligned_cols=264  Identities=35%  Similarity=0.576  Sum_probs=239.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -+.|++++.||+|+||.||+|+.+.+|..+|+|++.+.........+.+..|-.+|.... .+.||+++..|++.+++||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEE
Confidence            456999999999999999999999999999999999888777788889999999999954 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC--
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET--  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~--  227 (366)
                      ||||++||++..+|...+.|++.+++.++.+++.|++.||++|+|||||||+|+||   +..|++||+|||++.....  
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999   7899999999999853211  


Q ss_pred             --------------------C--Cc------------------------eecccCCCCCCccccccc-cCCCchhHHHHH
Q 017768          228 --------------------G--KV------------------------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAG  260 (366)
Q Consensus       228 --------------------~--~~------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG  260 (366)
                                          .  ..                        ....+|||.|+|||++.+ .|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                0  00                        012489999999999865 589999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccCCCC
Q 017768          261 VILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKEDGAT  337 (366)
Q Consensus       261 ~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~~l~hp~f~~~~~~  337 (366)
                      |||||||.|.+||...+..+..+.+.+....+.++.-..+++++.|||.+||+ ||++|.   .++||.+||||++..+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            99999999999999999999999999998777777667789999999999999 999998   49999999999997664


Q ss_pred             C
Q 017768          338 S  338 (366)
Q Consensus       338 ~  338 (366)
                      .
T Consensus       455 ~  455 (550)
T KOG0605|consen  455 H  455 (550)
T ss_pred             h
Confidence            3

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-55  Score=394.08  Aligned_cols=265  Identities=33%  Similarity=0.522  Sum_probs=231.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      ..+-++|.+.++||.|+||.||+|+.+.+|..||||.++++-.  ..+.-.-.+|+..|+++..||||+++.+++.+.+ 
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            4567889999999999999999999999999999998875532  2233345689999999998999999999999988 


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      .+|+|||||+. .|+++++..+ .|++..+..|+.||+.||+|+|.+|+.|||+||+|||+.+   ...|||+|||+|+.
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLARE  159 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEecccccccc
Confidence            99999999965 9999998765 4999999999999999999999999999999999999953   55699999999999


Q ss_pred             ccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC-----
Q 017768          225 IETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW-----  297 (366)
Q Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  297 (366)
                      ......++.++.|.+|+|||++.  +-|+.+.|+||+|||++|+.+-+..|.+.++-+.+-.++.-...+....|     
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            99889999999999999999875  45999999999999999999999999999888877777653333222222     


Q ss_pred             ---------------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          298 ---------------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       298 ---------------------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                           +..+.++.++|.+|+.+||.+|||+.++|+||||+.....
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                                 3468899999999999999999999999999999875543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-54  Score=366.91  Aligned_cols=256  Identities=36%  Similarity=0.643  Sum_probs=240.4

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||.|+||.|.+++.+.+|..+|+|++.+...+..+..+...+|..+|+.+. ||.++++++.+.+.+.+|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence            45899999999999999999999999999999999988888888999999999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||.+||.|++++++.+++++..++.++.||+.||+|||+++|++|||||+|||+   +.+|.+||+|||.|+.....  
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--
Confidence            9999999999999999999999999999999999999999999999999999999   78899999999999987654  


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      ..+.+||+.|+|||++. ..+++++|+|||||++|||+.|.+||...+..+..+.|..++..++.    .++.++++||.
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLK  273 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHH
Confidence            56789999999999876 56999999999999999999999999999999999999999998876    57899999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccCCC
Q 017768          310 KMLTKDPKKRI-----TAAEALEHPWLKEDGA  336 (366)
Q Consensus       310 ~~l~~dp~~Rp-----t~~~~l~hp~f~~~~~  336 (366)
                      ++|+.|-.+|.     ...+|..||||++...
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence            99999999993     6789999999997554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=394.05  Aligned_cols=258  Identities=43%  Similarity=0.735  Sum_probs=234.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc--cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..++|.+++.||+|+||+|+.|....+|..||+|++.+.....  ....+.+.+|+.+++.+..||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4557999999999999999999999999999999876642211  23456677899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC-CCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED-SPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~-~~vkl~Dfg~a~~~  225 (366)
                      +|+|||||.||+|++++...+++.+.++..+++||+.|++|||++||+||||||+|||++   .+ +++||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccccc
Confidence            999999999999999999988999999999999999999999999999999999999995   44 88999999999988


Q ss_pred             -cCCCceecccCCCCCCcccccccc--C-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC-
Q 017768          226 -ETGKVYKEIVGSAYYVAPEVLHQR--Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI-  300 (366)
Q Consensus       226 -~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  300 (366)
                       ..+....+.+||+.|+|||++.++  | +.++||||+||+||.|++|..||.+.+.......+..+.+.++..    + 
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~  247 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL  247 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence             466778889999999999998753  4 689999999999999999999999998888888888888877763    4 


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ++++.+|+.+||..||.+|+|+.++++||||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999998

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-54  Score=363.87  Aligned_cols=262  Identities=40%  Similarity=0.711  Sum_probs=241.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----cccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----DKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      +...|.-.+.||.|..++|-++..+.+|+.+|+|++.......     ..-.+.-.+|+.+|+++.+||+|+.+.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4556888899999999999999999999999999986432211     12244566899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      +...++|+|.|+.|.|++++...-.+++.+...|++|++++++|||.++||||||||+|||+   +++.+++|+|||.++
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC  171 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence            99999999999999999999999999999999999999999999999999999999999999   788889999999999


Q ss_pred             cccCCCceecccCCCCCCcccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLH-------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      ....+......+||++|.|||.+.       ..|+..+|+|++||+||.|+.|..|||....--.++.+..|++++..+.
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            999999999999999999999773       2488999999999999999999999999888889999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      |.+++....+||.+||+.||++|.|++|+|.||||.+
T Consensus       252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            9999999999999999999999999999999999954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=391.76  Aligned_cols=259  Identities=31%  Similarity=0.534  Sum_probs=239.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -++|++.+.||+|.||+|+++..+.+++.+|||+++++.....++.+....|.+++....+||.++.++..|+..+++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            45699999999999999999999999999999999999998899999999999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||+.||++.. +.....+++..+..++..++.||.|||++||||||||.+|||+   +..|++||+|||+++... .+
T Consensus       447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC
Confidence            999999999544 3445679999999999999999999999999999999999999   788999999999998764 66


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ....+.+||+.|+|||++. +.|+..+|+|||||+|||||.|..||.+++++++.+.|.+....++.    .++.+..++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i  598 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI  598 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence            6788899999999999987 46999999999999999999999999999999999999998877776    579999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCCCcccCCC
Q 017768          308 IRKMLTKDPKKRIT-----AAEALEHPWLKEDGA  336 (366)
Q Consensus       308 i~~~l~~dp~~Rpt-----~~~~l~hp~f~~~~~  336 (366)
                      ++++|..||++|..     +++|..||||+..+.
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence            99999999999985     589999999988654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-52  Score=352.21  Aligned_cols=263  Identities=35%  Similarity=0.555  Sum_probs=230.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|...+.||+|.||+||+|++..+|+.||||+++..... +.......+|++.|+.++ |+||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            4688889999999999999999999999999999876532 333456889999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +||++. +|...++.+. .++..++..++.+++.||+|||.+.|+||||||.|+|+   +.+|.+||+|||+|+......
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            999965 9999998765 49999999999999999999999999999999999999   678889999999999876444


Q ss_pred             -ceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC-------
Q 017768          230 -VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-------  299 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  299 (366)
                       .....+.|.+|+|||.+-  +.|+..+|+||.|||+.||+.|.+-|.+.+.-+++..+...-.++....||+       
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             334458899999999864  4699999999999999999999999999999888888877655555555543       


Q ss_pred             -----------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          300 -----------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       300 -----------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                       .+.++.+|+.+||..||.+|+|+.|+|+|+||+....++.
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~  292 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP  292 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence                             4678899999999999999999999999999998776554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-52  Score=379.37  Aligned_cols=265  Identities=29%  Similarity=0.478  Sum_probs=231.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--C
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--Q  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~  145 (366)
                      .-.+.|+..++||+|.||.||+|++..+|+.||+|++..+.. .+.......+||.+|++|. ||||+++.+...+.  .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCc
Confidence            345568999999999999999999999999999999976552 3455667889999999998 99999999998876  6


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      .+|+|+|||+. ||.-++.... .|++.++..++.||+.||+|+|.+||+|||||.+||||   +++|.+||+|||+|++
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARF  267 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceee
Confidence            89999999977 8877776643 59999999999999999999999999999999999999   7888899999999997


Q ss_pred             ccCCC--ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC--
Q 017768          225 IETGK--VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP--  298 (366)
Q Consensus       225 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  298 (366)
                      +....  .++..+-|.+|+|||.+.+  .|+..+|+||.||||.||++|++.|.+.++-+++..|..-...+....|+  
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            65433  4677789999999998764  59999999999999999999999999999999999998765555555443  


Q ss_pred             -----------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          299 -----------------------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       299 -----------------------~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                             .+++...+|+..||+.||.+|.|+.++|+++||.....+.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~  410 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPC  410 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCC
Confidence                                   3577899999999999999999999999999996555433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-53  Score=360.30  Aligned_cols=245  Identities=30%  Similarity=0.556  Sum_probs=215.4

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEece-EEeeCCe-EE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQN-LH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~-~~~~~~~-~~  148 (366)
                      ..|++.++||.|+||+||++....+|..+|.|.+.-.. .+.+.......|+.+|++|+ |||||++++ .+.++.. ++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhH
Confidence            45999999999999999999999999999999987433 45667778999999999998 999999998 4445554 89


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH--cC--CEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHF--MG--VIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~--~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      |+||||++|+|...++.    ++.+++..+|.++.|++.||.++|.  .+  |+||||||.||++   +.+|.|||+|||
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfG  173 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFG  173 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccch
Confidence            99999999999998865    3459999999999999999999999  55  9999999999999   677889999999


Q ss_pred             CcccccCCCc-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          221 LSVFIETGKV-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       221 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      +++.+..... ..+.+|||.||+||.+. ..|+.++||||+||++|||+.-+.||.+.+-.+....|.++.......  .
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--E  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--H
Confidence            9998876554 34579999999999876 579999999999999999999999999999999999999986543321  2


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCH
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITA  322 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~  322 (366)
                      .++..+..||..|+..||+.||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            578999999999999999999985

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-52  Score=363.24  Aligned_cols=273  Identities=36%  Similarity=0.530  Sum_probs=231.6

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--  143 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--  143 (366)
                      ...+...|...+.||+|+||.|+.+.++.+|+.||||++.. .+......++..+|+++|++++ |+||+.+.+++..  
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPS   94 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccc
Confidence            34566678778899999999999999999999999999852 3445567888999999999999 9999999999865  


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 ---KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                         -+.+|+|+|+| +.+|...++.+..|++..+..++.||+.||.|+|+.+|+||||||+|+|++   .+-.+||||||
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DFG  170 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDFG  170 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEecccc
Confidence               35799999999 559999998888899999999999999999999999999999999999994   55568999999


Q ss_pred             CcccccC---CCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC----
Q 017768          221 LSVFIET---GKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD----  291 (366)
Q Consensus       221 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  291 (366)
                      +|+....   ....+.++.|.+|+|||++.  ..|+...||||+||||.||++|+..|.+.+.-..+..+..-...    
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            9998853   44557789999999999764  46999999999999999999999999888766655555331111    


Q ss_pred             -------------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCch
Q 017768          292 -------------------LQ----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDS  344 (366)
Q Consensus       292 -------------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~  344 (366)
                                         .+    ...++..++.+.+|+++||.+||.+|+|++|+|+||||..-..+.+.|...
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~  326 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ  326 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence                               11    112467889999999999999999999999999999999988877777433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-52  Score=380.37  Aligned_cols=258  Identities=34%  Similarity=0.561  Sum_probs=224.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ....|...++||+|+.|.||.+....+++.||||.+....   ....+-+.+|+.+|+..+ |+|||.+++.|..++.+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeE
Confidence            3456888889999999999999999999999999997654   456778999999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||++||+|.+.+... .++|.++..|+++++.||+|||.+||+|||||.+|||+   +.++.+||+|||++......
T Consensus       347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccc
Confidence            999999999999988654 48999999999999999999999999999999999999   66777999999999877544


Q ss_pred             C-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCCCCHHHH
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-EGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  305 (366)
                      . ...+.+||++|||||+..+ .|+.++||||||++.+||+-|++||...+....+..+. ++..  .......++..++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P--~lk~~~klS~~~k  500 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--KLKNPEKLSPELK  500 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC--CcCCccccCHHHH
Confidence            3 5667899999999999874 69999999999999999999999998766655544443 3333  3333457899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +|+.+||+.|+++|+++.|+|+||||+....
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            9999999999999999999999999955443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.9e-52  Score=378.56  Aligned_cols=256  Identities=33%  Similarity=0.575  Sum_probs=233.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|-+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. ..+++...+.+|+++++.++ ||||+.++++|+...++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            45888899999999999999999999999999997654 34567888999999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      .|||.| +|+.++...+.++++++..++.+++.||.|||+++|+|||+||.|||+   +.++.+|+||||+|+.+..+. 
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999977 999999999999999999999999999999999999999999999999   778889999999999886654 


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ..+..-||+.|||||... +.|+..+|+|||||++||+++|++||.....-..++.|......++.    ..+..++.++
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence            345567999999999876 56999999999999999999999999998888888888887666554    5789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..+|..||.+|.|..+++.|||+++.-.
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            9999999999999999999999987433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-51  Score=352.99  Aligned_cols=263  Identities=30%  Similarity=0.426  Sum_probs=227.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~  147 (366)
                      .+.|+.+..|++|+||.||+|+++.+++.||+|.++... ..+...-.-.+|+.+|.+++ |||||.+-.+....  +.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            455899999999999999999999999999999997654 22333445789999999998 99999998887654  479


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |+|||||+. +|..++.... ++...++..++.|++.|++|||++.|+||||||+|+|+   .+.|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence            999999976 9999998765 79999999999999999999999999999999999999   678889999999999886


Q ss_pred             CC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC----
Q 017768          227 TG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS----  299 (366)
Q Consensus       227 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  299 (366)
                      .. ..++..+-|.+|+|||.+.+  .|+.+.|+||+|||+.||+++++.|.+...-+++..|......+....||+    
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            55 34566788999999998764  599999999999999999999999999999888888876544444444432    


Q ss_pred             ------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          300 ------------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       300 ------------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                              +++...+|++.+|..||.+|.|++|.|+|+||.+...+.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence                                    457888999999999999999999999999999966544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-50  Score=357.00  Aligned_cols=261  Identities=34%  Similarity=0.554  Sum_probs=235.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|.-|+||+++.+.++..+|+|++.+......+...++..|-.||+.+. ||.++.+|..++.++..+++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence            45899999999999999999999999999999999887776777888999999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-  227 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-  227 (366)
                      ||||+||+|+.+++++.  .+++..++.++.+++-||+|||-.|||+|||||+||||   .++|+|.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence            99999999999988764  59999999999999999999999999999999999999   7899999999998643210 


Q ss_pred             --------------------------------C-C-----------------------ceecccCCCCCCccccccc-cC
Q 017768          228 --------------------------------G-K-----------------------VYKEIVGSAYYVAPEVLHQ-RY  250 (366)
Q Consensus       228 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~-~~  250 (366)
                                                      . .                       ..+.++||--|.|||++.+ ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       0123588999999999986 48


Q ss_pred             CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHh
Q 017768          251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT----AAEAL  326 (366)
Q Consensus       251 ~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~~l  326 (366)
                      +.++|+|+||+++|||+.|..||.+.+.++.+..+......++...  .++..++|||+++|.+||++|..    ++||-
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999888777654  67899999999999999999998    99999


Q ss_pred             cCCCcccCCCC
Q 017768          327 EHPWLKEDGAT  337 (366)
Q Consensus       327 ~hp~f~~~~~~  337 (366)
                      +||||++.++.
T Consensus       391 ~HpFF~gVnWa  401 (459)
T KOG0610|consen  391 RHPFFEGVNWA  401 (459)
T ss_pred             cCccccCCChh
Confidence            99999997774

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-51  Score=363.46  Aligned_cols=257  Identities=36%  Similarity=0.555  Sum_probs=214.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--eEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--NLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~  148 (366)
                      ..|...+.||+|+||.||++.+..+|...|||.+....   ....+.+.+|+.+|.+++ |||||++++......  .++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence            45888899999999999999999889999999886542   122677999999999999 999999999755444  689


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a~~~~  226 (366)
                      |.|||+++|+|.+++...+ .|++..++.+.+||++||.|||++||+||||||+|||++   . ++.+||+|||++....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccccccc
Confidence            9999999999999999877 799999999999999999999999999999999999994   4 5779999999998765


Q ss_pred             C----CCceecccCCCCCCcccccc-cc-CCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCC
Q 017768          227 T----GKVYKEIVGSAYYVAPEVLH-QR-YGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       227 ~----~~~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .    ........||+.|||||++. +. ..+++|||||||+++||+||..||... .....+-.+......+  .....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--EIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--CCCcc
Confidence            3    12234568999999999987 33 335999999999999999999999873 3333333333333222  22335


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +++++.++|.+|+..||++|||++++|+|||.+....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            8999999999999999999999999999999987665

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=345.07  Aligned_cols=267  Identities=40%  Similarity=0.700  Sum_probs=239.5

Q ss_pred             ccccceeee-ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee---
Q 017768           68 DITTIYDLD-KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED---  143 (366)
Q Consensus        68 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---  143 (366)
                      .+++.|.+. +.||-|-.|.|..+..+.+|+.+|+|++.        +.....+|++.--...+|+|||.++++|+.   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--------DSPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            467778764 57999999999999999999999999873        445678899998888899999999999864   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       ...+.+|||.++||.|++.++..+.  +++.++..|++||..|+.|||+.+|.||||||+|+|++....+-.+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             3467899999999999999998765  9999999999999999999999999999999999999988888899999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCCCCCCC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFEAILEGNLDLQSS  295 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~  295 (366)
                      +|+.........+.+.|++|.|||++. .+|+...|+||+||+||-|+.|.+||....    ..+....|..+.+.++.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999887777778889999999999997 579999999999999999999999997553    446778899999999999


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       296 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      .|..+|+...++|+.+|..+|++|.|+++++.|||+.+...--.-++
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl  336 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL  336 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence            99999999999999999999999999999999999988766444333

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-50  Score=369.10  Aligned_cols=254  Identities=33%  Similarity=0.623  Sum_probs=225.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|+.+++.+. ||||+++++.+.+++..|++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997654433445677889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc-
Confidence            9999999999999988889999999999999999999999999999999999999   567789999999998664332 


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                       ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......+.+..+....+.    .++..+.++|.
T Consensus       173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  247 (329)
T PTZ00263        173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK  247 (329)
T ss_pred             -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence             34578999999998764 5789999999999999999999999988877777777777654432    36889999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccC
Q 017768          310 KMLTKDPKKRIT-----AAEALEHPWLKED  334 (366)
Q Consensus       310 ~~l~~dp~~Rpt-----~~~~l~hp~f~~~  334 (366)
                      +||+.||++|++     ++++++||||++.
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            999999999997     7999999999874

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-50  Score=362.69  Aligned_cols=256  Identities=31%  Similarity=0.541  Sum_probs=224.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.+. ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence            35899999999999999999999999999999987543333345567889999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence            9999999999999988889999999999999999999999999999999999999   56778999999999866432  


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+..+...++.    .++..+.++|.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHH
Confidence            233568999999998764 5789999999999999999999999988888888888777655443    46889999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccCCC
Q 017768          310 KMLTKDPKKRIT-----AAEALEHPWLKEDGA  336 (366)
Q Consensus       310 ~~l~~dp~~Rpt-----~~~~l~hp~f~~~~~  336 (366)
                      +||+.||.+|++     ++++++||||+....
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            999999999995     999999999986443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.1e-50  Score=367.66  Aligned_cols=250  Identities=34%  Similarity=0.597  Sum_probs=219.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++++. ||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654434445667889999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~  235 (366)
                      ++|.+++.....+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   567789999999987532 222334467


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+..+...++.    .+++++.++|.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            999999999886 45899999999999999999999999988887777777766554432    5789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCcccC
Q 017768          315 DPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       315 dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      ||++||     ++.++++||||.+.
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-50  Score=357.82  Aligned_cols=256  Identities=38%  Similarity=0.672  Sum_probs=241.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+..+|++.+.||+|.||.|-+|.....|+.||||.+.++....+.++-.+.+|++++..|+ ||||+.+|.+|+..+.+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKDKI  128 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCceE
Confidence            45678999999999999999999998899999999999999988889999999999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      .|||||..+|.|++++...+.|++.++..+++||+.|+.|+|.++++|||||.+|||+   +.+.++||+|||++..+..
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence            9999999999999999999999999999999999999999999999999999999999   6777899999999999999


Q ss_pred             CCceecccCCCCCCcccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ...+.+++|++-|.+||++++.  -++.+|-|||||+||.|+.|..||.+.+.+.++.++..|.+..+..     +..+.
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-----PSdA~  280 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-----PSDAS  280 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-----CchHH
Confidence            9999999999999999999875  3789999999999999999999999999999999999998766543     56788


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      -||+.||-.||++|.|++++.+|=|++
T Consensus       281 gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  281 GLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHHhcCcccchhHHHHhhhheee
Confidence            999999999999999999999997763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-49  Score=359.91  Aligned_cols=260  Identities=31%  Similarity=0.493  Sum_probs=217.5

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.+. |++|+.+++.+..++..+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            788899999999999999999999999999987554333334456788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          153 LCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.+|+||||||+|||+   ++++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887653  358999999999999999999999999999999999999   5677899999999987655444


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||..|+|||++. ..++.++|||||||++|+|++|..||...........+..............+++++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            45567999999999876 46899999999999999999999999876543322222222222222233457899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccCCC
Q 017768          310 KMLTKDPKKRIT-----AAEALEHPWLKEDGA  336 (366)
Q Consensus       310 ~~l~~dp~~Rpt-----~~~~l~hp~f~~~~~  336 (366)
                      +||+.||++||+     ++++++||||++...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999999997     999999999988553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-49  Score=369.84  Aligned_cols=261  Identities=31%  Similarity=0.503  Sum_probs=221.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.............+..|+.++.++. |++|+++++.+.+.+..|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999997644333345567888999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.....+++.++..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence            9999999999999988889999999999999999999999999999999999999   567789999999987542110 


Q ss_pred             -----------------------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCC
Q 017768          230 -----------------------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       230 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                                                         .....+||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               012357999999999875 45899999999999999999999999


Q ss_pred             CCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcC---CCCCHHHHhcCCCcccCCC
Q 017768          274 WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPK---KRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .+.+..+....+.........+....+++++.++|.+|++ +|.   .||+++|+++||||++...
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            9888887777777654443333334578999999999776 454   4589999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=352.25  Aligned_cols=262  Identities=30%  Similarity=0.479  Sum_probs=227.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||.|..++||+|+...++..||||++..+..  ..+.+.+.+|+..+..++ ||||+.++..|..++.+|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEE
Confidence            4569999999999999999999999999999999987654  345889999999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||.||.+|++.+++...  ..++|..+..|++++++||.|||.+|.||||||+.||||   +.+|.|||+|||....+..
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence            99999999999999874  349999999999999999999999999999999999999   7889999999998654422


Q ss_pred             -CC---c-eecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-----
Q 017768          228 -GK---V-YKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-----  294 (366)
Q Consensus       228 -~~---~-~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  294 (366)
                       +.   . .++.+||++|||||++.+   .|+.|+||||||++..||.+|..||.....-+++-.-+++......     
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence             11   1 256799999999999643   4999999999999999999999999998887777666666654222     


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          295 -SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       295 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                       .....++..++++|..||..||++|||++++|+|+||+.....
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence             2223467889999999999999999999999999999886543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=363.27  Aligned_cols=247  Identities=30%  Similarity=0.437  Sum_probs=212.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcE-EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-eEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRK-YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-NLHLV  150 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv  150 (366)
                      ..+.+.||.|+||+||+|.+.  |.. ||+|++......... ...+.+|+.+|.+++ |||||+++|++.+.. ...||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence            345566999999999999987  777 999999765543333 779999999999998 999999999999887 79999


Q ss_pred             EeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEeccCCCcEEeeecCCCC-CEEEeecCCccccc
Q 017768          151 MELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMG-VIHRDLKPENFLLASKEEDS-PIKATDFGLSVFIE  226 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~~~  226 (366)
                      |||+++|+|.+++..  +..++...+..++.||+.||+|||+++ ||||||||+|||+   +.+. ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeec
Confidence            999999999999988  577999999999999999999999999 9999999999999   5565 89999999998776


Q ss_pred             CC-CceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TG-KVYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .. ...+...||+.|||||++.+   .++.++||||||++||||+||..||.+....+....+......+..+.  .+++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCH
Confidence            54 23334689999999999984   499999999999999999999999999888666666654444433322  3789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+..++.+||..||++||++.+++..
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~  299 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSR  299 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence            99999999999999999999998763

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=357.95  Aligned_cols=263  Identities=37%  Similarity=0.641  Sum_probs=225.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----------cccHHHHHHHHHHHHHhcCCCceeEe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----------DKDMEDVRREILILQHLTGQPNIVEF  137 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~h~~i~~~  137 (366)
                      .-+.|++.+.||+|.||.|-+|++..+++.||+|++.+.....           ....+.+.+|+.+|+++. |+|||++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence            4556999999999999999999999999999999997543321           123468999999999998 8999999


Q ss_pred             ceEEee--CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          138 EGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       138 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                      +.+..+  .+.+|||+|||..|.+...-....-+++.+++.++++++.||+|||.+||+||||||+|+|+   +++++||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~VK  250 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTVK  250 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcEE
Confidence            999876  45899999999988774432222238999999999999999999999999999999999999   6679999


Q ss_pred             EeecCCcccccCC------CceecccCCCCCCccccccc---c--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 017768          216 ATDFGLSVFIETG------KVYKEIVGSAYYVAPEVLHQ---R--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA  284 (366)
Q Consensus       216 l~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~--~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~  284 (366)
                      |+|||.+.....+      ..+...+||+.|+|||...+   .  .+.+.||||+||+||.|+.|+.||.+....+....
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            9999998866322      23344689999999998653   2  47789999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      |.+..+.++..  +++.+.+.+||.+||++||++|++..+|..|||....+..
T Consensus       331 Ivn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  331 IVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            99988777665  3678999999999999999999999999999999887553

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-51  Score=335.85  Aligned_cols=256  Identities=34%  Similarity=0.633  Sum_probs=234.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -++|++++.||+|-||.||+|+.+.++..||+|++.+..........++.+|+++-..|+ ||||+++|++|.+....||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEE
Confidence            356999999999999999999999999999999998877766667778999999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRII--AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||...|+|+..+.  ....+++...+.++.|++.||.|+|.++|+||||||+|+|+   +-.+.+||+|||.+...+ 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-
Confidence            999999999999999  45679999999999999999999999999999999999999   455669999999998876 


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .....+.+||..|.+||+..+ ..+..+|+|++|++.||++.|..||...+..+....+..-...++.    .++..+.|
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~d  251 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAAD  251 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHH
Confidence            445677899999999999875 5899999999999999999999999999999999999887777663    68999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +|.+||..+|.+|.+..|++.|||+...
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999998754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-49  Score=365.18  Aligned_cols=257  Identities=34%  Similarity=0.520  Sum_probs=223.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++..+. |+||+++++++..++..|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999997654333345667889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      ||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence            999999999999888889999999999999999999999999999999999999   5677899999999976543  23


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC----CCCCHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW----PSISGQAKD  306 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  306 (366)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+............    ..+++++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            4457999999999876 46899999999999999999999999988877777666554322222221    256899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +|.+||..+|++||++.++++||||.+.
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-48  Score=361.29  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=209.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.+. |+||+++++++..++..+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEE
Confidence            3456888899999999999999999999999999985432  2334567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ++|||+++++|...    ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++......
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccc
Confidence            99999999988543    235788899999999999999999999999999999999   56778999999999765432


Q ss_pred             C-ceecccCCCCCCccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      . ......||..|+|||++..      ..+.++|||||||++|+|++|+.||......+....+..............++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 2234578999999998742      23568999999999999999999997443322222222111111222223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .++.+||.+||+.||++|||+.|+|+||||.+....
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999999887544

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-49  Score=368.59  Aligned_cols=260  Identities=32%  Similarity=0.568  Sum_probs=223.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++ |+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence            36899999999999999999999999999999997654333345567888999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.....+++.++..++.||+.||+|||++||+||||||+|||+   +.++.++|+|||++....... 
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   667889999999986542111 


Q ss_pred             --------------------------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCC
Q 017768          230 --------------------------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGV  270 (366)
Q Consensus       230 --------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~  270 (366)
                                                            .....+||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  001236899999999875 45899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccCC
Q 017768          271 PPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT---AAEALEHPWLKEDG  335 (366)
Q Consensus       271 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~~l~hp~f~~~~  335 (366)
                      .||...+..+....+..............+++++.++|.+||. +|.+|++   +.++++||||+...
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9999888777777776655444444334578999999999997 9999998   99999999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-49  Score=360.03  Aligned_cols=248  Identities=32%  Similarity=0.581  Sum_probs=218.0

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++ ||||+++++++...+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999997654434455677889999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceecccCC
Q 017768          159 LFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGS  237 (366)
Q Consensus       159 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt  237 (366)
                      |.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ........||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   5677899999999875432 2233445799


Q ss_pred             CCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017768          238 AYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP  316 (366)
Q Consensus       238 ~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  316 (366)
                      +.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++.    .+++++.++|.+||+.||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence            99999998764 5899999999999999999999999988888877777766554432    578999999999999999


Q ss_pred             CCCC---CHHHHhcCCCcccC
Q 017768          317 KKRI---TAAEALEHPWLKED  334 (366)
Q Consensus       317 ~~Rp---t~~~~l~hp~f~~~  334 (366)
                      ++||   ++.++++||||.+.
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-48  Score=358.67  Aligned_cols=257  Identities=32%  Similarity=0.541  Sum_probs=224.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+|++|+.+++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            38899999999999999999999999999999976544344556778889999999986778999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCc
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~  230 (366)
                      ||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   567789999999987532 2223


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+.    .+++++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            344579999999998764 5889999999999999999999999988888888887776554432    57899999999


Q ss_pred             HhcccCcCCCCCH-----HHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRITA-----AEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rpt~-----~~~l~hp~f~~~~  335 (366)
                      +||..||++|++.     .++++||||....
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999976     8999999998743

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-48  Score=359.55  Aligned_cols=252  Identities=33%  Similarity=0.563  Sum_probs=220.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.++.+++.||+|++.............+..|..++..+.+||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654333455667788999998887799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~  235 (366)
                      ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.... .........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   567789999999987542 222334457


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++. ..++.++||||||+++|+|++|..||...+..+....+..+....+.    .++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence            999999999876 45889999999999999999999999998888888888776554432    4789999999999999


Q ss_pred             CcCCCCCH------HHHhcCCCcccCC
Q 017768          315 DPKKRITA------AEALEHPWLKEDG  335 (366)
Q Consensus       315 dp~~Rpt~------~~~l~hp~f~~~~  335 (366)
                      ||++|+++      +++++||||+...
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99999998      9999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-48  Score=361.37  Aligned_cols=256  Identities=32%  Similarity=0.564  Sum_probs=224.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCC-cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATG-RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .+.|++.+.||+|+||.||+|.++.++ ..||+|.+.............+.+|+.+++.+. ||||+++++++..++..+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence            446999999999999999999876554 689999987654434455677889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence            999999999999999988889999999999999999999999999999999999999   56788999999999865432


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+..+....+.    .+++.+.++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l  258 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHL  258 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHH
Confidence              234579999999998764 5889999999999999999999999988887777777776654432    468899999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++|+     +++++++||||.+..
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999995     899999999998754

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-49  Score=366.34  Aligned_cols=260  Identities=37%  Similarity=0.636  Sum_probs=226.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+..|+.++..+. |+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            36999999999999999999999999999999997654434455677889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999   567789999999997654332 


Q ss_pred             -----------------------------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          230 -----------------------------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       230 -----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                                                   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         2234578999999998764 5899999999999999999999999988877


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCcccCC
Q 017768          280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT-AAEALEHPWLKEDG  335 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt-~~~~l~hp~f~~~~  335 (366)
                      .....+.........+....+++++.++|.+||. ||.+|++ ++++++||||++..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            7777776633333333334579999999999998 9999999 99999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-48  Score=360.31  Aligned_cols=250  Identities=33%  Similarity=0.587  Sum_probs=218.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999999999999999997654444455677889999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875422 22233457


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......++    ..++.++.++|++||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            999999999876 4689999999999999999999999998887777777666554433    25789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCcccC
Q 017768          315 DPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       315 dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      ||++|+     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.9e-48  Score=366.76  Aligned_cols=260  Identities=32%  Similarity=0.503  Sum_probs=218.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.+. |+||+++++.+.+.+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999997655444455677899999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   567789999999975321000  


Q ss_pred             ----------------------------------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHH
Q 017768          230 ----------------------------------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVI  262 (366)
Q Consensus       230 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~v  262 (366)
                                                                    .....+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          012347999999999876 458999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHHHHhcCCCcccCC
Q 017768          263 LYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK--DPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       263 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +|||++|..||...+.......+..............+++++.++|.+|++.  ++..|+++.++++||||.+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            9999999999988776665555554333333333345789999999996654  455599999999999998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-48  Score=359.53  Aligned_cols=251  Identities=34%  Similarity=0.600  Sum_probs=218.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||++.+..+|..||+|.+.............+.+|+.+++.+. ||||+++++.+...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654433445667788999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22233457


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++.    .+++++.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            999999999875 46899999999999999999999999988877777777665554432    5789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCcccCC
Q 017768          315 DPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       315 dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      ||++|+     ++.++++||||.+..
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999998     999999999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-48  Score=368.31  Aligned_cols=259  Identities=32%  Similarity=0.535  Sum_probs=218.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++++.+.+..|+||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEE
Confidence            5899999999999999999999999999999986544333345667889999999987 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      ||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   567789999999986321100  


Q ss_pred             ----------------------------------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHH
Q 017768          230 ----------------------------------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVI  262 (366)
Q Consensus       230 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~v  262 (366)
                                                                    .....+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          001246899999999875 458999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcccCC
Q 017768          263 LYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR---ITAAEALEHPWLKEDG  335 (366)
Q Consensus       263 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---pt~~~~l~hp~f~~~~  335 (366)
                      +|+|++|..||......+....+.........+....++.++.++|.+||. +|.+|   +++.+++.||||++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            999999999998887777777666544333333333578999999999998 77765   5999999999998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-48  Score=342.27  Aligned_cols=265  Identities=30%  Similarity=0.453  Sum_probs=227.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc-eeEeceEEeeCC---
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-IVEFEGAYEDKQ---  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~---  145 (366)
                      ...|..+++||+|+||+||+|+.+.+|+.||+|++...... +.......+|+.+|+.++ |+| |+.+++++...+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence            34578888899999999999999999999999999754321 334567889999999998 777 999999998877   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          146 ---NLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                         .+++|+||++. +|..++....    .++...++.++.||+.||+|||+++|+||||||.||||   +++|.+||+|
T Consensus        88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence               89999999965 9999998755    47888999999999999999999999999999999999   5688899999


Q ss_pred             cCCccccc-CCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 017768          219 FGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS  295 (366)
Q Consensus       219 fg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (366)
                      ||+|+... ..+.+...++|.+|+|||++.+  .|+...||||+||++.||++++..|.+....+.+..+..-...+...
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999766 4445777889999999998754  59999999999999999999999999999888888886654444444


Q ss_pred             CCCC--------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          296 PWPS--------------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       296 ~~~~--------------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      .||+                          ......+++.+||+.+|.+|.++..+|+||||+........
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            4432                          23578899999999999999999999999999998766543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.1e-49  Score=368.54  Aligned_cols=258  Identities=33%  Similarity=0.524  Sum_probs=220.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. |+||+++++.+.+++..++||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence            5999999999999999999999999999999986544333345667889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC---
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---  228 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~---  228 (366)
                      ||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.++|+|||+|......   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   56778999999997532100   


Q ss_pred             -----------------------------------------CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHH
Q 017768          229 -----------------------------------------KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYIL  266 (366)
Q Consensus       229 -----------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~l  266 (366)
                                                               ......+||+.|+|||++.+ .++.++|||||||++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     00113469999999998764 588999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccC
Q 017768          267 LSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKED  334 (366)
Q Consensus       267 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~~l~hp~f~~~  334 (366)
                      ++|..||......+....+..............+++++.++|.+|+ .+|.+|+   ++.++++||||+..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999999988777666666554444444444568999999999976 5999999   99999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-48  Score=367.48  Aligned_cols=259  Identities=34%  Similarity=0.552  Sum_probs=221.2

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+. |+||+++++.+.+++..|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            5889999999999999999999999999999987654333445667889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC---
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---  228 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~---  228 (366)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   66788999999997532100   


Q ss_pred             ---------------------------------------------CceecccCCCCCCcccccc-ccCCCchhHHHHHHH
Q 017768          229 ---------------------------------------------KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVI  262 (366)
Q Consensus       229 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~v  262 (366)
                                                                   ......+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         0012346899999999876 468999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccCC
Q 017768          263 LYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT---AAEALEHPWLKEDG  335 (366)
Q Consensus       263 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~~l~hp~f~~~~  335 (366)
                      +|+|++|..||...+..+....+.........+....+++++.++|.+|+ .||++|++   +.++++||||+...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            99999999999988777666666655444444444568999999999976 59999997   99999999998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-48  Score=357.61  Aligned_cols=251  Identities=31%  Similarity=0.544  Sum_probs=220.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.||+|++.............+..|..++..+.+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999999999999999997654444455667788999999887799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875432 22233457


Q ss_pred             CCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+..+....+.    .++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence            8999999998764 6899999999999999999999999999888888888776654332    4689999999999999


Q ss_pred             CcCCCC-------CHHHHhcCCCcccC
Q 017768          315 DPKKRI-------TAAEALEHPWLKED  334 (366)
Q Consensus       315 dp~~Rp-------t~~~~l~hp~f~~~  334 (366)
                      ||++|+       ++.++++||||...
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999       99999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.4e-48  Score=363.36  Aligned_cols=261  Identities=34%  Similarity=0.531  Sum_probs=224.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+++..++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEE
Confidence            457999999999999999999999999999999997543333344556788999999987 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            99999999999988654 58999999999999999999999999999999999999   667889999999997654332


Q ss_pred             --ceecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          230 --VYKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                        ......||+.|+|||++..     .++.++|||||||++|+|++|..||...+.......+.........+....++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence              1234579999999998743     378899999999999999999999999888777787776554444444456899


Q ss_pred             HHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~  335 (366)
                      ++.++|.+||..+|.+  |++++++++||||+...
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            9999999999999988  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-48  Score=355.94  Aligned_cols=257  Identities=31%  Similarity=0.521  Sum_probs=224.5

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.+|++|+.+++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            37889999999999999999999999999999976544334455667888899988877999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCc
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~  230 (366)
                      ||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   6677899999999875432 223


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++.    .++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence            34567999999999876 45899999999999999999999999998888888887776554433    47899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      +||+.||++|++     ..++++||||+...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999997     48999999998644

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-48  Score=360.23  Aligned_cols=260  Identities=33%  Similarity=0.512  Sum_probs=223.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.+. |+||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence            35899999999999999999999999999999997654333445667888999998876 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 679999999999999999999999999999999999999   567789999999998764333


Q ss_pred             c--eecccCCCCCCcccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          230 V--YKEIVGSAYYVAPEVLH-------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       230 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .  .....||+.|+|||++.       ..++.++||||||+++|+|++|..||...+.......+............+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            2  22346899999999874       34678999999999999999999999888877777777665443333344567


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +.++.++|..||+ ||.+|||++++++||||+...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            8999999999998 999999999999999998754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.4e-48  Score=349.34  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=210.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||.|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.+. |+||+++++++..++..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            459999999999999999999999999999999864321  233456778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999975 8988887654 47899999999999999999999999999999999999   567789999999987653222


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS------------  294 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  294 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+.........            
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             2334568999999998753  5889999999999999999999999887766655544321111000            


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          295 --------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       295 --------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                    ...+.++.++.++|.+||+.||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                          0123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.6e-48  Score=354.17  Aligned_cols=252  Identities=31%  Similarity=0.522  Sum_probs=217.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.++.+|..||+|.+................|..++....+|++|+++++++...+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999999999999999997654333345667788888888876799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++.++..++.||+.||+|||++||+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22334567


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||..|+|||++. ..++.++||||||+++|+|++|..||...+..+..+.+.......+.    .++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence            999999999876 46899999999999999999999999988888777777665443332    4688999999999999


Q ss_pred             CcCCCCCH-HHHhcCCCcccCC
Q 017768          315 DPKKRITA-AEALEHPWLKEDG  335 (366)
Q Consensus       315 dp~~Rpt~-~~~l~hp~f~~~~  335 (366)
                      ||++|+++ +++++||||+...
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCCC
Confidence            99999997 5899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=357.94  Aligned_cols=254  Identities=31%  Similarity=0.507  Sum_probs=222.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|+..+.||+|+||.||+|.+..+++.||+|++....  .....+++.+|+.+|..+. ++||.++|+.|..+..+|++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence            34777899999999999999999999999999997654  3567889999999999998 89999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||||.||++.+.+.....+.+.++.-++++++.||.|||..+.+|||||+.|||+.   ..+.|||+|||.+........
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence            99999999999999888889999999999999999999999999999999999994   558899999999988765443


Q ss_pred             -eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          231 -YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       231 -~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                       ..+++||+.|||||++.+ .|+.++||||||++.+||.+|.+|+.......++-.|-+...   ......+++.+++||
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P---P~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP---PRLDGDFSPPFKEFV  243 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC---CccccccCHHHHHHH
Confidence             377899999999999875 699999999999999999999999977665332222222211   111125788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ..||+.||+.||++.++|+|+|++.
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHh
Confidence            9999999999999999999999999

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-48  Score=353.48  Aligned_cols=251  Identities=32%  Similarity=0.538  Sum_probs=216.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.||+|.+................|..++..+.+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654333445566677888888776799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++.++..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999976432 22334557


Q ss_pred             CCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999998764 588999999999999999999999998888877777766543332    24788999999999999


Q ss_pred             CcCCCCCH-HHHhcCCCcccC
Q 017768          315 DPKKRITA-AEALEHPWLKED  334 (366)
Q Consensus       315 dp~~Rpt~-~~~l~hp~f~~~  334 (366)
                      ||++||++ .++++||||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCC
Confidence            99999986 588899999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.2e-48  Score=360.89  Aligned_cols=262  Identities=33%  Similarity=0.530  Sum_probs=222.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.+. ||||+++++.+..++..|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence            3467999999999999999999999999999999987544333344556788999999887 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++... .+++.++..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence            999999999999988654 58999999999999999999999999999999999999   56788999999999876433


Q ss_pred             Cc--eecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          229 KV--YKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ..  .....||+.|+|||++.+     .++.++|||||||++|+|++|..||...+.......+.........+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            22  234579999999998753     27889999999999999999999999888777777776654444444344679


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~  335 (366)
                      ..+.+++..||..++.+  |+++.++++||||+...
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            99999999999865544  89999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-48  Score=357.88  Aligned_cols=250  Identities=35%  Similarity=0.597  Sum_probs=217.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||++.+..+|..||+|++.............+..|+.+++.+. ||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654433445667788999999987 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceecc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEI  234 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~  234 (366)
                      ++|..++.....+++.++..++.||+.||.|||+ .||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   567789999999987542 22233445


Q ss_pred             cCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          235 VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       235 ~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      .||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+......++.    .+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence            7999999999875 46899999999999999999999999988887777777666554433    478999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCCcccC
Q 017768          314 KDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       314 ~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      .||++|+     ++.++++||||.+.
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     99999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.6e-48  Score=355.35  Aligned_cols=250  Identities=30%  Similarity=0.533  Sum_probs=212.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.||+|++.............+..|..+++.+.+||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999999999999999997654434455667889999999997899999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCCCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~  235 (366)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... ..........
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   56778999999998753 2233334567


Q ss_pred             CCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          236 GSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAET---------EKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       236 gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ||..|+|||++.+ .++.++|+||||+++|+|++|+.||....         .....+.+.......+    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            9999999998764 58899999999999999999999995321         1223344444443332    24788999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCCCccc
Q 017768          306 DLIRKMLTKDPKKRIT------AAEALEHPWLKE  333 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt------~~~~l~hp~f~~  333 (366)
                      ++|.+||+.||++|++      +.++++||||..
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999987      799999999976

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.5e-48  Score=356.39  Aligned_cols=261  Identities=30%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-----Ce
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-----QN  146 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~  146 (366)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            4899999999999999999999999999999886422 22234556889999999997 99999999987543     35


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            899999995 5899999888889999999999999999999999999999999999999   667889999999997643


Q ss_pred             CCC----ceecccCCCCCCcccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------------
Q 017768          227 TGK----VYKEIVGSAYYVAPEVLH---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-------------  286 (366)
Q Consensus       227 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~-------------  286 (366)
                      ...    ......||..|+|||++.   ..++.++|||||||++|+|++|+.||.+.+.......+.             
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    123457899999999875   358899999999999999999999997765433222111             


Q ss_pred             --------------cCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          287 --------------EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       287 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                    ..........++.+++.+.++|.+||+.||++|||++++|+||||++.....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence                          1111111122345788999999999999999999999999999998866643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-47  Score=353.32  Aligned_cols=252  Identities=33%  Similarity=0.568  Sum_probs=219.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.||+|++.............+..|..+++.+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654444455667888999999887799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++.++..++.||+.||.|||+++|+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875322 22233456


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||..|+|||++. ..++.++|||||||++|+|++|..||...+.......+.......+.    .+++.+.++|.+||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence            899999999876 46889999999999999999999999988887777777766554332    4789999999999999


Q ss_pred             CcCCCCCH-----HHHhcCCCcccCC
Q 017768          315 DPKKRITA-----AEALEHPWLKEDG  335 (366)
Q Consensus       315 dp~~Rpt~-----~~~l~hp~f~~~~  335 (366)
                      ||++||++     .++++||||+...
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999     9999999997743

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-47  Score=347.21  Aligned_cols=256  Identities=29%  Similarity=0.463  Sum_probs=210.4

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|++..... .....+.+.+|+.+++.++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence            369999999999999999999999999999999865432 2344667889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||++++.+..+......+++..++.++.||+.||.|||+.+|+||||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence            9999987766555445569999999999999999999999999999999999999   567789999999998764322 


Q ss_pred             -ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 017768          230 -VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------------  290 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  290 (366)
                       ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...+..+....+.....                 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             223456899999999875 4688999999999999999999999987765443333221100                 


Q ss_pred             --CCCC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 --DLQS---------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 --~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                        ..+.         .....++.++.++|.+||+.||++|||++++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              0000         0012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.4e-48  Score=360.64  Aligned_cols=260  Identities=33%  Similarity=0.549  Sum_probs=221.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||++.++.+++.||+|++.............+.+|+.++..+. |++|+++++.+.+++..|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            35889999999999999999999999999999997544333445677888999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||++|++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||+   +.++.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   567889999999986442110 


Q ss_pred             -----------------------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCC
Q 017768          230 -----------------------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       230 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                                                         .....+||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               011347999999999875 45899999999999999999999999


Q ss_pred             CCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccCC
Q 017768          274 WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKEDG  335 (366)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~~l~hp~f~~~~  335 (366)
                      ...+.......+..............+++++.++|.+|+ .||.+|+   ++.++++||||++..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence            988887777777654433333333347899999999977 4999998   589999999998854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.6e-48  Score=357.18  Aligned_cols=256  Identities=34%  Similarity=0.587  Sum_probs=213.4

Q ss_pred             ceeeeceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +|++.+.||+|+||.||++++.   .+++.||+|++.+.... .....+.+..|+.+++.+.+|++|+.+++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            3889999999999999998864   46889999998654322 2234566888999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   5677899999999876432


Q ss_pred             CC--ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCC
Q 017768          228 GK--VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       228 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ..  ......||..|+|||++.+  .++.++|||||||++|+|++|..||....    .......+.......    ...
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCC
Confidence            22  2234579999999998864  36889999999999999999999996432    223333333332222    235


Q ss_pred             CCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      ++..+.++|.+||+.||++||     +++++++||||++.
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            789999999999999999999     88999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-47  Score=348.59  Aligned_cols=259  Identities=26%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence            3579999999999999999999998999999999864331  233456778999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence            999996 5787777654 458999999999999999999999999999999999999   56778999999998754322


Q ss_pred             -CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCC----------
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQS----------  294 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~----------  294 (366)
                       .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+... ...+..+.........          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             22334568999999998753  478899999999999999999999976533 2222222110000000          


Q ss_pred             ----C--------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          295 ----S--------------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       295 ----~--------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                          .              ....++..+.++|.+||+.||++|||+.++|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                0              0012457889999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.3e-49  Score=343.27  Aligned_cols=258  Identities=29%  Similarity=0.468  Sum_probs=217.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      ..-.|.-.+.+|.|+||.||.|...++++.||||..-.+.       ..-.+|+.+|+.+. |||||++..+|....   
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLD-HPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence            4445888999999999999999999999999999874332       23457999999887 999999998886432   


Q ss_pred             --eEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 --NLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 --~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                        ...+||||++. +|.+.++.    +..++.-.++-+..||++||.|||+.||+||||||.|+|++  .+.+.+|||||
T Consensus        94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccC
Confidence              34589999965 89988875    46689999999999999999999999999999999999997  46688999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD------  291 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  291 (366)
                      |.|+....+....++..|..|+|||.+.  ..|+.+.||||.|||+.||+.|++.|.+.+..+++..+.+--..      
T Consensus       171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9999998887778889999999999865  46999999999999999999999999999888777776431110      


Q ss_pred             --------------CCCC-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          292 --------------LQSS-----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       292 --------------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                    +...     .....++++.+|+.++|..+|.+|.++.|++.||||+....+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                          0000     113468999999999999999999999999999999886664

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-47  Score=351.91  Aligned_cols=254  Identities=28%  Similarity=0.527  Sum_probs=217.3

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCeEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      |++.+.||+|+||.||+|.+..+|+.||||.+...........+.+.+|++++..+.  +||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999999999999999997654333445567777877765443  399999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~  229 (366)
                      |||+++++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCC
Confidence            999999999888754 468999999999999999999999999999999999999   5677899999999875322 22


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......|++.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+..+....+.    .++..+.++|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  232 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIM  232 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence            334467999999999876 45889999999999999999999999988888887777776554332    4789999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          309 RKMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      .+||+.||++||     ++.++++||||+..
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999999     79999999999874

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-47  Score=350.93  Aligned_cols=256  Identities=31%  Similarity=0.541  Sum_probs=222.9

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |+..+.||+|+||.||+|.++.+|+.||+|++.............+..|..++..+.+|++|+.+++++...+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            77889999999999999999999999999999765433344556788899999998878899999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-Cce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~  231 (366)
                      |+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...... ...
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCccc
Confidence            99999999999888889999999999999999999999999999999999999   56778999999998754322 223


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+.......+.    .++.++.+++.+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~  234 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG  234 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence            3456899999999876 45889999999999999999999999988888888887776554432    468899999999


Q ss_pred             hcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          311 MLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       311 ~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      ||+.||.+|++     ..++++||||+...
T Consensus       235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         235 LMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            99999999997     57999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-47  Score=345.39  Aligned_cols=260  Identities=32%  Similarity=0.507  Sum_probs=217.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++ |+||+.+++.+..++..+++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence            3788899999999999999998899999999987544333333456778999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999999999888653  358999999999999999999999999999999999999   567789999999998765444


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......|+..|+|||++. ..++.++||||||+++|+|++|..||.+.......+.+..............++..+.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            444557899999999875 4588999999999999999999999987765443333322222222222335789999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          309 RKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       309 ~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      .+||..||++||     +++++++||||....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            999999999999     999999999997743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-47  Score=349.65  Aligned_cols=252  Identities=30%  Similarity=0.512  Sum_probs=216.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||+||+|.+..+++.||+|.+................|..++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654333445566778888888776799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887789999999999999999999999999999999999999   5677899999999875322 22334557


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||..|+|||++. ..++.++|||||||++|+|++|..||...+..+..+.+.......+    ..++.++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            899999999876 4589999999999999999999999998887777777665543322    24788999999999999


Q ss_pred             CcCCCCCHH-HHhcCCCcccCC
Q 017768          315 DPKKRITAA-EALEHPWLKEDG  335 (366)
Q Consensus       315 dp~~Rpt~~-~~l~hp~f~~~~  335 (366)
                      ||++||++. ++++||||+...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCC
Confidence            999999996 899999998854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-47  Score=352.32  Aligned_cols=251  Identities=29%  Similarity=0.532  Sum_probs=211.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++.++.+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654434445667888999998887799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~  235 (366)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   567789999999987532 222334467


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE---------TEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ||..|+|||++. ..++.++||||||+++|+|++|..||...         ......+.+.......+    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            899999999876 45889999999999999999999999521         11223334444443333    25788999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCCCcccC
Q 017768          306 DLIRKMLTKDPKKRIT------AAEALEHPWLKED  334 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt------~~~~l~hp~f~~~  334 (366)
                      ++|.+||+.||++|++      +.++++||||+..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=351.04  Aligned_cols=245  Identities=27%  Similarity=0.441  Sum_probs=214.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.+++++.||+|.||.||.|.++. ...||+|.+....    -..+.+.+|+.+|++|+ |++||++++++..++.+||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEE
Confidence            3446778899999999999999972 4489999997543    34567889999999999 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||+..|+|.++|+.  ...+...+.+.++.||++||+||+++++|||||-..||||   +++..+||+|||+|+...+
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCC
Confidence            9999999999999997  4569999999999999999999999999999999999999   6788899999999995443


Q ss_pred             CCceecccC---CCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          228 GKVYKEIVG---SAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       228 ~~~~~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      +. +....|   ...|.|||++. ++|+.+||||||||+||||+| |+.||.+.+..++++.+.+|.......   .+|+
T Consensus       356 ~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~---~CP~  431 (468)
T KOG0197|consen  356 DE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE---GCPD  431 (468)
T ss_pred             Cc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC---CCCH
Confidence            33 333223   45699999986 689999999999999999999 999999999999999999998766654   5789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+++..||+.+|++|||++.+..
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHHH
Confidence            9999999999999999999987654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-47  Score=350.63  Aligned_cols=250  Identities=37%  Similarity=0.645  Sum_probs=215.8

Q ss_pred             ceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           77 KELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      +.||+|+||.||++.+.   .+++.||+|++...... .......+.+|+.+++.+. ||||+++++++..++..|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            57999999999999863   46889999998754321 1233456788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~  231 (366)
                      |+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence            99999999999888889999999999999999999999999999999999999   5677899999999875432 2223


Q ss_pred             ecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+....+    +.+++++.++|.+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            34579999999998764 578999999999999999999999998888887888777665443    3578999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          311 MLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       311 ~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      ||+.||++||     +++++++||||+..
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-47  Score=351.80  Aligned_cols=251  Identities=32%  Similarity=0.575  Sum_probs=213.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHH-HHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-QHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +.||+|+||+||+|.+..+|+.||+|++.............+..|...+ +.+. ||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            3699999999999999999999999999765433333445556665544 5565 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceecc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEI  234 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~  234 (366)
                      +++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   5677899999999875422 2233445


Q ss_pred             cCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          235 VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       235 ~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      .||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+..+.....    +.++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            7899999999876 4588999999999999999999999998888887777776654433    3578999999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCcccCC
Q 017768          314 KDPKKRITA----AEALEHPWLKEDG  335 (366)
Q Consensus       314 ~dp~~Rpt~----~~~l~hp~f~~~~  335 (366)
                      .||.+||++    .++++||||....
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999999987    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-47  Score=355.93  Aligned_cols=261  Identities=33%  Similarity=0.510  Sum_probs=221.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|++.............+.+|+.+++.++ ||||+++++.+..++..++
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence            467999999999999999999999999999999986543333344556778999999887 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCC
Confidence            99999999999988654 58999999999999999999999999999999999999   567889999999998664322


Q ss_pred             --ceecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          230 --VYKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                        ......||+.|+|||++..     .++.++|||||||++|+|++|..||...+.......+..............++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence              1234579999999998753     278899999999999999999999998888777777776554444444456899


Q ss_pred             HHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~  335 (366)
                      ++.++|..||..++.+  |++++++++||||++..
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            9999999999844433  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-48  Score=348.25  Aligned_cols=262  Identities=37%  Similarity=0.628  Sum_probs=238.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+...|.+.+.||+|-|++|-+|++..+|..||||++.+.+. +......+.+|+++++.++ |||||++|.+......+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence            355679999999999999999999999999999999987664 3455668999999999998 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |||+|+-++|+|++++-+. ..+.++.+..++.||+.|+.|+|+..+|||||||+||.+.  ..-|.|||.|||++..+.
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCC
Confidence            9999999999999998764 4599999999999999999999999999999999999986  566889999999999999


Q ss_pred             CCCceecccCCCCCCcccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQR-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      .+...++.+|+..|.|||++.+. | .+++||||||||||.|+.|+.||+..+..+.+-.|..-++..+.    .++.++
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eC  246 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKEC  246 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHH
Confidence            99999999999999999987653 4 57899999999999999999999999888888888887777665    579999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ++||..||..||.+|.+.++|.+++|++.....
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            999999999999999999999999999886553

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.3e-47  Score=342.67  Aligned_cols=255  Identities=28%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             ceeeeceecccCceEEEEEEEcc-CCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEe-----e
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKA-TGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYE-----D  143 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~-----~  143 (366)
                      +|++.+.||+|+||.||+|++.. +|..||+|.+..... .......+.+|+.+++.+.  +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            68999999999999999999854 467899998865432 2223345667888887764  4999999999875     3


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      ....+++|||++ ++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence            456899999996 5898888764  348999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC------
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS------  294 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------  294 (366)
                      +.............||..|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+.........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            98765544445567899999999875 46889999999999999999999999888776666665432111100      


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          295 -----------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       295 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                       ...+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             0123577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=332.18  Aligned_cols=267  Identities=37%  Similarity=0.650  Sum_probs=236.5

Q ss_pred             cccceee-eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           69 ITTIYDL-DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        69 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +.+.|++ .+.||+|+++.|--+....+|..+|||++.+.   ......++.+|++++.++++|+||++++++|+++...
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            5566775 46899999999999999999999999999764   3466788999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||.+.||+|...+++...+++.++..+..+|+.||.+||.+||.||||||+|||-...+.-.-||||||.++.....
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999997655556699999998754321


Q ss_pred             --------CCceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCC---------------Ch
Q 017768          228 --------GKVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAE---------------TE  278 (366)
Q Consensus       228 --------~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~---------------~~  278 (366)
                              .....+.+|+.-|||||+..      ..|+++.|+||||||+|-|+.|..||.+.               ..
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence                    12234568888999999752      24899999999999999999999999654               34


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +.+++.|..|.+.++...|..++.+..++|..+|..|+.+|.++.++++|||++....+.
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence            468899999999999999999999999999999999999999999999999998866643

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-46  Score=362.09  Aligned_cols=259  Identities=23%  Similarity=0.328  Sum_probs=203.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc-----CCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-----GQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...    .........|+.+++.+.     ++.+++.+++++..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            457899999999999999999999989999999998532    123345566788777765     24568889888876


Q ss_pred             C-CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCC-----------
Q 017768          144 K-QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEE-----------  210 (366)
Q Consensus       144 ~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~-----------  210 (366)
                      + ...++|||++ +++|.+++...+.+++.++..++.||+.||.|||+ .||+||||||+|||++..+.           
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5788999998 77999999888889999999999999999999998 59999999999999964221           


Q ss_pred             --CCCEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc
Q 017768          211 --DSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE  287 (366)
Q Consensus       211 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~  287 (366)
                        ...+||+|||.+.....  .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus       282 ~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              12599999998865322  2345679999999998764 689999999999999999999999987765544433322


Q ss_pred             CCCCCC-----------------------CCC-------------C--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017768          288 GNLDLQ-----------------------SSP-------------W--PSISGQAKDLIRKMLTKDPKKRITAAEALEHP  329 (366)
Q Consensus       288 ~~~~~~-----------------------~~~-------------~--~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp  329 (366)
                      ....++                       ...             +  ....+.+.+||.+||+.||++|||++|+|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            110000                       000             0  00135678999999999999999999999999


Q ss_pred             CcccC
Q 017768          330 WLKED  334 (366)
Q Consensus       330 ~f~~~  334 (366)
                      ||.+.
T Consensus       440 ~~~~~  444 (467)
T PTZ00284        440 YVLKY  444 (467)
T ss_pred             ccccc
Confidence            99873

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-46  Score=347.20  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=215.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||++++..+|..+|+|.+....  .......+.+|+.++++++ |+||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            357999999999999999999999999999999986432  2334567899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   56778999999998765432


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------------  290 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  290 (366)
                       ......||..|+|||++. ..++.++||||||+++|+|++|+.||...+..+....+.....                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             233457899999999876 4589999999999999999999999976655443222111000                 


Q ss_pred             ---------------------------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          291 ---------------------------DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       291 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                                 .........+++++.+||.+||..||++|||+.++++||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                       0001111246789999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.8e-47  Score=342.67  Aligned_cols=253  Identities=32%  Similarity=0.503  Sum_probs=207.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||+|+||+||++.+..+|+.+|+|.+...........+.+..|+.+++.++ |+||+++++++..++..+++|||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999987654433344567788999999996 9999999999999999999999999999


Q ss_pred             hHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-ceec
Q 017768          159 LFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKE  233 (366)
Q Consensus       159 L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~  233 (366)
                      |...+..    ...+++..++.++.||+.||.|||+++|+||||||+||++   ++++.++|+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9887743    3458999999999999999999999999999999999999   567789999999987654332 2234


Q ss_pred             ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 017768          234 IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML  312 (366)
Q Consensus       234 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  312 (366)
                      ..||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..............++..+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            57899999999876 46889999999999999999999999765432222222221111122222357899999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          313 TKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       313 ~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +.||++||     +++++++||||++..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            99999999     889999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-47  Score=353.86  Aligned_cols=250  Identities=33%  Similarity=0.576  Sum_probs=214.8

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      ||+|+||+||+|++..+|+.||+|++................|..++..+.  +||+|+.+++.+...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997554333344455666777777654  799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~  235 (366)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   5677899999999875422 22334567


Q ss_pred             CCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          236 GSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       236 gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      ||..|+|||++.+  .++.++|||||||++|+|++|..||...+..+....+..+...++..   .+++++.++|.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence            9999999998753  37899999999999999999999999888888777777666554432   468999999999999


Q ss_pred             cCcCCCC----CHHHHhcCCCcccC
Q 017768          314 KDPKKRI----TAAEALEHPWLKED  334 (366)
Q Consensus       314 ~dp~~Rp----t~~~~l~hp~f~~~  334 (366)
                      .||++||    ++.++++||||+..
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-46  Score=347.72  Aligned_cols=252  Identities=28%  Similarity=0.507  Sum_probs=212.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.+|+|++.............+.+|+.++.++.+|++|+.+++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999997654444455677889999999998899999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceeccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~  235 (366)
                      ++|..++.....+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   567789999999987532 233344567


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE-------TEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ||+.|+|||++. ..++.++||||||+++|+|++|..||...       ........+.......+    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            999999999875 46889999999999999999999999532       12223333433333222    2478899999


Q ss_pred             HHHhcccCcCCCCC------HHHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRIT------AAEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt------~~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++|++      ++++++||||+...
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999999997      57999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=346.73  Aligned_cols=260  Identities=30%  Similarity=0.515  Sum_probs=216.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||++....+++.||+|++.+...........+.+|+.+++.+. |+||+.+++++..++..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            36899999999999999999999999999999987543333345566888999998886 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 4569999999999999999999999999999999999999   567789999999987654332


Q ss_pred             c--eecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCCC
Q 017768          230 V--YKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWPSI  300 (366)
Q Consensus       230 ~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  300 (366)
                      .  .....||+.|+|||++.      +.++.++|||||||++|+|++|..||......+....+........ ....+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            2  12246899999999875      3468899999999999999999999988777666666655432222 1223357


Q ss_pred             CHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccC
Q 017768          301 SGQAKDLIRKMLTKDPKK--RITAAEALEHPWLKED  334 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~  334 (366)
                      ++.+.++|++||+.++++  |+++.++++||||.+.
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            899999999999765544  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=352.93  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=216.7

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..+....+...+.+.||+|.||+||+|.+.+   .||||++...... .+..+.|++|+.+|++-+ |.||+-+.|++..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTR-HENILLFMGACMN  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcc-hhhheeeehhhcC
Confidence            3344455556788999999999999999975   4999999877654 447889999999999998 9999999999988


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ... .||.-+|+|.+|+.+++-. ..|.....+.|++||+.|+.|||.++|||||||..|||+   .+++.|||+|||++
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLA  535 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccce
Confidence            877 9999999999999999754 458899999999999999999999999999999999999   67789999999998


Q ss_pred             ccc---cCCCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 017768          223 VFI---ETGKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS  295 (366)
Q Consensus       223 ~~~---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (366)
                      ...   ..........|...|||||++.    .+|+..+||||||+|+|||++|..||.....++++-.+-.|.......
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence            653   3344455567889999999875    358999999999999999999999999777777776666665444332


Q ss_pred             C-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          296 P-WPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       296 ~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      . ....+.++.+|+..||.+++++||.+.+||.
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            2 2346779999999999999999999999988

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-46  Score=353.07  Aligned_cols=259  Identities=21%  Similarity=0.343  Sum_probs=209.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++++ ||||+++++++......++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence            356999999999999999999999999999999642         234678999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      ++|++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence            999995 6899998888889999999999999999999999999999999999999   56678999999999753221 


Q ss_pred             -CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHcC-----------
Q 017768          229 -KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET-------EKGIFEAILEG-----------  288 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~-------~~~~~~~~~~~-----------  288 (366)
                       .......||+.|+|||++. ..++.++|||||||++|+|++|..||....       ....+..+...           
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             2233457999999999876 468999999999999999999998875431       11111111110           


Q ss_pred             ---------------CCCCCC--C---CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          289 ---------------NLDLQS--S---PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       289 ---------------~~~~~~--~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                     ......  .   ....++.++.++|.+||+.||++|||++|+|+||||+....+...|+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~  390 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM  390 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCCC
Confidence                           000000  0   01135678999999999999999999999999999998777665554

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.2e-47  Score=349.15  Aligned_cols=250  Identities=30%  Similarity=0.562  Sum_probs=212.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHH-HHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI-LQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +.||+|+||.||+|.+..+|+.+|+|++.............+..|... ++.+. ||||+++++.+..++..|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence            369999999999999999999999999976543333444556666665 44455 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceecc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEI  234 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~  234 (366)
                      +++|..++.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   667789999999987532 22233445


Q ss_pred             cCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          235 VGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       235 ~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      .||..|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+........    +..+..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            79999999998764 588999999999999999999999998888877777776544332    3578899999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCcccC
Q 017768          314 KDPKKRITA----AEALEHPWLKED  334 (366)
Q Consensus       314 ~dp~~Rpt~----~~~l~hp~f~~~  334 (366)
                      .||++||++    .++++||||+..
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.8e-47  Score=353.25  Aligned_cols=260  Identities=32%  Similarity=0.459  Sum_probs=217.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-----CCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-----QPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~i~~~~~~~~~  143 (366)
                      +.-+|.+.+.||+|+||.|-+|.+..+++.||||+++...    ....+...|+.+|..++.     .-|+|+++++|..
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            3346889999999999999999999999999999997543    456677889999999983     3489999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      .++.|||+|++ ..+|.++++.++  .|+...++.++.||+.+|.+||+++|||+||||+|||+...... .|||+|||.
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGS  337 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDFGS  337 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEeccc
Confidence            99999999999 459999998865  48999999999999999999999999999999999999764443 799999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC----------
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL----------  290 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------  290 (366)
                      ++.....-.  +++-+..|+|||++. .+|+.+.|+||||||+.||++|.+.|.+.+.-+++..|..-..          
T Consensus       338 Sc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  338 SCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            998755433  678899999999875 5799999999999999999999999999888777766632000          


Q ss_pred             ----CCCCC---------------------------------CCC------------CCCHHHHHHHHHhcccCcCCCCC
Q 017768          291 ----DLQSS---------------------------------PWP------------SISGQAKDLIRKMLTKDPKKRIT  321 (366)
Q Consensus       291 ----~~~~~---------------------------------~~~------------~~~~~~~~li~~~l~~dp~~Rpt  321 (366)
                          .+...                                 ..|            .-...+.++|.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                00000                                 001            11246789999999999999999


Q ss_pred             HHHHhcCCCcccCCC
Q 017768          322 AAEALEHPWLKEDGA  336 (366)
Q Consensus       322 ~~~~l~hp~f~~~~~  336 (366)
                      ..++|+||||.+...
T Consensus       496 p~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  496 PAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHhcCcccccccc
Confidence            999999999985433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-47  Score=349.37  Aligned_cols=255  Identities=32%  Similarity=0.560  Sum_probs=231.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe-EEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN-LHL  149 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-~~l  149 (366)
                      +.|.+++.+|+|+||.+++++.+.++..+++|.+..... .+.......+|+.+++++. ||||+.+.+.|..++. .+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            569999999999999999999999999999999976553 3445557899999999988 9999999999999988 999


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|+||+||+|.+.+...+  .++++.++.|+.||+.|+.|||+++|+|||||+.|||+   ..+..|+|+|||+|+.+..
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCC
Confidence            999999999999998765  48999999999999999999999999999999999999   5566689999999999887


Q ss_pred             CC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ...+.+||+.|+.||++.+ +|+.++|||||||++|||++-+.+|...+....+..+.++...+...   .++.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS---MYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc---cccHHHH
Confidence            76 6677899999999999875 69999999999999999999999999999999999999988544443   5789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+|..||..+|+.||++.++|.+|....
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999988864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-46  Score=337.98  Aligned_cols=255  Identities=34%  Similarity=0.552  Sum_probs=212.3

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.+++.++ |++|+.+++.+..++..+++||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEEE
Confidence            677888999999999999999999999999987654333334456778999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          153 LCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |+++++|.+++....  .+++.++..++.|++.||.|||+.+|+||||||+||++   +.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCcc
Confidence            999999999886543  48999999999999999999999999999999999999   5677799999999876654444


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .....|+..|+|||++. ..++.++||||||+++|+|++|..||......   ..........   .......+++++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHHH
Confidence            44557899999999876 45899999999999999999999999765432   1122221111   11122357889999


Q ss_pred             HHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017768          307 LIRKMLTKDPKKRIT-----AAEALEHPWLKED  334 (366)
Q Consensus       307 li~~~l~~dp~~Rpt-----~~~~l~hp~f~~~  334 (366)
                      ++.+||+.||++|||     ++++++||||++.
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999999     9999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5e-46  Score=337.13  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=206.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEee-----C
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYED-----K  144 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~-----~  144 (366)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+..... .........+|+.+++.+.  +|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48899999999999999999999999999999865432 1222345667888887764  49999999998764     3


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ...+++|||+.+ +|.+++....  .+++.++..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            458999999975 8888887643  48999999999999999999999999999999999999   56778999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC---------
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL---------  292 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------  292 (366)
                      .............+|..|+|||++. ..++.++|||||||++|+|++|..||......+....+.......         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            8765444444557899999999875 468999999999999999999999998776655544443211000         


Q ss_pred             --------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          293 --------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       293 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                    .....+.+++.+.++|.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          001124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.2e-46  Score=344.92  Aligned_cols=250  Identities=30%  Similarity=0.543  Sum_probs=211.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHH-HHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL-ILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|.. +++.+. |+||+++++.+...+..|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999999999999999997654333334445566655 456665 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceecc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEI  234 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~  234 (366)
                      +++|...+.....+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   5677899999999875322 2223445


Q ss_pred             cCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          235 VGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       235 ~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+.......+    +..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            78999999998764 588999999999999999999999998887777777776654433    2568899999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCcccC
Q 017768          314 KDPKKRITA----AEALEHPWLKED  334 (366)
Q Consensus       314 ~dp~~Rpt~----~~~l~hp~f~~~  334 (366)
                      .||.+|+++    .++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999865    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.9e-46  Score=344.83  Aligned_cols=261  Identities=27%  Similarity=0.469  Sum_probs=218.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||++..+.+++.+|+|++.+...........+.+|+.++..+. |++|+.+++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence            35899999999999999999999999999999986543323334455788999988886 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.++|+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            999999999999977 4568999999999999999999999999999999999999   567789999999987653322


Q ss_pred             --ceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCC
Q 017768          230 --VYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-SPWPSI  300 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  300 (366)
                        ......||+.|+|||++.      +.++.++|||||||++|+|++|..||...+..+....+......... .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence              122357999999999874      34788999999999999999999999988877777777665433222 222457


Q ss_pred             CHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCC
Q 017768          301 SGQAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDG  335 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~  335 (366)
                      ++++.++|.+||+.++.+  |++++++++||||.+..
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            899999999999775554  68999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-48  Score=331.82  Aligned_cols=259  Identities=34%  Similarity=0.598  Sum_probs=240.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -+.|+..+.||+|.||.|.+++.+.+|+.+|+|++++...........-..|-++|+..+ ||.+..+...|+..+++++
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            356889999999999999999999999999999999887777777888888999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~  228 (366)
                      ||||..||.|+-.+.....+++..++.+...|+.||.|||+.+||+||||.+|+|+   +.+|++||.|||+++.. ..+
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999   78999999999999754 455


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ....+.+||+-|.|||++. ..|++.+|+|.+|||||||+.|+.||...+++.+++.+......++.    .+++++..|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence            6678899999999999987 56999999999999999999999999999999999999998888776    479999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCcccCCC
Q 017768          308 IRKMLTKDPKKRI-----TAAEALEHPWLKEDGA  336 (366)
Q Consensus       308 i~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~~  336 (366)
                      +..+|..||.+|.     ++.|+.+|+||...+.
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            9999999999997     6899999999988665

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-46  Score=359.81  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+...       .....+|+.+++.++ |+||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence            345799999999999999999999989999999987532       123457999999997 99999998876432    


Q ss_pred             ----CeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          145 ----QNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                          ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+++|+||||||+|||++  .+++.+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence                246799999975 77666643    35689999999999999999999999999999999999994  23346999


Q ss_pred             eecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC----
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL----  290 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----  290 (366)
                      +|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.....    
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987655554455678999999998753  589999999999999999999999988766555444432110    


Q ss_pred             -------------CCCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          291 -------------DLQSS--------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       291 -------------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                   .++..        .....++++.+||.+||..||.+|||+.|+|+||||.....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                         00000        00135789999999999999999999999999999987543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.9e-47  Score=347.08  Aligned_cols=249  Identities=32%  Similarity=0.555  Sum_probs=215.1

Q ss_pred             ceecccCceEEEEEEE---ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +.||+|+||.||++.+   ..+|+.+|+|++..... .......+.+|+.+++++. ||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999876   35789999999975432 1233456778999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-Ccee
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYK  232 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~  232 (366)
                      +++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   ++++.++|+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999   56778999999998765433 2334


Q ss_pred             cccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 017768          233 EIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM  311 (366)
Q Consensus       233 ~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  311 (366)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+.......+.    .+++.+.++|.+|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence            4678999999998764 5789999999999999999999999988888777777766554332    4789999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCCCcccC
Q 017768          312 LTKDPKKRIT-----AAEALEHPWLKED  334 (366)
Q Consensus       312 l~~dp~~Rpt-----~~~~l~hp~f~~~  334 (366)
                      |+.||++||+     +.+++.||||+..
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-46  Score=345.13  Aligned_cols=250  Identities=31%  Similarity=0.564  Sum_probs=210.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHH-HHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI-LQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +.||+|+||+||+|++..+++.||+|++.............+..|... ++.+. |+||+++++++...+..|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence            369999999999999999999999999975443223333445555544 45565 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CCceecc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEI  234 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~  234 (366)
                      +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   5677899999999875422 2233445


Q ss_pred             cCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          235 VGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       235 ~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.......    .+.++..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence            79999999998764 58899999999999999999999999888877777776654432    23678999999999999


Q ss_pred             cCcCCCCCHH----HHhcCCCcccC
Q 017768          314 KDPKKRITAA----EALEHPWLKED  334 (366)
Q Consensus       314 ~dp~~Rpt~~----~~l~hp~f~~~  334 (366)
                      .||.+|+++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999865    89999999663

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.1e-46  Score=344.47  Aligned_cols=260  Identities=28%  Similarity=0.478  Sum_probs=217.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||++++..+++.||+|.+.............+.+|..++..+. |++|+.+++++..++..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999986543333344556778888888886 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999987 4578999999999999999999999999999999999999   567789999999997654333


Q ss_pred             ce--ecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCCC
Q 017768          230 VY--KEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWPSI  300 (366)
Q Consensus       230 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  300 (366)
                      ..  ....||+.|+|||++.      +.++.++||||||+++|+|++|..||......+....+........ ......+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  2346999999999875      3478899999999999999999999988877776666665433222 2223457


Q ss_pred             CHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccC
Q 017768          301 SGQAKDLIRKMLTKDPKK--RITAAEALEHPWLKED  334 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~  334 (366)
                      ++++.++|.+||+.++++  |++++++++||||+..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            899999999999976654  5799999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-46  Score=335.66  Aligned_cols=254  Identities=41%  Similarity=0.700  Sum_probs=211.7

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++++.||+|+||+||++.+..+++.+|+|.+...... ........+|+.+++++. |+||+++++++......+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence            78999999999999999999999999999999765432 222333456999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCCCce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~~~~  231 (366)
                      |+++++|.+++.....+++.++..++.||++||.+||+++|+|+||||+||++   +.++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999988889999999999999999999999999999999999999   56777999999999763 333344


Q ss_pred             ecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ....++..|+|||++.  ..++.++||||||+++|+|++|..||......   .....................+.++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5567899999999976  56899999999999999999999999887333   233333222221111111122489999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +|.+||+.||++||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-46  Score=334.97  Aligned_cols=259  Identities=33%  Similarity=0.532  Sum_probs=217.3

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |+..+.||+|+||+||++.+..+++.+|+|.+.............+.+|+.+++.++ |++|+.+++.+..++..+++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            677788999999999999999999999999987654333344556788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          153 LCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCCc
Confidence            99999999888654  358999999999999999999999999999999999999   5667799999999876554444


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....|+..|+|||++. ..++.++|+||||+++|+|++|..||...........+..............++.++.+++.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            44557899999999875 56889999999999999999999999877654443443332222222233467889999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      .||+.||++||+     +.+++.|+||+...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999999     89999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8e-46  Score=346.42  Aligned_cols=258  Identities=29%  Similarity=0.457  Sum_probs=207.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--  145 (366)
                      .+.++|++.+.||+|+||.||++.+..+|..||+|.+.... ........+.+|+.+++.++ ||||+++++++...+  
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence            45678999999999999999999999999999999986442 22344567889999999997 999999999986543  


Q ss_pred             ----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          146 ----NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       146 ----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                          ..|+||||+++ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence                57999999976 66666543  47899999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc-------------
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-------------  287 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~-------------  287 (366)
                      +.............||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+..             
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            976544444445678999999998764 588999999999999999999999987655433222211             


Q ss_pred             ---------CCCCCCC----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          288 ---------GNLDLQS----------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       288 ---------~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                               .......                ......++++.++|.+||+.||++|||+.|+|+||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                     1000000                001124578999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.8e-46  Score=339.11  Aligned_cols=261  Identities=28%  Similarity=0.432  Sum_probs=214.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|.+.+.||+|+||.||+|.++.+++.||+|.+.....  ......+.+|+.++++++ |+||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            469999999999999999999999999999999865432  233446778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++ +|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999975 8888776643 48999999999999999999999999999999999999   567789999999987643322


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC----------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL----------------  290 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------  290 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.....                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2233467899999998753  578999999999999999999999987766554444332110                


Q ss_pred             ---CCC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          291 ---DLQ-------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       291 ---~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                         ...       ....+.++.++.++|.+||+.||.+|||+.|+++||||+......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence               000       011235788999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-45  Score=332.55  Aligned_cols=250  Identities=30%  Similarity=0.522  Sum_probs=206.6

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||+|+||.||++..+.+|+.+|+|.+.............+..|+.+++++. ||||+++++.+..+...+++|||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999986544322233445667999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccC
Q 017768          159 LFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG  236 (366)
Q Consensus       159 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g  236 (366)
                      |.+++....  .+++..+..++.||+.||.|||+.||+||||||+||++   ++++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            988886543  48899999999999999999999999999999999999   5677899999999887655444445678


Q ss_pred             CCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 017768          237 SAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLDLQSSPWPSISGQAKDLIRKM  311 (366)
Q Consensus       237 t~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  311 (366)
                      +..|+|||++. ..++.++|||||||++|+|++|..||......    ..............   ...+++++.++|.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence            99999999875 45899999999999999999999999764332    22222222222221   235789999999999


Q ss_pred             cccCcCCCCCH----HHHhcCCCcccCC
Q 017768          312 LTKDPKKRITA----AEALEHPWLKEDG  335 (366)
Q Consensus       312 l~~dp~~Rpt~----~~~l~hp~f~~~~  335 (366)
                      |+.||++||++    ++++.||||+...
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCCC
Confidence            99999999999    7788999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-45  Score=340.34  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=213.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+....  .......+.+|+++++.++ |+||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            467999999999999999999999999999999886432  2334567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence            999999999999998888899999999999999999999985 79999999999999   56677999999998765332


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---CCC--------------
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE---GNL--------------  290 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~---~~~--------------  290 (366)
                       ......|+..|+|||++.+ .++.++|+|||||++|+|++|..||...........+..   +..              
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence             2234578999999998764 588999999999999999999999976544333221100   000              


Q ss_pred             -------------------------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          291 -------------------------DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       291 -------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                               .........++.++.+||.+||+.||++|||+.|++.||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                                     0000001135788999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.3e-45  Score=342.11  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=210.6

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|++.+.||+|+||.||++.+..+++.||||.+.... ........+.+|+.+++.+. |+||+.+++++...  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence            345678999999999999999999999999999999986432 22344567889999999997 99999999987643  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                          ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG  171 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  171 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCC
Confidence                357999999965 77776653  47899999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-------
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-------  292 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  292 (366)
                      ++.............+|..|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.......       
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            998765544445567899999999876 458899999999999999999999998876655544443211100       


Q ss_pred             ---------------C----------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          293 ---------------Q----------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       293 ---------------~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                     .                .......+..+.++|.+||+.||++|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                           0                0001113467899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-45  Score=353.05  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=217.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccC-CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKAT-GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ...|.+.+.||+|+||.||+|....+ +..||+|.+...   .......+.+|+.+++.+. ||||+++++++..++..|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence            34599999999999999999998877 778999876432   2344556788999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      |||||+++++|.+++..    ...+++.++..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence            99999999999988754    3458999999999999999999999999999999999999   5677899999999987


Q ss_pred             ccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          225 IETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       225 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+..+......   ..+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP---CPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---ccC
Confidence            64332   233457999999999876 45899999999999999999999999988887777777766543222   247


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      +.++.++|.+||..||++||++.+++.|+|++.
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            889999999999999999999999999999965

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-45  Score=342.90  Aligned_cols=263  Identities=28%  Similarity=0.422  Sum_probs=210.6

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .....+.++|++.+.||+|+||.||++.+..+++.+|+|.+.... ........+.+|+.+++.+. |+||+++++++..
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~   87 (355)
T cd07874          10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTP   87 (355)
T ss_pred             chhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeec
Confidence            334456778999999999999999999999899999999986432 22344567888999999997 9999999998864


Q ss_pred             C------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          144 K------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       144 ~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      .      ...+++|||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~  161 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL  161 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEe
Confidence            4      357999999976 67666643  48899999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-------
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN-------  289 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-------  289 (366)
                      |||++.............||..|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+....       
T Consensus       162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             eCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999987655444455678999999998764 58899999999999999999999998766443332221110       


Q ss_pred             ---------------CCC----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          290 ---------------LDL----------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       290 ---------------~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                                     ...                ........+.++.++|.+||..||++|||+.|+|+||||..-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                           000                000111245678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=343.03  Aligned_cols=264  Identities=37%  Similarity=0.664  Sum_probs=236.5

Q ss_pred             ccccceee--eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           68 DITTIYDL--DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        68 ~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ++...|++  .+.||+|.||+||-|..+.+|+.||||++.+-.+.. +....+.+|+.+|+.+. ||.||.+.--++..+
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~-HPGiV~le~M~ET~e  636 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLH-HPGIVNLECMFETPE  636 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcC-CCCeeEEEEeecCCc
Confidence            44455665  468999999999999999999999999998776643 34478999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..++|||.+.| ++.+.+..  +++|++.....++.||+.||.|||.++|+|+||||+|||+.+.++-..+||||||.|+
T Consensus       637 rvFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  637 RVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             eEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence            99999999965 66555543  4679999999999999999999999999999999999999988888899999999999


Q ss_pred             cccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ...........+||+.|.|||++. +.|.+.-|+||+|||+|.-++|..||..  .+++.+++.+..+.++..+|.++++
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH
Confidence            998887778889999999999986 4599999999999999999999999954  4567788999999999999999999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +++|||+.+|+..-++|.+.++.|.|||+++-..
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence            9999999999999999999999999999987543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-45  Score=353.63  Aligned_cols=257  Identities=29%  Similarity=0.483  Sum_probs=218.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      ..++|.+.+.||+|+||+||+|.+..+|+.||||.+..... .......+.+|+.++..+. |+||++++..+...+   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence            45689999999999999999999999999999999875432 2345667889999999987 999999887765432   


Q ss_pred             -----eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          146 -----NLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       146 -----~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                           .+++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence                 368999999999999988653    358999999999999999999999999999999999999   56778999


Q ss_pred             eecCCcccccCC---CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC
Q 017768          217 TDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       217 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      +|||+++.....   .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999998765432   22334579999999999864 58999999999999999999999999888877777777665443


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .   .+.+++++.+++.+||+.||.+||++.++++|||++.
T Consensus       265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            2   2357899999999999999999999999999999865

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-45  Score=345.62  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=210.9

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-----eE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-----NL  147 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-----~~  147 (366)
                      |++.+.||+|+||.||++.+..+|+.||+|.+.... ........+.+|+.+++.++ |+||+++++++...+     ..
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            678899999999999999998899999999885421 22234567889999999997 999999999998776     78


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence            99999996 5888888877789999999999999999999999999999999999999   5677899999999976543


Q ss_pred             CC--ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC---------------
Q 017768          228 GK--VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG---------------  288 (366)
Q Consensus       228 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~---------------  288 (366)
                      ..  ......++..|+|||++.+  .++.++|||||||++|+|++|+.||.+.+....+..+...               
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22  2233467899999998764  4789999999999999999999999877665544443221               


Q ss_pred             --------CCCCCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          289 --------NLDLQS-----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       289 --------~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                              ......     ......++++.++|.+||+.||++|||+.++|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                    000000     1123457899999999999999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.6e-45  Score=329.57  Aligned_cols=255  Identities=38%  Similarity=0.661  Sum_probs=223.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.+++++. ||||+++++.+..++..+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence            35899999999999999999999899999999987654433455677889999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||+++++|.+++.....+++..+..++.||+.||.+||+.||+|+||+|+||++   +.++.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   56778999999999876544  


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....+++.|+|||.+. ...+.++||||||+++|+|++|..||...........+..+....+.    .++..+.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHH
Confidence            23446889999999875 45788999999999999999999999887766666666655443332    46889999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +||..||.+|+     +++++++||||+...
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999     999999999997755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-46  Score=311.45  Aligned_cols=255  Identities=28%  Similarity=0.396  Sum_probs=217.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      ...+..||.|+.|.|++++.+.+|...|||.+.+.  .+.++.+++...+.++....++|+||+.+++|..+...+|+||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34567899999999999999999999999988654  3456677888889998888889999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          153 LCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      .| +..+..++.. .++++|..+-.+...++.||.||.+ ++|+|||+||+|||+   ++.|++||||||++..+-+...
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence            98 4456666554 4569999999999999999999975 689999999999999   7888999999999988887777


Q ss_pred             eecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .+...|.+.|||||.+.    .+|+.++||||||++++||.||+.||.+. +.-+.+-.+.+... +....-.++++.++
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ  326 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence            78889999999999875    25899999999999999999999999874 34466666666443 22222234899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +++..||..|+.+||...++|+|||++.-
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            99999999999999999999999999763

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-47  Score=337.68  Aligned_cols=261  Identities=34%  Similarity=0.540  Sum_probs=229.3

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|+.-+.||+|+||.||-++-+.+|+.+|+|.+.+.............+|-.+|.+++ .+.||.+-..|+..+.+++||
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEEE
Confidence            4777788999999999999999999999999987766555555667889999999998 889999999999999999999


Q ss_pred             eccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ..|+||+|.-.+...+  .+++..++.++.+|+.||++||+.+||+||+||+|||+   ++.|+|+|+|+|+|+....+.
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCCC
Confidence            9999999988887655  69999999999999999999999999999999999999   789999999999999999888


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      .....+||.+|||||++. +.|+...|+|||||++|+|+.|+.||.........+.+.....+.+......+++++.+|.
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc  421 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC  421 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence            888889999999999986 5699999999999999999999999977655444434443333334444446899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccCCC
Q 017768          309 RKMLTKDPKKRI-----TAAEALEHPWLKEDGA  336 (366)
Q Consensus       309 ~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~~  336 (366)
                      +.+|+.||++|.     .+.++-+||||+..+.
T Consensus       422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             HHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence            999999999997     5779999999999765

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=322.65  Aligned_cols=255  Identities=31%  Similarity=0.489  Sum_probs=213.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc--cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.|++.+.||+|++|.||.|.+..+++.+|+|.+.......  ......+.+|+.+++++. ||||+++++++..++..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence            45899999999999999999998899999999886432211  123457889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +++||+++++|.+++.....+++..+..++.|++.||.+||+.||+|+||+|+||++   ++++.++|+|||++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   56678999999998755332


Q ss_pred             Cce----ecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          229 KVY----KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       229 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ...    ....++..|+|||++.+ .++.++||||||+++|+|++|+.||....................  ....++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccCCHH
Confidence            111    23457889999998764 588999999999999999999999977655444444333322221  12357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.++|.+||..||++|||+.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-45  Score=341.04  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=211.7

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. |+||+++++++...  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   88 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccc
Confidence            356778999999999999999999999899999999986432 12234456778999999997 99999999887543  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                          ...|++++++ +++|.+++. ...+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg  163 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFG  163 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCc
Confidence                3578999998 778887765 4569999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC-------
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD-------  291 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------  291 (366)
                      ++......  .....||..|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+......       
T Consensus       164 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         164 LARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             cceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99875432  234578999999998754  5789999999999999999999999876654444333221100       


Q ss_pred             ----------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          292 ----------------LQS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       292 ----------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                      ...    ......++.+.++|.+||+.||++|||+.++|+||||.....+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                            000    01123567789999999999999999999999999998765543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-44  Score=330.40  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=212.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|.+.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.++ |+||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            469999999999999999999998999999999864331  233456778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++ +|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||+   +.++.++|+|||++.......
T Consensus        83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            999974 888888764 458999999999999999999999999999999999999   567789999999987643222


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC--------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--------------  292 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  292 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+.......              
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2233457889999998753  47889999999999999999999998877665544432211100              


Q ss_pred             -----C-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          293 -----Q-------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       293 -----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                           .       ....+.+++.+.++|.+||+.||.+|||+.++|+||||+..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                 0       0011357889999999999999999999999999999987664

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-44  Score=361.81  Aligned_cols=264  Identities=31%  Similarity=0.520  Sum_probs=215.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQ  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~  145 (366)
                      ...+.|.+.+.||+|+||+||+|.+..++..+|+|.+..... .......+..|+.+++.+. ||||++++++|..  ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCC
Confidence            345679999999999999999999999999999999865432 2345667889999999998 9999999998854  45


Q ss_pred             eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCEEeccCCCcEEeeec------
Q 017768          146 NLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFM-------GVIHRDLKPENFLLASK------  208 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~-------~ivH~Dlkp~NIll~~~------  208 (366)
                      .+||||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.       +|+||||||+||||+..      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            789999999999999998752    4699999999999999999999985       49999999999999532      


Q ss_pred             --------CCCCCEEEeecCCcccccCCCceecccCCCCCCcccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 017768          209 --------EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH---QRYGKEIDVWSAGVILYILLSGVPPFWAET  277 (366)
Q Consensus       209 --------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~vl~~ll~g~~pf~~~~  277 (366)
                              +....+||+|||++.............||+.|+|||++.   ..++.++||||||||||+|++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    123458999999998765444445567999999999874   347899999999999999999999997655


Q ss_pred             hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ....+.........   ......+.++.+||..||..+|.+||++.++|.|+||+....
T Consensus       248 ~~~qli~~lk~~p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 NFSQLISELKRGPD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cHHHHHHHHhcCCC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            43333332222222   222356899999999999999999999999999999986544

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-44  Score=323.17  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=210.6

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC---
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK---  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---  144 (366)
                      +.++.|++.+.||+|+||.||+|.+..+++.+|+|.+...    ......+.+|+.+++++.+|+||+++++.+...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            3566799999999999999999999999999999998643    234567889999999997799999999998753   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          145 ---QNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                         ...+++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+++|+|+||||+||++   ++++.++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccC
Confidence               4689999999999999998864  358999999999999999999999999999999999999   56777999999


Q ss_pred             CCcccccCC-CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC
Q 017768          220 GLSVFIETG-KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       220 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      |++...... .......|+..|+|||++.      ..++.++|+|||||++|+|++|..||................  .
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~  233 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A  233 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence            998765332 1223456889999999874      247789999999999999999999997665444333332221  1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .......++.++.+++.+||..||++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            111223568899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-44  Score=338.33  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             ccccceeeeceecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .+..+|.+.+.||+|+||.||++....  ++..||+|.+...        ....+|+.+|+.++ |+||+++++++...+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            345679999999999999999997643  4578999987432        23468999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..+++||++. ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence            9999999995 5898988777789999999999999999999999999999999999999   56778999999999765


Q ss_pred             cCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcC----CCCCCC
Q 017768          226 ETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEAILEG----NLDLQS  294 (366)
Q Consensus       226 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~----~~~~~~  294 (366)
                      .....   .....||..|+|||++. ..++.++|||||||++|+|++|..||.+....   ..+..+...    ...++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            43321   22457999999999886 45899999999999999999999999765321   111111110    000000


Q ss_pred             --------------------CC------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          295 --------------------SP------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       295 --------------------~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                          ..      ...++.++.++|.+||..||++|||+.++|.||||++....
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence                                00      01346788999999999999999999999999999876543

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=343.52  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=222.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|.-.+.||.|+||.||.|++..+.+.||||++.-..-.......++..|++.|+++. |||++.+-++|..+...||
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHH
Confidence            445777788999999999999999999999999987655444556778999999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||||-| +-.+++.- +.++-+.++..|+.+.+.||.|||+++.||||||..|||+   .+.|.|||+|||.|......
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCch
Confidence            9999955 76676653 4568999999999999999999999999999999999999   67888999999999876543


Q ss_pred             CceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCCCHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN-LDLQSSPWPSISGQ  303 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  303 (366)
                         ++++|||+|||||++.    +.|+-++||||||++.+||.-.++|+..++.-..+-.|.... .....   +..++.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~  253 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDY  253 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHH
Confidence               4678999999999863    679999999999999999999999999888766655555443 33333   355889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ++.||..||..-|++|||.+++|.|+|+.....++
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            99999999999999999999999999998876554

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=330.43  Aligned_cols=259  Identities=34%  Similarity=0.586  Sum_probs=220.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+.............+..|+.+++.+. |+||+++++.+..++..+++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence            5899999999999999999999889999999997654433345677899999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+.+++|.+++...  ..+++..+..++.|++.+|.|||+.|++|+||||+||++   +.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcccccc
Confidence            999999999998764  458999999999999999999999999999999999999   556789999999986543211


Q ss_pred             ------------------------------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 017768          230 ------------------------------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE  278 (366)
Q Consensus       230 ------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~  278 (366)
                                                    ......|+..|+|||++.+ .++.++||||||+++|+|++|..||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          1113467889999998764 578899999999999999999999988877


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHhcCCCcccCCC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT----AAEALEHPWLKEDGA  336 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~~l~hp~f~~~~~  336 (366)
                      ......+..........  ..++..+.++|.+||+.||++|||    +++++.||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~  297 (316)
T cd05574         238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW  297 (316)
T ss_pred             HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence            76666665544433322  236899999999999999999999    999999999988654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-45  Score=332.54  Aligned_cols=259  Identities=28%  Similarity=0.446  Sum_probs=209.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|++.++||+||.+.||++... +.+.+|+|.+.... .+.....-+.+|+..|.+|++|.+|++++++-..++.+|+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            445999999999999999999875 45667777654332 2355677899999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||-+ .+|..+|+.... ++...++.++.||+.++.++|++||||.||||.|+|+    ..|.+||+|||+|.....+
T Consensus       438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence            999974 499999988765 4446899999999999999999999999999999999    4788999999999887654


Q ss_pred             C---ceecccCCCCCCccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCCCC
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQ------------RYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLDL  292 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~  292 (366)
                      .   .....+||..||+||++..            +.++++||||||||||+|+.|+.||..-. .-..+..+.......
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            3   2345799999999998721            26789999999999999999999995543 222333344433333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .++..+. ..++++++..||..||.+||+..++|+|||++...-
T Consensus       593 efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  593 EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence            3333332 234999999999999999999999999999987443

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.8e-44  Score=327.03  Aligned_cols=260  Identities=30%  Similarity=0.528  Sum_probs=220.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.++ |+||+++++.+..++..+++|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999987554333345567889999999987 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      ||++|++|.+++.....+++..+..++.|++.||.|||+++++|+||||+||++   +.++.++|+|||++.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999999999999999999999   567789999999886421100  


Q ss_pred             --------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          230 --------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       230 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                                    ......++..|+|||.+. ..++.++|+||||+++|+|++|..||.+.+..+.......+....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          011235778899999865 46889999999999999999999999988877777777666544433


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccCCC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRIT---AAEALEHPWLKEDGA  336 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~~l~hp~f~~~~~  336 (366)
                      ... .++.++.++|.+||+.||++||+   +.++|+||||.....
T Consensus       238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            322 57899999999999999999998   799999999977443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.1e-44  Score=324.86  Aligned_cols=256  Identities=30%  Similarity=0.522  Sum_probs=211.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+.+++.+. |+||+++++.+..+...+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            468999999999999999999998999999998864331 2233456789999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||++++.|..++.....+++.++..++.||+.+|.|||+.|++|+||||+||++   +.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998888777666679999999999999999999999999999999999999   566789999999998764433 


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------------  290 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  290 (366)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+.....                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2334467889999998753  478899999999999999999999987765544333221000                 


Q ss_pred             --CCCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 --DLQS--------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 --~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                        ..+.        ...+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0000        0123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-44  Score=336.70  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=198.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|++.+.||+|+||.||+|.+..++..||+|+....         ....|+.+++.++ |+||+++++++...+..++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEE
Confidence            34699999999999999999999989999999975322         2346899999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||++. ++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......
T Consensus       135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccC
Confidence            999995 5888887653 568999999999999999999999999999999999999   56777999999999764443


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChH----------HHHHHHHcCCC---CCC
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE-TEK----------GIFEAILEGNL---DLQ  293 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~----------~~~~~~~~~~~---~~~  293 (366)
                      .......||..|+|||++. ..++.++|||||||++|+|+++..++... ...          .....+.....   .+.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            3344567999999999876 46899999999999999999865554322 110          11111110000   000


Q ss_pred             ---------------------C-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          294 ---------------------S-----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       294 ---------------------~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                           .     .....++.++.++|.+||+.||++|||+.|+|+||||++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                 0     001135667888999999999999999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=364.76  Aligned_cols=262  Identities=31%  Similarity=0.497  Sum_probs=230.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|.+++.||+|+||.|.+++.+.+++.||.|++.+.......+..-|..|-.+|..-. .+=|+.++..|+++.++|+
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence            457999999999999999999999999999999998765544556666777777777654 7889999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||++||+|..++.+...+++..++.++..|+.||..||+.|+|||||||+|||+   +..|++||+|||.+..+..+.
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence            99999999999999988899999999999999999999999999999999999999   789999999999998876433


Q ss_pred             c--eecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          230 V--YKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       230 ~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      .  ....+|||.|.+||++.      +.|++..|+||+||++|||+.|..||....--+....|.+-+-.+.++....+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            2  23458999999999873      458999999999999999999999999887777777777664444444455799


Q ss_pred             HHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccCCC
Q 017768          302 GQAKDLIRKMLTKDPKKRIT---AAEALEHPWLKEDGA  336 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt---~~~~l~hp~f~~~~~  336 (366)
                      +++.+||+++++ +|+.|..   ++++-.||||.++.+
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence            999999999998 7889988   999999999999877

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-44  Score=335.60  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=200.3

Q ss_pred             ccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            467999999999999999999752     345689999986432  2234567889999999996699999999987754


Q ss_pred             -CeEEEEEeccCCCchHHHHHHh---------------------------------------------------------
Q 017768          145 -QNLHLVMELCSGGELFDRIIAK---------------------------------------------------------  166 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  166 (366)
                       +..+++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998753                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc---eecccCCC
Q 017768          167 -----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSA  238 (366)
Q Consensus       167 -----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~  238 (366)
                           ..+++.++..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||++........   .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 237788899999999999999999999999999999999   5677899999999976533221   12234567


Q ss_pred             CCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017768          239 YYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG-IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD  315 (366)
Q Consensus       239 ~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  315 (366)
                      .|+|||++. ..++.++||||||+++|+|++ |..||.+..... ....+..+.....   ...+++.+.+++.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA---PENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHccCC
Confidence            899999875 558999999999999999997 999998765433 3333333322111   2356889999999999999


Q ss_pred             cCCCCCHHHHhc
Q 017768          316 PKKRITAAEALE  327 (366)
Q Consensus       316 p~~Rpt~~~~l~  327 (366)
                      |++|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.6e-44  Score=327.62  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=212.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||++.+..++..+|+|.+....  .......+.+|+.++++++ ||||+++++.+..++..+++|
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence            5899999999999999999999999999999886432  2234566889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+|||+   ++++.++|+|||++...... .
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-c
Confidence            999999999999888889999999999999999999997 699999999999999   55677999999998765332 2


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-----------------
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-----------------  292 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  292 (366)
                      .....++..|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+.......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            234578899999998754 57889999999999999999999997655333222221110000                 


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          293 -----------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       293 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                       +......++.++.+++.+||..||++|||+.++++||||.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence                             00011136778999999999999999999999999999976433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.9e-44  Score=322.00  Aligned_cols=254  Identities=30%  Similarity=0.494  Sum_probs=211.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.+. ||||+++++.+...+..++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence            357999999999999999999999899999999986432   234456788999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +|||+++++|.+++...+.+++.+++.++.|++.+|.|||+.|++|+||||+||++   +.++.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999   566779999999987553221


Q ss_pred             -ceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCCCHH
Q 017768          230 -VYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-SPWPSISGQ  303 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  303 (366)
                       ......|+..|+|||++.    +.++.++|+|||||++|+|++|..||..................... .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             223457899999999863    34788999999999999999999999765544333333332222211 111246788


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      +.++|.+||+.||++||+++++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=321.47  Aligned_cols=258  Identities=30%  Similarity=0.500  Sum_probs=218.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+.+++.+. |+||+++++.+.++...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            35888999999999999999999999999999986542  2344567889999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-C
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-K  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~  229 (366)
                      +||+++++|.+++... .+++..++.++.|++.+|.+||+.+++|+||+|+||++   ++++.++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999998765 78999999999999999999999999999999999999   56778999999999876543 2


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.........  ...++..+.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence            233456888999999876 45899999999999999999999999776655554444443222111  112688999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .+||..||++|||++++++||||+.....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999999999886555

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-44  Score=331.03  Aligned_cols=249  Identities=28%  Similarity=0.459  Sum_probs=192.1

Q ss_pred             eceecccCceEEEEEEEc--cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeEEEEE
Q 017768           76 DKELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNLHLVM  151 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  151 (366)
                      .++||+|+||+||+|.++  .+++.+|+|.+...     .....+.+|+.+++++. ||||+++++++..  +...+++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-----CCcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            457999999999999965  36789999988543     22345778999999997 9999999998854  45689999


Q ss_pred             eccCCCchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCCCEEEeecCC
Q 017768          152 ELCSGGELFDRIIAK---------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGL  221 (366)
Q Consensus       152 e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~vkl~Dfg~  221 (366)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            99954 888877532         248999999999999999999999999999999999999643 3456899999999


Q ss_pred             cccccCCC----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 017768          222 SVFIETGK----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK---------GIFEAIL  286 (366)
Q Consensus       222 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------~~~~~~~  286 (366)
                      +.......    ......||+.|+|||++.+  .++.++|||||||++|+|++|..||......         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654322    2234578999999998753  4789999999999999999999999643221         1111111


Q ss_pred             cCCCCC----------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          287 EGNLDL----------------------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       287 ~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ......                                  ........+.++.++|.+||+.||++|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            100000                                  000001235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.1e-44  Score=319.51  Aligned_cols=255  Identities=30%  Similarity=0.480  Sum_probs=215.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||.|+||+||+|....++..+++|.+.....  ......+.+|+.+++.+. |+||+++++.+..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            368999999999999999999988899999999865432  225678899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          151 MELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||++++++|.+++...   ..+++..+..++.|++.||.+||+.||+|+||+|+||++   ++++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999999764   358999999999999999999999999999999999999   5567799999999876643


Q ss_pred             CCc-----eecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCC
Q 017768          228 GKV-----YKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS--PWP  298 (366)
Q Consensus       228 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  298 (366)
                      ...     .....|+..|+|||++..  .++.++|+||||+++|+|++|..||......+...............  .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            322     133468899999998753  58899999999999999999999998776655555554443222111  123


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .+++.+.+++.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-43  Score=316.23  Aligned_cols=252  Identities=27%  Similarity=0.531  Sum_probs=212.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-CCeEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-KQNLHLV  150 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  150 (366)
                      .|++.+.||+|++|.||++.+..+++.+|+|.+..... .......+.+|+.++++++ |+|++++++.+.. +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            38999999999999999999998899999999865332 2344567889999999997 9999999988764 4468999


Q ss_pred             EeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+++++|.+++...  ..+++.+++.++.|++.+|.+||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999998763  358999999999999999999999999999999999999   56778999999998765432


Q ss_pred             -CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       .......+++.|+|||++. ..++.++||||||+++++|++|+.||...+.......+..+.....   ...+++++.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHH
Confidence             2223456889999999875 4578899999999999999999999987776666666655543221   2357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ++.+||+.||++|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=345.12  Aligned_cols=261  Identities=29%  Similarity=0.496  Sum_probs=220.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|.|+..||.|+||.||+|.++.++-..|.|++...   .+...+++.-|+.+|..+. ||+|+++++.|..++.+|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence            355699999999999999999999998888899988654   3577889999999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-c
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-E  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~  226 (366)
                      |++|||.||-+...+.. ...|++.++..+++|+++||.|||+++|||||||..|||+   .-+|.++|+|||.+... .
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchh
Confidence            99999999999887766 4569999999999999999999999999999999999999   45677999999987543 2


Q ss_pred             CCCceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ......++.||++|||||+..      .+|+.++||||||++|+||..+.+|....+.-.++-.+..........+ ...
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~W  261 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SHW  261 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-chh
Confidence            223345678999999999763      4699999999999999999999999877766655555544433322211 234


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      +..+.|++.+||..||..||++.++|+||||+...-+
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            7889999999999999999999999999999865443

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=319.19  Aligned_cols=253  Identities=33%  Similarity=0.525  Sum_probs=212.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||.|+||.||+|.+..+|+.||+|.+.............+..|..++....+|+|++++++.+..++..|+++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999999899999999986543222233344556666666655699999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccC
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG  236 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g  236 (366)
                      ++|.+++.....+++.++..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   5667799999999876433   223468


Q ss_pred             CCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017768          237 SAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD  315 (366)
Q Consensus       237 t~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  315 (366)
                      +..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..............++.++.++|.+||+.|
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999998764 4789999999999999999999999888877777776666555444444467899999999999999


Q ss_pred             cCCCC---CHHHHhcCCCcccCC
Q 017768          316 PKKRI---TAAEALEHPWLKEDG  335 (366)
Q Consensus       316 p~~Rp---t~~~~l~hp~f~~~~  335 (366)
                      |++||   +++|+++||||+...
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCC
Confidence            99999   558999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=341.71  Aligned_cols=256  Identities=25%  Similarity=0.480  Sum_probs=225.4

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe--EEEE
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN--LHLV  150 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--~~lv  150 (366)
                      +....||+|+|-+||+|.+..+|-.||.-.++-+.+. .....+++..|+.+|+.|+ |+||+++|+.|.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence            4567899999999999999999999998766543332 2345689999999999998 9999999999988765  7899


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      .|++..|+|..|+++.+.+....++.|++||++||.|||++.  |+|||||-+||||+  +..|.|||+|+|+|......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence            999999999999999999999999999999999999999986  99999999999998  66788999999999988665


Q ss_pred             CceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      .. ....|||-|||||++...|+..+||||||++|+||.|+..||. ..+..++..++..|...-......  .+++++|
T Consensus       200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--dPevr~f  276 (632)
T KOG0584|consen  200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--DPEVREF  276 (632)
T ss_pred             cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--CHHHHHH
Confidence            53 3478999999999999999999999999999999999999995 556678888888887665554433  6799999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      |.+||.. .++|+|+.|+|.||||..++.
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhccccc
Confidence            9999999 999999999999999998744

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-45  Score=336.55  Aligned_cols=259  Identities=36%  Similarity=0.615  Sum_probs=237.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|.+.+.||+|.|+.|.++++..+|..||+|++++... +......+.+|+.+++.+. ||||++++.+.+....+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEE
Confidence            3459999999999999999999999999999999987654 2334456899999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+.+|.+++++.+.+.+.+..+..++.|++.+++|||+++|||||||++|||+   +.+.++||+|||++..+..+.
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence            99999999999999999999999999999999999999999999999999999999   667779999999999998888


Q ss_pred             ceecccCCCCCCcccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ...+.+|++.|.|||++.+.  .++++|+|++|+++|.|+.|..||.+.+-.+..+.++.+++..+.    .++-++.++
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~l  285 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDL  285 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHH
Confidence            88899999999999998753  578999999999999999999999999988888888888888776    478899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      |+++|..+|.+|++.+++++|.|.......
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999998765544

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7e-44  Score=322.51  Aligned_cols=254  Identities=32%  Similarity=0.464  Sum_probs=206.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.+. |+||+++++++..++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            3888999999999999999999899999999986432 12334567889999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          152 ELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       152 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||++ ++|.+++...   ..+++.+++.++.||+.||.|||+++|+|+||||+||++   +.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9997 5888887653   458999999999999999999999999999999999999   56778999999998755322


Q ss_pred             C-ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC---------------
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL---------------  290 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------  290 (366)
                      . ......++..|+|||++.+  .++.++||||||+++|+|++|+.||.+.........+.....               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 2233457889999998753  468899999999999999999999987654433322211100               


Q ss_pred             ----------CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 ----------DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                .........+++++.++|.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      00011123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-43  Score=315.76  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=217.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|.+.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++ |+||+++++.+...+..+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            37888999999999999999999999999999865432 2445677889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence            999999999999774  468999999999999999999999999999999999999   556779999999988664432


Q ss_pred             c-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 V-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      . .....++..|+|||++. +.++.++|+||||+++|+|++|..||...+.......+..+.......   .++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ---MYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---ccCHHHHHH
Confidence            2 23346888999999876 457899999999999999999999998887766666666654433222   578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      |.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-44  Score=322.92  Aligned_cols=254  Identities=36%  Similarity=0.548  Sum_probs=210.8

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||+|+||+||+|.+..+|+.+|+|.+.............+.+|+.+++.++ ||||+++++.+...+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999987544333344556778999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccC
Q 017768          159 LFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG  236 (366)
Q Consensus       159 L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g  236 (366)
                      |.+++....  .+++.++..++.|++.+|.|||++|++|+||+|+||++   ++++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999997765  68999999999999999999999999999999999999   5677899999999877654443444567


Q ss_pred             CCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017768          237 SAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD  315 (366)
Q Consensus       237 t~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  315 (366)
                      +..|+|||++. +.++.++|+||||+++|+|++|..||...........+..............+++.+.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            88999999875 45888999999999999999999999765442222222222222222223357899999999999999


Q ss_pred             cCCCC-----CHHHHhcCCCcccCCC
Q 017768          316 PKKRI-----TAAEALEHPWLKEDGA  336 (366)
Q Consensus       316 p~~Rp-----t~~~~l~hp~f~~~~~  336 (366)
                      |++||     ++.++++||||.+...
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCCh
Confidence            99999     8999999999987553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-44  Score=325.37  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=205.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+..... .......+.+|+.+++.++ |+||+++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            48889999999999999999999999999999865432 2233456778999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-C
Q 017768          152 ELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-K  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~  229 (366)
                      ||+++ +|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+||++   +.++.++|+|||++...... .
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            99975 78887765 4568999999999999999999999999999999999999   56678999999998765432 2


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHcCCCC--------------C
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFEAILEGNLD--------------L  292 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~-~~~~~~~~~~~~~~~~--------------~  292 (366)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|..|+.. .+..+....+......              .
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2233467889999998754  368999999999999999999888643 3333333332211000              0


Q ss_pred             ------C-----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          293 ------Q-----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       293 ------~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                            .     ....+.+++++.++|.+||..||++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                  0     01123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.9e-44  Score=318.48  Aligned_cols=253  Identities=31%  Similarity=0.500  Sum_probs=212.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc------ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD------KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +|.+.+.||+|++|.||+|.+..+++.+|+|.+........      ...+.+.+|+.+++++. |+||+++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            47788899999999999999988899999998865432211      22356888999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..+++|||+++++|.+++.....+++..+..++.|++.||.+||++|++|+||+|+||++   ++++.++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   56778999999998766


Q ss_pred             cCCC-------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          226 ETGK-------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       226 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ....       ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+.......   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CC
Confidence            4211       112245788999999876 457889999999999999999999998766554444443322211   11


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ..++..+.++|.+||+.||++||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            2468999999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.6e-44  Score=325.34  Aligned_cols=264  Identities=33%  Similarity=0.488  Sum_probs=216.3

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+......  .......+..|+.+++.++ |+||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            478889999999999999999988999999999754432  1223445778999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+ +++|.+++.... .+++..++.++.||++||.|||++||+|+||+|+|||+   +.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 889999998766 79999999999999999999999999999999999999   56778999999999876443


Q ss_pred             C-ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-----------
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-----------  294 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  294 (366)
                      . ......++..|+|||.+.+  .++.++|+||||+++|+|++|..+|.+....+....+.........           
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 2233456788999998743  4788999999999999999998888766655444444321100000           


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          295 -------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       295 -------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                                   ......+..+.++|.+||..||++|||+.+++.||||++...++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                         0112357889999999999999999999999999999998888763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.1e-44  Score=319.91  Aligned_cols=254  Identities=29%  Similarity=0.484  Sum_probs=209.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++++. |+||+++++.+..++..++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence            456999999999999999999998899999999986432   234456788999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+++++|.+++.....+++.++..++.|++.+|.|||+.+|+|+||||+||++   +.++.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence            99999999999999887889999999999999999999999999999999999999   567779999999987653222


Q ss_pred             -ceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCCCHH
Q 017768          230 -VYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-SPWPSISGQ  303 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  303 (366)
                       ......++..|+|||.+.    ..++.++|+||||+++|+|++|..||...........+......... .....++..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence             123346888999999863    34778999999999999999999999655433322222222222111 112246789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      +.++|++||+.||++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.5e-44  Score=318.10  Aligned_cols=251  Identities=34%  Similarity=0.602  Sum_probs=214.4

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||.|++|.||+|.+..+++.+|+|.+...........+.+.+|+.+++.+. |+||+++++.+.+++..++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999999889999999997654433445678999999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCC
Q 017768          159 LFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA  238 (366)
Q Consensus       159 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~  238 (366)
                      |.+++.....+++..+..++.||+.||.|||+++++|+||+|+||++   +.++.++|+|||++.............++.
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999888789999999999999999999999999999999999999   567789999999998775543334456889


Q ss_pred             CCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017768          239 YYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD  315 (366)
Q Consensus       239 ~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  315 (366)
                      .|++||.+. ..++.++|+||||+++|+|++|..||....  .......+..+......+  ...++++.++|.+||+.|
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence            999999875 458899999999999999999999998776  445555555322222222  134789999999999999


Q ss_pred             cCCCCC-----HHHHhcCCCcccCC
Q 017768          316 PKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       316 p~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      |++||+     ++|+++||||++..
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCC
Confidence            999999     99999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-43  Score=322.39  Aligned_cols=260  Identities=30%  Similarity=0.511  Sum_probs=216.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ....+|++.+.||+|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.+. |+||+++++.+..+...
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEE
Confidence            34567999999999999999999998899999999886543   234567889999999987 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhccc
Confidence            999999999999998864 458999999999999999999999999999999999999   5677899999999876533


Q ss_pred             CC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||................ .........++..+.
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  247 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR  247 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHH
Confidence            22 2233468899999998764 57899999999999999999999998776544333332221 111112235788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ++|.+||..||++|||+.++++||||.....
T Consensus       248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-43  Score=321.16  Aligned_cols=261  Identities=31%  Similarity=0.497  Sum_probs=216.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.+.||.|+||.||+|.+..++..+++|.+....   ......+.+|+.+++.+. |+||+++++.+..++..+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            4567999999999999999999999999999999986432   345667888999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++|||+++++|..++.. ...+++..+..++.||+.+|.+||+.+++|+||||+||++   +.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence            99999999999887765 3468999999999999999999999999999999999999   5577899999999865432


Q ss_pred             C-CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          228 G-KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       228 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      . .......++..|+|||++.      ..++.++|+||||+++|+|++|..||...+.......+....... ......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCccc
Confidence            2 1223446788999999873      236789999999999999999999998776555544444332211 1112356


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      +.++.++|.+||+.||++||+++++++||||......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            7899999999999999999999999999999765543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-43  Score=315.45  Aligned_cols=253  Identities=29%  Similarity=0.492  Sum_probs=216.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++ |+||+++++.+..++..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            48899999999999999999999999999999875432 2345678899999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++...  ..+++..+..++.|++.+|.+||++|++|+||+|+||+++  .++..++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999995  234468999999998765544


Q ss_pred             ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+.........   ..++..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---CCcCHHHHHHH
Confidence            4444578899999998764 5788999999999999999999999887766666555554332221   24788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCc
Q 017768          309 RKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .+||..||++|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-43  Score=337.52  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+.+|++++ |+||+++++++..++..+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEE
Confidence            3457999999999999999999999999999999532         223568999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||++. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||+++....
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccc
Confidence            9999995 5888888664 459999999999999999999999999999999999999   5667799999999976543


Q ss_pred             CC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHcCCCCC---
Q 017768          228 GK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET--------EKGIFEAILEGNLDL---  292 (366)
Q Consensus       228 ~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~~---  292 (366)
                      ..   ......||..|+|||++. ..++.++|||||||+||||++|..++....        .....+.+.......   
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            22   122356999999999876 458999999999999999999876653321        122222222211110   


Q ss_pred             ------------------------CCCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          293 ------------------------QSSPW---PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       293 ------------------------~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                              ....|   ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    00111   134568999999999999999999999999999975

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-43  Score=321.42  Aligned_cols=260  Identities=32%  Similarity=0.527  Sum_probs=218.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ..+|++.+.||.|++|.||+|.+..+|+.|++|.+....   ....+.+.+|+.+++.++ |+||+.+++.+..++..++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence            456999999999999999999999899999999886432   234567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ++||+++++|..++... .+++.++..++.|++.+|++||+.|++|+||||+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence            99999999999988654 58999999999999999999999999999999999999   567789999999987654332


Q ss_pred             -ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+..... ........++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  248 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDF  248 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHH
Confidence             223346888999999876 4588999999999999999999999987765544444433221 1122233578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      |.+||..||++|||+.+++.||||+......
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~  279 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKLAKPLS  279 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence            9999999999999999999999998766533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-44  Score=320.21  Aligned_cols=252  Identities=31%  Similarity=0.507  Sum_probs=216.3

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+.............+.+|+.++++++ ||||+++++.+..++..++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            4889999999999999999999899999999997655433455778999999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      ||+++++|.+++.....+++.++..++.||+++|.|||+++++|+||+|+||++   ++++.++|+|||++.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   56778999999998876554444


Q ss_pred             ecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ....++..|+|||.+.. .++.++|+||||+++|+|++|..||.....   ............    ...+.++..+.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----LYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc----cCcccCcHHHHHH
Confidence            45678889999998764 578999999999999999999999987763   333222222111    1223568999999


Q ss_pred             HHHhcccCcCCCCCH--HHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITA--AEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~--~~~l~hp~f  331 (366)
                      |.+||..||.+||++  .|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.1e-44  Score=321.06  Aligned_cols=253  Identities=31%  Similarity=0.482  Sum_probs=202.1

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHh--cCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL--TGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||++.+..+++.+|+|.+...............+|..+++.+  .+|++|+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999999989999999998755432222233344555444443  258999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceeccc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV  235 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  235 (366)
                      +++|.+++.....+++..+..++.|++.||.|||+++|+|+||||+|||+   ++++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   567789999999987554322 22346


Q ss_pred             CCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 017768          236 GSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT  313 (366)
Q Consensus       236 gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  313 (366)
                      |+..|+|||.+.  ..++.++||||||+++|+|++|..||........ ..+............+.++.++.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            899999999874  3478999999999999999999999975432211 1111111112222233578999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCCcccCC
Q 017768          314 KDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       314 ~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      .||++|+     |+.++++||||++..
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-44  Score=321.03  Aligned_cols=257  Identities=33%  Similarity=0.517  Sum_probs=217.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||.|+||.||++.+..++..+|+|.+...   .....+.+..|+.++++++ |+||+++++.+..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            45699999999999999999999888999999998643   2345567889999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|||+++++|.+++... ..+++.+++.++.|++.+|.|||+.+|+|+||||+||++   +.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999998764 469999999999999999999999999999999999999   56778999999998765332


Q ss_pred             C-ceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          229 K-VYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      . ......++..|+|||++.      ..++.++|+||||+++|+|++|..||...........+........ .....++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCC
Confidence            2 223346889999999863      2367899999999999999999999988776665555554432211 1123568


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .++.++|.+||+.||++||++.++++||||...
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            899999999999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-43  Score=319.69  Aligned_cols=258  Identities=29%  Similarity=0.492  Sum_probs=214.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||.|+||.||+|.+..++..+++|.+....   ......+.+|+.+++.+. |+||+++++.+..++..+++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence            44788899999999999999999899999999885432   345667888999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      +||+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+|||+   +.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999888765 4568999999999999999999999999999999999999   56677999999998654322 


Q ss_pred             CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          229 KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .......++..|+|||++.      ..++.++|+|||||++|+|++|..||...+..+....+......... ....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence            1223456889999999873      23678999999999999999999999877665555555443222111 1124688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ++.++|.+||+.||++||++.++++||||+....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            9999999999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-43  Score=322.02  Aligned_cols=264  Identities=30%  Similarity=0.510  Sum_probs=217.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +...+|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.+. |+||+++++.+..++..
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEE
Confidence            44567999999999999999999998899999999986433   234566889999999986 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.. ..+++.++..++.|++.+|.+||+.|++|+||||+|||+   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccC
Confidence            999999999999998865 458999999999999999999999999999999999999   5677899999999876543


Q ss_pred             CC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+.... .........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  246 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFR  246 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHH
Confidence            32 223346888999999876 458899999999999999999999997765433222222111 111112235678899


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      +++.+||..||++||++.++++||||+........
T Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (297)
T cd06656         247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL  281 (297)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence            99999999999999999999999999987776553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-43  Score=321.31  Aligned_cols=259  Identities=29%  Similarity=0.401  Sum_probs=213.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||++.+..+|..+|+|.+....  .......+.+|+.+++++. |+||+++++.+...+..++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEEE
Confidence            5889999999999999999999899999999886431  2334567889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          152 ELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       152 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||+++++|..++...   ..+++..+..++.||+.+|.|||+ .+|+|+||||+||++   +.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccC
Confidence            999999998888763   368999999999999999999997 599999999999999   4577899999999876533


Q ss_pred             CCceecccCCCCCCccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .. .....++..|+|||.+.+       .++.++|+||||+++|+|++|..||...........+............+.+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         156 SL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             Cc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence            22 233467889999998742       2478999999999999999999999766554443332221111112222357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      +.++.++|.+||..||++||++.+++.||||......
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            8999999999999999999999999999999887755

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.6e-44  Score=328.21  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             eeceeccc--CceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           75 LDKELGRG--QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        75 ~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      +.+.||+|  +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            45789999  789999999999999999999865432 2334556778999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          153 LCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       153 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+++|+||||||+|||+   +.++.++++||+.+....... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999998653  458999999999999999999999999999999999999   556779999998654332110 


Q ss_pred             -------ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC------
Q 017768          230 -------VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ------  293 (366)
Q Consensus       230 -------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------  293 (366)
                             ......++..|+|||++.+   .++.++|||||||++|+|++|..||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112346778999998753   478999999999999999999999976554443333322211100      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          294 ------------------------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       294 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                                          ......+++++.++|++||+.||++|||+.++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                000113567899999999999999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-43  Score=316.74  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=207.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.+....  .......+.+|+.+++++. ||||+++++.+...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence            4788899999999999999999999999999986432  2334567889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++....... .
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-A  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-c
Confidence            99999988654    347899999999999999999999999999999999999   567789999999997654322 3


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-------GIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....++..|+|||++. ..++.++|+||||+++|+|++|..||......       .....+.....  ........+++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  228 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK  228 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence            3457899999999876 45889999999999999999999999643211       11222222111  11112346789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +.++|.+||+.||++||++++++.||||+..+.
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-43  Score=323.48  Aligned_cols=264  Identities=31%  Similarity=0.435  Sum_probs=213.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~  147 (366)
                      .+.|++.+.||.|+||.||+|.+..+|+.||+|.+..... .........+|+.++++++ |+||+++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            4569999999999999999999999999999999865432 1222335668999999998 99999999998755  568


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++ +|.+++... ..+++.++..++.||+.||.|||+.|++|+||||+||++   ++++.++|+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence            999999965 888887753 568999999999999999999999999999999999999   567789999999998764


Q ss_pred             CCC-ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC------------
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD------------  291 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------  291 (366)
                      ... ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...+..+.+..+......            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            332 2223345788999998753  4789999999999999999999999888777666655432111            


Q ss_pred             -------CCCCC-------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          292 -------LQSSP-------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       292 -------~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                             .....       ...+++++.++|.+||+.||++|||+++++.||||++...+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~  301 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE  301 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence                   00000       1235788999999999999999999999999999998777644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-43  Score=320.15  Aligned_cols=241  Identities=19%  Similarity=0.229  Sum_probs=205.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----CCeEEEEEe
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----KQNLHLVME  152 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~~~~lv~e  152 (366)
                      ..||+|++|.||+|.+  +|+.||+|.+...........+.+.+|+.+|++++ ||||+++++++.+    ....+++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            4689999999999998  48999999987543322233567889999999998 9999999999876    347899999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      |+++|+|.+++.....+++.....++.|++.||.+||+ .+++||||||+|||+   ++++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            99999999999888889999999999999999999998 499999999999999   567889999999988654322  


Q ss_pred             ecccCCCCCCcccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ....++..|+|||++.   ..++.++||||||+++|+|++|..||.+.+..+....+..........  ...++++.+++
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            2346889999999875   368999999999999999999999999888777777776554433322  25789999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 017768          309 RKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+||+.||++|||+.++++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999986

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-43  Score=320.98  Aligned_cols=258  Identities=30%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe----
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN----  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~----  146 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+.+|+||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            35899999999999999999999999999999876432 2223446788899999999878999999999887665    


Q ss_pred             -EEEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          147 -LHLVMELCSGGELFDRIIAK-----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       147 -~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||+++|+||||||+||+++.  .++.++|+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence             8999999986 788887653     34799999999999999999999999999999999999952  26789999999


Q ss_pred             CcccccCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-----
Q 017768          221 LSVFIETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-----  292 (366)
Q Consensus       221 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (366)
                      ++...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+.......+.......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98754322 22233456888999998743  47899999999999999999999998766544433332211000     


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          293 -------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       293 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                                         .....+.++.++.++|.+||..||.+||++.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               0011245788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.2e-43  Score=317.94  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=211.2

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ....++|.+.+.||+|+||.||++....+++.+|+|.+...    ......+.+|+.+++++.+|+|++++++++...  
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            34567799999999999999999999999999999988542    123456788999999997799999999988653  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          145 ---QNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                         +..++||||+++++|.+++..    ...+++..++.++.|++.||++||+.+++|+||||+||++   +.++.++|+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence               368999999999999988753    3468999999999999999999999999999999999999   566779999


Q ss_pred             ecCCcccccCCC-ceecccCCCCCCccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          218 DFGLSVFIETGK-VYKEIVGSAYYVAPEVLHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       218 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      |||++....... ......++..|+|||++..      .++.++||||||+++|+|++|+.||........+..+.....
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            999987654322 2233468889999998742      257899999999999999999999987765555444443322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ... .....++..+.++|.+||..||++||++.++++||||+
T Consensus       251 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            111 11124577899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-43  Score=319.73  Aligned_cols=255  Identities=30%  Similarity=0.511  Sum_probs=211.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.+. |+||+++++++..+...++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            48899999999999999999998999999999875432 2344567889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          152 ELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      ||+ +++|.+++... ..+++.+++.++.||+.+|.|||+.|++|+||||+||++   +.++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 99999998653 458999999999999999999999999999999999999   557779999999988764432 


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC--------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--------------  292 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  292 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..+|...........+.......              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             2334568899999998753  46899999999999999999988887766554444333211000              


Q ss_pred             -----C-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          293 -----Q-------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       293 -----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                           .       ....+..+..+.++|.+||..||++|||++++|+||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                 0       011235678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.5e-43  Score=311.70  Aligned_cols=252  Identities=31%  Similarity=0.536  Sum_probs=218.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|+..+.||.|+||.||.++...+++.+++|.+..... .......+.+|+.++++++ |+||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            48899999999999999999999999999999865432 2344567889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++...  ..+++.++..++.|++.+|.+||+.|++|+||+|+||++   ++++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999999765  458999999999999999999999999999999999999   566779999999987664433


Q ss_pred             -ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||++.+ .++.++|+||||+++|+|++|..||......+....+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             2334568999999998754 5788999999999999999999999888777777777666544322   4578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      |.+||..||++||++.++|+|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-43  Score=313.33  Aligned_cols=252  Identities=29%  Similarity=0.584  Sum_probs=216.5

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.++ |+||+++++++...+..++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            48899999999999999999999999999999865432 2344567899999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+.+++|.+++....  .+++.++..++.|++.+|.+||+++++|+||+|+|||+   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999887643  47899999999999999999999999999999999999   556779999999987654332


Q ss_pred             c-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 V-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      . .....|+..|+|||++. +.++.++|+||||+++++|++|..||......+....+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS---SHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc---ccCCHHHHHH
Confidence            1 22345788999999875 45788999999999999999999999888777777777665543322   2568899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      |.+||+.+|++||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=320.78  Aligned_cols=259  Identities=33%  Similarity=0.547  Sum_probs=236.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|..+..||+|+||.|.++..+.+.+.+|||+++++....+.+.+--..|-++|.....-|.++.++..|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            45888999999999999999999999999999999988888888888888999998877788999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~  229 (366)
                      |||+.||+|.-.++.-+.+.+..+..++.+|+.||-+||++||++||||.+|||+   +..|++||+|||+++.-- .+.
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   678889999999997643 344


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ...+.+||+.|+|||++. ++|+..+|+||+||+||||+.|+.||.+.++.++.+.|......++.    .++.++.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHH
Confidence            567789999999999875 78999999999999999999999999999999999999998877776    5899999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCcccCCC
Q 017768          309 RKMLTKDPKKRIT-----AAEALEHPWLKEDGA  336 (366)
Q Consensus       309 ~~~l~~dp~~Rpt-----~~~~l~hp~f~~~~~  336 (366)
                      ..+|...|.+|..     -.++-.||||+...+
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence            9999999999974     468999999987654

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-43  Score=318.78  Aligned_cols=259  Identities=30%  Similarity=0.464  Sum_probs=209.2

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe--
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE--  142 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--  142 (366)
                      .+....++|++.+.||+|+||.||++.+..+++.+|+|.+....    .....+.+|+.+++.+.+|+||+++++++.  
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34557788999999999999999999999999999999875421    234567889999999977999999999874  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          143 ---DKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       143 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                         .++..+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEE
Confidence               44678999999999999988753    2458899999999999999999999999999999999999   5567799


Q ss_pred             EeecCCcccccCCC-ceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          216 ATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       216 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                      |+|||++....... ......|+..|+|||++.      ..++.++|||||||++|+|++|..||...............
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  244 (286)
T cd06638         165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN  244 (286)
T ss_pred             EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence            99999987654322 223346899999999874      23788999999999999999999999776544333332222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ... .......++..+.++|.+||+.||++|||+.++++|+||
T Consensus       245 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            111 111112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=319.75  Aligned_cols=264  Identities=32%  Similarity=0.433  Sum_probs=215.9

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-----CceeEece
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-----PNIVEFEG  139 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-----~~i~~~~~  139 (366)
                      ....++.+|.++..+|+|.||.|..+.+.+++..||+|+++.    .....+...-|+++|+++..+     --++.+.+
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            345578899999999999999999999999999999999853    245667778899999999533     24888999


Q ss_pred             EEeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--------
Q 017768          140 AYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--------  209 (366)
Q Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------  209 (366)
                      ||...++.+||+|.+ |.++++++..++  +++..+++.+..||++++++||+.+++|-||||+|||+.+..        
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence            999999999999999 779999998865  488999999999999999999999999999999999995321        


Q ss_pred             ---------CCCCEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          210 ---------EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       210 ---------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                               .+..|+|+|||.|+......  ...+.|..|+|||++.+ .|+.++||||+||||+|+++|...|+..++.
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     23469999999998865443  56789999999998765 7999999999999999999999999888766


Q ss_pred             HHH---HHHHc------------------CCCCCCCCCCC---------------------CCCHHHHHHHHHhcccCcC
Q 017768          280 GIF---EAILE------------------GNLDLQSSPWP---------------------SISGQAKDLIRKMLTKDPK  317 (366)
Q Consensus       280 ~~~---~~~~~------------------~~~~~~~~~~~---------------------~~~~~~~~li~~~l~~dp~  317 (366)
                      +.+   +.++.                  +.+.++.....                     ..-.++.|||++||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            633   33322                  11111111000                     0123688999999999999


Q ss_pred             CCCCHHHHhcCCCcccCC
Q 017768          318 KRITAAEALEHPWLKEDG  335 (366)
Q Consensus       318 ~Rpt~~~~l~hp~f~~~~  335 (366)
                      +|+|+.|+|.||||+...
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998764

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=313.33  Aligned_cols=254  Identities=35%  Similarity=0.546  Sum_probs=214.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.+....   ......+.+|+.+++.++ |+||+++++.+..++..++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            356999999999999999999998889999999986543   235678899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|||+.+++|.+++... ..+++.++..++.|++.+|.|||+++++|+||+|+||++   ++++.++|+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999998876 679999999999999999999999999999999999999   56778999999998765432


Q ss_pred             C-ceecccCCCCCCcccccc-c---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCCCH
Q 017768          229 K-VYKEIVGSAYYVAPEVLH-Q---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-SPWPSISG  302 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~-~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  302 (366)
                      . ......++..|+|||.+. .   .++.++|+||||+++|+|++|..||...........+......... .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 223456888999999875 3   5788999999999999999999999877655544444433222111 11224577


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      ++.+++++||+.||++|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.3e-43  Score=314.37  Aligned_cols=254  Identities=30%  Similarity=0.491  Sum_probs=207.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNL  147 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~  147 (366)
                      +|.+.+.||+|+||.||+|.+..++..|++|.+......  .......+.+|+.+++.++ |+||+++++.+..  ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            588999999999999999999989999999988643221  1234567889999999997 9999999998865  3578


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++++||+++++|.+++.....+++..++.++.|++.+|.+||+.+|+|+||+|+||++   +.++.++|+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccccc
Confidence            8999999999999999887789999999999999999999999999999999999999   5667799999999875432


Q ss_pred             C----CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          228 G----KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       228 ~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .    .......++..|+|||.+. ..++.++|+||||+++|+|++|..||....................  ....+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--LPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC--CchhcCH
Confidence            1    1122345788999999876 4588999999999999999999999987655544443332221111  1124678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      .+.+++ +||..||++||+++|+++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            888998 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.7e-43  Score=318.28  Aligned_cols=254  Identities=28%  Similarity=0.475  Sum_probs=208.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----  143 (366)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+...    ......+..|+.+++++.+|+||+++++++..     
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            345699999999999999999999999999999988543    23456788999999999779999999998853     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       .+..+++|||+.+++|.+++...  ..+++..+..++.||+.||.|||+.+|+|+||+|+||++   ++++.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence             46789999999999999988763  348899999999999999999999999999999999999   567779999999


Q ss_pred             CcccccCC-CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC
Q 017768          221 LSVFIETG-KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       221 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  293 (366)
                      ++...... .......|+..|+|||++.      ..++.++|+||||+++|+|++|..||...........+....  ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~  244 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP  244 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC
Confidence            98765322 1223456889999999864      347789999999999999999999997665443333222221  11


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ......++.++.++|.+||+.||.+|||+.++|+||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11223578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4e-43  Score=314.29  Aligned_cols=254  Identities=27%  Similarity=0.441  Sum_probs=209.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc---ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV---YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .|++.+.||+|+||.||+|... +|+.+|+|.+......   .......+.+|+.+++++. |+||+++++++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            3788899999999999999864 7899999988643211   1223456889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-  227 (366)
                      +++||+++++|.+++.....+++..+..++.|++.+|++||+.+|+|+||+|+||++   +.++.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887789999999999999999999999999999999999999   5677899999999875421 


Q ss_pred             ------CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          228 ------GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       228 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                            ........++..|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+....... ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCC
Confidence                  111223468889999998764 57899999999999999999999998765544333333221111 1122357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.++.++|.+||+.||++||++.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.4e-43  Score=312.98  Aligned_cols=255  Identities=28%  Similarity=0.489  Sum_probs=213.5

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||+|.+..+++.+++|.+...... ......+.+|+.+++.++ |+||+++++.....+..++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            488999999999999999999888999999998755422 346778999999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc-
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-  230 (366)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++   ++++.++|+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887778999999999999999999999999999999999999   5577899999999877643322 


Q ss_pred             ----eecccCCCCCCccccccc-c---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          231 ----YKEIVGSAYYVAPEVLHQ-R---YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       231 ----~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                          .....++..|+|||++.. .   .+.++||||||+++|++++|..||.....................+.+..++.
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence                123467889999998763 3   68899999999999999999999976543322222222222222333345688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .+.++|.+||+.||++|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=335.00  Aligned_cols=235  Identities=26%  Similarity=0.441  Sum_probs=204.1

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      ++-||.|+.|.||+|+..  ++.||||++.          +.-..+|+.|++|. |+||+.+.+++...-.++||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~----------elkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVR----------ELKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHh----------hhhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            457999999999999987  8999999763          22345788999998 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceeccc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV  235 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  235 (366)
                      .|.|.+.|+..+.++......|..+|+.|+.|||.+.|||||||.-||||+.   +..|||+|||.++.+........++
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999964   4459999999998887666666789


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||..|||||++. ...+.|+|||||||||||||||..||.+-+...++--+-...+.++-  ...+++-+.-||+.||+.
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHHHHhc
Confidence            999999999987 56899999999999999999999999776655444433333332222  235788899999999999


Q ss_pred             CcCCCCCHHHHhcC
Q 017768          315 DPKKRITAAEALEH  328 (366)
Q Consensus       315 dp~~Rpt~~~~l~h  328 (366)
                      .|..||++.++|.|
T Consensus       351 KpRNRPSFrqil~H  364 (904)
T KOG4721|consen  351 KPRNRPSFRQILLH  364 (904)
T ss_pred             CCCCCccHHHHHHH
Confidence            99999999999999

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-43  Score=315.15  Aligned_cols=256  Identities=26%  Similarity=0.447  Sum_probs=211.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-------ccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-------KDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+........       ...+.+..|+.+++.+. |+||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            48889999999999999999988999999998854221111       12346788999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +..++||||+++++|.+++.....+++..+..++.||+.+|.+||+++++|+||+|+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   5677899999999876


Q ss_pred             ccCCC---ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--CCCCCCC
Q 017768          225 IETGK---VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQSSP  296 (366)
Q Consensus       225 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~  296 (366)
                      .....   ......++..|+|||.+..   .++.++|+||||+++|++++|..||...........+....  .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            53221   1223467889999998753   37889999999999999999999997655544333332222  2222233


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .+.++.++.++|.+||..||++|||++++|+||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.1e-43  Score=320.54  Aligned_cols=259  Identities=28%  Similarity=0.481  Sum_probs=213.8

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +....|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++ ||||+++++++..++..
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~   90 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence            34456999999999999999999998899999999986543333344567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++|+||+++ ++.+.+.. ...+++.++..++.||+.+|.|||+.+|+|+||+|+||++   ++++.++|+|||++....
T Consensus        91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecC
Confidence            999999975 67666654 4568999999999999999999999999999999999999   567789999999987654


Q ss_pred             CCCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ..   ....++..|+|||++.    +.++.++||||||+++|+|++|..||...+.......+......  .......+.
T Consensus       167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  241 (307)
T cd06607         167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSD  241 (307)
T ss_pred             CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCH
Confidence            32   2346788999999863    45788999999999999999999999877655544433322111  111124678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .+.++|.+||+.||++||++.+++.||||.....
T Consensus       242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence            9999999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-43  Score=312.68  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=211.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||+|....+++.+++|.+....     ....+.+|+.+++++. |+||+++++.+......|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence            56999999999999999999999889999999986432     2678999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +||+.+++|.+++.. ...+++..+..++.|++.+|.|||+.+++|+||+|+||++   +.++.++|+|||++.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence            999999999999876 4468999999999999999999999999999999999999   567789999999988765433


Q ss_pred             -ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||++.+ .++.++||||||+++|+|++|..||...........+..... ........++.++.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHHH
Confidence             2233457889999998764 588999999999999999999999977655444333322211 1111122467899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      |.+||+.||++|||+.++|+||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-43  Score=320.36  Aligned_cols=256  Identities=28%  Similarity=0.477  Sum_probs=209.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+.+|+.+++.+. |+||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence            358999999999999999999988899999998865332 2234556788999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-C
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-K  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~  229 (366)
                      +||+++++|..+......+++.++..++.||+.+|.|||+.+++|+||+|+||++   ++++.++|+|||++...... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            9999998888877766679999999999999999999999999999999999999   56778999999998765432 2


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------------  290 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  290 (366)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|..||......+....+.....                 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2334567889999998753  467899999999999999999999976654333222221000                 


Q ss_pred             --CCC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 --DLQ--------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 --~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                        ...        ....+.++..+.+++.+||..||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              000        01134578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3e-43  Score=317.79  Aligned_cols=252  Identities=30%  Similarity=0.518  Sum_probs=205.5

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNLHLV  150 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  150 (366)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+.....  ........+|+.++.++.+|+||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788899999999999999998999999998864321  222234557899999998899999999999987  889999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++ +|.+.+... ..+++.++..++.|++.||+|||+.+++|+||+|+||+++   . +.++|+|||++.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence            999975 888887764 4689999999999999999999999999999999999994   4 889999999998765544


Q ss_pred             ceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC----------------CC
Q 017768          230 VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN----------------LD  291 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~----------------~~  291 (366)
                      ......++..|+|||++.  +.++.++|||||||++|+|++|..||.+.+..+....+....                ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            444456889999999763  347889999999999999999999998776554433332210                00


Q ss_pred             CCCC---------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          292 LQSS---------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       292 ~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ....         ..+.++.++.++|.+||..||++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0000         013468899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-43  Score=317.20  Aligned_cols=259  Identities=26%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||++.++.+|+.||+|.+.....  ......+..|+..+.+..+|+||+++++++..++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            358899999999999999999999999999998865421  233445666777766666699999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          151 MELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      |||++ ++|.+++..    ...+++..++.++.||+.||.|||++ +++||||||+||++   +.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence            99996 578777754    23589999999999999999999997 99999999999999   56778999999999876


Q ss_pred             cCCCceecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ..........++..|+|||++.+     .++.++|+||||+++|+|++|..||.... ..+.......+.....  ....
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  232 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--PAEK  232 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--Cccc
Confidence            44333333568889999998742     36789999999999999999999996532 2222333332211111  1124


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ++.++.++|.+||..||++||++.++++||||......
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            78999999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=319.68  Aligned_cols=253  Identities=28%  Similarity=0.494  Sum_probs=217.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|.++++||+|+||.||++.++++|+.+|||.+..     +.+..++..|+.+++++. .+++|++|+.|.....+|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEee
Confidence            458999999999999999999999999999998754     467889999999999998 89999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||-.|++.+.++.. ..|++.++..+++..+.||+|||...-+|||||..|||+   +.+|+.||+|||.|..+.+..
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence            9999999999999865 469999999999999999999999999999999999999   678889999999998764332


Q ss_pred             -ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--cCCCCCCCCCCCCCCHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL--EGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  305 (366)
                       ..++..||+.|||||++.. .|..++||||||++..||..|++||.+--.-   +++.  .....+.+......+.++.
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~  260 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFN  260 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHH
Confidence             3466789999999999875 5999999999999999999999999653221   1111  1112222222234578999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ++|+.||...|++|-|+.++++|||++...
T Consensus       261 DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  261 DFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            999999999999999999999999998754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4e-43  Score=314.87  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=200.4

Q ss_pred             ccceeeecee--cccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           70 TTIYDLDKEL--GRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        70 ~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.|++.+.+  |.|+||.||++..+.++..+|+|.+......      .  .|+.....+.+|+||+++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3456666665  9999999999999999999999998653221      1  1233333344699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC-CEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS-PIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++.....+++.+++.++.||+.||.+||+.|++|+||||+||+++   .++ .++|+|||++....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecC
Confidence            99999999999999998877899999999999999999999999999999999999995   444 79999999987654


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF-EAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ...   ...++..|+|||++. ..++.++|+||||+++|+|++|..||......... ....... .......+.++..+
T Consensus       162 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        162 TPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             CCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            332   346889999999876 45889999999999999999999999755433321 1111111 22223334688999


Q ss_pred             HHHHHHhcccCcCCCCC-HHHHhcCCCccc
Q 017768          305 KDLIRKMLTKDPKKRIT-AAEALEHPWLKE  333 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt-~~~~l~hp~f~~  333 (366)
                      .++|.+||+.||.+|++ ++++|+||||+.
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999973

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-43  Score=315.54  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=209.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .|+..+.||+|++|.||++.+..+++.+|+|.+.......   ......+.+|+.++++++ |+||+++++++.+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            3788899999999999999999999999999986432111   124567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +++||+++++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.  ++..++|+|||++......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999942  2335999999998765432


Q ss_pred             C-----ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCCC
Q 017768          229 K-----VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG-NLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  301 (366)
                      .     ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+... ...........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     112346788999999876 45789999999999999999999999654433222222111 1111111223468


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      +++.+++.+||..||++|||+.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-43  Score=314.79  Aligned_cols=255  Identities=31%  Similarity=0.487  Sum_probs=210.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      ..++|++.+.||.|++|.||+|.++.+++.+++|.+....    .....+.+|+.+++++.+|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4577999999999999999999998889999999986432    245678899999999977999999999987644   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          146 ---NLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                         ..+++|||+++++|.+++...    ..+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence               589999999999999988653    468999999999999999999999999999999999999   5567799999


Q ss_pred             cCCcccccCC-CceecccCCCCCCccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC
Q 017768          219 FGLSVFIETG-KVYKEIVGSAYYVAPEVLHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       219 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      ||++...... .......++..|+|||++..      .++.++||||||++||+|++|..||...........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            9998765332 22234568889999998642      3678899999999999999999999766554444444443221


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .. .....++..+.++|.+||..||++|||+.++++|||+
T Consensus       237 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            11 1112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.3e-43  Score=320.48  Aligned_cols=262  Identities=31%  Similarity=0.547  Sum_probs=218.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++ |+||+++++.+..++..+
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence            4455666778999999999999998899999999885432   344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ++|||+++++|.+++.. ..+++.++..++.||+.+|.|||+++|+||||||+||++   ++++.++|+|||++......
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccc
Confidence            99999999999988754 458999999999999999999999999999999999999   56678999999998754322


Q ss_pred             C-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      . ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..... ........++..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHH
Confidence            2 2233568899999998764 588999999999999999999999987776655555443321 121222346889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ++.+||..||++|||++++++||||.....+..
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            999999999999999999999999998887765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-44  Score=342.41  Aligned_cols=254  Identities=32%  Similarity=0.504  Sum_probs=211.5

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEece-EE
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AY  141 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~-~~  141 (366)
                      |..+..-..++++.+.|.+|||+.||+|.+...|..||+|++-..   ++...+.+.+|+.+|+.|.+|+|||.+++ ..
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~  105 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA  105 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence            333334445688999999999999999999987799999988643   45678889999999999999999999999 33


Q ss_pred             ee------CCeEEEEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCC
Q 017768          142 ED------KQNLHLVMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEED  211 (366)
Q Consensus       142 ~~------~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~  211 (366)
                      ..      ...+.|.||||.||.|.++++.  ...|++.++++|+.|+++|+.+||.+.  |||||||-+||||   ..+
T Consensus       106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~  182 (738)
T KOG1989|consen  106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SAD  182 (738)
T ss_pred             ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCC
Confidence            21      1357899999999999999985  356999999999999999999999998  9999999999999   667


Q ss_pred             CCEEEeecCCcccccCCCce----------ecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 017768          212 SPIKATDFGLSVFIETGKVY----------KEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAET  277 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~  277 (366)
                      ++.||||||.|...-.....          -....|+.|++||+++    ..++.|+|||+|||+||-|+....||....
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            78999999998653221100          0125689999999874    358999999999999999999999997653


Q ss_pred             hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .    -+|+++.+.++..  +.++..+.+||+.||+.||++||++-+++++
T Consensus       263 ~----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  263 K----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             c----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            2    4566777766654  5789999999999999999999999999986

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-43  Score=315.45  Aligned_cols=257  Identities=28%  Similarity=0.479  Sum_probs=216.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|+..+.||.|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++++. |+||+++++.+.+++..++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence            45888899999999999999998889999999886432  1344567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||+++++|.+++.. ..+++.++..++.|++.+|.+||+.+++|+||+|+||++   +.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence            999999999998864 568999999999999999999999999999999999999   5667799999999876543321


Q ss_pred             -eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          231 -YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       231 -~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                       .....++..|+|||++. ..++.++|+||||+++|+|++|..||...........+......   .....++..+.+++
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li  233 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFKEFI  233 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHHHHH
Confidence             22345788899999875 45889999999999999999999999877665555444332221   11224678899999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .+||+.||++||++.++++||||......
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            99999999999999999999999877665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.4e-43  Score=315.51  Aligned_cols=253  Identities=30%  Similarity=0.447  Sum_probs=211.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||.|++|.||++.++.+++.+|+|.+.....  ......+.+|+.+++.+. |+||+++++.+..++..++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence            57888999999999999999999999999999865432  245567889999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++... ..+++..+..++.|++.+|.+||+ .+++|+||||+||++   ++++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHH
Confidence            999999999999876 678999999999999999999999 999999999999999   567789999999987654322


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET-----EKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .. ...++..|+|||.+. ..++.++|+||||+++|+|++|..||....     ..+....+..........  ..++.+
T Consensus       156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  232 (265)
T cd06605         156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS--GKFSPD  232 (265)
T ss_pred             hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh--hhcCHH
Confidence            21 256888999999875 458899999999999999999999996542     223333333322111111  126889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      +.++|.+||+.||++|||+.+++.||||+.
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-43  Score=310.11  Aligned_cols=254  Identities=31%  Similarity=0.470  Sum_probs=213.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +|+..+.||+|+||.||+|.+..++..|++|.+......  .......+.+|+.+++.+. |+||+++++++..+...++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            477788999999999999999888999999998653321  1234567889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ++||+++++|.+++.....+++..+..++.||+.+|.+||+.||+|+||+|+||++   +.++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999887779999999999999999999999999999999999999   567789999999987765444


Q ss_pred             ceecccCCCCCCcccccc-cc-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......++..|++||.+. .. ++.++|+||||+++|+|++|..||......+....+.....  .....+.+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence            344556889999999865 34 78999999999999999999999977664444444333111  111223578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.+||+.||++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-42  Score=310.71  Aligned_cols=255  Identities=29%  Similarity=0.507  Sum_probs=208.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccc--cccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--Ce
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL--VYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~  146 (366)
                      ..|++.+.||+|+||.||+|.+..+|..||+|.+.....  ........+.+|+.+++++. |+||+++++.+.+.  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            358999999999999999999999999999998754321  11234567889999999997 99999999988763  46


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+++|||+++++|.+++.....+++..+..++.|++.+|.+||+.+|+|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            88999999999999999887778999999999999999999999999999999999999   567789999999987543


Q ss_pred             CC----CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          227 TG----KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ..    .......++..|+|||++. ..++.++||||||+++|+|++|..||..................  ....+.++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhC
Confidence            21    1122346888999999875 45889999999999999999999999876555444443322211  11123567


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ..+.++|.+||. +|++||+++++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-42  Score=310.54  Aligned_cols=252  Identities=32%  Similarity=0.560  Sum_probs=214.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~l  149 (366)
                      +|++.+.||.|+||.||++.+..+|..+|+|.+..... .....+.+.+|+.+++.++ |+||+++++.+..  +...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            48888999999999999999999999999998865432 2345667889999999998 9999999997754  456899


Q ss_pred             EEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-----HcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          150 VMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACH-----FMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      +|||+++++|.+++..    ...+++.+++.++.||+.||.+||     +.+++|+||+|+||++   ++++.++|+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            9999999999999876    356899999999999999999999     8999999999999999   557789999999


Q ss_pred             CcccccCCCc-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          221 LSVFIETGKV-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       221 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ++........ .....++..|+|||++. ..++.++|+||||+++|+|++|..||...+.....+.+..+......   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP---Y  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc---c
Confidence            9987755443 33456899999999876 45788999999999999999999999888777666666665443222   2


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .++..+.+++.+||..+|++|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            568899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.8e-43  Score=316.44  Aligned_cols=254  Identities=30%  Similarity=0.450  Sum_probs=206.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.++++++ |+||+++++++.+++..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            38889999999999999999998999999998864331 2233457889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+. ++|.+++...  ..+++..+..++.|++.||+|||+.+++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence            9996 5888888663  458999999999999999999999999999999999999   567789999999987654322


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC-------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-------------  293 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  293 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..||...+.......+........             
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             2233456888999998753  358899999999999999999999977665443333222110000             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          294 ------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       294 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                  ....+.++.++.++|.+||+.||++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        01123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-43  Score=330.05  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=202.3

Q ss_pred             ccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++.+.+||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            44699999999999999999974     3456789999986432  2334567889999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC---------------------------------------------------------
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG---------------------------------------------------------  167 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  167 (366)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886532                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          168 ------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       168 ------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                                        .+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence                              36788899999999999999999999999999999999   456779999999997654332


Q ss_pred             ce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          230 VY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       230 ~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..   ....++..|+|||++. ..++.++||||||+++|+|++ |..||.....................  ....+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHH
Confidence            11   1223456799999875 468999999999999999998 89999776544333333332222111  12357899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .++|.+||+.||++||++.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=324.43  Aligned_cols=265  Identities=33%  Similarity=0.467  Sum_probs=210.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      ++++|++.+.||+|+||.||+|.+..+|+.||+|.+...  ........+.+|+.++++++ |+||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            567899999999999999999999999999999988532  12334566788999999998 99999999887644    


Q ss_pred             -CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 -QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                       ...++++||+.+ +|.+.+. ...+++..++.++.|++.||.+||+.||+||||||+|||+   +.++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence             358999999965 8877764 3468999999999999999999999999999999999999   567789999999987


Q ss_pred             cccCCCc----eecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-------
Q 017768          224 FIETGKV----YKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-------  290 (366)
Q Consensus       224 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  290 (366)
                      .......    .....|+..|+|||.+.  ..++.++||||||+++|+|++|+.||.+.+.......+.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6533221    12346889999999764  3588999999999999999999999976654332222211000       


Q ss_pred             ---------------CC-C----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCC
Q 017768          291 ---------------DL-Q----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP  341 (366)
Q Consensus       291 ---------------~~-~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~  341 (366)
                                     .. .    ....+.+++++.++|.+||+.||++|||+.++++||||+........+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence                           00 0    001234678899999999999999999999999999998866554433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.9e-43  Score=318.47  Aligned_cols=255  Identities=31%  Similarity=0.451  Sum_probs=208.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~  148 (366)
                      +.|++.+.||.|+||.||+|.+..+++.+++|.+...... ......+.+|+.+++++. ||||+.+++++...  +..|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            4689999999999999999999989999999998754322 233445678999999998 99999999998877  8899


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++|||+++ +|.+++.... .+++.+++.++.||+.||.|||+++++|+||||+|||+   +.++.++|+|||++.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            99999975 8988887644 48999999999999999999999999999999999999   5667899999999887654


Q ss_pred             C-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC-------------
Q 017768          228 G-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD-------------  291 (366)
Q Consensus       228 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------  291 (366)
                      . .......++..|+|||.+.+  .++.++|+||||+++|+|++|..||...........+......             
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 22334567889999998753  3688999999999999999999999877655544443221100             


Q ss_pred             -------------CCCCCCCC--CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          292 -------------LQSSPWPS--ISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       292 -------------~~~~~~~~--~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                   ......+.  +++.+.++|.+||+.||++|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         00011122  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.9e-43  Score=325.43  Aligned_cols=268  Identities=32%  Similarity=0.452  Sum_probs=215.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      +.++|.+.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+++.+. |+||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            4567999999999999999999999999999999886432 22334556788999999997 99999999987654    


Q ss_pred             -CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 -QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                       ...++++||+. ++|.+++.....+++..+..++.|++.||.|||+++++|+||||+|||+   +.++.++|+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             35899999995 6899998887889999999999999999999999999999999999999   566789999999998


Q ss_pred             cccCC-CceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-----------
Q 017768          224 FIETG-KVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN-----------  289 (366)
Q Consensus       224 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-----------  289 (366)
                      ..... .......++..|+|||.+.  ..++.++||||||+++|+|++|..||.+.+.......+....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            66443 2223446788999999865  358899999999999999999999997665433222221100           


Q ss_pred             ------------CCC----CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          290 ------------LDL----QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       290 ------------~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                  ...    .....+.+++++.++|.+||+.||++|||++++++||||.........+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~  305 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV  305 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc
Confidence                        000    01112467889999999999999999999999999999988666554433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.4e-43  Score=321.20  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=190.7

Q ss_pred             eceecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeEEEEE
Q 017768           76 DKELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNLHLVM  151 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  151 (366)
                      ..+||+|+||.||+|..+.  ++..+|+|.+...     .....+.+|+.+++.+. ||||+++++++..  +...+++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            3579999999999999653  5678999988543     22345788999999998 9999999998853  56789999


Q ss_pred             eccCCCchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCCCEEEeecCC
Q 017768          152 ELCSGGELFDRIIAK---------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGL  221 (366)
Q Consensus       152 e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~vkl~Dfg~  221 (366)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.+|+||||||+|||+... +.++.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99965 787777532         247889999999999999999999999999999999999543 3456899999999


Q ss_pred             cccccCCC----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 017768          222 SVFIETGK----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK---------GIFEAIL  286 (366)
Q Consensus       222 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------~~~~~~~  286 (366)
                      +.......    ......+|..|+|||++.+  .++.++||||||+++|+|++|..||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654322    1234568999999998753  4789999999999999999999999643221         1111111


Q ss_pred             cCCCCC----------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          287 EGNLDL----------------------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       287 ~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ......                                  ........+..+.++|.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000                                  000011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-43  Score=329.66  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=203.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccC-----CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKAT-----GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+.+|+||+++++++...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            45699999999999999999986443     3579999986542  2234567889999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----------------------------------------------------------
Q 017768          145 QNLHLVMELCSGGELFDRIIAK----------------------------------------------------------  166 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  166 (366)
                      +..++||||+++++|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988642                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce---
Q 017768          167 ------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---  231 (366)
Q Consensus       167 ------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---  231 (366)
                                  ..+++.+++.++.||+.||.|||++||+||||||+|||+   ++++.++|+|||++.........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence                        136788899999999999999999999999999999999   56778999999999765433211   


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      ....++..|+|||++. ..++.++||||||+++|+|++ |..||......................  ..+++++.+++.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHH
Confidence            1223456799999875 568999999999999999997 999997765544333333332222221  235889999999


Q ss_pred             HhcccCcCCCCCHHHHhcC
Q 017768          310 KMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +||+.||++|||+.++++.
T Consensus       350 ~cl~~dp~~RPs~~~l~~~  368 (374)
T cd05106         350 MCWNLEPTERPTFSQISQL  368 (374)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999999763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.9e-43  Score=312.39  Aligned_cols=248  Identities=20%  Similarity=0.307  Sum_probs=207.0

Q ss_pred             cceeeeceecccCceEEEEEEEc---cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ..|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|+..++++. ||||+++++++..++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence            45899999999999999999765   346689999886432  2234567889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++... ..+++.+++.++.||+.||+|||+++++||||||+|||+   +.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence            9999999999999999774 468999999999999999999999999999999999999   567789999999876543


Q ss_pred             CCCcee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKVYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ......  ...++..|+|||.+. +.++.++||||||+++|++++ |..||+.....+....+..+....   ....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCH
Confidence            222111  223457899999875 568999999999999999875 999999988887777776553322   2235788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-42  Score=313.40  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=201.9

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHh--cCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL--TGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||++.+..+++.||+|.+................|..+++.+  .+|++|+.+++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999889999999998765433222223344454444433  248999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceeccc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV  235 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  235 (366)
                      |++|..++.....+++..++.++.|++.||.|||+.+|+|+||||+||++   +.++.++|+|||++....... .....
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCcC
Confidence            99999999887889999999999999999999999999999999999999   567789999999987553322 23447


Q ss_pred             CCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          236 GSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       236 gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      |+..|+|||++. + .++.++||||+|+++|+|++|..||....   ..............    ....++.++.+++.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHHH
Confidence            899999999875 3 47899999999999999999999997663   22222222222222    122468999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          311 MLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       311 ~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      ||..||++|+     ++.++++||||++..
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            9999999999     999999999998855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-43  Score=317.69  Aligned_cols=258  Identities=28%  Similarity=0.364  Sum_probs=206.5

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|...+.||+|+||.||++.+..+++.+|+|.+.....  ......+.+|+.++.++.+|+||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            46667889999999999999999999999999865432  2445678899999999987999999999999999999999


Q ss_pred             eccCCCchHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          152 ELCSGGELFDRII-----AKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       152 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ||+.. ++.++..     ....+++..+..++.|++.||+|||+. +|+||||||+||++   +.++.++|+|||++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHh
Confidence            99854 5544332     235689999999999999999999974 99999999999999   55677999999999766


Q ss_pred             cCCCceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCC-CCCCCCCCCC
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGN-LDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~  299 (366)
                      ..........|+..|+|||++..    .++.++||||||+++|+|++|..||..... .+....+..+. ..........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            54433344568899999998753    478999999999999999999999965542 11222222221 1122222235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ++.++.+||.+||+.||++|||++++++||||+...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            789999999999999999999999999999998733

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=316.18  Aligned_cols=255  Identities=30%  Similarity=0.483  Sum_probs=209.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.+. |+||+++++.+..++..+++|
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            6999999999999999999999899999999886432 22344577899999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      ||++++.+..+......+++.+++.++.||+.+|.|||+.+++|+||+|+||++   ++++.++|+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence            999987776666666669999999999999999999999999999999999999   567889999999988765433  


Q ss_pred             ceecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 017768          230 VYKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------------  290 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------  290 (366)
                      ......++..|+|||++. . .++.++|+||||+++|+|++|..||......+.+..+.....                 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            233456788999999875 3 578899999999999999999999976654443332211000                 


Q ss_pred             --CCCCC---------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 --DLQSS---------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 --~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                        .....         ....++.++.++|.+||..||++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              00000         011248899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-42  Score=315.96  Aligned_cols=260  Identities=29%  Similarity=0.449  Sum_probs=210.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. |+||+++++++..++..++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            469999999999999999999998999999998864432 2234467888999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||++ ++|.+++.....  +++..++.++.||+.||.|||+++++|+||+|+||+++.  .++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            99996 488888765443  578889999999999999999999999999999999952  3456999999999765332


Q ss_pred             -CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC------------
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ------------  293 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------  293 (366)
                       .......++..|+|||++.+  .++.++||||||+++|+|++|..||...+..+....+........            
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22233467889999998753  478899999999999999999999987766554444322110000            


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          294 -------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       294 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                   ....+.+++++.++|.+||+.||++||++.++++||||.+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                         001245788999999999999999999999999999998754

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=314.52  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=203.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||.|++|.||+|.++.+++.||+|.+.....  ......+.+|+.+++.++ |+||+++++++..++..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            569999999999999999999998999999999865321  222345678999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+.+ +|.+++... ..+++..++.++.|++.||.|||+.+|+|+||||+|||+   +.++.++|+|||++.......
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence            999975 898888764 458999999999999999999999999999999999999   567789999999986543211


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCCC--------------
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLD--------------  291 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~--------------  291 (366)
                       ......++..|+|||++.+  .++.++||||||+++|+|++|..||.... ..+....+......              
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1222356788999998753  47889999999999999999999997654 22322222110000              


Q ss_pred             -----CC-------CCCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          292 -----LQ-------SSPWPSIS--GQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       292 -----~~-------~~~~~~~~--~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                           ..       ....+.++  .++.+++.+||+.||++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                 00       00011233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.4e-43  Score=315.10  Aligned_cols=254  Identities=35%  Similarity=0.634  Sum_probs=218.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++++.+|+||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            35899999999999999999999899999999987644433445567889999999997799999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.....+++.+++.++.|++.+|.+||++|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999   567789999999987654322 


Q ss_pred             --------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          230 --------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       230 --------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                                          ......++..|+|||++. ..++.++|+||||++++++++|..||...........+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                112345788999999865 45788999999999999999999999877766655555544


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCc
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITA----AEALEHPWL  331 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~----~~~l~hp~f  331 (366)
                      ....+    ..+++.+.++|.+||+.||++||++    +++++||||
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            33333    2468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=313.33  Aligned_cols=258  Identities=29%  Similarity=0.546  Sum_probs=213.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .|++.+.||.|+||.||+|.+..+++.+|+|.+....  .......+.+|+.+++.+.  .|+|++++++.+..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999899999999886432  2345667889999999986  59999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +|||+++++|.+++.. ..+++..++.++.|++.+|.+||+.||+|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999999999998865 468999999999999999999999999999999999999   557789999999987664432


Q ss_pred             -ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       ......|+..|+|||.+..  .++.++|+||||+++|+|++|..||...........+....  ........++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHHHH
Confidence             2233468889999998753  36889999999999999999999997766544433322221  111111236889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ++.+||..||++||++.+++.|+||++....
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            9999999999999999999999999775543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.9e-43  Score=315.05  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=210.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCC-----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATG-----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +.|++.+.||+|+||.||+|.....+     ..+|+|.+....  .......+.+|+.++..+. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            35889999999999999999876554     679999885432  2334567889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          146 NLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ..+++|||+++++|.+++...                ..+++.++..++.|++.||.|||+++++|+||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence            999999999999999999764                347889999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA  284 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~  284 (366)
                      +++.++|+|||++.......   ......++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            67789999999987653322   122335678899999865 568999999999999999998 9999998888887777


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+.....   ...++.++.+++.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            766544322   23578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-42  Score=310.67  Aligned_cols=255  Identities=33%  Similarity=0.493  Sum_probs=217.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|++|.||+|.+..+++.|++|.+.....  ......+.+|+..+.+++ |+||+++++.+...+..+++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            58889999999999999999999999999999865432  145678899999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||+++++|.+++.....+++..++.++.|++++|.+||+ .+++|+||+|+||++   +.++.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            999999999999887889999999999999999999999 999999999999999   5677899999999887644332


Q ss_pred             e-ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCC-CCHHH
Q 017768          231 Y-KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFEAILEGNLDLQSSPWPS-ISGQA  304 (366)
Q Consensus       231 ~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  304 (366)
                      . ....++..|+|||.+. ..++.++|+||||+++|+|++|..||...   ...+....+........   ... ++..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  232 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPEF  232 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHHH
Confidence            2 2456788999999876 45788999999999999999999999766   33444444443322211   123 78899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      .++|.+||..+|++||++.++++||||+...
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-42  Score=317.10  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             ccceeeeceecccCceEEEEEEEcc----------------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA----------------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN  133 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~  133 (366)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+....  .......+.+|+.++.++. |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            3569999999999999999997532                34479999886432  2334567889999999997 999


Q ss_pred             eeEeceEEeeCCeEEEEEeccCCCchHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 017768          134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-------------------IYSEREAANICRQIVNVVHACHFMGVI  194 (366)
Q Consensus       134 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~LH~~~iv  194 (366)
                      |+++++++.+.+..+++|||+++++|.+++....                   .+++.++..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   367788999999999999999999999


Q ss_pred             EeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh--
Q 017768          195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS--  268 (366)
Q Consensus       195 H~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~--  268 (366)
                      ||||||+|||+   +.++.+||+|||++........   .....++..|+|||++. +.++.++||||||+++|+|++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   5677899999999976543321   12234577899999865 568999999999999999986  


Q ss_pred             CCCCCCCCChHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          269 GVPPFWAETEKGIFEAILE----GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       269 g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +..||......+....+..    ..........+.++..+.+++.+||..||++|||+.++.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            6678877666655544322    1111111122356889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.7e-43  Score=325.18  Aligned_cols=259  Identities=29%  Similarity=0.462  Sum_probs=207.9

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+. |+||+++++++...  
T Consensus        12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   89 (353)
T cd07850          12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCC
Confidence            346678999999999999999999999999999999885432 22344566778999999997 99999999988643  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                          ...|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||+.||+||||||+||++   +.++.++|+|||
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg  163 (353)
T cd07850          90 LEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  163 (353)
T ss_pred             ccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCc
Confidence                357999999965 888877654  8999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC----------
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN----------  289 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~----------  289 (366)
                      ++.............++..|+|||++. ..++.++||||||+++|+|++|..||...+.......+....          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            998765444334456889999999875 468999999999999999999999997765443333322100          


Q ss_pred             ------------CCCC---------C--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          290 ------------LDLQ---------S--------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       290 ------------~~~~---------~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                  ....         .        ......++.+.++|.+||+.||++|||+.|+|.||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                        0000         0        001124667899999999999999999999999998864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=334.48  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=219.3

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCC
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGG  157 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  157 (366)
                      .||+|.||+||.|++..+....|||.+..+.   .....-+..|+..-++|+ |.|||+++|.+..++.+-|.||-.+||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            6999999999999999999999999986443   345666889999999998 999999999999999999999999999


Q ss_pred             chHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCCceec
Q 017768          158 ELFDRIIAK-GIY--SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKE  233 (366)
Q Consensus       158 ~L~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~  233 (366)
                      +|.++++.+ +++  .+..+..+.+||++||.|||++.|||||||-+||||+  .-.|.+||+|||.++.+. -.....+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999999876 445  7888999999999999999999999999999999997  567889999999987664 3445667


Q ss_pred             ccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          234 IVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       234 ~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      +.||..|||||++.+   .|+.++|||||||++.||.||++||......+ .....-|.+....+...+++.+++.+|.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            889999999999863   48999999999999999999999996554332 23344455555555445789999999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          311 MLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      |+.+||.+||++.++|..||++..+.....
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~kk~r~  844 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNNKKPRP  844 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCCCCCCC
Confidence            999999999999999999999887554443

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-42  Score=311.03  Aligned_cols=251  Identities=38%  Similarity=0.621  Sum_probs=216.0

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||.|+||.||++.+..+|+.+++|.+.............+.+|+.+++++. |+||+++++.+..+...++++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999889999999987654433456678899999999998 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC---------
Q 017768          159 LFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---------  229 (366)
Q Consensus       159 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---------  229 (366)
                      |.+++.....+++..++.++.||+.+|.+||+.+++|+||+|+||++   ++++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999   567789999999987653321         


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......++..|++||... ...+.++|+||||+++|++++|..||......+....+..+...+...  ..++..+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            123346788999999865 457889999999999999999999998888877777776655443322  12489999999


Q ss_pred             HHhcccCcCCCCCH---HHHhcCCCcccCC
Q 017768          309 RKMLTKDPKKRITA---AEALEHPWLKEDG  335 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~---~~~l~hp~f~~~~  335 (366)
                      .+||+.+|++|||+   .++|+||||++.+
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            99999999999999   9999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-42  Score=314.20  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=215.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||+||++.+..+|+.+|+|++....  .......+.+|+.+++.++ |+||+++++.+...+..++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            56899999999999999999999899999999886432  2344667889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||||+||++   ++++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence            9999999999999887789999999999999999999997 689999999999999   567789999999986543221


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHcCCCCCCCCCC
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-----------GIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~  297 (366)
                       .....|+..|+|||++. ..++.++|||||||++|+|++|..||......           +....+......  ....
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS  235 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence             23346899999999865 56889999999999999999999999765432           222222222111  1111


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ..++.++.+++.+||+.||++|||+.|+++|+||.+....+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~  277 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN  277 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccccc
Confidence            236789999999999999999999999999999987665543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.1e-44  Score=341.95  Aligned_cols=246  Identities=28%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             ceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .-+..+.||+|+||+||+|+...     +...||||.++...  ..+...+|.+|++++..++ |||||+++|++..++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence            35667899999999999997543     23579999987543  2346788999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          147 LHLVMELCSGGELFDRIIAKG--------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      +++|+|||+.|||.++|....              .|+..+.+.|+.||+.||+||-++.+|||||-..|+||   +++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence            999999999999999997642              27889999999999999999999999999999999999   7888


Q ss_pred             CEEEeecCCcccccCCCceecc---cCCCCCCccccc-cccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 017768          213 PIKATDFGLSVFIETGKVYKEI---VGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE  287 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~-~~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~  287 (366)
                      .|||+|||+++.....+.+...   .-..+|||||.+ .++|+.+||||||||||||+++ |+.||.+..++++++.+.+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            8999999999987665544332   235689999965 5889999999999999999998 9999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017768          288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL  326 (366)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l  326 (366)
                      +..-....   ..|.++.+|+..||+.+|.+||++.||=
T Consensus       721 g~lL~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  721 GQLLSCPE---NCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCcccCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            98733333   5789999999999999999999999983

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.2e-44  Score=306.44  Aligned_cols=265  Identities=32%  Similarity=0.487  Sum_probs=211.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-C
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-K  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~  144 (366)
                      -..|++.+.||+|.||.||+|..+.++.    .+|+|.++.... .........+|+..++.++ |+|++.+..++.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELK-HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence            3458999999999999999996554433    689998865432 3344567889999999998 9999999999877 7


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCCCEEEee
Q 017768          145 QNLHLVMELCSGGELFDRIIAK-----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATD  218 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~vkl~D  218 (366)
                      ..+++++||.+. +|.+.++..     ..++...+..|+.||++|+.|||++-|+||||||.|||+..+ .+.|.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            789999999976 898888654     348999999999999999999999999999999999999653 2458899999


Q ss_pred             cCCcccccCCC----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 017768          219 FGLSVFIETGK----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK---------GIFE  283 (366)
Q Consensus       219 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------~~~~  283 (366)
                      ||+++.+.+.-    .....+.|.+|+|||.+.+  .|+++.|+|++|||+.||++-.+.|.+....         +.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999875432    1233567999999998754  6999999999999999999998888654222         3344


Q ss_pred             HHHcCCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017768          284 AILEGNLDLQSSPWPS---------------------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       284 ~~~~~~~~~~~~~~~~---------------------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      .|.+-...+....||+                                 -++...+|+.+||+.||-+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            4443333333333332                                 1345789999999999999999999999999


Q ss_pred             cccCCCC
Q 017768          331 LKEDGAT  337 (366)
Q Consensus       331 f~~~~~~  337 (366)
                      |.++..+
T Consensus       340 F~~d~lp  346 (438)
T KOG0666|consen  340 FTEDPLP  346 (438)
T ss_pred             cccCCCC
Confidence            9998655

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-42  Score=313.31  Aligned_cols=253  Identities=27%  Similarity=0.475  Sum_probs=207.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|++|.||+|++..+|..||+|.+.....  ......+.+|+.++++++ |+||+++++.+...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            48899999999999999999999999999999865432  234566778999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          152 ELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||+++ +|.+++....   .+++..+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99975 8888886543   58999999999999999999999999999999999999   56778999999998755332


Q ss_pred             -CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-----------
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-----------  294 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  294 (366)
                       .......++..|++||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.........           
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             12233457889999998753  4688999999999999999999999877665544443321110000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          295 --------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       295 --------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                    ...+.++..+.++|.+||+.||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=298.53  Aligned_cols=252  Identities=27%  Similarity=0.379  Sum_probs=206.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC---
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK---  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---  144 (366)
                      .-.++|++.+.||+|+|+.||+++...++..+|+|++....   .++.+...+|+...++++ |||+++++++...+   
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhcc
Confidence            34567999999999999999999999999999999997654   467888999999999998 89999998876433   


Q ss_pred             --CeEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEE
Q 017768          145 --QNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       145 --~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                        ...||+++|...|+|.+.+...    ..+++.+++.|+.+|++||++||+..  +.||||||+|||+   .+.+.++|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl  170 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVL  170 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEE
Confidence              3589999999999999988653    35999999999999999999999999  9999999999999   45778999


Q ss_pred             eecCCcccccCCC----------ceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--
Q 017768          217 TDFGLSVFIETGK----------VYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAETEKG--  280 (366)
Q Consensus       217 ~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~--  280 (366)
                      +|||.+....-.-          .......|..|+|||.++-    ..+.++|||||||+||.|+.|..||...-.++  
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            9999988753211          1122357899999998862    37899999999999999999999995332211  


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.-++.+++..++..  +.+++.+.++|+.||+.||.+||++.+++++
T Consensus       251 laLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111233444444433  3589999999999999999999999999875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-42  Score=316.64  Aligned_cols=259  Identities=29%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      ...-++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++...+ 
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   85 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKAT   85 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence            3345569999999999999999999999999999998864332 1223345678999999997 999999999876543 


Q ss_pred             -------eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          146 -------NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       146 -------~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                             ..+++|||+.+ +|.+.+.... .+++.+++.++.||+.||.|||++|++|+||||+||++   +.++.++|+
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~  161 (310)
T cd07865          86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLA  161 (310)
T ss_pred             cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEEC
Confidence                   45999999965 7888776543 68999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCC-----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          218 DFGLSVFIETGK-----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       218 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      |||++.......     ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+..-..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999987653322     1123457788999998753  368899999999999999999999977665544333222110


Q ss_pred             CCCCCC----------------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 DLQSSP----------------------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 ~~~~~~----------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ......                            ....+..+.++|.+||..||++|||++++|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000000                            00125678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-43  Score=339.13  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCc-EEEEEE--------------eecccccccccHHHHHHHHHHHHHhcCCC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGR-KYACKS--------------ISRRKLVYDKDMEDVRREILILQHLTGQP  132 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vavK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~~h~  132 (366)
                      .+.++|++.+.||+|+||+||+|..+.... ..+.|.              +.+...........+.+|+.+|++++ |+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CC
Confidence            456789999999999999999987643322 222221              11111111223456789999999997 99


Q ss_pred             ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee
Q 017768          133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-----IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS  207 (366)
Q Consensus       133 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~  207 (366)
                      ||+++++++...+..|++++++. ++|.+++....     .....++..++.||+.||.|||++||+||||||+|||+  
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--  300 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--  300 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence            99999999999999999999995 47777765432     23467788999999999999999999999999999999  


Q ss_pred             cCCCCCEEEeecCCcccccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHH
Q 017768          208 KEEDSPIKATDFGLSVFIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET---EKGI  281 (366)
Q Consensus       208 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~---~~~~  281 (366)
                       +.++.+||+|||++........  .....||..|+|||++. ..++.++|||||||++|||++|..++....   ....
T Consensus       301 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 -NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             -CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence             5677899999999987644322  22357999999999876 458999999999999999999876543321   1111


Q ss_pred             HHHHHcCCC----CCC------------------CC------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          282 FEAILEGNL----DLQ------------------SS------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       282 ~~~~~~~~~----~~~------------------~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      +..+.....    .++                  ..      ....++..+.++|.+||+.||.+|||+.|+|+||||..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~  459 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA  459 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence            111111000    000                  00      00124667888999999999999999999999999987


Q ss_pred             CC
Q 017768          334 DG  335 (366)
Q Consensus       334 ~~  335 (366)
                      ..
T Consensus       460 ~~  461 (501)
T PHA03210        460 EE  461 (501)
T ss_pred             CC
Confidence            54

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-42  Score=315.33  Aligned_cols=259  Identities=30%  Similarity=0.569  Sum_probs=217.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|+....||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.+. ||||+++++.+..++..++++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEE
Confidence            3555668999999999999998899999999986432   234567889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-c
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-V  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~  230 (366)
                      ||+++++|.+++.. ..+++.+++.++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||++....... .
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccccc
Confidence            99999999887654 568999999999999999999999999999999999999   567789999999987553322 2


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....++..|+|||++. ..++.++|+||||+++|+|++|..||......+....+...... .......++..+.++|.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFLE  252 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHHH
Confidence            23456889999999876 46889999999999999999999999877666655555433222 22233457889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          310 KMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      +||+.||++||+++++++||||.+...+..
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            999999999999999999999998887665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-42  Score=310.17  Aligned_cols=252  Identities=26%  Similarity=0.483  Sum_probs=207.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++ ||||+++++.+...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            46999999999999999999999899999999886543333445567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          151 MELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +||+++++|.+++..    ...+++.++..++.||+.||.|||+++++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999888753    2348999999999999999999999999999999999999   566779999999987654


Q ss_pred             CCCc-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKV-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .... .....++..|+|||.+. ..++.++|+||||+++|+|++|..||.....  ......+.....  .......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CCCChhhcCH
Confidence            3221 22346888999999875 4588899999999999999999999965532  233333333222  1111224678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+.+++.+||+.||++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-42  Score=317.46  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcE--EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRK--YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.|++.+.||+|+||.||+|.++.++..  +++|.+...  ........+.+|+.++.++.+|+||+++++++..++..|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            4589999999999999999998877765  466655421  223445678899999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          149 LVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      ++|||+++++|.+++....                .+++.+++.++.||+.||+|||++||+||||||+|||+   +.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999997542                47889999999999999999999999999999999999   5667


Q ss_pred             CEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCC
Q 017768          213 PIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      .++|+|||++.............++..|+|||++.+ .++.++||||||+++|+|++ |..||...+..+....+..+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            799999999864322111112234567999998764 57899999999999999998 9999988777666665544321


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                       .  ......++++.+++.+||+.||++||++.+++.+
T Consensus       242 -~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         242 -L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1  1122467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-42  Score=311.11  Aligned_cols=258  Identities=33%  Similarity=0.591  Sum_probs=215.3

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|...+.||+|++|.||++.+..+++.+++|.+....   ....+.+.+|+.+++.+. |+||+++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEE
Confidence            3555578999999999999998889999999875322   234556889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-c
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-V  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~  230 (366)
                      ||+++++|.+++.. ..+++.++..++.|++.+|.+||++||+||||+|+||++   +.++.++|+|||.+....... .
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcc
Confidence            99999999998877 568999999999999999999999999999999999999   567789999999886543322 2


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+....... ......++..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  250 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-LKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-CcccccCCHHHHHHHH
Confidence            233468899999998764 58899999999999999999999998776666655555442211 1122247889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          310 KMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +||+.||++|||+.++++||||+....+.
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCCCcc
Confidence            99999999999999999999999877543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.6e-43  Score=323.55  Aligned_cols=268  Identities=29%  Similarity=0.454  Sum_probs=215.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----C
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----K  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~  144 (366)
                      +.++|.+.+.||.|+||.||+|.++.+|+.||+|.+.... ........+.+|+.+++++. |+||+++++++..    .
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence            4577999999999999999999999999999999986532 22344667788999999998 9999999998753    3


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ...++||||+. ++|.+++.....+++..++.++.||+.||.|||+++|+||||||+||++   +.++.+||+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence            56899999995 5899998877779999999999999999999999999999999999999   5678899999999876


Q ss_pred             ccCCCc-----eecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc----------
Q 017768          225 IETGKV-----YKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE----------  287 (366)
Q Consensus       225 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~----------  287 (366)
                      ......     .....++..|+|||++.+  .++.++||||||+++|+|++|+.||...+....+..+..          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            533221     123468889999998743  478999999999999999999999977654332222111          


Q ss_pred             -------------CCCCCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          288 -------------GNLDLQSS----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       288 -------------~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                   ........    ..+.+++++.++|.+||+.||++|||+.+++.||||.+...+...+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence                         00000011    12457899999999999999999999999999999988777665444

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=278.62  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=222.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|+..++||+|.||+|++|++..+++.||+|.+..+. .++.......+|+-+|+.+. |.||++++++...+..+.+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            4777789999999999999999999999999987654 23445667899999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          152 ELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+. +|..++.. ++.++.+.+..++.|++.||.++|++++.|||+||.|.||   +.+|.+||+|||+++...-.- 
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence            99954 88888766 4568999999999999999999999999999999999999   678889999999998775432 


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC-------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS-------  299 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  299 (366)
                      .+...+.|.+|++|.++-+  -|+...|+||-||++.|+.. |++.|.+.+..+.+..+......+....||.       
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            4566678999999998754  38999999999999999987 8888999988888888876555544444432       


Q ss_pred             ------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          300 ------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       300 ------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                        ++..-+++++++|.-+|.+|++++++|+||||.+..
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                              345678999999999999999999999999998754

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-42  Score=306.82  Aligned_cols=248  Identities=31%  Similarity=0.552  Sum_probs=212.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|+||.||++.+..++..+|+|.+....  .....+.+.+|+.+++.+. |+||+++++.+..++..+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            4889999999999999999999999999999986432  2345667889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++...  ..+++..+..++.||+.||.+||++||+|+||||+||++   ++++.++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999988653  348999999999999999999999999999999999999   567789999999987654322


Q ss_pred             -ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+......   ..++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence             2234568889999998764 5889999999999999999999999888777777666665544322   2467899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcC
Q 017768          308 IRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      |.+||+.||++|||+.++++-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=312.60  Aligned_cols=253  Identities=30%  Similarity=0.470  Sum_probs=207.1

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++ |+|++++++++..++..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            5678899999999999999998999999999865432 2233456888999999998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          153 LCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |++ ++|.+++....  .+++..+..++.|++.+|.|||+++++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            995 58999887765  68999999999999999999999999999999999999   457789999999987653221 


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC------------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN------------------  289 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~------------------  289 (366)
                      ......++..|+|||++.+  .++.++|+||||+++|+|++|..||...+.......+....                  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2233356888999998753  46889999999999999999999997765543333222110                  


Q ss_pred             -------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          290 -------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       290 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                             ........+.++..+.++|.+||+.||++|||+++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                   001111234577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-42  Score=307.10  Aligned_cols=253  Identities=29%  Similarity=0.548  Sum_probs=213.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+..... .....+.+.+|+.+++.++ |+||+++++.+...+..++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            48889999999999999999999999999999865432 2234567889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||+++++|.+++....  .+++..+..++.|++.+|.|||+.+++|+||||+||+++.  ++..++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987643  4789999999999999999999999999999999999952  22457999999987664332


Q ss_pred             -ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......|+..|+|||++. ..++.++|+||||+++++|++|..||...+..+....+........   .+.++.++.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---SPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---CCCCCHHHHHH
Confidence             222346888999999875 4588999999999999999999999987776666665555443322   23578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      |.+||..+|++|||+.+++.||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=328.03  Aligned_cols=246  Identities=37%  Similarity=0.579  Sum_probs=214.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.+.|.+...+|.|+|+.|-.+....+++..++|++.+..       ....+|+.++....+|+||+++++.+.++.+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            35777999999999999999999999999999999997552       23456787888888999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |+|||++.|+-+.+.+.....+. .++..|+.+|+.++.|||++|||||||||+|||+.  +..++++|+|||.+.....
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence            99999999998888887766555 88889999999999999999999999999999995  4678899999999988765


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .  ..+.+-|..|.|||++.. .++.++||||||++||+||+|+.||...... +....+..+.+.      ..+|++++
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK  540 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK  540 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence            5  344467889999999874 5999999999999999999999999887766 444444444333      36899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +||+.||+.||.+|+++.+++.||||
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999999

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-42  Score=310.31  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=213.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++.+. |+||+++++.+..++..++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            45888899999999999999998889999999875432  1234567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999988864 458999999999999999999999999999999999999   566779999999987654322 


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+.......   ....++.++.+++
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHH
Confidence            122346788999999875 457889999999999999999999998766655555543332211   1235788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .+||+.||++||++.++++||||.+.
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=311.56  Aligned_cols=253  Identities=33%  Similarity=0.503  Sum_probs=209.4

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNLHLV  150 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  150 (366)
                      |++.+.||.|++|.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.+. |+|++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            678899999999999999999889999999997543 22344567889999999998 99999999999988  899999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +||+++ +|.+++... ..+++.+++.++.||+.||++||+.|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            999975 888888665 468999999999999999999999999999999999999   567789999999998765433


Q ss_pred             --ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC--------
Q 017768          230 --VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW--------  297 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  297 (366)
                        ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+...........+        
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2233456888999997643  4789999999999999999999999887766555554432111111111        


Q ss_pred             ------------------CC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          298 ------------------PS-ISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       298 ------------------~~-~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                        .. ++..+.+++.+||+.||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                              11 37889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.6e-42  Score=311.74  Aligned_cols=255  Identities=29%  Similarity=0.421  Sum_probs=201.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||+|+||.||+|.+..+|..||+|.+.....  ......+.+|+.+++.+. |+||+++++++..++..++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEE
Confidence            3579999999999999999999998999999999865431  233446778999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+. ++|.+++... ..+++.++..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCC
Confidence            999996 5777766543 457889999999999999999999999999999999999   56778999999998754322


Q ss_pred             -CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCC--------------C
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGN--------------L  290 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~--------------~  290 (366)
                       .......++..|+|||++.+  .++.++||||||+++|+|++|..||...... +.+..+....              .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             12233457889999998754  4788999999999999999999999755432 1111111000              0


Q ss_pred             CCCC------------CCC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          291 DLQS------------SPW--PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       291 ~~~~------------~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ....            ..+  -..+..+.+++.+||..||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000            000  0125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.3e-43  Score=316.22  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=212.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|+..+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. |+||+++++.+..++..++
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence            345888899999999999999998889999999886432  1234567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+++++|.+++.. ..+++..+..++.||+.||.|||+++++|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence            9999999999988764 568999999999999999999999999999999999999   566779999999987654332


Q ss_pred             -ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||++.+ .++.++|+||||+++|+|++|..||...........+......   .....++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHH
Confidence             1223457889999998764 5788999999999999999999999766554444333322211   1112467899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      |.+||..+|++||++.++++||||..-.
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999997644

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-42  Score=321.15  Aligned_cols=264  Identities=29%  Similarity=0.438  Sum_probs=213.3

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+.++|++.+.||+|+||.||++.+..+|..||+|.+.... ........+.+|+.+++++. |+||+++++++..+.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   87 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL   87 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence            4457788999999999999999999999999999999885432 22334556889999999997 999999999887654


Q ss_pred             ------eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 ------NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 ------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                            ..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+||
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~df  162 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  162 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeec
Confidence                  468999999 7788877754 568999999999999999999999999999999999999   56777999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-----
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-----  292 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (366)
                      |++......  .....++..|+|||++.+  .++.++|+||||+++|++++|..||...+.......+.......     
T Consensus       163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         163 GLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998765432  223467889999998753  47889999999999999999999998766544433332211100     


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          293 ----------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       293 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                            ....++.+++.+.++|.+||+.||++|||+.+++.||||+......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence                                  0011245788899999999999999999999999999998865543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-42  Score=312.97  Aligned_cols=257  Identities=33%  Similarity=0.580  Sum_probs=212.1

Q ss_pred             ceeeeceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .|++.+.||+|+||.||++.+.   .+|..||+|.+...... .....+.+.+|+.+++.+.+|++|+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3788999999999999999874   37899999998653321 1234567888999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++||||+|+|||+   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   5677899999999876543


Q ss_pred             CC--ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCC
Q 017768          228 GK--VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       228 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ..  ......|+..|+|||.+..   .++.++||||||+++|+|++|..||.....    ......+.......    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence            22  2223468899999998753   367899999999999999999999964322    22333332322222    12


Q ss_pred             CCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      .++..+.+++.+||..||++||     +++++++||||+..+
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            4788999999999999999997     899999999998876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.8e-42  Score=320.33  Aligned_cols=266  Identities=29%  Similarity=0.441  Sum_probs=211.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      +..+|.+.+.||.|+||.||+|.+..+|..||+|.+....   ....+.+.+|+.+++.++ |+||+++++.+...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            4678999999999999999999999999999999986543   245567889999999997 99999999776543    


Q ss_pred             ----------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCE
Q 017768          145 ----------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       145 ----------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                                ...+++|||++ ++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++  .++..+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence                      35789999997 488887754 4689999999999999999999999999999999999995  245568


Q ss_pred             EEeecCCcccccCCCc----eecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          215 KATDFGLSVFIETGKV----YKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                      +|+|||++........    .....++..|+|||.+.  ..++.++|||||||++|+|++|..||...........+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999876532211    12235788999999764  34788999999999999999999999776654444333221


Q ss_pred             CCC----------------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          289 NLD----------------------LQ----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       289 ~~~----------------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      ...                      ..    ....+.++.++.++|.+||+.||++|||+.++++||||+....+.+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~  314 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV  314 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccC
Confidence            100                      00    0012357889999999999999999999999999999987665555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.2e-42  Score=309.82  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             ccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+.|.+.+.||+|+||.||+|.+..     ++..|++|.+....  .......+.+|+.+++.+. |+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence            4569999999999999999999876     67789999875332  2233456888999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG-------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      +..+++|||+++++|.+++....       .+++..+..++.||+.+|.|||+++++|+||||+||+++.+++...+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       48899999999999999999999999999999999999765555679999


Q ss_pred             ecCCcccccCCCcee---cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCC
Q 017768          218 DFGLSVFIETGKVYK---EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      |||++..........   ....+..|+|||++. ..++.++|||||||++|+|++ |..||...+..+....+...... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL-  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            999998663322111   122346799999875 568999999999999999997 99999888777766665543221 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                        .....++..+.+++.+||+.||++||++.++++|
T Consensus       241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              1123578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.9e-42  Score=307.28  Aligned_cols=250  Identities=28%  Similarity=0.458  Sum_probs=202.1

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEecc
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC  154 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  154 (366)
                      ....||+|+||.||+|.+..++..|++|.+....   ......+.+|+.+++.++ |+||+++++++..++..++++||+
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecC
Confidence            3457999999999999998889999999886432   234567889999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-c
Q 017768          155 SGGELFDRIIAK-GIY--SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-V  230 (366)
Q Consensus       155 ~~~~L~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~  230 (366)
                      ++++|.+++... ..+  ++..+..++.||+.||.|||+.||+||||||+||+++  .+++.++|+|||++....... .
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCc
Confidence            999999999764 345  7889999999999999999999999999999999995  235679999999987653322 2


Q ss_pred             eecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      .....++..|+|||++..   .++.++|+||||+++|+|++|..||........... ..............+++++.++
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCcccCHHHHHH
Confidence            223457889999998753   378899999999999999999999965433221111 1111111111223578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.+||+.+|++|||+.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.3e-42  Score=304.09  Aligned_cols=252  Identities=31%  Similarity=0.598  Sum_probs=217.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|+||.||++.+..++..+++|.+..... .......+.+|+++++.++ |+|++++.+.+..++..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            48889999999999999999998999999999865432 2345667889999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          152 ELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       152 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||+++++|.+++...    ..+++.++..++.+++.||.+||++|++|+||+|+||++   ++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999998774    669999999999999999999999999999999999999   5567899999999877644


Q ss_pred             CC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ......+++.|+|||.+. ..++.++|+||+|+++++|++|..||......+..............   ..++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            33 233356888999999865 45889999999999999999999999887777666666554433222   25789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-41  Score=310.78  Aligned_cols=257  Identities=29%  Similarity=0.462  Sum_probs=212.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|...+.||+|+||.||+|.+..+|..+++|.+.............+.+|+.+++.++ |+|++++++++.+.+..|
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence            4455777788999999999999999899999999987544333344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++|||+.+ ++.+++.. ...+++.++..++.||+.+|.|||++|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence            99999964 77777755 4468999999999999999999999999999999999999   5667799999999865432


Q ss_pred             CCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                         .....|+..|+|||++.    +.++.++||||||+++|+|++|..||...+.......+.....  .....+.++..
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  248 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDS  248 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCHH
Confidence               23456888999999863    4578899999999999999999999987765554444433322  12222346788


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +.+++.+||+.+|++||++.+++.||||....
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=318.53  Aligned_cols=259  Identities=25%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             CCCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           62 LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        62 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      .-..+...+++|.-...||+|+||.||+|... +|..||||.+......  . ..+|.+|+.++.+++ |+|+++++|+|
T Consensus        66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~LlGyC  140 (361)
T KOG1187|consen   66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVKLLGYC  140 (361)
T ss_pred             eHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCcccEEEEE
Confidence            33445567888998899999999999999987 4689999977643321  1 456999999999999 99999999999


Q ss_pred             eeCC-eEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcC---CEEeccCCCcEEeeecCCCCCEE
Q 017768          142 EDKQ-NLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       142 ~~~~-~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                      .+.+ ..+||+||+++|+|.+++....  .++|....+|+.+++.||+|||...   |+||||||+|||+   +++...|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEE
Confidence            9998 5999999999999999998765  7999999999999999999999854   9999999999999   7888899


Q ss_pred             EeecCCcccccC-CCceecc-cCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHH----HHH
Q 017768          216 ATDFGLSVFIET-GKVYKEI-VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIF----EAI  285 (366)
Q Consensus       216 l~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~---~~~~~----~~~  285 (366)
                      |+|||+|+..+. ....... .||.+|+|||++. +..+.++|||||||||+|+++|+.+.....   .....    ..+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999977665 4433333 8999999999875 679999999999999999999998876432   11111    122


Q ss_pred             HcCCCC-CCCCCC--CCCC-----HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          286 LEGNLD-LQSSPW--PSIS-----GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       286 ~~~~~~-~~~~~~--~~~~-----~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+... ...+..  ...+     ..+..+..+|++.+|.+||++.++++.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence            222111 111111  1222     236678889999999999999998653

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.2e-42  Score=317.68  Aligned_cols=266  Identities=29%  Similarity=0.406  Sum_probs=213.8

Q ss_pred             ccccee-eeceecccCceEEEEEEEccCCcEEEEEEeecccccccc-----------cHHHHHHHHHHHHHhcCCCceeE
Q 017768           69 ITTIYD-LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK-----------DMEDVRREILILQHLTGQPNIVE  136 (366)
Q Consensus        69 ~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~h~~i~~  136 (366)
                      +.++|. +.+.||.|+||+||+|.+..+++.||+|.+.........           ....+.+|+.+++.+. |+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence            456676 457799999999999999989999999998643321100           1125778999999997 999999


Q ss_pred             eceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      +++++..++..+++|||+. ++|.+++.....+++..+..++.|++.||.+||+.||+|+||+|+||++   +.++.++|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl  160 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI  160 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence            9999999999999999996 5899999887789999999999999999999999999999999999999   56778999


Q ss_pred             eecCCcccccCC---------------CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          217 TDFGLSVFIETG---------------KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       217 ~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                      +|||++......               .......++..|+|||.+.+  .++.++|+||||+++|+|++|..||...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998765411               11122356788999998754  3688999999999999999999999887766


Q ss_pred             HHHHHHHcCCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          280 GIFEAILEGNLDLQSS------------------------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +....+..........                        ..+..+.++.++|.+||+.||++|||++++|.||||+...
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            5554443211110000                        0123578899999999999999999999999999999876


Q ss_pred             CCCC
Q 017768          336 ATSD  339 (366)
Q Consensus       336 ~~~~  339 (366)
                      ....
T Consensus       321 ~~~~  324 (335)
T PTZ00024        321 LPCD  324 (335)
T ss_pred             CCCC
Confidence            6543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.2e-42  Score=312.38  Aligned_cols=262  Identities=31%  Similarity=0.515  Sum_probs=215.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.+. ||||+++++.+...+..|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence            467999999999999999999998889999999885332   334567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |+||+++++|.+++... .+++.++..++.|++.+|.+||++|++|+||||+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence            99999999999988654 57899999999999999999999999999999999999   566789999999886553322


Q ss_pred             -ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       ......++..|+|||.+. +.++.++|+||||+++|++++|..||...+.......+.... .........++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence             223346888999999875 458899999999999999999999997665443332222211 11122223467889999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      |++||..||++||++.+++.|+||+.....+..
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~  281 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL  281 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence            999999999999999999999999887755543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.8e-42  Score=308.19  Aligned_cols=251  Identities=27%  Similarity=0.498  Sum_probs=206.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||.|+||.||++.+..++..+|+|.+.............+.+|+.+++.+. |+||+++++.+..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence            35888999999999999999998899999999886544333445567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          151 MELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |||+++++|.+++..    ...+++..++.++.||+.+|.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998864    3458999999999999999999999999999999999999   566779999999987654


Q ss_pred             CCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK--GIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ... ......++..|+|||++. ..++.++|+||||+++|+|++|..||.+....  .....+....  ........+++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence            332 223346889999999875 45788999999999999999999999765432  2223332222  12222235788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.+++.+||..||++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6e-42  Score=311.98  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.|++.+.||+|+||.||+|....++.  .+++|.+...  ........+.+|+.++.++.+||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            468999999999999999999877665  4688876521  123345678899999999977999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          149 LVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      ++|||+++++|.+++....                .+++.+++.++.||+.||+|||++||+||||||+|||+   ++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999997532                47889999999999999999999999999999999999   5677


Q ss_pred             CEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCC
Q 017768          213 PIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      .+||+|||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            79999999986432211111122345699999875 458899999999999999997 9999988887777776655432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..   ....++..+.+++.+||..||.+|||++++++.
T Consensus       237 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21   122478999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-41  Score=303.30  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||++.++ ++..+|+|.+....    .....+.+|+.++++++ ||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            35888999999999999999876 46789999875332    23467889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||++   ++++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999998754 458999999999999999999999999999999999999   567789999999987654322


Q ss_pred             cee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          230 VYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       230 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ...  ...++..|+|||++. ..++.++|+||||+++|+|++ |+.||...+..+....+..+......   ...+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence            221  223456799999876 468899999999999999999 99999888877777777665433222   23578899


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017768          306 DLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++.+||+.||++||++.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=357.56  Aligned_cols=264  Identities=27%  Similarity=0.446  Sum_probs=225.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..++-+|.....||.|.||.||-|.+..+|.-.|+|.+.-.... ....+.+.+|+.+|..+. |||+|++|++-...+.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHH
Confidence            34556788888999999999999999999999999988654433 556778999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+|.||||++|+|.+.+...+..++....-+-.|++.|+.|||++|||||||||.||++   +.+|.+|++|||.|+...
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEec
Confidence            99999999999999999998888899999999999999999999999999999999999   677889999999998775


Q ss_pred             CCC-----ceecccCCCCCCcccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          227 TGK-----VYKEIVGSAYYVAPEVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       227 ~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ...     ......||+.|||||++.+.    -..+.||||||||.+||+||+.||...+++-.+-........++.+. 
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~- 1464 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE- 1464 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch-
Confidence            432     34567899999999998642    46789999999999999999999987776644433333222222222 


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                       .++.+..++|.+||..||.+|+++.|+++|-|-+.....
T Consensus      1465 -~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1465 -RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             -hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence             389999999999999999999999999999988765543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=315.65  Aligned_cols=258  Identities=33%  Similarity=0.508  Sum_probs=202.9

Q ss_pred             ceeeeceecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNL  147 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~  147 (366)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+.............+.+|+.+++.+. ||||+++++++.+.  +..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48889999999999999999988  78999999987643223344567888999999997 99999999999988  789


Q ss_pred             EEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee-cCCCCCEEEeecCC
Q 017768          148 HLVMELCSGGELFDRIIAK-----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS-KEEDSPIKATDFGL  221 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~vkl~Dfg~  221 (366)
                      ++||||+++ +|.+++...     ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.++.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999975 676766432     25889999999999999999999999999999999999953 12277899999999


Q ss_pred             cccccCCCc----eecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHH
Q 017768          222 SVFIETGKV----YKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKG---------IFEAIL  286 (366)
Q Consensus       222 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~---------~~~~~~  286 (366)
                      +........    .....++..|+|||++.+  .++.++||||||+++|+|++|..||.+.....         .+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886543221    223467889999998653  47899999999999999999999997554321         111110


Q ss_pred             cCCC---------------------CCCCCCC------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          287 EGNL---------------------DLQSSPW------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       287 ~~~~---------------------~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ....                     .......            ...+.++.+++.+||+.||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0000                     0000001            1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-41  Score=307.60  Aligned_cols=260  Identities=29%  Similarity=0.432  Sum_probs=208.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~  148 (366)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+.....  ......+.+|+++++.+. |+||+++++++...  +..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence            358889999999999999999998999999999864422  245567899999999997 99999999988653  4789


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +||||+++++|.+++..    ...+++..+..++.||+.+|.|||+.+++|+||+|+||++   ++++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence            99999999999887653    3458999999999999999999999999999999999999   5567799999999875


Q ss_pred             ccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCCCCCCCCC-
Q 017768          225 IETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET-----EKGIFEAILEGNLDLQSSPW-  297 (366)
Q Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~-  297 (366)
                      ..... .....++..|+|||.+. ..++.++|+||||+++|+|++|..||....     ..+....+............ 
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            43322 12345788999999875 468899999999999999999999997652     22333333332111111110 


Q ss_pred             --CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          298 --PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       298 --~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                        ...++.+.++|.+||..||++|||+.|++.||||+.....
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence              1246789999999999999999999999999999665554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-42  Score=319.21  Aligned_cols=264  Identities=36%  Similarity=0.495  Sum_probs=218.5

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-----e
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-----N  146 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-----~  146 (366)
                      +|++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |+||+++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            4889999999999999999998889999999886432 22345667889999999997 999999999988775     7


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .|++|||+. ++|.+++.....+++..++.++.||+.||.+||+.||+|+||||+|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            899999997 4898988877789999999999999999999999999999999999999   556889999999998765


Q ss_pred             CCC----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC------
Q 017768          227 TGK----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS------  294 (366)
Q Consensus       227 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------  294 (366)
                      ...    ......++..|+|||++.+  .++.++|+||||+++|+|++|..||...+..+....+.........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2334567889999998753  5789999999999999999999999887766555544332111100      


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCC
Q 017768          295 ---------------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP  341 (366)
Q Consensus       295 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~  341 (366)
                                           ...+.++.++.++|.+||+.||++|||+++++.||||++...+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~  302 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP  302 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence                                 01134678999999999999999999999999999998876665433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.9e-42  Score=309.65  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=209.2

Q ss_pred             cceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +.|.+.+.||+|+||.||+|....     ++..||+|.+....  .......+.+|+.+++.+. |+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            458899999999999999998743     35789999886432  2234578899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          146 NLHLVMELCSGGELFDRIIAKG--------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      ..+++|||+++++|.+++...+              .+++.++..++.|++.+|.+||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            9999999999999999997642              37888999999999999999999999999999999999   567


Q ss_pred             CCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017768          212 SPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL  286 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~  286 (366)
                      +.++|+|||++........   .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            8899999999876432221   12234567899999875 568899999999999999998 999998888888777777


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+......   ..++..+.+++.+||+.||++||++.|+++
T Consensus       239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66544332   257899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-41  Score=310.45  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=216.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ....|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.+. |+|++++++++..++..+
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEE
Confidence            3445888899999999999999998899999999987544333445567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||+.| +|.+.+.. ...+++.++..++.|++.+|.|||+++|+|+||+|+||++   +.++.++|+|||++.....
T Consensus       102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence            99999975 77776654 4568999999999999999999999999999999999999   5677899999999875433


Q ss_pred             CCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .   ....++..|+|||++.    +.++.++|+||||+++|+|++|..||...........+........  ....+++.
T Consensus       178 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  252 (317)
T cd06635         178 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDY  252 (317)
T ss_pred             c---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHH
Confidence            2   2346888999999863    4578899999999999999999999987766655555544432221  12346788


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      +.++|.+||+.+|.+||++.++++|+|+........
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            999999999999999999999999999977665553

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-41  Score=311.97  Aligned_cols=262  Identities=26%  Similarity=0.427  Sum_probs=215.0

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ....|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++.++ |+|++++++++...+..+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            3445888889999999999999999899999999886433333344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||+. +++.+.+.. ...+++.++..++.|++.+|.|||+.+++|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence            9999996 477776654 4458999999999999999999999999999999999999   5567899999999876543


Q ss_pred             CCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .   ....++..|+|||.+.    +.++.++||||||+++|+|++|..||...+.......+..+.....  ....++..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence            2   2346788999999863    3578899999999999999999999987665544444443322211  12256889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      +.++|.+||..+|++||++.++++|||+.....+...
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~  279 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI  279 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHH
Confidence            9999999999999999999999999999987665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.6e-42  Score=341.35  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++............++.+|+.+++.+. ||||+++++++.+++..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999986543333344567899999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          151 MELCSGGELFDRIIAK-----------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      |||++|++|.+++...           ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988642           235567789999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCC-------------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          220 GLSVFIETGK-------------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       220 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                      |++.......                   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   011246899999999876 45899999999999999999999999775544


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .......... .........+++.+.+++.+||..||++|++..+.+.+
T Consensus       238 ki~~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccC-hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3322211111 11112234678999999999999999999876665543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-42  Score=320.40  Aligned_cols=267  Identities=30%  Similarity=0.478  Sum_probs=216.7

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. |+||+++++++...+.
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   88 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASS   88 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccc
Confidence            356778999999999999999999999899999999886432 12234456778999999996 9999999988876554


Q ss_pred             ------EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          147 ------LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       147 ------~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                            .++++||+ +++|.+++.. ..+++..++.++.||+.||.+||+.||+|+||||+||++   ++++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg  163 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFG  163 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccc
Confidence                  89999999 6699888865 468999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC-----
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-----  293 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----  293 (366)
                      ++......  .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+....+.+..+........     
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            99876433  234467889999998753  578899999999999999999999987766555544433211100     


Q ss_pred             ----------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          294 ----------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       294 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                            ......+++.+.++|.+||+.||++|||+.++++||||++-......+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~  312 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV  312 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc
Confidence                                  0011245889999999999999999999999999999988766655443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.6e-42  Score=307.44  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++ |+||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            56779999999999999999998642     35679999875322  2234556889999999987 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      +...+++|||+++++|.+++....          .++...+..++.|++.||.|||+.+++|+||||+||++   ++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence            999999999999999999987532          25678899999999999999999999999999999999   56778


Q ss_pred             EEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 017768          214 IKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~  288 (366)
                      ++|+|||++.........   ....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998755432221   1124567899999876 458999999999999999999 78999888777777666555


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ......   ...++.+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            432222   2468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-41  Score=299.92  Aligned_cols=251  Identities=34%  Similarity=0.591  Sum_probs=212.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|.+.+.||+|++|.||++.+..++..+++|++.....   .....+.+|+.+++.+. |++++++++.+..++..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            37888999999999999999988899999999865432   45678999999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          152 ELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||+++++|.+++... ..+++..+..++.|++.+|.+||++|++|+||+|+||++   ++++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence            999999999998876 578999999999999999999999999999999999999   5577899999999887655432


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....++..|+|||.+. ..++.++|+||||+++|+|++|..||...+................ .....++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHH
Confidence            34456888999999876 4578899999999999999999999987755444444433222111 111224789999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCC
Q 017768          310 KMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      +||+.||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-42  Score=302.35  Aligned_cols=245  Identities=42%  Similarity=0.708  Sum_probs=212.8

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||.|+||.||++.+..+++.+|+|.+.............+..|+.+++.+. |+||+++++.+..++..+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999998889999999987665444446678899999999998 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-CceecccCC
Q 017768          159 LFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGS  237 (366)
Q Consensus       159 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt  237 (366)
                      |.+++.....+++..+..++.|++.+|.+||+.+++|+||+|+||++   +.++.++|+|||++...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888789999999999999999999999999999999999999   56677999999998776443 223445678


Q ss_pred             CCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017768          238 AYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP  316 (366)
Q Consensus       238 ~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  316 (366)
                      ..|++||...+ ..+.++|+||||+++|++++|..||...........+.......+.    .++..+.+++.+||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence            89999998764 4788999999999999999999999877766666666554333322    458899999999999999


Q ss_pred             CCCCCH---HHHhcCCCc
Q 017768          317 KKRITA---AEALEHPWL  331 (366)
Q Consensus       317 ~~Rpt~---~~~l~hp~f  331 (366)
                      ++||++   +++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=307.77  Aligned_cols=254  Identities=31%  Similarity=0.463  Sum_probs=207.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCe----
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQN----  146 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~----  146 (366)
                      |++.+.||+|+||.||+|.++.+++.+|+|.+..... .......+.+|+.+++++.  +|+||+++++.+...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6788999999999999999988899999999865432 2223445667888888775  49999999999988776    


Q ss_pred             -EEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          147 -LHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       147 -~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                       .+++|||+.+ +|.+++....  .+++..++.++.|++.||.+||+.+++|+||+|+||++   +.++.++|+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             9999999975 8888887643  48999999999999999999999999999999999999   556789999999998


Q ss_pred             cccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC----------
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL----------  292 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------  292 (366)
                      ............++..|+|||++. ..++.++|+||||+++|+|++|..||......+....+.......          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            765444444456788999999875 458899999999999999999999998877666555543311100          


Q ss_pred             -------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          293 -------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       293 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                   .....+.++..+.++|.+||+.||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                         000112456788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-41  Score=309.65  Aligned_cols=263  Identities=27%  Similarity=0.379  Sum_probs=211.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .-.+.|++.+.||+|+||.||+|.+..+++.+|+|.+....  .......+..|+.++.+..+|+||+++++++..+...
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            34466899999999999999999999889999999986432  1233456677888888887899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      +++|||+.+ ++.+++.. ...+++..+..++.||+.+|.|||+ .+|+||||+|+||++   ++++.++|+|||++...
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhc
Confidence            999999854 77776655 3568999999999999999999997 699999999999999   56778999999998766


Q ss_pred             cCCCceecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ..........++..|+|||.+.+     .++.++||||||+++|+|++|..||..... .+....+........ .....
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCC
Confidence            54433344467889999998753     268899999999999999999999975332 233344433322111 11124


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ++.++.+++.+||..||++||++++++.||||+.....
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            68899999999999999999999999999999865443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-41  Score=308.34  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             ccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..+|.+.+.||+|+||.||++..     ..++..+|+|.+....   ......+.+|+.+++++. |+||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence            35689999999999999999975     2345678999875422   334567899999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG-------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      +..+++|||+++++|.+++....             .+++.++..++.||+.||+|||++|++||||||+|||+   +++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence            99999999999999999997543             38999999999999999999999999999999999999   567


Q ss_pred             CCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017768          212 SPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL  286 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~  286 (366)
                      +.++|+|||++........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+.
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            7899999999976543221   12233567899999876 458899999999999999998 999998888777777777


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+......   ..++.++.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            76543222   246789999999999999999999999966

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.2e-42  Score=322.16  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=202.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccC-----CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT-----GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      -.+.|.+++.||+|+||.||+|.+...     +..||+|.+....  .....+.+.+|+.+++++..||||+++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            456789999999999999999986433     3479999986432  234456789999999999779999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh---------------------------------------------------------
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK---------------------------------------------------------  166 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  166 (366)
                      .+..+||||||++|+|.+++...                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999888642                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee
Q 017768          167 ---------------------------------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS  207 (366)
Q Consensus       167 ---------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~  207 (366)
                                                             ..+++.++..++.||+.||.|||+.+|+|+||||+|||+  
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--  270 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--  270 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE--
Confidence                                                   136778889999999999999999999999999999999  


Q ss_pred             cCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH-
Q 017768          208 KEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI-  281 (366)
Q Consensus       208 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~-  281 (366)
                       ++++.+||+|||++........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||........ 
T Consensus       271 -~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         271 -AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             -eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence             4567799999999976543221   12234667899999875 468999999999999999997 9999977654333 


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...+..+. ...  ....++.++.+++.+||+.||++|||+.++.+
T Consensus       350 ~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSGY-RMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcCC-CCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33333332 221  12357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=300.36  Aligned_cols=252  Identities=32%  Similarity=0.534  Sum_probs=214.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||+|++|.||++.+..+++.+++|.+..... .......+.+|+++++++. |+|++++++++..++..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            48889999999999999999998899999999876532 2345678999999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc-
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-  230 (366)
                      ||+++++|.+++.....+++..++.++.|++.+|.+||++||+|+||+|+||++   +.++.++|+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   4567899999999987654332 


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....++..|+|||...+ ..+.++|||+||+++|+|++|..||..................   .....++..+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence            233467889999998753 4788999999999999999999999876654444343322221   122357899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCc
Q 017768          310 KMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.7e-41  Score=300.42  Aligned_cols=253  Identities=34%  Similarity=0.547  Sum_probs=213.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~l  149 (366)
                      +|.+.+.||+|++|.||+|.+..++..+++|.+..... .....+.+.+|+.+++++. |+||+++++.+...  +..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            37888999999999999999998999999999865432 1345678899999999998 99999999999988  89999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ++||+++++|.+++.....+++.+++.++.|++.+|.|||+.+++|+||+|+||++   ..++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   456789999999998776544


Q ss_pred             c---eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          230 V---YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       230 ~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      .   .....++..|+|||.+.. ..+.++|+||||+++|+|++|..||..... ......+....  ........++..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG--EPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC--CCcCCCcccCHHH
Confidence            2   344568889999998764 488999999999999999999999977652 22222222111  1111223458899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .++|.+||+.||++||++.+++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-41  Score=307.09  Aligned_cols=258  Identities=23%  Similarity=0.336  Sum_probs=209.2

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.+....  .......+.+|+.+++.+. |+||+++++++..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            35679999999999999999997542     34589999875332  1223446788999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      .+..+++|||+++++|.+++....          .++...+..++.||+.||.|||+++|+||||||+||++   +.++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence            999999999999999999997532          24667889999999999999999999999999999999   56778


Q ss_pred             EEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 017768          214 IKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~  288 (366)
                      ++|+|||++........   .....++..|+|||.+. +.++.++|+||||+++|+|++ |..||.+....+....+..+
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999875433221   11223467799999875 568999999999999999998 78899887777766666554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCcccCC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE------HPWLKEDG  335 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~------hp~f~~~~  335 (366)
                      ......   ...++.+.+++.+||+.||++|||+.++++      ||||.+..
T Consensus       238 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         238 GYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            332221   245789999999999999999999999988      89998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-41  Score=307.55  Aligned_cols=259  Identities=34%  Similarity=0.567  Sum_probs=218.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +..+.|++.+.||+|++|.||+|.+..++..+++|.+.....    ....+.+|+..++.+. |+||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence            355668999999999999999999998899999999864321    4667889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++++||+++++|.+++.... .+++.++..++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence            99999999999999998876 79999999999999999999999999999999999999   566779999999886553


Q ss_pred             CCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ... ......++..|++||.+. ..++.++|+||||+++|+|++|..||...........+....... ......++..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l  246 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEF  246 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHH
Confidence            322 223345788999999875 458899999999999999999999998776555444443332221 11223378899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      .++|.+||+.+|.+|||+.++++|+||++..
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            9999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.8e-42  Score=317.65  Aligned_cols=266  Identities=34%  Similarity=0.515  Sum_probs=213.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--C
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--Q  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~  145 (366)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++++.+|+||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            35678999999999999999999998889999999885432 22334456778999999995599999999988653  3


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..++||||+++ +|.+++... .+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++...
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL  157 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence            68999999974 998888765 78899999999999999999999999999999999999   67788999999998765


Q ss_pred             cCCC------ceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--------
Q 017768          226 ETGK------VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--------  289 (366)
Q Consensus       226 ~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--------  289 (366)
                      ....      ......|+..|+|||++.  ..++.++|+||||+++|+|++|+.||.+.........+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            3322      223356889999999864  347889999999999999999999997665443333221111        


Q ss_pred             -------------------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          290 -------------------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       290 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                         ........+.++.++.++|.+||+.||++|||+.++++||||++..+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~  306 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD  306 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence                               11111222446889999999999999999999999999999988766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=301.77  Aligned_cols=254  Identities=30%  Similarity=0.512  Sum_probs=209.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeeccc--ccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--Ce
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK--LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~  146 (366)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+....  .........+.+|+.++++++ |+||+++++.+.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            36999999999999999999999999999999875321  112334567889999999997 99999999998764  46


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++++||+++++|.+++.....+++..+..++.|++.||.+||+.+++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            88999999999999999887779999999999999999999999999999999999999   566779999999987653


Q ss_pred             C----CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          227 T----GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      .    ........++..|+|||++.+ .++.++|+||||+++|+|++|+.||...........+......  ......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCCcccC
Confidence            2    112233568889999998764 5789999999999999999999999877655544444332211  22234578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.+.++|.+||. +|..||++.+++.|||+
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-41  Score=314.38  Aligned_cols=266  Identities=32%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             ceeeeceecccCceEEEEEEEccC--CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----CC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----KQ  145 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~  145 (366)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+.... ........+.+|+.+++++.+|+||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488899999999999999999887  8899999885321 2223355678899999999889999999986432    24


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..++++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            5789999985 5899999877889999999999999999999999999999999999999   56778999999999765


Q ss_pred             cCCC-----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC---------
Q 017768          226 ETGK-----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN---------  289 (366)
Q Consensus       226 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~---------  289 (366)
                      ....     ......|+..|+|||++.+  .++.++||||||+++|+|++|..||...+.......+....         
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            3221     1223468899999997643  57899999999999999999999997665443333222110         


Q ss_pred             ------------------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          290 ------------------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       290 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                        .......++..+..+.+++.+||+.||++|||+.+++.||||.+-.++...+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~  306 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV  306 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccc
Confidence                              00011123456789999999999999999999999999999987666554444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-41  Score=302.67  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=208.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|.+.+.||+|+||.||+|.++.+++.+|+|.+...    ......+.+|+.+++.+. |+||+++++++..++..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence            3588999999999999999999988999999988643    234567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+++++|.+++....  .+++..+..++.|++.+|.+||+++++|+||||+||++   ++++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccc
Confidence            99999999999987643  48899999999999999999999999999999999999   56778999999998776443


Q ss_pred             Ccee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          229 KVYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       229 ~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ....  ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+..+...   .....++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHH
Confidence            2211  122356799999875 468899999999999999998 99999887777766666554221   1223578999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .++|.+||..||++|||+.++++.
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-41  Score=301.80  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=215.9

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +|++.+.||.|+||.||++.+..+++.+++|.+..... .......+.+|+.+++.++ |+||+++++.+......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            48889999999999999999998999999999865432 2345567788999999998 999999999999999999999


Q ss_pred             eccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          152 ELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       152 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++   +++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence            99999999998866    34689999999999999999999999999999999999994   567799999999987654


Q ss_pred             CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      . ......++..|++||.+. ..++.++|+||||+++|+|++|..||...+.......+.........   ..++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence            4 333456888999999875 45788999999999999999999999888877666666555443322   256889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=307.75  Aligned_cols=253  Identities=34%  Similarity=0.519  Sum_probs=207.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |.+.+.||.|++|+||+|....+++.|++|.+.....  ........+|+..++++.+|+||+++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            6788899999999999999988899999998864321  12233456799999999889999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          153 LCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |+ +++|.+.+....  .+++.++..++.|++.+|.|||+++++|+||+|+||++   ++++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 779999887765  68999999999999999999999999999999999999   5678899999999987665444


Q ss_pred             eecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC---------------
Q 017768          231 YKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ---------------  293 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  293 (366)
                      .....++..|+|||++.  ..++.++|+||||+++++|++|..||......+....+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            45567889999999874  3478999999999999999999999977655444333221100000               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          294 -----------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       294 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                 ....+..+..+.++|++||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00012336789999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-41  Score=301.45  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++++. ||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            45899999999999999999876 35579999876432    23467889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+.+++|.+++... ..+++.+++.++.||+.||.|||+.|++|+||||+||++   ++++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999998764 358999999999999999999999999999999999999   567789999999987654332


Q ss_pred             cee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          230 VYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       230 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ...  ...++..|+|||++. ..++.++||||||+++|+|++ |..||...........+..+......   ...++.+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            211  123456799999876 468899999999999999998 99999887777777777665433222   23578999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+||+.||++|||+.+++++
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3e-41  Score=302.18  Aligned_cols=251  Identities=27%  Similarity=0.514  Sum_probs=208.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++++. |++|+++++.+..++..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            46999999999999999999999899999999886544334445678899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          151 MELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |||+++++|.+++..    ...+++.+++.++.|++.+|.+||+.||+|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999998864    2348999999999999999999999999999999999999   567789999999987654


Q ss_pred             CCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||.....  ....+.+..+.....  ....++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--ChhhcCH
Confidence            322 223346888999999875 4588999999999999999999999965432  233344443332221  1225678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.7e-42  Score=316.89  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             ccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-  143 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-  143 (366)
                      .++|++.+.||+|+||.||+|....     +++.||+|++....  .......+.+|+.+++++.+|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4579999999999999999997543     45789999886432  223456778899999999769999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh---------------------------------------------------------
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK---------------------------------------------------------  166 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  166 (366)
                      +...+++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45788999999999999988642                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCC
Q 017768          167 ----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAY  239 (366)
Q Consensus       167 ----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~  239 (366)
                          ..+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.++|+|||++........   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257889999999999999999999999999999999999   4567799999999987543221   122345678


Q ss_pred             CCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 017768          240 YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF-EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP  316 (366)
Q Consensus       240 y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  316 (366)
                      |+|||++. ..++.++|||||||++|+|++ |..||.+....+.. ..+..+.....   ....++++.+++.+||+.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---PEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---CccCCHHHHHHHHHHccCCh
Confidence            99999765 568999999999999999998 99999765443333 33333222111   12467899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 017768          317 KKRITAAEALEH  328 (366)
Q Consensus       317 ~~Rpt~~~~l~h  328 (366)
                      ++||++.++++|
T Consensus       318 ~~RPs~~ell~~  329 (337)
T cd05054         318 EDRPTFSELVEI  329 (337)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-41  Score=301.70  Aligned_cols=246  Identities=22%  Similarity=0.334  Sum_probs=207.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.++||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.++ |+||+++++.+...+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEE
Confidence            456999999999999999999875 56789999875432    24567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||||+||++   +.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCC
Confidence            99999999999998764  458899999999999999999999999999999999999   5677899999999987643


Q ss_pred             CCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....  ....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+......   .....++.+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPDE  232 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence            3211  1233566799999875 458889999999999999998 99999888777776666554322   222357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+++.+||+.||++||+++++++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-41  Score=306.44  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             cceeeeceecccCceEEEEEEEc----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.|++.+.||+|+||.||+|.+.    .++..+++|.+....  .......+.+|+.+++.++ |+||+++++++..++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            35889999999999999999853    356789999886432  2334567889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          147 LHLVMELCSGGELFDRIIAK-----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      .|++|||+++++|.+++...                 ..+++.++..++.|++.||.|||+++|+|+||||+|||+   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            99999999999999998643                 237888999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA  284 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~  284 (366)
                      +++.++|+|||++.......   ......++..|+|||++. ..++.++||||||+++|+|++ |..||.+.......+.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            66779999999997653322   122334567799999875 568899999999999999998 9999988777666666


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.......   ....+++.+.+++.+||+.||++||++.+++++
T Consensus       239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66544322   123578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=301.95  Aligned_cols=243  Identities=26%  Similarity=0.400  Sum_probs=208.7

Q ss_pred             ceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +.||+|+||.||+|.+...   +..+++|.+.....  ......+.+|+..++.+. |+||+++++++..+...+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            3699999999999999866   88999999865432  224678899999999998 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          154 CSGGELFDRIIAK---------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       154 ~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +++++|.+++...         ..+++.+++.++.|++.||.+||+++++|+||||+||++   +.++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999885         679999999999999999999999999999999999999   5668899999999987


Q ss_pred             ccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          225 IETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       225 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .....   ......++..|+|||.+. ..++.++||||||+++|+|++ |..||......+..+.+..+.....   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK---PEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            65432   223345788999999876 468899999999999999999 6999988887777777766432222   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.++.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            68999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-41  Score=312.04  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcE----EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRK----YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..|++.+.||+|+||.||+|.+..++..    ||+|.+....  .......+.+|+.+++.+. |+||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            4599999999999999999998666654    8999885322  2344567889999999997 99999999988764 5


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++++||+++|+|.+++.... .++...+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence            779999999999999998753 58899999999999999999999999999999999999   56777999999999876


Q ss_pred             cCCCcee---cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGKVYK---EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .......   ...++..|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+. ....  .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCC
Confidence            4332211   123456799999875 568999999999999999998 999998776665544443332 2222  2346


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.++.+++.+||..||++||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=302.47  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=208.1

Q ss_pred             cceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ++|++.+.||+|+||.||+|.+..+   ...||+|.+....  .......+.+|+.+++.++ |+||+++++.+...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            4689999999999999999988644   4579999875432  2344567888999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +++|||+++++|.+++... ..+++.++..++.|++.||.|||+++|+|+||||+||++   ++++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998764 368999999999999999999999999999999999999   567789999999998764


Q ss_pred             CCC-cee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          227 TGK-VYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ... ...  ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+.....   ...++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence            211 111  123456799999876 468899999999999999998 9999988887777776665432222   13578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.+.+++.+||+.||++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.7e-41  Score=309.50  Aligned_cols=257  Identities=34%  Similarity=0.492  Sum_probs=207.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      ..+.|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.+..   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            45679999999999999999999998999999999865431 2234456778999999997 999999999887654   


Q ss_pred             -------eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          146 -------NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       146 -------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                             ..++++||+++ ++...+... ..+++.+++.++.||+.||.|||+.||+|+||||+||++   ++++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence                   78999999976 676766653 358999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCC--ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC
Q 017768          218 DFGLSVFIETGK--VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       218 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  293 (366)
                      |||++.......  ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||......+....+........
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987654332  1222346778999998753  468899999999999999999999987665554444333111100


Q ss_pred             C--------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          294 S--------------------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       294 ~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .                          ..+..++..+.++|.+||+.||++||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                          1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-41  Score=300.59  Aligned_cols=242  Identities=27%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|.+..+++.+|+|.+....  .......+.+|+.+++.+. |+||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36999999999999999899999999875322  2344567899999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCcee---
Q 017768          157 GELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---  232 (366)
Q Consensus       157 ~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~---  232 (366)
                      ++|.+++.... .+++.+++.++.|++.||.|||+++|+|+||||+|||+   +.++.++|+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987644 58999999999999999999999999999999999999   566779999999987644322111   


Q ss_pred             cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          233 EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       233 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ....+..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.......   ....++..+.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP---CPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CcccCCHHHHHHHHH
Confidence            112245699999875 458899999999999999998 899998777666555554432211   123568899999999


Q ss_pred             hcccCcCCCCCHHHHhc
Q 017768          311 MLTKDPKKRITAAEALE  327 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~  327 (366)
                      ||+.||++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-41  Score=310.16  Aligned_cols=270  Identities=31%  Similarity=0.489  Sum_probs=217.5

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-CC
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-KQ  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~  145 (366)
                      ..++++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+. ||||+++++++.. ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCC
Confidence            346788999999999999999999999999999999886432 22334567889999999997 9999999998865 56


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..++++||+ +++|.+++.. ..+++..+..++.||++||.+||+.+|+|+||+|+||++   ++++.++|+|||++...
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQ  158 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCcccccccc
Confidence            789999999 5688877754 457899999999999999999999999999999999999   56778999999998754


Q ss_pred             cCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC---------------
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG---------------  288 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~---------------  288 (366)
                      ...  .....++..|+|||.+.+  .++.++||||||+++|+|++|..||...........+.+.               
T Consensus       159 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         159 DPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             CCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            322  233467889999998653  5789999999999999999999999766543222211110               


Q ss_pred             ------------CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchH
Q 017768          289 ------------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA  345 (366)
Q Consensus       289 ------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~  345 (366)
                                  .........+.+++.+.++|.+||+.||++|||+++++.||||.....+...+..+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~  305 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEE  305 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchh
Confidence                        000001112356889999999999999999999999999999999888877777554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-41  Score=300.94  Aligned_cols=241  Identities=25%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             eecccCceEEEEEEE--ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTK--KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.+. |+||+++++++. ++..+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999964  4567899999886432 22334567889999999997 999999999875 456789999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce----
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY----  231 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~----  231 (366)
                      +++|.+++.....+++..+..++.|++.||.+||++||+||||||+|||+   ++++.++|+|||++.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999887789999999999999999999999999999999999999   56678999999999876433221    


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      ....++..|+|||.+. ..++.++|+||||+++|||++ |..||......+....+..+....   ....+++++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHH
Confidence            1123357899999876 457889999999999999998 999998887777777776654321   12357899999999


Q ss_pred             HhcccCcCCCCCHHHHhc
Q 017768          310 KMLTKDPKKRITAAEALE  327 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~  327 (366)
                      +||+.||++||++.+|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-41  Score=310.78  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=204.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-----
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-----  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----  144 (366)
                      .++|++.+.||.|+||.||+|.++.+++.+|+|.+..... .......+.+|+.+++.++ |+||+++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            5679999999999999999999999999999999865432 2223345678999999997 99999999887543     


Q ss_pred             ---CeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ---QNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                         ...++++||+.+ +|...+.. ...+++.++..++.||++||.|||+.||+|+||||+||++   ++++.++|+|||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence               357999999965 67666654 3469999999999999999999999999999999999999   667789999999


Q ss_pred             CcccccCCCc------------eecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017768          221 LSVFIETGKV------------YKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL  286 (366)
Q Consensus       221 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~  286 (366)
                      ++........            .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.+.....+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9876532211            122356788999998653  47889999999999999999999998777665555443


Q ss_pred             cCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          287 EGNLDLQS--------------------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       287 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ........                          ..+..+.+.+.++|.+||..||++|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            21111000                          0012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-41  Score=307.19  Aligned_cols=258  Identities=31%  Similarity=0.561  Sum_probs=214.5

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |.....||+|+||.||++....+|..||+|.+....   ......+.+|+.+++.+. |+||+++++.+..++..+++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence            444467999999999999999899999999875332   234567889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-ce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~  231 (366)
                      |+++++|.+++. ...+++..+..++.|++.+|+|||+.|++|+||+|+||++   +.++.++|+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccc
Confidence            999999988764 4468999999999999999999999999999999999999   566789999999887553322 22


Q ss_pred             ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          232 KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ....++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+..... ........++..+.+++.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHHH
Confidence            3346888999999875 4578999999999999999999999987766555554433222 2222234578899999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          311 MLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ||..||.+||++.++++||||.....++.
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence            99999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-42  Score=305.57  Aligned_cols=245  Identities=33%  Similarity=0.498  Sum_probs=200.2

Q ss_pred             eeeceecccCceEEEEEEEc----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           74 DLDKELGRGQFGVTYLCTKK----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ++.+.||.|+||.||+|.+.    ..+..|+||.+...  ......+.+.+|+..+++++ ||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence            46688999999999999988    34678999998542  22344788999999999995 9999999999998888999


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |+||+++++|.+++...  ..+++.++..++.||+.||.|||+++++|+||+++||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999987  669999999999999999999999999999999999999   4567899999999987632


Q ss_pred             CCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          228 GKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       228 ~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....   ........|+|||.+. ..++.++||||||+++||+++ |..||...+..+....+..+......   ..++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIP---DNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSB---TTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceec---cchhH
Confidence            2211   2234667899999986 458999999999999999999 78999988888878887665443322   25789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.++|..||..||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=320.33  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc---E-EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR---K-YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ++-.+.++||+|+||.||+|+.+..+.   . ||+|..............++.+|.++++.++ ||||+++||+......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCc
Confidence            334566899999999999998876433   3 8999886544445667889999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ++||||+|.||+|.++|++.+. ++..+...++.+.+.||+|||+++++||||-.+|+|+   ..+..+||+|||+++..
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence            9999999999999999999874 9999999999999999999999999999999999999   45566899999998765


Q ss_pred             cCCCcee-cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          226 ETGKVYK-EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       226 ~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....... ..--...|+|||.+. +.|+.++|||||||++||+++ |..||.+....+....+.........+.  ..+.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHH
Confidence            4211111 112456899999986 569999999999999999999 8899999999998888844433333322  5688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++..++..||..||++||++.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999999876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-41  Score=299.36  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=205.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||+|++|.||+|.+. +++.||+|.+....    .....+.+|+.++++++ |+||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            456999999999999999999975 46789999886432    23566889999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++....  .+++.++..++.|++.||.+||++||+|+||||+||++   ++++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999997654  68999999999999999999999999999999999999   5677799999999987653


Q ss_pred             CCcee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .....  ....+..|+|||++. ..++.++||||||+++|+|++ |+.||.+.+.......+...... .  ....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-P--CPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C--CCCcCCHH
Confidence            22111  112235799999875 468899999999999999999 99999887777666666544221 1  12356899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+++.+||+.||++||++.++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-41  Score=307.74  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ..++|.+.+.||+|+||.||++.+..       ++..+|+|.+....  .......+.+|+.+++.+.+|+||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            35679999999999999999998643       23579999886432  2344567888999999997799999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ...+..+++|||+.+++|.+++....                .+++.++..++.|++.||+|||++|++||||||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                37889999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.++|+|||++........   .....++..|+|||++. ..++.++|+||||+++|+|++ |..||......+
T Consensus       174 ---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         174 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             ---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence               5667899999999876543221   11123456799999875 458899999999999999998 889998877766


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....+.......   .....+.++.+++.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            666665543221   123568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.7e-41  Score=336.61  Aligned_cols=149  Identities=32%  Similarity=0.487  Sum_probs=135.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|.+.+.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.+. |+||+++++.+...+..|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999997654444445677889999999987 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||.++|+||||||+|||+   +.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999887889999999999999999999999999999999999999   566789999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=301.93  Aligned_cols=242  Identities=27%  Similarity=0.346  Sum_probs=197.6

Q ss_pred             eecccCceEEEEEEEccCCc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKKATGR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||+|.+..++.  .+++|.+...  ........+.+|+.++.++.+||||+++++++...+..+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999999987776  4577776432  1234456788999999999779999999999999999999999999


Q ss_pred             CCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          156 GGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       156 ~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      +++|.+++....                .+++.+++.++.|++.||+|||++|++|+||||+||++   ++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCC
Confidence            999999987543                37889999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      |++..............+..|+|||++. ..++.++||||||+++|+|++ |..||...+..+....+..+....   ..
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~  233 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE---KP  233 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC---CC
Confidence            9986432211111122356799999875 458899999999999999997 999998877777666665542211   12


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..++.++.+++.+||..||.+|||+.+++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.1e-41  Score=306.08  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=207.4

Q ss_pred             cceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..|++.+.||+|+||.||+|.+..     .+..||+|.+....  .......+.+|+.++..+. |+||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence            358889999999999999998754     35789999986432  1233567889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          146 NLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||+   .
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence            999999999999999998642                247888999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA  284 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~  284 (366)
                      +++.+||+|||++........   .....+++.|+|||++. +.++.++||||||+++|||++ |..||.+....+..+.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            667799999999876543221   12334567899999864 568899999999999999998 8899988888888887


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+......   ..++.++.+++.+||+.||++||++.+++..
T Consensus       239 i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            7776543322   3578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-41  Score=313.96  Aligned_cols=256  Identities=20%  Similarity=0.291  Sum_probs=201.5

Q ss_pred             ceeccc--CceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEecc
Q 017768           77 KELGRG--QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC  154 (366)
Q Consensus        77 ~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  154 (366)
                      ..||+|  +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++ |+||+++++++..++..++++||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            456766  999999999999999999999865432 2344577889999988887 999999999999999999999999


Q ss_pred             CCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc--
Q 017768          155 SGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV--  230 (366)
Q Consensus       155 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~--  230 (366)
                      .+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++++||+.+........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence            999999988764  348999999999999999999999999999999999999   4567799999986543221110  


Q ss_pred             ------eecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC---------
Q 017768          231 ------YKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL---------  292 (366)
Q Consensus       231 ------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------  292 (366)
                            .....++..|+|||++.+   .++.++||||||+++|+|++|..||...................         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  011234567999998754   36889999999999999999999997765544433332211100         


Q ss_pred             ----------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          293 ----------------------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       293 ----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                                        .......+++.+.+||.+||+.||++|||+.++|+||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                              000112356789999999999999999999999999999765543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.9e-41  Score=305.07  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=206.0

Q ss_pred             cceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..|.+.+.||+|+||.||+|....     ++..+++|.+....   ......+.+|+.+++++. |+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            358899999999999999998532     45568888875332   233467889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          146 NLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ..++||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||+   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence            9999999999999999997642                37899999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA  284 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~  284 (366)
                      +++.++|+|||++........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||.........+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            677899999999976543221   12335678899999875 568899999999999999998 9999988877777776


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+......   ...+..+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         238 ITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            6665443222   2467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-41  Score=305.77  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=205.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCC----------------cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCce
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATG----------------RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI  134 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i  134 (366)
                      ++|++++.||+|+||.||+|.+...+                ..||+|.+.....  ....+.+.+|+.+++++. |+||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCCE
Confidence            46999999999999999999876543                4689998864421  245667889999999997 9999


Q ss_pred             eEeceEEeeCCeEEEEEeccCCCchHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcE
Q 017768          135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-----------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF  203 (366)
Q Consensus       135 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  203 (366)
                      +++++++..++..+++|||+++++|.+++....           .+++..++.++.|++.||.|||+++|+|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999997765           689999999999999999999999999999999999


Q ss_pred             EeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 017768          204 LLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS--GVPPFWAET  277 (366)
Q Consensus       204 ll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~--g~~pf~~~~  277 (366)
                      ++   +.++.++|+|||++........   .....++..|+|||++. +.++.++||||||+++|+|++  +..||....
T Consensus       162 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99   5567899999999876533321   12334577899999875 468999999999999999998  788887766


Q ss_pred             hHHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          278 EKGIFEAILEG----NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       278 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ....+......    .........+.++.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66655554432    111111122346789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=302.39  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=207.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCC-----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATG-----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|.+.+.||+|+||.||+|.++..+     ..+|+|.+....  .......+.+|+.+++.+. |+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcC
Confidence            3467999999999999999999886433     789999975432  2233456888999999987 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      ....+++|||+++++|.+++....          .+++..+..++.||+.||.|||+.+|+|+||||+|||+   +.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence            999999999999999999986532          36788999999999999999999999999999999999   56778


Q ss_pred             EEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 017768          214 IKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~  288 (366)
                      ++|+|||++........   .....++..|+|||.+. +.++.++||||||+++|++++ |..||...+..+....+..+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            99999999876543321   22334678899999875 568899999999999999998 99999888877777766644


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ......   ..++.++.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         238 GHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            322222   2458899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=305.21  Aligned_cols=253  Identities=34%  Similarity=0.521  Sum_probs=208.7

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+..... .......+.+|+.+++.+. |+||+++++++..++..++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            5677899999999999999988999999999865432 2234567889999999998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-c
Q 017768          153 LCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-V  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~  230 (366)
                      |+++ +|.+++... ..+++.++..++.||+.+|.+||+.+|+|+||||+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9975 888887764 568999999999999999999999999999999999999   566789999999987765443 2


Q ss_pred             eecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC----------------
Q 017768          231 YKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL----------------  292 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------  292 (366)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|+.||...+..+....+.......                
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            333567889999998753  57899999999999999999999997776554443332211000                


Q ss_pred             ----------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          293 ----------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       293 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                                .....+.++.++.++|.+||..||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      001123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3e-41  Score=306.67  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccC-----CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKAT-----GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||++.....     ...+|+|.+....  .......+.+|+.+++++.+|+||+++++++..+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            45699999999999999999987643     3689999886432  2334567889999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec
Q 017768          145 QNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK  208 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~  208 (366)
                      +..+++|||+++++|..++...                ..+++..+..++.|++.||.|||+++|+|+||||+|||+   
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence            9999999999999999998642                358899999999999999999999999999999999999   


Q ss_pred             CCCCCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017768          209 EEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFE  283 (366)
Q Consensus       209 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~  283 (366)
                      ++++.++|+|||++.........   ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            56778999999999876443211   1123456799999865 568899999999999999997 999998887777776


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+..+....   .....+..+.+++.+||..||++|||+.+++++
T Consensus       246 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            665543221   123568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-42  Score=338.44  Aligned_cols=256  Identities=32%  Similarity=0.513  Sum_probs=205.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      ....|+..+.||+||||.||+++++-+|+.||||++....  .......+.+|+..|.+|+ |||||+++..|.+.    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcc
Confidence            3445788899999999999999999999999999996543  3566778999999999998 99999998665210    


Q ss_pred             --------------------------------------------------------------------------------
Q 017768          145 --------------------------------------------------------------------------------  144 (366)
Q Consensus       145 --------------------------------------------------------------------------------  144 (366)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEeccCCCchHHHHHHhCCC-CHHHHHHHHHHHHHHHHHH
Q 017768          145 -----------------------------------QNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHAC  188 (366)
Q Consensus       145 -----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qi~~~l~~L  188 (366)
                                                         ..+||-||||+...+.+++..+... ....+|.++++|++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               0168899999987777766665544 4788999999999999999


Q ss_pred             HHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-------------------CCCceecccCCCCCCccccccc-
Q 017768          189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-------------------TGKVYKEIVGSAYYVAPEVLHQ-  248 (366)
Q Consensus       189 H~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-  248 (366)
                      |+.|||||||||.|||+   +.+..|||+|||+|+...                   +....+..+||..|+|||++.+ 
T Consensus       714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999   566779999999998721                   0113455789999999999853 


Q ss_pred             ---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHH
Q 017768          249 ---RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE  324 (366)
Q Consensus       249 ---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  324 (366)
                         +|+.|+|+||||+||+||+.   ||....+ -..+..+..+.++.+...+..--+.-..+|+.||+.||++|||+.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               58999999999999999986   6755433 3455556655555542222223456678999999999999999999


Q ss_pred             HhcCCCccc
Q 017768          325 ALEHPWLKE  333 (366)
Q Consensus       325 ~l~hp~f~~  333 (366)
                      +|++.||..
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-41  Score=312.95  Aligned_cols=268  Identities=27%  Similarity=0.439  Sum_probs=212.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-  144 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-  144 (366)
                      ...+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.++++++ |+||+++++++... 
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~   89 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR   89 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence            4457788999999999999999999998899999999886432 12233456778999999997 99999999988643 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          145 -----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       145 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                           ...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||++   +.++.++|+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~df  164 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF  164 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecc
Confidence                 3478888887 7789887754 458999999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-------  290 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  290 (366)
                      |++......  .....++..|+|||.+.+  .++.++||||||+++|+|++|..||...........+.....       
T Consensus       165 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         165 GLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  242 (345)
T ss_pred             ccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998765332  234467889999998653  478899999999999999999999976655443333222110       


Q ss_pred             ----------------CCC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          291 ----------------DLQ----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       291 ----------------~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                                      ...    .......++++.++|.+||+.||++||++.++++||||++...+...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~  314 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV  314 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcccc
Confidence                            000    0011235788999999999999999999999999999998666555443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-41  Score=313.22  Aligned_cols=261  Identities=31%  Similarity=0.469  Sum_probs=208.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+. |+||+++++++...  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~   88 (342)
T cd07879          11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVS   88 (342)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheeccccc
Confidence            345678999999999999999999998899999999986532 22333456789999999997 99999999988654  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                          ...++++||+.. +|..+.  ...+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg  162 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFG  162 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCC
Confidence                346899999964 676654  3458999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC--------
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL--------  290 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~--------  290 (366)
                      ++......  .....++..|+|||++.+  .++.++|+||||+++|+|++|+.||.+.+....+..+.....        
T Consensus       163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         163 LARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98765332  233467889999998753  478899999999999999999999987765444333322100        


Q ss_pred             ---------------CCCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          291 ---------------DLQS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       291 ---------------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                     ....    ..++..+.++.++|.+||+.||++||++.+++.||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                           0000    0123567889999999999999999999999999999886553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-41  Score=306.23  Aligned_cols=257  Identities=33%  Similarity=0.552  Sum_probs=209.2

Q ss_pred             eeeeceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      |++.+.||+|++|.||++...   .++..+|+|.+...... .......+.+|+.++.++.+|++|+.+++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            788899999999999999854   35788999998643321 12345568899999999988999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++..+..++.|++.+|.+||+.+++|+||+|+||++   +.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccccc
Confidence            999999999999999887789999999999999999999999999999999999999   56678999999998765332


Q ss_pred             Cc--eecccCCCCCCcccccccc---CCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCC
Q 017768          229 KV--YKEIVGSAYYVAPEVLHQR---YGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       229 ~~--~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ..  .....|+..|+|||.+.+.   .+.++|+||||+++|+|++|..||.....    ......+......    ....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~  234 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----FPKT  234 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----CCcc
Confidence            21  1234578899999987542   67899999999999999999999964322    2222333333222    2234


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccCCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRIT---AAEALEHPWLKEDGA  336 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt---~~~~l~hp~f~~~~~  336 (366)
                      ++..+.++|.+||+.||++|||   +.++|+||||+....
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            6889999999999999999998   567899999988654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-42  Score=319.98  Aligned_cols=262  Identities=33%  Similarity=0.527  Sum_probs=227.2

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|..++.||-|+||+|.+++...+...+|.|.+.+...........++.|-.||.... ++-||++|..|.+++.+|+||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEE
Confidence            4778889999999999999999898999999998777666677778889999999986 789999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-----
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----  226 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-----  226 (366)
                      ||++||++..+|...+.|+|+.++.++.++..|+++.|..|+|||||||+||||   +.+|++||.|||++.-+.     
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecccc
Confidence            999999999999999999999999999999999999999999999999999999   789999999999986431     


Q ss_pred             ----CCC----------------------------------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHH
Q 017768          227 ----TGK----------------------------------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILL  267 (366)
Q Consensus       227 ----~~~----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll  267 (366)
                          .++                                  .....+||+.|+|||++.. .++.-.|+||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                100                                  0012589999999999864 5899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccCCCCC
Q 017768          268 SGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKEDGATS  338 (366)
Q Consensus       268 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~~l~hp~f~~~~~~~  338 (366)
                      .|+.||-..+..+.-..+.+..-.+.......+++++.++|.++.+ +++.|.   .++++..||||+.....+
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHh
Confidence            9999998877666555666666666666777899999999998655 778887   577899999999877644

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.9e-41  Score=301.29  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=201.0

Q ss_pred             eeeceecccCceEEEEEEEccCCc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC------C
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK------Q  145 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~------~  145 (366)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+.+|+.+++.++ |+||+++++++...      .
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCC
Confidence            467889999999999999877665  68999876432 23345677889999999997 99999999876432      2


Q ss_pred             eEEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 NLHLVMELCSGGELFDRIIAK------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      ..+++|||+++++|.+++...      ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCC
Confidence            468999999999999887532      237899999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          220 GLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       220 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                      |++.........   ....++..|++||.+. ..++.++||||||+++|+|++ |..||......+....+..+..... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-  235 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ-  235 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            999876433221   1224566799999876 458899999999999999999 8999988777777776666543221 


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                        .+.++..+.++|.+||+.||++|||+.+++++
T Consensus       236 --~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         236 --PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              23578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=298.38  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||+|+||.||++.++ ++..+|+|.+....    .....+.+|+.+++.+. |+||+++++++...+..+++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            4888999999999999999886 46789999875432    23456788999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          152 ELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||+++++|.+++... ..+++..++.++.||+.+|.|||+.||+|+||||+||++   ++++.+||+|||++........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc
Confidence            999999999998764 458999999999999999999999999999999999999   5677899999999876543221


Q ss_pred             ee--cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          231 YK--EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       231 ~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ..  ...++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+....+..+....   ....++.++.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY---RPKLAPTEVYT  232 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHH
Confidence            11  112345799999875 568899999999999999999 899998777766666665542211   12347899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 017768          307 LIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.+||+.+|++|||+.++++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-41  Score=300.79  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             eeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe---
Q 017768           73 YDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN---  146 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---  146 (366)
                      |.+.+.||+|+||.||+|....+   +..+|+|.+.... ........+.+|+..++.+. |+||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            56788999999999999987653   3789999986532 22344567899999999997 9999999998766544   


Q ss_pred             ---EEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          147 ---LHLVMELCSGGELFDRIIAK------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       147 ---~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                         .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999999888543      258999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCC
Q 017768          218 DFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       218 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      |||++.........   ....++..|+|||.+. ..++.++||||||+++|||++ |..||.+....+..+.+..+....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999865433221   1123456799999875 458899999999999999999 899998877777777666554322


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .   ...++.++.+++.+||..||++|||+.+++++
T Consensus       236 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 Q---PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             C---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   23578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=304.12  Aligned_cols=253  Identities=32%  Similarity=0.516  Sum_probs=209.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++.+.||+|.+|.||+|....+++.+|+|.+.... ......+.+.+|+.+++.+. |+||+++++++.+.+..++++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            567788999999999999999899999999987543 22344567788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-c
Q 017768          153 LCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-V  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~  230 (366)
                      |+++ +|.+++... ..+++..+..++.|++.+|.+||+.||+|+||+|+||++   ++++.++|+|||++....... .
T Consensus        79 ~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            9974 899999876 579999999999999999999999999999999999999   567889999999987664332 2


Q ss_pred             eecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC-----------------
Q 017768          231 YKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD-----------------  291 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----------------  291 (366)
                      .....++..|+|||.+. . .++.++|+||||+++|++++|..||...+..+....+......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            33345677899999874 3 5788999999999999999999999877655544433221000                 


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          292 --------LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       292 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                              ......+.++..+.++|.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                    0001123457899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-41  Score=301.07  Aligned_cols=247  Identities=20%  Similarity=0.317  Sum_probs=208.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|++.+.||.|+||.||+|.+.. +..+++|.+....   ......+..|+.+++.++ |+||+++++++...+..++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEE
Confidence            4569999999999999999999986 8999999986532   234567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++...  ..+++.++..++.||+.||.|||++||+|+||||+||++   ++++.++|+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCC
Confidence            99999999999999763  358999999999999999999999999999999999999   5677899999999976543


Q ss_pred             CCc-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          228 GKV-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       228 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ... .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+..+....   ....+++.+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  233 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP---CPAKCPQEI  233 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC---CCCCCCHHH
Confidence            221 11234566799999875 468899999999999999998 899998887777777666442221   123678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017768          305 KDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+++.+||+.||++|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-40  Score=298.32  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.+....    ...+.+.+|+.+++.+. |+||+++++.+. .+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----cCHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCCcEE
Confidence            45699999999999999999988754 569999986432    23457889999999997 999999998874 456899


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.+||+.+++|+||||+||++   ++++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999763  347899999999999999999999999999999999999   5677799999999976543


Q ss_pred             CCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....  ....++..|+|||+.. ..++.++||||||+++|+|++ |..||......+....+..+....   ....++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC---CccccCHH
Confidence            3321  1234566799999865 568999999999999999999 888998877776666655443211   12357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+++.+||+.||++||++.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.7e-41  Score=304.73  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             cccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|.+.+.||+|+||.||++..     ..++..+|+|.+....  .....+.+.+|+.+++++.+|+||+++++.+..
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            345799999999999999999975     2345689999886432  233456788999999999669999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      .+..+++|||+.+++|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+|||+   ++++.++|+|||+
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~  187 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL  187 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence            999999999999999999997643  38999999999999999999999999999999999999   5667799999999


Q ss_pred             cccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          222 SVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       222 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      +........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||....................  .
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~  265 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--Q  265 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--C
Confidence            876543221   11234567899999875 458899999999999999998 9999987665544433333222221  1


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ....++++.+++.+||..+|++|||+.++++
T Consensus       266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-40  Score=304.78  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=208.0

Q ss_pred             cccceeeeceecccCceEEEEEEEc-------cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-------ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ..++|.+.+.||+|+||.||+|...       .++..+|+|.+....  .......+.+|+.+++.+.+|+||+++++.+
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            4567999999999999999999752       234579999875432  2345667899999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ...+..+++|||+++++|.+++...                ..++..++..++.||+.||.|||++||+||||||+||++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            9999999999999999999999764                236778899999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         ++++.++|+|||++........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||...+..+
T Consensus       171 ---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         171 ---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             ---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence               5667899999999986643221   12234567899999875 458899999999999999998 889998888877


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....+..+.....   ...++.++.+++.+||..+|++|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7777765543222   12568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-40  Score=300.20  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .+.|++.+.||+|+||+||+|.+..+|.    .||+|.+....  .......+.+|+.+++.+. |+||+++++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence            3468899999999999999999877776    48999885432  2334567889999999987 9999999998865 4


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..++++||+++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||+   .+++.+||+|||++..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence            578999999999999999774 458999999999999999999999999999999999999   5567799999999987


Q ss_pred             ccCCCcee---cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          225 IETGKVYK---EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       225 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ........   ...++..|+|||++. ..++.++||||||+++|||++ |..||...........+..+.....   .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---Ccc
Confidence            64332211   123456799999875 568899999999999999998 8999987766666555554432221   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.++.+++.+||..||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-40  Score=296.98  Aligned_cols=246  Identities=23%  Similarity=0.317  Sum_probs=204.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.++||+|+||.||+|..+ +++.+|+|.+....    .....+.+|+.++++++ |+||+++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            4567999999999999999999865 57899999886433    34567889999999997 999999999874 45689


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++|||+.+++|.+++....  .+++.++..++.|++.+|+|||+.|++|+||||+||++   ++++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            9999999999999987643  58899999999999999999999999999999999999   567789999999987654


Q ss_pred             CCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....  .....++..|+|||++. ..++.++||||||+++|++++ |..||.+.+..+....+..+....   .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCH
Confidence            3221  12234567899999876 457889999999999999998 999998887777666665543221   1234688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.++|.+||+.||++|||++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-40  Score=304.92  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ..++|.+.+.||+|+||.||+|....       ....+|+|.+....  .......+.+|+.+++.+.+|+||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34679999999999999999997532       34579999876432  2344567889999999997799999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ...+..+++|||+++++|.+++...                ..+++.++..++.||+.||.|||++||+|+||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999999763                237889999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         ++++.+||+|||+++.......   .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               5567899999999976543221   11123445799999875 458899999999999999999 899998887777


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ....+..+....   ....++.++.+++.+||..||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            777666543221   12356789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=296.10  Aligned_cols=241  Identities=24%  Similarity=0.336  Sum_probs=199.8

Q ss_pred             ceecccCceEEEEEEEccCC---cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTKKATG---RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +.||+|+||.||+|.+...+   ..+|+|.+......  .....+.+|+.+++.+. |+||+++++++. .+..+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999876554   78999998654322  35567889999999997 999999999876 4568999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCcee-
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-  232 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~-  232 (366)
                      +++++|.+++.....+++..+..++.|++.+|.+||+.+++|+||||+|||+   +.++.++|+|||++.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999887789999999999999999999999999999999999999   567789999999998664333211 


Q ss_pred             ---cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          233 ---EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       233 ---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                         ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+.......   ....++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHH
Confidence               112345799999875 458899999999999999998 999998877776666665543221   223578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhc
Q 017768          308 IRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~  327 (366)
                      |.+||+.||++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-43  Score=294.83  Aligned_cols=267  Identities=29%  Similarity=0.482  Sum_probs=221.0

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-  143 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-  143 (366)
                      ++.+..+.|.-..+||+|.||.||+|+.+.+|+.||+|++.... ..+.......+|+.+|..+. |+|++.++..+.. 
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lk-Henv~nliEic~tk   88 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLK-HENVVNLIEICRTK   88 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhc
Confidence            34555667888899999999999999999999999998764322 12344567889999999998 9999998877643 


Q ss_pred             -------CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          144 -------KQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       144 -------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                             ...+|+||++|+. +|.-++... .+++..++..++.++++||.|+|...|+|||+|+.|+||   +.++.+|
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilk  164 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILK  164 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEE
Confidence                   3358999999976 888877654 469999999999999999999999999999999999999   6788999


Q ss_pred             EeecCCcccccCC-----CceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          216 ATDFGLSVFIETG-----KVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       216 l~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                      |+|||+++.....     +.++..+.|.+|++||.+.  ..++++.|||+-||||.+|+++.+.+++.++.+.+..+..-
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            9999999765322     2344557799999999865  35999999999999999999999999999998888877654


Q ss_pred             CCCCCCCCCCCC-------------------------------CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          289 NLDLQSSPWPSI-------------------------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       289 ~~~~~~~~~~~~-------------------------------~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ..+.....||++                               .++..+|++.+|..||.+|+++.++|.|.||..+..+
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            444444444431                               3478899999999999999999999999999988766

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-40  Score=298.22  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=205.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .......+.+|+.+++++. ||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            468999999999999999998764443   79999885432  2344567899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +++|||+++++|.+++... ..+++.++..++.|++.||.+||+++++|+||||+|||+   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999999775 358999999999999999999999999999999999999   567789999999998764


Q ss_pred             CCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          227 TGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       227 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....    ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+..+.. .  .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-L--PAPMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-C--CCCCCC
Confidence            33211    1112345799999876 468999999999999999886 9999988877766666665432 1  122357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=294.83  Aligned_cols=243  Identities=24%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||.|+||.||+|...  |+.||+|.+....    .....+.+|+.+++.+. |+||+++++++...+..+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            45888999999999999999875  8999999986432    24677899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+++++|.+++....  .+++..+..++.|++.+|.|||++|++|+||||+||++   +.++.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence            99999999999998765  68999999999999999999999999999999999999   56778999999999876432


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ..  ....+..|+|||++. +.++.++|+||||+++|++++ |..||......+....+..+...   .....+++.+.+
T Consensus       156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  230 (256)
T cd05039         156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---EAPEGCPPEVYK  230 (256)
T ss_pred             cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCccCCCHHHHH
Confidence            22  223456799999875 568889999999999999997 99999888777666655543221   112356899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 017768          307 LIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +|.+||..+|++|||+.++++.
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~~  252 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLREQ  252 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-40  Score=300.45  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             cceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .+|.+.++||+|+||.||++...     .++..+|+|.+....   ......+.+|+.+++.++ |+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            45788899999999999999642     346689999875432   345668999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC
Q 017768          146 NLHLVMELCSGGELFDRIIAKG---------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE  210 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~  210 (366)
                      ..+++|||+++++|.+++....               .+++..+..++.||+.||.|||++|++|+||||+|||+   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999987642               37889999999999999999999999999999999999   56


Q ss_pred             CCCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017768          211 DSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI  285 (366)
Q Consensus       211 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~  285 (366)
                      ++.++|+|||++.........   ....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            778999999998755332211   1223467899999875 568899999999999999998 99999877777766666


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+.....   ...+++.+.++|.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55533221   2257889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=298.02  Aligned_cols=247  Identities=23%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             ceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .|++.+.||+|+||.||+|..+.++.   .||+|.+....  .......+..|+.+++.+. ||||+++++++..++..+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence            48999999999999999999887665   59999886432  2345678899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++|||+++++|.+++... +.+++.+++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999999999999998764 458999999999999999999999999999999999999   5677899999999876543


Q ss_pred             CCce---eccc---CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          228 GKVY---KEIV---GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       228 ~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ....   ....   .+..|+|||++. ..++.++||||||+++||+++ |..||+.....+....+.... ..  .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~--~~~~~  235 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RL--PPPMD  235 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cC--CCccc
Confidence            2211   1111   134699999876 468899999999999999886 999999887777666664432 11  12246


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++..+.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-40  Score=307.09  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccC-------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT-------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ...+|++.+.||+|+||.||+|.+...       +..+|+|.+....  .......+.+|+.+++++.+|+||+++++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            345799999999999999999986432       2368999875432  2344667889999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ..++..+++|||+++++|.+++....                .++..++..++.|++.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999999999999987532                36778899999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.++|+|||+++........   ....++..|+|||++. ..++.++||||||+++|+|++ |..||...+..+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         168 ---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             ---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence               56678999999998765432211   1123356799999875 458899999999999999998 899998888777


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....+..+.....   ...++.++.+++.+||+.+|++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7776665433221   22568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.2e-41  Score=310.23  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             ccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-  143 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-  143 (366)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||.+....  .......+.+|+.++.++.+|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            45799999999999999999984     3457899999986432  233456788999999999879999999998765 


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh---------------------------------------------------------
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK---------------------------------------------------------  166 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  166 (366)
                      +...+++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45678999999999999998653                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc---eec
Q 017768          167 ----------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV---YKE  233 (366)
Q Consensus       167 ----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~  233 (366)
                                ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.++|+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence                      136778889999999999999999999999999999999   5677899999999876532221   112


Q ss_pred             ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          234 IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       234 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ..++..|+|||++. ..++.++||||||+++|+|++ |..||...... .....+..+... ...  ...++++.+++..
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAP--DYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCC--CCCCHHHHHHHHH
Confidence            23566799999865 568899999999999999997 99999765433 233333333221 111  1357889999999


Q ss_pred             hcccCcCCCCCHHHHhcC
Q 017768          311 MLTKDPKKRITAAEALEH  328 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~h  328 (366)
                      ||+.||++|||+.++++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-40  Score=301.00  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             ceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +|++.+.||+|+||.||+|....     ....+++|.+....  .......+.+|+.+++.+. ||||+++++.+..++.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            37888999999999999998753     23568888875432  2234567889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCc
Q 017768          147 LHLVMELCSGGELFDRIIAK------------------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPEN  202 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  202 (366)
                      .++++||+.+++|.+++...                        ..+++..++.++.|++.+|.|||+++|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999988652                        237788999999999999999999999999999999


Q ss_pred             EEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017768          203 FLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAET  277 (366)
Q Consensus       203 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~  277 (366)
                      ||+   ++++.++|+|||++........   .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   5677899999999876533221   12224567899999865 458899999999999999998 999998877


Q ss_pred             hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+..+.+..... ..  ....++.++.+++..||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGYR-ME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCCC-CC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            7776665554322 11  12357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-40  Score=298.65  Aligned_cols=248  Identities=25%  Similarity=0.329  Sum_probs=200.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.|++.+.||+|+||.||+|.+..++.    .+++|.+...  .......++..|+..+.++. |+||+++++++. +..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence            458889999999999999999877776    4677766422  11234456778888888887 999999999875 456


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++++||+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            78899999999999999764 468999999999999999999999999999999999999   56778999999999765


Q ss_pred             cCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ....   ......++..|+|||++. +.++.++||||||+++||+++ |..||.+.......+.+..+......   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence            3322   122334667899999875 568999999999999999998 99999887766655555444332222   135


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+.+++.+||..||++|||+.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6789999999999999999999999773

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-40  Score=295.31  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|.+....    .....+.+|+.+++++. |++++++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT----MSPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC----CCHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcE
Confidence            3457999999999999999999876 56789999886533    23456889999999997 999999999875 45688


Q ss_pred             EEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++|||+++++|.+++...  ..+++.++..++.|++.||.|||+++|+|+||||+||++   ++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeecc
Confidence            999999999999998763  348999999999999999999999999999999999999   566789999999997654


Q ss_pred             CCCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .....  ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+..+....   .....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP---CPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCH
Confidence            32211  1223456799999865 568899999999999999999 899998887777777665542221   1235688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-40  Score=297.52  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=206.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +|.+.+.||+|+||.||++.+...+..+++|.++.....  .......+..|+.+++.++ ||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            488999999999999999999877777777776532211  1223445678999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          150 VMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ++||+++++|.+++..    ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++    ++.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999988864    34589999999999999999999999999999999999994    245999999998765


Q ss_pred             cCCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          226 ETGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       226 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+..+......   ..++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP---ETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc---chhcHH
Confidence            4322 233456788999999875 45788999999999999999999999877665555555444322221   256889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.++|.+||..||++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-40  Score=294.19  Aligned_cols=241  Identities=25%  Similarity=0.326  Sum_probs=196.6

Q ss_pred             eecccCceEEEEEEEc--cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.+++++. |+||+++++++. .+..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            4899999999999765  345579999886432  2334567889999999997 999999999875 457899999999


Q ss_pred             CCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce---
Q 017768          156 GGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---  231 (366)
Q Consensus       156 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---  231 (366)
                      +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++   +.++.+||+|||++.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999999875 3468999999999999999999999999999999999999   56677999999998755332211   


Q ss_pred             -ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          232 -KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       232 -~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                       ....++..|+|||++. +.++.++||||||+++|++++ |..||......+....+..+.....   .+..++++.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence             1112356799999875 468899999999999999996 9999988877777666665543221   235689999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 017768          309 RKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+||..||++||++.++++.
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=301.71  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             cceeeeceecccCceEEEEEEEccC--------------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKAT--------------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE  136 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~  136 (366)
                      ++|++.+.||+|+||.||++.+..+              ...||+|.+....  .......+.+|+++++++. |+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            5699999999999999999987542              2358999886432  2334567889999999998 999999


Q ss_pred             eceEEeeCCeEEEEEeccCCCchHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEE
Q 017768          137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKG------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL  204 (366)
Q Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  204 (366)
                      +++++...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||+++++|+||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999986532            3678899999999999999999999999999999999


Q ss_pred             eeecCCCCCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh--CCCCCCCCCh
Q 017768          205 LASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS--GVPPFWAETE  278 (366)
Q Consensus       205 l~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~--g~~pf~~~~~  278 (366)
                      +   ++++.+||+|||++.........   ....++..|+|||++. +.++.++|+||||+++|+|++  +..||.....
T Consensus       162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9   55677999999998765433211   1223467899999865 568999999999999999988  6788877666


Q ss_pred             HHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          279 KGIFEAILE----GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       279 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+....+..    ..........+..++.+.+++.+||..||++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            655544322    1111111223356889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=293.52  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=207.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|.+.+.||+|+||.||+|.+. ++..+|+|.+....    .....+.+|+.+++++. |+||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            3467999999999999999999976 56889999886432    34567899999999998 999999999999989999


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++|||+++++|.+++....  .+++.++..++.||+.||.|||+++++|+||||+||++   ++++.++|+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence            9999999999999997643  58999999999999999999999999999999999999   567889999999987654


Q ss_pred             CCCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .....  ....++..|+|||.+. ..++.++|+||||+++|++++ |+.||.+.........+..+.....   ....+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCH
Confidence            32111  1123456799999876 458889999999999999998 9999988887777777665432211   124588


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+++.+||+.||++||+++++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=333.41  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=212.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc-----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR-----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..-.+.+.||+|+||.||.|.......     .||+|.+.+.  .......+|.+|..+++++. ||||++++|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCC
Confidence            345678899999999999998765433     3888877543  34677889999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          146 NLHLVMELCSGGELFDRIIAK-------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      ..+|++|||+||+|..+|++.       ..|+..+.+.++.||+.|+.||+++++|||||..+|+|+   +....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcc
Confidence            999999999999999999886       248999999999999999999999999999999999999   5668899999


Q ss_pred             cCCcccccCCCceecc---cCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 017768          219 FGLSVFIETGKVYKEI---VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       219 fg~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~  293 (366)
                      ||+|+.......+...   .-...|||||.+. +.|+.++|||||||+|||+++ |..||.+..+.+++..+..+-...+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~  925 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP  925 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence            9999966554433321   2235799999876 789999999999999999999 9999999999998886666552222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .   +.+++.+.+++..||+.+|++||++..+++
T Consensus       926 P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 P---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             C---CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            2   367889999999999999999999999998

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-40  Score=312.93  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=203.2

Q ss_pred             cccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..+.|.+.+.||+|+||.||+|++.     .++..||+|++....  .......+.+|+.+|.++..|+||+++++++..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3456888999999999999999864     345689999996432  233345788999999999779999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC--------------------------------------------------------
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG--------------------------------------------------------  167 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------  167 (366)
                      .+..++||||+++|+|.+++...+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999986531                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          168 ------------------------------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       168 ------------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                                                                .+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      25677889999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         ++++.++|+|||++........   .....++..|+|||.+. ..++.++||||||+++|||++ |..||......+
T Consensus       273 ---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         273 ---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             ---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence               4567799999999976432221   12235678899999875 458899999999999999998 899997665554


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .............  ....++.++.+++.+||+.||++||++.++++.
T Consensus       350 ~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4433333222221  123468999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5e-40  Score=293.50  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=201.3

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|++|.||+|.+.. +..+|+|.+....    .....+.+|+.+++.+. |+|++++++++. .+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEE
Confidence            569999999999999999998764 4569999875432    23456888999999997 999999998875 4568899


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCC
Confidence            99999999999997643  37899999999999999999999999999999999999   56778999999999765433


Q ss_pred             Cc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          229 KV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       229 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..  .....++..|+|||... ..++.++||||||+++|+|++ |..||.+....+....+..+...   ......+..+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPESL  232 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHH
Confidence            21  11234567799999875 568899999999999999999 99999888777666666544221   1223578999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 017768          305 KDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+++.+||..||++||+++++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.6e-40  Score=293.47  Aligned_cols=245  Identities=29%  Similarity=0.448  Sum_probs=208.2

Q ss_pred             eeeceecccCceEEEEEEEccCC----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           74 DLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ++.+.||.|+||.||++.+..++    ..+|+|.+.....  ......+.+|+..++.+. |+||+++++++...+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence            46788999999999999998766    8999999854421  225678899999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++.....  +++.++..++.|++.+|.+||+.+++|+||||+||++   ++++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence            9999999999999976554  8999999999999999999999999999999999999   5667899999999987654


Q ss_pred             CCceec--ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYKE--IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~~--~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ......  ..++..|+|||.+. ..++.++|+||||+++|+|++ |..||...+.....+.+..+......   ..++.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHH
Confidence            432221  23678899999875 458899999999999999998 88999888777777777665543322   247899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-40  Score=295.06  Aligned_cols=248  Identities=23%  Similarity=0.382  Sum_probs=205.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +.|+..+.||+|+||.||+|....++.   .+|+|.+....  .......+.+|+.+++++. |+||+++.+++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            468889999999999999999876655   69999875432  2334567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +++|||+++++|.+++... ..+++.++..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999999999998764 468999999999999999999999999999999999999   567789999999987654


Q ss_pred             CCCc--eec--ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          227 TGKV--YKE--IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       227 ~~~~--~~~--~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ....  ...  ...+..|+|||++. +.++.++||||||+++|+|++ |..||+.....+....+........   ...+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---PMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---CCCC
Confidence            3221  111  12345699999876 468899999999999999997 9999988887777777765432211   2246


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.++.+++.+||+.||++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-40  Score=293.57  Aligned_cols=241  Identities=23%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe-eCCeEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE-DKQNLHL  149 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~~~~l  149 (366)
                      +.|.+.+.||+|+||.||++...  |..+|+|.+...     .....+.+|+.+++++. |++++++++++. .++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            35889999999999999999875  889999987532     33567889999999997 999999998754 5567899


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||+++++|.+++....  .+++..+..++.|++.+|.+||++|++||||||+||++   ++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987654  37899999999999999999999999999999999999   5677899999999876433


Q ss_pred             CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ..  ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...   ...+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence            22  2223456799999876 458889999999999999997 99999887777766666554322   12235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017768          306 DLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++.+||+.||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-40  Score=299.74  Aligned_cols=249  Identities=23%  Similarity=0.355  Sum_probs=206.0

Q ss_pred             ccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|.+....  .......+.+|+.+++++. |+||+++++++..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence            3568999999999999999998753     57899999886432  1234567889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG----------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPEN  202 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  202 (366)
                      +..+++|||+++++|.+++....                      .+++.+++.++.||+.||.+||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36788899999999999999999999999999999


Q ss_pred             EEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017768          203 FLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAET  277 (366)
Q Consensus       203 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~  277 (366)
                      ||+   ++++.++|+|||++........   ......+..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus       161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999   5677899999999875433221   11223456799999865 568999999999999999997 889998888


Q ss_pred             hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+....+..+......   ..++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77777777665443211   246889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-40  Score=304.71  Aligned_cols=255  Identities=23%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      .+.+.+|.|  |.||+++...+++.||+|++.... ........+.+|+.+++.++ |+||+++++++...+..+++|||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence            344444444  455555566689999999987542 23456678999999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          154 CSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       154 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++|+|+||||+||++   +.++.++|+|||.+.......  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccc
Confidence            9999999998764  458999999999999999999999999999999999999   556779999999886543211  


Q ss_pred             ------ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC--------
Q 017768          230 ------VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--------  292 (366)
Q Consensus       230 ------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------  292 (366)
                            ......++..|+|||++..   .++.++|+||||+++|+|++|..||..............+....        
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                  1123456778999998754   47889999999999999999999997665433322221111000        


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          293 ----------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       293 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                            .......++.++.+++.+||+.||++|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                  0000012346788999999999999999999999999998665

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=290.92  Aligned_cols=260  Identities=24%  Similarity=0.310  Sum_probs=216.1

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +-...||.|+||+|++..++.+|+..|||.+....  .+.+..++..|.....+-.+.||||++||....++..||+||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            34567999999999999999999999999997543  3577888999999999999999999999999999999999999


Q ss_pred             cCCCchHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          154 CSGGELFDRII-----AKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       154 ~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |+- +|..+..     .+..++|..+..|....+.||.||-. .+|+||||||+|||+   +..|.|||||||++..+.+
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence            954 6544332     24569999999999999999999974 689999999999999   6677799999999988876


Q ss_pred             CCceecccCCCCCCcccccc--c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCCCCCCC--CCCCCC
Q 017768          228 GKVYKEIVGSAYYVAPEVLH--Q-RYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLDLQSS--PWPSIS  301 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~--~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~  301 (366)
                      +-..+..+|...|||||.+.  . .++.++|+||||++|||+.||+.||..-+ .-+.+.++..+.+.....  ..-.++
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            66666678999999999875  2 48999999999999999999999995433 234445555555443322  223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ..+..+|.-||.+|-+.||...+++++||++.--+...
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~  338 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP  338 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence            99999999999999999999999999999987655443

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.4e-40  Score=297.56  Aligned_cols=247  Identities=27%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             cce-eeeceecccCceEEEEEEE----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-
Q 017768           71 TIY-DLDKELGRGQFGVTYLCTK----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-  144 (366)
Q Consensus        71 ~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-  144 (366)
                      ++| ++.+.||+|+||+||++..    ..++..||+|.+....  .......+.+|+.+++.+. |+||+++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            445 8889999999999988653    3467899999986432  2234567889999999997 99999999987653 


Q ss_pred             -CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 -QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                       ...+++|||+++++|.+++... .+++.+++.++.|++.||.|||+++|+|+||||+|||+   +.++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence             4689999999999999998764 58999999999999999999999999999999999999   566789999999998


Q ss_pred             cccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH--H-------------HHH
Q 017768          224 FIETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK--G-------------IFE  283 (366)
Q Consensus       224 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~--~-------------~~~  283 (366)
                      .......    .....++..|+|||++. ..++.++||||||+++|+|++|..||......  +             ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            6643321    11223566799999875 56889999999999999999999998543211  0             000


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+..+ ...  .....++.++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERG-MRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcC-CCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            01111 111  112346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.4e-40  Score=295.58  Aligned_cols=250  Identities=22%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             cceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ++|++.+.||.|+||.||+|+.+.     +.+.+++|.+....  .......+.+|+.+++++. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            568899999999999999999754     34679999875432  1224567899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          146 NLHLVMELCSGGELFDRIIAKG---------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      ..+++|||+++++|.+++....         .+++.++..++.||+.+|.|||+++|+|+||||+||++   +.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999998765         68999999999999999999999999999999999999   55677999


Q ss_pred             eecCCcccccCCC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCC
Q 017768          217 TDFGLSVFIETGK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       217 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      +|||++.......  ......++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  122334567799999865 457889999999999999998 889998777777777666555443


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..  ...++..+.+++.+||+.||++|||+.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  23578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-39  Score=290.32  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=205.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .|++.+.||.|+||.||++.+. ++..+|+|.+....    .....+.+|+.+++++. |++|+++++++......+++|
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA----MSEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC----CCHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence            5888999999999999999875 47789999886432    23456889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          152 ELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||+++++|.+++... ..+++..++.++.|++.+|.+||+.+++|+||||+||++   +.++.++|+|||++........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc
Confidence            999999999998764 458999999999999999999999999999999999999   5667799999999876533221


Q ss_pred             --eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          231 --YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       231 --~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                        .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.........+.+..+......   ...+..+.+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYE  232 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHH
Confidence              11223456899999876 568889999999999999998 99999888777777776654322221   135789999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 017768          307 LIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.+||+.+|++|||+.+++++
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7e-40  Score=291.87  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=200.9

Q ss_pred             ceecccCceEEEEEEEcc-CCc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTKKA-TGR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +.||+|++|.||+|.+.. ++.  .+|+|.+......  .....+.+|+.++++++ |+||+++++.+.. ...+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999998765 333  6999998765432  55678899999999997 9999999999988 889999999


Q ss_pred             cCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc-
Q 017768          154 CSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-  230 (366)
Q Consensus       154 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-  230 (366)
                      +++++|.+++....  .+++..++.++.|++.||.+||+++++|+||||+||++   +.++.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997754  58999999999999999999999999999999999999   4567899999999987643221 


Q ss_pred             ---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          231 ---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       231 ---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                         .....++..|+|||++. ..++.++||||||+++|+|++ |..||...+..+....+........  ....++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               11234677899999876 468899999999999999998 9999987777776666654222222  1224688999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017768          306 DLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++.+||+.+|++||++.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-39  Score=288.96  Aligned_cols=242  Identities=26%  Similarity=0.356  Sum_probs=199.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.+. |+||+++++++...+..+++|||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999865 68899999876432  2233456889999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce--ec
Q 017768          157 GELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--KE  233 (366)
Q Consensus       157 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~  233 (366)
                      ++|.+++... ..+++.++..++.|++.+|.+||++|++|+||||+||++   ++++.++|+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988764 357899999999999999999999999999999999999   56778999999998754332211  11


Q ss_pred             ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 017768          234 IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM  311 (366)
Q Consensus       234 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  311 (366)
                      ..++..|+|||++. +.++.++||||||+++|++++ |..||...........+..+...   .....++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence            23456799999876 468889999999999999998 99999887766666655544221   11235789999999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 017768          312 LTKDPKKRITAAEALEH  328 (366)
Q Consensus       312 l~~dp~~Rpt~~~~l~h  328 (366)
                      |+.+|++||++.++++.
T Consensus       231 l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         231 WDYKPENRPKFSELQKE  247 (250)
T ss_pred             cccCcccCCCHHHHHHH
Confidence            99999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=291.38  Aligned_cols=259  Identities=28%  Similarity=0.507  Sum_probs=229.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -+.|++.+.||+|+|+.|.+++.+.+.+.+|+|++++.-+..+++..-+..|-.+..+..+||.+|.++..|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            34699999999999999999999999999999999988777778888889999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~  228 (366)
                      |.||.+||+|.-.++..++|+++.++.+..+|+.||.|||+.||++||||.+|+|+   +..|++||.|+|+++.- ..+
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999   67788999999999754 566


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC-------C-ChHHHHHHHHcCCCCCCCCCCCC
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWA-------E-TEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~-------~-~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      +...+++||+.|.|||++.+ .|+..+|+|+|||+|+||+.|+.||.-       . +..-.++.++..+...+.    .
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----s  481 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----S  481 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----e
Confidence            67788999999999999986 599999999999999999999999931       2 233355556666655554    4


Q ss_pred             CCHHHHHHHHHhcccCcCCCC------CHHHHhcCCCcccCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRI------TAAEALEHPWLKEDG  335 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rp------t~~~~l~hp~f~~~~  335 (366)
                      ++-.+..+++..|+.||.+|.      .+.++-.|+||....
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            677888999999999999996      588999999998644

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-39  Score=290.74  Aligned_cols=246  Identities=21%  Similarity=0.326  Sum_probs=203.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||++.+. .+..+|+|.+...    ......+.+|+.+++.+. |+||+++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            3567999999999999999999865 4677999987543    224567889999999997 9999999999887 7789


Q ss_pred             EEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.+||+.|++|+||||+||++   +.++.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence            999999999999999764  347888999999999999999999999999999999999   567789999999987654


Q ss_pred             CCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....  .....++..|+|||++. +.++.++|+||||+++|++++ |..||...+.......+..+...   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCH
Confidence            3221  11223456799999876 457889999999999999998 99999888777666666554322   12235788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.9e-40  Score=298.26  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             ccceeeeceecccCceEEEEEEEcc----------------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA----------------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN  133 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~  133 (366)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|.+....  .......+.+|+.+++.++ |+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3569999999999999999986432                34478999886432  2334567889999999997 999


Q ss_pred             eeEeceEEeeCCeEEEEEeccCCCchHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCc
Q 017768          134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-----------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPEN  202 (366)
Q Consensus       134 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  202 (366)
                      |+++++++..++..+++|||+++++|.+++....           .+++.++..++.||+.||.|||++|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987643           36678899999999999999999999999999999


Q ss_pred             EEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCccccc-cccCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 017768          203 FLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS--GVPPFWAE  276 (366)
Q Consensus       203 Ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~Di~slG~vl~~ll~--g~~pf~~~  276 (366)
                      ||+   ++++.++|+|||++........   .....++..|++||+. .+.++.++||||||+++|+|++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   5677899999999876543221   1122345679999975 4668999999999999999998  77899776


Q ss_pred             ChHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          277 TEKGIFEAILE----GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       277 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...+.......    ............+++.+.+++.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65554443311    1111111112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-39  Score=292.50  Aligned_cols=251  Identities=29%  Similarity=0.483  Sum_probs=208.1

Q ss_pred             eeeeceecccCceEEEEEEEcc-CCcEEEEEEeecccc-------cccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           73 YDLDKELGRGQFGVTYLCTKKA-TGRKYACKSISRRKL-------VYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+.....       .......++.+|+.++.+..+|+||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7888999999999999999887 678999998854321       12234556778999888755699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          145 QNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      +..+++|||+++++|.+++..    ...+++..++.++.|++.+|.+||+ .+++|+||+|+||++   +.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEecc
Confidence            999999999999999888743    3458999999999999999999996 789999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      |.+.............++..|++||++. +.++.++|+||||+++|+|++|..||...........+..........  .
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE--G  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc--c
Confidence            9998765544444557889999999876 458899999999999999999999998776666666655544332221  2


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .++.++.++|.+||+.||++||++.|+.++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            468899999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=293.32  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..|++.+.||+|+||.||+|.++.+|.    .+|+|.+.....  ......+.+|+.+++++. |+||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            568999999999999999999876665    588998754432  344567889999999997 9999999999877 78


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+++|||+++++|.+++... ..+++..+..++.||+.||+|||+++++|+||||+||++   ++++.++|+|||++...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence            89999999999999998774 458999999999999999999999999999999999999   56677999999999876


Q ss_pred             cCCCceec---ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGKVYKE---IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ........   ..++..|+|||.+. ..++.++|+||||+++|++++ |..||......+....+..+......   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---PIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---CCC
Confidence            43322111   12356799999875 568899999999999999998 99999888777776666654322221   246


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +..+.+++.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-39  Score=294.01  Aligned_cols=249  Identities=19%  Similarity=0.232  Sum_probs=203.9

Q ss_pred             ccceeeeceecccCceEEEEEEEcc----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-C
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-K  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~  144 (366)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.+. |+||+++++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            4679999999999999999999875    2578999987532  22345677889999999996 9999999998765 5


Q ss_pred             CeEEEEEeccCCCchHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          145 QNLHLVMELCSGGELFDRIIAK--------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      ...++++||+.+++|.+++...        ..+++.+++.++.||+.||+|||+++++|+||||+||++   ++++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            6789999999999999998763        348899999999999999999999999999999999999   56678999


Q ss_pred             eecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCC
Q 017768          217 TDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      +|||+++........   ....++..|+|||++. ..++.++||||||+++|++++ |..||...+..+....+..+. .
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence            999999765332211   1234566799999875 458899999999999999999 999998777666555544432 2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..  ....+++++.+++.+||..||++|||+.++++
T Consensus       238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22  12346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=288.70  Aligned_cols=241  Identities=27%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.||.|+||.||++.+.. ++.||+|.+.....  ......+.+|+.+++++. |+||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            369999999999999876 99999998865432  235567899999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce---e
Q 017768          157 GELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---K  232 (366)
Q Consensus       157 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---~  232 (366)
                      ++|.+++... ..+++..+..++.+++.+|.+||+++++||||||+|||+   +.++.++|+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998764 458899999999999999999999999999999999999   56778999999998765422211   1


Q ss_pred             cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 017768          233 EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK  310 (366)
Q Consensus       233 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  310 (366)
                      ....+..|+|||++. +.++.++|+||||+++|+|++ |..||...........+...... .  ....++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-P--APQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC-C--CCccCCHHHHHHHHH
Confidence            122355699999875 568899999999999999999 88999877766655555443211 1  123568899999999


Q ss_pred             hcccCcCCCCCHHHHhc
Q 017768          311 MLTKDPKKRITAAEALE  327 (366)
Q Consensus       311 ~l~~dp~~Rpt~~~~l~  327 (366)
                      ||+.+|++|||+.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=311.00  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=237.8

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      .+++..||-|+||.|=++..+.....+|+|++++...+.....+.+..|-.+|..++ .|.||++|..|.++...|+.||
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHH
Confidence            566778999999999999887555569999999999998899999999999999998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCcee
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK  232 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~  232 (366)
                      -|-||.|...+...+.+++..+..++.-+++|++|||.+|||+|||||+|.|+   +.+|-+||.|||+|+....+....
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999   788889999999999999999999


Q ss_pred             cccCCCCCCccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 017768          233 EIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM  311 (366)
Q Consensus       233 ~~~gt~~y~aPE~~-~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  311 (366)
                      +++||+-|.|||++ +...+..+|.||||+++|||++|.+||.+.+.-.....++++.-....+  ..++....++|+++
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKL  655 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHH
Confidence            99999999999975 5668999999999999999999999999999999999999886555444  25788999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCCCcccCCC
Q 017768          312 LTKDPKKRIT-----AAEALEHPWLKEDGA  336 (366)
Q Consensus       312 l~~dp~~Rpt-----~~~~l~hp~f~~~~~  336 (366)
                      ...+|.+|..     ..||-.|-||.+.++
T Consensus       656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  656 CRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             HhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence            9999999985     899999999988665

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.6e-40  Score=295.85  Aligned_cols=248  Identities=28%  Similarity=0.428  Sum_probs=197.4

Q ss_pred             ceeeeceecccCceEEEEEEE----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--C
Q 017768           72 IYDLDKELGRGQFGVTYLCTK----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--Q  145 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~  145 (366)
                      .|++.+.||+|+||.||++..    ..++..||+|.+....  .......+.+|+.+++.+. |+||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            478899999999999999974    4468899999986432  2344567899999999997 99999999988775  5


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..+++|||+++++|.+++.... .+++.++..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence            6899999999999999987653 58999999999999999999999999999999999999   5567799999999886


Q ss_pred             ccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHH
Q 017768          225 IETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET---------------EKGIFEA  284 (366)
Q Consensus       225 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~---------------~~~~~~~  284 (366)
                      ......    .....++..|+|||++. ..++.++||||||+++|+|+++..|+....               .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543321    12345677899999865 458899999999999999999876643211               1112222


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+..   ......++..+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            222221   11233578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-39  Score=291.60  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=203.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+.|.+.+.||+|+||.||+|.+...   ...|++|......  .....+.+.+|+.+++.+. |+||+++++++.+ +.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence            34588999999999999999987543   3468999875432  1345567899999999997 9999999998875 45


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+++|+||||+||++   +.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence            789999999999999997744 58999999999999999999999999999999999999   45677999999998765


Q ss_pred             cCCCceec--ccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          226 ETGKVYKE--IVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       226 ~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ........  ..++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+..+....   ..+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCC
Confidence            44332221  22346799999875 458899999999999999986 999998887776666665543222   224678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+.++|.+||..+|++|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-39  Score=291.00  Aligned_cols=244  Identities=23%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             ceecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEecc
Q 017768           77 KELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC  154 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  154 (366)
                      +.||+|+||.||+|....  ++..+|+|.+....  .......+.+|+.+++.++ ||||+++++.+.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            358999999999998643  45679999875432  1233457888999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          155 SGGELFDRIIAKG-----IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       155 ~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.+++|+||||+||++   +.++.++|+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999987532     35677888999999999999999999999999999999   567789999999987543332


Q ss_pred             ce---ecccCCCCCCccccccc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc-CCCCCCCCC
Q 017768          230 VY---KEIVGSAYYVAPEVLHQ--------RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE-GNLDLQSSP  296 (366)
Q Consensus       230 ~~---~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~  296 (366)
                      ..   ....++..|+|||++..        .++.++||||||+++|+|++ |..||......+....... .........
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            21   12356788999998752        24789999999999999996 9999977665554333222 222222211


Q ss_pred             -CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          297 -WPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       297 -~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                       ....++.+.+++..|| .+|++|||+++++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1246788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-39  Score=291.41  Aligned_cols=240  Identities=19%  Similarity=0.229  Sum_probs=189.6

Q ss_pred             ceecccCceEEEEEEEccC------------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           77 KELGRGQFGVTYLCTKKAT------------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      +.||+|+||.||+|.....            ...+++|.+....   ......+.+|+.+++.+. ||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            3689999999999985422            2358888875432   234556788899999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC----CCCEEEeec
Q 017768          145 QNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE----DSPIKATDF  219 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~----~~~vkl~Df  219 (366)
                      ...+++|||+++++|..++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++..+.    ...++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999998888754 45899999999999999999999999999999999999953221    123899999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILL-SGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      |++......   ....++..|+|||.+.  ..++.++||||||+++|+|+ .|..||......+... .........   
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~---  229 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV---  229 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC---
Confidence            998654322   2345788899999875  45889999999999999998 5888887655443322 222222211   


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                       ...++++.++|.+||+.||++||++.+++++
T Consensus       230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence             2346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.6e-41  Score=275.58  Aligned_cols=256  Identities=28%  Similarity=0.529  Sum_probs=211.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--e
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--N  146 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~  146 (366)
                      ..++|++++++|+|.++.|+.|....+.+.++||++++      -..+.+.+|+.+|+.|.++|||++++++..+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            45679999999999999999999998999999999964      346789999999999999999999999987754  5


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ..||+||.++.+...+.   ..|+.-.+..++.+++.||.|+|+.||+|||+||.|+||+.  ....++|+|+|+|.++.
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhcC
Confidence            67999999887665544   34788899999999999999999999999999999999973  44569999999999999


Q ss_pred             CCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHc-------------CCC
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILE-------------GNL  290 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~-------------~~~  290 (366)
                      .+..++..+.+..|-.||.+-  +.++..-|+|||||+|..|+..+.||. +.++.+++..+..             -..
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            998899899999999999763  568999999999999999999998885 3333333333211             000


Q ss_pred             CC-----------CCCCC---------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          291 DL-----------QSSPW---------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       291 ~~-----------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ..           ....|         .-+++++.|++.++|..|-++|+|+.|++.||||....
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            00           00011         12568999999999999999999999999999997643

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-39  Score=288.67  Aligned_cols=241  Identities=27%  Similarity=0.389  Sum_probs=201.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||.||++..  +++.+|+|.+...     .....+.+|+.+++.++ |+||+++++++..+ ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence            4689999999999999999874  5889999988542     23467889999999997 99999999998765 47999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+.+++|.+++....  .+++..+..++.|++.||.+||+.|++||||||+||++   +.++.++|+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999997653  47899999999999999999999999999999999999   56677999999998764322


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .  .....+..|+|||++. +.++.++|+||||+++|+|++ |..||......+....+..+....   ....++..+.+
T Consensus       154 ~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  228 (254)
T cd05083         154 V--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYV  228 (254)
T ss_pred             C--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHH
Confidence            1  2223456799999875 568899999999999999997 999998887777666665543221   22357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 017768          307 LIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.+||+.+|++||++.++++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~~  250 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLREK  250 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-39  Score=289.96  Aligned_cols=244  Identities=20%  Similarity=0.323  Sum_probs=190.8

Q ss_pred             eecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||+|....  ....+++|.+....  .......+.+|+.+++.+. |+||+++++.+...+..++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCC
Confidence            58999999999996532  34478888764322  2334556788999999986 9999999999999999999999999


Q ss_pred             CCchHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          156 GGELFDRIIAKG-----IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       156 ~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      +++|.+++....     .+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh
Confidence            999999997643     24677889999999999999999999999999999999   5677899999999865432221


Q ss_pred             e---ecccCCCCCCcccccc--------ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC-CCCCCCC-C
Q 017768          231 Y---KEIVGSAYYVAPEVLH--------QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG-NLDLQSS-P  296 (366)
Q Consensus       231 ~---~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~-~  296 (366)
                      .   ....++..|+|||++.        ..++.++||||||+++|+|++ |..||......+........ ....... .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence            1   2234566799999863        246789999999999999999 78898777665555544332 2222222 1


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ...++..+.+++..|| .||++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            2357888999999999 599999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-40  Score=293.41  Aligned_cols=240  Identities=19%  Similarity=0.275  Sum_probs=190.9

Q ss_pred             ceecccCceEEEEEEEccCCc-------EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGR-------KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +.||+|+||.||+|.+...+.       .+++|.+....   ....+.+.+|+.+++.+. ||||+++++++..++..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            369999999999998865544       38888764322   234557788999999987 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-----CCCEEEeecCCcc
Q 017768          150 VMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-----DSPIKATDFGLSV  223 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-----~~~vkl~Dfg~a~  223 (366)
                      ||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.     .+.++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 4899999999999999999999999999999999999964322     1237999999986


Q ss_pred             cccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....   ....++..|+|||++.+  .++.++||||||+++|+|++|. .||.......... ........+.    ..
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CC
Confidence            55332   23457889999998864  4788999999999999999984 6665544443322 2222222222    34


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.++.++|.+||+.||++|||++++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            6789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-39  Score=289.13  Aligned_cols=237  Identities=20%  Similarity=0.231  Sum_probs=189.7

Q ss_pred             ceecccCceEEEEEEEccCC----------cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           77 KELGRGQFGVTYLCTKKATG----------RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.||+|+||.||+|.+..++          ..+++|.+....    .....+.+|+.+++.+. |+||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            36899999999999998766          357788765432    12677889999999997 9999999999887 77


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC----CCCCEEEeecCC
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE----EDSPIKATDFGL  221 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~----~~~~vkl~Dfg~  221 (366)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++...    ....++|+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998766 689999999999999999999999999999999999996432    112699999999


Q ss_pred             cccccCCCceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      +......   ....++..|+|||++..   .++.++||||||+++|+|++ |..||............... .....   
T Consensus       155 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~---  227 (259)
T cd05037         155 PITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM---  227 (259)
T ss_pred             ccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence            8875432   22356778999998764   47899999999999999999 57888666443333322211 11111   


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                       .....+.++|.+||..||++|||+.++++
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 -PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence             12378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-39  Score=286.80  Aligned_cols=228  Identities=25%  Similarity=0.355  Sum_probs=186.1

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCchHH
Q 017768           82 GQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD  161 (366)
Q Consensus        82 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  161 (366)
                      |.+|.||++.+..+++.+|+|.+....        ....|...+.... ||||+++++.+...+..+++|||+++++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            889999999999999999999986532        1223444444443 8999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCC
Q 017768          162 RIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV  241 (366)
Q Consensus       162 ~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~  241 (366)
                      ++.....+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++++|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   56677999999987655432  22335677899


Q ss_pred             cccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017768          242 APEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI  320 (366)
Q Consensus       242 aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  320 (366)
                      |||.+. +.++.++|+||+|+++|+|++|..|+.......      .......  ..+.+++.+.++|.+||+.||++|+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLN--IPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccC--CcccCCHHHHHHHHHHccCCHHHhc
Confidence            999876 458889999999999999999998875432210      0001111  1124688999999999999999999


Q ss_pred             CH-----HHHhcCCCc
Q 017768          321 TA-----AEALEHPWL  331 (366)
Q Consensus       321 t~-----~~~l~hp~f  331 (366)
                      ++     +++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            85     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=299.28  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=211.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.-.++++||+|.||.|.+|.-. .+..||||+++....  .....++.+|+++|.+|+ ||||+++++++..++.+++|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHH
Confidence            34678899999999999999865 369999999976543  234578999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||+++|+|.+++.++.  .+.......|+.||+.||+||.+.++|||||.+.|+|+   +.+.++||+|||+++.+..+
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccC
Confidence            99999999999998873  34556778899999999999999999999999999999   67888999999999987666


Q ss_pred             Cceec---ccCCCCCCcccc-ccccCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHcCC---C-CCCCCCCC
Q 017768          229 KVYKE---IVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLS--GVPPFWAETEKGIFEAILEGN---L-DLQSSPWP  298 (366)
Q Consensus       229 ~~~~~---~~gt~~y~aPE~-~~~~~~~~~Di~slG~vl~~ll~--g~~pf~~~~~~~~~~~~~~~~---~-~~~~~~~~  298 (366)
                      +.+..   .+-..+|||+|. +.++++.++|+|+||++|||+++  ...||...+.+++++....--   . ..-....+
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            65443   244678999996 56899999999999999999976  789999888888777653311   1 11111223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      -++..+.+++.+||..|-++||+++++-.  +|++
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~--~lq~  803 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHL--FLQE  803 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence            46889999999999999999999999844  4544

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=315.80  Aligned_cols=245  Identities=32%  Similarity=0.491  Sum_probs=199.9

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC------e
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ------N  146 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~------~  146 (366)
                      |...+.||+|+||.||+++++.+|+.||||.+....  .....+.+-+|+++|+++. |+|||++.++-+...      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccccc
Confidence            667788999999999999999999999999986543  4567888999999999998 999999999876544      4


Q ss_pred             EEEEEeccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCc
Q 017768          147 LHLVMELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLS  222 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a  222 (366)
                      ..++||||.||||...++..   ..|++.+++.++.++..||.|||++||+||||||.||++-...+ ....||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            67999999999999999764   35999999999999999999999999999999999999965443 334699999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCC------
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNL------  290 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~------  290 (366)
                      +..+++......+||+.|.+||++.  +.|+..+|.|||||++|+..||..||...-.    .+....+..++.      
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            9999999899999999999999886  5689999999999999999999999943322    222222222111      


Q ss_pred             ---------CC------CCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017768          291 ---------DL------QSSPWPSISGQAKDLIRKMLTKDPKKRI  320 (366)
Q Consensus       291 ---------~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp  320 (366)
                               .+      +....+.+-..+...+..+|..+|++|.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                     11      1111122334566788899999999998

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-39  Score=291.72  Aligned_cols=239  Identities=19%  Similarity=0.199  Sum_probs=189.1

Q ss_pred             eecccCceEEEEEEEccC------------------------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc
Q 017768           78 ELGRGQFGVTYLCTKKAT------------------------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN  133 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~  133 (366)
                      .||+|+||.||+|....+                        ...|++|.+....   ......+.+|+.+++.+. |+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            599999999999975322                        2358888875432   233456778888998887 999


Q ss_pred             eeEeceEEeeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC---
Q 017768          134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE---  209 (366)
Q Consensus       134 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~---  209 (366)
                      |+++++++......++||||+++++|..++.. .+.+++.++..++.||+.||+|||+++|+||||||+|||++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999998876 45689999999999999999999999999999999999996422   


Q ss_pred             -CCCCEEEeecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q 017768          210 -EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILL-SGVPPFWAETEKGIFEAI  285 (366)
Q Consensus       210 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll-~g~~pf~~~~~~~~~~~~  285 (366)
                       ....++++|||++......   ....++..|+|||.+.+  .++.++||||||+++|+++ +|..||............
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence             2234899999987654222   22357788999998753  4789999999999999985 699999876655443322


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                       ......+.    ..+..+.++|.+||+.+|++|||+.+++++
T Consensus       235 -~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 -EKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             22222221    245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.7e-39  Score=290.38  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=194.1

Q ss_pred             cceeeeceecccCceEEEEEEE----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--C
Q 017768           71 TIYDLDKELGRGQFGVTYLCTK----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--K  144 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~  144 (366)
                      ..|++.+.||+|+||.||++..    ..++..||+|.+....   ......+.+|+.+++.+. |+||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence            3688999999999999999974    4568899999986432   344567889999999997 9999999997643  3


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 QNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ...+++|||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||++   ++++.++|+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence            4689999999999999999764 458999999999999999999999999999999999999   567789999999998


Q ss_pred             cccCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------------HHH
Q 017768          224 FIETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GIF  282 (366)
Q Consensus       224 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----------------~~~  282 (366)
                      ........    ....++..|+|||++. ..++.++||||||+++|||++|..++......                ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            76433221    1112344699999876 45889999999999999999987765332211                011


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+... ...  .....++.++.+++.+||..+|++|||+.++++
T Consensus       237 ~~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         237 ELLKNN-GRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHhcC-CcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111111 111  112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=299.36  Aligned_cols=264  Identities=31%  Similarity=0.463  Sum_probs=220.6

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc----ccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD----KDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .+.++|-++.+||+|+|+.||+|.+....+.||||+-.....+.+    ...+...+|.++-+.|. ||.||++|+++.-
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeee
Confidence            456789999999999999999999998899999998654433322    23445678999999998 9999999999964


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       .+.++-|+|||+|.+|.-+++....+++.+++.|+.||+.||.||....  |||.||||.|||+......|.+||.|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence             5678999999999999999999999999999999999999999999875  9999999999999888888999999999


Q ss_pred             CcccccCCCc--------eecccCCCCCCcccccc-c----cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH--
Q 017768          221 LSVFIETGKV--------YKEIVGSAYYVAPEVLH-Q----RYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEA--  284 (366)
Q Consensus       221 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~--  284 (366)
                      +++.+..+..        .....||.+|.+||.+- +    +++.++||||+|||+|..+.|+.||.....+ ++++.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9998864331        23458999999999763 2    4789999999999999999999999765433 33322  


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      +++. ....++..|-++.++.++|++||..--++|.+..++..||||..
T Consensus       699 IlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            2221 23344455678999999999999999999999999999999976

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.5e-39  Score=286.45  Aligned_cols=243  Identities=24%  Similarity=0.347  Sum_probs=192.5

Q ss_pred             ceecccCceEEEEEEEcc---CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe-eCCeEEEEEe
Q 017768           77 KELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE-DKQNLHLVME  152 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~~~~lv~e  152 (366)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .......+.+|+.+++.+. ||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998653   24579999874321  2234567888999999987 999999999765 4556899999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc-
Q 017768          153 LCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-  230 (366)
                      |+.+++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+|||+   ++++.+||+|||++........ 
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            999999999987643 46788889999999999999999999999999999999   5677899999999875532211 


Q ss_pred             ----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          231 ----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       231 ----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                          .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+..+......   ...++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP---EYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHHH
Confidence                11234567899999875 568899999999999999999 56677766666665555554322211   2357899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++.+||..+|++||++.++++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.3e-39  Score=293.43  Aligned_cols=248  Identities=25%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++.+. |+||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            458888999999999999999877776    46888775332  1233446889999999997 99999999988654 4


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++++||+++++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||++   ++++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence            678999999999999987654 58999999999999999999999999999999999999   55677999999999865


Q ss_pred             cCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....   .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.. ...  .+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LPQ--PPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCC--CCCC
Confidence            43221   11233567899999876 468899999999999999997 8999987766555554443322 221  2346


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+.+++.+||..||++||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.4e-39  Score=289.37  Aligned_cols=244  Identities=26%  Similarity=0.403  Sum_probs=197.5

Q ss_pred             eecccCceEEEEEEEccCC------cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           78 ELGRGQFGVTYLCTKKATG------RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      .||+|+||.||+|......      ..+|+|.+....  .......+.+|+.+++.+. |+||+++++++...+..+++|
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEE
Confidence            5899999999999876433      679999875432  1244667889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCc
Q 017768          152 ELCSGGELFDRIIAK-------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLS  222 (366)
Q Consensus       152 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a  222 (366)
                      ||+++++|.+++...       ..+++.++..++.|++.+|.|||+.+++|+||||+||+++.++  ....++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998753       2378899999999999999999999999999999999996433  2237999999998


Q ss_pred             ccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          223 VFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       223 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ........   .....++..|+|||++. +.++.++||||||+++|+|++ |..||...+..+....+..+...   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~  235 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKP  235 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCc
Confidence            76533221   11234567899999875 568999999999999999998 99999877766665555443211   112


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..++..+.++|.+||..+|++||++.++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            356889999999999999999999999976

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-39  Score=292.47  Aligned_cols=249  Identities=14%  Similarity=0.160  Sum_probs=184.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccC---CcEEEEEEeeccccccccc--------HHHHHHHHHHHHHhcCCCceeEe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKD--------MEDVRREILILQHLTGQPNIVEF  137 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~  137 (366)
                      ..++|++.+.||+|+||.||+|.+..+   +..+|+|+...........        ......+...+..+. |++|+.+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~   88 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKY   88 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcE
Confidence            346799999999999999999998876   6677777643221110000        011122233344444 8999999


Q ss_pred             ceEEeeCC----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          138 EGAYEDKQ----NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       138 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      ++......    ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||+   +.++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~~  164 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNNR  164 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCc
Confidence            98765543    3477888874 3666666665557889999999999999999999999999999999999   55677


Q ss_pred             EEEeecCCcccccCCC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-H---
Q 017768          214 IKATDFGLSVFIETGK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK-G---  280 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~---  280 (366)
                      ++|+|||+++......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .   
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999997653211        1123469999999998764 5899999999999999999999999876322 2   


Q ss_pred             -----HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 -----IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                           ....+..+..     ..+..++++.+++..||..+|++||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                 1222222222     22356889999999999999999999999976

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=314.97  Aligned_cols=247  Identities=24%  Similarity=0.434  Sum_probs=218.8

Q ss_pred             eeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -.|.+.||.|.||.||+|+.+..|+   .||||.++..-  .++...+|+.|..||-++. ||||+++.++........|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEE
Confidence            4688999999999999999988775   79999997543  3566778999999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |.|||++|+|..+|+.+ +.|+..++.-+++.|+.|+.||.+.++|||||-..|||+   +.+..+|++|||+++..+++
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence            99999999999999875 458999999999999999999999999999999999999   56777999999999988655


Q ss_pred             C--ceecccCC--CCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          229 K--VYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~--~~~~~~gt--~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .  .+++..|.  .+|.|||++. ++++.++||||+|+||||.++ |..|||+..+++++..+.++..-++..   +++.
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---DCP~  861 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---DCPA  861 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---CCcH
Confidence            4  23333333  5799999886 789999999999999999988 999999999999999999986655543   6789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+.+|+..||++|-.+||.+.+|+++
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.3e-39  Score=287.18  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             eeeeceecccCceEEEEEEEcc---CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC----
Q 017768           73 YDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ----  145 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~----  145 (366)
                      |.+.+.||+|+||.||+|.+..   ++..+|+|.+.... ......+.+.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            5678899999999999998643   57899999986543 23345667889999999997 999999999886532    


Q ss_pred             --eEEEEEeccCCCchHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          146 --NLHLVMELCSGGELFDRIIAKG------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       146 --~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                        ..+++++|+.+++|..++....      .+++..++.++.|++.||+|||+++|+|+||||+||++   +.++.++|+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              2478899999999988875432      47889999999999999999999999999999999999   567779999


Q ss_pred             ecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCC
Q 017768          218 DFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       218 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      |||++........   .....++..|++||.+. +.++.++||||||+++|+|++ |..||...+..+....+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999886543321   11223456799999875 457889999999999999999 899998777766666555443221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                         ..+..+..+.+++.+||+.+|++||++.+++.+
T Consensus       236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               113567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=307.92  Aligned_cols=256  Identities=29%  Similarity=0.471  Sum_probs=214.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----  143 (366)
                      -.+.|++.+.||.|.+|.||+++.+.+++.+|+|+....    ....++++.|.++|+.+.+|||++.++++|..     
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            345699999999999999999999999999999998654    35567889999999999999999999999864     


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      ++.+|||||||.||+..++++..  ..+.|..+..|++.++.||.+||.+.++|||||-.|||+   ..++.|||+|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeee
Confidence            56899999999999999998763  468999999999999999999999999999999999999   5667799999999


Q ss_pred             cccccCC-CceecccCCCCCCccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          222 SVFIETG-KVYKEIVGSAYYVAPEVLHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       222 a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                      +...... ...++.+||+.|||||++.-      .|+..+|+||||++.+||--|.+|+-++-.-..+-.+-.. ..+..
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkL  248 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL  248 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccc
Confidence            8876543 24567799999999999852      3778999999999999999999999766443222111111 11111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ..+...+.++.++|..||..|.++||+..++|.|||++
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            12334578999999999999999999999999999999

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.4e-39  Score=288.93  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=198.2

Q ss_pred             ceeeeceecccCceEEEEEEEcc----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKA----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQ  145 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~  145 (366)
                      .|++.+.||+|+||.||+|....    ++..+|+|.+.....  ......+.+|+.+++.+. |+||+++++++..  ..
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCC
Confidence            47788999999999999998653    478999999865432  134678999999999997 9999999998877  55


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..+++|||+++++|.+++.... .+++..+..++.||+.||.+||++|++|+||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence            7899999999999999997654 58999999999999999999999999999999999999   5568899999999987


Q ss_pred             ccCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHH
Q 017768          225 IETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK---------------GIFEA  284 (366)
Q Consensus       225 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------------~~~~~  284 (366)
                      .......    ....++..|++||.+. ..++.++||||||+++|+|++|..|+......               ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532211    1123456799999875 56888999999999999999999998543221               12222


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.... ...  ....++.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         239 LKEGE-RLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHcCC-cCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22221 111  12346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=284.00  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=189.6

Q ss_pred             eecccCceEEEEEEEccCC--cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGVTYLCTKKATG--RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .||+|+||.||++....++  ..+++|.+....  .....+.+.+|+.+++.++ ||||+++++.+......+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence            5999999999999754322  346666654332  1234568899999999987 9999999999999999999999999


Q ss_pred             CCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          156 GGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       156 ~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      +++|.+++...    ..+++..+..++.||+.||.|||+.+++||||||+|||+   +.++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999999764    235677889999999999999999999999999999999   567789999999986432211  


Q ss_pred             -ceecccCCCCCCccccccc--------cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC-CCCCC-CCC
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ--------RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN-LDLQS-SPW  297 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~-~~~~~-~~~  297 (366)
                       ......++..|+|||++..        .++.++||||||+++|+|++ |..||......+....+..+. ..... ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1123467889999998632        34678999999999999997 577887776666666554332 22211 112


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+++.+.+++..|| .+|++||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            347889999999999 68999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=298.50  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             eeeeceecccCceEEEEEEEccC--Cc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKAT--GR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.+.||.|.||.||+|.+..-  |.  .||||.-+.+.  ..++.+.|..|..+++.+. ||||++++|++.+ ...|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec-ccee
Confidence            44567899999999999987532  33  57778765543  3456889999999999998 9999999999865 4689


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||+++.|.|.++++.+. .|+......++.||+.+|.|||+.++|||||-..|||+.   ...-|||+|||+++...+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccc
Confidence            9999999999999998764 589999999999999999999999999999999999995   445599999999999887


Q ss_pred             CCceecccCC--CCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~~~~~gt--~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ...+....|.  .-|||||-++ .+|+.++|||-|||+|||+++ |..||.+..+.+++-.+.+|...+..+   .+++.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~---nCPp~  620 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP---NCPPA  620 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC---CCChH
Confidence            7766655543  4699999987 579999999999999999987 999999999998888888876554443   57889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +..|+.+||..||.+||++.++..
T Consensus       621 LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999999999988765

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=301.50  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=214.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+..++.++||+|.||+|++|.++..+.   .||||.+.....  .....+|.+|+.+|.+|+ |+|++++|++..+ ..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--chhHHHHHHHHHHHHhcc-CcceeEEeeeecc-ch
Confidence            3446777899999999999999876433   799999976654  337889999999999998 9999999999877 67


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          147 LHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..+|||+++.|+|.+.|++.  ..|.......++.||+.||.||..++.|||||-..|+|+.   ....|||+|||+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceec
Confidence            78999999999999999872  3488899999999999999999999999999999999995   455699999999998


Q ss_pred             ccCCCceeccc----CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          225 IETGKVYKEIV----GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       225 ~~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      +..++.+-...    -...|+|||.+. .+|+.++|+|+|||++|||++ |..||.+....++++.+..+..-...   +
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---k  338 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---K  338 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---C
Confidence            86555333322    234699999987 679999999999999999999 89999999999999988865443333   3


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      .+++.+.+++..||..+|++|||+..|.+..+..
T Consensus       339 ~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             CChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            5789999999999999999999999987654443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.1e-38  Score=309.69  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=176.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccC----CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceE----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT----GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGA----  140 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~----  140 (366)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|.+....     ..+....|  .++... +.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~-~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRAC-PNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhc-hhhHHHHHHhhhcc
Confidence            456799999999999999999999988    8999999875321     11111111  111111 1222222111    


Q ss_pred             --EeeCCeEEEEEeccCCCchHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCEEecc
Q 017768          141 --YEDKQNLHLVMELCSGGELFDRIIAKGI--------------------YSEREAANICRQIVNVVHACHFMGVIHRDL  198 (366)
Q Consensus       141 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  198 (366)
                        ...+...++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+++|+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2356679999999999999998875421                    123456789999999999999999999999


Q ss_pred             CCCcEEeeecCCCCCEEEeecCCcccccCC--CceecccCCCCCCcccccc-c----------------------cCCCc
Q 017768          199 KPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSAYYVAPEVLH-Q----------------------RYGKE  253 (366)
Q Consensus       199 kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~----------------------~~~~~  253 (366)
                      ||+|||++  .+++.+||+|||++......  .......+++.|+|||.+. .                      .++.+
T Consensus       282 KP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999995  24567999999999865332  2234567899999999652 1                      12345


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-------CC----------CCCCCCCHHHHHHHHHhcccCc
Q 017768          254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-------QS----------SPWPSISGQAKDLIRKMLTKDP  316 (366)
Q Consensus       254 ~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~li~~~l~~dp  316 (366)
                      +|||||||+||||+++..++... .......+.......       ..          ...........+||.+||+.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            69999999999999976664322 111111111110000       00          0000113345689999999999


Q ss_pred             CCCCCHHHHhcCCCcccCCCC
Q 017768          317 KKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       317 ~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ++|||+.++|+||||++....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999886654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=294.89  Aligned_cols=241  Identities=23%  Similarity=0.388  Sum_probs=213.1

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      ....+||-|.||.||.|.++.-...||||.++.+.    -..++|..|..+++.+. |||+|+++++|..+-.+|||.||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEec
Confidence            44568999999999999999888899999987543    46789999999999998 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          154 CSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      |..|.|.++|+..++  ++.-..+.++.||..|++||..+++|||||-..|.|+   +++..||++|||+++++..+. +
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT-Y  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT-Y  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc-e
Confidence            999999999987654  6777889999999999999999999999999999999   788889999999999885443 4


Q ss_pred             ecccC---CCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          232 KEIVG---SAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       232 ~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      +...|   .+.|.|||-+. ..++.++|||+|||+|||+.| |..||.+-+..++...+.++.......   ++++.+.+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe---GCPpkVYe  497 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE---GCPPKVYE  497 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC---CCCHHHHH
Confidence            44444   35699999876 579999999999999999998 999999999998888888876555443   68899999


Q ss_pred             HHHHhcccCcCCCCCHHHHh
Q 017768          307 LIRKMLTKDPKKRITAAEAL  326 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l  326 (366)
                      |++.||++.|.+||++.|+-
T Consensus       498 LMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHH
Confidence            99999999999999999983

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.1e-40  Score=297.20  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=212.0

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-----CCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-----QPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~i~~~~~~~~~  143 (366)
                      +.++|.+....|+|-|++|..|.+...|+.||||++....    .-.+.-..|+++|++|..     .-|+++++..|..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            4557888889999999999999999999999999996443    334556789999999973     3589999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      .+++|||+|-+ ...|.+.|++.+   .|....+..++.||+.||..|-.+||+|.||||+|||++  .....+||||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfG  582 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFG  582 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCc
Confidence            99999999988 458999998765   388899999999999999999999999999999999996  345578999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC----
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS----  295 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  295 (366)
                      .|....... .+.+..+..|+|||++.+ .|+...|+||+||+||||+||+..|.+.+++.++.....-...++..    
T Consensus       583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  583 SASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            998876554 334456778999998765 69999999999999999999999999999888777653211111000    


Q ss_pred             -----------------------------------C----------CCCC-------CHHHHHHHHHhcccCcCCCCCHH
Q 017768          296 -----------------------------------P----------WPSI-------SGQAKDLIRKMLTKDPKKRITAA  323 (366)
Q Consensus       296 -----------------------------------~----------~~~~-------~~~~~~li~~~l~~dp~~Rpt~~  323 (366)
                                                         +          .+.+       -.++.+|+.+||..||++|.|..
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                               0          0011       23688999999999999999999


Q ss_pred             HHhcCCCccc
Q 017768          324 EALEHPWLKE  333 (366)
Q Consensus       324 ~~l~hp~f~~  333 (366)
                      ++|.||||+.
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=308.59  Aligned_cols=249  Identities=32%  Similarity=0.510  Sum_probs=201.1

Q ss_pred             ceeeeceecccCceE-EEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           72 IYDLDKELGRGQFGV-TYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      .|.-.+.+|.|+.|+ ||+|.+.  |+.||||.+-.      .....+.+|+..|+....||||+++++.-.+....||+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            356667899999875 7999986  89999998743      34556789999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC--CCEEEeecCCccc
Q 017768          151 MELCSGGELFDRIIAKGI----YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED--SPIKATDFGLSVF  224 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~--~~vkl~Dfg~a~~  224 (366)
                      .|+|. .+|.+++.....    ......+.++.|+++||++||+.+||||||||.||||+..+.+  ..++|+|||+++.
T Consensus       582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            99995 599999987411    1114568899999999999999999999999999999864333  4689999999998


Q ss_pred             ccCCCc----eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          225 IETGKV----YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       225 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      +..+..    ..+..||.+|+|||++.. .-..++||||||||+|+.++| ..||.+.-.++  ..|..+......... 
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~-  737 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEP-  737 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeecc-
Confidence            865542    345679999999999874 456789999999999999995 99996654433  345555554433211 


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ....++.+||.+|+++||..||++.++|.||||=
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            1122899999999999999999999999999993

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2e-37  Score=272.53  Aligned_cols=242  Identities=48%  Similarity=0.770  Sum_probs=206.0

Q ss_pred             CceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCchHHH
Q 017768           83 QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR  162 (366)
Q Consensus        83 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  162 (366)
                      +||.||+|....+|+.+++|++......  .....+.+|+..++++. |+||+++++.+......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK--KKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc--cHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            5899999999988999999998654321  11678999999999995 99999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCc
Q 017768          163 IIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA  242 (366)
Q Consensus       163 l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a  242 (366)
                      +.....++...++.++.+++.++.+||+.+++|+||+|+||++   ++++.++|+|||.+.............++..|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            9877668999999999999999999999999999999999999   4557899999999988766544555678899999


Q ss_pred             ccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017768          243 PEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI  320 (366)
Q Consensus       243 PE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  320 (366)
                      ||.+. ..++.++|||+||++++++++|..||.. .......+........... ....++.++.+++.+||..||++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence            99875 5688899999999999999999999977 4455555555444433322 1122788999999999999999999


Q ss_pred             CHHHHhcCCCc
Q 017768          321 TAAEALEHPWL  331 (366)
Q Consensus       321 t~~~~l~hp~f  331 (366)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=270.58  Aligned_cols=258  Identities=29%  Similarity=0.465  Sum_probs=212.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+..+|.-.+.+|.|+- .|..+.+.-.+++||+|+.... +......++..+|..++..+. |+||++++.++....
T Consensus        12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK   88 (369)
T ss_pred             ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence            3455667888899999998 7888888889999999998765 556677888999999999998 999999999997543


Q ss_pred             ------eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 ------NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 ------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                            ..|+|||+++. +|.+.+..  .++-..+..++.|++.|+.|||+.||+||||||+||++   ..+..+||.||
T Consensus        89 ~l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~df  162 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDF  162 (369)
T ss_pred             cHHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccc
Confidence                  58999999965 88888873  36888999999999999999999999999999999999   56677999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC--------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL--------  290 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~--------  290 (366)
                      |+|+.....-..+.++.|..|+|||++-+ .+...+||||+||++.||++|...|.+.+.-+...++...-.        
T Consensus       163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            99998777656677889999999998643 488999999999999999999999987766554444322100        


Q ss_pred             -----------------------CCCCCCCC-------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          291 -----------------------DLQSSPWP-------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       291 -----------------------~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                                             .++...++       .-+..+++++.+||..||++|.++.++|.||||+
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                   01111111       1245789999999999999999999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.9e-37  Score=291.81  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=186.4

Q ss_pred             cccceeeeceecccCceEEEEEEEc----------------cCCcEEEEEEeecccccc-----------cccHHHHHHH
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK----------------ATGRKYACKSISRRKLVY-----------DKDMEDVRRE  121 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e  121 (366)
                      ..++|++.++||+|+||+||+|...                ..++.||||.+.......           ....+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3567999999999999999999642                245689999985432110           0011223457


Q ss_pred             HHHHHHhcCCC----ceeEeceEEee--------CCeEEEEEeccCCCchHHHHHHhC----------------------
Q 017768          122 ILILQHLTGQP----NIVEFEGAYED--------KQNLHLVMELCSGGELFDRIIAKG----------------------  167 (366)
Q Consensus       122 ~~~l~~l~~h~----~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------  167 (366)
                      +.++.++.+++    +++++++++..        .+..+||+||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            77777776333    24566666543        356899999999999999886421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecc--cCCCCCCcc
Q 017768          168 --IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--VGSAYYVAP  243 (366)
Q Consensus       168 --~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~--~gt~~y~aP  243 (366)
                        .+++..+..++.|++.+|.|||+.+|+||||||+|||+   +.++.+||+|||++............  .+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              23566789999999999999999999999999999999   55678999999999765433322222  347899999


Q ss_pred             cccccc---------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHHHHHcC
Q 017768          244 EVLHQR---------------------Y--GKEIDVWSAGVILYILLSGVP-PFWAETEK-----------GIFEAILEG  288 (366)
Q Consensus       244 E~~~~~---------------------~--~~~~Di~slG~vl~~ll~g~~-pf~~~~~~-----------~~~~~~~~~  288 (366)
                      |++...                     +  ..+.|+||+||++|+|++|.. ||......           ...+.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            986421                     1  124799999999999999875 66432110           111111222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCc---CCCCCHHHHhcCCCcccC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDP---KKRITAAEALEHPWLKED  334 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rpt~~~~l~hp~f~~~  334 (366)
                      ..  ....+...++...+++.+||..+|   .+|+|+.|+|+||||...
T Consensus       460 ~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        460 KY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            22  233455678999999999999876   689999999999999653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=271.91  Aligned_cols=260  Identities=31%  Similarity=0.511  Sum_probs=201.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-------CceeEeceEEee
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-------PNIVEFEGAYED  143 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-------~~i~~~~~~~~~  143 (366)
                      .+|-+.++||.|-|++||+|.+..+.+.||+|+.+..    +...+....||++|++++.+       .+||++++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            6899999999999999999999999999999998643    35667788999999998743       479999999975


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecC-------
Q 017768          144 ----KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKE-------  209 (366)
Q Consensus       144 ----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~-------  209 (366)
                          +.++++|+|++ |..|..++....  .++...++.|++||+.||.|||. +||||-||||+|||+...+       
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence                45899999999 889999998754  49999999999999999999995 6999999999999993110       


Q ss_pred             --------------------------------------------------------------------------------
Q 017768          210 --------------------------------------------------------------------------------  209 (366)
Q Consensus       210 --------------------------------------------------------------------------------  209 (366)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------C----------------------------------------------------CCC
Q 017768          210 ------------------------E----------------------------------------------------DSP  213 (366)
Q Consensus       210 ------------------------~----------------------------------------------------~~~  213 (366)
                                              .                                                    +..
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                    0                                                    002


Q ss_pred             EEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHH-
Q 017768          214 IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET------EKGIFEAI-  285 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~------~~~~~~~~-  285 (366)
                      |||+|||-|+...  ..++....|..|+|||++. ..|+..+||||++|+++||.||-..|....      .++.+..+ 
T Consensus       393 vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  393 VKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             EEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            5666666665432  2234446788999999875 579999999999999999999999994331      12222222 


Q ss_pred             -----------HcCCCCCC-------------CCCCC-------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          286 -----------LEGNLDLQ-------------SSPWP-------------SISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       286 -----------~~~~~~~~-------------~~~~~-------------~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                                 +.|+....             ...|+             .-..++.+|+.-||+.+|++|||+.++|+|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence                       11221111             11121             123568899999999999999999999999


Q ss_pred             CCcccCCCC
Q 017768          329 PWLKEDGAT  337 (366)
Q Consensus       329 p~f~~~~~~  337 (366)
                      ||+.....+
T Consensus       551 PwLn~~~~~  559 (590)
T KOG1290|consen  551 PWLNPVAGP  559 (590)
T ss_pred             ccccCCCCC
Confidence            999976654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=273.37  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=198.2

Q ss_pred             CCCCCCCc---cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHH--hcCCCc
Q 017768           59 GPILGKPY---VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH--LTGQPN  133 (366)
Q Consensus        59 ~~~~~~~~---~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~  133 (366)
                      |.-+|.+.   ..+...-.+.+.||+|.||.||+|.++  |+.||||++..      .+...+.+|.++++.  |+ |+|
T Consensus       196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLR-HEN  266 (513)
T KOG2052|consen  196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVMLR-HEN  266 (513)
T ss_pred             CCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHhc-cch
Confidence            33344443   345666789999999999999999998  99999999964      345567888888877  45 999


Q ss_pred             eeEeceEEeeCC----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeccCCC
Q 017768          134 IVEFEGAYEDKQ----NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--------GVIHRDLKPE  201 (366)
Q Consensus       134 i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~  201 (366)
                      |+.+++.-..++    .+|||.+|.+.|||+++|.. ..++.....+++..++.||++||..        .|.|||||..
T Consensus       267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK  345 (513)
T KOG2052|consen  267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK  345 (513)
T ss_pred             hhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence            999998765433    68999999999999999988 5689999999999999999999953        4999999999


Q ss_pred             cEEeeecCCCCCEEEeecCCcccccCCC-----ceecccCCCCCCccccccccC-------CCchhHHHHHHHHHHHHhC
Q 017768          202 NFLLASKEEDSPIKATDFGLSVFIETGK-----VYKEIVGSAYYVAPEVLHQRY-------GKEIDVWSAGVILYILLSG  269 (366)
Q Consensus       202 NIll~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~Di~slG~vl~~ll~g  269 (366)
                      |||+   ..++.+.|+|+|+|.......     ..+..+||.+|||||++....       -+.+||||||.||||+...
T Consensus       346 NILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  346 NILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             cEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            9999   678889999999998765432     345679999999999997532       2468999999999999752


Q ss_pred             ----------CCCCCCC-----ChHHHHHHHHcCCCCCCC-CCCCC--CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          270 ----------VPPFWAE-----TEKGIFEAILEGNLDLQS-SPWPS--ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       270 ----------~~pf~~~-----~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                                ..||.+.     ..++..+-+...+..+.. ..|..  .-..+.++++.||..||..|.|+-.+-+
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                      5777543     223333334444433332 22322  2245678899999999999999866643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=268.49  Aligned_cols=257  Identities=28%  Similarity=0.441  Sum_probs=207.4

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-----eEE
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-----NLH  148 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-----~~~  148 (366)
                      +-.+.||.|+||+||.+.+..+|+.||+|++.. -+..-..-+.+.+|+++|..++ |.|++..+++....+     .+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHH
Confidence            345689999999999999999999999998742 2223345667889999999998 999999998876544     467


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ++.|++.. +|+..+.....++.+.++-++.||+.||.|||+.+|.||||||.|.|+   +.+-.+||||||+|+..+.+
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence            88898854 888888888889999999999999999999999999999999999999   45666999999999987654


Q ss_pred             C--ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC----------------
Q 017768          229 K--VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG----------------  288 (366)
Q Consensus       229 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~----------------  288 (366)
                      .  ..+..+-|.+|+|||++.+  +|+...||||+||++.|++..+..|+....-+.++.+..-                
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            4  3344577899999998764  6999999999999999999999999877666655555321                


Q ss_pred             -------CCCCC-CCCC------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          289 -------NLDLQ-SSPW------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       289 -------~~~~~-~~~~------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                             ....+ ....      ..-..+...++..+|.+||++|.+.++++.|++..+...
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence                   11000 0000      123457889999999999999999999999999977443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3.6e-37  Score=274.24  Aligned_cols=256  Identities=31%  Similarity=0.481  Sum_probs=202.6

Q ss_pred             ccccceeeeceecccCceEEEEEEEcc---CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+.+.|.++.+||.|.|++||++.+..   .++.||+|.+..     .....++.+|+++|..+.++.||+.+.+.+..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-----ccCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            455669999999999999999998877   688999998854     345677999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +...+|+||++.....++...   ++..++..+++.++.||.++|.+|||||||||+|+|++.  ..+.-.|+|||+|..
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLAQR  182 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhHHH
Confidence            999999999998777776654   679999999999999999999999999999999999974  455678999999872


Q ss_pred             ccC-------------------CC--------------------------ceecccCCCCCCcccccc--ccCCCchhHH
Q 017768          225 IET-------------------GK--------------------------VYKEIVGSAYYVAPEVLH--QRYGKEIDVW  257 (366)
Q Consensus       225 ~~~-------------------~~--------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~  257 (366)
                      .+.                   +.                          ..-...||++|+|||++.  ..-+.++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            100                   00                          001247999999999976  3568899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChH-HHHHHH--------------HcCC-------------------CC------------
Q 017768          258 SAGVILYILLSGVPPFWAETEK-GIFEAI--------------LEGN-------------------LD------------  291 (366)
Q Consensus       258 slG~vl~~ll~g~~pf~~~~~~-~~~~~~--------------~~~~-------------------~~------------  291 (366)
                      |.|||++.+++++.||...... +.+..+              ..+.                   ..            
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999999432111 000000              0011                   00            


Q ss_pred             -CCCCCC-CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          292 -LQSSPW-PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       292 -~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                       .....+ ...+..+.+++.+||+.||.+|.|++++|.||||..
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence             000011 124558999999999999999999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=241.91  Aligned_cols=209  Identities=27%  Similarity=0.366  Sum_probs=176.1

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      -.....||+|++|.|=+.++..+|...|+|.+...  ...+...+..+|+.+..+...+|.+|.+|+.+......||+||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            33456799999999999999999999999998654  3467778899999999998889999999999999999999999


Q ss_pred             ccCCCchHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          153 LCSGGELFDRI----IAKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       153 ~~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      .++. +|..+-    .....++|..+-+|+..++.||.|||++ .++|||+||+|||+   +..|+||+||||.+..+.+
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehh
Confidence            9954 775443    3456799999999999999999999975 79999999999999   7788999999999988876


Q ss_pred             CCceecccCCCCCCccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHc
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-----RYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILE  287 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~  287 (366)
                      +-..+...|...|||||.+..     .|+.++||||||++++||.+++.||..- +.-+++.++..
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            665555689999999998752     4889999999999999999999999432 33344444443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=265.99  Aligned_cols=241  Identities=28%  Similarity=0.402  Sum_probs=187.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc-CCCceeEeceEEeeCC----eE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-GQPNIVEFEGAYEDKQ----NL  147 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~----~~  147 (366)
                      -++.+.||+|.||.||+|...  ++.||||++.      ..+...+.+|-+++.... .|+||++++++-....    .+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            456778999999999999986  7999999985      356777888888887743 4999999999877665    89


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---------GVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      +||++|.+.|+|.++|..+ .+++....+++..|++||+|||+-         .|+|||||..||||   ..+++..|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeec
Confidence            9999999999999999765 479999999999999999999964         59999999999999   6788999999


Q ss_pred             cCCcccccCCC---ceecccCCCCCCccccccccC--C-----CchhHHHHHHHHHHHHhCCC------------CCCCC
Q 017768          219 FGLSVFIETGK---VYKEIVGSAYYVAPEVLHQRY--G-----KEIDVWSAGVILYILLSGVP------------PFWAE  276 (366)
Q Consensus       219 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~-----~~~Di~slG~vl~~ll~g~~------------pf~~~  276 (366)
                      ||+|..+..+.   .....+||.+|||||++.+..  .     .+.||||+|.|||||++...            ||...
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            99998875433   223378999999999997642  2     46899999999999998643            33211


Q ss_pred             -----ChHHHHHHHHcCCCCCC-CCCCC--CCCHHHHHHHHHhcccCcCCCCCHHHH
Q 017768          277 -----TEKGIFEAILEGNLDLQ-SSPWP--SISGQAKDLIRKMLTKDPKKRITAAEA  325 (366)
Q Consensus       277 -----~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~~~  325 (366)
                           +.++.-+.+...+..+. ...|.  .....+.+.++.||..|++.|.|+.=+
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 22233333333222221 11121  234678899999999999999997543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=288.94  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             eeeeceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           73 YDLDKELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..+.+.||+|+||.|++|....       ....||||.++...  ...+.+.+..|+.+++.+..|+||+.+++++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3566799999999999997432       14579999886543  23678889999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          146 NLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ..++|+||++.|+|.++++..+                .++..+...++.||+.|++||++.++|||||-..|||+   .
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---T  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---c
Confidence            9999999999999999998876                38889999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCCceec--ccC--CCCCCccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGKVYKE--IVG--SAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAET-EKGIF  282 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~-g~~pf~~~~-~~~~~  282 (366)
                      .+..+||+|||+|+.......+..  ..+  ...|||||.+.. .|+.++||||||++|||+++ |..||.+-. ..+..
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            667899999999997655554432  222  235999998874 69999999999999999999 899998755 66677


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.+..|.......   .+++++.+++..||+.+|++||++.++.+
T Consensus       533 ~~l~~G~r~~~P~---~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 EFLKEGNRMEQPE---HCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHhcCCCCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            7777776654443   45899999999999999999999999977

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=309.70  Aligned_cols=240  Identities=22%  Similarity=0.266  Sum_probs=182.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|+..+.||+|+||.||+|.+..+|..||+|.+.....       ....|+..+++++ ||||+++++++.+.+..++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence            346667789999999999999988999999998853211       1234688888987 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH---FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||+++++|.+++..   +++.++..++.|++.||+|||   +.+|+||||||+||+++   .++..++. ||.......
T Consensus       762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccccc
Confidence            999999999999863   789999999999999999999   66999999999999994   44555554 555443321


Q ss_pred             CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--H---HHHHHHHcCC-----CCCCC--
Q 017768          228 GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE--K---GIFEAILEGN-----LDLQS--  294 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~--~---~~~~~~~~~~-----~~~~~--  294 (366)
                      .   ....+|..|+|||++. ..++.++|||||||++|||++|+.||.....  .   +.........     .....  
T Consensus       835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence            1   2236789999999876 4689999999999999999999999853211  1   1111111000     00000  


Q ss_pred             --CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          295 --SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       295 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                        ........++.+++.+||+.||++|||+.|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              0000112356789999999999999999999885

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=271.94  Aligned_cols=200  Identities=32%  Similarity=0.545  Sum_probs=178.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccc-----cccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL-----VYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDK  144 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~  144 (366)
                      .|...+.+|.|+||.|++|.++.+...|+||.+.+...     ..+...-.+-.|+.+|..+.  .|+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            48889999999999999999999999999999876443     33444556778999999986  489999999999999


Q ss_pred             CeEEEEEecc-CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 QNLHLVMELC-SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 ~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      +.+||+||-. +|.+|++++..+..++|.++..|++|++.|+++||+.||||||||-+|+.+   +.+|-+||+|||.|.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchh
Confidence            9999999975 567999999999999999999999999999999999999999999999999   678889999999998


Q ss_pred             cccCCCceecccCCCCCCcccccccc--CCCchhHHHHHHHHHHHHhCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWA  275 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~vl~~ll~g~~pf~~  275 (366)
                      ....+. ...++||..|.|||++.+.  .+++-|||++|++||.++....||..
T Consensus       719 ~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            876654 5667899999999999864  58899999999999999999988853

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=276.90  Aligned_cols=260  Identities=30%  Similarity=0.505  Sum_probs=219.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +..++|.+...+|.|.+|.||+++++.+++..|+|+++..   ...+..-+.+|+.+++.++ |+||+-+++.|...+..
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            3456799999999999999999999999999999999754   3567778889999999998 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||+||||.||+|++.-+..+.+++.++..+++..+.+|+|||+.|-+|||||-.||++   .+.+.+|+.|||.+.....
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999998888999999999999999999999999999999999999999   5667799999999866532


Q ss_pred             C-CceecccCCCCCCccccc----cccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC-CCCCC
Q 017768          228 G-KVYKEIVGSAYYVAPEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-WPSIS  301 (366)
Q Consensus       228 ~-~~~~~~~gt~~y~aPE~~----~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  301 (366)
                      . .....+.||++|||||+-    .+.|...+|||++|+...|+-.-+.|..+.-....+-.+.+-.+..+... ....+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 234557899999999974    25689999999999999999887777666554444444444333333222 22357


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +.+.+|++.+|..+|.+|||++.+|.|||+...
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            889999999999999999999999999999765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=271.11  Aligned_cols=245  Identities=27%  Similarity=0.370  Sum_probs=205.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .+..+.||+|+||+||+|.+--.|+    +||+|++....  ..+.-.++..|+-+|.++. |||++++++++.... .-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence            3445689999999999998876665    78888875432  3445678999999999998 999999999998776 77


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||++|+++|+|.++++.+ ..+.....+.|+.||++||.|||++++|||||-..||||   ..-.++||.|||+++....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence            899999999999999875 458899999999999999999999999999999999999   4556699999999998754


Q ss_pred             CC-ceecccC--CCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          228 GK-VYKEIVG--SAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       228 ~~-~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      +. .+....|  .+.|||=|.+. ..++.++|||||||++||++| |..|+.+...+++-+.+..+..-...   |..+-
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP---piCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP---PICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---CCccH
Confidence            43 2332222  34588888776 569999999999999999999 99999999999888888777663333   35678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.-++.+||..|+..||+++++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7.7e-32  Score=231.35  Aligned_cols=211  Identities=49%  Similarity=0.759  Sum_probs=183.5

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      ||+|++|.||++....+++.+++|++.......  ....+.+|+..++.+. |++|+++++++......++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999986543211  3567999999999998 7999999999999999999999999899


Q ss_pred             hHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-ceecccC
Q 017768          159 LFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVG  236 (366)
Q Consensus       159 L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g  236 (366)
                      |.+++... ..++...++.++.+++.+|.+||+.|++|+||+|+||+++.  .++.++|+|||.+....... ......+
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhcccC
Confidence            99998776 46899999999999999999999999999999999999952  15779999999998765432 1233457


Q ss_pred             CCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          237 SAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       237 t~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ...|++||.+..  ..+.+.|+|++|++++++                                   ..+.+++..|++.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence            888999998764  678899999999999998                                   5788999999999


Q ss_pred             CcCCCCCHHHHhcCC
Q 017768          315 DPKKRITAAEALEHP  329 (366)
Q Consensus       315 dp~~Rpt~~~~l~hp  329 (366)
                      ||++||++.++++++
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=239.29  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEece-EE
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AY  141 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~-~~  141 (366)
                      ..+..++.+.|.|.+.||+|.||.+.+++++.+...+++|.+.+.    .....++.+|.-.--.|..|.||+.-|+ .|
T Consensus        16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            344567888899999999999999999999999999999988643    3457788899888778888999998765 46


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      +..+.+.+++||++.|+|.+-+... .+-+.....++.|+++|++|+|++++||||||.+||||-. .+..+|||||||+
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~  169 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGL  169 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeeccc
Confidence            7778888999999999998877664 4788999999999999999999999999999999999965 3445899999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc----c--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH----Q--RYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLD  291 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~  291 (366)
                      ....+..-  ...--+..|.+||...    +  ...+.+|+|.||+++|+.++|+.||+.....    -...+...+...
T Consensus       170 t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~  247 (378)
T KOG1345|consen  170 TRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP  247 (378)
T ss_pred             ccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence            87643211  1122456799999753    2  2577899999999999999999999643211    122333333333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCc
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKR---ITAAEALEHPWL  331 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~R---pt~~~~l~hp~f  331 (366)
                      ........+++.+..+.++-|..++++|   .++.+...-.|.
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            3334445689999999999999999999   566555555554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=6e-31  Score=228.92  Aligned_cols=211  Identities=45%  Similarity=0.741  Sum_probs=180.7

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |.+.+.||.|++|.||++....+++.+++|.+......  ...+.+.+|+..++.+. |+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            56778999999999999999988999999998754321  25678899999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC--
Q 017768          153 LCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--  229 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~--  229 (366)
                      ++++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|+||++   +.++.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999988766 8999999999999999999999999999999999999   455789999999998775543  


Q ss_pred             ceecccCCCCCCccccc-c-ccCCCchhHHHHHHHHHHHHhCCCCCCC--CChHHHHHHHHcCC
Q 017768          230 VYKEIVGSAYYVAPEVL-H-QRYGKEIDVWSAGVILYILLSGVPPFWA--ETEKGIFEAILEGN  289 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~vl~~ll~g~~pf~~--~~~~~~~~~~~~~~  289 (366)
                      ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||..  .......+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33445678889999987 3 3577799999999999999999999977  34446666666654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-31  Score=230.71  Aligned_cols=249  Identities=18%  Similarity=0.240  Sum_probs=199.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCC-----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATG-----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..++++.-.+.+|.||.||.|.+.+..     +.|-+|.++...  .+-....+..|-..+..+. |||+..+.++..++
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~  359 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIED  359 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEeec
Confidence            456788888999999999999776432     345556553221  2334566778888888887 99999999987654


Q ss_pred             -CeEEEEEeccCCCchHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          145 -QNLHLVMELCSGGELFDRIIAK--------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                       +..++++.+..-|.|..++.-.        +.++..++..++.|++.|++|||++||||.||-..|.+|   ++..+||
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEE
Confidence             4667888888888999999732        237788999999999999999999999999999999999   6778899


Q ss_pred             EeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCC
Q 017768          216 ATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       216 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      |+|=.+++.+-..+..   ........||+||.+. ..|+..+|+|||||+||||+| |+.||..-+..+....+..|..
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            9999998876433321   1122456799999875 679999999999999999999 9999988888888777777764


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      --+..   .+++++..++..||..+|++||+++|+..
T Consensus       517 laQP~---NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 LAQPF---NCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ecCCC---CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            44333   57899999999999999999999999865

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-30  Score=223.58  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ++-.|+++++||+|+||+++.|.+.-++++||||.-..+     ....++..|.+.++.|.+.++|+..|.+..++-+-.
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            445699999999999999999999999999999976433     456788999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCcccc
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLSVFI  225 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a~~~  225 (366)
                      ||||++ |.+|.+++.- .+.|+...+..++.|++.-++++|++.+|+|||||+|+||+..+  +...|.|+|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 8899998864 45699999999999999999999999999999999999996422  2345899999999987


Q ss_pred             cCCC--------ceecccCCCCCCccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCCCC-
Q 017768          226 ETGK--------VYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFEAILEGNLDL-  292 (366)
Q Consensus       226 ~~~~--------~~~~~~gt~~y~aPE~~-~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~-  292 (366)
                      .+..        ......||.+||+-... ...-+++.|+-|||-|++++|.|..||++..   .++..+.|-..+... 
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            5543        23456899999997653 3457899999999999999999999998763   444455554333222 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITA  322 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~  322 (366)
                      ....+.+++.++...++-.-..+-.+-|+.
T Consensus       260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  260 IEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            222334567777766665555555555553

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.6e-31  Score=273.36  Aligned_cols=197  Identities=20%  Similarity=0.240  Sum_probs=145.1

Q ss_pred             CceeEeceEE-------eeCCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcE
Q 017768          132 PNIVEFEGAY-------EDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF  203 (366)
Q Consensus       132 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  203 (366)
                      +||..+++++       ...+.+++++|++ +++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5676677666       2234677889988 55999999753 4589999999999999999999999999999999999


Q ss_pred             Eeeec----------------CCCCCEEEeecCCcccccCCC-----------------ceecccCCCCCCcccccc-cc
Q 017768          204 LLASK----------------EEDSPIKATDFGLSVFIETGK-----------------VYKEIVGSAYYVAPEVLH-QR  249 (366)
Q Consensus       204 ll~~~----------------~~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~  249 (366)
                      ||+..                +.++.+|++|||+++......                 ......||+.|+|||++. ..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99531                234567788888876421100                 011235889999999875 56


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017768          250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP  329 (366)
Q Consensus       250 ~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp  329 (366)
                      ++.++|||||||+||||++|..|+....  .....+.......  . .........+++.+||+.||.+||++.|+|+||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP--Q-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh--h-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            8999999999999999999988875321  1222222211111  1 111245667899999999999999999999999


Q ss_pred             CcccC
Q 017768          330 WLKED  334 (366)
Q Consensus       330 ~f~~~  334 (366)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=214.81  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=203.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ...+|+++++||+|+||.+|+|....+|..||||+-...     .....+.-|.++++.|++...|+.+..+..+.+.-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            456799999999999999999999999999999986432     345678889999999998899999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +|||++ |.+|.++++- .+.++..+++-++-|++.-++|+|.++++||||||+|+|++-......+.|+|||+|+.+.+
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999999 8899998875 45699999999999999999999999999999999999997666677899999999987643


Q ss_pred             CC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCCC-C
Q 017768          228 GK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDLQ-S  294 (366)
Q Consensus       228 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~-~  294 (366)
                      ..        ......||.+|.+-.+..+ .-+++.|+-|+|.||.++..|..||++...   .+..+.+.+.+.+.+ .
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            32        1234579999998665443 467899999999999999999999987644   344555555544433 3


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITA  322 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  322 (366)
                      ..+.++|.++.-.+.-|-..--++-|+.
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            3456788888888888877766666764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-27  Score=220.10  Aligned_cols=253  Identities=24%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCC-cEEEEEEeecccccccccHHHHHHHHHHHHHhc---CCCceeEeceEE-eeCCe
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATG-RKYACKSISRRKLVYDKDMEDVRREILILQHLT---GQPNIVEFEGAY-EDKQN  146 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~-~~~~~  146 (366)
                      +|.+.+.||+|+||.||.+.+..++ ..+|+|.......   .....+..|..++..+.   +..+++.+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~---~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG---SKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc---CCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999988664 5788887654321   11226788889988887   346899999998 57788


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCc
Q 017768          147 LHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLS  222 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a  222 (366)
                      .++||+.+ |.+|.++....  +.++...+..|+.|++.+|++||+.|++||||||+|++++...  +...+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 88999988654  4699999999999999999999999999999999999996533  1256999999999


Q ss_pred             c--ccc-CCC-------c-eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          223 V--FIE-TGK-------V-YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       223 ~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      +  ... ...       . .....||..|+++.+..+ ..+++.|+||++.++.+++.|..||...........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321 111       1 123469999999998764 589999999999999999999999976654332333322222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          291 DLQSS-PWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       291 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..... .....+.++.++...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111 222356788888888888999999998887664

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.6e-28  Score=206.10  Aligned_cols=162  Identities=27%  Similarity=0.355  Sum_probs=126.9

Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceeccc
Q 017768          157 GELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV  235 (366)
Q Consensus       157 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  235 (366)
                      |+|.+++... ..+++.+++.++.|++.||.|||+.+      ||+|||+   +.++.+++  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            5899999874 45999999999999999999999999      9999999   56777888  99988764432    26


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCC---CCCCCCH--HHHHHH
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSS---PWPSISG--QAKDLI  308 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~li  308 (366)
                      ||+.|+|||++. ..++.++||||||+++|+|++|..||..... ......+..........   ....+++  ++.++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            889999999876 4689999999999999999999999976533 23333333322221111   1112333  689999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+||..||++||++.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-29  Score=246.85  Aligned_cols=262  Identities=27%  Similarity=0.449  Sum_probs=199.1

Q ss_pred             ccce-eeeceecccCceEEEEEEEccCCcEEEEEEeecc--ccccccc-HHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIY-DLDKELGRGQFGVTYLCTKKATGRKYACKSISRR--KLVYDKD-MEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .+.| ...+.+|.|++|.|+.+........++.|.+..+  ....... ...+..|+-+-..+. |+|++.......+..
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEID  394 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcc
Confidence            3445 4567899999998888887777777777765422  1111111 112556666666776 999988777776666


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ...-.||||++ +|+.++.....++..++..++.||+.||.|+|+.||.|||+|++|+++   ..++.+||+|||.+...
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVF  470 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceee
Confidence            66556999999 999999888789999999999999999999999999999999999999   56778999999998765


Q ss_pred             cCC-----CceecccCCCCCCccccccc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHcCCC---CCC
Q 017768          226 ETG-----KVYKEIVGSAYYVAPEVLHQ-RYG-KEIDVWSAGVILYILLSGVPPFWAETEKGIF--EAILEGNL---DLQ  293 (366)
Q Consensus       226 ~~~-----~~~~~~~gt~~y~aPE~~~~-~~~-~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~--~~~~~~~~---~~~  293 (366)
                      ...     ......+|+..|+|||++.+ .|. ...||||.|++++.|.+|+.||......+..  ........   .-.
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence            332     23445789999999999864 454 5689999999999999999999654433221  11111111   112


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ...+..++.+.+.+|.+||+.||.+|.|+++|++.+||+....
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            2233468899999999999999999999999999999987643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=3.8e-26  Score=209.16  Aligned_cols=259  Identities=39%  Similarity=0.582  Sum_probs=208.8

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+..+..+.++++|+.+++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778889999999999999986   78999998765543333577899999999999855589999999987778899999


Q ss_pred             ccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC-CEEEeecCCcccccCC
Q 017768          153 LCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS-PIKATDFGLSVFIETG  228 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~~~~~  228 (366)
                      ++.++++.+++....   .++...+..++.|++.++.++|..+++|||+||+||+++   ..+ .++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence            999999997777664   689999999999999999999999999999999999994   444 6999999999865433


Q ss_pred             C-------ceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCCC-C
Q 017768          229 K-------VYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNLD-L  292 (366)
Q Consensus       229 ~-------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~-~  292 (366)
                      .       ......|+..|++||.+..    ......|+|++|++++++++|..||.....    ......+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            2       2356789999999998764    578899999999999999999999876653    4444444444333 2


Q ss_pred             CCCCCCCC----CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          293 QSSPWPSI----SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       293 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ........    ...+.+++..++..+|..|.+..+...++|.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            22111111    2578999999999999999999999998776654443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.3e-27  Score=216.84  Aligned_cols=172  Identities=19%  Similarity=0.190  Sum_probs=131.1

Q ss_pred             CCCCCccccccceeeeceecccCceEEEEEEEcc-CCcEEEEEEeecccc--cccccHHHHHHHHHHHHHhcCCCcee-E
Q 017768           61 ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKA-TGRKYACKSISRRKL--VYDKDMEDVRREILILQHLTGQPNIV-E  136 (366)
Q Consensus        61 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~-~  136 (366)
                      ..+.+...+.+.|.+.+.||+|+||+||+|.++. +++.+|||.+.....  ........+.+|+.+|+++. |+|++ .
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~   86 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQ   86 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcE
Confidence            3445555667789999999999999999998876 677789998753211  11223556899999999998 77877 4


Q ss_pred             eceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecc-CCCcEEeeecCCCCCEE
Q 017768          137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL-KPENFLLASKEEDSPIK  215 (366)
Q Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl-kp~NIll~~~~~~~~vk  215 (366)
                      ++++    +..|+||||++|++|.. +.   ...   ...++.|++++|.+||++||+|||| ||+|||+   +.++.++
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ik  152 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAA  152 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEE
Confidence            5442    45799999999999963 21   111   2568899999999999999999999 9999999   4567799


Q ss_pred             EeecCCcccccCCCc---------eecccCCCCCCcccccc
Q 017768          216 ATDFGLSVFIETGKV---------YKEIVGSAYYVAPEVLH  247 (366)
Q Consensus       216 l~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  247 (366)
                      |+|||+|........         .....++..|+|||++.
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999999986643321         12456788899999885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=223.96  Aligned_cols=243  Identities=29%  Similarity=0.516  Sum_probs=205.9

Q ss_pred             ecccCceEEEEEEE---ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           79 LGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        79 lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +|+|+||.|++++.   ...|.-+|.|++.+........ .....|..++..+++||.+++++..++.+...++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            79999999987643   3347788999887655433222 2666788889999889999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceeccc
Q 017768          156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV  235 (366)
Q Consensus       156 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  235 (366)
                      |++|...+.....+.+.....+...++-+++++|+.+|+|||+|++||++   +.+|++++.|||+.+..-.....   +
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---C  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---c
Confidence            99999999888888999999999999999999999999999999999999   78888999999999876443322   8


Q ss_pred             CCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 017768          236 GSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD  315 (366)
Q Consensus       236 gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  315 (366)
                      ||.-|||||+++ .....+|.||||+++++|++|..||..    +....|....+..+.    .++..+++++..++..+
T Consensus       155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhC
Confidence            999999999998 456889999999999999999999987    556666665555554    46788999999999999


Q ss_pred             cCCCCC-----HHHHhcCCCcccCCCC
Q 017768          316 PKKRIT-----AAEALEHPWLKEDGAT  337 (366)
Q Consensus       316 p~~Rpt-----~~~~l~hp~f~~~~~~  337 (366)
                      |..|..     ..++++|+||+.....
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHHhccCcchhHHHhccchheeeeHh
Confidence            999975     5799999999886554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=9.8e-26  Score=220.92  Aligned_cols=224  Identities=32%  Similarity=0.559  Sum_probs=174.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|+.++.|..|++|.||.++++.+.+.+|+|+ .+....       +.+   ++. +.++|.+|             
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-------lRn---ilt-~a~npfvv-------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LRN---ILT-FAGNPFVV-------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-------hhc---ccc-ccCCccee-------------
Confidence            34568999999999999999999999999999954 222210       000   111 12233333             


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                              |+-...++..+.++..-        +.+++|||+.||+|||+||+|.+|   ..-|++|+.|||+.+..-..
T Consensus       136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhh
Confidence                    23334444444444332        789999999999999999999999   56777999999997653211


Q ss_pred             C----------------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC
Q 017768          229 K----------------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       229 ~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      .                .-...+||+.|+|||++. +.|++++|+|++|+|+|+++.|+.||.+++.++++..+......
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            1                112348999999999865 56999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccCCCC
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPWLKEDGAT  337 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~~l~hp~f~~~~~~  337 (366)
                      +++..+ .++++++++|..+|..+|..|.   .+-++.+|+||+...+.
T Consensus       277 wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            888844 5789999999999999999996   67889999999987776

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=3.2e-25  Score=195.49  Aligned_cols=234  Identities=24%  Similarity=0.364  Sum_probs=154.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC---------CCceeEeceEEe
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG---------QPNIVEFEGAYE  142 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~---------h~~i~~~~~~~~  142 (366)
                      ....++.||.|+++.||.+++.++|+++|+|++...........+.+.+|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35677899999999999999999999999999876654445567777777766655432         223333333322


Q ss_pred             e---------C---C-----eEEEEEeccCCCchHHHHHH---hCC----CCHHHHHHHHHHHHHHHHHHHHcCCEEecc
Q 017768          143 D---------K---Q-----NLHLVMELCSGGELFDRIIA---KGI----YSEREAANICRQIVNVVHACHFMGVIHRDL  198 (366)
Q Consensus       143 ~---------~---~-----~~~lv~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  198 (366)
                      -         .   .     ..+++|+-+. ++|.+++..   ...    +.......+..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1         1   1     2356777774 478776542   222    122233555689999999999999999999


Q ss_pred             CCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccc---------cCCCchhHHHHHHHHHHHHhC
Q 017768          199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ---------RYGKEIDVWSAGVILYILLSG  269 (366)
Q Consensus       199 kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Di~slG~vl~~ll~g  269 (366)
                      +|+|+++   +.+|.+.|+||+.....+..  ......+..|.+||....         .++.+.|.|+||+++|.|+++
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   67889999999877654332  222345678999997532         367889999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 017768          270 VPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR  319 (366)
Q Consensus       270 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  319 (366)
                      ..||.........        ......+..+++.++.||..+|..||++|
T Consensus       247 ~lPf~~~~~~~~~--------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADP--------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTS--------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccc--------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999655332111        11233344789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=6.4e-25  Score=185.78  Aligned_cols=143  Identities=21%  Similarity=0.219  Sum_probs=110.6

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeeccccccccc-----------------------HHHHHHHHHHHHHhcCCC
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD-----------------------MEDVRREILILQHLTGQP  132 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~~h~  132 (366)
                      ...||+|+||.||+|.+. +|+.||+|++..........                       ......|+.++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            457999999999999987 89999999997543211110                       122345999999997 66


Q ss_pred             ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeccCCCcEEeeecCCC
Q 017768          133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC-HFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       133 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      ++.....+...  ..+|||||++|+++.........+++.++..++.|++.+|.++ |+.||+||||||+|||++    +
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~  153 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D  153 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence            66443333222  2389999999877766545556789999999999999999999 799999999999999995    2


Q ss_pred             CCEEEeecCCccccc
Q 017768          212 SPIKATDFGLSVFIE  226 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~  226 (366)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            569999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=7.5e-25  Score=187.64  Aligned_cols=174  Identities=16%  Similarity=0.181  Sum_probs=132.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHH------HHHHHHHHHHhcCCCceeEeceEEe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED------VRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      +..+|++.+.||.|+||.||++..  ++..+|+|.+.......+.....      +.+|+..+.++. |++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence            567899999999999999999655  47789999996544322222222      678999999997 999999998866


Q ss_pred             eC--------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCE
Q 017768          143 DK--------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       143 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                      ..        +..+|+|||++|.+|.++..    +++    ..+.+++.+|..+|+.|++|||+||+||+++   +++ +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~~g-i  173 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---KNG-L  173 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---CCC-E
Confidence            43        35889999999999977632    333    3466999999999999999999999999994   455 9


Q ss_pred             EEeecCCcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHH
Q 017768          215 KATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILL  267 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll  267 (366)
                      +|+|||.............      |    ++...+..++|+|+||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHH
Confidence            9999998866532221110      0    12344678999999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.1e-24  Score=179.32  Aligned_cols=189  Identities=22%  Similarity=0.280  Sum_probs=141.8

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccc-cHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK-DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      .+...|++|+||+||.+..  .+.+++.+.+......... ....+.+|+++|+++.+++++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3456799999999998765  4888888777543321111 122578999999999878999999886    45699999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEecc-CCCcEEeeecCCCCCEEEeecCCcccccCCCce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL-KPENFLLASKEEDSPIKATDFGLSVFIETGKVY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl-kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~  231 (366)
                      |++|.+|......       ....++.|++.+|.++|++||+|||| ||+|||+   +.++.++|+|||+|.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence            9999888654321       12457889999999999999999999 7999999   45677999999999865433210


Q ss_pred             ----e----------cccCCCCCCccccc--cccCC-CchhHHHHHHHHHHHHhCCCCCCCCCh
Q 017768          232 ----K----------EIVGSAYYVAPEVL--HQRYG-KEIDVWSAGVILYILLSGVPPFWAETE  278 (366)
Q Consensus       232 ----~----------~~~gt~~y~aPE~~--~~~~~-~~~Di~slG~vl~~ll~g~~pf~~~~~  278 (366)
                          .          -...++.|+.|+..  ....+ ...++++.|.-+|.++|+..+++.+.+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                0          11356777777742  22333 567999999999999999999877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.1e-23  Score=177.10  Aligned_cols=144  Identities=20%  Similarity=0.215  Sum_probs=112.1

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccc------------------c-----HHHHHHHHHHHHHhcCCC
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK------------------D-----MEDVRREILILQHLTGQP  132 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------~-----~~~~~~e~~~l~~l~~h~  132 (366)
                      .+.||+|+||.||+|.+. +|+.||||++.........                  .     ......|...+.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            467999999999999987 8999999998764321100                  0     122457899999997 77


Q ss_pred             ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCC
Q 017768          133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       133 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      ++.....+....  .+|||||++|+++.........++..++..++.|++.+|.++|+ .||+||||||+|||++    +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~  153 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D  153 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence            775544443332  48999999987654443344568889999999999999999999 9999999999999994    5


Q ss_pred             CCEEEeecCCcccccC
Q 017768          212 SPIKATDFGLSVFIET  227 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~  227 (366)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            6799999999987644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.8e-23  Score=208.48  Aligned_cols=197  Identities=24%  Similarity=0.336  Sum_probs=162.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|.|.+.||+|+||.||+|.... |+.||+|+-+....+.-.--.++...++ ++.   -+.|..+...+...+..+|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCCccee
Confidence            4568999999999999999999875 9999999887655433222333333333 222   3678888888888888999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec----CCCCCEEEeecCCcccc
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK----EEDSPIKATDFGLSVFI  225 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~----~~~~~vkl~Dfg~a~~~  225 (366)
                      |+||.+.|+|.++++..+.+++..+..+..||+..+++||..+|||+||||+|+||...    .+..-++|+|||.+..+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            99999999999999988889999999999999999999999999999999999999532    23445899999998654


Q ss_pred             ---cCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCC
Q 017768          226 ---ETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVP  271 (366)
Q Consensus       226 ---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~  271 (366)
                         .++......++|-.+-.+|+..+ .|+.+.|.|.|+.+++.||.|+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence               45556677789999999999875 59999999999999999999843

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-23  Score=185.62  Aligned_cols=194  Identities=28%  Similarity=0.419  Sum_probs=142.8

Q ss_pred             cCCCceeEeceEEeeC---------------------------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHH
Q 017768          129 TGQPNIVEFEGAYEDK---------------------------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI  181 (366)
Q Consensus       129 ~~h~~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi  181 (366)
                      ..||||+++..+|.++                           ..+|+||...+. +|.+++-.+. .+.....-++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence            3699999998887542                           348999998854 8988886654 5788889999999


Q ss_pred             HHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCcccccC-------CCceecccCCCCCCccccccccC---
Q 017768          182 VNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLSVFIET-------GKVYKEIVGSAYYVAPEVLHQRY---  250 (366)
Q Consensus       182 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~---  250 (366)
                      ++|+.|||.+||.|||+|.+|||+.-+++ ...+.|+|||++.....       ........|....||||+.....   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999965322 24578999998754321       11223346788899999875322   


Q ss_pred             ----CCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH---
Q 017768          251 ----GKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITA---  322 (366)
Q Consensus       251 ----~~~~Di~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~---  322 (366)
                          -.++|.|+.|.+.||++....||.....-. ....+.+.+.....   ..+++.+++++..+|+.||++|++.   
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp---~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP---SRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc---ccCChHHHHHHHHHhcCCccccCCccHH
Confidence                247999999999999999999997632211 11112222222222   2478899999999999999999974   


Q ss_pred             HHHhc
Q 017768          323 AEALE  327 (366)
Q Consensus       323 ~~~l~  327 (366)
                      ..+|+
T Consensus       508 ANvl~  512 (598)
T KOG4158|consen  508 ANVLN  512 (598)
T ss_pred             HhHHH
Confidence            44554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=7.3e-24  Score=208.26  Aligned_cols=243  Identities=24%  Similarity=0.327  Sum_probs=178.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++-+.... .-....+...|++ .. +..+||++.+..+...+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHHHH
Confidence            57888999999999999999873 55 999998665421 1223334444444 22 33599999999887777888999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc--cCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~--~~~  228 (366)
                      -+|... +|++.+.....+..-+.+-|+.||+.||..+|..||+|+|||.+||||++.+-   +.|+||..-+..  +.+
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW---~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW---LYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech---hhhhcccccCCccCCCC
Confidence            999855 99999988888889999999999999999999999999999999999987666   899999876543  222


Q ss_pred             C--cee----cccCCCCCCccccccc-----------c-CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 017768          229 K--VYK----EIVGSAYYVAPEVLHQ-----------R-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN  289 (366)
Q Consensus       229 ~--~~~----~~~gt~~y~aPE~~~~-----------~-~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~  289 (366)
                      +  .++    +...-.+|.|||.+..           . .+++.||||+|||+.||++ |+++|.-   .+ +-++..+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQ-L~aYr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQ-LLAYRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HH-HHhHhccC
Confidence            1  111    1222346999997632           1 4678999999999999998 7888831   11 11111111


Q ss_pred             CCCC---CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          290 LDLQ---SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       290 ~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....   ....  -+..++.+|..|++.||++|.++++.|+.
T Consensus       252 ~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0000   0000  13368899999999999999999999985

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.1e-21  Score=165.90  Aligned_cols=138  Identities=19%  Similarity=0.228  Sum_probs=108.3

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc----CCCceeEeceEEeeCC---e-E
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT----GQPNIVEFEGAYEDKQ---N-L  147 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~---~-~  147 (366)
                      .+.||+|+||.||.  +..++.. +||++....   ....+.+.+|+.+++.+.    .||||++++++++.+.   . +
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            35799999999995  6666555 699886532   234567999999999995    3899999999998874   4 3


Q ss_pred             EEEEec--cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCc
Q 017768          148 HLVMEL--CSGGELFDRIIAKGIYSEREAANICRQIVNVV-HACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLS  222 (366)
Q Consensus       148 ~lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a  222 (366)
                      .+|+||  +.+++|.+++... .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            378999  5578999999664 46655  46688888877 999999999999999999997543 3347999995443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-22  Score=170.82  Aligned_cols=238  Identities=20%  Similarity=0.272  Sum_probs=184.4

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      ..+..+|.+.-.|..|+|++.  |..+++|++..+... .....+|..|.-.|+-+. ||||+.+++.+....+..++..
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            345667888999999999987  778899988765532 334456888998898887 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEE--eecCCccccc
Q 017768          153 LCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKA--TDFGLSVFIE  226 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl--~Dfg~a~~~~  226 (366)
                      |++.++|+..++....  .+..++.+++.+++.|+.|||+..  |----|+...+++   +++.+.+|  +|--++-.  
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq--  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--
Confidence            9999999999987654  677899999999999999999986  4445688899999   56655544  33222211  


Q ss_pred             CCCceecccCCCCCCcccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCCCC
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA-ILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  301 (366)
                          .......+.||+||.+..+    --...|+|||++++||+.|...||.+...-+.=-. .+.+.   .....|+.+
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl---rv~ippgis  415 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL---RVHIPPGIS  415 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc---cccCCCCcc
Confidence                1123457889999998653    24578999999999999999999977654432222 22322   122335789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHh
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEAL  326 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l  326 (366)
                      ..+..|+.-|++.||.+||.+..++
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999999987764

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=2.4e-21  Score=169.41  Aligned_cols=149  Identities=19%  Similarity=0.181  Sum_probs=114.4

Q ss_pred             ccceeeeceecccCceEEEEEE-EccCCcEEEEEEeecccccccc---------------------cHHHHHHHHHHHHH
Q 017768           70 TTIYDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDK---------------------DMEDVRREILILQH  127 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~~---------------------~~~~~~~e~~~l~~  127 (366)
                      +..|.+.+.||+|+||.||+|. +..+|+.||+|++.........                     ....+..|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3358899999999999999998 6668999999998754321000                     11235689999999


Q ss_pred             hcC-CCceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEeccCCCcEEe
Q 017768          128 LTG-QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-VIHRDLKPENFLL  205 (366)
Q Consensus       128 l~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll  205 (366)
                      +.. ...+++++++    ...++||||++|.+|.........+...++..++.||+.+|.+||+.| |+|+||||+||++
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            973 1233444432    235899999999888766544455677778899999999999999999 9999999999999


Q ss_pred             eecCCCCCEEEeecCCccccc
Q 017768          206 ASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +    ++.++|+|||.+....
T Consensus       183 ~----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E----CCCEEEEEChhhhccC
Confidence            5    5569999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=9.8e-22  Score=180.96  Aligned_cols=245  Identities=24%  Similarity=0.328  Sum_probs=165.6

Q ss_pred             ceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEec------eEE-
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE------GAY-  141 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~------~~~-  141 (366)
                      .+.+.+..+..+++.+.......+   ..-++.+....+.   ........+++..+....+|+..+..-      ..+ 
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~  321 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK  321 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence            345555666666666665443322   1222223222111   123334455555555555455444322      011 


Q ss_pred             ----eeCCeEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCE
Q 017768          142 ----EDKQNLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       142 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                          ....+.||.|++|+..+|.+|+.....   .+......++.|+..+++|   ++.+|+|+||.||++   ..+..+
T Consensus       322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~  395 (516)
T KOG1033|consen  322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQL  395 (516)
T ss_pred             ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhh
Confidence                112358899999999999999976543   6778899999999999999   999999999999999   455679


Q ss_pred             EEeecCCcccccCCC-------ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017768          215 KATDFGLSVFIETGK-------VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI  285 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~  285 (366)
                      ||+|||+........       ..+...||.+||+||.+. +.|+.++||||||++|+|++. -...+.   .-.....+
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~  472 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI  472 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence            999999988775554       456678999999999987 569999999999999999997 222221   12233334


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ..+.+....  +.++ ++-.+|+..+|...|.+||++.+.--|.|.
T Consensus       473 r~g~ip~~~--~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 RDGIIPPEF--LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hcCCCChHH--hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            444443211  1123 345689999999999999988777777664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.4e-19  Score=156.32  Aligned_cols=137  Identities=30%  Similarity=0.364  Sum_probs=112.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeeccccccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      +.||+|++|.||+|.+  +|..+++|..........     .....+.+|+.++..+. +++|+....++...+..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5699999999999987  588899998654332111     12345778999999997 778877777777777889999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ||++|++|.+++....   . ....++.+++.+|.++|+.+++|+|++|+|||++    ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            9999999999886542   2 8889999999999999999999999999999995    56699999998865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.5e-19  Score=153.39  Aligned_cols=134  Identities=25%  Similarity=0.288  Sum_probs=105.5

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeeccccccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      .||+|+||.||+|..  +|..+++|..........     ....++.+|+.++..+. ++++.....++...+..+++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            389999999999985  478999998654332111     12356778999999998 5555544444455667799999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      |++|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++    ++.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            9999999888754321       8899999999999999999999999999995    567999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.5e-19  Score=167.97  Aligned_cols=199  Identities=24%  Similarity=0.327  Sum_probs=154.9

Q ss_pred             HHhcCCCceeEeceEEeeCCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCC-EEeccCCCcE
Q 017768          126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGV-IHRDLKPENF  203 (366)
Q Consensus       126 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~i-vH~Dlkp~NI  203 (366)
                      +.+. |.|+.++++...++...++|.+||..|+|++.+... ..++.--...++++|+.||.|||.-.| .|+.++..|.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3455 899999999999999999999999999999999873 457888899999999999999999876 9999999999


Q ss_pred             EeeecCCCCCEEEeecCCcccccCC---CceecccCCCCCCcccccccc--------CCCchhHHHHHHHHHHHHhCCCC
Q 017768          204 LLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR--------YGKEIDVWSAGVILYILLSGVPP  272 (366)
Q Consensus       204 ll~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~Di~slG~vl~~ll~g~~p  272 (366)
                      ++   +....+||.|||+.......   ..........-|.|||.+...        .+.+.||||||++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   56677999999998766421   111122234569999988642        46789999999999999999999


Q ss_pred             CCCC----ChHHHHHHHHc-CCCCCCCCC--CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          273 FWAE----TEKGIFEAILE-GNLDLQSSP--WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       273 f~~~----~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      |...    ...+.+..+.. +...+....  .....+++..+++.||..+|++||+++++-..
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            9652    22345555555 221111111  11456689999999999999999999988653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=4e-19  Score=151.92  Aligned_cols=140  Identities=21%  Similarity=0.263  Sum_probs=107.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-------------------ccHHHHHHHHHHHHHhcCCC-
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-------------------KDMEDVRREILILQHLTGQP-  132 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~h~-  132 (366)
                      |.+.+.||+|+||.||++... +|+.||||++........                   ........|+.++..+. +. 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            778899999999999999875 799999998754321000                   01123677899999886 44 


Q ss_pred             -ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          133 -NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       133 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                       .++..++    .+..+++|||++|++|.....      ......++.+++.++.++|+.||+|+||||+||++   +++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence             3444443    245589999999998866432      14567889999999999999999999999999999   457


Q ss_pred             CCEEEeecCCcccccC
Q 017768          212 SPIKATDFGLSVFIET  227 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~  227 (366)
                      +.++|+|||++.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            7899999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.8e-21  Score=189.00  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=204.0

Q ss_pred             eeeeceecccCceEEEEEEEccC-CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKAT-GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      |.+.+.||+|+|+.|-......+ ...+|.|.+.... ........+..|..+-+.+.+|.|++.+++.....+..++++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            67777899999999998876433 3356666654332 223345556667777777777999999999999999999999


Q ss_pred             eccCCCchHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-HcCCEEeccCCCcEEeeecCCCC-CEEEeecCCcccccC
Q 017768          152 ELCSGGELFDRI-IAKG-IYSEREAANICRQIVNVVHACH-FMGVIHRDLKPENFLLASKEEDS-PIKATDFGLSVFIET  227 (366)
Q Consensus       152 e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~~~~  227 (366)
                      +|.+|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++   ..+ .+++.|||+|.....
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccccc
Confidence            999999999888 4443 5778899999999999999999 99999999999999994   455 799999999987755


Q ss_pred             -CC---ceecccC-CCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCCCCCCCCCCC
Q 017768          228 -GK---VYKEIVG-SAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF-EAILEGNLDLQSSPWPS  299 (366)
Q Consensus       228 -~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  299 (366)
                       ..   .....+| ++.|+|||...+  ...+..|+||.|+++..+++|..|+......... .........+....|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             22   2344578 999999998765  3578899999999999999999998655443311 11122222334555677


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ++....+++.+++..+|+.|.+.+++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999988

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=8.2e-19  Score=171.92  Aligned_cols=140  Identities=22%  Similarity=0.261  Sum_probs=111.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..|...+.||+|+||+||++.+.  +..+++|+........     ....+.+.+|+.+++.++ |++++....+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCC
Confidence            34567789999999999999875  4555655443221111     112356789999999998 888888777777777


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..++||||++|++|.+++.        ....++.+++.+|.+||+.+++||||||+|||++    ++.++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence            7899999999999988875        3567899999999999999999999999999992    456999999998763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.3e-18  Score=163.39  Aligned_cols=259  Identities=21%  Similarity=0.261  Sum_probs=202.3

Q ss_pred             ccccceeeeceecc--cCceEEEEEEE--ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           68 DITTIYDLDKELGR--GQFGVTYLCTK--KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .+...+.+...+|.  |.+|.||.+..  ..++..+|+|.-+.. .........-.+|+...+.+..|++.++.+..++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence            34455778889999  99999999998  888999999974321 12223444556777777888889999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHHHcCCEEeccCCCcEEeeecCCC-CCEEEe
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVN----VVHACHFMGVIHRDLKPENFLLASKEED-SPIKAT  217 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~----~l~~LH~~~ivH~Dlkp~NIll~~~~~~-~~vkl~  217 (366)
                      ++..++-+|+|. .+|..+...... ++...++..+.+...    ||.++|..+++|-|+||+||++.   .+ ...+++
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLT  265 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecC
Confidence            999999999994 688888776554 889999999999999    99999999999999999999994   44 678999


Q ss_pred             ecCCcccccCCCcee------cccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC
Q 017768          218 DFGLSVFIETGKVYK------EIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      |||+...........      ...|...|++||..++-++..+|||++|.|+.+...+..+........ ...+.++.  
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~--  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGY--  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccccccc--
Confidence            999998876554221      125677899999999999999999999999999888765543321111 11111111  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .+.+.+...+.++...+..|+..+|-.|+++..++.|+++...
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            2333334556777889999999999999999999999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=3.1e-18  Score=145.01  Aligned_cols=140  Identities=21%  Similarity=0.253  Sum_probs=99.2

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHH---------------------HHHHHHHHHHHhcCC-Cc
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME---------------------DVRREILILQHLTGQ-PN  133 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~~h-~~  133 (366)
                      .+.||+|+||.||+|.+. +|+.||||++............                     ....|...+.++.++ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 7999999998653321111111                     114567777776522 22


Q ss_pred             eeEeceEEeeCCeEEEEEeccCCCchHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCC
Q 017768          134 IVEFEGAYEDKQNLHLVMELCSGGELFD-RIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       134 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      +++.++.    ...+++|||++++.+.. .+... .. ..++..++.+++.++.++|. .+|+|+||||+||+++    +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence            4444443    24589999999854321 11111 11 16788999999999999999 9999999999999995    6


Q ss_pred             CCEEEeecCCccccc
Q 017768          212 SPIKATDFGLSVFIE  226 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~  226 (366)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            679999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=7.3e-17  Score=141.44  Aligned_cols=137  Identities=20%  Similarity=0.261  Sum_probs=102.2

Q ss_pred             ceec-ccCceEEEEEEEccCCcEEEEEEeecccc----c------ccccHHHHHHHHHHHHHhcCCCce--eEeceEEee
Q 017768           77 KELG-RGQFGVTYLCTKKATGRKYACKSISRRKL----V------YDKDMEDVRREILILQHLTGQPNI--VEFEGAYED  143 (366)
Q Consensus        77 ~~lG-~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~------~~~~~~~~~~e~~~l~~l~~h~~i--~~~~~~~~~  143 (366)
                      ..|| .|+.|+||.+...  +..+++|.+.....    .      .......+.+|+.++.++. +++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            3577 7888889988764  78999998864321    0      0123456788999999997 6664  666665433


Q ss_pred             C-C---eEEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          144 K-Q---NLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       144 ~-~---~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      . .   ..++|||+++| .+|.+++.. ..+++.    .+.+|+.+|.+||++||+|+||||+|||++   .++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence            2 2   23599999997 688887754 345554    367899999999999999999999999994   455799999


Q ss_pred             cCCccc
Q 017768          219 FGLSVF  224 (366)
Q Consensus       219 fg~a~~  224 (366)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1e-16  Score=130.37  Aligned_cols=133  Identities=26%  Similarity=0.306  Sum_probs=110.5

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEeceEEeeCCeEEEEEec
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +++.||.|.++.||++...  +..+++|.......     ...+..|+.+++.+.++ .++++++.+....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3567999999999999975  47899998754321     45788999999999854 6889999888888889999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc---CCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +++..+..+       +......++.+++.+|..+|..   +++|+|++|+||+++   ..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            998777543       5567788899999999999985   699999999999995   356799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=3.4e-17  Score=161.55  Aligned_cols=261  Identities=29%  Similarity=0.453  Sum_probs=198.5

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      +.+.+-+.+|+++.+..+.-..+|...++|.............+.+..+-.++-... +|.++....-+......+|+++
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~~~  884 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLVGH  884 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchhhH
Confidence            455556778888888887777677666666543322222222333333333322222 5666665555566778999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-----
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-----  227 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-----  227 (366)
                      |+.+++|...++..+..+.+-+...+..+...+++||...+.|+|++|+|+++   ..+++.++.|||.......     
T Consensus       885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccCcC
Confidence            99999999999888878888889999999999999999999999999999999   6788899999984322100     


Q ss_pred             -------------------------C--CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          228 -------------------------G--KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       228 -------------------------~--~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                                               +  .......+|+.|.+||... ......+|+|++|+++++.++|..||.....+
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                                     0  0012247899999999865 45788999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCcccCCCCC
Q 017768          280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAA---EALEHPWLKEDGATS  338 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~---~~l~hp~f~~~~~~~  338 (366)
                      +.++.+.++...++.-.. ..+.++++++..++..+|.+|..+.   ++-.|+||+......
T Consensus      1042 ~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             hhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            999998888776665432 4688999999999999999999888   999999999866643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.63  E-value=2.1e-15  Score=145.09  Aligned_cols=156  Identities=22%  Similarity=0.300  Sum_probs=100.0

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--------------------c-----------
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--------------------Y-----------  111 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------~-----------  111 (366)
                      |.+...+...|+. +.||+|++|.||+|+.+.+|+.||||++.+....                    .           
T Consensus       112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v  190 (537)
T PRK04750        112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV  190 (537)
T ss_pred             CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence            4455555566776 7899999999999999877999999999754210                    0           


Q ss_pred             cccHH------HHHHHHHHHHHhcC---CCceeEeceEE-eeCCeEEEEEeccCCCchHHH--HHHhC----CCCHHHHH
Q 017768          112 DKDME------DVRREILILQHLTG---QPNIVEFEGAY-EDKQNLHLVMELCSGGELFDR--IIAKG----IYSEREAA  175 (366)
Q Consensus       112 ~~~~~------~~~~e~~~l~~l~~---h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~  175 (366)
                      .+...      ++.+|...+.++..   +...+.+-.++ ......+|||||++|+++.+.  +...+    .+.+..+.
T Consensus       191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~  270 (537)
T PRK04750        191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE  270 (537)
T ss_pred             HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence            01111      23445555555431   22222222222 234567899999999999764  33322    13344444


Q ss_pred             HHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCccccc
Q 017768          176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLSVFIE  226 (366)
Q Consensus       176 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a~~~~  226 (366)
                      .++.|+       ...|++|+|+||.||+++.++ ..+.++++|||++....
T Consensus       271 ~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        271 VFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            445554       469999999999999995321 22389999999987653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.62  E-value=7.2e-15  Score=123.42  Aligned_cols=144  Identities=15%  Similarity=0.133  Sum_probs=104.0

Q ss_pred             eceecccCceEEEEEEEcc------CCcEEEEEEeecccccc-------------------cccHHHH----HHHHHHHH
Q 017768           76 DKELGRGQFGVTYLCTKKA------TGRKYACKSISRRKLVY-------------------DKDMEDV----RREILILQ  126 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~-------------------~~~~~~~----~~e~~~l~  126 (366)
                      ...||.|-.+.||.|....      .+..+|||++.......                   ......+    .+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3468999999999998653      35799999885322110                   0112223    38999999


Q ss_pred             HhcCC-CceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeccCCCcEE
Q 017768          127 HLTGQ-PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC-HFMGVIHRDLKPENFL  204 (366)
Q Consensus       127 ~l~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~Dlkp~NIl  204 (366)
                      ++... -+++.++++    ...+|||||+.+..+.........+++.+...+..+++.+|..+ |+.||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            98743 466777764    45689999997654422222233456677788899999999998 8999999999999999


Q ss_pred             eeecCCCCCEEEeecCCcccccC
Q 017768          205 LASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       205 l~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +.    ++.+.|+|||.+.....
T Consensus       158 ~~----~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE----CCcEEEEECCCceeCCC
Confidence            94    35699999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=5.7e-15  Score=140.45  Aligned_cols=143  Identities=21%  Similarity=0.229  Sum_probs=99.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccc-cc----------------------c--------------HHHHH
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DK----------------------D--------------MEDVR  119 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~----------------------~--------------~~~~~  119 (366)
                      +.||.|++|.||+|+.+ +|+.||||+..+..... ..                      .              .-++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999976 79999999986432100 00                      0              00244


Q ss_pred             HHHHHHHHhc----CCCceeEeceEEeeCCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 017768          120 REILILQHLT----GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVN-VVHACHFMGV  193 (366)
Q Consensus       120 ~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~-~l~~LH~~~i  193 (366)
                      +|...+.++.    +++++.-..-++......+|||||++|.+|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            5666666654    3454443333333445679999999999998876532 112   23445666665 4788999999


Q ss_pred             EEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       194 vH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +|+|+||.||++   .+++.++++|||++....
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence            999999999999   566789999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.1e-14  Score=127.27  Aligned_cols=237  Identities=19%  Similarity=0.202  Sum_probs=155.0

Q ss_pred             EEEEEEEccCCcEEEEEEeecccccc-cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-----eEEEEEeccCCCch
Q 017768           86 VTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-----NLHLVMELCSGGEL  159 (366)
Q Consensus        86 ~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L  159 (366)
                      .||++-+...|.+|+.-.+.-....+ ....+....-+..|-.+. |.||++++.+|.+..     ...++.||+..|++
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            46776666666666654432111001 111222223333444454 789999999987643     47899999999999


Q ss_pred             HHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCccccc---CC--
Q 017768          160 FDRIIAKG----IYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TG--  228 (366)
Q Consensus       160 ~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~---~~--  228 (366)
                      ..+|++..    .+......+|+-||+.||.|||+..  |+|+++..+-|++   ..++.+|++----.....   ..  
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence            99997643    4788889999999999999999986  9999999999999   567777774321111000   00  


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .......+.++|.+||.-. ...+-++|||+||+..++|..+..--...... ..-+.+.+..+..       -...-++
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr~  309 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------ENGLQRG  309 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-------cCccccC
Confidence            0111124678899999743 45677899999999999998875542221111 1111111111111       1223457


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ++.+|++..|..||++.+++-||.+=+
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeee
Confidence            899999999999999999999987633

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=6.2e-15  Score=138.72  Aligned_cols=256  Identities=20%  Similarity=0.228  Sum_probs=189.2

Q ss_pred             cccceeeeceecccCceEEEEEEEc-cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ....|.++..||.|.|+.|+.+... .++..+++|.+...... ......-..|+.+...+.-|.+++.++..|......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            4455788899999999999998766 67889999987654332 122233446777777777789999998888888888


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||-.|||+++++.........+.+...+.+..|++.++.++|+..++|+|+||+||++..+  ++..++.|||....+.-
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccccccce
Confidence            9999999999887777655668899999999999999999999999999999999999632  26789999999864221


Q ss_pred             CCceecccCCCCCC-ccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          228 GKVYKEIVGSAYYV-APEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       228 ~~~~~~~~gt~~y~-aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..  .......++. ..|++..  .+..+.|+++||..+.+..++...-+....   ...+..+..    ...+....++
T Consensus       420 ~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~----p~~~~~~~~~  490 (524)
T KOG0601|consen  420 SS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDT----PNLPGLKLQL  490 (524)
T ss_pred             ec--ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccc----cCCCchHHhh
Confidence            11  1222334444 3555443  478899999999999999987544322211   122222211    1223445788


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..+...++..|+..|+.+.++..|+=|..+..
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~  522 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFYRDSR  522 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhhhhcc
Confidence            89999999999999999999999887766544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.53  E-value=5e-14  Score=117.19  Aligned_cols=128  Identities=18%  Similarity=0.180  Sum_probs=96.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +.|+.|.++.||++...  +..+++|......    ........|+.+++.+.+...+++++....  ...++||||++|
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            56899999999999865  8899999874332    122346789999999874444556665533  345899999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCC-----EEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV-----IHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       157 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-----vH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      .++...        ......++.+++.+|..||..++     +|+|++|.||+++    ++.++++|||.+..
T Consensus        76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            877543        11123467899999999999985     9999999999995    34699999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2.3e-13  Score=110.61  Aligned_cols=134  Identities=25%  Similarity=0.295  Sum_probs=103.2

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccccc-----cHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK-----DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      .+++|+-+.+|.+.+.  |.++++|.-.++......     ...+-.+|.+++.++. --.|...+-+..+.+...|+||
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEEE
Confidence            5789999999999775  667888865444433322     2335567999999987 4466555555667777889999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      |.+|..|.+.+...       ...++..+-..+.-||..||+|+||.++||+++    ++.+.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccccc
Confidence            99998888888765       256778888889999999999999999999995    333999999998753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.51  E-value=3.2e-13  Score=109.25  Aligned_cols=148  Identities=20%  Similarity=0.172  Sum_probs=113.3

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ....|-+|+.+.|+++.+.  |+..+||.-..+.+...     -...+..+|.+.|.++. --.|.-..-++.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            3456889999999999886  89989986544433322     23456778999999987 4466655556667777789


Q ss_pred             EEeccCC-CchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          150 VMELCSG-GELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       150 v~e~~~~-~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      +|||.+| .++.+++.....  ....-...++.+|-+.+.-||.++|+|+||..+||++.+.+....+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 467777766432  233334789999999999999999999999999999987777777899999998653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=1.1e-12  Score=125.11  Aligned_cols=183  Identities=21%  Similarity=0.215  Sum_probs=134.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |++ +...-++.+..-.|..+.++.+|.|..++...-   .....+.+-+..|+.++ ||||+++++.++.++..|||+|
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEee
Confidence            555 333444444222566777899999998865432   34556788889999998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc-
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH-FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-  230 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~-  230 (366)
                      .+.  .|..++...   +...+..-+.||+.||.+|| +++++|++|.-+.|+|   +..|..||++|.++........ 
T Consensus        90 rV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~  161 (690)
T KOG1243|consen   90 RVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP  161 (690)
T ss_pred             ccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc
Confidence            985  667777653   47778888999999999997 7789999999999999   6778899999998865433221 


Q ss_pred             eecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhC
Q 017768          231 YKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSG  269 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g  269 (366)
                      .....--..|..|+.+.. -.-..|.|.||+++++++.|
T Consensus       162 ~~~~~~~~s~~~P~~~~~-s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDP-SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhcccChhhcCc-cccchhhhhHHHHHHHHhCc
Confidence            111111223555554321 11346999999999999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=2.1e-11  Score=105.79  Aligned_cols=143  Identities=27%  Similarity=0.383  Sum_probs=102.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEeceEEeeC---CeEEEEEe
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEGAYEDK---QNLHLVME  152 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~---~~~~lv~e  152 (366)
                      +.|+.|..+.||++... +|..+++|.......  ......+..|+.+++.+..+ ..+++++.+....   +..+++||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL--LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCccc--CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            46899999999999875 368999998754321  12355788999999999743 3466677766553   36689999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF------------------------------------------  190 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------------  190 (366)
                      |++|.++.+.+.. ..+++.+...++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999877654421 235666666667777777766663                                          


Q ss_pred             --------------cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 --------------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 --------------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                                    ..++|+|++|+||+++.. .++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                          236999999999999532 145589999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.25  E-value=2.6e-10  Score=101.23  Aligned_cols=136  Identities=18%  Similarity=0.135  Sum_probs=96.0

Q ss_pred             EEEEEEEccCCcEEEEEEeecccccc--------cccHHHHHHHHHHHHHhcCCCcee--EeceEEee-----CCeEEEE
Q 017768           86 VTYLCTKKATGRKYACKSISRRKLVY--------DKDMEDVRREILILQHLTGQPNIV--EFEGAYED-----KQNLHLV  150 (366)
Q Consensus        86 ~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~i~--~~~~~~~~-----~~~~~lv  150 (366)
                      .|.++..  .|+.+.||.........        ......+.+|...+.++. ..+|.  .+..+.+.     ....+||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEE
Confidence            4556554  47889999764322100        011124779999999886 23333  33444433     2357899


Q ss_pred             EeccCCC-chHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee----cCCCCCEEEeecCCcc
Q 017768          151 MELCSGG-ELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS----KEEDSPIKATDFGLSV  223 (366)
Q Consensus       151 ~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~----~~~~~~vkl~Dfg~a~  223 (366)
                      +|++++. +|.+++..  ....+......++.+++..+..||+.||+|+|+++.|||++.    .+++..+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999885 78888754  234567788899999999999999999999999999999964    1235679999999875


Q ss_pred             c
Q 017768          224 F  224 (366)
Q Consensus       224 ~  224 (366)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.25  E-value=3.1e-11  Score=101.12  Aligned_cols=130  Identities=21%  Similarity=0.200  Sum_probs=83.9

Q ss_pred             EEEEEEEccCCcEEEEEEeecccccc-----------------------cccHHHHHHHHHHHHHhcCC-CceeEeceEE
Q 017768           86 VTYLCTKKATGRKYACKSISRRKLVY-----------------------DKDMEDVRREILILQHLTGQ-PNIVEFEGAY  141 (366)
Q Consensus        86 ~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~  141 (366)
                      .||.|... +|..+|+|+........                       ........+|+++|.++... -++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999875 68899999885321111                       01133567899999999844 2577777553


Q ss_pred             eeCCeEEEEEeccC--CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          142 EDKQNLHLVMELCS--GGELFDRIIAKGIYSEREAANICRQIVNVVHA-CHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       142 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                          ..+|||||++  |..+..+....  ++..+...++.+++..+.. +|..||+|+||.+.|||++   ++ .+.|+|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KVYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CEEE--
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eEEEEe
Confidence                3379999998  65554433221  2245677888888885544 6899999999999999995   22 699999


Q ss_pred             cCCccccc
Q 017768          219 FGLSVFIE  226 (366)
Q Consensus       219 fg~a~~~~  226 (366)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=6.8e-10  Score=103.22  Aligned_cols=211  Identities=16%  Similarity=0.224  Sum_probs=153.9

Q ss_pred             ceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe----eCCeEEEEEeccCC-Cc
Q 017768           84 FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE----DKQNLHLVMELCSG-GE  158 (366)
Q Consensus        84 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~  158 (366)
                      -.+.|++...-+|..|++|.+.....   ........-+.+++++. |.|||.+.+++.    .+..+++|++|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~---~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD---QSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc---cCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            36789999999999999999843332   22233445677788887 999999999886    34578999999876 45


Q ss_pred             hHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          159 LFDRIIA---------------KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       159 L~~~l~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      |.++.-.               +...++..+|.++.||..||.++|+.|+.-+-|.|.+|+++   .+.+++|...|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEeccccee
Confidence            6654421               12478899999999999999999999999999999999995   44468888777765


Q ss_pred             cccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHH-HHHHHcCCCCCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGI-FEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ....+.           .  |-+.+  -.+-|.=.||.+++.|.+|..--+..+. .+. +..+..           .++
T Consensus       442 vl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~yS  495 (655)
T KOG3741|consen  442 VLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TYS  495 (655)
T ss_pred             eecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hhh
Confidence            554433           0  11111  1567899999999999998654332222 111 222221           468


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++++|.-+...++++ -+..+++.+
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            89999999999999987 688888876

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.20  E-value=1.6e-10  Score=99.78  Aligned_cols=141  Identities=24%  Similarity=0.262  Sum_probs=107.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc-------------------ccccHHHHHHHHHHHHHhcCC-C
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-------------------YDKDMEDVRREILILQHLTGQ-P  132 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~~h-~  132 (366)
                      +.++.+||-|--+.||.|.+. .|.++|+|.=......                   -.-......+|+++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567789999999999999976 6999999953211100                   011234577899999999854 4


Q ss_pred             ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       133 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      .+++.+++    +...+|||+.+|..|...-     ++......++..|++-+..+-..||||+|+++-||++   ++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            68888765    6778999999997664432     2455667777888887777779999999999999999   5677


Q ss_pred             CEEEeecCCccccc
Q 017768          213 PIKATDFGLSVFIE  226 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~  226 (366)
                      .+.++||-.+....
T Consensus       240 ~~~vIDwPQ~v~~~  253 (304)
T COG0478         240 DIVVIDWPQAVPIS  253 (304)
T ss_pred             CEEEEeCcccccCC
Confidence            79999998776543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.20  E-value=7.6e-10  Score=100.56  Aligned_cols=238  Identities=18%  Similarity=0.183  Sum_probs=157.1

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE-------eeCCeE
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY-------EDKQNL  147 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-------~~~~~~  147 (366)
                      ..+.||+|+.+.+|-.-.   -..-+.|++.....      ....+.+..|.....||-+-.-+.|-       ..+...
T Consensus        15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp------a~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP------AAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecch---hhchhheeecCCCc------hHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            456799999999996432   23345577754322      12223334444444455433311111       112236


Q ss_pred             EEEEeccCCCc-hHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          148 HLVMELCSGGE-LFDRIIA------KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       148 ~lv~e~~~~~~-L~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      -++|..+.|.. ...+...      .....+..+..+++.|+.+...||..|.+-+|++++|+|+   .+++.|.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEccc
Confidence            68888876642 2222211      1236778899999999999999999999999999999999   677779999877


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-c-----cCCCchhHHHHHHHHHHHHhC-CCCCCCCC----hHHHHH-HHHcC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-Q-----RYGKEIDVWSAGVILYILLSG-VPPFWAET----EKGIFE-AILEG  288 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Di~slG~vl~~ll~g-~~pf~~~~----~~~~~~-~~~~~  288 (366)
                      .-....++..+...+|...|.+||... .     .-+...|.|.||+++++++.| +.||.+-.    ...-.+ .|..+
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            665556666677778999999999764 2     236689999999999999986 99995421    111111 22222


Q ss_pred             C------------CCCCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHHH
Q 017768          289 N------------LDLQSSPWPSISGQAKDLIRKMLTK--DPKKRITAAE  324 (366)
Q Consensus       289 ~------------~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rpt~~~  324 (366)
                      .            ......+|.-+++.+.-+..+|+..  ++.-|||++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1            1222334455789999999999986  3568998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=1.5e-11  Score=117.74  Aligned_cols=156  Identities=19%  Similarity=0.275  Sum_probs=111.5

Q ss_pred             HHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCcee----------cccCCCCCCccccccc
Q 017768          180 QIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK----------EIVGSAYYVAPEVLHQ  248 (366)
Q Consensus       180 qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~~~  248 (366)
                      +.++||.++|. .++||++|.|++|.+   +.++.+||+.|+.+........+.          -..-...|.|||++..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34489999996 489999999999999   567779999999987654422111          1233456999998764


Q ss_pred             -cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 017768          249 -RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDL-QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEA  325 (366)
Q Consensus       249 -~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~  325 (366)
                       ..+.++|+||+|+++|.+.. |+..+........ .......... .......++.++++-+.+++..|+..||++..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence             47889999999999998884 5444433322111 1111111111 111124689999999999999999999999999


Q ss_pred             hcCCCcccCCCCCC
Q 017768          326 LEHPWLKEDGATSD  339 (366)
Q Consensus       326 l~hp~f~~~~~~~~  339 (366)
                      +..|||.+...++-
T Consensus       263 ~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  263 LSIPFFSDPGLKAL  276 (700)
T ss_pred             hcccccCCchhhhh
Confidence            99999998776553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.7e-09  Score=92.86  Aligned_cols=112  Identities=21%  Similarity=0.219  Sum_probs=87.0

Q ss_pred             cHHHHHHHHHHHHHhcCC-CceeEeceEEeeC----CeEEEEEeccCCC-chHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 017768          114 DMEDVRREILILQHLTGQ-PNIVEFEGAYEDK----QNLHLVMELCSGG-ELFDRIIAKGIYSEREAANICRQIVNVVHA  187 (366)
Q Consensus       114 ~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~  187 (366)
                      ......+|...+..+... =.+++.+++.+..    ...+||+|++++. +|.+++.....++......++.+++..+.-
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            345688899988888621 1244455555442    2458999999874 799988875557788899999999999999


Q ss_pred             HHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       188 LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ||++||+|+|+++.|||++..+....+.++||+-+...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999976554457999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.93  E-value=3.3e-08  Score=83.47  Aligned_cols=143  Identities=13%  Similarity=0.116  Sum_probs=100.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeec---ccccccccHHHHHHHHHHHHHhcCC-CceeEeceEEee----CCeEEEE
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISR---RKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEGAYED----KQNLHLV  150 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~----~~~~~lv  150 (366)
                      -|.|+-+.|+.....  |+.+-+|....   ...........+.+|+..|.++... -.++++......    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            466888889987665  66788887641   1111133567899999999998721 124444422111    1246789


Q ss_pred             EeccCC-CchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          151 MELCSG-GELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       151 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +|-++| .+|.+++...  ...+..+...++.+++.++.-||+.|+.|+|+.+.||+++..+ +..+.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            997754 5888887653  2457778889999999999999999999999999999995322 23499999986543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.89  E-value=1.1e-08  Score=98.23  Aligned_cols=158  Identities=19%  Similarity=0.228  Sum_probs=103.3

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--------------------cc-------ccH
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--------------------YD-------KDM  115 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------~~-------~~~  115 (366)
                      |.+..+....|+- +.|+.++-|.||+|+.+ +|+.||||+..+.-..                    ..       ...
T Consensus       118 G~~iee~F~eF~~-~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv  195 (517)
T COG0661         118 GRPIEELFSEFEP-EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVV  195 (517)
T ss_pred             CCCHHHHHHHcCC-CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHH
Confidence            4444444444443 57999999999999987 5999999987542110                    00       001


Q ss_pred             ----------HHHHHHHHHHHHhc----CCCceeEeceEEeeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHH
Q 017768          116 ----------EDVRREILILQHLT----GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQ  180 (366)
Q Consensus       116 ----------~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~q  180 (366)
                                -++.+|...+.+++    +.+++.-..-+++..+...|+|||++|..+.+.... ...++...+...+.+
T Consensus       196 ~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~  275 (517)
T COG0661         196 DEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVR  275 (517)
T ss_pred             HHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHH
Confidence                      12445666666654    445555555555666778999999999988877422 234554443333333


Q ss_pred             HHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       181 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +  .+..+=..|++|.|.+|.||++   ..++.+.+.|||+......
T Consensus       276 ~--f~~q~~~dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         276 A--FLRQLLRDGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             H--HHHHHHhcCccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            2  2333445899999999999999   5668899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.81  E-value=9e-08  Score=83.25  Aligned_cols=73  Identities=23%  Similarity=0.218  Sum_probs=55.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc-eeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-IVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      ..||.|..+.||+.    .|..+++|.....     .....+.+|.++++.+....- +++.+++....+...++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999973    2557888877432     234567899999999874433 6788888888888899999999


Q ss_pred             CCc
Q 017768          156 GGE  158 (366)
Q Consensus       156 ~~~  158 (366)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=8.2e-08  Score=81.43  Aligned_cols=141  Identities=22%  Similarity=0.229  Sum_probs=87.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccH------HHHHHHHHHHHHhcC--CCceeEeceEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM------EDVRREILILQHLTG--QPNIVEFEGAY  141 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~e~~~l~~l~~--h~~i~~~~~~~  141 (366)
                      ...|++.+.+-......|.+..-  +|..+++|.........+...      ....+++..+.++.+  ......++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34566666666666666666554  488999997653221111111      123344444555431  22222322222


Q ss_pred             e-----eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          142 E-----DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       142 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      +     .....+++|||++|..|.+...    +++    .+...+.+++.-||+.|++|+|.+|.|++++    ++.+++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~i  175 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRI  175 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEE
Confidence            2     2345678999999988765432    222    3456677889999999999999999999995    333999


Q ss_pred             eecCCccc
Q 017768          217 TDFGLSVF  224 (366)
Q Consensus       217 ~Dfg~a~~  224 (366)
                      +||+..+.
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99986654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.79  E-value=7.2e-08  Score=82.65  Aligned_cols=143  Identities=22%  Similarity=0.215  Sum_probs=97.2

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccc----------------c-----HHHHHHHHHHHHHhcC-CCc
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK----------------D-----MEDVRREILILQHLTG-QPN  133 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------------~-----~~~~~~e~~~l~~l~~-h~~  133 (366)
                      ...|.+|-.+.||+|.. .++..+|+|++.........                +     ..-...|+..|+++.+ +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44677888999999986 46899999998643322111                1     1124468888888762 234


Q ss_pred             eeEeceEEeeCCeEEEEEeccCCCch-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCC
Q 017768          134 IVEFEGAYEDKQNLHLVMELCSGGEL-FDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       134 i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      +++.+.+.    .-.|+|||+..... .-.|. .-.+...++..+..++++.+.-|-. .++||+||..=|||+.    +
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~  202 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----D  202 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----C
Confidence            45555543    34799999843211 00111 1123444788889999999988766 9999999999999993    5


Q ss_pred             CCEEEeecCCcccccCC
Q 017768          212 SPIKATDFGLSVFIETG  228 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~  228 (366)
                      +.+.|||||.|......
T Consensus       203 ~~p~iID~~QaV~~~hp  219 (268)
T COG1718         203 GEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             CeEEEEECccccccCCC
Confidence            66999999999876543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.73  E-value=1.4e-07  Score=76.65  Aligned_cols=130  Identities=26%  Similarity=0.305  Sum_probs=97.0

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +..+.|++|.+|.||+|.+.  |..+|+|+-..     +.....+..|.++|..+.+..--+++|.+..+    ++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            45678999999999999987  78999998654     34567899999999999866666777776433    455999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCC-C-cEEeeecCCCCCEEEeecCCcccc
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKP-E-NFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp-~-NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+|..|.++....   +    ...+..+++.-.-|-..||-|+.|.- . ||+++    +..+.|+||..|...
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhc
Confidence            9998886655421   1    33445566666777888999999874 3 66663    235999999998743

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.68  E-value=3e-07  Score=80.24  Aligned_cols=79  Identities=23%  Similarity=0.205  Sum_probs=56.5

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceEEe---eCCeEEEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGAYE---DKQNLHLVM  151 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~---~~~~~~lv~  151 (366)
                      ++.|+.|..+.||++...  +..+++|.....     .....+..|..+++.+..+. .+++++....   .....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD--DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEET--TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEEC--CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            356899999999999876  359999986432     34567889999999887442 3566766432   233578999


Q ss_pred             eccCCCchHH
Q 017768          152 ELCSGGELFD  161 (366)
Q Consensus       152 e~~~~~~L~~  161 (366)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.67  E-value=1.5e-06  Score=73.01  Aligned_cols=129  Identities=20%  Similarity=0.232  Sum_probs=92.9

Q ss_pred             cceeeeceecccCc-eEEEEEEEccCCcEEEEEEeeccccccc------------------ccHHHHHHHHHHHHHhcC-
Q 017768           71 TIYDLDKELGRGQF-GVTYLCTKKATGRKYACKSISRRKLVYD------------------KDMEDVRREILILQHLTG-  130 (366)
Q Consensus        71 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~e~~~l~~l~~-  130 (366)
                      ..++..+.||.|.. |.||+++..  |+.+|+|++..-.....                  ....-+..|.++..+|+. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            56888999999999 999999876  88999999432111100                  123357789998888763 


Q ss_pred             -CCce--eEeceEEeeC------------------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 017768          131 -QPNI--VEFEGAYEDK------------------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH  189 (366)
Q Consensus       131 -h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH  189 (366)
                       +.++  ++.++|..-.                  -...||.||.+...         .++    ..-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence             3455  8888887322                  12568888876543         122    333567777889999


Q ss_pred             HcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       190 ~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ..||+=+|+++.|..=        -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999873        499999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.62  E-value=4e-07  Score=80.37  Aligned_cols=75  Identities=19%  Similarity=0.130  Sum_probs=55.0

Q ss_pred             ecccCc-eEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCC
Q 017768           79 LGRGQF-GVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGG  157 (366)
Q Consensus        79 lG~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  157 (366)
                      |-.|.. ..||+....  +..+++|+.....      ...+..|+.+++.+..+--+++++++...++..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444554 788988653  5688888764321      3457789999999976656778888877777789999999987


Q ss_pred             chHH
Q 017768          158 ELFD  161 (366)
Q Consensus       158 ~L~~  161 (366)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=4.7e-07  Score=86.97  Aligned_cols=158  Identities=21%  Similarity=0.196  Sum_probs=97.7

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc----------------------------ccc
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY----------------------------DKD  114 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~  114 (366)
                      |.+..++...|+ .+.||..+.|.||+|+.+. |+.||||+.++.-...                            ++-
T Consensus       154 G~~ie~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~  231 (538)
T KOG1235|consen  154 GAPIEDIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI  231 (538)
T ss_pred             CCCHHHHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence            444444444443 2579999999999999884 9999999875422100                            000


Q ss_pred             HH------HHHHHHHHHHHhcC---CCc------eeEeceEEeeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHH
Q 017768          115 ME------DVRREILILQHLTG---QPN------IVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANIC  178 (366)
Q Consensus       115 ~~------~~~~e~~~l~~l~~---h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~  178 (366)
                      .+      ++.+|.+...++++   |-+      |++++.  .......|+|||++|..+.+.-.- ...++...+..-+
T Consensus       232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l  309 (538)
T KOG1235|consen  232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKL  309 (538)
T ss_pred             HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHH
Confidence            11      23345544444331   222      444432  334567999999999866554322 2235666544444


Q ss_pred             HHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCCCEEEeecCCccccc
Q 017768          179 RQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       179 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+...  +-+=..|++|+|-+|.||++... ..+..+.+-|||+.....
T Consensus       310 ~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  310 VEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            44322  33345689999999999999743 256779999999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.52  E-value=5.6e-06  Score=70.05  Aligned_cols=135  Identities=19%  Similarity=0.205  Sum_probs=97.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccc-------------cccccHHHHHHHHHHHHHhc-----CCCceeEec
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKL-------------VYDKDMEDVRREILILQHLT-----GQPNIVEFE  138 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~  138 (366)
                      ..||+|+.=.||.  +. .....+||+......             .......+..+|+..+..+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4699999999996  33 466788998876540             01123456677777776665     357899999


Q ss_pred             eEEeeCCeEEEEEeccC------CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          139 GAYEDKQNLHLVMELCS------GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       139 ~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      |+.+.+....+|+|...      ..+|.+++... .+++    .+...+-+-..+|-+++|+.+|++|+||++...+++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            99999999999999852      23677877443 3555    3334444556788999999999999999998766655


Q ss_pred             -CEEEeec
Q 017768          213 -PIKATDF  219 (366)
Q Consensus       213 -~vkl~Df  219 (366)
                       .+.|+|-
T Consensus       159 ~~lvlIDG  166 (199)
T PF10707_consen  159 FRLVLIDG  166 (199)
T ss_pred             eEEEEEeC
Confidence             6888883

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.49  E-value=1.1e-08  Score=97.51  Aligned_cols=244  Identities=19%  Similarity=0.221  Sum_probs=165.8

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc-eeEeceEEeeCCeEEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-IVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~lv~  151 (366)
                      |......++|+++.+++.+...+...+ .+.+..      .  ....-++++|.+++ ||| .+..++-++.++..++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~------~--l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ------T--LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeecc------c--hhhHHHHHHHHHcc-CCCCcccccccCCcccccchhh
Confidence            455567899999999997765432222 444321      1  45667889999997 888 777777777788899999


Q ss_pred             eccCCC-ch-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          152 ELCSGG-EL-FDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       152 e~~~~~-~L-~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +++.++ +. .........+..-+...+++.-+++++++|+..-+|+|    ||+.+    .+..+..||+....+....
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCccc
Confidence            999776 22 11111112244456677778888899999998888888    88874    3558999999998887776


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--CCCCC-CCCCCCCHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQS-SPWPSISGQAK  305 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~  305 (366)
                      ..++..+++.++|||+.. ..+....|.|++|+--.++--|..|-..-..  ....+-.+.  ..... ..|...  .-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~--~~~  461 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPV--FHR  461 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcc--ccc
Confidence            667788999999999754 5688899999999876666666655422100  000000000  00000 112111  112


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ++...|+...|..|+....++-|.+|.+.....
T Consensus       462 ~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i  494 (829)
T KOG0576|consen  462 DFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI  494 (829)
T ss_pred             CCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence            577889999999999999999999998866543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.48  E-value=9.8e-07  Score=89.87  Aligned_cols=206  Identities=17%  Similarity=0.210  Sum_probs=143.5

Q ss_pred             cHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE----EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 017768          114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH----LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH  189 (366)
Q Consensus       114 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH  189 (366)
                      ......-|+..+.++. |+|++.++.+....-...    +..++|...++...+..-...+...++.+..++++||.++|
T Consensus       225 ~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3444556777777777 999999988876544333    44578888899999998888999999999999999999999


Q ss_pred             HcCCEEeccCCCcEEeeecCCCCCEEEe--ecCCcccccCCCceecccCCCCCCcccccccc---CCCchhHHHHHHHHH
Q 017768          190 FMGVIHRDLKPENFLLASKEEDSPIKAT--DFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR---YGKEIDVWSAGVILY  264 (366)
Q Consensus       190 ~~~ivH~Dlkp~NIll~~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~vl~  264 (366)
                      +....|.-+..+-..-...+..+.+.+.  ||+................+..+.++|.....   .+...|+|.+|....
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9966555554442222222344456666  88888777655544444556667888876543   344569999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          265 ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       265 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+..|..+-...   .....+..       .   .......+.+.+|+..|+++|+.+.+++.|+|.+.
T Consensus       384 ~~~~~~~i~~~~---~~~~~~l~-------~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  384 QLSQGEDISEKS---AVPVSLLD-------V---LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhhcCcccccc---cchhhhhc-------c---ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            888765442110   00011110       0   01126778999999999999999999999999865

>PLN02876 acyl-CoA dehydrogenase

Probab=98.42  E-value=2.3e-06  Score=88.43  Aligned_cols=81  Identities=22%  Similarity=0.313  Sum_probs=56.8

Q ss_pred             eceecccCceEEEEEEEccCC--cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCce--eEeceEEeeC---CeEE
Q 017768           76 DKELGRGQFGVTYLCTKKATG--RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI--VEFEGAYEDK---QNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--~~~~~~~~~~---~~~~  148 (366)
                      .+.++.|.+..+|+......+  ..+++|+......  ......+.+|+.+++.+.+|.++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            456899999999998765332  4677776543221  12345688999999999755554  7777776654   4678


Q ss_pred             EEEeccCCCc
Q 017768          149 LVMELCSGGE  158 (366)
Q Consensus       149 lv~e~~~~~~  158 (366)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.28  E-value=7.9e-06  Score=74.01  Aligned_cols=146  Identities=21%  Similarity=0.248  Sum_probs=101.7

Q ss_pred             eeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-------------------cc----HHHHHHHHHHHHHhcC
Q 017768           74 DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-------------------KD----MEDVRREILILQHLTG  130 (366)
Q Consensus        74 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~----~~~~~~e~~~l~~l~~  130 (366)
                      .|...|..|--+.||.+... +|..+|||+++.....+.                   ..    .--...|++.|+++. 
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-  224 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-
Confidence            45667889999999999854 799999999864322211                   11    113557999999997 


Q ss_pred             CCceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeccCCCcEEeeecC
Q 017768          131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC-HFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       131 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ...|+..--+...  ...|||+++-...-..=..+.-.++...+..+-.+++..+.-| |.+++||.||.==|+|+    
T Consensus       225 ~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----  298 (520)
T KOG2270|consen  225 NAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----  298 (520)
T ss_pred             hcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence            4555544333322  3479999984321111112223477888888888888888766 78899999999999999    


Q ss_pred             CCCCEEEeecCCcccccC
Q 017768          210 EDSPIKATDFGLSVFIET  227 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~  227 (366)
                      .+|.+.|+|.+.+.....
T Consensus       299 hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             ECCEEEEEEccccccCCC
Confidence            467799999998876543

>PRK10593 hypothetical protein; Provisional

Probab=98.21  E-value=2.7e-05  Score=70.71  Aligned_cols=77  Identities=9%  Similarity=-0.010  Sum_probs=56.5

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC--CceeEeceEEee---CCeEEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--PNIVEFEGAYED---KQNLHLV  150 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~---~~~~~lv  150 (366)
                      .+.||.|..+.||.....  +..+++|..+.     ......+..|...|+.+...  -.++++++++..   .+..+||
T Consensus        19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYDS--QGNPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEcC--CCCEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            356999999999997643  33577776421     11345789999999999754  367888887754   3668999


Q ss_pred             EeccCCCch
Q 017768          151 MELCSGGEL  159 (366)
Q Consensus       151 ~e~~~~~~L  159 (366)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.21  E-value=2.1e-05  Score=68.90  Aligned_cols=75  Identities=16%  Similarity=0.201  Sum_probs=49.9

Q ss_pred             ceecccCceEEEEEEEcc-CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           77 KELGRGQFGVTYLCTKKA-TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      +.|..|-...+|++.... .++.+++|+.....    ...-...+|+.+++.+..+...+++++...  +  .++|||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT----ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc----cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence            457788888999987542 25789999764321    111234578999998875555666655432  2  47999998


Q ss_pred             CCch
Q 017768          156 GGEL  159 (366)
Q Consensus       156 ~~~L  159 (366)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.21  E-value=4.9e-05  Score=71.27  Aligned_cols=80  Identities=18%  Similarity=0.163  Sum_probs=55.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccc----cccHHHHHHHHHHHHHhcCC--CceeEeceEEeeCCeEEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY----DKDMEDVRREILILQHLTGQ--PNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.||.|.+..||++.....++.++||.-.......    ....++...|.+.|+.+...  .++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            56999999999999986433589999753211110    12456778888888887533  457778776  44567899


Q ss_pred             EeccCCCc
Q 017768          151 MELCSGGE  158 (366)
Q Consensus       151 ~e~~~~~~  158 (366)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.19  E-value=9.6e-06  Score=71.13  Aligned_cols=73  Identities=19%  Similarity=0.120  Sum_probs=46.2

Q ss_pred             ceecccCce-EEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC--ceeEeceEEeeC---CeEEEE
Q 017768           77 KELGRGQFG-VTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP--NIVEFEGAYEDK---QNLHLV  150 (366)
Q Consensus        77 ~~lG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~i~~~~~~~~~~---~~~~lv  150 (366)
                      +.|+.|+.. .||+.     +..+++|....     ......+.+|..++..+.++-  .++++++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc-----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457777766 48874     23577886532     123457889999999987431  344555443332   234789


Q ss_pred             EeccCCCch
Q 017768          151 MELCSGGEL  159 (366)
Q Consensus       151 ~e~~~~~~L  159 (366)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999998666

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.09  E-value=1.9e-05  Score=70.17  Aligned_cols=134  Identities=17%  Similarity=0.110  Sum_probs=76.9

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCc
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGE  158 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  158 (366)
                      +..|-...+|+...  ++..+++|.......   ...-...+|..+++.+..+.-.++++...  .  -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence            55677788998763  477888987543211   11013577999999987543345555443  2  368999998865


Q ss_pred             hHH--------------HHHH---hC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCEEeccC
Q 017768          159 LFD--------------RIIA---KG----IYSE-REAANICRQI---------VNVVHACHF--------MGVIHRDLK  199 (366)
Q Consensus       159 L~~--------------~l~~---~~----~l~~-~~~~~i~~qi---------~~~l~~LH~--------~~ivH~Dlk  199 (366)
                      +..              .+.+   ..    .++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            431              1111   00    1111 1122222121         112222222        248999999


Q ss_pred             CCcEEeeecCCCCCEEEeecCCcccc
Q 017768          200 PENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       200 p~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      |.||+++   +++ +.|+||..+...
T Consensus       155 ~~Nil~~---~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVT---PQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEe---CCC-CEEEeccccCcC
Confidence            9999995   333 789999987653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.08  E-value=2.3e-05  Score=71.17  Aligned_cols=138  Identities=17%  Similarity=0.169  Sum_probs=81.6

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceE------EeeCCeEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGA------YEDKQNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~------~~~~~~~~  148 (366)
                      .+.|..|....+|+....  +..+++|+...      .....+..|+.++..+..+. .+++++..      ...++..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            345777887899987653  55799997642      23456778888888886332 24454431      23345678


Q ss_pred             EEEeccCCCchHH----HH----------HHh-CCCCH--------HHHH------------HHHHHHHHHHHHHHH---
Q 017768          149 LVMELCSGGELFD----RI----------IAK-GIYSE--------REAA------------NICRQIVNVVHACHF---  190 (366)
Q Consensus       149 lv~e~~~~~~L~~----~l----------~~~-~~l~~--------~~~~------------~i~~qi~~~l~~LH~---  190 (366)
                      ++++|++|..+..    ..          +.. ..+..        ....            .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998866421    11          100 00000        0000            011112334444443   


Q ss_pred             ----cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 ----MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 ----~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                          .+++|+|+.|.||+++   ++..+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence                4699999999999994   444468999987754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.04  E-value=6.3e-06  Score=73.43  Aligned_cols=141  Identities=16%  Similarity=0.222  Sum_probs=99.8

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-------------------cccHHHHHHHHHHHHHhcCCC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-------------------DKDMEDVRREILILQHLTGQP  132 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~~h~  132 (366)
                      -+.+++.||-|--+-||.+.+. .|++.++|.=.......                   .-..-...+|+..|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3677889999999999999875 69999998432111000                   011223557888888887443


Q ss_pred             -ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          133 -NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       133 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                       -+++.+++    +..++|||+++|.+|...-+      ...+..+...+...+--|-.+|+||+|.+-=||++   .++
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd  238 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD  238 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence             24455443    56789999999988855432      22344556666667778889999999999999999   567


Q ss_pred             CCEEEeecCCccccc
Q 017768          212 SPIKATDFGLSVFIE  226 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~  226 (366)
                      +.++++||-......
T Consensus       239 ~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  239 DKIVVIDFPQMVSTS  253 (465)
T ss_pred             CCEEEeechHhhccC
Confidence            779999998766543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.04  E-value=1.8e-05  Score=66.56  Aligned_cols=100  Identities=21%  Similarity=0.258  Sum_probs=78.5

Q ss_pred             HHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCchHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 017768          119 RREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR---IIAKGIYSEREAANICRQIVNVVHACHF---MG  192 (366)
Q Consensus       119 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~  192 (366)
                      .+|..+++.+++.+++++++|.+    ..+++.||...+++...   +..-...++....+|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            45888999999778999999987    23678899976655321   1111125899999999999999999987   45


Q ss_pred             CEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       193 ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      +.-.|++++|+-+   .+++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            8889999999999   56677999999877554

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.89  E-value=0.00011  Score=67.05  Aligned_cols=76  Identities=14%  Similarity=0.203  Sum_probs=49.6

Q ss_pred             ceecccCceEEEEEEEcc------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           77 KELGRGQFGVTYLCTKKA------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|..|-...+|++....      .++.+++|+.....    .......+|..++..+....-.+++++....    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            345666677888887543      25789999864321    2234567898899888755445566665532    358


Q ss_pred             EeccCCCchH
Q 017768          151 MELCSGGELF  160 (366)
Q Consensus       151 ~e~~~~~~L~  160 (366)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9998886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.00012  Score=66.91  Aligned_cols=139  Identities=18%  Similarity=0.179  Sum_probs=79.4

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceE------EeeCCeEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGA------YEDKQNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~------~~~~~~~~  148 (366)
                      .+.++.|....+|++...  +..+++|+....     .....+..|+.++..|.++. .+++++..      ...++..+
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            345777777899987643  446888876432     12345667778888875221 24444432      12245678


Q ss_pred             EEEeccCCCchH----HH----------HHH-hCCC--------CHHH---H-H-----------HHHHHHHHHHHHHHH
Q 017768          149 LVMELCSGGELF----DR----------IIA-KGIY--------SERE---A-A-----------NICRQIVNVVHACHF  190 (366)
Q Consensus       149 lv~e~~~~~~L~----~~----------l~~-~~~l--------~~~~---~-~-----------~i~~qi~~~l~~LH~  190 (366)
                      ++++|++|.++.    ..          ++. ...+        ....   . .           .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885431    10          111 0001        0000   0 0           001112334555532


Q ss_pred             -------cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 -------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 -------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                             .+++|+|+++.||+++   +++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence                   5799999999999995   344568999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.73  E-value=9.1e-06  Score=85.09  Aligned_cols=203  Identities=15%  Similarity=0.035  Sum_probs=129.1

Q ss_pred             HHHHHHHHhcCCCceeEeceEEee--CCeEEEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHc--
Q 017768          120 REILILQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACHFM--  191 (366)
Q Consensus       120 ~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~--  191 (366)
                      .|..-++... |+++.....-...  ....|..++|+.+|.+++.+.++.    .+...-+.....+.+....-+|..  
T Consensus      1278 ~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3333333444 7777766554443  335688999999999999987642    233333444444436666665543  


Q ss_pred             ---CCEEeccCCCcEEeeecCCCCCEEEeecCCccc-ccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHH
Q 017768          192 ---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVF-IETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYIL  266 (366)
Q Consensus       192 ---~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~l  266 (366)
                         -.+|+++|+-|.+|.   .+..++++++|+.+. -......+...+++.|+.|+..+. .++.++|+|..|+-+|..
T Consensus      1357 lg~T~v~~~Lkf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             CCccchhhhhhhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence               279999999999994   556699999999983 333334455678888999998764 577789999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHcCCCCCCCCC-CC-CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          267 LSGVPPFWAETEKGIFEAILEGNLDLQSSP-WP-SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       267 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ..|..+|-     ...+.+.++........ .+ -.+.+.......+|-.....||.-..+++-+.|
T Consensus      1434 s~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            88877762     23333333322211110 00 123344444555555556678877777776665

>PRK05231 homoserine kinase; Provisional

Probab=97.73  E-value=0.00081  Score=61.80  Aligned_cols=75  Identities=16%  Similarity=0.137  Sum_probs=45.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEece------EEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEG------AYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~------~~~~~~~~~l  149 (366)
                      +.|+.|....+|+....  +..+++|++. .     ...+.+..|+.+++.|..+ -.+++++.      +....+..++
T Consensus        28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-----~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~   99 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT--QGEYVLTLFE-R-----LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA   99 (319)
T ss_pred             chhccccccceEEEEeC--CCcEEEEEec-c-----CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence            45677777889998754  4478999874 1     1233445566666666422 12334332      1233556789


Q ss_pred             EEeccCCCch
Q 017768          150 VMELCSGGEL  159 (366)
Q Consensus       150 v~e~~~~~~L  159 (366)
                      +++|++|..+
T Consensus       100 l~~~l~G~~~  109 (319)
T PRK05231        100 IVTFLEGKWP  109 (319)
T ss_pred             EEEecCCCCC
Confidence            9999988643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.65  E-value=0.00093  Score=61.53  Aligned_cols=77  Identities=19%  Similarity=0.168  Sum_probs=51.3

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeeccccc----ccccHHHHHHHHHHHHHhcCC-C-ceeEeceEEeeCCeEEEEE
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLV----YDKDMEDVRREILILQHLTGQ-P-NIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~lv~  151 (366)
                      .||.|....||++.....++.++||.-......    -.-..++..-|...|+..... | .++++|.+  +.+...++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999997643368999965321111    133456667788888876532 2 46666554  455567999


Q ss_pred             eccCC
Q 017768          152 ELCSG  156 (366)
Q Consensus       152 e~~~~  156 (366)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.59  E-value=0.00065  Score=61.64  Aligned_cols=78  Identities=19%  Similarity=0.181  Sum_probs=46.3

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEeceEEeeCC--eEEEEEe
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEGAYEDKQ--NLHLVME  152 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~--~~~lv~e  152 (366)
                      ++.+-.|..-.+|.....  ++.+++. . +.....-.......+|+.+++.+... --+...++.+.++.  ..+.||+
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            333433433344544443  7788887 3 22222334566778899999988632 23444555555554  5699999


Q ss_pred             ccCCC
Q 017768          153 LCSGG  157 (366)
Q Consensus       153 ~~~~~  157 (366)
                      |++|.
T Consensus       106 ~veGe  110 (321)
T COG3173         106 WVEGE  110 (321)
T ss_pred             Eecce
Confidence            99884

>PLN02236 choline kinase

Probab=97.57  E-value=0.00075  Score=62.66  Aligned_cols=137  Identities=15%  Similarity=0.157  Sum_probs=79.9

Q ss_pred             eecccCceEEEEEEEcc----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           78 ELGRGQFGVTYLCTKKA----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      .|-.|-.-.+|++....    .++.+++|+.....   .... ...+|..+++.+..+.--+++++.+..+    .|.+|
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            45557778899986532    24689999875432   1222 2367999999988655556677665332    57888


Q ss_pred             cCCCchHHH-------H----------HHhC----C-CC-HHHHHHHHHHH-----------------HHHHHHHH----
Q 017768          154 CSGGELFDR-------I----------IAKG----I-YS-EREAANICRQI-----------------VNVVHACH----  189 (366)
Q Consensus       154 ~~~~~L~~~-------l----------~~~~----~-l~-~~~~~~i~~qi-----------------~~~l~~LH----  189 (366)
                      +++.++...       +          +...    . .. ...+..++.++                 ...+..|.    
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            877665321       0          0000    0 11 12222332211                 11122221    


Q ss_pred             ----HcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          190 ----FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       190 ----~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                          ...++|+|+++.|||++  +.++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence                22589999999999995  2235699999988754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.46  E-value=0.0012  Score=60.90  Aligned_cols=75  Identities=11%  Similarity=0.158  Sum_probs=46.4

Q ss_pred             ceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      +.|..|-...+|++.....   +..|++|+.....    ...-.-.+|..+++.+..+.--+++++++. ++   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence            3455577778888765432   3378999775321    122234678888988875544456666653 22   48888


Q ss_pred             cCCCch
Q 017768          154 CSGGEL  159 (366)
Q Consensus       154 ~~~~~L  159 (366)
                      ++|..|
T Consensus        92 i~g~~l   97 (330)
T PLN02421         92 INARTL   97 (330)
T ss_pred             hcCCCC
Confidence            877654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.43  E-value=0.0014  Score=58.75  Aligned_cols=47  Identities=13%  Similarity=0.042  Sum_probs=31.1

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ  131 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h  131 (366)
                      .++|-...|+.... .+|..+++|.-..     ......+.+|.++|+.+.++
T Consensus        19 ~~~g~~~~v~~i~~-~~g~~~VlR~p~~-----~~~~~~l~rE~~vL~~L~~~   65 (276)
T cd05152          19 NESGLDFQVVFAKD-TDGVPWVLRIPRR-----PDVSERAAAEKRVLALVRKH   65 (276)
T ss_pred             cCCcceeEEEEEEc-CCCCeEEEEecCC-----HHHHHHHHHHHHHHHHHHhc
Confidence            34555556666533 3578899986532     22345688999999999754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.42  E-value=0.00067  Score=64.33  Aligned_cols=168  Identities=24%  Similarity=0.233  Sum_probs=107.6

Q ss_pred             ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017768          113 KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM  191 (366)
Q Consensus       113 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~  191 (366)
                      .....+.....+++.+. |++...++++..... ...+|||++ +.+|.+.+..+. +-.....              .+
T Consensus        24 ~~s~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~   86 (725)
T KOG1093|consen   24 PNSIQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AH   86 (725)
T ss_pred             CcHHHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cc
Confidence            34456777888889988 999999988876544 467899999 669988887654 2111111              22


Q ss_pred             CCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCC
Q 017768          192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVP  271 (366)
Q Consensus       192 ~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~  271 (366)
                      ++.|     -||          ++.+| -++..               |  |-    ...+++|||++|.++.++..|..
T Consensus        87 ~~~~-----~~~----------~~~td-~~~t~---------------~--~~----~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLH-----LNI----------IYITD-HFLTK---------------Y--PS----PIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ccce-----ehh----------hhccc-ccccc---------------C--CC----CCCcchhhhhHHHHHHHHHHhhH
Confidence            2221     222          23333 01100               0  11    12259999999999999999988


Q ss_pred             CCCCCChHHHHHHHHcCCCCCCCCCC--------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          272 PFWAETEKGIFEAILEGNLDLQSSPW--------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       272 pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .+......+..+.+..-.........        -.++..+.++..+|+...|..||...++.+++-|.+.
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            87666666555555442222111100        1246678899999999999999999999999888654

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.39  E-value=0.0026  Score=59.65  Aligned_cols=77  Identities=14%  Similarity=0.078  Sum_probs=52.6

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeeccccccc----ccHHHHHHHHHHHHHhcCC--CceeEeceEEeeCCeEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD----KDMEDVRREILILQHLTGQ--PNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.||.|....||+..+.  +..++||.-........    ....+...|...|+.+...  ..+++++.+..  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            457899999999998864  56799997542221111    2455666678888776522  47888887766  44578


Q ss_pred             EEeccCC
Q 017768          150 VMELCSG  156 (366)
Q Consensus       150 v~e~~~~  156 (366)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.07  E-value=0.004  Score=56.04  Aligned_cols=74  Identities=18%  Similarity=0.174  Sum_probs=48.9

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCeEEEEEec
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      .+.++.|....+|+..  .+++.+.||.-.      ......+..|..-|+.|.  ..-.+++++++....+..+|+|||
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEE------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecC------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            4568889999999877  468899999764      233456788888888884  345688999998887778999999


Q ss_pred             cCCC
Q 017768          154 CSGG  157 (366)
Q Consensus       154 ~~~~  157 (366)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            8765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.04  E-value=0.017  Score=52.68  Aligned_cols=29  Identities=28%  Similarity=0.471  Sum_probs=24.0

Q ss_pred             cCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       191 ~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      .+++|+|+++.||+++   . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4789999999999995   2 458999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.03  E-value=0.0013  Score=56.53  Aligned_cols=56  Identities=20%  Similarity=0.140  Sum_probs=34.0

Q ss_pred             CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCch
Q 017768           96 GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL  159 (366)
Q Consensus        96 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  159 (366)
                      ++.|++++....    ....-.-..|..+++.+..+..-+++++.+..+    +|.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred             CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence            467888887543    234556778899999888555556777665332    46688866543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.88  E-value=0.0093  Score=55.76  Aligned_cols=79  Identities=19%  Similarity=0.139  Sum_probs=53.5

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeeccccc---ccccHHHHHHHHHHHHHhcCC-C-ceeEeceEEeeCCeEEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV---YDKDMEDVRREILILQHLTGQ-P-NIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~lv  150 (366)
                      .+.||.|.-..||++.+...++.++||.-......   -.-..++..-|..+|+..... | .+++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            45689999999999997534568999964321111   134566777888888886532 2 56667654  45566789


Q ss_pred             EeccCC
Q 017768          151 MELCSG  156 (366)
Q Consensus       151 ~e~~~~  156 (366)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>PTZ00384 choline kinase; Provisional

Probab=96.86  E-value=0.011  Score=55.61  Aligned_cols=75  Identities=19%  Similarity=0.194  Sum_probs=46.7

Q ss_pred             ceecccCceEEEEEEEccC-CcE-----EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           77 KELGRGQFGVTYLCTKKAT-GRK-----YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|..|-...+|++..... +..     |.++....    .....-.-.+|+.+++.+..+..-+++++.+..    +++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            4565687888999875432 122     33333211    111122345788999999877677778777643    589


Q ss_pred             EeccCCCch
Q 017768          151 MELCSGGEL  159 (366)
Q Consensus       151 ~e~~~~~~L  159 (366)
                      .||++|.+|
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999988665

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.72  E-value=0.062  Score=49.49  Aligned_cols=71  Identities=14%  Similarity=0.098  Sum_probs=43.3

Q ss_pred             CceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEe---ce--EEeeCCeEEEEEeccCC
Q 017768           83 QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEF---EG--AYEDKQNLHLVMELCSG  156 (366)
Q Consensus        83 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~---~~--~~~~~~~~~lv~e~~~~  156 (366)
                      ....||+.... +|..+++|+.....    .....+..|+..+..|..+. .++..   -+  +...++..+.++++++|
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            34568887653 57789999874321    24566778888888876321 12221   11  22335667889999877


Q ss_pred             Cc
Q 017768          157 GE  158 (366)
Q Consensus       157 ~~  158 (366)
                      ..
T Consensus       112 ~~  113 (325)
T PRK11768        112 RA  113 (325)
T ss_pred             CC
Confidence            53

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.58  E-value=0.024  Score=52.05  Aligned_cols=135  Identities=19%  Similarity=0.253  Sum_probs=77.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc-----eeEeceEE--eeCC--eEEE
Q 017768           79 LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-----IVEFEGAY--EDKQ--NLHL  149 (366)
Q Consensus        79 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-----i~~~~~~~--~~~~--~~~l  149 (366)
                      |.+ .-..||+.... +|.. ++|+....     ....++..|...+..+..+.-     +...-|-.  .-.+  ..+-
T Consensus        34 l~s-~eN~~f~~~~~-~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          34 LNS-EENSNFRVQTE-DGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             ccc-ccCceEEEEec-CCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            444 45668887765 3444 99987543     355677888888888874321     22222211  1223  6788


Q ss_pred             EEeccCCCchHH-----HH----------HH-hCC-----------CCHH-------------HHHHHHHHHHHHHHHHH
Q 017768          150 VMELCSGGELFD-----RI----------IA-KGI-----------YSER-------------EAANICRQIVNVVHACH  189 (366)
Q Consensus       150 v~e~~~~~~L~~-----~l----------~~-~~~-----------l~~~-------------~~~~i~~qi~~~l~~LH  189 (366)
                      +++|++|..+..     .+          +. ...           ..+.             .-.....++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            899999877762     11          00 000           1111             00112333444444444


Q ss_pred             H--------cC--CEEeccCCCcEEeeecCCCC-CEEEeecCCccc
Q 017768          190 F--------MG--VIHRDLKPENFLLASKEEDS-PIKATDFGLSVF  224 (366)
Q Consensus       190 ~--------~~--ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~  224 (366)
                      +        .+  +||+|+.|+||+++   ++. .+.++|||-+..
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~~  228 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEc---CCCCeeeEEEcccccc
Confidence            3        24  99999999999995   333 478999997753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.47  E-value=0.014  Score=54.19  Aligned_cols=61  Identities=23%  Similarity=0.237  Sum_probs=43.8

Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHHcCCEEeccCCCcEEeeec
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV-HACHFMGVIHRDLKPENFLLASK  208 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~ivH~Dlkp~NIll~~~  208 (366)
                      ..++-+|..|.++..++.... .++.....++.-.+.|+ .-|--.+++|.|++|.||++...
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            456777888888888887654 35555666665555554 33445689999999999999653

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.37  E-value=0.057  Score=49.33  Aligned_cols=30  Identities=23%  Similarity=0.331  Sum_probs=25.6

Q ss_pred             CCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       192 ~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +++|+|+.++|||+   ++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            69999999999999   4556699999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.25  E-value=0.023  Score=48.47  Aligned_cols=116  Identities=12%  Similarity=0.104  Sum_probs=72.7

Q ss_pred             cCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCCchHH
Q 017768           82 GQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD  161 (366)
Q Consensus        82 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  161 (366)
                      |+.++.-.+..+  =.+..+|++..-..  .-...-+.++.+++.++.   .|+++..-  ....+-+++|+|-....  
T Consensus        73 ~gNsTl~~~kt~--iG~L~lKKi~slp~--~~~~~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTK--IGPLFLKKIRSLPC--CINDALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEeccc--cchhhhhhccCCCc--ccchhhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCccc--
Confidence            344444444333  23556666643222  223445678899999985   78887632  34456799999843211  


Q ss_pred             HHHHhCCCCHHHHHHHHHHHHHHHHHHHH--cCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          162 RIIAKGIYSEREAANICRQIVNVVHACHF--MGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       162 ~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                                 .-..++..=+..|.-+|+  .+.+|+|-.|+|||-   +..|.+||.|=+..
T Consensus       142 -----------~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -----------NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             -----------chhHHHHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhhh
Confidence                       111222222567778884  469999999999999   77888999997643

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.20  E-value=0.019  Score=52.60  Aligned_cols=104  Identities=15%  Similarity=0.189  Sum_probs=67.5

Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ....|++|++. |+++.. +..   -..+++..++.+.+..+.-+..+ ..-|||+..+||||   + .|+|.|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-IKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-eec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence            34567888876 555522 221   24678888888888887777654 69999999999999   4 788999999999


Q ss_pred             ccccCCCceecccCCCCCCccccccccCCCchhHHHHH
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAG  260 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG  260 (366)
                      +........    .-...--|-.+.+.-+.+-+||-+-
T Consensus       369 Rl~~~q~~i----sy~rldhp~lF~G~dd~QFeIYrlM  402 (488)
T COG5072         369 RLSYSQGII----SYNRLDHPDLFNGVDDYQFEIYRLM  402 (488)
T ss_pred             ecccCCcee----eccccCchhhhcCccceeeeHHHHH
Confidence            854322211    1111222444444445566676643

>PRK06148 hypothetical protein; Provisional

Probab=96.16  E-value=0.043  Score=58.33  Aligned_cols=141  Identities=17%  Similarity=0.207  Sum_probs=75.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-Cc--eeEece--------EEee-C
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PN--IVEFEG--------AYED-K  144 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~--i~~~~~--------~~~~-~  144 (366)
                      +.|+. ..-.+|+.... +|..+++|+....     .....+..|...|..|..+ +.  +++++-        .... +
T Consensus        31 ~~L~s-~~d~nf~v~~~-~g~~yVLKi~~~~-----~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLDG-ERDLNFRLTTD-DGADYILKIVNPS-----EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecCC-cCCceEEEEeC-CCCeEEEEEcCCc-----cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            34643 45667887643 5778999988643     2233445566677666532 22  223221        1111 2


Q ss_pred             C--eEEEEEeccCCCchHHH-------H----------HH----h------CCCCH-----------------HHHHHHH
Q 017768          145 Q--NLHLVMELCSGGELFDR-------I----------IA----K------GIYSE-----------------REAANIC  178 (366)
Q Consensus       145 ~--~~~lv~e~~~~~~L~~~-------l----------~~----~------~~l~~-----------------~~~~~i~  178 (366)
                      +  ..+.+++|++|..+.+.       +          ..    .      ..+.+                 .....++
T Consensus       104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l  183 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV  183 (1013)
T ss_pred             CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence            2  46778999999776541       1          00    0      00111                 1112223


Q ss_pred             HHHHHHHHH-----HH--HcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          179 RQIVNVVHA-----CH--FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       179 ~qi~~~l~~-----LH--~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      .++++.+..     +.  ..++||+|++++|||++.+......-|+|||.+..
T Consensus       184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            333333221     21  24699999999999996432222234999998765

>PTZ00296 choline kinase; Provisional

Probab=95.67  E-value=0.12  Score=49.71  Aligned_cols=76  Identities=9%  Similarity=0.090  Sum_probs=45.9

Q ss_pred             eceecccCceEEEEEEEccC--------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           76 DKELGRGQFGVTYLCTKKAT--------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.|..|-.-.+|++.....        ++.|++++.....    ...-.-..|..+++.+..+.--+++++.+.    -
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----g  181 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS----G  181 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC----C
Confidence            34566676777888865421        4678898874322    112234568888888775444445665543    2


Q ss_pred             EEEEeccCCCch
Q 017768          148 HLVMELCSGGEL  159 (366)
Q Consensus       148 ~lv~e~~~~~~L  159 (366)
                      +.|.||++|.+|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            457888887644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	366
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-65
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-64
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-64
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-63
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-63
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-63
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-63
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-62
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-62
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-62
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-62
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-62
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-62
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-61
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-61
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-61
3soa_A	444	Full-Length Human Camkii Length = 444		5e-61
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-61
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-61
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-59
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-59
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-59
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-59
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-58
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-58
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-58
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-57
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-57
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-57
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-56
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-55
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-55
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-54
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-54
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-54
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-54
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-54
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-54
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-54
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-54
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-54
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-54
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-54
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-54
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-54
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-53
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-53
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-53
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-53
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-53
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-52
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-51
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-50
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-50
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-50
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-49
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-49
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-49
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-49
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-49
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-49
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-47
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-46
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-45
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-45
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-45
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-45
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-45
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-44
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-44
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-44
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-44
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-43
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-43
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-43
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-43
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-42
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-42
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-42
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-41
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-40
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-39
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-39
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-39
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-39
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-39
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-39
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-39
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-39
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-39
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-39
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-39
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-39
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-39
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-38
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-38
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-38
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-38
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-38
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-37
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-37
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-37
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-37
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-37
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-37
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-37
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-37
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-37
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-37
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-37
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-37
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-37
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-36
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-36
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-36
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-36
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-35
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-35
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-35
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-35
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-35
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-35
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-35
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-35
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-35
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-35
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-35
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-35
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-35
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-35
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-35
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-35
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-35
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-35
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-34
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-34
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-34
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-34
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-34
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-34
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-34
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-34
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-34
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-34
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-34
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-34
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-34
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-34
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-34
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-34
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-34
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-34
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-34
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-34
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-34
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-34
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-34
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-34
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-34
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-34
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-34
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-34
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-34
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-34
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-34
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-33
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-33
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-33
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-33
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-33
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-33
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-33
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-33
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-33
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-33
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-33
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-33
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-33
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-33
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-33
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-33
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-33
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-33
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-33
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-33
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-33
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-33
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-33
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-33
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-33
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-33
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-33
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-33
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-33
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-33
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-33
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-33
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-33
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-32
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-32
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-32
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-32
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-32
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-32
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-32
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-31
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-31
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-31
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-31
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-31
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-31
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-31
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-30
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-30
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-30
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-30
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-30
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-30
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-30
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-30
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-30
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-30
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-30
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-30
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-30
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-29
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-29
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-29
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-29
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-29
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-29
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-29
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-29
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-29
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-29
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-29
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-29
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-29
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-29
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-29
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-29
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-29
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-29
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-29
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-29
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-29
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-29
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-29
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-29
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-28
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-28
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-28
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-28
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-28
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-28
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-28
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-28
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-28
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-28
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-28
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-28
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-27
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-27
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-26
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-26
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-26
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-25
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-25
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-25
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-23
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-23
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-23
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-23
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-23
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-23
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-22
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-21
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-21
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-21
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-20
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-20
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-20
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-20
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-20
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-20
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-20
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-20
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-20
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-20
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-19
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-19
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-19
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-19
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-19
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-19
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-19
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-18
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-18
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-18
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-18
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-18
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-18
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-18
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-18
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-17
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-17
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-17
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-17
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-17
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-17
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-17
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-17
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-17
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-17
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-17
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-17
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-17
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-17
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-17
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-17
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-17
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-17
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-17
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-17
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-16
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-16
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-16
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-16
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-16
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-16
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-16
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-16
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-16
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-16
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-16
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-16
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-16
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-16
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-15
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-15
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-14
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-14
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-14
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-14
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-13
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-13
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-11
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-11
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-08
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		8e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		8e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  244 bits (622), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 129/290 (44%), Positives = 182/290 (62%), Gaps = 6/290 (2%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   LC  K TG++ A K IS+R++    D E + RE+ +L+ L   PNI++  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLY 92
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             +EDK   +LV E+ +GGELFD II++  +SE +AA I RQ+++ +   H   ++HRDL
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KPEN LL SK +D+ I+  DFGLS   E  K  K+ +G+AYY+APEVLH  Y ++ DVWS
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWS 212
Query: 259 AGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKK 318
            GVILYILLSG PPF    E  I + + +G    +   W  +S  AKDLIRKMLT  P  
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
Query: 319 RITAAEALEHPWL----KEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL 364
           RI+A +AL+H W+    KE  +     +D+A+L  ++QF+   K+ + AL
Sbjct: 273 RISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKLAQAAL 321

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 129/290 (44%), Positives = 182/290 (62%), Gaps = 6/290 (2%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   LC  K TG++ A K IS+R++    D E + RE+ +L+ L   PNI++  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLY 115
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             +EDK   +LV E+ +GGELFD II++  +SE +AA I RQ+++ +   H   ++HRDL
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KPEN LL SK +D+ I+  DFGLS   E  K  K+ +G+AYY+APEVLH  Y ++ DVWS
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWS 235
Query: 259 AGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKK 318
            GVILYILLSG PPF    E  I + + +G    +   W  +S  AKDLIRKMLT  P  
Sbjct: 236 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 295
Query: 319 RITAAEALEHPWL----KEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL 364
           RI+A +AL+H W+    KE  +     +D+A+L  ++QF+   K+ + AL
Sbjct: 296 RISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKLAQAAL 344

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 129/290 (44%), Positives = 182/290 (62%), Gaps = 6/290 (2%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   LC  K TG++ A K IS+R++    D E + RE+ +L+ L   PNI++  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLY 116
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             +EDK   +LV E+ +GGELFD II++  +SE +AA I RQ+++ +   H   ++HRDL
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KPEN LL SK +D+ I+  DFGLS   E  K  K+ +G+AYY+APEVLH  Y ++ DVWS
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWS 236
Query: 259 AGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKK 318
            GVILYILLSG PPF    E  I + + +G    +   W  +S  AKDLIRKMLT  P  
Sbjct: 237 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 296
Query: 319 RITAAEALEHPWL----KEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL 364
           RI+A +AL+H W+    KE  +     +D+A+L  ++QF+   K+ + AL
Sbjct: 297 RISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKLAQAAL 345

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  240 bits (612), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 128/290 (44%), Positives = 180/290 (62%), Gaps = 6/290 (2%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   LC  K TG++ A K IS+R++    D E + RE+ +L+ L   PNI +  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIXKLY 92
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             +EDK   +LV E+ +GGELFD II++  +SE +AA I RQ+++ +   H   ++HRDL
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KPEN LL SK +D+ I+  DFGLS   E  K  K+ +G+AYY+APEVLH  Y ++ DVWS
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDEKCDVWS 212
Query: 259 AGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKK 318
            GVILYILLSG PPF    E  I + + +G    +   W  +S  AKDLIRK LT  P  
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSX 272
Query: 319 RITAAEALEHPWL----KEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL 364
           RI+A +AL+H W+    KE  +     +D+A+L  ++QF+   K+ + AL
Sbjct: 273 RISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKLAQAAL 321

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 127/290 (43%), Positives = 176/290 (60%), Gaps = 6/290 (2%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  + T ++YA K I++     +KD   + RE+ +L+ L   PNI++  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL-DHPNIMKLF 87
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
              ED  + ++V EL +GGELFD II +  +SE +AA I +Q+ + +   H   ++HRDL
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KPEN LL SKE+D  IK  DFGLS   +     K+ +G+AYY+APEVL   Y ++ DVWS
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWS 207
Query: 259 AGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKK 318
           AGVILYILLSG PPF+ + E  I + +  G        W +IS  AKDLIRKMLT  P  
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 319 RITAAEALEHPWLK----EDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL 364
           RITA + LEHPW++    E    SD P   + +T ++QF+A  K+ + AL
Sbjct: 268 RITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAAL 317

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  239 bits (609), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 126/295 (42%), Positives = 179/295 (60%), Gaps = 5/295 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  I++  + LG G F    L  +KATG+ +A K I ++ L        +  EI +L+ 
Sbjct: 19  DIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRK 76
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           +  + NIV  E  YE   +L+LVM+L SGGELFDRI+ KG Y+E++A+ + RQ+++ V+ 
Sbjct: 77  IKHE-NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H MG++HRDLKPEN L  S++E+S I  +DFGLS     G V     G+  YVAPEVL 
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Q+ Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKD 255
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            IR ++ KDP KR T  +A  HPW+  D A  +K I  +V  ++++  A +K ++
Sbjct: 256 FIRNLMEKDPNKRYTCEQAARHPWIAGDTAL-NKNIHESVSAQIRKNFAKSKWRQ 309

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  237 bits (604), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 130/295 (44%), Positives = 176/295 (59%), Gaps = 5/295 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  IYD    LG G F    L   K T +  A K I+++ L  +     +  EI +L H
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVL-H 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV  +  YE   +L+L+M+L SGGELFDRI+ KG Y+ER+A+ +  Q+++ V  
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H +G++HRDLKPEN L  S +EDS I  +DFGLS   + G V     G+  YVAPEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Q+ Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            IR ++ KDP+KR T  +AL+HPW+  D A  DK I  +V  ++K+  A +K K+
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  236 bits (602), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 130/295 (44%), Positives = 175/295 (59%), Gaps = 5/295 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  IYD    LG G F    L   K T +  A K I++  L  +     +  EI +L H
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVL-H 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV  +  YE   +L+L+M+L SGGELFDRI+ KG Y+ER+A+ +  Q+++ V  
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H +G++HRDLKPEN L  S +EDS I  +DFGLS   + G V     G+  YVAPEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Q+ Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            IR ++ KDP+KR T  +AL+HPW+  D A  DK I  +V  ++K+  A +K K+
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 126/304 (41%), Positives = 187/304 (61%), Gaps = 4/304 (1%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           G  LG   +   ++Y L +ELG+G F V   C K   G++YA K I+ +KL   +D + +
Sbjct: 10  GVDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLS-ARDHQKL 68
Query: 119 RREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANIC 178
            RE  I + L   PNIV    +  ++ + +L+ +L +GGELF+ I+A+  YSE +A++  
Sbjct: 69  EREARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 127
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGS 237
           +QI+  V  CH MGV+HRDLKPEN LLASK + + +K  DFGL++ +E   + +    G+
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 238 AYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
             Y++PEVL +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 247
Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAM 356
           W +++ +AKDLI KMLT +P KRITAAEAL+HPW+      +        +  +K+F A 
Sbjct: 248 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNAR 307
Query: 357 NKMK 360
            K+K
Sbjct: 308 RKLK 311

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 130/295 (44%), Positives = 175/295 (59%), Gaps = 5/295 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  IYD    LG G F    L   K T +  A K I++  L  +     +  EI +L H
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVL-H 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV  +  YE   +L+L+M+L SGGELFDRI+ KG Y+ER+A+ +  Q+++ V  
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H +G++HRDLKPEN L  S +EDS I  +DFGLS   + G V     G+  YVAPEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Q+ Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            IR ++ KDP+KR T  +AL+HPW+  D A  DK I  +V  ++K+  A +K K+
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  235 bits (600), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 114/273 (41%), Positives = 173/273 (63%), Gaps = 4/273 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI   Y L+  +GRG +G   +  +K T  + A K I +    + +D++  ++EI I++ 
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 62
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNI+     +ED  +++LVMELC+GGELF+R++ K ++ E +AA I + +++ V  
Sbjct: 63  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
           CH + V HRDLKPENFL  +   DSP+K  DFGL+   + GK+ +  VG+ YYV+P+VL 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             YG E D WSAGV++Y+LL G PPF A T+  +   I EG        W ++S QA+ L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
           IR++LTK PK+RIT+ +ALEH W ++  ++S +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  235 bits (600), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 114/273 (41%), Positives = 173/273 (63%), Gaps = 4/273 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI   Y L+  +GRG +G   +  +K T  + A K I +    + +D++  ++EI I++ 
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKS 79
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNI+     +ED  +++LVMELC+GGELF+R++ K ++ E +AA I + +++ V  
Sbjct: 80  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 138
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
           CH + V HRDLKPENFL  +   DSP+K  DFGL+   + GK+ +  VG+ YYV+P+VL 
Sbjct: 139 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             YG E D WSAGV++Y+LL G PPF A T+  +   I EG        W ++S QA+ L
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
           IR++LTK PK+RIT+ +ALEH W ++  ++S +
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 291

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  234 bits (597), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 120/260 (46%), Positives = 166/260 (63%), Gaps = 1/260 (0%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   + LG+G FG   LC  K TG++ A K IS+R++    D E + RE+ +L+ L   P
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI++    +EDK   +LV E+ +GGELFD II++  +SE +AA I RQ+++ +   H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGK 252
           ++HRDLKPEN LL SK +D+ I+  DFGLS   E  K  K+ +G+AYY+APEVLH  Y +
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 212
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + DVWS GVILYILLSG PPF    E  I + + +G    +   W  +S  AKDLIRKML
Sbjct: 213 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 272
Query: 313 TKDPKKRITAAEALEHPWLK 332
           T  P  RI+A +AL+H W++
Sbjct: 273 TYVPSMRISARDALDHEWIQ 292

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  233 bits (594), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 125/300 (41%), Positives = 186/300 (62%), Gaps = 6/300 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           ++ +Y   K+LG G +G   LC  K T  + A K I R+  V       +  E+ +L+ L
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII-RKTSVSTSSNSKLLEEVAVLK-L 92
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              PNI++    +EDK+N +LVME   GGELFD II +  ++E +AA I +Q+++ V   
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ 248
           H   ++HRDLKPEN LL SKE+D+ IK  DFGLS   E  K  KE +G+AYY+APEVL +
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
           +Y ++ DVWS GVIL+ILL+G PPF  +T++ I   + +G     S  W ++S  AKDLI
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272
Query: 309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPID----SAVLTRMKQFRAMNKMKKLAL 364
           ++ML  D ++RI+A +ALEHPW+KE  +  +  I+    +  +  M++F+   K+ + AL
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAAL 332

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 122/294 (41%), Positives = 184/294 (62%), Gaps = 4/294 (1%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +T  Y L +ELG+G F V   C K  TG++YA K I+ +KL   +D + + RE  I + L
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-RDHQKLEREARICR-L 59
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              PNIV    +  ++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  V+ C
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLH 247
           H  G++HRDLKPEN LLASK + + +K  DFGL++ ++  +  +    G+  Y++PEVL 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AKD
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 239
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           LI KMLT +P KRITA+EAL+HPW+ +    +        +  +K+F A  K+K
Sbjct: 240 LINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK 293

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  232 bits (591), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 122/294 (41%), Positives = 184/294 (62%), Gaps = 4/294 (1%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +T  Y L +ELG+G F V   C K  TG++YA K I+ +KL   +D + + RE  I + L
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLS-ARDHQKLEREARICR-L 59
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              PNIV    +  ++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  V+ C
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLH 247
           H  G++HRDLKPEN LLASK + + +K  DFGL++ ++  +  +    G+  Y++PEVL 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AKD
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 239
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           LI KMLT +P KRITA+EAL+HPW+ +    +        +  +K+F A  K+K
Sbjct: 240 LINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK 293

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  231 bits (589), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 124/300 (41%), Positives = 183/300 (61%), Gaps = 4/300 (1%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
            T  Y L +ELG+G F V   C K   G++YA   I+ +KL   +D + + RE  I + L
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICR-L 66
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              PNIV    +  ++ + +L+ +L +GGELF+ I+A+  YSE +A++  +QI+  V  C
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLH 247
           H MGV+HR+LKPEN LLASK + + +K  DFGL++ +E   + +    G+  Y++PEVL 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AKD
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           LI KMLT +P KRITAAEAL+HPW+      +        +  +K+F A  K+K   L V
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTV 306

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 126/280 (45%), Positives = 166/280 (59%), Gaps = 5/280 (1%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  IYD    LG G F    L   K T +  A K I++  L  +     +  EI +L H
Sbjct: 15  DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVL-H 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV  +  YE   +L+L+M+L SGGELFDRI+ KG Y+ER+A+ +  Q+++ V  
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H +G++HRDLKPEN L  S +EDS I  +DFGLS   + G V     G+  YVAPEVL 
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Q+ Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 251
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
            IR ++ KDP+KR T  +AL+HPW+  D A  DK I  +V
Sbjct: 252 FIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSV 290

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 121/292 (41%), Positives = 176/292 (60%), Gaps = 5/292 (1%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K+LG G +G   LC  K TG + A K I +  +    +   +  E+ +L+ L   PNI++
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HPNIMK 68
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
               +EDK+N +LVME+  GGELFD II +  +SE +AA I +Q+++     H   ++HR
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHR 128
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDV 256
           DLKPEN LL SK  D+ IK  DFGLS   E G   KE +G+AYY+APEVL ++Y ++ DV
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDV 188
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS GVILYILL G PPF  +T++ I + + +G        W  +S +AK L++ MLT +P
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 248
Query: 317 KKRITAAEALEHPWLKEDGATSDKPIDSAVLT----RMKQFRAMNKMKKLAL 364
            KRI+A EAL HPW+ +  +     +    LT     MK+F++  K+ + A+
Sbjct: 249 SKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAM 300

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 115/259 (44%), Positives = 161/259 (62%), Gaps = 1/259 (0%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K+LG G +G   LC  K TG + A K I +  +    +   +  E+ +L+ L   P
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI++    +EDK+N +LVME+  GGELFD II +  +SE +AA I +Q+++     H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGK 252
           ++HRDLKPEN LL SK  D+ IK  DFGLS   E G   KE +G+AYY+APEVL ++Y +
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDE 201
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + DVWS GVILYILL G PPF  +T++ I + + +G        W  +S +AK L++ ML
Sbjct: 202 KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLML 261
Query: 313 TKDPKKRITAAEALEHPWL 331
           T +P KRI+A EAL HPW+
Sbjct: 262 TYEPSKRISAEEALNHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 117/261 (44%), Positives = 162/261 (62%), Gaps = 2/261 (0%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   LG+G FG    C  + T ++YA K I++     +KD   + RE+ +L+ L   P
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL-DHP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI++     ED  + ++V EL +GGELFD II +  +SE +AA I +Q+ + +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGK 252
           ++HRDLKPEN LL SKE+D  IK  DFGLS   +     K+ +G+AYY+APEVL   Y +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + DVWSAGVILYILLSG PPF+ + E  I + +  G        W +IS  AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 313 TKDPKKRITAAEALEHPWLKE 333
           T  P  RITA + LEHPW+++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 117/261 (44%), Positives = 162/261 (62%), Gaps = 2/261 (0%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   LG+G FG    C  + T ++YA K I++     +KD   + RE+ +L+ L   P
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL-DHP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI++     ED  + ++V EL +GGELFD II +  +SE +AA I +Q+ + +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGK 252
           ++HRDLKPEN LL SKE+D  IK  DFGLS   +     K+ +G+AYY+APEVL   Y +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + DVWSAGVILYILLSG PPF+ + E  I + +  G        W +IS  AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 313 TKDPKKRITAAEALEHPWLKE 333
           T  P  RITA + LEHPW+++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  224 bits (572), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 119/294 (40%), Positives = 181/294 (61%), Gaps = 4/294 (1%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +T  Y L +++G+G F V   C K  TG +YA K I+ +KL   +D + + RE  I + L
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLS-ARDHQKLEREARICR-L 59
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
               NIV    +  ++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  V  C
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLH 247
           H MGV+HRDLKPEN LLASK + + +K  DFGL++ ++  +  +    G+  Y++PEVL 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AK+
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKN 239
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           LI +MLT +P KRITA EAL+HPW+ +    +        +  +K+F A  K+K
Sbjct: 240 LINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK 293

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  222 bits (565), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 126/322 (39%), Positives = 187/322 (58%), Gaps = 14/322 (4%)
Query: 41  TSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYA 100
           T+S  P  +  +P       I G     ++  ++++ ELGRG   + Y C +K T + YA
Sbjct: 27  TASAAPGTASLVPDYW----IDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYA 82
Query: 101 CKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELF 160
            K + +       D + VR EI +L  L+  PNI++ +  +E    + LV+EL +GGELF
Sbjct: 83  LKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELF 136
Query: 161 DRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG 220
           DRI+ KG YSER+AA+  +QI+  V   H  G++HRDLKPEN L A+   D+P+K  DFG
Sbjct: 137 DRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAET-E 278
           LS  +E   + K + G+  Y APE+L    YG E+D+WS G+I YILL G  PF+ E  +
Sbjct: 197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
Query: 279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           + +F  IL       S  W  +S  AKDL+RK++  DPKKR+T  +AL+HPW+    A  
Sbjct: 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
Query: 339 DKPIDSAVLTRMKQFRAMNKMK 360
              +D+A   ++++F A  K+K
Sbjct: 317 VH-MDTA-QKKLQEFNARRKLK 336

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  221 bits (562), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 114/289 (39%), Positives = 175/289 (60%), Gaps = 3/289 (1%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG+G F V   C  K TG ++A K I+ +KL   +D + + RE  I + L   P
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HP 88
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV    + +++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  +  CH  G
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++HR+LKPEN LLASK + + +K  DFGL++ +   + +    G+  Y++PEVL +  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D+W+ GVILYILL G PPFW E +  ++  I  G  D  S  W +++ +AK LI  M
Sbjct: 209 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           LT +PKKRITA +AL+ PW+      +        +  +K+F A  K+K
Sbjct: 269 LTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLK 317

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  220 bits (561), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 117/261 (44%), Positives = 162/261 (62%), Gaps = 8/261 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG G F   +L  ++ TG+ +A K I +     D  +E+   EI +L+ +  + NIV  E
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHE-NIVTLE 72
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             YE   + +LVM+L SGGELFDRI+ +G+Y+E++A+ + +Q+++ V   H  G++HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVW 257
           KPEN L  + EE+S I  TDFGLS   + G +     G+  YVAPEVL Q+ Y K +D W
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 258 SAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPK 317
           S GVI YILL G PPF+ ETE  +FE I EG  + +S  W  IS  AKD I  +L KDP 
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251
Query: 318 KRITAAEALEHPWLKEDGATS 338
           +R T  +AL HPW+  DG T+
Sbjct: 252 ERYTCEKALSHPWI--DGNTA 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  218 bits (554), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 109/260 (41%), Positives = 165/260 (63%), Gaps = 3/260 (1%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG+G F V   C  K TG ++A K I+ +KL   +D + + RE  I + L   P
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV    + +++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  +  CH  G
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++HR+LKPEN LLASK + + +K  DFGL++ +   + +    G+  Y++PEVL +  Y 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D+W+ GVILYILL G PPFW E +  ++  I  G  D  S  W +++ +AK LI  M
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 244
Query: 312 LTKDPKKRITAAEALEHPWL 331
           LT +PKKRITA +AL+ PW+
Sbjct: 245 LTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  218 bits (554), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 109/260 (41%), Positives = 165/260 (63%), Gaps = 3/260 (1%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG+G F V   C  K TG ++A K I+ +KL   +D + + RE  I + L   P
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV    + +++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  +  CH  G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++HR+LKPEN LLASK + + +K  DFGL++ +   + +    G+  Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D+W+ GVILYILL G PPFW E +  ++  I  G  D  S  W +++ +AK LI  M
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 312 LTKDPKKRITAAEALEHPWL 331
           LT +PKKRITA +AL+ PW+
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  218 bits (554), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 109/260 (41%), Positives = 165/260 (63%), Gaps = 3/260 (1%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG+G F V   C  K TG ++A K I+ +KL   +D + + RE  I + L   P
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV    + +++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  +  CH  G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++HR+LKPEN LLASK + + +K  DFGL++ +   + +    G+  Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D+W+ GVILYILL G PPFW E +  ++  I  G  D  S  W +++ +AK LI  M
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 312 LTKDPKKRITAAEALEHPWL 331
           LT +PKKRITA +AL+ PW+
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  214 bits (545), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 115/294 (39%), Positives = 178/294 (60%), Gaps = 4/294 (1%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
            T  Y L +ELG+G F V   C KK   ++YA K I+ +KL   +D + + RE  I + L
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLS-ARDHQKLEREARICR-L 86
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              PNIV    +  ++   +LV +L +GGELF+ I+A+  YSE +A++   QI+  V+  
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLH 247
           H   ++HRDLKPEN LLASK + + +K  DFGL++ ++   + +    G+  Y++PEVL 
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AK+
Sbjct: 207 KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKN 266
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMK 360
           LI +MLT +P KRITA +AL+HPW+ +    +        +  +++F A  K+K
Sbjct: 267 LINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLK 320

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 118/301 (39%), Positives = 176/301 (58%), Gaps = 10/301 (3%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM--EDVRREILILQHLT 129
           +Y+L + +G+G F V   C  + TG+++A K +   K      +  ED++RE  I  H+ 
Sbjct: 25  VYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HML 83
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVV 185
             P+IVE    Y     L++V E   G +L   I+ +     +YSE  A++  RQI+  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPE 244
             CH   +IHRD+KPEN LLASKE  +P+K  DFG+++ + E+G V    VG+ +++APE
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 245 VLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           V+ +  YGK +DVW  GVIL+ILLSG  PF+   E+ +FE I++G   +    W  IS  
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISES 262
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           AKDL+R+ML  DP +RIT  EAL HPWLKE    + K      + ++++F A  K+K   
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAV 322
Query: 364 L 364
           L
Sbjct: 323 L 323

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  211 bits (536), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 117/304 (38%), Positives = 175/304 (57%), Gaps = 15/304 (4%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDS-AVLTRMKQFRAMNKMKK 361
            AKD IR++L KDPKKR+T  ++L+HPW+        KP D+   L+R      M K KK
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI--------KPKDTQQALSRKASAVNMEKFKK 298
Query: 362 LALK 365
            A +
Sbjct: 299 FAAR 302

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 162/265 (61%), Gaps = 6/265 (2%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILILQHLT 129
           Y++ +ELG GQF +   C +K TG++YA K I +R+L   +     E++ RE+ IL+ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             PNI+     +E+K ++ L++EL SGGELFD +  K   +E EA    +QI++ VH  H
Sbjct: 67  -HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 190 FMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-H 247
              + H DLKPEN +L  K   +P IK  DFG++  IE G  +K I G+  +VAPE++ +
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           +  G E D+WS GVI YILLSG  PF  ET++     I   N D     + + S  AKD 
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF 245
Query: 308 IRKMLTKDPKKRITAAEALEHPWLK 332
           IR++L KDPK+R+T A++LEH W+K
Sbjct: 246 IRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           D+   Y++ +ELG GQF +   C +K TG++YA K I +R+L   +     E++ RE+ I
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PNI+     +E+K ++ L++EL SGGELFD +  K   +E EA    +QI++ 
Sbjct: 69  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 127
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           VH  H   + H DLKPEN +L  K   +P IK  DFG++  IE G  +K I G+  +VAP
Sbjct: 128 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 187
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  ET++     I   N D     + + S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 247
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPK+R+  A++LEH W+K
Sbjct: 248 LAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  208 bits (530), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  208 bits (530), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 110/265 (41%), Positives = 161/265 (60%), Gaps = 6/265 (2%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILILQHLT 129
           Y++ +ELG GQF +   C +K TG++YA K I +R+L   +     E++ RE+ IL+ + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             PNI+     +E+K ++ L++EL SGGELFD +  K   +E EA    +QI++ VH  H
Sbjct: 88  -HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 190 FMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-H 247
              + H DLKPEN +L  K   +P IK  DFG++  IE G  +K I G+  +VAPE++ +
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           +  G E D+WS GVI YILLSG  PF  ET++     I   N D     + + S  AKD 
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF 266
Query: 308 IRKMLTKDPKKRITAAEALEHPWLK 332
           IR++L KDPK+R+  A++LEH W+K
Sbjct: 267 IRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 67  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 67  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  207 bits (527), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 163/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG G+F V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 162/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L+ EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  204 bits (520), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 162/270 (60%), Gaps = 6/270 (2%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG G F V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            AKD IR++L KDPKKR+T  ++L+HPW+K
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 115/301 (38%), Positives = 173/301 (57%), Gaps = 10/301 (3%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM--EDVRREILILQHLT 129
           +Y+L + +G+G F V   C  + TG+++A K +   K      +  ED++RE  I  H+ 
Sbjct: 27  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HML 85
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVV 185
             P+IVE    Y     L++V E   G +L   I+ +     +YSE  A++  RQI+  +
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPE 244
             CH   +IHRD+KP   LLASKE  +P+K   FG+++ + E+G V    VG+ +++APE
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 205
Query: 245 VLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           V+ +  YGK +DVW  GVIL+ILLSG  PF+   E+ +FE I++G   +    W  IS  
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISES 264
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           AKDL+R+ML  DP +RIT  EAL HPWLKE    + K      + ++++F A  K+K   
Sbjct: 265 AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAV 324
Query: 364 L 364
           L
Sbjct: 325 L 325

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 172/301 (57%), Gaps = 14/301 (4%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKD-------MEDVRREILILQ 126
           ++LG G +G   LC +K    + A K I + +     Y  D        E++  EI +L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            L   PNI++    +EDK+  +LV E   GGELF++II +  + E +AANI +QI++ + 
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
             H   ++HRD+KPEN LL +K     IK  DFGLS F       ++ +G+AYY+APEVL
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            ++Y ++ DVWS GVI+YILL G PPF  + ++ I + + +G      + W +IS +AK+
Sbjct: 221 KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGAT---SDKPIDSAVLTRMKQFRAMNKMKKLA 363
           LI+ MLT D  KR TA EAL   W+K+       SD+      L+ M++F    K+ + A
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA 340
Query: 364 L 364
           +
Sbjct: 341 I 341

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 115/301 (38%), Positives = 173/301 (57%), Gaps = 10/301 (3%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM--EDVRREILILQHLT 129
           +Y+L + +G+G F V   C  + TG+++A K +   K      +  ED++RE  I  H+ 
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC-HML 83
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVV 185
             P+IVE    Y     L++V E   G +L   I+ +     +YSE  A++  RQI+  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPE 244
             CH   +IHRD+KP   LLASKE  +P+K   FG+++ + E+G V    VG+ +++APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 245 VLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           V+ +  YGK +DVW  GVIL+ILLSG  PF+   E+ +FE I++G   +    W  IS  
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISES 262
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           AKDL+R+ML  DP +RIT  EAL HPWLKE    + K      + ++++F A  K+K   
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAV 322
Query: 364 L 364
           L
Sbjct: 323 L 323

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 158/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD---MEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +   PNI+     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  194 bits (493), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 107/268 (39%), Positives = 157/268 (58%), Gaps = 6/268 (2%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILIL 125
           +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
           + +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ V
Sbjct: 70  RQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAPE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           ++ ++  G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S  
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           AKD IRK+L K+ +KR+T  EAL HPW+
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 103/274 (37%), Positives = 156/274 (56%), Gaps = 16/274 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACK--SISRRKLVYDKDMEDVR----REILILQ 126
           Y+  + LGRG   V   C  K T ++YA K   ++       ++++++R    +E+ IL+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            ++G PNI++ +  YE      LV +L   GELFD +  K   SE+E   I R ++ V+ 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A H + ++HRDLKPEN LL   ++D  IK TDFG S  ++ G+  +E+ G+  Y+APE++
Sbjct: 139 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195
Query: 247 -------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
                  H  YGKE+D+WS GVI+Y LL+G PPFW   +  +   I+ GN    S  W  
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            S   KDL+ + L   P+KR TA EAL HP+ ++
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 103/274 (37%), Positives = 156/274 (56%), Gaps = 16/274 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACK--SISRRKLVYDKDMEDVR----REILILQ 126
           Y+  + LGRG   V   C  K T ++YA K   ++       ++++++R    +E+ IL+
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            ++G PNI++ +  YE      LV +L   GELFD +  K   SE+E   I R ++ V+ 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A H + ++HRDLKPEN LL   ++D  IK TDFG S  ++ G+  +E+ G+  Y+APE++
Sbjct: 126 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182
Query: 247 -------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
                  H  YGKE+D+WS GVI+Y LL+G PPFW   +  +   I+ GN    S  W  
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            S   KDL+ + L   P+KR TA EAL HP+ ++
Sbjct: 243 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 153/272 (56%), Gaps = 15/272 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACK--SISRRKLV---YDKDMEDVRREILILQH 127
           YD    +GRG   V   C  +ATG ++A K   ++  +L     ++  E  RRE  IL+ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           + G P+I+    +YE    + LV +L   GELFD +  K   SE+E  +I R ++  V  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H   ++HRDLKPEN LL   +++  I+ +DFG S  +E G+  +E+ G+  Y+APE+L 
Sbjct: 216 LHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 247 ------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
                 H  YGKE+D+W+ GVIL+ LL+G PPFW   +  +   I+EG     S  W   
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           S   KDLI ++L  DP+ R+TA +AL+HP+ +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  191 bits (486), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 155/274 (56%), Gaps = 16/274 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACK--SISRRKLVYDKDMEDVR----REILILQ 126
           Y+  + LGRG   V   C  K T ++YA K   ++       ++++++R    +E+ IL+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            ++G PNI++ +  YE      LV +L   GELFD +  K   SE+E   I R ++ V+ 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A H + ++HRDLKPEN LL   ++D  IK TDFG S  ++ G+  + + G+  Y+APE++
Sbjct: 139 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEII 195
Query: 247 -------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
                  H  YGKE+D+WS GVI+Y LL+G PPFW   +  +   I+ GN    S  W  
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            S   KDL+ + L   P+KR TA EAL HP+ ++
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/282 (36%), Positives = 159/282 (56%), Gaps = 7/282 (2%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG G FGV + C +KATGR +  K I+     Y  D   V+ EI I+  L   P
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN---TPYPLDKYTVKNEISIMNQLH-HP 108
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFM 191
            ++    A+EDK  + L++E  SGGELFDRI A+    SE E  N  RQ    +   H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
            ++H D+KPEN +  +K+  S +K  DFGL+  +   ++ K    +A + APE++ +   
Sbjct: 169 SIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G   D+W+ GV+ Y+LLSG+ PF  E +    + +   + +     + S+S +AKD I+ 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQ 352
           +L K+P+KR+T  +ALEHPWLK D +     I S+   +++Q
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 115/312 (36%), Positives = 168/312 (53%), Gaps = 30/312 (9%)
Query: 73  YDLD---KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHL 128
           YDLD   K LG G F +   C  K + + +A K IS+R       ME + ++EI  L+  
Sbjct: 10  YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLC 62
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
            G PNIV+    + D+ +  LVMEL +GGELF+RI  K  +SE EA+ I R++V+ V   
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVLH 247
           H +GV+HRDLKPEN L   + ++  IK  DFG +       +  K    + +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEK-------GIFEAILEGNLDLQSSPWPS 299
           Q  Y +  D+WS GVILY +LSG  PF +            I + I +G+   +   W +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI---------DSAVLTRM 350
           +S +AKDLI+ +LT DP KR+  +    + WL++    S  P+          +AV T +
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCV 302
Query: 351 K-QFRAMNKMKK 361
           K  F A NK K+
Sbjct: 303 KATFHAFNKYKR 314

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A K IS+RK       E     +V  EI IL+ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 72  LN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A K IS+RK       E     +V  EI IL+ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 72  L-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A K IS+RK       E     +V  EI IL+ 
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 71  L-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 248
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 249 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A K IS+RK       E     +V  EI IL+ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 72  LN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A K IS+RK       E     +V  EI IL+ 
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 78  LN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 255
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 256 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 287

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A + IS+RK       E     +V  EI IL+ 
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 211 L-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 388
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 389 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 420

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/272 (38%), Positives = 150/272 (55%), Gaps = 12/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-----DVRREILILQH 127
           Y + K LG G  G   L  ++ T +K A + IS+RK       E     +V  EI IL+ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   P I++ +  + D ++ ++V+EL  GGELFD+++      E        Q++  V  
Sbjct: 197 LN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+APEVL 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG 302
                 Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W  +S 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +A DL++K+L  DPK R T  EAL HPWL+++
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 101/282 (35%), Positives = 151/282 (53%), Gaps = 8/282 (2%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG G FGV +  T++ATG  +A K +      ++ D E VR+EI  +  L   P
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR-HP 108
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFM 191
            +V    A+ED   + ++ E  SGGELF+++  +    SE EA    RQ+   +   H  
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
             +H DLKPEN +  +K  +  +K  DFGL+  ++  +  K   G+A + APEV   +  
Sbjct: 169 NYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 227
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G   D+WS GV+ YILLSG+ PF  E +      +   + ++  S +  IS   KD IRK
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 287
Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATS-DKPIDSAVLTRMK 351
           +L  DP  R+T  +ALEHPWL    A   D  I S+  T+++
Sbjct: 288 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 329

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 101/282 (35%), Positives = 151/282 (53%), Gaps = 8/282 (2%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG G FGV +  T++ATG  +A K +      ++ D E VR+EI  +  L   P
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR-HP 214
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFM 191
            +V    A+ED   + ++ E  SGGELF+++  +    SE EA    RQ+   +   H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
             +H DLKPEN +  +K  +  +K  DFGL+  ++  +  K   G+A + APEV   +  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G   D+WS GV+ YILLSG+ PF  E +      +   + ++  S +  IS   KD IRK
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393
Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATS-DKPIDSAVLTRMK 351
           +L  DP  R+T  +ALEHPWL    A   D  I S+  T+++
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 435

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 157/271 (57%), Gaps = 12/271 (4%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           I  ++   ++LG G FG  +L  ++++G +   K+I++ +      ME +  EI +L+ L
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSL 77
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII---AKG-IYSEREAANICRQIVNV 184
              PNI++    +ED  N+++VME C GGEL +RI+   A+G   SE   A + +Q++N 
Sbjct: 78  -DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +   H   V+H+DLKPEN L       SPIK  DFGL+   ++ +      G+A Y+APE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 245 VLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL--EGNLDLQSSPWPSISG 302
           V  +    + D+WSAGV++Y LL+G  PF   + + + +     E N  ++  P   ++ 
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP---LTP 253
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           QA DL+++MLTKDP++R +AA+ L H W K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 103/277 (37%), Positives = 146/277 (52%), Gaps = 15/277 (5%)
Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           L +  +  T  Y++ +++G G + V   C  KAT  ++A K I       DK   D   E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII-------DKSKRDPTEE 65
Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           I IL      PNI+  +  Y+D + +++V EL  GGEL D+I+ +  +SEREA+ +   I
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEED-SPIKATDFGLS--VFIETGKVYKEIVGSA 238
              V   H  GV+HRDLKP N L   +  +   I+  DFG +  +  E G +      +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TA 184
Query: 239 YYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFEAILEGNLDLQS 294
            +VAPEVL  Q Y    D+WS GV+LY +L+G  PF     +T + I   I  G   L  
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             W S+S  AKDL+ KML  DP +R+TAA  L HPW+
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 153/289 (52%), Gaps = 21/289 (7%)
Query: 69  ITTIYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           +T  Y L K+ LG G  G    C  + TG+K A K      L+YD      R+E+     
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK------LLYDS--PKARQEVDHHWQ 77
Query: 128 LTGQPNIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQI 181
            +G P+IV     YE+    K+ L ++ME   GGELF RI  +G   ++EREAA I R I
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV 241
              +   H   + HRD+KPEN L  SKE+D+ +K TDFG +    T    +    + YYV
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYV 196
Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLDLQSSP 296
           APEVL  ++Y K  D+WS GVI+YILL G PPF++ T +    G+   I  G     +  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           W  +S  AK LIR +L  DP +R+T  + + HPW+ +       P+ +A
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 109/289 (37%), Positives = 153/289 (52%), Gaps = 21/289 (7%)
Query: 69  ITTIYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           +T  Y L K+ LG G  G    C  + TG+K A K      L+YD      R+E+     
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK------LLYDS--PKARQEVDHHWQ 58
Query: 128 LTGQPNIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQI 181
            +G P+IV     YE+    K+ L ++ME   GGELF RI  +G   ++EREAA I R I
Sbjct: 59  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV 241
              +   H   + HRD+KPEN L  SKE+D+ +K TDFG +    T    +    + YYV
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYV 177
Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLDLQSSP 296
           APEVL  ++Y K  D+WS GVI+YILL G PPF++ T +    G+   I  G     +  
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           W  +S  AK LIR +L  DP +R+T  + + HPW+ +       P+ +A
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 286

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 105/290 (36%), Positives = 151/290 (52%), Gaps = 24/290 (8%)
Query: 52  IPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY 111
           +P+ S +  +    YV   TI       G G +     C  KAT  +YA K       V 
Sbjct: 15  VPRGSHMNLVFSDGYVVKETI-------GVGSYSECKRCVHKATNMEYAVK-------VI 60
Query: 112 DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE 171
           DK   D   EI IL      PNI+  +  Y+D ++++LV EL  GGEL D+I+ +  +SE
Sbjct: 61  DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE 120
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP--IKATDFGLS--VFIET 227
           REA+ +   I   V   H  GV+HRDLKP N L    E  +P  ++  DFG +  +  E 
Sbjct: 121 REASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVD-ESGNPECLRICDFGFAKQLRAEN 179
Query: 228 GKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFE 283
           G +      +A +VAPEVL  Q Y +  D+WS G++LY +L+G  PF    ++T + I  
Sbjct: 180 GLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILT 238
Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            I  G   L    W ++S  AKDL+ KML  DP +R+TA + L+HPW+ +
Sbjct: 239 RIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 100/269 (37%), Positives = 145/269 (53%), Gaps = 17/269 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + +G G +     C  KAT  +YA K I       DK   D   EI IL      P
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI-------DKSKRDPSEEIEILLRYGQHP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+  +  Y+D ++++LV EL  GGEL D+I+ +  +SEREA+ +   I   V   H  G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 193 VIHRDLKPENFLLASKEEDSP--IKATDFGLS--VFIETGKVYKEIVGSAYYVAPEVL-H 247
           V+HRDLKP N L    E  +P  ++  DFG +  +  E G +      +A +VAPEVL  
Sbjct: 142 VVHRDLKPSNILYVD-ESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKR 199
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           Q Y +  D+WS G++LY +L+G  PF    ++T + I   I  G   L    W ++S  A
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETA 259
Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           KDL+ KML  DP +R+TA + L+HPW+ +
Sbjct: 260 KDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 102/277 (36%), Positives = 144/277 (51%), Gaps = 15/277 (5%)
Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           L +  +  T  Y++ +++G G + V   C  KAT  ++A K I       DK   D   E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKII-------DKSKRDPTEE 65
Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           I IL      PNI+  +  Y+D + +++V EL  GGEL D+I+ +  +SEREA+ +   I
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEED-SPIKATDFGLS--VFIETGKVYKEIVGSA 238
              V   H  GV+HRDLKP N L   +  +   I+  DFG +  +  E G +      +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TA 184
Query: 239 YYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFEAILEGNLDLQS 294
            +VAPEVL  Q Y    D+WS GV+LY  L+G  PF     +T + I   I  G   L  
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             W S+S  AKDL+ K L  DP +R+TAA  L HPW+
Sbjct: 245 GYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 100/269 (37%), Positives = 151/269 (56%), Gaps = 9/269 (3%)
Query: 69  ITTIYDLDKE--LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           + + Y + K   LG G+FG  + C + ATG K A K I  R +   KD E+V+ EI ++ 
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMN 141
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVV 185
            L    N+++   A+E K ++ LVME   GGELFDRII +    +E +     +QI   +
Sbjct: 142 QLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
              H M ++H DLKPEN L  +++    IK  DFGL+   +  +  K   G+  ++APEV
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDA-KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 246 LHQRY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           ++  +     D+WS GVI Y+LLSG+ PF  + +      IL    DL+   +  IS +A
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           K+ I K+L K+   RI+A+EAL+HPWL +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 102/291 (35%), Positives = 143/291 (49%), Gaps = 33/291 (11%)
Query: 72  IYDLDKEL-GRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +Y L  EL G G +           G++YA K I ++          V RE+  L    G
Sbjct: 13  MYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSRVFREVETLYQCQG 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
             NI+E    +ED    +LV E   GG +   I  +  ++EREA+ + R +   +   H 
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHT 129
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV--------GSAYYVA 242
            G+ HRDLKPEN L  S E+ SP+K  DF L   ++       I         GSA Y+A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 243 PEVLH------QRYGKEIDVWSAGVILYILLSGVPPF---------WAETE------KGI 281
           PEV+         Y K  D+WS GV+LYI+LSG PPF         W   E        +
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 249
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           FE+I EG  +     W  IS +AKDLI K+L +D K+R++AA+ L+HPW++
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/278 (34%), Positives = 142/278 (51%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 75
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +     E   + YYVAPEVL  ++Y 
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD 195
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 255
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 256 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/260 (34%), Positives = 143/260 (55%), Gaps = 4/260 (1%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELGRG+F V   C  K+TG++YA K + +R+   D   E +  EI +L+     P ++ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVIN 93
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVI 194
               YE+   + L++E  +GGE+F   + +   + SE +   + +QI+  V+  H   ++
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKE 253
           H DLKP+N LL+S      IK  DFG+S  I      +EI+G+  Y+APE+L +      
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213
Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
            D+W+ G+I Y+LL+   PF  E  +  +  I + N+D     + S+S  A D I+ +L 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273
Query: 314 KDPKKRITAAEALEHPWLKE 333
           K+P+KR TA   L H WL++
Sbjct: 274 KNPEKRPTAEICLSHSWLQQ 293

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 139/264 (52%), Gaps = 10/264 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   LG G FG   +   + TG K A K ++R+K+     +  +RREI  L+ L   P
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++         ++ +VME  SGGELFD I   G   E+E+  + +QI++ V  CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           V+HRDLKPEN LL +       K  DFGLS  +  G+  +   GS  Y APEV+  R   
Sbjct: 137 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+D+WS+GVILY LL G  PF  +    +F+ I +G         PS+      L++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS----LLKH 249
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  DP KR T  +  EH W K+D
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQD 273

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 81
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 82  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 141
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 142 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 201
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 202 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 261
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 262 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 82
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 83  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 142
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 143 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 202
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 203 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 262
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 263 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 300

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 121
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 301
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 302 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 76
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 77  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 136
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 137 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 196
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 197 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 256
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 257 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 294

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 83
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 84  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 143
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 203
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 204 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 263
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 264 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 75
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 195
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 196 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 255
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 256 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 127
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 128 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 187
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 188 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 247
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 248 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 307
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 308 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 197
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 198 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 257
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 258 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 197
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 198 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 257
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 258 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 91
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 92  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 151
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 152 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 211
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K L
Sbjct: 212 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 271
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 272 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 309

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 144/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A + I + +L     ++ + RE+ I++ L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G    E  GS  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMN 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMN 268

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 100/321 (31%), Positives = 157/321 (48%), Gaps = 52/321 (16%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL--VYDKDMEDVRR 120
           G   +++   Y L   +G+G +GV  +  +  T    A K +++ K+  +  KD+E ++ 
Sbjct: 18  GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------- 163
           E+ +++ L   PNI      YED+Q + LVMELC GG L D++                 
Sbjct: 78  EVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 164 -------------IAKGIYSEREA----------ANICRQIVNVVHACHFMGVIHRDLKP 200
                        I   I+  RE+          +NI RQI + +H  H  G+ HRD+KP
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 201 ENFLLASKEEDSPIKATDFGLS---VFIETGKVYKEIV--GSAYYVAPEVLH---QRYGK 252
           ENFL  S  +   IK  DFGLS     +  G+ Y      G+ Y+VAPEVL+   + YG 
Sbjct: 197 ENFLF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + D WSAGV+L++LL G  PF    +      +L   L  ++  +  +S  A+DL+  +L
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315
Query: 313 TKDPKKRITAAEALEHPWLKE 333
            ++  +R  A  AL+HPW+ +
Sbjct: 316 NRNVDERFDAMRALQHPWISQ 336

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMN 268

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 66
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 239
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMN 261

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 143/263 (54%), Gaps = 8/263 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + ++LGRG+FG+ + C + ++ + Y  K +     V   D   V++EI IL ++    
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISIL-NIARHR 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFM 191
           NI+    ++E  + L ++ E  SG ++F+RI       +ERE  +   Q+   +   H  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
            + H D++PEN +  ++   S IK  +FG +  ++ G  ++ +  +  Y APEV  H   
Sbjct: 122 NIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
               D+WS G ++Y+LLSG+ PF AET + I E I+          +  IS +A D + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 311 MLTKDPKKRITAAEALEHPWLKE 333
           +L K+ K R+TA+EAL+HPWLK+
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQ 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 149/271 (54%), Gaps = 10/271 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ + LG+G+FG  YL  +K      A K + + +L  +     +RREI I  HL   P
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+     + D++ ++L++E    GEL+  +   G + E+ +A    ++ + +H CH   
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN L+  K E   +K  DFG SV   + +  + + G+  Y+ PE++  + + 
Sbjct: 136 VIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLR-RRXMCGTLDYLPPEMIEGKTHD 191
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+W AGV+ Y  L G+PPF + +       I+  N+DL+  P+  +S  +KDLI K+
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPF--LSDGSKDLISKL 247
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           L   P +R+     +EHPW+K +      P+
Sbjct: 248 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 278

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A + I + +L     ++ + RE+ I++ L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMN 268

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       G+  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPWLK 332
            L  +P KR T  + ++  W+ 
Sbjct: 247 FLILNPSKRGTLEQIMKDRWMN 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 139/264 (52%), Gaps = 11/264 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + K LG G FG   L     TG+K A K I+++ L        + REI  L+ L   P
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++     + K  + +V+E  +G ELFD I+ +   SE+EA    +QI++ V  CH   
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           ++HRDLKPEN LL   +E   +K  DFGLS  +  G   K   GS  Y APEV+  +   
Sbjct: 133 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY++L    PF  E+   +F+ I  G   L     P  +G    LI++
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG----LIKR 245
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  +P  RI+  E ++  W K D
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVD 269

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 139/264 (52%), Gaps = 11/264 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + K LG G FG   L     TG+K A K I+++ L        + REI  L+ L   P
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++     + K  + +V+E  +G ELFD I+ +   SE+EA    +QI++ V  CH   
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           ++HRDLKPEN LL   +E   +K  DFGLS  +  G   K   GS  Y APEV+  +   
Sbjct: 124 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY++L    PF  E+   +F+ I  G   L     P  +G    LI++
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG----LIKR 236
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  +P  RI+  E ++  W K D
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVD 260

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 136/264 (51%), Gaps = 10/264 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   LG G FG   +   + TG K A K ++R+K+     +  ++REI  L+ L   P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++         +  +VME  SGGELFD I   G   E EA  + +QI++ V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           V+HRDLKPEN LL +       K  DFGLS  +  G+  ++  GS  Y APEV+  R   
Sbjct: 132 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+D+WS GVILY LL G  PF  E    +F+ I  G   +      S++     L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA----TLLMH 244
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  DP KR T  +  EH W K+D
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 139/264 (52%), Gaps = 11/264 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + K LG G FG   L     TG+K A K I+++ L        + REI  L+ L   P
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++     + K  + +V+E  +G ELFD I+ +   SE+EA    +QI++ V  CH   
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           ++HRDLKPEN LL   +E   +K  DFGLS  +  G   K   GS  Y APEV+  +   
Sbjct: 128 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY++L    PF  E+   +F+ I  G   L     P  +G    LI++
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG----LIKR 240
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  +P  RI+  E ++  W K D
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVD 264

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 139/264 (52%), Gaps = 11/264 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + K LG G FG   L     TG+K A K I+++ L        + REI  L+ L   P
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++     + K  + +V+E  +G ELFD I+ +   SE+EA    +QI++ V  CH   
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           ++HRDLKPEN LL   +E   +K  DFGLS  +  G   K   GS  Y APEV+  +   
Sbjct: 134 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY++L    PF  E+   +F+ I  G   L     P  +G    LI++
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAG----LIKR 246
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  +P  RI+  E ++  W K D
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVD 270

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 144/261 (55%), Gaps = 11/261 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TGR+ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+L+ME  SGGE+FD ++A G   E+EA +  RQIV+ V  CH   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L+++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKR 244
Query: 311 MLTKDPKKRITAAEALEHPWL 331
            L  +P KR T  + ++  W+
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI 265

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 149/271 (54%), Gaps = 10/271 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ + LG+G+FG  YL  +K      A K + + +L  +     +RREI I  HL   P
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+     + D++ ++L++E    GEL+  +   G + E+ +A    ++ + +H CH   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN L+  K E   +K  DFG SV   + +  + + G+  Y+ PE++  + + 
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLR-RRXMCGTLDYLPPEMIEGKTHD 190
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+W AGV+ Y  L G+PPF + +       I+  N+DL+  P+  +S  +KDLI K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPF--LSDGSKDLISKL 246
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           L   P +R+     +EHPW+K +      P+
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 140/266 (52%), Gaps = 16/266 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L K++G G FGV  L   K +    A K I R     +K  E+V+REI+  + L   P
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLR-HP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV F+       +L +VME  SGGELF+RI   G +SE EA    +Q+++ V  CH M 
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 193 VIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
           V HRDLK EN LL    + SP   +K  DFG S         K  VG+  Y+APEVL ++
Sbjct: 135 VCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 250 Y--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS--PWPSISGQAK 305
              GK  DVWS GV LY++L G  PF    E   F   +   L++Q +   +  IS + +
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
            LI ++   DP KRI+  E   H W 
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   LG G FG   +   + TG K A K ++R+K+     +  ++REI  L+ L   P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++         +  +VME  SGGELFD I   G   E EA  + +QI++ V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY-- 250
           V+HRDLKPEN LL +       K  DFGLS  +  G+  +   GS  Y APEV+  R   
Sbjct: 132 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+D+WS GVILY LL G  PF  E    +F+ I  G   +      S++     L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA----TLLMH 244
Query: 311 MLTKDPKKRITAAEALEHPWLKED 334
           ML  DP KR T  +  EH W K+D
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQD 268

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 144/261 (55%), Gaps = 11/261 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TGR+ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+L+ME  SGGE+FD ++A G   E+EA +  RQIV+ V  CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       G+  Y APE+   ++Y 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+  +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YMSTDCENLLKR 247
Query: 311 MLTKDPKKRITAAEALEHPWL 331
            L  +P KR T  + ++  W+
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI 268

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 135/278 (48%), Gaps = 19/278 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELHWRASQCPHIVRIV 121
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +V E   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 122 DVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN 181
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYG 251
           + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  ++Y 
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 241
Query: 252 KEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           K  D WS GVI YILL G PPF++        G    I  G  +  +  W  +S + K L
Sbjct: 242 KSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXL 301
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           IR +L  +P +R T  E   HPW+ +       P+ ++
Sbjct: 302 IRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 139/266 (52%), Gaps = 16/266 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L K++G G FGV  L   K +    A K I R     +K   +V+REI+  + L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLR-HP 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV F+       +L +VME  SGGELF+RI   G +SE EA    +Q+++ V  CH M 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 193 VIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
           V HRDLK EN LL    + SP   +K  DFG S         K  VG+  Y+APEVL ++
Sbjct: 136 VCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 250 Y--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS--PWPSISGQAK 305
              GK  DVWS GV LY++L G  PF    E   F   +   L++Q +   +  IS + +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
            LI ++   DP KRI+  E   H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 140/266 (52%), Gaps = 16/266 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L K++G G FGV  L   K +    A K I R     +K  E+V+REI+  + L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLR-HP 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV F+       +L +VME  SGGELF+RI   G +SE EA    +Q+++ V  CH M 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 193 VIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
           V HRDLK EN LL    + SP   +K   FG S         K+ VG+  Y+APEVL ++
Sbjct: 136 VCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 250 Y--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS--PWPSISGQAK 305
              GK  DVWS GV LY++L G  PF    E   F   +   L++Q +   +  IS + +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
            LI ++   DP KRI+  E   H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 144/291 (49%), Gaps = 33/291 (11%)
Query: 72  IYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +Y L ++ LG G       C    T ++YA K I ++          V RE+ +L    G
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
             N++E    +E++   +LV E   GG +   I  +  ++E EA+ + + + + +   H 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--------VGSAYYVA 242
            G+ HRDLKPEN L     + SP+K  DFGL   I+       I         GSA Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 243 PEVLH------QRYGKEIDVWSAGVILYILLSGVPPF---------WAETEKG------I 281
           PEV+         Y K  D+WS GVILYILLSG PPF         W   E        +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           FE+I EG  +     W  IS  AKDLI K+L +D K+R++AA+ L+HPW++
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 103/266 (38%), Positives = 139/266 (52%), Gaps = 16/266 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L K++G G FGV  L   K +    A K I R     +K  E+V+REI+  + L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLR-HP 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV F+       +L +VME  SGGELF+RI   G +SE EA    +Q+++ V  CH M 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 193 VIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR 249
           V HRDLK EN LL    + SP   +K   FG S         K  VG+  Y+APEVL ++
Sbjct: 136 VCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 250 Y--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS--PWPSISGQAK 305
              GK  DVWS GV LY++L G  PF    E   F   +   L++Q +   +  IS + +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
            LI ++   DP KRI+  E   H W 
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 99/276 (35%), Positives = 146/276 (52%), Gaps = 13/276 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y + + LG G FG   L T   T +K A K ISR +L+   DM   V REI  L+ L   
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLK-LLRH 68
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           P+I++         ++ +V+E  +GGELFD I+ K   +E E     +QI+  +  CH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRY- 250
            ++HRDLKPEN LL   +++  +K  DFGLS  +  G   K   GS  Y APEV++ +  
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 251 -GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
            G E+DVWS G++LY++L G  PF  E    +F+ +   N  +   P   +S  A+ LIR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---NSCVYVMP-DFLSPGAQSLIR 240
Query: 310 KMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           +M+  DP +RIT  E    PW   +     +P++  
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEV 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 106/280 (37%), Positives = 144/280 (51%), Gaps = 17/280 (6%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           GP +  P +  +  Y+L K++G G FGV  L   K      A K I R     +K  E+V
Sbjct: 8   GP-MDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG----EKIDENV 62
Query: 119 RREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANIC 178
           +REI+  + L   PNIV F+       +L +VME  SGGELF+RI   G +SE EA    
Sbjct: 63  KREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 121
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIV 235
           +Q+++ V   H M V HRDLK EN LL    + SP   +K  DFG S         K  V
Sbjct: 122 QQLISGVSYAHAMQVAHRDLKLENTLL----DGSPAPRLKIADFGYSKASVLHSQPKSAV 177
Query: 236 GSAYYVAPEVLHQRY--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           G+  Y+APEVL ++   GK  DVWS GV LY++L G  PF    E   F   +   L++Q
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 294 SS--PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            +   +  IS + + LI ++   DP KRI+  E   H W 
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 143/291 (49%), Gaps = 33/291 (11%)
Query: 72  IYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +Y L ++ LG G       C    T ++YA K I ++          V RE+ +L    G
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
             N++E    +E++   +LV E   GG +   I  +  ++E EA+ + + + + +   H 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--------VGSAYYVA 242
            G+ HRDLKPEN L     + SP+K  DF L   I+       I         GSA Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 243 PEVLH------QRYGKEIDVWSAGVILYILLSGVPPF---------WAETEKG------I 281
           PEV+         Y K  D+WS GVILYILLSG PPF         W   E        +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           FE+I EG  +     W  IS  AKDLI K+L +D K+R++AA+ L+HPW++
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 97/260 (37%), Positives = 138/260 (53%), Gaps = 11/260 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TG++ A K I + +L     ++ + RE+ I + L   P
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIXKVLN-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LV E  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       G+  Y APE+   ++Y 
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P+   S   ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PF-YXSTDCENLLKK 246
Query: 311 MLTKDPKKRITAAEALEHPW 330
            L  +P KR T  +  +  W
Sbjct: 247 FLILNPSKRGTLEQIXKDRW 266

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 88
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 89  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 148
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   +E   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 149 LIYRDLKPENLLI---DEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 203
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 204 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 259
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 260 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 288

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ + LG+G+FG  YL  ++ +    A K + + +L        +RRE+ I  HL   P
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 133 VIHRDIKPENLLLGSNGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 188
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G+PPF A T +  +  I              ++  A+DLI ++
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FVTEGARDLISRL 244
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +  +R+T AE LEHPW+K   A S KP
Sbjct: 245 LKHNASQRLTLAEVLEHPWIK---ANSSKP 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ + LG+G+FG  YL  ++ +    A K + + +L        +RRE+ I  HL   P
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 133 VIHRDIKPENLLLGSNGE---LKIADFGWSVHAPSSR-RDTLCGTLDYLPPEMIEGRMHD 188
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G+PPF A T +  +  I              ++  A+DLI ++
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FVTEGARDLISRL 244
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +  +R+T AE LEHPW+K   A S KP
Sbjct: 245 LKHNASQRLTLAEVLEHPWIK---ANSSKP 271

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLPNGVNDIKNHKWF----ATTD 301

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 102
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 162
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 163 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 217
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 273
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 274 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 90/218 (41%), Positives = 121/218 (55%), Gaps = 7/218 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TGR+ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKILN-HP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+LVME  SGGE+FD ++A G   E+EA    RQIV+ V  CH   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       GS  Y APE+   ++Y 
Sbjct: 135 IVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG 288
           G E+DVWS GVILY L+SG  PF  +  K + E +L G
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIXNHKWF----ATTD 302

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K++E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFGL+  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 98
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 213
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF----ATTD 294

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 122
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 182
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G  +  + G+  Y+APE +L + Y 
Sbjct: 183 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYN 237
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 293
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 294 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 322

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G ++E  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 126
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 241
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 297
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWF----ATTD 322

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G + E  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 145/273 (53%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           +I+RDLKPEN ++   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE++  + Y 
Sbjct: 162 LIYRDLKPENLII---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 122
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G + E  A     QIV      H + 
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD 182
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 183 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 237
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 293
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 294 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 322

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K++E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   I+ TDFGL+  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G + E  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 96
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G + E  A     QIV      H + 
Sbjct: 97  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD 156
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 157 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 211
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 212 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 267
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 268 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 296

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 106/281 (37%), Positives = 142/281 (50%), Gaps = 19/281 (6%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           GP L  P +  +  YD  K++G G FGV  L   K T    A K I R   +     E+V
Sbjct: 9   GP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENV 63
Query: 119 RREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANIC 178
           +REI+  + L   PNIV F+       +L ++ME  SGGEL++RI   G +SE EA    
Sbjct: 64  QREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF 122
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEIV 235
           +Q+++ V  CH M + HRDLK EN LL    + SP   +K  DFG S         K  V
Sbjct: 123 QQLLSGVSYCHSMQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 236 GSAYYVAPEV-LHQRY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           G+  Y+APEV L Q Y GK  DVWS GV LY++L G  PF    E   +   ++  L ++
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238
Query: 294 SSPWPS---ISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            S  P    IS +   LI ++   DP  RI+  E   H W 
Sbjct: 239 YS-IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G + E  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+AP  +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF----ATTD 301

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  +A K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 134/277 (48%), Gaps = 38/277 (13%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-- 136
           LG G  G       K T  K+A K +        +D    RRE+ +    +  P+IV   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 137 --FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG 192
             +E  Y  ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   H + 
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGK 252
           + HRD+KPEN L  SK  ++ +K TDFG +         KE  G           ++Y K
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTG-----------EKYDK 177
Query: 253 EIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
             D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S + K LI
Sbjct: 178 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 237
Query: 309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           R +L  +P +R+T  E + HPW+ +       P+ ++
Sbjct: 238 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 98
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 213
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 269
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 270 LTKRFGNLKNGVNDIKNHKWF----ATTD 294

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 88/247 (35%), Positives = 137/247 (55%), Gaps = 11/247 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKK 318
           L  D  K
Sbjct: 273 LQVDLTK 279

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  +A K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF----ATTD 301

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L   K TG  +A K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF----ATTD 301

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 91
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 151
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 152 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKAVD 206
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 207 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 262
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 263 LTKRFGNLKDGVNDIKNHKWF----ATTD 287

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 140/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    GE++  +     + E+  A    ++ N +  CH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 189
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 246 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 274

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 140/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    GE++  +     + E+  A    ++ N +  CH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RXXLXGTLDYLPPEMIEGRMHD 189
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 246 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 274

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 20/273 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-P 101
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+   +APE +L + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYN 216
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272
Query: 312 LTKDPKKRI-----TAAEALEHPWLKEDGATSD 339
           L  D  KR         +   H W     AT+D
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKDGVNDIKNHKWF----ATTD 301

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 140/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   E+ G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTELCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 269

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 237
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 237
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 237
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 129 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 240
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 241 GLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 237
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 70
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 131 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 242
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 243 GLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 144/267 (53%), Gaps = 17/267 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIR 309
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P ++S +AK L+ 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----MEEIRFPRTLSPEAKSLLA 237
Query: 310 KMLTKDPKKRI-----TAAEALEHPWL 331
            +L KDPK+R+      A E +EH + 
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 140/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RDDLCGTLDYLPPEMIEGRMHD 210
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 267 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 295

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   IK  DFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   I+ TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RDDLCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 244 LKHNPSQRPMLREVLEHPWIT---ANSSKP 270

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 210
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 267 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 295

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHD 185
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 242 LKHNPSQRPMLREVLEHPWIT---ANSSKP 268

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHD 189
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 246 LKHNPSQRPMLREVLEHPWIT---ANSSKP 272

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 139/269 (51%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GGE+F  +   G + E  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN ++   ++   IK TDFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 139/269 (51%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           + LG G FG   L   K TG  YA K + ++K+V  K +E    E  I Q     P +V+
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI-QQAVNFPFLVK 106
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++V+E   GGE+F  +   G +SE  A     QIV      H + +I+R
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   IK  DFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 167 DLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 277
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWF----ATTD 302

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 67
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 128 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 183
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 239
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 240 LKHNPSQRPMLREVLEHPWIT---ANSSKP 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 269

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 244 LKHNPSQRPMLREVLEHPWIT---ANSSKP 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRMHD 186
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 243 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 271

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTXLCGTLDYLPPEMIEGRMHD 184
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWIT---ANSSKP 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 132
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 133 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 188
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 244
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 245 LKHNPSQRPMLREVLEHPWIT---ANSSKP 271

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 189
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 246 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 274

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RAALCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 244 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 272

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GG++F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   IK  DFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RDTLCGTLDYLPPEMIEGRMHD 185
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 242 LKHNPSQRPMLREVLEHPWIT---ANSSKP 268

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G FG   L     TG  YA K + ++K+V  K +E    E  ILQ +   P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            E +++D  NL++VME   GG++F  +   G +SE  A     QIV      H + +I+R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEID 255
           DLKPEN L+   ++   IK  DFG +  ++ G+ +  + G+  Y+APE +L + Y K +D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ GV++Y + +G PPF+A+    I+E I+ G +   S      S   KDL+R +L  D
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276
Query: 316 PKKRI-----TAAEALEHPWLKEDGATSD 339
             KR         +   H W     AT+D
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF----ATTD 301

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 85
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 146 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 201
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 257
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 258 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 286

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 13/273 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG S    + +    + G+  Y+ PE++  R + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSCHAPSSR-RTTLSGTLDYLPPEMIEGRMHD 185
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPIDS 344
           L  +P +R    E LEHPW+    A S KP +S
Sbjct: 242 LKHNPSQRPMLREVLEHPWIT---ANSSKPSNS 271

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 138/272 (50%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE +  R + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEXIEGRXHD 189
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 246 LKHNPSQRPXLREVLEHPWIT---ANSSKPSN 274

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  +FG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 186
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
           L  +P +R    E LEHPW+    A S KP +
Sbjct: 243 LKHNPSQRPMLREVLEHPWIT---ANSSKPSN 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 16/259 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L K LG G +G  +L  K +   TG+ YA K + +  +V   K  E  R E  +L+H+
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V    A++ +  LHL+++  +GGELF  +  +  ++E E      +IV  +   
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS---VFIETGKVYKEIVGSAYYVAPEV 245
           H +G+I+RD+K EN LL S   +  +  TDFGLS   V  ET + Y +  G+  Y+AP++
Sbjct: 176 HKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDI 231
Query: 246 LH---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SIS 301
           +      + K +D WS GV++Y LL+G  PF  + EK   +A +   +     P+P  +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPPYPQEMS 290
Query: 302 GQAKDLIRKMLTKDPKKRI 320
             AKDLI+++L KDPKKR+
Sbjct: 291 ALAKDLIQRLLMKDPKKRL 309

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 138/270 (51%), Gaps = 13/270 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  +FG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           L  +P +R    E LEHPW+    A S KP
Sbjct: 244 LKHNPSQRPMLREVLEHPWIT---ANSSKP 270

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 10/265 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGA 336
           L  +P +R    E LEHPW+  + +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 10/265 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RXXLCGTLDYLPPEMIEGRMHD 187
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 312 LTKDPKKRITAAEALEHPWLKEDGA 336
           L  +P +R    E LEHPW+  + +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSS 268

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 132/263 (50%), Gaps = 16/263 (6%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           + LG G FG  +L   +  GR YA K + +  +V  K +E    E L+L  +T  P I+ 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIR 70
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
             G ++D Q + ++M+   GGELF  +     +    A     ++   +   H   +I+R
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR 130
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEID 255
           DLKPEN LL   +++  IK TDFG + ++    V   + G+  Y+APEV+  + Y K ID
Sbjct: 131 DLKPENILL---DKNGHIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVSTKPYNKSID 185
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            WS G+++Y +L+G  PF+       +E IL   L       P  +   KDL+ +++T+D
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRD 241
Query: 316 PKKRI-----TAAEALEHPWLKE 333
             +R+        +   HPW KE
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K      A K + + +L        +RRE+ I  HL   P
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +    + G+  Y+ PE++  R + 
Sbjct: 126 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 181
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 237
Query: 312 LTKDPKKRITAAEALEHPWLKEDGA 336
           L  +P +R    E LEHPW+  + +
Sbjct: 238 LKHNPSQRPMLREVLEHPWITANSS 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 142/266 (53%), Gaps = 13/266 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   Y      TG + A K I ++ +     ++ V+ E+ I   L   P+I+E  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELY 77
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHR 196
             +ED   ++LV+E+C  GE+ +R +   +  +SE EA +   QI+  +   H  G++HR
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVLHQR-YGKEI 254
           DL   N LL     +  IK  DFGL+  ++   + +  + G+  Y++PE+  +  +G E 
Sbjct: 137 DLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           DVWS G + Y LL G PPF  +T K     ++  + ++ S     +S +AKDLI ++L +
Sbjct: 194 DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRR 249
Query: 315 DPKKRITAAEALEHPWLKEDGATSDK 340
           +P  R++ +  L+HP++  + +T  K
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTKSK 275

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 132/244 (54%), Gaps = 9/244 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L  L   P + +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L+ VME  +GG+L   I   G + E +A     +I   +   H  G+I+RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 199 KPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDV 256
           K +N +L S   +  IK  DFG+    +  G   +E  G+  Y+APE++ +Q YGK +D 
Sbjct: 147 KLDNVMLDS---EGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L+G PPF  E E  +F++I+E N+   S P  S+S +A  + + ++TK P
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV---SYP-KSLSKEAVSICKGLMTKHP 259
Query: 317 KKRI 320
            KR+
Sbjct: 260 AKRL 263

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 133/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F  T L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 264 EKLLVLDATKRLGCEE 279

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 142/264 (53%), Gaps = 10/264 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + ++  +     +RREI I  HL   P
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH-HP 83
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+     + D++ ++L++E    GEL+  +     + E+  A I  ++ + +  CH   
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL  K E       DFG SV   + +  K + G+  Y+ PE++  R + 
Sbjct: 144 VIHRDIKPENLLLGLKGELK---IADFGWSVHAPSLR-RKTMCGTLDYLPPEMIEGRMHN 199
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+W  GV+ Y LL G PPF + +    +  I++ +L   +    S+   A+DLI K+
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA----SVPTGAQDLISKL 255
Query: 312 LTKDPKKRITAAEALEHPWLKEDG 335
           L  +P +R+  A+   HPW++ + 
Sbjct: 256 LRHNPSERLPLAQVSAHPWVRANS 279

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 19/271 (7%)
Query: 73  YDLDKELGRGQFGVTYLC---TKKATGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L + LG+G +G  +     T   TG+ +A K + +  +V + KD    + E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P IV+   A++    L+L++E  SGGELF ++  +GI+ E  A     +I   +   
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH 247
           H  G+I+RDLKPEN +L        +K TDFGL    I  G V     G+  Y+APE+L 
Sbjct: 138 HQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  + + +D WS G ++Y +L+G PPF  E  K   + IL+  L+L     P ++ +A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 307 LIRKMLTKDPKKRI-----TAAEALEHPWLK 332
           L++K+L ++   R+      A E   HP+ +
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/304 (31%), Positives = 158/304 (51%), Gaps = 25/304 (8%)
Query: 35  QQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDIT-TIYDLDKELGRGQFGVTYLCTKK 93
           + DFR  S    + ++++  +      L KP   +T   ++  K LG+G FG   L  +K
Sbjct: 117 EMDFRSGSPSDNSGAEEMEVS------LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 94  ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL 153
           ATGR YA K + +  +V   ++     E  +LQ+ +  P +   + +++    L  VME 
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEY 229
Query: 154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDS 212
            +GGELF  +  + ++SE  A     +IV+ +   H    V++RDLK EN +L   ++D 
Sbjct: 230 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDG 286
Query: 213 PIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGV 270
            IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ +D W  GV++Y ++ G 
Sbjct: 287 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
Query: 271 PPFWAETEKGIFEAILEGNLDLQSSPWPSISG-QAKDLIRKMLTKDPKKRI-----TAAE 324
            PF+ +  + +FE IL     ++   +P   G +AK L+  +L KDPK+R+      A E
Sbjct: 347 LPFYNQDHEKLFELIL-----MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
Query: 325 ALEH 328
            ++H
Sbjct: 402 IMQH 405

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 19/271 (7%)
Query: 73  YDLDKELGRGQFGVTYLC---TKKATGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L + LG+G +G  +     T   TG+ +A K + +  +V + KD    + E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P IV+   A++    L+L++E  SGGELF ++  +GI+ E  A     +I   +   
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH 247
           H  G+I+RDLKPEN +L        +K TDFGL    I  G V     G+  Y+APE+L 
Sbjct: 138 HQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  + + +D WS G ++Y +L+G PPF  E  K   + IL+  L+L     P ++ +A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 307 LIRKMLTKDPKKRI-----TAAEALEHPWLK 332
           L++K+L ++   R+      A E   HP+ +
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 134/256 (52%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 95
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D  ++ +P    +A+DL+
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARDLV 268
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 269 EKLLVLDATKRLGCEE 284

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 97/304 (31%), Positives = 158/304 (51%), Gaps = 25/304 (8%)
Query: 35  QQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDIT-TIYDLDKELGRGQFGVTYLCTKK 93
           + DFR  S    + ++++  +      L KP   +T   ++  K LG+G FG   L  +K
Sbjct: 120 EMDFRSGSPSDNSGAEEMEVS------LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 173
Query: 94  ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL 153
           ATGR YA K + +  +V   ++     E  +LQ+ +  P +   + +++    L  VME 
Sbjct: 174 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSFQTHDRLCFVMEY 232
Query: 154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDS 212
            +GGELF  +  + ++SE  A     +IV+ +   H    V++RDLK EN +L   ++D 
Sbjct: 233 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDG 289
Query: 213 PIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGV 270
            IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ +D W  GV++Y ++ G 
Sbjct: 290 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349
Query: 271 PPFWAETEKGIFEAILEGNLDLQSSPWPSISG-QAKDLIRKMLTKDPKKRI-----TAAE 324
            PF+ +  + +FE IL     ++   +P   G +AK L+  +L KDPK+R+      A E
Sbjct: 350 LPFYNQDHEKLFELIL-----MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 404
Query: 325 ALEH 328
            ++H
Sbjct: 405 IMQH 408

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 141/264 (53%), Gaps = 18/264 (6%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATGR YA K + +  +V   ++     E  +LQ+ +  P +  
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 73
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIH 195
            + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H    V++
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 196 RDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKE 253
           RDLK EN +L   ++D  IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ 
Sbjct: 134 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG-QAKDLIRKML 312
           +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P   G +AK L+  +L
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLGPEAKSLLSGLL 245
Query: 313 TKDPKKRI-----TAAEALEHPWL 331
            KDPK+R+      A E ++H + 
Sbjct: 246 KKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 141/264 (53%), Gaps = 18/264 (6%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATGR YA K + +  +V   ++     E  +LQ+ +  P +  
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 72
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIH 195
            + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H    V++
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 196 RDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKE 253
           RDLK EN +L   ++D  IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ 
Sbjct: 133 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG-QAKDLIRKML 312
           +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P   G +AK L+  +L
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLGPEAKSLLSGLL 244
Query: 313 TKDPKKRI-----TAAEALEHPWL 331
            KDPK+R+      A E ++H + 
Sbjct: 245 KKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 141/264 (53%), Gaps = 18/264 (6%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K LG+G FG   L  +KATGR YA K + +  +V   ++     E  +LQ+ +  P +  
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 74
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIH 195
            + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H    V++
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 196 RDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKE 253
           RDLK EN +L   ++D  IK TDFGL    I+ G   K   G+  Y+APEVL    YG+ 
Sbjct: 135 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 254 IDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG-QAKDLIRKML 312
           +D W  GV++Y ++ G  PF+ +  + +FE IL     ++   +P   G +AK L+  +L
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----MEEIRFPRTLGPEAKSLLSGLL 246
Query: 313 TKDPKKRI-----TAAEALEHPWL 331
            KDPK+R+      A E ++H + 
Sbjct: 247 KKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 67
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 240
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 241 EKLLVLDATKRLGCEE 256

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 70
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 243
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 244 EKLLVLDATKRLGCEE 259

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 241
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 242 EKLLVLDATKRLGCEE 257

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 264 EKLLVLDATKRLGCEE 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 267 EKLLVLDATKRLGCEE 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 264 EKLLVLDATKRLGCEE 279

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 263 EKLLVLDATKRLGCEE 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 264 EKLLVLDATKRLGCEE 279

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 267 EKLLVLDATKRLGCEE 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 242
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 243 EKLLVLDATKRLGCEE 258

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 97
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 270
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 271 EKLLVLDATKRLGCEE 286

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 247
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 248 EKLLVLDATKRLGCEE 263

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 263 EKLLVLDATKRLGCEE 278

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 29/269 (10%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL---QHLTGQPNI 134
           ++G G  G+  L  +K +GR+ A K +  RK    +  E +  E++I+   QH     N+
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHF----NV 104
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           VE   +Y   + L ++ME   GG L D I+++   +E + A +C  ++  +   H  GVI
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQR-YGK 252
           HRD+K ++ LL     D  +K +DFG    I       K +VG+ Y++APEV+ +  Y  
Sbjct: 164 HRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK------D 306
           E+D+WS G+++  ++ G PP+++++        ++    L+ SP P +    K      D
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNSHKVSPVLRD 273
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            + +ML +DP++R TA E L+HP+L + G
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQTG 302

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 148/282 (52%), Gaps = 14/282 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ K +GRG FG   L   KA+ + YA K +S+ +++   D      E  I+      P
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEI-VGSAYYVAPEVLHQR- 249
           +IHRD+KP+N LL   ++   +K  DFG  + + ETG V+ +  VG+  Y++PEVL  + 
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV L+ +L G  PF+A++  G +  I++    L       IS  AK
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAK 311
Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKEDGATSDKPIDSA 345
           +LI   LT    +  R    E  +HP+ K D    D   ++A
Sbjct: 312 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 353

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 131/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF  I++   D     +P    +A+DL+
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 131/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF  I++   D     +P    +A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 138/273 (50%), Gaps = 11/273 (4%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
           Q   +GP    P+   +  + L K +G+G FG   L   KA    YA K + ++ ++  K
Sbjct: 23  QQINLGPS-SNPHAKPSDFHFL-KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK 80
Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE 173
           + + +  E  +L      P +V    +++    L+ V++  +GGELF  +  +  + E  
Sbjct: 81  EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYK 232
           A     +I + +   H + +++RDLKPEN LL S+     I  TDFGL    IE      
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTS 197
Query: 233 EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD 291
              G+  Y+APEVLH Q Y + +D W  G +LY +L G+PPF++     +++ IL   L 
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257
Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
           L+    P+I+  A+ L+  +L KD  KR+ A +
Sbjct: 258 LK----PNITNSARHLLEGLLQKDRTKRLGAKD 286

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 147/279 (52%), Gaps = 17/279 (6%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 213
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQ-RYGKEID 255
           +K ++ LL     D  +K +DFG    +       K +VG+ Y++APE++ +  YG E+D
Sbjct: 273 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
           +WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + ++L +D
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 316 PKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFR 354
           P +R TAAE L+HP+L + G        ++++  M+Q R
Sbjct: 389 PAQRATAAELLKHPFLAKAGPP------ASIVPLMRQNR 421

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/256 (32%), Positives = 131/256 (51%), Gaps = 12/256 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     G L   I   G + E        +IV+ +   H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKV-YKEIVGSAYYVAPEVLHQR 249
           +IHRDLKPEN LL    ED  I+ TDFG +  +  E+ +      VG+A YV+PE+L ++
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 250 YG-KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D     +P    +A+DL+
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 309 RKMLTKDPKKRITAAE 324
            K+L  D  KR+   E
Sbjct: 266 EKLLVLDATKRLGCEE 281

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 147/279 (52%), Gaps = 17/279 (6%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 136
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQ-RYGKEID 255
           +K ++ LL     D  +K +DFG    +       K +VG+ Y++APE++ +  YG E+D
Sbjct: 196 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
           +WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + ++L +D
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 316 PKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFR 354
           P +R TAAE L+HP+L + G        ++++  M+Q R
Sbjct: 312 PAQRATAAELLKHPFLAKAGPP------ASIVPLMRQNR 344

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 139/260 (53%), Gaps = 11/260 (4%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 91
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQR-YGKEID 255
           +K ++ LL     D  +K +DFG    +       K +VG+ Y++APE++ +  YG E+D
Sbjct: 151 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
           +WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + ++L +D
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 316 PKKRITAAEALEHPWLKEDG 335
           P +R TAAE L+HP+L + G
Sbjct: 267 PAQRATAAELLKHPFLAKAG 286

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 139/260 (53%), Gaps = 11/260 (4%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 93
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVLHQR-YGKEID 255
           +K ++ LL     D  +K +DFG    +       K +VG+ Y++APE++ +  YG E+D
Sbjct: 153 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
           +WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + ++L +D
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 316 PKKRITAAEALEHPWLKEDG 335
           P +R TAAE L+HP+L + G
Sbjct: 269 PAQRATAAELLKHPFLAKAG 288

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 146/280 (52%), Gaps = 19/280 (6%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T+K TG++ A K +  RK    +  E +  E++I++      N+V+ 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HDNVVDM 107
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKEIVGSAYYVAPEVLHQR-YGKEI 254
           +K ++ LL S   D  IK +DFG    +  E  K  K +VG+ Y++APEV+ +  YG E+
Sbjct: 167 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
           D+WS G+++  ++ G PP++ E        I + +L  +      +S   +  +  ML +
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-SLPPRVKDLHKVSSVLRGFLDLMLVR 281
Query: 315 DPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFR 354
           +P +R TA E L HP+LK  G        S ++  M+Q+R
Sbjct: 282 EPSQRATAQELLGHPFLKLAGPP------SCIVPLMRQYR 315

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 141/265 (53%), Gaps = 21/265 (7%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 82
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI------VGSAYYVAPEVLHQR-Y 250
           +K ++ LL     D  +K +DFG        +V KE+      VG+ Y++APE++ +  Y
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGF-----CAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+D+WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + +
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDR 252
Query: 311 MLTKDPKKRITAAEALEHPWLKEDG 335
           +L +DP +R TAAE L+HP+L + G
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAG 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 141/265 (53%), Gaps = 21/265 (7%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ++G G  G+  + T +++G+  A K +  RK    +  E +  E++I++    + N+VE 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 86
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
             +Y     L +VME   GG L D I+     +E + A +C  ++  +   H  GVIHRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI------VGSAYYVAPEVLHQR-Y 250
           +K ++ LL     D  +K +DFG        +V KE+      VG+ Y++APE++ +  Y
Sbjct: 146 IKSDSILLT---HDGRVKLSDFGF-----CAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+D+WS G+++  ++ G PP++ E      + I + NL  +      +S   K  + +
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDR 256
Query: 311 MLTKDPKKRITAAEALEHPWLKEDG 335
           +L +DP +R TAAE L+HP+L + G
Sbjct: 257 LLVRDPAQRATAAELLKHPFLAKAG 281

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 12/265 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++L K LG+G FG  +L   K T + +A K++ +  ++ D D+E    E  +L      P
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +      ++ K+NL  VME  +GG+L   I +   +    A     +I+  +   H  G
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPEV-LHQRY 250
           +++RDLK +N LL   ++D  IK  DFG+      G     E  G+  Y+APE+ L Q+Y
Sbjct: 140 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-WPSISGQAKDLIR 309
              +D WS GV+LY +L G  PF  + E+ +F +I    +D    P W  +  +AKDL+ 
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLV 251
Query: 310 KMLTKDPKKRI-TAAEALEHPWLKE 333
           K+  ++P+KR+    +  +HP  +E
Sbjct: 252 KLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 124 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 240 LHKILVENPSARITIPDIKKDRW 262

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   Y  T   T   +A K + +  L+     E +  EI I + L   P++V F 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNPHVVGFH 108
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   +++V+E+C    L +    +   +E EA    RQ +  V   H   VIHRDL
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    +D  +K  DFGL+  IE  G+  K++ G+  Y+APEVL ++ +  E+D+
Sbjct: 169 KLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G ILY LL G PPF     K  +  I +    +       I+  A  LIR+ML  DP
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADP 281
Query: 317 KKRITAAEAL 326
             R + AE L
Sbjct: 282 TLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   Y  T   T   +A K + +  L+     E +  EI I + L   P++V F 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFH 92
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   +++V+E+C    L +    +   +E EA    RQ +  V   H   VIHRDL
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 152
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    +D  +K  DFGL+  IE  G+  K++ G+  Y+APEVL ++ +  E+D+
Sbjct: 153 KLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDI 209
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G ILY LL G PPF     K  +  I +    +       I+  A  LIR+ML  DP
Sbjct: 210 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADP 265
Query: 317 KKRITAAEAL 326
             R + AE L
Sbjct: 266 TLRPSVAELL 275

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 15/269 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++  + LG+G FG   L   K TG  YA K + +  ++ D D+E    E  IL      P
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            + +    ++    L  VME  +GG+L   I     + E  A     +I++ +   H  G
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR-Y 250
           +I+RDLK +N LL   + +   K  DFG+    I  G       G+  Y+APE+L +  Y
Sbjct: 145 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G  +D W+ GV+LY +L G  PF AE E  +FEAIL  N ++    W  +   A  +++ 
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTW--LHEDATGILKS 257
Query: 311 MLTKDPKKRITAAEA------LEHPWLKE 333
            +TK+P  R+ +         L HP+ KE
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I   L  + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLNHE- 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 124/250 (49%), Gaps = 10/250 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   Y  T   T   +A K + +  L+     E +  EI I + L   P++V F 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNPHVVGFH 108
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   +++V+E+C    L +    +   +E EA    RQ +  V   H   VIHRDL
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    +D  +K  DFGL+  IE  G+  K + G+  Y+APEVL ++ +  E+D+
Sbjct: 169 KLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G ILY LL G PPF     K  +  I +    +       I+  A  LIR+ML  DP
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADP 281
Query: 317 KKRITAAEAL 326
             R + AE L
Sbjct: 282 TLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 124/250 (49%), Gaps = 10/250 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   Y  T   T   +A K + +  L+     E +  EI I + L   P++V F 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DNPHVVGFH 108
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   +++V+E+C    L +    +   +E EA    RQ +  V   H   VIHRDL
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    +D  +K  DFGL+  IE  G+  K + G+  Y+APEVL ++ +  E+D+
Sbjct: 169 KLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G ILY LL G PPF     K  +  I +    +       I+  A  LIR+ML  DP
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRRMLHADP 281
Query: 317 KKRITAAEAL 326
             R + AE L
Sbjct: 282 TLRPSVAELL 291

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 137/259 (52%), Gaps = 13/259 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     PNIV 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNPNIVN 81
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-EIVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  + E+VG+ Y++APEV+ ++ YG ++
Sbjct: 141 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLD 255
Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E L+H +LK
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 140/258 (54%), Gaps = 18/258 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRK----YACKSISRRKL-VYDKDMEDVRREILILQH 127
           ++L K LG+G FG  +L  KK +G      YA K + +  L V D+    + R+IL+   
Sbjct: 26  FELLKVLGQGSFGKVFLV-KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-- 82
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               P IV+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +  
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL 246
            H +G+I+RDLKPEN LL   +E+  IK TDFGLS   I+  K      G+  Y+APEV+
Sbjct: 142 LHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           ++R + +  D WS GV+++ +L+G  PF  +  K     IL+  L +       +S +A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254
Query: 306 DLIRKMLTKDPKKRITAA 323
            L+R +  ++P  R+ A 
Sbjct: 255 SLLRMLFKRNPANRLGAG 272

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G  G   L   + T    A K +  ++ V     E++++EI I + L  + 
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHE- 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG---KVYKEIVGSAYYVAPEVLHQR 249
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L +R
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 250 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +DVWS G++L  +L+G  P W +      E           +PW  I      L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPW 330
           + K+L ++P  RIT  +  +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 141/258 (54%), Gaps = 18/258 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKL-VYDKDMEDVRREILILQH 127
           ++L K LG+G FG  +L  KK +G    + YA K + +  L V D+    + R+IL+   
Sbjct: 27  FELLKVLGQGSFGKVFLV-KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-- 83
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               P IV+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +  
Sbjct: 84  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL 246
            H +G+I+RDLKPEN LL   +E+  IK TDFGLS   I+  K      G+  Y+APEV+
Sbjct: 143 LHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           ++R + +  D WS GV+++ +L+G  PF  +  K     IL+  L +       +S +A+
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 255
Query: 306 DLIRKMLTKDPKKRITAA 323
            L+R +  ++P  R+ A 
Sbjct: 256 SLLRMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 141/258 (54%), Gaps = 18/258 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKL-VYDKDMEDVRREILILQH 127
           ++L K LG+G FG  +L  KK +G    + YA K + +  L V D+    + R+IL+   
Sbjct: 26  FELLKVLGQGSFGKVFLV-KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-- 82
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               P IV+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +  
Sbjct: 83  -VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL 246
            H +G+I+RDLKPEN LL   +E+  IK TDFGLS   I+  K      G+  Y+APEV+
Sbjct: 142 LHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           ++R + +  D WS GV+++ +L+G  PF  +  K     IL+  L +       +S +A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254
Query: 306 DLIRKMLTKDPKKRITAA 323
            L+R +  ++P  R+ A 
Sbjct: 255 SLLRMLFKRNPANRLGAG 272

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 127/245 (51%), Gaps = 11/245 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L      P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L+ VME  +GG+L   I   G + E  A     +I   +      G+I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 199 KPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDV 256
           K +N +L S   +  IK  DFG+    I  G   K   G+  Y+APE++ +Q YGK +D 
Sbjct: 148 KLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP-SISGQAKDLIRKMLTKD 315
           W+ GV+LY +L+G  PF  E E  +F++I+E N+      +P S+S +A  + + ++TK 
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKSMSKEAVAICKGLMTKH 259
Query: 316 PKKRI 320
           P KR+
Sbjct: 260 PGKRL 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 125/244 (51%), Gaps = 9/244 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L      P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
             ++    L+ VME  +GG+L   I   G + E  A     +I   +      G+I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 199 KPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDV 256
           K +N +L S   +  IK  DFG+    I  G   K   G+  Y+APE++ +Q YGK +D 
Sbjct: 469 KLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           W+ GV+LY +L+G  PF  E E  +F++I+E N+        S+S +A  + + ++TK P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHP 581
Query: 317 KKRI 320
            KR+
Sbjct: 582 GKRL 585

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 12/263 (4%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K LG+G FG  +L   K T + +A K++ +  ++ D D+E    E  +L      P +
Sbjct: 21  LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
                 ++ K+NL  VME  +GG+L   I +   +    A     +I+  +   H  G++
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPEV-LHQRYGK 252
           +RDLK +N LL   ++D  IK  DFG+      G        G+  Y+APE+ L Q+Y  
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-WPSISGQAKDLIRKM 311
            +D WS GV+LY +L G  PF  + E+ +F +I    +D    P W  +  +AKDL+ K+
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLVKL 252
Query: 312 LTKDPKKRI-TAAEALEHPWLKE 333
             ++P+KR+    +  +HP  +E
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFRE 275

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 13/259 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     PNIV 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNPNIVN 81
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 141 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLE 255
Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E L+H +LK
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 136/259 (52%), Gaps = 13/259 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     PNIV 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNPNIVN 81
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 141 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLD 255
Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E L+H +LK
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 137/289 (47%), Gaps = 37/289 (12%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD------------------ 114
           Y L  E+G+G +GV  L   +     YA K +S++KL+                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 115 -----MEDVRREILILQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKG 167
                +E V +EI IL+ L   PN+V+     +D  + +L++V EL + G + +    K 
Sbjct: 75  QPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 168 IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIE 226
           + SE +A    + ++  +   H+  +IHRD+KP N L+    ED  IK  DFG+S  F  
Sbjct: 134 L-SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189
Query: 227 TGKVYKEIVGSAYYVAPEVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIF 282
           +  +    VG+  ++APE L +      GK +DVW+ GV LY  + G  PF  E    + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             I    L+    P   I+   KDLI +ML K+P+ RI   E   HPW+
Sbjct: 250 SKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 140/259 (54%), Gaps = 12/259 (4%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G G FG   L      GR+Y  K I+  ++   K+ E+ RRE+ +L ++   PNIV+
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK-HPNIVQ 87
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIA-KGI-YSEREAANICRQIVNVVHACHFMGVI 194
           +  ++E+  +L++VM+ C GG+LF RI A KG+ + E +  +   QI   +   H   ++
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL 147
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR-YGK 252
           HRD+K +N  L    +D  ++  DFG++ V   T ++ +  +G+ YY++PE+   + Y  
Sbjct: 148 HRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + D+W+ G +LY L +    F A + K +   I+ G+    S  +   S   + L+ ++ 
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY---SYDLRSLVSQLF 261
Query: 313 TKDPKKRITAAEALEHPWL 331
            ++P+ R +    LE  ++
Sbjct: 262 KRNPRDRPSVNSILEKGFI 280

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 136/259 (52%), Gaps = 13/259 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     PNIV 
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNPNIVN 82
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   VIHR
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ YG ++
Sbjct: 142 DIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 255 DVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLT 313
           D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + + L 
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLE 256
Query: 314 KDPKKRITAAEALEHPWLK 332
            D +KR +A E ++H +LK
Sbjct: 257 MDVEKRGSAKELIQHQFLK 275

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 137/257 (53%), Gaps = 16/257 (6%)
Query: 73  YDLDKELGRGQFGVTYLC---TKKATGRKYACKSISRRKL-VYDKDMEDVRREILILQHL 128
           ++L K LG+G FG  +L    T+  +G  YA K + +  L V D+    + R+IL     
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILAD--- 86
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +   
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVLH 247
           H +G+I+RDLKPEN LL   +E+  IK TDFGLS   I+  K      G+  Y+APEV++
Sbjct: 147 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 248 -QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            Q +    D WS GV+++ +L+G  PF  +  K     IL+  L +       +S +A+ 
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQS 259
Query: 307 LIRKMLTKDPKKRITAA 323
           L+R +  ++P  R+ + 
Sbjct: 260 LLRALFKRNPANRLGSG 276

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K +GRG FG   L   K+T + YA K +S+ +++   D      E  I+      P
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQR- 249
            IHRD+KP+N LL   ++   +K  DFG  + +    + +    VG+  Y++PEVL  + 
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I+     L       IS +AK
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKED 334
           +LI   LT    +  R    E   H + K D
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K +GRG FG   L   K+T + YA K +S+ +++   D      E  I+      P
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 129
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQR- 249
            IHRD+KP+N LL   ++   +K  DFG  + +    + +    VG+  Y++PEVL  + 
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I+     L       IS +AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKED 334
           +LI   LT    +  R    E   H + K D
Sbjct: 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K +GRG FG   L   K+T + YA K +S+ +++   D      E  I+      P
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L + +++     E+ A     ++V  + A H MG
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQR- 249
            IHRD+KP+N LL   ++   +K  DFG  + +    + +    VG+  Y++PEVL  + 
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 250 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I+     L       IS +AK
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 306 DLIRKMLTKDPKK--RITAAEALEHPWLKED 334
           +LI   LT    +  R    E   H + K D
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 87
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 148 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 260
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 261 TARPTINELLNDEFFTSGYIPARLPI 286

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   +++G+G  G  Y     ATG++ A   I +  L      E +  EIL+++     P
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 78
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +   H   
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-Y 250
           VIHR++K +N LL     D  +K TDFG    I   +  +  +VG+ Y++APEV+ ++ Y
Sbjct: 138 VIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           G ++D+WS G++   ++ G PP+  E   + ++     G  +LQ+     +S   +D + 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLN 252
Query: 310 KMLTKDPKKRITAAEALEHPWLK 332
           + L  D +KR +A E ++H +LK
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 83
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 83
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 107
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPI 306

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 105
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 166 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 279 TARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G F   +  +   T   +A K + +  L+     E +  EI I + L  Q ++V F 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 81
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G +ED   + +V+ELC    L +    +   +E EA    RQIV      H   VIHRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N  L    ED  +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DV
Sbjct: 142 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           WS G I+Y LL G PPF     K  +  I +    +       I+  A  LI+KML  DP
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 254
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R T  E L   +       +  PI
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPI 280

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 96/323 (29%), Positives = 144/323 (44%), Gaps = 60/323 (18%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           +I++ + L   LG G +GV    T K TG   A K I      +DK +  +R  REI IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKIL 63
Query: 126 QHLTGQPNIVEFE----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           +H   +  I  F      ++E+   ++++ EL        R+I+  + S+        Q 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQT 121
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-------------ETG 228
           +  V   H   VIHRDLKP N L+ S   +  +K  DFGL+  I             ++G
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 229 KVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL 286
            V  E V + +Y APEV+    +Y + +DVWS G IL  L    P F     +     I 
Sbjct: 179 MV--EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 287 --------EGNLDLQSSP--------------------WPSISGQAKDLIRKMLTKDPKK 318
                   + +L    SP                    +P ++ +  DL+++ML  DP K
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 319 RITAAEALEHPWLKEDGATSDKP 341
           RITA EALEHP+L+     +D+P
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEP 319

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 96/321 (29%), Positives = 144/321 (44%), Gaps = 56/321 (17%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           +I++ + L   LG G +GV    T K TG   A K I      +DK +  +R  REI IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKIL 63
Query: 126 QHLTGQPNIVEFE----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           +H   +  I  F      ++E+   ++++ EL        R+I+  + S+        Q 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQT 121
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------TGKV-- 230
           +  V   H   VIHRDLKP N L+ S   +  +K  DFGL+  I+         TG+   
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 231 YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-- 286
             E V + +Y APEV+    +Y + +DVWS G IL  L    P F     +     I   
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 287 ------EGNLDLQSSP--------------------WPSISGQAKDLIRKMLTKDPKKRI 320
                 + +L    SP                    +P ++ +  DL+++ML  DP KRI
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
Query: 321 TAAEALEHPWLKEDGATSDKP 341
           TA EALEHP+L+     +D+P
Sbjct: 299 TAKEALEHPYLQTYHDPNDEP 319

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 96/321 (29%), Positives = 144/321 (44%), Gaps = 56/321 (17%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           +I++ + L   LG G +GV    T K TG   A K I      +DK +  +R  REI IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKIL 63
Query: 126 QHLTGQPNIVEFE----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           +H   +  I  F      ++E+   ++++ EL        R+I+  + S+        Q 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQT 121
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------TGKV-- 230
           +  V   H   VIHRDLKP N L+ S   +  +K  DFGL+  I+         TG+   
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 231 YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-- 286
             E V + +Y APEV+    +Y + +DVWS G IL  L    P F     +     I   
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
Query: 287 ------EGNLDLQSSP--------------------WPSISGQAKDLIRKMLTKDPKKRI 320
                 + +L    SP                    +P ++ +  DL+++ML  DP KRI
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
Query: 321 TAAEALEHPWLKEDGATSDKP 341
           TA EALEHP+L+     +D+P
Sbjct: 299 TAKEALEHPYLQTYHDPNDEP 319

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 42/290 (14%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L + +G G   V           K A K I+  K      M+++ +EI  +      P
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQ-CHHP 73
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFD---RIIAKG-----IYSEREAANICRQIVNV 184
           NIV +  ++  K  L LVM+L SGG + D    I+AKG     +  E   A I R+++  
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG------KVYKEIVGSA 238
           +   H  G IHRD+K  N LL    ED  ++  DFG+S F+ TG      KV K  VG+ 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 239 YYVAPEVLHQRYGKEI--DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
            ++APEV+ Q  G +   D+WS G+    L +G  P+       +        L LQ+ P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQNDP 244
Query: 297 WPSISGQAKD---------LIRKM----LTKDPKKRITAAEALEHPWLKE 333
            PS+    +D           RKM    L KDP+KR TAAE L H + ++
Sbjct: 245 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 27/277 (9%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++D+ ++LG G +G  Y    K TG+  A K +       + D++++ +EI I+Q     
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQQCDS- 83
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHF 190
           P++V++ G+Y    +L +VME C  G + D I +     +E E A I +  +  +   HF
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQ- 248
           M  IHRD+K  N LL +   +   K  DFG++    +       ++G+ +++APEV+ + 
Sbjct: 144 MRKIHRDIKAGNILLNT---EGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLDLQSSPWPSI------S 301
            Y    D+WS G+    +  G PP+      + IF         + ++P P+       S
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--------IPTNPPPTFRKPELWS 252
Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
               D +++ L K P++R TA + L+HP+++     S
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 136/290 (46%), Gaps = 42/290 (14%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L + +G G   V           K A K I+  K      M+++ +EI  +      P
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQ-CHHP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFD---RIIAKG-----IYSEREAANICRQIVNV 184
           NIV +  ++  K  L LVM+L SGG + D    I+AKG     +  E   A I R+++  
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG------KVYKEIVGSA 238
           +   H  G IHRD+K  N LL    ED  ++  DFG+S F+ TG      KV K  VG+ 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 239 YYVAPEVLHQRYGKEI--DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
            ++APEV+ Q  G +   D+WS G+    L +G  P+       +        L LQ+ P
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQNDP 239
Query: 297 WPSISGQAKD---------LIRKM----LTKDPKKRITAAEALEHPWLKE 333
            PS+    +D           RKM    L KDP+KR TAAE L H + ++
Sbjct: 240 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 135/263 (51%), Gaps = 12/263 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +  +  +V   
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 139 GAYEDKQNLHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ L +GG+L   I  + +  + E  A     +I   +   H   +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V +  G+  K  VG+  Y+APEV+ ++RY    D
Sbjct: 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ G +LY +++G  PF    +K   E +     ++        S QA+ L  ++L KD
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 316 PKKRI-----TAAEALEHPWLKE 333
           P +R+     +A E  EHP  K+
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 135/263 (51%), Gaps = 12/263 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG    C  +ATG+ YACK + ++++   K       E  IL+ +  +  +V   
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLA 250
Query: 139 GAYEDKQNLHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            AYE K  L LV+ L +GG+L   I  + +  + E  A     +I   +   H   +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEID 255
           DLKPEN LL   ++   I+ +D GL+V +  G+  K  VG+  Y+APEV+ ++RY    D
Sbjct: 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 256 VWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKD 315
            W+ G +LY +++G  PF    +K   E +     ++        S QA+ L  ++L KD
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427
Query: 316 PKKRI-----TAAEALEHPWLKE 333
           P +R+     +A E  EHP  K+
Sbjct: 428 PAERLGCRGGSAREVKEHPLFKK 450

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + +GRG +    L   K T R YA K + +  +  D+D++ V+ E  + +  +  P
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V     ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
           +I+RDLK +N LL S+     IK TD+G+    +  G       G+  Y+APE+L  + Y
Sbjct: 131 IIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 251 GKEIDVWSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSIS 301
           G  +D W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 243
Query: 302 GQAKDLIRKMLTKDPKKRITA------AEALEHPWLK 332
            +A  +++  L KDPK+R+        A+   HP+ +
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + +GRG +    L   K T R YA K + +  +  D+D++ V+ E  + +  +  P
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V     ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
           +I+RDLK +N LL S+     IK TD+G+    +  G       G+  Y+APE+L  + Y
Sbjct: 127 IIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 251 GKEIDVWSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSIS 301
           G  +D W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 239
Query: 302 GQAKDLIRKMLTKDPKKRITA------AEALEHPWLK 332
            +A  +++  L KDPK+R+        A+   HP+ +
Sbjct: 240 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + +GRG +    L   K T R YA K + +  +  D+D++ V+ E  + +  +  P
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V     ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
           +I+RDLK +N LL S   +  IK TD+G+    +  G       G+  Y+APE+L  + Y
Sbjct: 142 IIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 251 GKEIDVWSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSIS 301
           G  +D W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SMS 254
Query: 302 GQAKDLIRKMLTKDPKKRITA------AEALEHPWLK 332
            +A  +++  L KDPK+R+        A+   HP+ +
Sbjct: 255 VKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + +GRG +    L   K T R YA + + +  +  D+D++ V+ E  + +  +  P
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V     ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGL-SVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
           +I+RDLK +N LL S   +  IK TD+G+    +  G       G+  Y+APE+L  + Y
Sbjct: 174 IIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 251 GKEIDVWSAGVILYILLSGVPPF---------WAETEKGIFEAILEGNLDLQSSPWPSIS 301
           G  +D W+ GV+++ +++G  PF            TE  +F+ ILE  + +      S+S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 286
Query: 302 GQAKDLIRKMLTKDPKKRITA------AEALEHPWLK 332
            +A  +++  L KDPK+R+        A+   HP+ +
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 138/291 (47%), Gaps = 29/291 (9%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-----VRREILILQH 127
           Y     LG G FG  +    K   ++   K I + K++ D  +ED     V  EI IL  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVME-LCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           +    NI++    +E++    LVME   SG +LF  I       E  A+ I RQ+V+ V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
                 +IHRD+K EN ++A   ED  IK  DFG + ++E GK++    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
Query: 247 --HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
             +   G E+++WS GV LY L+    PF  E E+ +  AI          P   +S + 
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKEL 251
Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRA 355
             L+  +L   P++R T  + +  PW+        +P++ A  T  + FR 
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVT-------QPVNLADYTWEEVFRV 295

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 144/292 (49%), Gaps = 26/292 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D   ++++  ELG G FG  Y    K TG   A K I  +    ++++ED   EI IL 
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILA 63
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI---IAKGIYSEREAANICRQIVN 183
                P IV+  GAY     L +++E C GG + D I   + +G+ +E +   +CRQ++ 
Sbjct: 64  -TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLE 120
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVA 242
            ++  H   +IHRDLK  N L+     +  I+  DFG+S   ++T +     +G+ Y++A
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 243 PEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQS 294
           PEV+         Y  + D+WS G+ L  +    PP        +   I + +    L  
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 237
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
           S W   S + +D ++  L K+P+ R +AA+ LEHP++     TS+K +   V
Sbjct: 238 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVS--SITSNKALRELV 284

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 133/249 (53%), Gaps = 12/249 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  + C  KATG+ YACK +++++L   K  +    E  IL  +  +  IV   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVI 194
            A+E K +L LVM + +GG++   I         + E  A     QIV+ +   H   +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPE-VLHQRYGK 252
           +RDLKPEN LL   ++D  ++ +D GL+V ++ G+   K   G+  ++APE +L + Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRKM 311
            +D ++ GV LY +++   PF A  EK +    L+  +  Q+  +P   S  +KD    +
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 312 LTKDPKKRI 320
           L KDP+KR+
Sbjct: 428 LQKDPEKRL 436

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 144/292 (49%), Gaps = 26/292 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D   ++++  ELG G FG  Y    K TG   A K I  +    ++++ED   EI IL 
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILA 71
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI---IAKGIYSEREAANICRQIVN 183
                P IV+  GAY     L +++E C GG + D I   + +G+ +E +   +CRQ++ 
Sbjct: 72  -TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLE 128
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVA 242
            ++  H   +IHRDLK  N L+     +  I+  DFG+S   ++T +     +G+ Y++A
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 243 PEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQS 294
           PEV+         Y  + D+WS G+ L  +    PP        +   I + +    L  
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
           S W   S + +D ++  L K+P+ R +AA+ LEHP++     TS+K +   V
Sbjct: 246 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVS--SITSNKALRELV 292

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 133/249 (53%), Gaps = 12/249 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  + C  KATG+ YACK +++++L   K  +    E  IL  +  +  IV   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVI 194
            A+E K +L LVM + +GG++   I         + E  A     QIV+ +   H   +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPE-VLHQRYGK 252
           +RDLKPEN LL   ++D  ++ +D GL+V ++ G+   K   G+  ++APE +L + Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRKM 311
            +D ++ GV LY +++   PF A  EK +    L+  +  Q+  +P   S  +KD    +
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 312 LTKDPKKRI 320
           L KDP+KR+
Sbjct: 428 LQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 133/249 (53%), Gaps = 12/249 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  + C  KATG+ YACK +++++L   K  +    E  IL  +  +  IV   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVI 194
            A+E K +L LVM + +GG++   I         + E  A     QIV+ +   H   +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPE-VLHQRYGK 252
           +RDLKPEN LL   ++D  ++ +D GL+V ++ G+   K   G+  ++APE +L + Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRKM 311
            +D ++ GV LY +++   PF A  EK +    L+  +  Q+  +P   S  +KD    +
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 312 LTKDPKKRI 320
           L KDP+KR+
Sbjct: 428 LQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 133/249 (53%), Gaps = 12/249 (4%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  + C  KATG+ YACK +++++L   K  +    E  IL  +  +  IV   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVSLA 251
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVI 194
            A+E K +L LVM + +GG++   I         + E  A     QIV+ +   H   +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-YKEIVGSAYYVAPE-VLHQRYGK 252
           +RDLKPEN LL   ++D  ++ +D GL+V ++ G+   K   G+  ++APE +L + Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRKM 311
            +D ++ GV LY +++   PF A  EK +    L+  +  Q+  +P   S  +KD    +
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 312 LTKDPKKRI 320
           L KDP+KR+
Sbjct: 428 LQKDPEKRL 436

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 143/310 (46%), Gaps = 55/310 (17%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPN 133
           ++G G +GV + C  + TG+  A K     K +  +D   ++    REI +L+ L   PN
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLK-HPN 63
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           +V     +  K+ LHLV E C    L   DR   +G+  E    +I  Q +  V+ CH  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGV-PEHLVKSITWQTLQAVNFCHKH 121
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSAYYVAPEVL--H 247
             IHRD+KPEN L+      S IK  DFG +  + TG    Y + V + +Y +PE+L   
Sbjct: 122 NCIHRDVKPENILITKH---SVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGD 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--------------- 292
            +YG  +DVW+ G +   LLSGVP +  +++      I +   DL               
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 293 --------QSSP----WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK-----EDG 335
                      P    +P+IS  A  L++  L  DP +R+T  + L HP+ +     ED 
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 336 ATS-DKPIDS 344
           A   DKP ++
Sbjct: 298 AKEHDKPAEN 307

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 137/275 (49%), Gaps = 23/275 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   +G G +G      +K+ G+    K +    +  + + + +  E+ +L+ L   P
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 65
Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIAKGI-----YSEREAANICRQIVNVV 185
           NIV +     D+ N  L++VME C GG+L   +I KG        E     +  Q+   +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 186 HACHFMG-----VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSAY 239
             CH        V+HRDLKP N  L  K+    +K  DFGL+  +   + + KE VG+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDEDFAKEFVGTPY 181
Query: 240 YVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           Y++PE +++  Y ++ D+WS G +LY L + +PPF A ++K +   I EG    +  P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FRRIPY- 238
Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             S +  ++I +ML      R +  E LE+P + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 135/282 (47%), Gaps = 25/282 (8%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
            +++  ELG G FG  Y    K T    A K I  +    ++++ED   EI IL      
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDH 93
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACH 189
           PNIV+   A+  + NL +++E C+GG + D ++ +     +E +   +C+Q ++ ++  H
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL-- 246
              +IHRDLK  N L      D  IK  DFG+S     T +     +G+ Y++APEV+  
Sbjct: 153 DNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 247 ----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQSSPWPSI 300
                + Y  + DVWS G+ L  +    PP        +   I +       Q S W   
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW--- 266
Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           S   KD ++K L K+   R T ++ L+HP++  D   S+KPI
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 132/290 (45%), Gaps = 40/290 (13%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNIV 135
           +++G G +GV Y   +   G  +A K I   K   D+ +     REI IL+ L    NIV
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELK-HSNIV 63
Query: 136 EFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           +       K+ L LV E       +L D  + +G      A +   Q++N +  CH   V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQRY 250
           +HRDLKP+N L+  + E   +K  DFGL+  F    + Y   V + +Y AP+VL   ++Y
Sbjct: 122 LHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK----- 305
              ID+WS G I   +++G P F   +E      I        S  WP+++   K     
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 306 --------------------DLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
                               DL+ KML  DP +RITA +ALEH + KE+ 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 132/290 (45%), Gaps = 40/290 (13%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNIV 135
           +++G G +GV Y   +   G  +A K I   K   D+ +     REI IL+ L    NIV
Sbjct: 8   EKIGEGTYGVVY-KAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELK-HSNIV 63
Query: 136 EFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           +       K+ L LV E       +L D  + +G      A +   Q++N +  CH   V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQRY 250
           +HRDLKP+N L+  + E   +K  DFGL+  F    + Y   V + +Y AP+VL   ++Y
Sbjct: 122 LHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK----- 305
              ID+WS G I   +++G P F   +E      I        S  WP+++   K     
Sbjct: 179 STTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 306 --------------------DLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
                               DL+ KML  DP +RITA +ALEH + KE+ 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNIV 135
           +++G G +GV Y   +   G  +A K I   K   D+ +     REI IL+ L    NIV
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELK-HSNIV 63
Query: 136 EFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           +       K+ L LV E       +L D  + +G      A +   Q++N +  CH   V
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVGSAYYVAPEVL--HQR 249
           +HRDLKP+N L+  + E   +K  DFGL+    I   K   EIV + +Y AP+VL   ++
Sbjct: 122 LHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKK 177
Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK---- 305
           Y   ID+WS G I   +++G P F   +E      I        S  WP+++   K    
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 306 ---------------------DLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
                                DL+ KML  DP +RITA +ALEH + KE+ 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/328 (26%), Positives = 137/328 (41%), Gaps = 75/328 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L K+LG+G +G+ +    + TG   A K I         D +   REI+IL  L+G  
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHE 69
Query: 133 NIVEFEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV        ++ ++++LV +          +I   I        +  Q++ V+   H 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEI--------------- 234
            G++HRD+KP N LL +   +  +K  DFGLS  F+   +V   I               
Sbjct: 128 GGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 235 ------VGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL 286
                 V + +Y APE+L    +Y K ID+WS G IL  +L G P F   +     E I+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 287 E-------------------------------------------GNLDLQSSPWPSISGQ 303
                                                        NL L+ +P    + +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWL 331
           A DL+ K+L  +P KRI+A +AL+HP++
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 23/275 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   +G G +G      +K+ G+    K +    +  + + + +  E+ +L+ L   P
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 65
Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIAKGI-----YSEREAANICRQIVNVV 185
           NIV +     D+ N  L++VME C GG+L   +I KG        E     +  Q+   +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 186 HACHFMG-----VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSAY 239
             CH        V+HRDLKP N  L  K+    +K  DFGL+  +     + K  VG+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 240 YVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           Y++PE +++  Y ++ D+WS G +LY L + +PPF A ++K +   I EG    +  P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FRRIPY- 238
Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             S +  ++I +ML      R +  E LE+P + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 135/275 (49%), Gaps = 23/275 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   +G G +G      +K+ G+    K +    +  + + + +  E+ +L+ L   P
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 65
Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIAKGI-----YSEREAANICRQIVNVV 185
           NIV +     D+ N  L++VME C GG+L   +I KG        E     +  Q+   +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 186 HACHFMG-----VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGSAY 239
             CH        V+HRDLKP N  L  K+    +K  DFGL+  +     + K  VG+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPY 181
Query: 240 YVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           Y++PE +++  Y ++ D+WS G +LY L + +PPF A ++K +   I EG    +  P+ 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FRRIPY- 238
Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             S +  ++I +ML      R +  E LE+P + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 27/283 (9%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
            +++  ELG G FG  Y    K T    A K I  +    ++++ED   EI IL      
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDH 93
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACH 189
           PNIV+   A+  + NL +++E C+GG + D ++ +     +E +   +C+Q ++ ++  H
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVL- 246
              +IHRDLK  N L      D  IK  DFG+S    T  + +    +G+ Y++APEV+ 
Sbjct: 153 DNKIIHRDLKAGNILFTL---DGDIKLADFGVSA-KNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 247 -----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQSSPWPS 299
                 + Y  + DVWS G+ L  +    PP        +   I +       Q S W  
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-- 266
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
            S   KD ++K L K+   R T ++ L+HP++  D   S+KPI
Sbjct: 267 -SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 132/275 (48%), Gaps = 23/275 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELG G FG  Y    K T    A K I  +    ++++ED   EI IL      PNIV+ 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDHPNIVKL 99
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIH 195
             A+  + NL +++E C+GG + D ++ +     +E +   +C+Q ++ ++  H   +IH
Sbjct: 100 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE--IVGSAYYVAPEVL------H 247
           RDLK  N L      D  IK  DFG+S    T  + +    +G+ Y++APEV+       
Sbjct: 159 RDLKAGNILFTL---DGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           + Y  + DVWS G+ L  +    PP        +   I +      + P    S   KD 
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDF 273
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           ++K L K+   R T ++ L+HP++  D   S+KPI
Sbjct: 274 LKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 132/268 (49%), Gaps = 14/268 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + +G+G FG   +  K  T + YA K ++++K V   ++ +V +E+ I+Q L   P
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HP 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V    +++D++++ +V++L  GG+L   +     + E        ++V  +       
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR--- 249
           +IHRD+KP+N LL   +E   +  TDF ++  +        + G+  Y+APE+   R   
Sbjct: 136 IIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 250 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI--LEGNLDLQSSPWPSISGQAKD 306
            Y   +D WS GV  Y LL G  P+   +     E +   E  +    S W   S +   
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW---SQEMVS 249
Query: 307 LIRKMLTKDPKKRITAAEALEH-PWLKE 333
           L++K+L  +P +R +    +++ P++ +
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 22/254 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K   + +A K +++ +++   +    R E  +L  + G  
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDS 133
Query: 133 N-IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHA 187
             I     A++D  NL+LVM+   GG+L   +++K  + +R    + R    ++V  + +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSK--FEDRLPEEMARFYLAEMVIAIDS 190
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEI-VGSAYYVAPEV 245
            H +  +HRD+KP+N L+   + +  I+  DFG  +  +E G V   + VG+  Y++PE+
Sbjct: 191 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 246 LHQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWP 298
           L        RYG E D WS GV +Y +L G  PF+AE+    +  I+      Q  +   
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307
Query: 299 SISGQAKDLIRKML 312
            +S  AKDLIR+++
Sbjct: 308 DVSENAKDLIRRLI 321

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 140/310 (45%), Gaps = 32/310 (10%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   I++L + +G G +G  Y      TG+  A K +     V   + E++++EI +L+ 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKK 76
Query: 128 LTGQPNIVEFEGAYEDKQ------NLHLVMELCSGGELFDRI--IAKGIYSEREAANICR 179
            +   NI  + GA+  K        L LVME C  G + D I         E   A ICR
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSA 238
           +I+  +   H   VIHRD+K +N LL    E++ +K  DFG+S  ++ T       +G+ 
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 239 YYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLD 291
           Y++APEV+         Y  + D+WS G+    +  G PP       + +F         
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253
Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMK 351
           L+S  W   S + +  I   L K+  +R    + ++HP+++      D+P +  V  ++K
Sbjct: 254 LKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR------DQPNERQVRIQLK 304
Query: 352 QFRAMNKMKK 361
                 K K+
Sbjct: 305 DHIDRTKKKR 314

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 24/282 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED---VRREILILQHL- 128
           Y L   LG+G FG  +   +     + A K I R +++    + D      E+ +L  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 129 --TGQPNIVEFEGAYEDKQNLHLVMEL-CSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
              G P ++     +E ++   LV+E      +LFD I  KG   E  +     Q+V  +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
             CH  GV+HRD+K EN L+  +   +  K  DFG    +   + Y +  G+  Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLHD-EPYTDFDGTRVYSPPEW 209
Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           +  HQ +     VWS G++LY ++ G  PF  + E      ILE  L   +     +S  
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPA----HVSPD 259
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
              LIR+ L   P  R +  E L  PW++      D P++ +
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQT--PAEDVPLNPS 299

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQPNI 134
           +G G +G+   C  K TGR  A K     K +   D + V+    REI +L+ L  + N+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHE-NL 86
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           V      + K+  +LV E      L D  +       +       QI+N +  CH   +I
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQRYG 251
           HRD+KPEN L++   +   +K  DFG +      G+VY + V + +Y APE+L    +YG
Sbjct: 147 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD------LQSSP------- 296
           K +DVW+ G ++  +  G P F  +++      I+   GNL          +P       
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 297 ------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
                       +P +S    DL +K L  DP KR   AE L H + + DG
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 211
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 264
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 265 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 137/259 (52%), Gaps = 20/259 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K T R YA K +++ +++   +    R E  +L +   Q 
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHAC 188
            I     A++D+ +L+LVM+   GG+L   +++K  + ++   ++ R    ++V  + + 
Sbjct: 136 -ITALHYAFQDENHLYLVMDYYVGGDLL-TLLSK--FEDKLPEDMARFYIGEMVLAIDSI 191
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEI-VGSAYYVAPEVL 246
           H +  +HRD+KP+N LL   + +  I+  DFG  + + + G V   + VG+  Y++PE+L
Sbjct: 192 HQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 247 HQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWPS 299
                   +YG E D WS GV +Y +L G  PF+AE+    +  I+      Q  S    
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD 308
Query: 300 ISGQAKDLIRKMLTKDPKK 318
           +S +AKDLI++++    ++
Sbjct: 309 VSEEAKDLIQRLICSRERR 327

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 191
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 244
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 245 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQ 131
           + + + +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  + TG 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV    A+     L  +++L +GG+L   +   G++SE +      +I+  +   H 
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +  
Sbjct: 310 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y    D +S G +L+ LL G  PF     K   E I    L +      S S + + L+
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLL 424
Query: 309 RKMLTKDPKKRI-----TAAEALEHPWLK 332
             +L +D  +R+      A E  E P+ +
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 137/259 (52%), Gaps = 20/259 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K T R YA K +++ +++   +    R E  +L +   Q 
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHAC 188
            I     A++D+ +L+LVM+   GG+L   +++K  + ++   ++ R    ++V  + + 
Sbjct: 152 -ITALHYAFQDENHLYLVMDYYVGGDLL-TLLSK--FEDKLPEDMARFYIGEMVLAIDSI 207
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEI-VGSAYYVAPEVL 246
           H +  +HRD+KP+N LL   + +  I+  DFG  + + + G V   + VG+  Y++PE+L
Sbjct: 208 HQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 247 HQ------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-SSPWPS 299
                   +YG E D WS GV +Y +L G  PF+AE+    +  I+      Q  S    
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTD 324
Query: 300 ISGQAKDLIRKMLTKDPKK 318
           +S +AKDLI++++    ++
Sbjct: 325 VSEEAKDLIQRLICSRERR 343

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQ 131
           + + + +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  + TG 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV    A+     L  +++L +GG+L   +   G++SE +      +I+  +   H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y    D +S G +L+ LL G  PF     K   E I    L +      S S + + L+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLL 425
Query: 309 RKMLTKDPKKRI-----TAAEALEHPWLK 332
             +L +D  +R+      A E  E P+ +
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 192
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 245
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 246 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 204
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 257
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQ 131
           + + + +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  + TG 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV    A+     L  +++L +GG+L   +   G++SE +      +I+  +   H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y    D +S G +L+ LL G  PF     K   E I    L +      S S + + L+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLL 425
Query: 309 RKMLTKDPKKRI-----TAAEALEHPWLK 332
             +L +D  +R+      A E  E P+ +
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQ 131
           + + + +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  + TG 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 132 -PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV    A+     L  +++L +GG+L   +   G++SE +      +I+  +   H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y    D +S G +L+ LL G  PF     K   E I    L +      S S + + L+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLL 425
Query: 309 RKMLTKDPKKRI-----TAAEALEHPWLK 332
             +L +D  +R+      A E  E P+ +
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 192
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 245
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 246 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 219
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 272
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 273 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 191
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 244
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 245 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 130 -GQPNIVEFEGAYEDKQNLHLVME-LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E +    +LFD I  +G   E  A +   Q++  V  
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 186
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 236
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 48  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 107
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 224
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 277
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 278 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 312

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 219
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 272
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 273 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 192
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ- 245
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 246 ---RVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 55/300 (18%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L ++LGRG++   +         K   K +   K         ++REI IL++L G P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLRGGP 92
Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CRQIVNVVHA 187
           NI+      +D   +   LV E  +  +       K +Y      +I     +I+  +  
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFEAILEGNLD 291
            +Q Y   +D+WS G +L  ++    PF+   +              + +++ I + N++
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 292 L--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           L                     S     +S +A D + K+L  D + R+TA EA+EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 16/256 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + ++K++GRGQF   Y       G   A K +    L+  K   D  +EI +L+ L   P
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII-----AKGIYSEREAANICRQIVNVVHA 187
           N++++  ++ +   L++V+EL   G+L  R+I      K +  ER       Q+ + +  
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVL 246
            H   V+HRD+KP N  + +      +K  D GL  F  +       +VG+ YY++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS--ISGQ 303
           H+  Y  + D+WS G +LY + +   PF+   +K    ++ +        P PS   S +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 304 AKDLIRKMLTKDPKKR 319
            + L+   +  DP+KR
Sbjct: 267 LRQLVNMCINPDPEKR 282

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 205
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 258
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 259 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 204
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 257
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 205
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 258
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 259 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 187
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 237
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 204
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 257
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 187
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +      +S + +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSECQ 237
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 187
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 237
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 186
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 236
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 205
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 258
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 259 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 205
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 258
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 259 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 232
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR-- 120
           GK    + + Y +   LG G FG  Y   + +     A K + + ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 121 -EILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANI 177
            E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A + 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGT 204
Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +  
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ- 257
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 258 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 185
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSSECQ 235
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 209
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSXECQ 259
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 260 HLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVSXECQ 232
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 20/268 (7%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR---EILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +  R   E+++L+ ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 130 -GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            G   ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  +      E I+ G +  +      +S + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQ----RVSSECQ 232
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 129/294 (43%), Gaps = 51/294 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED------VRREILILQHLTG 130
           +++G G +GV Y   K + GR  A K I         D ED        REI +L+ L  
Sbjct: 27  EKVGEGTYGVVY-KAKDSQGRIVALKRIRL-------DAEDEGIPSTAIREISLLKELH- 77
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
            PNIV        ++ L LV E       ++ D    K    + +      Q++  V  C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL- 246
           H   ++HRDLKP+N L+ S   D  +K  DFGL+  F    + Y   V + +Y AP+VL 
Sbjct: 136 HQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLD---------- 291
             ++Y   +D+WS G I   +++G P F   T+      IF  +   N            
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 292 --------LQSSPWPSI----SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                    +  PW SI      +  DL+  ML  DP KRI+A +A+ HP+ K+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 129/294 (43%), Gaps = 51/294 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED------VRREILILQHLTG 130
           +++G G +GV Y   K + GR  A K I         D ED        REI +L+ L  
Sbjct: 27  EKVGEGTYGVVY-KAKDSQGRIVALKRIRL-------DAEDEGIPSTAIREISLLKELH- 77
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
            PNIV        ++ L LV E       ++ D    K    + +      Q++  V  C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL- 246
           H   ++HRDLKP+N L+ S   D  +K  DFGL+  F    + Y   V + +Y AP+VL 
Sbjct: 136 HQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLD---------- 291
             ++Y   +D+WS G I   +++G P F   T+      IF  +   N            
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 292 --------LQSSPWPSI----SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                    +  PW SI      +  DL+  ML  DP KRI+A +A+ HP+ K+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 118/235 (50%), Gaps = 17/235 (7%)
Query: 117 DVRREILILQHLTGQPNIVEFEGAY-EDKQNLHLVMELCSGG--ELFDRIIAKGIYSERE 173
           +V++EI +L+ L  +  I   +  Y E+KQ +++VME C  G  E+ D +  K     + 
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA 111
Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKV 230
               C Q+++ +   H  G++H+D+KP N LL +      +K +  G++  +        
Sbjct: 112 HGYFC-QLIDGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDT 167
Query: 231 YKEIVGSAYYVAPEV---LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
            +   GS  +  PE+   L    G ++D+WSAGV LY + +G+ PF  +    +FE I +
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227
Query: 288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           G+  +     P +S    DL++ ML  +P KR +  +  +H W ++    ++ P+
Sbjct: 228 GSYAIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 137/312 (43%), Gaps = 55/312 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+         G   A K +SR         +   RE+++L+      NI+ 
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLK-CVNHKNIIS 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 86  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH-LHS 142
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 143 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 250 YGKEIDVWSAGVILYILLSGVPPF--------WAE------TEKGIFEAILEGNLD--LQ 293
           Y + +D+WS G I+  L+ G   F        W +      T    F A L+  +   ++
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 294 SSP-WPSI---------------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           + P +P I                     + QA+DL+ KML  DP KRI+  EAL HP++
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 332 K--EDGATSDKP 341
               D A ++ P
Sbjct: 320 TVWYDPAEAEAP 331

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 133/300 (44%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +V + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D+ +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS GVI+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 15/257 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y           A K +S      ++  +D+ +E+  LQ L   PN ++
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G Y  +    LVME C G       + K    E E A +    +  +   H   +IHR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRYGK 252
           D+K  N LL+   E   +K  DFG +  +     +   VG+ Y++APEV+      +Y  
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 253 EIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           ++DVWS G+    L    PP F       ++      +  LQS  W   S   ++ +   
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 289
Query: 312 LTKDPKKRITAAEALEH 328
           L K P+ R T+   L+H
Sbjct: 290 LQKIPQDRPTSEVLLKH 306

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E  S    +  D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKPEN L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 45/303 (14%)
Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----R 120
           P VD+     ++K +G G +GV Y    K TG   A K I       D + E V     R
Sbjct: 2   PLVDMENFQKVEK-IGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIR 55
Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANIC 178
           EI +L+ L   PNIV+       +  L+LV E       +  D     GI      + + 
Sbjct: 56  EISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGS 237
            Q++  +  CH   V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V +
Sbjct: 115 -QLLQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 238 AYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
            +Y APE+L   + Y   +D+WS G I   +++    F  ++E      I          
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 296 PWPSISGQ-------------------------AKDLIRKMLTKDPKKRITAAEALEHPW 330
            WP ++                            + L+ +ML  DP KRI+A  AL HP+
Sbjct: 231 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 290
Query: 331 LKE 333
            ++
Sbjct: 291 FQD 293

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 136/312 (43%), Gaps = 55/312 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+         G   A K +SR         +   RE+++L+      NI+ 
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLK-CVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVILYILLSGVPPF--------WAE------TEKGIFEAILEGNLD--LQ 293
           Y   +D+WS G I+  L+ G   F        W +      T    F A L+  +   ++
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 294 SSP-WPSI---------------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           + P +P I                     + QA+DL+ KML  DP KRI+  EAL HP++
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 332 K--EDGATSDKP 341
               D A ++ P
Sbjct: 322 TVWYDPAEAEAP 333

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E  S    +  D     GI      + +  Q++  +  CH 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 122
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKPEN L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 133/300 (44%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +V + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D+ +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS GVI+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 15/257 (5%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y           A K +S      ++  +D+ +E+  LQ L   PN ++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G Y  +    LVME C G       + K    E E A +    +  +   H   +IHR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----HQRYGK 252
           D+K  N LL+   E   +K  DFG +  +     +   VG+ Y++APEV+      +Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 253 EIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           ++DVWS G+    L    PP F       ++      +  LQS  W   S   ++ +   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 312 LTKDPKKRITAAEALEH 328
           L K P+ R T+   L+H
Sbjct: 251 LQKIPQDRPTSEVLLKH 267

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 124/263 (47%), Gaps = 18/263 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G +G+ Y     +   + A K I  R   Y + + +   EI + +HL    NIV++ 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---EIALHKHLK-HKNIVQYL 85
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREA--ANICRQIVNVVHACHFMGVIH 195
           G++ +   + + ME   GG L   + +K G   + E       +QI+  +   H   ++H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR---YG 251
           RD+K +N L+ +      +K +DFG S  +       +   G+  Y+APE++ +    YG
Sbjct: 146 RDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 252 KEIDVWSAGVILYILLSGVPPFW--AETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           K  D+WS G  +  + +G PPF+   E +  +F+    G   +      S+S +AK  I 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFKVHPEIPESMSAEAKAFIL 260
Query: 310 KMLTKDPKKRITAAEALEHPWLK 332
           K    DP KR  A + L   +LK
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 124/263 (47%), Gaps = 18/263 (6%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G +G+ Y     +   + A K I  R   Y + + +   EI + +HL    NIV++ 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---EIALHKHLK-HKNIVQYL 71
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREA--ANICRQIVNVVHACHFMGVIH 195
           G++ +   + + ME   GG L   + +K G   + E       +QI+  +   H   ++H
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVLHQR---YG 251
           RD+K +N L+ +      +K +DFG S  +       +   G+  Y+APE++ +    YG
Sbjct: 132 RDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 252 KEIDVWSAGVILYILLSGVPPFW--AETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           K  D+WS G  +  + +G PPF+   E +  +F+    G   +      S+S +AK  I 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFKVHPEIPESMSAEAKAFIL 246
Query: 310 KMLTKDPKKRITAAEALEHPWLK 332
           K    DP KR  A + L   +LK
Sbjct: 247 KCFEPDPDKRACANDLLVDEFLK 269

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E  S    +  D     GI      + +  Q++  +  CH 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 123
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E  S    +  D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKPEN L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  ++++LV  L  G +L+ +++     S         QI+  +   H   V
Sbjct: 109 IIR-APTIEQMKDVYLVTHLM-GADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 166 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 221
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 281
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 282 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 342 EPIAEA 347

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 123
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKPEN L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 122
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKPEN L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 138/312 (44%), Gaps = 58/312 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G       K +G K A K +SR  +  ++ K      RE+L+L+H+      G 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR---AYRELLLLKHMQHENVIGL 106
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     +  +  + +LVM          +I+    +SE +   +  Q++  +   H  
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGME-FSEEKIQYLVYQMLKGLKYIHSA 163
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG---SAYYVAPEVL-- 246
           GV+HRDLKP N  +    ED  +K  DFGL+   +      E+ G   + +Y APEV+  
Sbjct: 164 GVVHRDLKPGNLAV---NEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS 215
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------------GN 289
              Y + +D+WS G I+  +L+G   F  +        IL+                   
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275
Query: 290 LDLQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK-----ED 334
             +QS P          +P  S QA DL+ KML  D  KR+TAA+AL HP+ +     E+
Sbjct: 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 335
Query: 335 GATSDKPIDSAV 346
              + +P D ++
Sbjct: 336 ETEAQQPFDDSL 347

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--H 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 138/312 (44%), Gaps = 58/312 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G       K +G K A K +SR  +  ++ K      RE+L+L+H+      G 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR---AYRELLLLKHMQHENVIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     +  +  + +LVM          +I+    +SE +   +  Q++  +   H  
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGLK-FSEEKIQYLVYQMLKGLKYIHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG---SAYYVAPEVL-- 246
           GV+HRDLKP N  +    ED  +K  DFGL+   +      E+ G   + +Y APEV+  
Sbjct: 146 GVVHRDLKPGNLAV---NEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS 197
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------------GN 289
              Y + +D+WS G I+  +L+G   F  +        IL+                   
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 290 LDLQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK-----ED 334
             +QS P          +P  S QA DL+ KML  D  KR+TAA+AL HP+ +     E+
Sbjct: 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317
Query: 335 GATSDKPIDSAV 346
              + +P D ++
Sbjct: 318 ETEAQQPFDDSL 329

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +V + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D+ +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 128
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--H 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 129 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGX 185
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLSFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 20/271 (7%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           VD   ++     +G+G FG  Y      T    A K I   +     ++ED+++EI +L 
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAE--DEIEDIQQEITVLS 72
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
                P I  + G+Y     L ++ME   GG   D ++  G   E   A I R+I+  + 
Sbjct: 73  Q-CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLD 130
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEV 245
             H    IHRD+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV
Sbjct: 131 YLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 246 LHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + Q  Y  + D+WS G+    L  G PP    ++      +    L  ++SP P++ GQ 
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPP---NSDLHPMRVLF---LIPKNSP-PTLEGQH 240
Query: 305 ----KDLIRKMLTKDPKKRITAAEALEHPWL 331
               K+ +   L KDP+ R TA E L+H ++
Sbjct: 241 SKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 140/311 (45%), Gaps = 55/311 (17%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + +++  G+G FG   L  +K+TG   A K + +     +++++ + +++ +L H    P
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH----P 79
Query: 133 NIVEFEGAY-----EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN-------ICRQ 180
           NIV+ +  +      D+++++L + +    +   R      Y  R+ A           Q
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN--YYRRQVAPPPILIKVFLFQ 137
Query: 181 IVNVVHACHF--MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
           ++  +   H   + V HRD+KP N L+   E D  +K  DFG +  +   +     + S 
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 239 YYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL---------- 286
           YY APE++  +Q Y   +D+WS G I   ++ G P F  +   G    I+          
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255
Query: 287 -------EGNLDLQSS---PWPSI--------SGQAKDLIRKMLTKDPKKRITAAEALEH 328
                    ++DL +S   PW ++        + +A DL+  +L   P++R+   EAL H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315
Query: 329 PWLKE--DGAT 337
           P+  E  D AT
Sbjct: 316 PYFDELHDPAT 326

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 123
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 122
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 122
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 179
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 147/340 (43%), Gaps = 59/340 (17%)
Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRR 120
           P+ D  + Y+   ++G+G FG  +    + TG+K A K     K++ + + E       R
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALR 66
Query: 121 EILILQHLTGQP--NIVEF----EGAYED-KQNLHLVMELCSG--GELFDRIIAKGIYSE 171
           EI ILQ L  +   N++E        Y   K +++LV + C      L   ++ K  ++ 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTL 124
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV- 230
            E   + + ++N ++  H   ++HRD+K  N L+     D  +K  DFGL+      K  
Sbjct: 125 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNS 181
Query: 231 ----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
               Y   V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+     
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241
Query: 285 ILEGNLDLQSSPWPSIS------------GQ----------------AKDLIRKMLTKDP 316
           I +    +    WP++             GQ                A DLI K+L  DP
Sbjct: 242 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 301
Query: 317 KKRITAAEALEHPWLKEDGATSD-KPIDSAVLTRMKQFRA 355
            +RI + +AL H +   D   SD K + S  LT M ++ A
Sbjct: 302 AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLA 341

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 69
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 128
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 129 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HP 66
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 125
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 126 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 182
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 243 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV----RREILILQHL 128
           Y+  +++G G +G  +    + T    A K +       D D E V     REI +L+ L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKEL 58
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVH 186
             + NIV         + L LV E C     + FD     G        +   Q++  + 
Sbjct: 59  KHK-NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLG 115
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   V+HRDLKP+N L+    E   +K  DFGL+  F    + Y   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 246 LH--QRYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFEAI----------LEG 288
           L   + Y   ID+WSAG I   L +   P +   +     K IF  +          +  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 289 NLDLQSSPW-----------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             D +  P            P ++   +DL++ +L  +P +RI+A EAL+HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 64
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 123
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 124 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 142/291 (48%), Gaps = 31/291 (10%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG F    +   K TG+ YA K +++  ++   ++   R E  +L +   + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR 121
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR----QIVNVVHAC 188
            I +   A++D+  L+LVME   GG+L   +++K  + ER  A + R    +IV  + + 
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSK--FGERIPAEMARFYLAEIVMAIDSV 178
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--VGSAYYVAPEVL 246
           H +G +HRD+KP+N LL   +    I+  DFG  + +      + +  VG+  Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 247 H--------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW- 297
                      YG E D W+ GV  Y +  G  PF+A++    +  I+     L S P  
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL-SLPLV 294
Query: 298 -PSISGQAKDLIRKMLTKDPKKRI---TAAEALEHPW---LKEDGATSDKP 341
              +  +A+D I+++L   P+ R+    A +   HP+   L  DG     P
Sbjct: 295 DEGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP 344

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 63
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 122
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 123 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 179
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 239
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 240 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 118 VRREILILQHLT-GQPNIVEFEGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAA 175
           V  E+++L+ ++ G   ++     +E   +  L++E      +LFD I  +G   E  A 
Sbjct: 101 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
           +   Q++  V  CH  GV+HRD+K EN L+     +  +K  DFG    ++   VY +  
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFD 217
Query: 236 GSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
           G+  Y  PE +  H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +  +
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR 271
Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                 +S + + LIR  L   P  R T  E   HPW+++
Sbjct: 272 Q----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 147/340 (43%), Gaps = 59/340 (17%)
Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRR 120
           P+ D  + Y+   ++G+G FG  +    + TG+K A K     K++ + + E       R
Sbjct: 11  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALR 65
Query: 121 EILILQHLTGQP--NIVEF----EGAYED-KQNLHLVMELCSG--GELFDRIIAKGIYSE 171
           EI ILQ L  +   N++E        Y   K +++LV + C      L   ++ K  ++ 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTL 123
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV- 230
            E   + + ++N ++  H   ++HRD+K  N L+     D  +K  DFGL+      K  
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNS 180
Query: 231 ----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
               Y   V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+     
Sbjct: 181 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 285 ILEGNLDLQSSPWPSIS------------GQ----------------AKDLIRKMLTKDP 316
           I +    +    WP++             GQ                A DLI K+L  DP
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300
Query: 317 KKRITAAEALEHPWLKEDGATSD-KPIDSAVLTRMKQFRA 355
            +RI + +AL H +   D   SD K + S  LT M ++ A
Sbjct: 301 AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLA 340

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 40/291 (13%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM--EDVRREILILQHLTGQPNIV 135
           +LG G +G  Y      T    A K I   +L ++++       RE+ +L+ L  + NI+
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHR-NII 96
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
           E +        LHL+ E     +L   +      S R   +   Q++N V+ CH    +H
Sbjct: 97  ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH 155
Query: 196 RDLKPENFLLA-SKEEDSPI-KATDFGL--SVFIETGKVYKEIVGSAYYVAPEVL--HQR 249
           RDLKP+N LL+ S   ++P+ K  DFGL  +  I   +   EI+ + +Y  PE+L   + 
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRH 214
Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG------- 302
           Y   +D+WS   I   +L   P F  ++E      I E       + WP ++        
Sbjct: 215 YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS 274
Query: 303 ----QAKDLIR---------------KMLTKDPKKRITAAEALEHPWLKED 334
               + K L R                ML  DP KRI+A  ALEHP+   +
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E          D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/336 (27%), Positives = 152/336 (45%), Gaps = 57/336 (16%)
Query: 54  QTSQIGP--------ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSIS 105
           +T  +GP        + G+P+ D+   Y   + +G G +G+           + A K IS
Sbjct: 19  RTEGVGPGVPGEVEMVKGQPF-DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS 77
Query: 106 RRKLVYDKDMEDVRREILIL-----QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELF 160
                +    +   REI IL     +++ G  +I+      E  +++++V +L    +L+
Sbjct: 78  --PFEHQTYCQRTLREIQILLRFRHENVIGIRDILR-ASTLEAMRDVYIVQDLMET-DLY 133
Query: 161 DRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG 220
            +++     S         QI+  +   H   V+HRDLKP N L+ +  +   +K  DFG
Sbjct: 134 -KLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFG 189
Query: 221 LSVFIE-----TGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPF 273
           L+   +     TG    E V + +Y APE++   + Y K ID+WS G IL  +LS  P F
Sbjct: 190 LARIADPEHDHTG-FLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 274 WAETE-------KGIFEAILEGNLD----------LQSSP----------WPSISGQAKD 306
             +          GI  +  + +L+          LQS P          +P    +A D
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALD 308
Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           L+ +MLT +P KRIT  EAL HP+L++    +D+P+
Sbjct: 309 LLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPV 344

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG           R YA K I       ++ +  +  E+++L  L  Q  +V + 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY-VVRYY 68
Query: 139 GAYEDKQN-------------LHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNV 184
            A+ +++N             L + ME C  G L+D I ++ +  +R E   + RQI+  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------------TGK 229
           +   H  G+IHRDLKP N  +   +E   +K  DFGL+  +                +  
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 230 VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAIL 286
                +G+A YVA EVL     Y ++ID++S G+I + +   + PF    E+  I + + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLR 242
Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             +++       +     K +IR ++  DP KR  A   L   WL
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HP 65
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 124
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 125 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 20/261 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  +      T +  A K I   +     ++ED+++EI +L      P + +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ-CDSPYVTK 84
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +   H    IHR
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + 
Sbjct: 144 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRK 310
           D+WS G+    L  G PP        +   I + N        P++ G      K+ +  
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 253
Query: 311 MLTKDPKKRITAAEALEHPWL 331
            L K+P  R TA E L+H ++
Sbjct: 254 CLNKEPSFRPTAKELLKHKFI 274

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D+ +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D+ +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 136/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 91  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +    S +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 148 LHRDLKPSNLLLNTT---SDLKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 203
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI-----------LEGNLDLQSS 295
            + Y K ID+WS G IL  +LS  P F  +        I           L   ++L++ 
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKAR 263
Query: 296 ------------PW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L +    SD
Sbjct: 264 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSD 323
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 324 EPIAEA 329

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKXVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNI 134
           +K LG G  G T +      GR  A K    R L+   D  D+   EI +L      PN+
Sbjct: 38  EKILGYGSSG-TVVFQGSFQGRPVAVK----RMLI---DFCDIALMEIKLLTESDDHPNV 89
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER-------EAANICRQIVNVVHA 187
           + +  +    + L++ +ELC+   L D + +K +  E           ++ RQI + V  
Sbjct: 90  IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 188 CHFMGVIHRDLKPENFLLASKE----------EDSPIKATDFGLSVFIETGKV-----YK 232
            H + +IHRDLKP+N L+++            E+  I  +DFGL   +++G+        
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 233 EIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLS-GVPPFWAE--TEKGIFEAI 285
              G++ + APE+L +    R  + ID++S G + Y +LS G  PF  +   E  I   I
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
              + +++     S+  +A DLI +M+  DP KR TA + L HP
Sbjct: 269 FSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNI 134
           +K LG G  G T +      GR  A K    R L+   D  D+   EI +L      PN+
Sbjct: 38  EKILGYGSSG-TVVFQGSFQGRPVAVK----RMLI---DFCDIALMEIKLLTESDDHPNV 89
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER-------EAANICRQIVNVVHA 187
           + +  +    + L++ +ELC+   L D + +K +  E           ++ RQI + V  
Sbjct: 90  IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 188 CHFMGVIHRDLKPENFLLASKE----------EDSPIKATDFGLSVFIETGKV-----YK 232
            H + +IHRDLKP+N L+++            E+  I  +DFGL   +++G+        
Sbjct: 149 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 233 EIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLS-GVPPFWAE--TEKGIFEAI 285
              G++ + APE+L +    R  + ID++S G + Y +LS G  PF  +   E  I   I
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 268
Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
              + +++     S+  +A DLI +M+  DP KR TA + L HP
Sbjct: 269 FSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 22/285 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  +      T +  A K I   +     ++ED+++EI +L      P + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ-CDSPYVTK 69
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +   H    IHR
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + 
Sbjct: 129 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRK 310
           D+WS G+    L  G PP        +   I + N        P++ G      K+ +  
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 238
Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRA 355
            L K+P  R TA E L+H ++  +   +     + ++ R K+++A
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWKA 281

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG     + ++  K+  D + E V     REI +L+ L   P
Sbjct: 9   EKIGEGTYGVVYKARNKLTG-----EVVALXKIRLDTETEGVPSTAIREISLLKEL-NHP 62
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 121
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 122 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG     + ++  K+  D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTG-----EVVALXKIRLDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E       +  D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 22/285 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  +      T +  A K I   +     ++ED+++EI +L      P + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ-CDSPYVTK 69
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +   H    IHR
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + 
Sbjct: 129 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRK 310
           D+WS G+    L  G PP        +   I + N        P++ G      K+ +  
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 238
Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRA 355
            L K+P  R TA E L+H ++  +   +     + ++ R K+++A
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWKA 281

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 44/291 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHLTGQP 132
           +++G G +GV Y    K TG   A K I       D + E V     REI +L+ L   P
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHP 61
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+       +  L+LV E          D     GI      + +  Q++  +  CH 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLF-QLLQGLAFCHS 120
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-- 247
             V+HRDLKP+N L+ +   +  IK  DFGL+  F    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ---- 303
           + Y   +D+WS G I   +++    F  ++E      I           WP ++      
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 304 ---------------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                 + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 80
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKH-LHS 137
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 332 K 332
Sbjct: 315 N 315

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 124/261 (47%), Gaps = 20/261 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +++G+G FG  +      T +  A K I   +     ++ED+++EI +L      P + +
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ-CDSPYVTK 89
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +   H    IHR
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEI 254
           D+K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + 
Sbjct: 149 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 205
Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ----AKDLIRK 310
           D+WS G+    L  G PP        +   I + N        P++ G      K+ +  
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 258
Query: 311 MLTKDPKKRITAAEALEHPWL 331
            L K+P  R TA E L+H ++
Sbjct: 259 CLNKEPSFRPTAKELLKHKFI 279

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKXVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLCGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 89  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 201
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-------EGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +        IL       + +L+        
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKAR 261
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 322 EPIAEA 327

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 89  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 201
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKAR 261
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 322 EPIAEA 327

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 89  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 146 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 201
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 261
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 322 EPIAEA 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 88
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 146 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 332 K 332
Sbjct: 323 N 323

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 125
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 182
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 183 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 332 K 332
Sbjct: 360 N 360

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 81
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 138
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 139 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 332 K 332
Sbjct: 316 N 316

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 86
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 144 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 332 K 332
Sbjct: 321 N 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 81
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 138
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 139 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 332 K 332
Sbjct: 316 N 316

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 119/258 (46%), Gaps = 17/258 (6%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           G  +  P+  +   Y++ K +G+G FG           +  A K +   K  + +  E++
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 119 RREILILQHLTGQP-----NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSE 171
           R    IL+HL  Q      N++     +  + ++ +  EL S    EL  +   +G +S 
Sbjct: 145 R----ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSL 199
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    I+  + A H   +IH DLKPEN LL  ++  S IK  DFG S + E  +VY
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY-EHQRVY 257
Query: 232 KEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
             I  S +Y APEV L  RYG  ID+WS G IL  LL+G P    E E      ++E  L
Sbjct: 258 TXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE-LL 315
Query: 291 DLQSSPWPSISGQAKDLI 308
            + S      S +AK+ +
Sbjct: 316 GMPSQKLLDASKRAKNFV 333

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 88
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 146 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 332 K 332
Sbjct: 323 N 323

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 93  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 150 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 205
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 326 EPIAEA 331

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 80
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 137
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 138 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 332 K 332
Sbjct: 315 N 315

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKCVNHKNIIS 125
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 182
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 183 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 332 K 332
Sbjct: 360 N 360

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 93  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 150 LHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 205
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 326 EPIAEA 331

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 119/258 (46%), Gaps = 17/258 (6%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           G  +  P+  +   Y++ K +G+G FG           +  A K +   K  + +  E++
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 119 RREILILQHLTGQP-----NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSE 171
           R    IL+HL  Q      N++     +  + ++ +  EL S    EL  +   +G +S 
Sbjct: 145 R----ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSL 199
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    I+  + A H   +IH DLKPEN LL  ++  S IK  DFG S + E  +VY
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY-EHQRVY 257
Query: 232 KEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
             I  S +Y APEV L  RYG  ID+WS G IL  LL+G P    E E      ++E  L
Sbjct: 258 TXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE-LL 315
Query: 291 DLQSSPWPSISGQAKDLI 308
            + S      S +AK+ +
Sbjct: 316 GMPSQKLLDASKRAKNFV 333

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 147
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 148 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 264
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 265 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 324

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNI 134
           +K LG G  G T +      GR  A K    R L+   D  D+   EI +L      PN+
Sbjct: 20  EKILGYGSSG-TVVFQGSFQGRPVAVK----RMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER-------EAANICRQIVNVVHA 187
           + +  +    + L++ +ELC+   L D + +K +  E           ++ RQI + V  
Sbjct: 72  IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 188 CHFMGVIHRDLKPENFLLASKE----------EDSPIKATDFGLSVFIETGKV-----YK 232
            H + +IHRDLKP+N L+++            E+  I  +DFGL   +++G+        
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 233 EIVGSAYYVAPEVLHQ--------RYGKEIDVWSAGVILYILLS-GVPPFWAE--TEKGI 281
              G++ + APE+L +        R  + ID++S G + Y +LS G  PF  +   E  I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
              I   + +++     S+  +A DLI +M+  DP KR TA + L HP
Sbjct: 251 IRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/336 (25%), Positives = 145/336 (43%), Gaps = 52/336 (15%)
Query: 42  SSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYAC 101
           SS PPA S    Q       + K   ++  +Y   + +G G +G         TG K A 
Sbjct: 2   SSPPPARSGFYRQE------VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAI 55
Query: 102 KSISRRKLVYDKDMEDVR--REILILQHL-----TGQPNIVEFEGAYEDKQNLHLVMELC 154
           K + R    +  ++   R  RE+ +L+H+      G  ++   +   +D  + +LVM   
Sbjct: 56  KKLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM 112
Query: 155 SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI 214
             G    +++      E     +  Q++  +   H  G+IHRDLKP N  +    ED  +
Sbjct: 113 --GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCEL 167
Query: 215 KATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSG--- 269
           K  DFGL+   +        V + +Y APEV+    RY + +D+WS G I+  +++G   
Sbjct: 168 KILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
Query: 270 ------------------VPP--FWAETEKGIFEAILEGNLDLQSSPWPSI----SGQAK 305
                              PP  F    +    +  ++G  +L+   + SI    S  A 
Sbjct: 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 285
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           +L+ KML  D ++R+TA EAL HP+ +    T D+P
Sbjct: 286 NLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S   ++ + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 138/323 (42%), Gaps = 58/323 (17%)
Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRR 120
           P+ D  + Y+   ++G+G FG  +    + TG+K A K     K++ + + E       R
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALR 66
Query: 121 EILILQHLTGQP--NIVEF----EGAYED-KQNLHLVMELCSG--GELFDRIIAKGIYSE 171
           EI ILQ L  +   N++E        Y   K +++LV + C      L   ++ K  ++ 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTL 124
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV- 230
            E   + + ++N ++  H   ++HRD+K  N L+     D  +K  DFGL+      K  
Sbjct: 125 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNS 181
Query: 231 ----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
               Y   V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+     
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241
Query: 285 ILEGNLDLQSSPWPSIS------------GQ----------------AKDLIRKMLTKDP 316
           I +    +    WP++             GQ                A DLI K+L  DP
Sbjct: 242 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 301
Query: 317 KKRITAAEALEHPWLKEDGATSD 339
            +RI + +AL H +   D   SD
Sbjct: 302 AQRIDSDDALNHDFFWSDPMPSD 324

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNI 134
           +K LG G  G T +      GR  A K    R L+   D  D+   EI +L      PN+
Sbjct: 20  EKILGYGSSG-TVVFQGSFQGRPVAVK----RMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER-------EAANICRQIVNVVHA 187
           + +  +    + L++ +ELC+   L D + +K +  E           ++ RQI + V  
Sbjct: 72  IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 188 CHFMGVIHRDLKPENFLLASKE----------EDSPIKATDFGLSVFIETGKV-----YK 232
            H + +IHRDLKP+N L+++            E+  I  +DFGL   +++G+        
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 233 EIVGSAYYVAPEVLHQ--------RYGKEIDVWSAGVILYILLS-GVPPFWAE--TEKGI 281
              G++ + APE+L +        R  + ID++S G + Y +LS G  PF  +   E  I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
              I   + +++     S+  +A DLI +M+  DP KR TA + L HP
Sbjct: 251 IRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV----RREILILQHL 128
           Y+  +++G G +G  +    + T    A K +       D D E V     REI +L+ L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKEL 58
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVH 186
             + NIV         + L LV E C     + FD     G        +   Q++  + 
Sbjct: 59  KHK-NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLG 115
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   V+HRDLKP+N L+    E   +K  +FGL+  F    + Y   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 246 LH--QRYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFEAI----------LEG 288
           L   + Y   ID+WSAG I   L +   P +   +     K IF  +          +  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 289 NLDLQSSPW-----------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             D +  P            P ++   +DL++ +L  +P +RI+A EAL+HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 89  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 146 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 201
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 261
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 322 EPIAEA 327

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G  G+          R  A K +SR         +   RE L+L       NI+ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRE-LVLMKXVNHKNIIS 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+ Q+++LVMEL        ++I   +  ER +  + + +  + H  H 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHS 144
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQR 249
            G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   
Sbjct: 145 AGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 250 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI----- 281
           Y + +D+WS G I+       IL  G                  P F  + +  +     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 282 ---------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
                    F  +   +L    S    + + QA+DL+ KML  DP KRI+  +AL+HP++
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 332 K 332
Sbjct: 322 N 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 146
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 147 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 264 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 52/285 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSIS--RRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           LGRG FGV +    K     YA K I    R+L  +K M +V+  +  L+H    P IV 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEH----PGIVR 67
Query: 137 FEGAYEDKQN------------LHLVMELCSGGELFDRIIAKGIYSEREAA---NICRQI 181
           +  A+ +K              L++ M+LC    L D +  +    ERE +   +I  QI
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI------- 234
              V   H  G++HRDLKP N        D  +K  DFGL   ++  +  + +       
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 235 ------VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
                 VG+  Y++PE +H   Y  ++D++S G+IL+ LL    PF  + E+      + 
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER------VR 235
Query: 288 GNLDLQSSPWPSISGQAKD----LIRKMLTKDPKKRITAAEALEH 328
              D+++  +P +  Q       +++ ML+  P +R  A   +E+
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 109 IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 166 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 221
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 281
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 282 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 342 EPIAEA 347

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 91  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 148 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 203
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 263
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 264 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 323
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 324 EPIAEA 329

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 138/323 (42%), Gaps = 58/323 (17%)
Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME----DVRR 120
           P+ D  + Y+   ++G+G FG  +    + TG+K A K     K++ + + E       R
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALR 66
Query: 121 EILILQHLTGQP--NIVEF----EGAYED-KQNLHLVMELCSG--GELFDRIIAKGIYSE 171
           EI ILQ L  +   N++E        Y   K +++LV + C      L   ++ K  ++ 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTL 124
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV- 230
            E   + + ++N ++  H   ++HRD+K  N L+     D  +K  DFGL+      K  
Sbjct: 125 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNS 181
Query: 231 ----YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
               Y   V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+     
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 241
Query: 285 ILEGNLDLQSSPWPSIS------------GQ----------------AKDLIRKMLTKDP 316
           I +    +    WP++             GQ                A DLI K+L  DP
Sbjct: 242 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 301
Query: 317 KKRITAAEALEHPWLKEDGATSD 339
            +RI + +AL H +   D   SD
Sbjct: 302 AQRIDSDDALNHDFFWSDPMPSD 324

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGI------ 281
            + +D+WS G I+  ++ G                        P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 97  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 154 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 209
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 269
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 270 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 329
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 330 EPIAEA 335

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 89  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 146 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 201
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 261
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 262 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 322 EPIAEA 327

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 110/237 (46%), Gaps = 16/237 (6%)
Query: 59  GPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV 118
           G  +  P+  +   Y++ K +G+G FG           +  A K +   K  + +  E++
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 119 RREILILQHLTGQP-----NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSE 171
           R    IL+HL  Q      N++     +  + ++ +  EL S    EL  +   +G +S 
Sbjct: 145 R----ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSL 199
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    I+  + A H   +IH DLKPEN LL  ++  S IK  DFG S + E  +VY
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY-EHQRVY 257
Query: 232 KEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
             I  S +Y APEV L  RYG  ID+WS G IL  LL+G P    E E      ++E
Sbjct: 258 XXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 87  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 144 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 199
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 259
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 260 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 320 EPIAEA 325

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 87  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 144 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 199
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-------EGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +        IL       + +L+        
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKAR 259
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 260 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 320 EPIAEA 325

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 94  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 151 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 206
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 266
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 267 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 327 EPIAEA 332

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 95  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 152 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 207
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 267
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 268 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 327
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 328 EPIAEA 333

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 86  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 143 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 198
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 258
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 259 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 318
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 319 EPIAEA 324

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 93  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 150 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 205
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 326 EPIAEA 331

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 93  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 150 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-XEXVATRWYRAPEIMLN 205
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 326 EPIAEA 331

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPNIV 135
           ++LG G +   Y    K TG   A K +   KL  ++       REI +++ L  + NIV
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHE-NIV 66
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR------------QIVN 183
                   +  L LV E        D  + K + S R   N  R            Q++ 
Sbjct: 67  RLYDVIHTENKLTLVFEF------MDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVA 242
            +  CH   ++HRDLKP+N L+  + +   +K  DFGL+  F      +   V + +Y A
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 243 PEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           P+VL   + Y   ID+WS G IL  +++G P F    ++   + I +       S WPS+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 301 S------------------------------GQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           +                              G   D +  +L  +P  R++A +AL HPW
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 331 LKE 333
             E
Sbjct: 297 FAE 299

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 94  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 151 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-XEXVATRWYRAPEIMLN 206
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 266
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 267 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 327 EPIAEA 332

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 7/212 (3%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y +  +LG G     YL        K A K+I       ++ ++   RE+     L+ Q 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ- 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV      E+    +LVME   G  L + I + G  S   A N   QI++ +   H M 
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQRY 250
           ++HRD+KP+N L+ S   +  +K  DFG++  +    + +   ++G+  Y +PE      
Sbjct: 132 IVHRDIKPQNILIDS---NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 251 GKE-IDVWSAGVILYILLSGVPPFWAETEKGI 281
             E  D++S G++LY +L G PPF  ET   I
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 136/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+ +++     S         QI+  +   H   V
Sbjct: 91  IIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 148 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 203
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 263
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L +    SD
Sbjct: 264 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSD 323
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 324 EPIAEA 329

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 48/306 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILIL-----QHLTGQPN 133
           +G G +G+           + A K IS     +    +   REI IL     +++ G  +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           I+      E  +++++V +L    +L+  +  + + S         QI+  +   H   V
Sbjct: 93  IIR-APTIEQMKDVYIVQDLMET-DLYKLLKCQHL-SNDHICYFLYQILRGLKYIHSANV 149
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEIVGSAYYVAPEVL-- 246
           +HRDLKP N LL +  +   +K  DFGL+   +     TG +  E V + +Y APE++  
Sbjct: 150 LHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEYVATRWYRAPEIMLN 205
Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAILEGNLDL------- 292
            + Y K ID+WS G IL  +LS  P F  +          GI  +  + +L+        
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265
Query: 293 ---------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
                       PW    P+   +A DL+ KMLT +P KRI   +AL HP+L++    SD
Sbjct: 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 340 KPIDSA 345
           +PI  A
Sbjct: 326 EPIAEA 331

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  + +  V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI------ 281
            + +D+WS G I+       IL  G                  P F  + +  +      
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 43/285 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G FG           R YA K I       ++ +  +  E+++L  L  Q  +V + 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY-VVRYY 68
Query: 139 GAYEDKQN-------------LHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNV 184
            A+ +++N             L + ME C    L+D I ++ +  +R E   + RQI+  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------------TGK 229
           +   H  G+IHRDLKP N  +   +E   +K  DFGL+  +                +  
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 230 VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAIL 286
                +G+A YVA EVL     Y ++ID++S G+I + +   + PF    E+  I + + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLR 242
Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             +++       +     K +IR ++  DP KR  A   L   WL
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKH-LHSA 150
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 151 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 251 GKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI------ 281
            + +D+WS G I+       IL  G                  P F  + +  +      
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 267
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 268 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 327

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 96/200 (48%), Gaps = 38/200 (19%)
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----TGKVYKEI 234
           QI+  +   H   V+HRDLKP N LL +  +   +K  DFGL+   +     TG +  E 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFL-TEY 191
Query: 235 VGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFEAI 285
           V + +Y APE++   + Y K ID+WS G IL  +LS  P F  +          GI  + 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 286 LEGNLDL----------------QSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEA 325
            + +L+                    PW    P+   +A DL+ KMLT +P KRI   +A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 326 LEHPWLKEDGATSDKPIDSA 345
           L HP+L++    SD+PI  A
Sbjct: 312 LAHPYLEQYYDPSDEPIAEA 331

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 139
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  +    V + YY APEV L   Y
Sbjct: 140 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 251 GKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI------ 281
            + +D+WS G I+       IL  G                  P F  + +  +      
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 256
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 257 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 316

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSI--SRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           LG GQF   Y    K T +  A K I    R    D       REI +LQ L+  PNI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 76
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG---V 193
              A+  K N+ LV +     E    +I K        ++I   ++  +    ++    +
Sbjct: 77  LLDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 133
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH--QRY 250
           +HRDLKP N LL   +E+  +K  DFGL+  F    + Y   V + +Y APE+L   + Y
Sbjct: 134 LHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK----- 305
           G  +D+W+ G IL  LL  VP    +++      I E         WP +          
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 306 -------------------DLIRKMLTKDPKKRITAAEALE 327
                              DLI+ +   +P  RITA +AL+
Sbjct: 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 118/269 (43%), Gaps = 23/269 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           E+GRG +G       K +G+  A K I  R  V +K+ + +  ++ ++   +  P IV+F
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS-------EREAANICRQIVNVV-HACH 189
            GA   + +  + MEL S    FD+   K +YS       E     I    V  + H   
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--- 246
            + +IHRD+KP N LL   +    IK  DFG+S  +          G   Y+APE +   
Sbjct: 144 NLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 247 --HQRYGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFEAILEGNLDLQSSPWPSISG 302
              Q Y    DVWS G+ LY L +G  P+  W      + + +      L +S     S 
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              + +   LTKD  KR    E L+HP++
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ-----HLTGQ 131
           K +G G  G+          R  A K +SR         +   RE+++++     ++ G 
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            N+   + + E+ Q++++VMEL        ++I   +  ER +  + + +  + H  H  
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LHQRY 250
           G+IHRDLKP N ++ S   D  +K  DFGL+    T  + +  V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 251 GKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGI------ 281
            + +D+WS G I+       IL  G                  P F  + +  +      
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 282 --------FEAILEGNLDLQSSPWPSI-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                   FE +    L    S    + + QA+DL+ KML  D  KRI+  EAL+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 55/300 (18%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L ++LGRG++   +         K A K +   K       + ++REI IL++L G P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVK------KKKIKREIKILENLRGGP 92
Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CRQIVNVVHA 187
           NI+      +D   +   LV E  +  +       K +Y      +I     +I+  +  
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH MG++HRD+KP N L+    E   ++  D+GL+ F   G+ Y   V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVLI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFEAILEGNLD 291
            +Q Y   +D+WS G +L  ++    PF+   +              + +++ I + N++
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 292 L--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           L                     S     +S +A D + K+L  D + R+TA EA+EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 50/266 (18%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWLKEDGATSDKPI-DSAVLT 348
           EA+EHP+         +P  D+AVL+
Sbjct: 317 EAMEHPYFYPVVKEQSQPCADNAVLS 342

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 39/280 (13%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 118
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGNLDLQSSPWPSI- 300
           L    Y  + D+WS G+ L  +  G   +PP  A+ +     AI E    + + P P + 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLP 234
Query: 301 ----SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
               S + +D + K L K+P +R    + + H ++K   A
Sbjct: 235 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 274

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  EDS +K  DFGL     T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDSELKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 112
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 172 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 288 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 13  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 68
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 69  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 127
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 128 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 183
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 243
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 244 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 134/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 91
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  EDS +K  DFGL+    T       V + +Y APE++    
Sbjct: 150 ADIIHRDLKPSNL---AVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 265 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 319 DPDDEPV 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 84
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 144 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 260 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 65
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 125 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 241 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 16/225 (7%)
Query: 120 REILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANIC 178
           RE+ +L+     PN++ +    +D+Q  ++ +ELC+   L + +  K   +   E   + 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLL 124
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA--TDFGLSVFIETGKVY----K 232
           +Q  + +   H + ++HRDLKP N L++       IKA  +DFGL   +  G+       
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 233 EIVGSAYYVAPEVLHQRYGKE----IDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE 287
            + G+  ++APE+L +   +     +D++SAG + Y ++S G  PF    ++     IL 
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILL 242
Query: 288 GNLDLQS-SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
           G   L    P       A++LI KM+  DP+KR +A   L+HP+ 
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 112
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 172 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 288 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 134/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  EDS +K  DFGL+    T       V + +Y APE++    
Sbjct: 146 ADIIHRDLKPSNL---AVNEDSELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 261 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 315 DPDDEPV 321

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 9   IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 64
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 65  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 123
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 124 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 179
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 239
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 240 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 22/283 (7%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G+G FG  +      T +  A K I   +     ++ED+++EI +L        + ++ 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSS-YVTKYY 87
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           G+Y     L ++ME   GG   D ++  G + E + A + ++I+  +   H    IHRD+
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 146
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-IVGSAYYVAPEVLHQR-YGKEIDV 256
           K  N LL+   E   +K  DFG++  +   ++ +   VG+ +++APEV+ Q  Y  + D+
Sbjct: 147 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 257 WSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG----QAKDLIRKML 312
           WS G+    L  G PP        +   I + N        P++ G      K+ I   L
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLVGDFTKSFKEFIDACL 256
Query: 313 TKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRA 355
            KDP  R TA E L+H ++ ++   +    +  ++ R K+++A
Sbjct: 257 NKDPSFRPTAKELLKHKFIVKNSKKTSYLTE--LIDRFKRWKA 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 112
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++   T  V    VG+  Y+ PE 
Sbjct: 172 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 288 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 37/294 (12%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-- 130
           Y+   E+G G +G  +       G ++      R +   +       RE+ +L+HL    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 131 QPNIVEF----EGAYEDKQN-LHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVN 183
            PN+V        +  D++  L LV E          D++   G+ +E    ++  Q++ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLR 131
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   V+HRDLKP+N L+ S  +   IK  DFGL+           +V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------GNLD 291
           EVL Q  Y   +D+WS G I   +    P F   ++      IL+            ++ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 292 LQSSPWPSISGQ------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           L    + S S Q             KDL+ K LT +P KRI+A  AL HP+ ++
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 82
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQR 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 141 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 256 QSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 337 TSDKPI 342
             D+P+
Sbjct: 310 PDDEPV 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG G FG       + TG + A K    R+ +  K+ E    EI I++ L   P
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLN-HP 73
Query: 133 NIVEFEGAYEDKQNLH------LVMELCSGGEL---FDRIIAKGIYSEREAANICRQIVN 183
           N+V      +  Q L       L ME C GG+L    ++        E     +   I +
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   +IHRDLKPEN +L    +    K  D G +  ++ G++  E VG+  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 244 EVLHQ-RYGKEIDVWSAGVILYILLSGVPPF 273
           E+L Q +Y   +D WS G + +  ++G  PF
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG G FG       + TG + A K    R+ +  K+ E    EI I++ L   P
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLN-HP 72
Query: 133 NIVEFEGAYEDKQNLH------LVMELCSGGEL---FDRIIAKGIYSEREAANICRQIVN 183
           N+V      +  Q L       L ME C GG+L    ++        E     +   I +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   +IHRDLKPEN +L    +    K  D G +  ++ G++  E VG+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 244 EVLHQ-RYGKEIDVWSAGVILYILLSGVPPF 273
           E+L Q +Y   +D WS G + +  ++G  PF
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 82
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQR 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 141 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 256 QSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 337 TSDKPI 342
             D+P+
Sbjct: 310 PDDEPV 315

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 37/274 (13%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 121
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +   ++  E VG+  Y++PE 
Sbjct: 122 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDEMANEFVGTRSYMSPER 177
Query: 246 LH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS--ISG 302
           L    Y  + D+WS G+ L  +  G  P        IFE +L+  ++      PS   S 
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFE-LLDYIVNEPPPKLPSAVFSL 233
Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           + +D + K L K+P +R    + + H ++K   A
Sbjct: 234 EFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 267

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 37/294 (12%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-- 130
           Y+   E+G G +G  +       G ++      R +   +       RE+ +L+HL    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 131 QPNIVEF----EGAYEDKQN-LHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVN 183
            PN+V        +  D++  L LV E          D++   G+ +E    ++  Q++ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLR 131
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   V+HRDLKP+N L+ S  +   IK  DFGL+           +V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------GNLD 291
           EVL Q  Y   +D+WS G I   +    P F   ++      IL+            ++ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 292 LQSSPWPSISGQ------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           L    + S S Q             KDL+ K LT +P KRI+A  AL HP+ ++
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 137/315 (43%), Gaps = 48/315 (15%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D+   Y++ + +G G +GV     ++ TG++ A K I     V   + +   RE+ IL+H
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKH 110
Query: 128 LTGQPNIVEFEG------AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
                NI+  +        Y + +++++V++L    +L   I +    +         Q+
Sbjct: 111 FK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-----YKEIVG 236
           +  +   H   VIHRDLKP N L+    E+  +K  DFG++  + T          E V 
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 237 SAYYVAPEV---LHQRYGKEIDVWSAGVI---------------------LYILLSGVPP 272
           + +Y APE+   LH+ Y + ID+WS G I                     L +++ G P 
Sbjct: 226 TRWYRAPELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 284
Query: 273 FWAETEKGI--FEAILEGNLDLQSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
                  G     A ++     Q  PW    P    QA  L+ +ML  +P  RI+AA AL
Sbjct: 285 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 344
Query: 327 EHPWLKEDGATSDKP 341
            HP+L +     D+P
Sbjct: 345 RHPFLAKYHDPDDEP 359

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 137/315 (43%), Gaps = 48/315 (15%)
Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D+   Y++ + +G G +GV     ++ TG++ A K I     V   + +   RE+ IL+H
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKH 109
Query: 128 LTGQPNIVEFEG------AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
                NI+  +        Y + +++++V++L    +L   I +    +         Q+
Sbjct: 110 FK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV-----YKEIVG 236
           +  +   H   VIHRDLKP N L+    E+  +K  DFG++  + T          E V 
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 237 SAYYVAPEV---LHQRYGKEIDVWSAGVI---------------------LYILLSGVPP 272
           + +Y APE+   LH+ Y + ID+WS G I                     L +++ G P 
Sbjct: 225 TRWYRAPELMLSLHE-YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283
Query: 273 FWAETEKGI--FEAILEGNLDLQSSPW----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
                  G     A ++     Q  PW    P    QA  L+ +ML  +P  RI+AA AL
Sbjct: 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343
Query: 327 EHPWLKEDGATSDKP 341
            HP+L +     D+P
Sbjct: 344 RHPFLAKYHDPDDEP 358

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-- 130
           Y+   E+G G +G  +       G ++      R +   +       RE+ +L+HL    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 131 QPNIVEF----EGAYEDKQN-LHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVN 183
            PN+V        +  D++  L LV E          D++   G+ +E    ++  Q++ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMFQLLR 131
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   V+HRDLKP+N L+ S  +   IK  DFGL+           +V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----------GNLD 291
           EVL Q  Y   +D+WS G I   +    P F   ++      IL+            ++ 
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 292 LQSSPWPSISGQ------------AKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           L    + S S Q             KDL+ K LT +P KRI+A  AL HP+ +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 316 EAMEHPYF 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 152 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMH 206
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 267 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 337 TSDKPI 342
             D+P+
Sbjct: 321 PDDEPV 326

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 92
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 151 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWM 205
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 266 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 320 DPDDEPV 326

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 316 EAMEHPYF 323

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 105
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 164 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 279 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 333 DPDDEPV 339

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 256
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 317 EAMEHPYF 324

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 91
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N  +    ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 150 ADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 265 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 319 DPDDEPV 325

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 83  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 136
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 194
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 315 EAMEHPYF 322

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 49/248 (19%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CR 179
           L++L G PNI+      +D   +   LV E  +  +       K +Y      +I     
Sbjct: 90  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMY 143
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I+  +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y
Sbjct: 144 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 201
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++
Sbjct: 202 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 261
Query: 284 AILEGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAA 323
            I + N++L                     S     +S +A D + K+L  D + R+TA 
Sbjct: 262 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 321
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 322 EAMEHPYF 329

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 104
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N  +    ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 163 ADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 278 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 332 DPDDEPV 338

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 93
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 152 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMH 206
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 267 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 337 TSDKPI 342
             D+P+
Sbjct: 321 PDDEPV 326

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 81
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 140 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 255 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 309 DPDDEPV 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQ 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 105
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 164 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWM 218
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 279 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 333 DPDDEPV 339

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 95
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 96  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 154 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 208
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 268
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 269 IQSLAQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 322
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 323 DPDDEPV 329

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T+ Y+   E+G G +G  Y      +G   A KS+          +  VR E+ +L+ L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLE 61
Query: 130 G--QPNIVEF----EGAYEDKQ-NLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQ 180
               PN+V        +  D++  + LV E          D+    G+ +E    ++ RQ
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQ 120
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
            +  +   H   ++HRDLKPEN L+ S      +K  DFGL+           +V + +Y
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALAPVVVTLWY 177
Query: 241 VAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAI---------- 285
            APEVL Q  Y   +D+WS G I   +    P F   +E      IF+ I          
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 286 ----------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                       G   +QS   P +      L+ +MLT +P KRI+A  AL+H +L +D
Sbjct: 238 DVSLPRGAFPPRGPRPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T+ Y+   E+G G +G  Y      +G   A KS+          +  VR E+ +L+ L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLE 61
Query: 130 G--QPNIVEF----EGAYEDKQ-NLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQ 180
               PN+V        +  D++  + LV E          D+    G+ +E    ++ RQ
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQ 120
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
            +  +   H   ++HRDLKPEN L+ S      +K  DFGL+           +V + +Y
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALDPVVVTLWY 177
Query: 241 VAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAI---------- 285
            APEVL Q  Y   +D+WS G I   +    P F   +E      IF+ I          
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 286 ----------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                       G   +QS   P +      L+ +MLT +P KRI+A  AL+H +L +D
Sbjct: 238 DVSLPRGAFPPRGPRPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 125/301 (41%), Gaps = 41/301 (13%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQH 127
           T+ Y+   E+G G +G  Y      +G   A KS+             +   RE+ +L+ 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 128 LTG--QPNIVEF----EGAYEDKQ-NLHLVMELCSGG--ELFDRIIAKGIYSEREAANIC 178
           L     PN+V        +  D++  + LV E          D+    G+ +E    ++ 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLM 126
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
           RQ +  +   H   ++HRDLKPEN L+ S      +K  DFGL+           +V + 
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 239 YYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAI-------- 285
           +Y APEVL Q  Y   +D+WS G I   +    P F   +E      IF+ I        
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 286 ------------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                         G   +QS   P +      L+ +MLT +P KRI+A  AL+H +L +
Sbjct: 244 PRDVSLPRGAFPPRGPRPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
Query: 334 D 334
           D
Sbjct: 303 D 303

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 35/275 (12%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 137
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 138 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 193
Query: 246 LH-QRYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAILEGNLDLQSSPWPS--IS 301
           L    Y  + D+WS G+ L  +  G  P  + +    IFE +L+  ++      PS   S
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFE-LLDYIVNEPPPKLPSGVFS 252
Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
            + +D + K L K+P +R    + + H ++K   A
Sbjct: 253 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 287

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 131/320 (40%), Gaps = 54/320 (16%)
Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVR 119
           L K   ++   Y     +G G +G         +G K A K +SR  + +++ K      
Sbjct: 42  LNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR---TY 98
Query: 120 REILILQHL-----TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREA 174
           RE+ +L+H+      G  ++     + E+  +++LV  L   G   + I+     ++   
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHV 156
Query: 175 ANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI 234
             +  QI+  +   H   +IHRDLKP N  +    ED  +K  DFGL+    T       
Sbjct: 157 QFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGY 211
Query: 235 VGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL 292
           V + +Y APE++     Y   +D+WS G I+  LL+G   F         + I+     L
Sbjct: 212 VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMR----L 267
Query: 293 QSSPWPSISGQ-------------------------------AKDLIRKMLTKDPKKRIT 321
             +P  S+  +                               A DL+ KML  D  KRIT
Sbjct: 268 TGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRIT 327
Query: 322 AAEALEHPWLKEDGATSDKP 341
           A+EAL HP+  +     D+P
Sbjct: 328 ASEALAHPYFSQYHDPDDEP 347

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 90
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 149 ADIIHRDLKPSNL---AVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 264 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 318 DPDDEPV 324

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 145 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 260 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 337 TSDKPI 342
             D+P+
Sbjct: 314 PDDEPV 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 86
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 145 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 260 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 337 TSDKPI 342
             D+P+
Sbjct: 314 PDDEPV 319

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 92
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 151 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 205
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 266 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 320 DPDDEPV 326

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 91
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 149
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 150 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 265 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 337 TSDKPI 342
             D+P+
Sbjct: 319 PDDEPV 324

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 109
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 168 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 283 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 337 TSDKPI 342
             D+P+
Sbjct: 337 PDDEPV 342

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 105
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 164 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 279 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 333 DPDDEPV 339

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 146 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 261 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 315 DPDDEPV 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 96
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 155 ADIIHRDLKPSNL---AVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 270 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 324 DPDDEPV 330

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 90
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 149 ADIIHRDLKPSNL---AVNEDXELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 264 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 318 DPDDEPV 324

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 83
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 142 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 257 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 337 TSDKPI 342
             D+P+
Sbjct: 311 PDDEPV 316

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 104
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 163 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 278 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 332 DPDDEPV 338

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 146 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 261 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 315 DPDDEPV 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 108
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 167 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWM 221
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 281
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 282 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 336 DPDDEPV 342

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 98
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 157 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 272 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 337 TSDKPI 342
             D+P+
Sbjct: 326 PDDEPV 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 98
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 157 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 272 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 337 TSDKPI 342
             D+P+
Sbjct: 326 PDDEPV 331

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 91
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 150 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 265 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 319 DPDDEPV 325

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 96
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 155 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 270 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 324 DPDDEPV 330

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 90
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 149 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 264 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 318 DPDDEPV 324

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 84
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 85  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 143 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 197
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 257
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 258 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 311
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 312 DPDDEPV 318

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 87
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 146 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 261 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 315 DPDDEPV 321

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 92/324 (28%), Positives = 128/324 (39%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TG 130
           Y++   LG G FG    C   KA GR  A K +       D+  E  R EI +L+HL T 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTT 71
Query: 131 QPN----IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER--EAANICRQIVNV 184
            PN     V+    +E   ++ +V EL  G   +D I   G    R      +  QI   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 185 VHACHFMGVIHRDLKPENFLLASKEE----------------DSPIKATDFGLSVFIETG 228
           V+  H   + H DLKPEN L    +                 +  IK  DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVIL---YILLSGVPPFWAETEKGIFEA 284
           + +  +V + +Y APEV L   + +  DVWS G IL   Y+  +  P   ++    + E 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 285 IL--------------------EGNLDLQSSPWPSISGQAK-----------------DL 307
           IL                      + D  SS    +S   K                 DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           I+KML  DP KRIT  EAL+HP+ 
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFF 332

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 83
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 141
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 142 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 257 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 337 TSDKPI 342
             D+P+
Sbjct: 311 PDDEPV 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 91
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 150 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 265 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 319 DPDDEPV 325

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 43/245 (17%)
Query: 125 LQHLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           L++L G PNI+      +D   +   LV E  +  + F ++  +   ++ +      +I+
Sbjct: 85  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEIL 141
Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
             +  CH MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y+  
Sbjct: 142 KALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 243 PEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFEAIL 286
           PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + +++ I 
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 259
Query: 287 EGNLDL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
           + N++L                     S     +S +A D + K+L  D + R+TA EA+
Sbjct: 260 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319
Query: 327 EHPWL 331
           EHP+ 
Sbjct: 320 EHPYF 324

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 58/306 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----TGQ 131
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+      G 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVIGL 84
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
            ++     + E+  +++LV  L   G   + I+     ++     +  QI+  +   H  
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--R 249
            +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++     
Sbjct: 143 DIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 250 YGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGIF 282
           Y + +D+WS G I+  LL+G   F                            +E+ +   
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 283 EAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +   
Sbjct: 258 QSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 311
Query: 337 TSDKPI 342
             D+P+
Sbjct: 312 PDDEPV 317

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 81
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 140 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 255 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 309 DPDDEPV 315

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 72  IYDLDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           IY + K++G G     +  L  KK     YA K ++  +   ++ ++  R EI  L  L 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI---YAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQ 84
Query: 130 GQPNIVEFEGAYE-DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              + +     YE   Q +++VME C   +L   +  K      E  +  + ++  VH  
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEV 245
           H  G++H DLKP NFL+     D  +K  DFG++  ++      V    VG+  Y+ PE 
Sbjct: 144 HQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEA 199
Query: 246 LHQRYGKE------------IDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDL 292
           +                    DVWS G ILY +  G  PF     +     AI++ N ++
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           +    P    Q  D+++  L +DPK+RI+  E L HP+++
Sbjct: 260 EFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 77/308 (25%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           K +G G FGV +        +      ++ +K++ DK  ++  RE+ I++ +   PN+V+
Sbjct: 46  KVIGNGSFGVVF------QAKLVESDEVAIKKVLQDKRFKN--RELQIMR-IVKHPNVVD 96
Query: 137 FE------GAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICR---------- 179
            +      G  +D+  L+LV+E           + + +Y + R  A + +          
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEY----------VPETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 180 --QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP---IKATDFGLSVFIETGKVYKEI 234
             Q++  +   H +G+ HRD+KP+N LL     D P   +K  DFG +  +  G+     
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLL-----DPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 235 VGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI----------- 281
           + S YY APE++     Y   ID+WS G ++  L+ G P F  E+  GI           
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLG 259
Query: 282 ---FEAILEGNLDLQSSPWPSISGQ-------------AKDLIRKMLTKDPKKRITAAEA 325
               E I   N +     +P I                A DLI ++L   P  R+TA EA
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 326 LEHPWLKE 333
           L HP+  E
Sbjct: 320 LCHPFFDE 327

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T+ Y+   E+G G +G  Y      +G   A KS+          +  VR E+ +L+ L 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLE 61
Query: 130 G--QPNIVEF----EGAYEDKQ-NLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQ 180
               PN+V        +  D++  + LV E          D+    G+ +E    ++ RQ
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQ 120
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
            +  +   H   ++HRDLKPEN L+ S      +K  DFGL+           +V + +Y
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFPVVVTLWY 177
Query: 241 VAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAI---------- 285
            APEVL Q  Y   +D+WS G I   +    P F   +E      IF+ I          
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 286 ----------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                       G   +QS   P +      L+ +MLT +P KRI+A  AL+H +L +D
Sbjct: 238 DVSLPRGAFPPRGPRPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/326 (25%), Positives = 135/326 (41%), Gaps = 59/326 (18%)
Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           LG  Y+D+       K LG G  G+ +        ++ A K I    L   + ++   RE
Sbjct: 9   LGSRYMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALRE 58
Query: 122 ILILQHLTGQPNIVEFE-------------GAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           I I++ L     +  FE             G+  +  ++++V E          ++ +G 
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP 116
Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
             E  A     Q++  +   H   V+HRDLKP N  + +  ED  +K  DFGL+  ++  
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174
Query: 229 KVYK----EIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF 282
             +K    E + + +Y +P +L     Y K ID+W+AG I   +L+G   F    E    
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 283 EAILE----------------------GNLDLQSSPW----PSISGQAKDLIRKMLTKDP 316
           + ILE                       ++     P     P IS +A D + ++LT  P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 317 KKRITAAEALEHPWLKEDGATSDKPI 342
             R+TA EAL HP++       D+PI
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----T 129
           + +G G +G           +K A K +SR  + L++ +      RE+ +L+HL      
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHLKHENVI 90
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
           G  ++     + ED   ++LV  L   G   + I+     S+     +  Q++  +   H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ- 248
             G+IHRDLKP N    +  EDS ++  DFGL+   +  +     V + +Y APE++   
Sbjct: 149 SAGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNW 203
Query: 249 -RYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAI-------------LEGNL 290
             Y + +D+WS G I+  LL G   F    + +  K I E +                  
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 291 DLQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
            +QS P          +   +  A DL+ +ML  D  +R++AAEAL H +  +     D+
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE 323
Query: 341 P 341
           P
Sbjct: 324 P 324

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  D+GL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +S+  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 97
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DFGL+    T       V + +Y APE++    
Sbjct: 156 ADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 271 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 325 DPDDEPV 331

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM----EDVRREILILQHLTG 130
           L++ +G G FG  Y       G + A K+        D+D+    E+VR+E  +   L  
Sbjct: 11  LEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDP---DEDISQTIENVRQEAKLFAMLK- 64
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI---VNVVHA 187
            PNI+   G    + NL LVME   GG L +R+++          N   QI   +N +H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPI-----KATDFGLSVFIETGKVYKEIVGSAY-YV 241
              + +IHRDLK  N L+  K E+  +     K TDFGL+   E  +  K     AY ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWM 181
Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLSGVPPF 273
           APEV+    + K  DVWS GV+L+ LL+G  PF
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 92/324 (28%), Positives = 127/324 (39%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TG 130
           Y++   LG G FG    C   KA GR  A K +       D+  E  R EI +L+HL T 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTT 71
Query: 131 QPN----IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER--EAANICRQIVNV 184
            PN     V+    +E   ++ +V EL  G   +D I   G    R      +  QI   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 185 VHACHFMGVIHRDLKPENFLLASKEE----------------DSPIKATDFGLSVFIETG 228
           V+  H   + H DLKPEN L    +                 +  IK  DFG + + +  
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVIL---YILLSGVPPFWAETEKGIFEA 284
             +  +V   +Y APEV L   + +  DVWS G IL   Y+  +  P   ++    + E 
Sbjct: 191 --HSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 285 IL--------------------EGNLDLQSSPWPSISGQAK-----------------DL 307
           IL                      + D  SS    +S   K                 DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           I+KML  DP KRIT  EAL+HP+ 
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFF 332

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 24/266 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D++ +  +++ +G G+FG       KA G+K +C +I   K  Y    E  RRE L   
Sbjct: 11  IDVSYV-KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY---TERQRREFLSEA 66
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQI 181
            + GQ   PNI+  EG   +   + ++ E    G L  F R +  G ++  +   + R I
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRGI 125
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSA 238
            + +     M  +HRDL   N L+ S   +   K +DFGLS F+E   +   Y   +G  
Sbjct: 126 ASGMRYLAEMSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 239 Y---YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQ 293
               + APE +  +++    D WS G++++ ++S G  P+W  + + +  AI +   D +
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ---DYR 239
Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKR 319
             P P        L+     KD   R
Sbjct: 240 LPPPPDCPTSLHQLMLDCWQKDRNAR 265

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 126/264 (47%), Gaps = 28/264 (10%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI-LQHLT--G 130
           ++++ +GRG FGV  +C  K   +  A K I         + E  R+  ++ L+ L+   
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQI---------ESESERKAFIVELRQLSRVN 60
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHA 187
            PNIV+  GA  +   + LVME   GG L++ +        Y+   A + C Q    V  
Sbjct: 61  HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 188 CHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
            H M    +IHRDLKP N LL +    + +K  DFG +  I+T     +  GSA ++APE
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 174
Query: 245 VLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           V     Y ++ DV+S G+IL+ +++   PF  E     F  +   +   +     ++   
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 304 AKDLIRKMLTKDPKKRITAAEALE 327
            + L+ +  +KDP +R +  E ++
Sbjct: 234 IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 31/259 (11%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  +    K TG + A K +          +E  R E L+       P IV   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           GA  +   +++ MEL  GG L   +  +G   E  A     Q +  +   H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV------GSAYYVAPE-VLHQRYG 251
           K +N LL+S  + S     DFG +V ++   + K+++      G+  ++APE VL +   
Sbjct: 193 KADNVLLSS--DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP------WPSISGQAK 305
            ++DVWS+  ++  +L+G  P W +  +G         L + S P       PS +    
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHP-WTQFFRGPL------CLKIASEPPPVREIPPSCAPLTA 303
Query: 306 DLIRKMLTKDPKKRITAAE 324
             I++ L K+P  R++AAE
Sbjct: 304 QAIQEGLRKEPIHRVSAAE 322

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 41/284 (14%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ------- 131
           LG+G FG           R YA K I       ++ +  +  E+ +L  L  Q       
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 132 -----PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVV 185
                 N V+   A + K  L +  E C    L+D I ++ +  +R E   + RQI+  +
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------------TGKV 230
              H  G+IHR+LKP N  +   +E   +K  DFGL+  +                +   
Sbjct: 130 SYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 231 YKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILE 287
               +G+A YVA EVL     Y ++ID +S G+I +     + PF    E+  I + +  
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLRS 243
Query: 288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            +++       +     K +IR ++  DP KR  A   L   WL
Sbjct: 244 VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----T 129
           + +G G +G           +K A K +SR  + L++ +      RE+ +L+HL      
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHLKHENVI 90
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
           G  ++     + ED   ++LV  L   G   + I+     S+     +  Q++  +   H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ- 248
             G+IHRDLKP N    +  EDS ++  DFGL+   +  +     V + +Y APE++   
Sbjct: 149 SAGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNW 203
Query: 249 -RYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAI-------------LEGNL 290
             Y + +D+WS G I+  LL G   F    + +  K I E +                  
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 291 DLQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
            +QS P          +   +  A DL+ +ML  D  +R++AAEAL H +  +     D+
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE 323
Query: 341 P 341
           P
Sbjct: 324 P 324

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 28/261 (10%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI-LQHLT--G 130
           ++++ +GRG FGV  +C  K   +  A K I         + E  R+  ++ L+ L+   
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQI---------ESESERKAFIVELRQLSRVN 59
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHA 187
            PNIV+  GA  +   + LVME   GG L++ +        Y+   A + C Q    V  
Sbjct: 60  HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 188 CHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
            H M    +IHRDLKP N LL +    + +K  DFG +  I+T     +  GSA ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 173
Query: 245 VLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           V     Y ++ DV+S G+IL+ +++   PF  E     F  +   +   +     ++   
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 304 AKDLIRKMLTKDPKKRITAAE 324
            + L+ +  +KDP +R +  E
Sbjct: 233 IESLMTRCWSKDPSQRPSMEE 253

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  DF L+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 31/259 (11%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  +    K TG + A K +          +E  R E L+       P IV   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           GA  +   +++ MEL  GG L   +  +G   E  A     Q +  +   H   ++H D+
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV------GSAYYVAPE-VLHQRYG 251
           K +N LL+S  + S     DFG +V ++   + K ++      G+  ++APE VL +   
Sbjct: 212 KADNVLLSS--DGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP------WPSISGQAK 305
            ++DVWS+  ++  +L+G  P W +  +G         L + S P       PS +    
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHP-WTQFFRGPL------CLKIASEPPPVREIPPSCAPLTA 322
Query: 306 DLIRKMLTKDPKKRITAAE 324
             I++ L K+P  R++AAE
Sbjct: 323 QAIQEGLRKEPIHRVSAAE 341

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K   FGL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  D GL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 43/303 (14%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF- 137
           L  G F   Y      +GR+YA K +   +   ++    + +E+  ++ L+G PNIV+F 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 138 -------EGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
                  E +   +    L+ ELC G   E   ++ ++G  S      I  Q    V   
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 189 HFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-----------TGKVYKEIV 235
           H     +IHRDLK EN LL+++     IK  DFG +  I               V +EI 
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 236 --GSAYYVAPEV--LHQRY--GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN 289
              +  Y  PE+  L+  +  G++ D+W+ G ILY+L     PF    E G    I+ G 
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGK 265
Query: 290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTR 349
             +   P  +       LIR ML  +P++R++ AE +    L+E  A  +    S +   
Sbjct: 266 YSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAAARNVNPKSPITEL 321
Query: 350 MKQ 352
           ++Q
Sbjct: 322 LEQ 324

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--- 131
           +++ +G G+FG       K  G++    +I   K+ Y    E  RR+ L    + GQ   
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGY---TEKQRRDFLCEASIMGQFDH 103
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACH 189
           PN+V  EG     + + +V+E    G L D  + K  G ++  +   + R I   +    
Sbjct: 104 PNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGS--AYYVAPEV 245
            MG +HRDL   N L+ S   +   K +DFGLS  IE     VY    G     + APE 
Sbjct: 163 DMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 246 L-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           + ++++    DVWS G++++ ++S G  P+W  + + + +AI EG
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 264

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  D GL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 60/307 (19%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +G G +G         TG + A K +SR  + +++ K      RE+ +L+H+  + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHE-NVIG 85
Query: 137 FEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
               +      E+  +++LV  L   G   + I+     ++     +  QI+  +   H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-- 248
             +IHRDLKP N    +  ED  +K  D GL+    T       V + +Y APE++    
Sbjct: 144 ADIIHRDLKPSNL---AVNEDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 249 RYGKEIDVWSAGVILYILLSGVPPF---------------------------WAETEKGI 281
            Y + +D+WS G I+  LL+G   F                            +E+ +  
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 282 FEAILE------GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
            +++ +       N+ + ++P       A DL+ KML  D  KRITAA+AL H +  +  
Sbjct: 259 IQSLTQMPKMNFANVFIGANPL------AVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 336 ATSDKPI 342
              D+P+
Sbjct: 313 DPDDEPV 319

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 111/257 (43%), Gaps = 13/257 (5%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG G +G  +    K  GR YA K  S       KD      E+   + +   P  V  E
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGVIHRD 197
            A+E+   L+L  ELC G  L     A G    E +     R  +  +   H  G++H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVW 257
           +KP N  L  +      K  DFGL V + T    +   G   Y+APE+L   YG   DV+
Sbjct: 183 VKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVF 239
Query: 258 SAGV-ILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDP 316
           S G+ IL +  +   P   E     ++ + +G L  + +    +S + + ++  ML  DP
Sbjct: 240 SLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDP 293
Query: 317 KKRITAAEALEHPWLKE 333
           K R TA   L  P L++
Sbjct: 294 KLRATAEALLALPVLRQ 310

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 129/301 (42%), Gaps = 46/301 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHL-----T 129
           + +G G +G           +K A K +SR  + L++ +      RE+ +L+HL      
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHLKHENVI 82
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
           G  ++     + ED   ++LV  L   G   + I+     S+     +  Q++  +   H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ- 248
             G+IHRDLKP N    +  ED  ++  DFGL+   +  +     V + +Y APE++   
Sbjct: 141 SAGIIHRDLKPSN---VAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNW 195
Query: 249 -RYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFEAI-------------LEGNL 290
             Y + +D+WS G I+  LL G   F    + +  K I E +                  
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 255
Query: 291 DLQSSP----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
            +QS P          +   +  A DL+ +ML  D  +R++AAEAL H +  +     D+
Sbjct: 256 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE 315
Query: 341 P 341
           P
Sbjct: 316 P 316

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 107
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 107
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 109
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 227
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 287
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 288 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 344

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 92
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 270
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 271 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 327

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 81
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 259
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 260 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 316

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 152
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 330
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 331 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 387

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 66/307 (21%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 111
Query: 133 NIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           NIV         G  +D+  L+LV++           + + +Y      +  +Q + V++
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDY----------VPETVYRVARHYSRAKQTLPVIY 161
Query: 187 A-------------CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                          H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+    
Sbjct: 162 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 219
Query: 234 IVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF--------- 282
            + S YY APE++     Y   IDVWSAG +L  LL G P F  ++              
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 279
Query: 283 ---EAILEGNLD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
              E I E N +        +++ PW     P    +A  L  ++L   P  R+T  EA 
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 327 EHPWLKE 333
            H +  E
Sbjct: 340 AHSFFDE 346

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 24/266 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D++ +  +++ +G G+FG       KA G+K +C +I   K  Y    E  RRE L   
Sbjct: 13  IDVSYV-KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY---TERQRREFLSEA 68
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQI 181
            + GQ   PNI+  EG   +   + ++ E    G L  F R +  G ++  +   + R I
Sbjct: 69  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRGI 127
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS---- 237
            + +     M  +HRDL   N L+ S   +   K +DFGLS F+E          S    
Sbjct: 128 ASGMRYLAEMSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 238 --AYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQ 293
               + APE +  +++    D WS G++++ ++S G  P+W  + + +  AI +   D +
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ---DYR 241
Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKR 319
             P P        L+     KD   R
Sbjct: 242 LPPPPDCPTSLHQLMLDCWQKDRNAR 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 78
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 256
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 257 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 313

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 66/307 (21%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 101
Query: 133 NIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           NIV         G  +D+  L+LV++           + + +Y      +  +Q + V++
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDY----------VPETVYRVARHYSRAKQTLPVIY 151
Query: 187 A-------------CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                          H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+    
Sbjct: 152 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 209
Query: 234 IVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF--------- 282
            + S YY APE++     Y   IDVWSAG +L  LL G P F  ++              
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 269
Query: 283 ---EAILEGNLD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
              E I E N +        +++ PW     P    +A  L  ++L   P  R+T  EA 
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 327 EHPWLKE 333
            H +  E
Sbjct: 330 AHSFFDE 336

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 85
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 86
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 264
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 265 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 321

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 85
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 320

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 77
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 255
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 256 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 312

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 74
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 252
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 253 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 309

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 66/307 (21%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK----LDHC---- 73
Query: 133 NIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           NIV         G  +D+  L+LV++           +   +Y      +  +Q + V++
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDY----------VPATVYRVARHYSRAKQTLPVIY 123
Query: 187 A-------------CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                          H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 234 IVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF--------- 282
            + S YY APE++     Y   IDVWSAG +L  LL G P F  ++              
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 283 ---EAILEGNLD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
              E I E N +        +++ PW     P    +A  L  ++L   P  R+T  EA 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 327 EHPWLKE 333
            H +  E
Sbjct: 302 AHSFFDE 308

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K + + K   +++++ +R+    L H     
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK----LDHC---- 73
Query: 133 NIVE----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-----CRQIVN 183
           NIV     F  + E K  ++L + L    E   R+      +++    I       Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 244 EVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF------------EAILEGN 289
           E++     Y   IDVWSAG +L  LL G P F  ++                 E I E N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 290 LD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            +        +++ PW     P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 24/267 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L   
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 132 PNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           P IV      E +       ++VME   G  L D +  +G  + + A  +       ++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAP 243
            H  G+IHRD+KP N L+++    + +K  DFG++  I ++G    +   ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANILISAT---NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188
Query: 244 EVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQSSPWP 298
           E   Q  G  +    DV+S G +LY +L+G PPF  ++   + ++ + E  +   S+   
Sbjct: 189 E---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHE 244
Query: 299 SISGQAKDLIRKMLTKDPKKRI-TAAE 324
            +S     ++ K L K+P+ R  TAAE
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 21/266 (7%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELGRG +GV        +G+  A K I  R  V  ++ + +  ++ I       P  V F
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 138 EGAYEDKQNLHLVMEL--CSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHF-MGV 193
            GA   + ++ + MEL   S  + + ++I KG    E     I   IV  +   H  + V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-VGSAYYVAPE----VLHQ 248
           IHRD+KP N L+ +  +   +K  DFG+S ++    V K I  G   Y+APE     L+Q
Sbjct: 176 IHRDVKPSNVLINALGQ---VKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 249 R-YGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           + Y  + D+WS G+ +  L     P+  W    + + + + E +  L   P    S +  
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PADKFSAEFV 288
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
           D   + L K+ K+R T  E ++HP+ 
Sbjct: 289 DFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 180
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 181 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 236
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 296
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 297 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQ 356
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 357 LMVHAFIKRSDA 368

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 131/318 (41%), Gaps = 42/318 (13%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQH 127
           + T   LDK LG G +   Y    K T    A K I   +L +++       RE+ +L+ 
Sbjct: 1   METYIKLDK-LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKD 56
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVV 185
           L    NIV        +++L LV E       +  D      I +         Q++  +
Sbjct: 57  LK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGL 113
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPE 244
             CH   V+HRDLKP+N L+  + E   +K  DFGL+       K Y   V + +Y  P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--------------G 288
           +L     Y  +ID+W  G I Y + +G P F   T +     I                 
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 289 NLDLQSSPWPSISGQA------------KDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           N + ++  +P    +A             DL+ K+L  + + RI+A +A++HP+    G 
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290
Query: 337 TSDKPIDSAVLTRMKQFR 354
              K  D+  +  +K+ +
Sbjct: 291 RIHKLPDTTSIFALKEIQ 308

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L   
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 132 PNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           P IV      E +       ++VME   G  L D +  +G  + + A  +       ++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAP 243
            H  G+IHRD+KP N ++++    + +K  DFG++  I ++G    +   ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 244 EVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           E   Q  G  +    DV+S G +LY +L+G PPF  ++   +    +  +    S+    
Sbjct: 189 E---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEG 245
Query: 300 ISGQAKDLIRKMLTKDPKKRI-TAAE 324
           +S     ++ K L K+P+ R  TAAE
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 21/266 (7%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELGRG +GV        +G+  A K I  R  V  ++ + +  ++ I       P  V F
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 138 EGAYEDKQNLHLVMEL--CSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHF-MGV 193
            GA   + ++ + MEL   S  + + ++I KG    E     I   IV  +   H  + V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-VGSAYYVAPE----VLHQ 248
           IHRD+KP N L+ +  +   +K  DFG+S ++    V K+I  G   Y+APE     L+Q
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 249 R-YGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           + Y  + D+WS G+ +  L     P+  W    + + + + E +  L   P    S +  
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PADKFSAEFV 244
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
           D   + L K+ K+R T  E ++HP+ 
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 22/266 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L   
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 132 PNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           P IV      E +       ++VME   G  L D +  +G  + + A  +       ++ 
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAP 243
            H  G+IHRD+KP N ++++      +K  DFG++  I ++G    +   ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 244 EVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           E   Q  G  +    DV+S G +LY +L+G PPF  ++   +    +  +    S+    
Sbjct: 189 E---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 300 ISGQAKDLIRKMLTKDPKKRI-TAAE 324
           +S     ++ K L K+P+ R  TAAE
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 80  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 133
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 134 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 312 EAMTHPYFQQVRAAEN 327

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 80  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 133
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 134 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 312 EAMTHPYFQQVRAAEN 327

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 311 EAMTHPYFQQVRAAEN 326

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 49/250 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKE 333
           EA+ HP+ ++
Sbjct: 311 EAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 81  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 134
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 135 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 192
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 252
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 253 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 312
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 313 EAMTHPYFQQVRAAEN 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 311 EAMTHPYFQQVRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 311 EAMTHPYFQQVRAAEN 326

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 311 EAMTHPYFQQVRAAEN 326

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 79  LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 132
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 281
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +                  +
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 282 FEAILEGNLDLQ---------SSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
           +       LD Q           PW           +S +A D + K+L  D ++R+TA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 311 EAMTHPYFQQVRAAEN 326

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 118
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 295 LMVHAFIKRSDA 306

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 49/256 (19%)
Query: 125 LQHLTGQPNIVEFEGAYEDKQNL--HLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           LQ+L G PNIV+      D+ +    L+ E  +  +       K +Y      +I   I 
Sbjct: 100 LQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDF------KVLYPTLTDYDIRYYIY 153
Query: 183 NVVHA---CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
            ++ A   CH  G++HRD+KP N ++    E   ++  D+GL+ F   GK Y   V S Y
Sbjct: 154 ELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK--------------GIFE 283
           +  PE+L   Q Y   +D+WS G +   ++    PF+   +               G+  
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 284 AILEGNLDL-----------QSSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
            + +  ++L              PW           +S +A D + K+L  D ++R+TA 
Sbjct: 272 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 331
Query: 324 EALEHPWLKEDGATSD 339
           EA+ HP+ ++  A  +
Sbjct: 332 EAMTHPYFQQVRAAEN 347

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L   
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 132 PNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           P IV      E +       ++VME   G  L D +  +G  + + A  +       ++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAP 243
            H  G+IHRD+KP N ++++    + +K  DFG++  I ++G    +   ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 244 EVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           E   Q  G  +    DV+S G +LY +L+G PPF  ++   +    +  +    S+    
Sbjct: 189 E---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 300 ISGQAKDLIRKMLTKDPKKRI-TAAE 324
           +S     ++ K L K+P+ R  TAAE
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 72  IYDLDK--ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           I DL+   E+G G  G  +    + TG   A K + R       + E+ +R ++ L  + 
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-----SGNKEENKRILMDLDVVL 78
Query: 130 GQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
                P IV+  G +    ++ + MEL        +   +G   ER    + +  V +V 
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER---ILGKMTVAIVK 135
Query: 187 ACHFM----GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
           A +++    GVIHRD+KP N LL   +E   IK  DFG+S  +   K      G A Y+A
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 243 PEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP 296
           PE +         Y    DVWS G+ L  L +G  P+  +  K  FE + +    LQ  P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTK---VLQEEP 247
Query: 297 -----WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                    SG  +  ++  LTKD +KR    + LEH ++K
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L   
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 132 PNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           P IV      E +       ++VME   G  L D +  +G  + + A  +       ++ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAP 243
            H  G+IHRD+KP N ++++      +K  DFG++  I ++G    +   ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 244 EVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQSSPWP 298
           E   Q  G  +    DV+S G +LY +L+G PPF  ++   + ++ + E  +   S+   
Sbjct: 189 E---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHE 244
Query: 299 SISGQAKDLIRKMLTKDPKKRI-TAAE 324
            +S     ++ K L K+P+ R  TAAE
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAE 271

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 118
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 295 LMVHAFIKRSDA 306

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 145
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 201
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 322 LMVHAFIKRSDA 333

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 118
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 295 LMVHAFIKRSDA 306

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 71/312 (22%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV +  + K +G   A      RKL++ +    +R +I   L + H    P I
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++ K       A  I  QI+  V      G  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPEQILGKVSIAVIKGLT 118
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y++PE 
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIFEAILEGN------------ 289
           L    Y  + D+WS G+ L  +  G   +PP  A+  + +F   +EG+            
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 290 -------------------LD-LQSSPWPSI-----SGQAKDLIRKMLTKDPKKRITAAE 324
                              LD + + P P +     S + +D + K L K+P +R    +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 325 ALEHPWLKEDGA 336
            + H ++K   A
Sbjct: 295 LMVHAFIKRSDA 306

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 86/340 (25%), Positives = 142/340 (41%), Gaps = 75/340 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++D  +G+G FG       +      A K I  +K   ++   +VR   L+ +H T   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 133 N-IVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGI---YSEREAANICRQIVNVVH 186
             IV  +  +  + +L LV E+ S    +L      +G+    + + A  +C  ++ +  
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL-- 154
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A   + +IH DLKPEN LL + +  S IK  DFG S   + G+   + + S +Y +PEVL
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQXIQSRFYRSPEVL 211
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------------------------KG 280
               Y   ID+WS G IL  + +G P F    E                         + 
Sbjct: 212 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 271
Query: 281 IFEAILEGNLDLQSS-------------------------PWPSISGQA----------K 305
            FE + +G  +L+ +                         P    +G++          K
Sbjct: 272 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 331
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
           DLI +ML  DPK RI    AL+H + K+   T+D+  +++
Sbjct: 332 DLILRMLDYDPKTRIQPYYALQHSFFKK---TADEGTNTS 368

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 95/186 (51%), Gaps = 15/186 (8%)
Query: 148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS 207
           ++VME   G  L D +  +G  + + A  +       ++  H  G+IHRD+KP N ++++
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 208 KEEDSPIKATDFGLSVFI-ETGKVYKE---IVGSAYYVAPEVLHQRYGKEI----DVWSA 259
               + +K  DFG++  I ++G    +   ++G+A Y++PE   Q  G  +    DV+S 
Sbjct: 169 T---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---QARGDSVDARSDVYSL 222
Query: 260 GVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR 319
           G +LY +L+G PPF  ++   +    +  +    S+    +S     ++ K L K+P+ R
Sbjct: 223 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 282
Query: 320 I-TAAE 324
             TAAE
Sbjct: 283 YQTAAE 288

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 18  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 70
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + A    +  ++  +I RQ    +   H   +
Sbjct: 71  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 129
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED+ +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 130 IHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGAVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 130/264 (49%), Gaps = 29/264 (10%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSI----SRRKLVYDKDMEDVRREILILQHLT 129
           + +K++G+G FG+ +           A KS+    S  +    +  ++ +RE+ I+ +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             PNIV+  G   +     +VME    G+L+ R++ K  +  + +  + R ++++     
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKL-RLMLDIALGIE 136
Query: 190 FMG-----VIHRDLKPENFLLASKEEDSPI--KATDFGLSVFIETGKVYKEIVGSAYYVA 242
           +M      ++HRDL+  N  L S +E++P+  K  DFGLS   ++      ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMA 194
Query: 243 PEVL---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           PE +    + Y ++ D +S  +ILY +L+G  PF  E   G  + I   N+  +    P+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF-DEYSYGKIKFI---NMIREEGLRPT 250
Query: 300 ISGQAKDLIRKML----TKDPKKR 319
           I       +R ++    + DPKKR
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/328 (25%), Positives = 135/328 (41%), Gaps = 72/328 (21%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++D  +G+G FG       +      A K I  +K   ++   +VR   L+ +H T   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 133 N-IVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGI---YSEREAANICRQIVNVVH 186
             IV  +  +  + +L LV E+ S    +L      +G+    + + A  +C  ++ +  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL-- 173
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A   + +IH DLKPEN LL + +  S IK  DFG S   + G+   + + S +Y +PEVL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQXIQSRFYRSPEVL 230
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------------------------KG 280
               Y   ID+WS G IL  + +G P F    E                         + 
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290
Query: 281 IFEAILEGNLDLQSS-------------------------PWPSISGQA----------K 305
            FE + +G  +L+ +                         P    +G++          K
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
           DLI +ML  DPK RI    AL+H + K+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKK 378

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 39/206 (18%)
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +++  +  CH  G++HRD+KP N ++  +++   ++  D+GL+ F    + Y   V S Y
Sbjct: 140 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRY 197
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + ++ 
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 257
Query: 284 AILEGNLDL-----------QSSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
            + + ++DL               W +         +S +A DL+ K+L  D ++R+TA 
Sbjct: 258 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 317
Query: 324 EALEHPWLKEDGATSDKP-IDSAVLT 348
           EA+EHP+         +P  D+AVL+
Sbjct: 318 EAMEHPYFYPVVKEQSQPSADNAVLS 343

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T  ++L+K +G G+FG  + C K+  G  YA K  S++ L    D ++  RE+     L 
Sbjct: 7   TEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVV 185
              ++V +  A+ +  ++ +  E C+GG L D I         + E E  ++  Q+   +
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 186 HACHFMGVIHRDLKPENFLL--------ASKEEDSP--------IKATDFGLSVFIETGK 229
              H M ++H D+KP N  +        AS+E D           K  D G    I + +
Sbjct: 125 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 184
Query: 230 VYKEIVGSAYYVAPEVLHQRYGK--EIDVWSAGVILYILLSGVPPF------WAETEKGI 281
           V +   G + ++A EVL + Y    + D+++  + + +  +G  P       W E  +G 
Sbjct: 185 VEE---GDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGR 240
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              I +            +S +  +L++ M+  DP++R +A   ++H  L
Sbjct: 241 LPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T  ++L+K +G G+FG  + C K+  G  YA K  S++ L    D ++  RE+     L 
Sbjct: 11  TEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVV 185
              ++V +  A+ +  ++ +  E C+GG L D I         + E E  ++  Q+   +
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 186 HACHFMGVIHRDLKPENFLL--------ASKEEDSP--------IKATDFGLSVFIETGK 229
              H M ++H D+KP N  +        AS+E D           K  D G    I + +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 230 VYKEIVGSAYYVAPEVLHQRYGK--EIDVWSAGVILYILLSGVPPF------WAETEKGI 281
           V +   G + ++A EVL + Y    + D+++  + + +  +G  P       W E  +G 
Sbjct: 189 VEE---GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGR 244
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              I +            +S +  +L++ M+  DP++R +A   ++H  L
Sbjct: 245 LPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T  ++L+K +G G+FG  + C K+  G  YA K  S++ L    D ++  RE+     L 
Sbjct: 9   TEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVV 185
              ++V +  A+ +  ++ +  E C+GG L D I         + E E  ++  Q+   +
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 186 HACHFMGVIHRDLKPENFLL--------ASKEEDSP--------IKATDFGLSVFIETGK 229
              H M ++H D+KP N  +        AS+E D           K  D G    I + +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 230 VYKEIVGSAYYVAPEVLHQRYGK--EIDVWSAGVILYILLSGVPPF------WAETEKGI 281
           V +   G + ++A EVL + Y    + D+++  + + +  +G  P       W E  +G 
Sbjct: 187 VEE---GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGR 242
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              I +            +S +  +L++ M+  DP++R +A   ++H  L
Sbjct: 243 LPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 13  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 68
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 127
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 30  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 85
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 144
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 145 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 254

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 112/239 (46%), Gaps = 31/239 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY-- 239
            + +     MG +HRDL   N L+ S   +   K +DFGL      G+V ++   +AY  
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGL------GRVLEDDPEAAYTT 207
Query: 240 --------YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
                   + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           T  ++L+K +G G+FG  + C K+  G  YA K  S++ L    D ++  RE+     L 
Sbjct: 9   TEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVV 185
              ++V +  A+ +  ++ +  E C+GG L D I         + E E  ++  Q+   +
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 186 HACHFMGVIHRDLKPENFLL--------ASKEEDSP--------IKATDFGLSVFIETGK 229
              H M ++H D+KP N  +        AS+E D           K  D G    I + +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 230 VYKEIVGSAYYVAPEVLHQRYGK--EIDVWSAGVILYILLSGVPPF------WAETEKGI 281
           V +   G + ++A EVL + Y    + D+++  + + +  +G  P       W E  +G 
Sbjct: 187 VEE---GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGR 242
Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
              I +            +S +  +L++ M+  DP++R +A   ++H  L
Sbjct: 243 LPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 13  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 68
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 127
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 30  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 82
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + A    +  ++  +I RQ    +   H   +
Sbjct: 83  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED+ +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 142 IHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQP 132
           L   +G G FG  Y       G+ +   ++   K+V    +  +  R E+ +L+  T   
Sbjct: 40  LSTRIGSGSFGTVY------KGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRK-TRHV 92
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFM 191
           NI+ F G Y  K NL +V + C G  L+  + + +  +   +  +I RQ    +   H  
Sbjct: 93  NILLFMG-YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI---VGSAYYVAPEVLHQ 248
            +IHRD+K  N  L    E   +K  DFGL+         +++    GS  ++APEV+  
Sbjct: 152 NIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 249 R----YGKEIDVWSAGVILYILLSGVPPF 273
           +    +  + DV+S G++LY L++G  P+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 40  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 95
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 154
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G   
Sbjct: 155 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 264

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 135/328 (41%), Gaps = 72/328 (21%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++D  +G+G FG       +      A K I  +K   ++   +VR   L+ +H T   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 133 N-IVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAKGI---YSEREAANICRQIVNVVH 186
             IV  +  +  + +L LV E+ S    +L      +G+    + + A  +C  ++ +  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL-- 173
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A   + +IH DLKPEN LL + +  + IK  DFG S   + G+   + + S +Y +PEVL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSC--QLGQRIYQXIQSRFYRSPEVL 230
Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE-------------------------KG 280
               Y   ID+WS G IL  + +G P F    E                         + 
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290
Query: 281 IFEAILEGNLDLQSS-------------------------PWPSISGQA----------K 305
            FE + +G  +L+ +                         P    +G++          K
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
           DLI +ML  DPK RI    AL+H + K+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKK 378

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 21/232 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +DI+ +  +++ +G G+FG       K  G++    +I   K  Y    E  RR+ L   
Sbjct: 30  IDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEA 85
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PN++  EG       + ++ E    G L D  + +  G ++  +   + R I
Sbjct: 86  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGI 144
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSA 238
              +     M  +HRDL   N L+ S   +   K +DFGLS F+E   +   Y   +G  
Sbjct: 145 AAGMKYLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 239 Y---YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
               + APE + ++++    DVWS G++++ ++S G  P+W  T + +  AI
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++ L   LG+G     +    K TG  +A K  +    +   D++   RE  +L+ L   
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLN-H 66
Query: 132 PNIVEFEGAYEDKQNLH--LVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNVV 185
            NIV+     E+    H  L+ME C  G L+  +     A G+  E E   + R +V  +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL-PESEFLIVLRDVVGGM 125
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPI-KATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +     G++HR++KP N +    E+   + K TDFG +  +E  + +  + G+  Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 245 VL--------HQR-YGKEIDVWSAGVILYILLSGVPPF 273
           +         HQ+ YG  +D+WS GV  Y   +G  PF
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 14/223 (6%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPN 133
           ++K +G G+FG       K  G++  C +I   K  Y DK   D   E  I+      PN
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 91
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM 191
           I+  EG     + + ++ E    G L D  + K  G ++  +   + R I + +     M
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA--YYVAPEVL- 246
             +HRDL   N L+ S   +   K +DFG+S  +E      Y    G     + APE + 
Sbjct: 151 SAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++++    DVWS G++++ ++S G  P+W  + + + +AI EG
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 250

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           ++ L   LG+G     +    K TG  +A K  +    +   D++   RE  +L+ L   
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLN-H 66
Query: 132 PNIVEFEGAYEDKQNLH--LVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNVV 185
            NIV+     E+    H  L+ME C  G L+  +     A G+  E E   + R +V  +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL-PESEFLIVLRDVVGGM 125
Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPI-KATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           +     G++HR++KP N +    E+   + K TDFG +  +E  + +  + G+  Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 245 VL--------HQR-YGKEIDVWSAGVILYILLSGVPPF 273
           +         HQ+ YG  +D+WS GV  Y   +G  PF
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 19/233 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D T I  +DK +G G+FG       K   +K    +I   K+ Y    E  RR+ L   
Sbjct: 42  LDATNI-SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEA 97
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PNI+  EG     + + +V E    G L D  + K    ++  +   + R I
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA- 238
            + +     MG +HRDL   N L+ S   +   K +DFGL+  +E      Y    G   
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 239 -YYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 38/188 (20%)
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +++  +  CH  G++HRD+KP N ++  +++   ++  D+GL+ F    + Y   V S Y
Sbjct: 145 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRY 202
Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFE 283
           +  PE+L  +Q Y   +D+WS G +L  ++    PF+   +              + ++ 
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 262
Query: 284 AILEGNLDL-----------QSSPWPS---------ISGQAKDLIRKMLTKDPKKRITAA 323
            + + ++DL               W +         +S +A DL+ K+L  D ++R+TA 
Sbjct: 263 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 322
Query: 324 EALEHPWL 331
           EA+EHP+ 
Sbjct: 323 EAMEHPYF 330

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 177 ICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
           I + ++N     H    + HRD+KP N L+   +++  +K +DFG S ++   K+ K   
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKKI-KGSR 211
Query: 236 GSAYYVAPEVLHQR---YGKEIDVWSAGVILYILLSGVPPF-----WAETEKGIFEAILE 287
           G+  ++ PE         G ++D+WS G+ LY++   V PF       E    I    +E
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 288 GNLDLQSSPWP-----------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
             LD     +P            +S +  D ++  L K+P +RIT+ +AL+H WL
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 129/264 (48%), Gaps = 29/264 (10%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSI----SRRKLVYDKDMEDVRREILILQHLT 129
           + +K++G+G FG+ +           A KS+    S  +    +  ++ +RE+ I+ +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             PNIV+  G   +     +VME    G+L+ R++ K  +  + +  + R ++++     
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKL-RLMLDIALGIE 136
Query: 190 FMG-----VIHRDLKPENFLLASKEEDSPI--KATDFGLSVFIETGKVYKEIVGSAYYVA 242
           +M      ++HRDL+  N  L S +E++P+  K  DFG S   ++      ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMA 194
Query: 243 PEVL---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           PE +    + Y ++ D +S  +ILY +L+G  PF  E   G  + I   N+  +    P+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF-DEYSYGKIKFI---NMIREEGLRPT 250
Query: 300 ISGQAKDLIRKML----TKDPKKR 319
           I       +R ++    + DPKKR
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 14/223 (6%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPN 133
           ++K +G G+FG       K  G++  C +I   K  Y DK   D   E  I+      PN
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 70
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM 191
           I+  EG     + + ++ E    G L D  + K  G ++  +   + R I + +     M
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA--YYVAPEVL- 246
             +HRDL   N L+ S   +   K +DFG+S  +E      Y    G     + APE + 
Sbjct: 130 SYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++++    DVWS G++++ ++S G  P+W  + + + +AI EG
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 229

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 19  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 71
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 72  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 129/264 (48%), Gaps = 29/264 (10%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSI----SRRKLVYDKDMEDVRREILILQHLT 129
           + +K++G+G FG+ +           A KS+    S  +    +  ++ +RE+ I+ +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             PNIV+  G   +     +VME    G+L+ R++ K  +  + +  + R ++++     
Sbjct: 82  -HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKL-RLMLDIALGIE 136
Query: 190 FMG-----VIHRDLKPENFLLASKEEDSPI--KATDFGLSVFIETGKVYKEIVGSAYYVA 242
           +M      ++HRDL+  N  L S +E++P+  K  DF LS   ++      ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMA 194
Query: 243 PEVL---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           PE +    + Y ++ D +S  +ILY +L+G  PF  E   G  + I   N+  +    P+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF-DEYSYGKIKFI---NMIREEGLRPT 250
Query: 300 ISGQAKDLIRKML----TKDPKKR 319
           I       +R ++    + DPKKR
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 49/282 (17%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDME-DVRREILILQHLTGQPNIVEF 137
           LG+G FG     T + TG     K + R    +D++ +    +E+ +++ L   PN+++F
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLE-HPNVLKF 72
Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMGVI 194
            G     + L+ + E   GG L  R I K +   Y   +  +  + I + +   H M +I
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTL--RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE---------------IVGSAY 239
           HRDL   N L+    E+  +   DFGL+  +   K   E               +VG+ Y
Sbjct: 131 HRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 240 YVAPEVLHQR-YGKEIDVWSAGVILYILLSGV---PPFWAETEKGIFEAILEGNLDLQSS 295
           ++APE+++ R Y +++DV+S G++L  ++  V   P +   T    F   + G LD    
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGLNVRGFLDRYCP 245
Query: 296 PW--PS---ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
           P   PS   I+ +  DL       DP+KR +  + LEH WL+
Sbjct: 246 PNCPPSFFPITVRCCDL-------DPEKRPSFVK-LEH-WLE 278

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 16  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 68
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 69  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 128 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 14  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 67  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 19  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 71
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 72  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 14/223 (6%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPN 133
           ++K +G G+FG       K  G++  C +I   K  Y DK   D   E  I+      PN
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 76
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM 191
           I+  EG     + + ++ E    G L D  + K  G ++  +   + R I + +     M
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA--YYVAPEVL- 246
             +HRDL   N L+ S   +   K +DFG+S  +E      Y    G     + APE + 
Sbjct: 136 SYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           ++++    DVWS G++++ ++S G  P+W  + + + +AI EG
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 42  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 94
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 95  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 27/242 (11%)
Query: 48  LSKQIPQTSQIGPILGKPYVDITTIYD-----LDKELGRGQFGVTYLCTKKATGRKYACK 102
           LS Q P T + G +L +       + +     L +++GRG FG  +    +A     A K
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR 162
           S  R  L  D   + ++   ++ Q+    PNIV   G    KQ +++VMEL  GG+    
Sbjct: 146 S-CRETLPPDLKAKFLQEARILKQY--SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 163 IIAKGIYSEREAANICRQIVNVVHACHFM---GVIHRDLKPENFLLASKEEDSPIKATDF 219
           +  +G  +      + + + +      ++     IHRDL   N L+  K   + +K +DF
Sbjct: 203 LRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDF 257
Query: 220 GLS------VFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVP 271
           G+S      V+  +G + +  V    + APE L + RY  E DVWS G++L+   S G  
Sbjct: 258 GMSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 272 PF 273
           P+
Sbjct: 315 PY 316

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 41  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 93
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 94  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 152
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 153 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LGRG FG  +    K TG + A K +          +E  R E L+       P IV   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           GA  +   +++ MEL  GG L   I   G   E  A     Q +  +   H   ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV------GSAYYVAPEVLHQR-YG 251
           K +N LL+S  + S     DFG ++ ++   + K ++      G+  ++APEV+  +   
Sbjct: 191 KADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
            ++D+WS+  ++  +L+G  P W +  +G     +           PS +      I++ 
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 307
Query: 312 LTKDPKKRITAAE 324
           L K+P  R +A E
Sbjct: 308 LRKEPVHRASAME 320

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 30  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 82
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGV 193
           + F G Y     L +V + C G  L+  + A    +  ++  +I RQ    +   H   +
Sbjct: 83  LLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED+ +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 142 IHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--- 131
           +++ +G G+FG       K  G++    +I   K+ Y    E  RR+ L    + GQ   
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGY---TEKQRRDFLGEASIMGQFDH 82
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACH 189
           PNI+  EG     + + +V E    G L D  + K  G ++  +   + R I   +    
Sbjct: 83  PNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYLS 141
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGS--AYYVAPEV 245
            MG +HRDL   N L+ S   +   K +DFGLS  +E      Y    G     + APE 
Sbjct: 142 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 246 L-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           +  +++    DVWS G++++ ++S G  P+W  T + + +A+ EG
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG 243

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI---LILQHLTGQPNI 134
           ELG G  GV      + +G       I  RKL++ +    +R +I   L + H    P I
Sbjct: 23  ELGAGNGGVVTKVQHRPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           V F GA+     + + ME   GG L D+++       +EA  I  +I+  V      G  
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSL-DQVL-------KEAKRIPEEILGKVSIAVLRGLA 128
Query: 193 -------VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  ++HRD+KP N L+ S+ E   IK  DFG+S  +    +    VG+  Y+APE 
Sbjct: 129 YLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMAPER 184
Query: 246 LH-QRYGKEIDVWSAGVILYILLSG---VPPFWAETEKGIF 282
           L    Y  + D+WS G+ L  L  G   +PP  A+  + IF
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 110/258 (42%), Gaps = 55/258 (21%)
Query: 118 VRREILILQHLTGQPNI-------VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
           V REI +L H    PNI       V FE     K  L+LV EL          +A+ I+ 
Sbjct: 76  VLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHK--LYLVTELMRTD------LAQVIHD 126
Query: 171 EREAAN------ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
           +R   +          I+  +H  H  GV+HRDL P N LLA   +++ I   DF L+  
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLARE 183
Query: 225 IETGKVYKEIVGSAYYVAPEVLHQRYG--KEIDVWSAGVILYILLSGVPPFWAETEKGIF 282
                     V   +Y APE++ Q  G  K +D+WSAG ++  + +    F   T     
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 283 EAILE-------GNLDLQSSP-----------------W----PSISGQAKDLIRKMLTK 314
             I+E        ++ + SSP                 W    P+    A DLI KML  
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 315 DPKKRITAAEALEHPWLK 332
           +P++RI+  +AL HP+ +
Sbjct: 304 NPQRRISTEQALRHPYFE 321

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 110/258 (42%), Gaps = 55/258 (21%)
Query: 118 VRREILILQHLTGQPNI-------VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
           V REI +L H    PNI       V FE     K  L+LV EL          +A+ I+ 
Sbjct: 76  VLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHK--LYLVTELMRTD------LAQVIHD 126
Query: 171 EREAAN------ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
           +R   +          I+  +H  H  GV+HRDL P N LLA   +++ I   DF L+  
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLARE 183
Query: 225 IETGKVYKEIVGSAYYVAPEVLHQRYG--KEIDVWSAGVILYILLSGVPPFWAETEKGIF 282
                     V   +Y APE++ Q  G  K +D+WSAG ++  + +    F   T     
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 283 EAILE-------GNLDLQSSP-----------------W----PSISGQAKDLIRKMLTK 314
             I+E        ++ + SSP                 W    P+    A DLI KML  
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 315 DPKKRITAAEALEHPWLK 332
           +P++RI+  +AL HP+ +
Sbjct: 304 NPQRRISTEQALRHPYFE 321

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 34  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 86
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 87  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 146 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 42  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 94
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 95  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 14  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y  K  L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 67  LLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSV---FIETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 68/282 (24%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG  +    +  G+ Y  K +         + E   RE+  L  L    NIV + 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLD-HVNIVHYN 70
Query: 139 GAYE----------------DKQNLHLVMELCSGGEL-----------FDRIIAKGIYSE 171
           G ++                  + L + ME C  G L            D+++A  ++  
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE- 129
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                   QI   V   H   +I+RDLKP N  L   ++   +K  DFGL   ++     
Sbjct: 130 --------QITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGKR 178
Query: 232 KEIVGSAYYVAPE-VLHQRYGKEIDVWSAGVILYILLS------GVPPFWAETEKGIFEA 284
               G+  Y++PE +  Q YGKE+D+++ G+IL  LL           F+ +   GI   
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 238
Query: 285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
           I +               + K L++K+L+K P+ R   +E L
Sbjct: 239 IFD--------------KKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 116/295 (39%), Gaps = 81/295 (27%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG  +    +  G+ Y       R++ Y+   E   RE+  L  L    NIV + 
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVI-----RRVKYNN--EKAEREVKALAKL-DHVNIVHYN 71
Query: 139 GAYE------------------DKQN-----------LHLVMELCSGGEL---------- 159
           G ++                  D +N           L + ME C  G L          
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 160 -FDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD 218
             D+++A  ++          QI   V   H   +IHRDLKP N  L   ++   +K  D
Sbjct: 132 KLDKVLALELFE---------QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ---VKIGD 179
Query: 219 FGLSVFIETGKVYKEIVGSAYYVAPE-VLHQRYGKEIDVWSAGVILYILLS------GVP 271
           FGL   ++         G+  Y++PE +  Q YGKE+D+++ G+IL  LL          
Sbjct: 180 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS 239
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            F+ +   GI   I +               + K L++K+L+K P+ R   +E L
Sbjct: 240 KFFTDLRDGIISDIFD--------------KKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +GRG FG  +    K TG + A K +          +E  R E L+       P IV   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           GA  +   +++ MEL  GG L   I   G   E  A     Q +  +   H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV------GSAYYVAPEVLHQR-YG 251
           K +N LL+S  + S     DFG ++ ++   + K ++      G+  ++APEV+  +   
Sbjct: 193 KADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
            ++D+WS+  ++  +L+G  P W +  +G     +           PS +      I++ 
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 309
Query: 312 LTKDPKKRITAAE 324
           L K+P  R +A E
Sbjct: 310 LRKEPVHRASAME 322

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +GRG FG  +    K TG + A K +          +E  R E L+       P IV   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDL 198
           GA  +   +++ MEL  GG L   I   G   E  A     Q +  +   H   ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV------GSAYYVAPEVLHQR-YG 251
           K +N LL+S  + S     DFG ++ ++   + K ++      G+  ++APEV+  +   
Sbjct: 177 KADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
            ++D+WS+  ++  +L+G  P W +  +G     +           PS +      I++ 
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP-WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 312 LTKDPKKRITAAE 324
           L K+P  R +A E
Sbjct: 294 LRKEPVHRASAME 306

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 74
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D + A   ++ER +   + +    +     
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA---HAERIDHIKLLQYTSQICKGME 131
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 132 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 77  KELGRGQFGVTYLC----TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG G FG   LC        TG + A KS+          + D+++EI IL++L  + 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 83
Query: 133 NIVEFEG-AYEDKQN-LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+++G   ED  N + L+ME    G L + +        +   N+ +Q+   V  C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-----KNKNKINLKQQLKYAVQICKG 138
Query: 191 MGV------IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK----VYKEIVGSAYY 240
           M        +HRDL   N L+ S+ +   +K  DFGL+  IET K    V  +     ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 241 VAPEVLHQ-RYGKEIDVWSAGVILYILLS 268
            APE L Q ++    DVWS GV L+ LL+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +GRG +G  YL   K T +  A K ++R    L+   D + + REI IL  L     I  
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREITILNRLKSDYIIRL 90
Query: 137 FEGAYEDK----QNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHACHFM 191
           ++    D       L++V+E+        ++    I+ +E     I   ++   +  H  
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--------------------VY 231
           G+IHRDLKP N LL    +D  +K  DFGL+  I + K                    + 
Sbjct: 149 GIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 232 KEI---VGSAYYVAPE--VLHQRYGKEIDVWSAGVILYILLS 268
           K++   V + +Y APE  +L + Y K ID+WS G I   LL+
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 18/37 (48%), Positives = 26/37 (70%)
Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           +PSIS    +L+  ML  +P KRIT  +AL+HP+LK+
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G GQFG+ +L        K A K+I R   + ++D  +    ++ L H    P +V+
Sbjct: 13  QEIGSGQFGLVHL-GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH----PKLVQ 66
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G   ++  + LV E    G L D +   +G+++      +C  +   +       VIH
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIH 126
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY 
Sbjct: 127 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 77  KELGRGQFGVTYLC----TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG G FG   LC        TG + A KS+          + D+++EI IL++L  + 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 71
Query: 133 NIVEFEG-AYEDKQN-LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NIV+++G   ED  N + L+ME    G L + +        +   N+ +Q+   V  C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-----KNKNKINLKQQLKYAVQICKG 126
Query: 191 MGV------IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK----VYKEIVGSAYY 240
           M        +HRDL   N L+ S+ +   +K  DFGL+  IET K    V  +     ++
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 241 VAPEVLHQ-RYGKEIDVWSAGVILYILLS 268
            APE L Q ++    DVWS GV L+ LL+
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 27/242 (11%)
Query: 48  LSKQIPQTSQIGPILGKPYVDITTIYD-----LDKELGRGQFGVTYLCTKKATGRKYACK 102
           LS Q P T + G +L +       + +     L +++GRG FG  +    +A     A K
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR 162
           S  R  L  D   + ++   ++ Q+    PNIV   G    KQ +++VMEL  GG+    
Sbjct: 146 S-CRETLPPDLKAKFLQEARILKQY--SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202
Query: 163 IIAKGIYSEREAANICRQIVNVVHACHFM---GVIHRDLKPENFLLASKEEDSPIKATDF 219
           +  +G  +      + + + +      ++     IHRDL   N L+  K   + +K +DF
Sbjct: 203 LRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDF 257
Query: 220 GLS------VFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVP 271
           G+S      V   +G + +  V    + APE L + RY  E DVWS G++L+   S G  
Sbjct: 258 GMSREEADGVXAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 272 PF 273
           P+
Sbjct: 315 PY 316

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNI 134
           + +G G FG  Y       G+ +   ++    +     + ++  + E+ +L+  T   NI
Sbjct: 14  QRIGSGSFGTVY------KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK-TRHVNI 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGV 193
           + F G Y     L +V + C G  L+  + I +  +   +  +I RQ    +   H   +
Sbjct: 67  LLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVF---IETGKVYKEIVGSAYYVAPEVLHQR- 249
           IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  + 
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 250 ---YGKEIDVWSAGVILYILLSGVPPF 273
              Y  + DV++ G++LY L++G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI-LQHLTGQPNIV 135
           +E+G GQFG+ +L        K A K+I    +  D  +E+   E+++ L H    P +V
Sbjct: 33  QEIGSGQFGLVHL-GYWLNKDKVAIKTIKEGSMSEDDFIEEA--EVMMKLSH----PKLV 85
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           +  G   ++  + LV E    G L D +   +G+++      +C  +   +       VI
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRY 250
           HRDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY
Sbjct: 146 HRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY 201
Query: 251 GKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
             + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 240

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 21/232 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +DI+ +  +++ +G G+FG       K  G++    +I   K  Y    E  RR+ L   
Sbjct: 4   IDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEA 59
Query: 127 HLTGQ---PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQI 181
            + GQ   PN++  EG       + ++ E    G L D  + +  G ++  +   + R I
Sbjct: 60  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGI 118
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---TGKVYKEIVGSA 238
              +     M  +HR L   N L+ S   +   K +DFGLS F+E   +   Y   +G  
Sbjct: 119 AAGMKYLADMNYVHRALAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 239 Y---YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
               + APE + ++++    DVWS G++++ ++S G  P+W  T + +  AI
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G GQFG+ +L        K A K+I R   + ++D  +    ++ L H    P +V+
Sbjct: 11  QEIGSGQFGLVHL-GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH----PKLVQ 64
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G   ++  + LV E    G L D +   +G+++      +C  +   +       VIH
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY 
Sbjct: 125 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 21/266 (7%)
Query: 78  ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF 137
           ELGRG +GV        +G+  A K I  R  V  ++ + +  ++ I       P  V F
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 138 EGAYEDKQNLHLVMEL--CSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHF-MGV 193
            GA   + ++ +  EL   S  + + ++I KG    E     I   IV  +   H  + V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-VGSAYYVAPE----VLHQ 248
           IHRD+KP N L+ +  +   +K  DFG+S ++    V K+I  G   Y APE     L+Q
Sbjct: 159 IHRDVKPSNVLINALGQ---VKXCDFGISGYL-VDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 249 R-YGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           + Y  + D+WS G+    L     P+  W    + + + + E +  L   P    S +  
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PADKFSAEFV 271
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWL 331
           D   + L K+ K+R T  E  +HP+ 
Sbjct: 272 DFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G GQFG+ +L        K A K+I R   + ++D  +    ++ L H    P +V+
Sbjct: 13  QEIGSGQFGLVHL-GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH----PKLVQ 66
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G   ++  + LV E    G L D +   +G+++      +C  +   +       VIH
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY 
Sbjct: 127 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 20/281 (7%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
           Q +  G  +  P+ D+    ++ +++G G FG  +    +  G   A K +  +   + +
Sbjct: 24  QGAMDGDDMDIPWCDL----NIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDF-HAE 76
Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI---YS 170
            + +  RE+ I++ L   PNIV F GA     NL +V E  S G L+  +   G      
Sbjct: 77  RVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 171 EREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           ER   ++   +   ++  H     ++HRDLK  N L+  K     +K  DFGLS    + 
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKASX 192
Query: 229 KVY-KEIVGSAYYVAPEVLHQRYGKE-IDVWSAGVILYILLSGVPPFWAETEKGIFEAIL 286
            +  K   G+  ++APEVL      E  DV+S GVIL+ L +   P W         A +
Sbjct: 193 FLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP-WGNLNPAQVVAAV 251
Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
                    P  +++ Q   +I    T +P KR + A  ++
Sbjct: 252 GFKCKRLEIP-RNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G GQFG+ +L        K A K+I R   + ++D  +    ++ L H    P +V+
Sbjct: 16  QEIGSGQFGLVHL-GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH----PKLVQ 69
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G   ++  + LV E    G L D +   +G+++      +C  +   +       VIH
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 129
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY 
Sbjct: 130 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G GQFG+ +L        K A K+I R   + ++D  +    ++ L H    P +V+
Sbjct: 14  QEIGSGQFGLVHL-GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH----PKLVQ 67
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G   ++  + LV E    G L D +   +G+++      +C  +   +       VIH
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    E+  IK +DFG++ F+   + Y    G+ +   + +PEV    RY 
Sbjct: 128 RDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLC----TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 102
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 159
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 160 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 71
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 70
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 127
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 128 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 69
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 126
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 127 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 78
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 135
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 136 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLS 268
           PE L + ++    DVWS GV+LY L +
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
            D E+GRG F   Y      T  + A   +  RKL    + +  + E   L+ L   PNI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEXLKGLQ-HPNI 87
Query: 135 VEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           V F  ++E     K+ + LV EL + G L   +    +   +   + CRQI+  +   H 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 191 MG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ 248
               +IHRDLK +N  +        +K  D GL+  ++     K ++G+  + APE   +
Sbjct: 148 RTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEE 204
Query: 249 RYGKEIDVWSAG-VILYILLSGVPPFWAETEKGIFEAILEG----NLDLQSSPWPSISGQ 303
           +Y + +DV++ G   L    S  P    +    I+  +  G    + D  + P      +
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------E 258
Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
            K++I   + ++  +R +  + L H + +E+
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 75
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 132
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 133 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 71
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 76
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 133
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 134 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 77
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 134
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 135 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 74
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 132 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 89
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 147 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLS 268
           PE L + ++    DVWS GV+LY L +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 89
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 147 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLS 268
           PE L + ++    DVWS GV+LY L +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 129/325 (39%), Gaps = 74/325 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH----- 127
           Y L K LG G FG+        +G+++A K + +     +++++ ++    +L H     
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMK----VLDHVNIIK 64
Query: 128 ------------------------LTGQPNIVEFEGA---YEDKQN--LHLVMELCSGGE 158
                                   L G+ N V            QN  L+++ME     +
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP--D 122
Query: 159 LFDRIIAKGIYSERE-AANICR----QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP 213
              +++   I S R    N+      Q+   V   H +G+ HRD+KP+N L+ SK  D+ 
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK--DNT 180
Query: 214 IKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVP 271
           +K  DFG +  +   +     + S +Y APE++     Y   ID+WS G +   L+ G P
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 272 PFWAETEKGIF------------EAILEGNLDLQSSPWPSISGQ-------------AKD 306
            F  ET                 E ++  N       +P++  +             A D
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 307 LIRKMLTKDPKKRITAAEALEHPWL 331
           L+ ++L  +P  RI   EA+ HP+ 
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 74
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L + +     + ER +   + +    +     
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFI----ETGKVYKEIVGSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +    E  KV +      ++ A
Sbjct: 132 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLC----TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 71
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV----GSAYYVA 242
           ++G    IHRDL   N L+   E ++ +K  DFGL+  +   K + ++        ++ A
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 77  KELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG+G FG   +C     +  TG   A K +       ++ + D  REI IL+ L    
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HD 72
Query: 133 NIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSER-EAANICRQIVNVVHACH 189
           NIV+++G      ++NL L+ME    G L D +     + ER +   + +    +     
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 129
Query: 190 FMGV---IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV----GSAYYVA 242
           ++G    IHR+L   N L+   E ++ +K  DFGL+  +   K Y ++        ++ A
Sbjct: 130 YLGTKRYIHRNLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 243 PEVLHQ-RYGKEIDVWSAGVILYILLSGV 270
           PE L + ++    DVWS GV+LY L + +
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 41  TSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYA 100
           T+   PA  +  P    + P   K  ++ T I  +  +LG GQ+G  Y    K      A
Sbjct: 230 TTLHYPAPKRNKPTVYGVSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVA 288
Query: 101 CKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELF 160
            K++    +    ++E+  +E  +++ +   PN+V+  G    +   +++ E  + G L 
Sbjct: 289 VKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 161 DRIIAKGIYSEREAAN------ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI 214
           D +        R+  N      +  QI + +        IHR+L   N L+    E+  +
Sbjct: 344 DYLRE----CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLV 396
Query: 215 KATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSG 269
           K  DFGLS  + TG  Y    G+ +   + APE L + ++  + DVW+ GV+L+ I   G
Sbjct: 397 KVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 455
Query: 270 VPPF 273
           + P+
Sbjct: 456 MSPY 459

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L KELG GQFGV  L   K      A K I    +  D+  ++ +  ++ L H    P +
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQT-MMKLSH----PKL 65
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--- 191
           V+F G    +  +++V E  S G L + + + G     E + +     +V     F+   
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLHQ 248
             IHRDL   N L+   + D  +K +DFG++ ++   + Y   VG+ +   + APEV H 
Sbjct: 124 QFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHY 179
Query: 249 -RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
            +Y  + DVW+ G++++ + S G  P+   T   +   + +G+
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 41  TSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYA 100
           T+   PA  +  P    + P   K  ++ T I  +  +LG GQ+G  Y    K      A
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVA 249
Query: 101 CKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELF 160
            K++    +    ++E+  +E  +++ +   PN+V+  G    +   +++ E  + G L 
Sbjct: 250 VKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 161 D--RIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD 218
           D  R   +   S      +  QI + +        IHR+L   N L+    E+  +K  D
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVAD 361
Query: 219 FGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           FGLS  + TG  Y    G+ +   + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 362 FGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 18  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 69
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   ++++E  + G L D +        R+  N      +  Q
Sbjct: 70  EIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 124
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 180
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   ++++E  + G L D  R   +   S      +  QI + 
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 179
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 121/324 (37%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   LG G FG    C   A G+      I R      K  E  R EI +L+ +  + 
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKD 77
Query: 133 NIVEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGI-------YSEREAANICRQIVNV 184
              +F      D  N H  M  C   EL  +   + +       Y      ++  Q+ + 
Sbjct: 78  KENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 185 VHACHFMGVIHRDLKPENFLLASKE----------------EDSPIKATDFGLSVFIETG 228
           +   H   + H DLKPEN L  + E                +++ I+  DFG + F    
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 193
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFEA 284
           + +  IV + +Y  PEV L   + +  DVWS G IL+    G   F     +    + E 
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 285 IL------------------EGNL--DLQSSPWPSISGQAK-----------------DL 307
           IL                  +G L  D  SS    +    K                 DL
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           +R+ML  DP +RIT AEAL HP+ 
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 14  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 65
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 66  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 120
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 121 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAPAGAKFP 176
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 18  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 69
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 70  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 124
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 180
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 121/324 (37%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   LG G FG    C   A G+      I R      K  E  R EI +L+ +  + 
Sbjct: 53  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKD 109
Query: 133 NIVEFEGA-YEDKQNLHLVMELCSGGELFDR----IIAKGIYSEREAANICRQIVNVVHA 187
              +F      D  N H  M  C   EL  +     + +  +      ++      + HA
Sbjct: 110 KENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 167
Query: 188 CHFMG---VIHRDLKPENFLLASKE----------------EDSPIKATDFGLSVFIETG 228
             F+    + H DLKPEN L  + E                +++ I+  DFG + F    
Sbjct: 168 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 225
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFEA 284
           + +  IV + +Y  PEV L   + +  DVWS G IL+    G   F     +    + E 
Sbjct: 226 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 285 IL------------------EGNL--DLQSSPWPSISGQAK-----------------DL 307
           IL                  +G L  D  SS    +    K                 DL
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 345
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           +R+ML  DP +RIT AEAL HP+ 
Sbjct: 346 MRRMLEFDPAQRITLAEALLHPFF 369

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 18  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 69
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 70  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 124
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 180
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   ++++E  + G L D  R   +   S      +  QI + 
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 179
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 15  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 66
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 67  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 121
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 122 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAPAGAKFP 177
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 17  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 68
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 69  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 123
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 179
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 121/324 (37%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   LG G FG    C   A G+      I R      K  E  R EI +L+ +  + 
Sbjct: 30  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKD 86
Query: 133 NIVEFEGA-YEDKQNLHLVMELCSGGELFDR----IIAKGIYSEREAANICRQIVNVVHA 187
              +F      D  N H  M  C   EL  +     + +  +      ++      + HA
Sbjct: 87  KENKFLCVLMSDWFNFHGHM--CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 144
Query: 188 CHFMG---VIHRDLKPENFLLASKE----------------EDSPIKATDFGLSVFIETG 228
             F+    + H DLKPEN L  + E                +++ I+  DFG + F    
Sbjct: 145 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 202
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFEA 284
           + +  IV + +Y  PEV L   + +  DVWS G IL+    G   F     +    + E 
Sbjct: 203 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 262
Query: 285 IL------------------EGNL--DLQSSPWPSISGQAK-----------------DL 307
           IL                  +G L  D  SS    +    K                 DL
Sbjct: 263 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 322
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           +R+ML  DP +RIT AEAL HP+ 
Sbjct: 323 MRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 15  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 66
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 67  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 121
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 122 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 177
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 18  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 69
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI + 
Sbjct: 70  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 128
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + 
Sbjct: 129 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 184
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 119
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 175
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 15  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 66
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 67  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 121
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 122 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 177
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 81
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 198
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 258
Query: 287 EGN 289
           EG+
Sbjct: 259 EGH 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 77  KELGRGQFG-VTYLC---TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++LG G FG V+  C   T   TG   A K++  +     +     ++EI IL+ L  + 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYHE- 93
Query: 133 NIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYSERE---AANICRQIVNVVHA 187
           +I++++G  ED    +L LVME    G L D +    I   +    A  IC  +   +HA
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA-YLHA 152
Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG----KVYKEIVGSAYYVAP 243
            H+   IHRDL   N LL   + D  +K  DFGL+  +  G    +V ++     ++ AP
Sbjct: 153 QHY---IHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 244 EVLHQ-RYGKEIDVWSAGVILYILLS 268
           E L + ++    DVWS GV LY LL+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 78
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 195
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 255
Query: 287 EGN 289
           EG+
Sbjct: 256 EGH 258

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI + 
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 179
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 26  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 77
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 78  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 132
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 133 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 188
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 287 EGN 289
           EG+
Sbjct: 267 EGH 269

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 57/238 (23%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTG 130
           Y++   +GRG +G  YL   K   +  A K ++R    L+   D + + REI IL  L  
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLI---DCKRILREITILNRLKS 86
Query: 131 Q-----------PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANIC 178
                        ++++F+  Y       +V+E+        ++    I+ +E+    I 
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELY-------IVLEIADSD--LKKLFKTPIFLTEQHVKTIL 137
Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--------- 229
             ++      H  G+IHRDLKP N LL    +D  +K  DFGL+  I + K         
Sbjct: 138 YNLLLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 230 --------------VYKEI---VGSAYYVAPEV--LHQRYGKEIDVWSAGVILYILLS 268
                         + K++   V + +Y APE+  L + Y   ID+WS G I   LL+
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 82
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 199
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 259
Query: 287 EGN 289
           EG+
Sbjct: 260 EGH 262

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 287 EGN 289
           EG+
Sbjct: 267 EGH 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI + 
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ +   + 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 179
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 31/269 (11%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 13  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 65  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 119
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG  Y    G+ + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 175
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
             + APE L + ++  + DVW+ GV+L+ I   G+ P+       ++E +LE +  ++  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERP 234
Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAE 324
                  +  +L+R     +P  R + AE
Sbjct: 235 --EGCPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 130
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-YSEREAANICRQIVN 183
           +    NI+   GA      L++++E  S G L + + A+   G+ YS   + N   Q+ +
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 184 ---------VVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                    V     ++     IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 247
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307
Query: 287 EGN 289
           EG+
Sbjct: 308 EGH 310

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-------------YSE 171
           +    NI+   GA      L++++E  S G L + + A+   G+              S 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           ++  +   Q+   +        IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 287 EGN 289
           EG+
Sbjct: 267 EGH 269

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 74
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-------------YSE 171
           +    NI+   GA      L++++E  S G L + + A+   G+              S 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           ++  +   Q+   +        IHRDL   N L+    ED+ +K  DFGL+  I     Y
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 191
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 287 EGN 289
           EG+
Sbjct: 252 EGH 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 77  KELGRGQFGVTYL-CTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNI 134
           K +G G+FG  Y    K ++G+K    +I   K  Y +K   D   E  I+   +   NI
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-NI 108
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMG 192
           +  EG     + + ++ E    G L D+ + +  G +S  +   + R I   +     M 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA--YYVAPEVL-H 247
            +HRDL   N L+ S   +   K +DFGLS  +E      Y    G     + APE + +
Sbjct: 168 YVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 248 QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
           +++    DVWS G++++ ++  G  P+W  +   + +AI +G
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +LG+G FG   LC     G    A  ++ + +        D +REI IL+ L     IV+
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD-FIVK 75
Query: 137 FEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           + G      +Q+L LVME    G L D +  +   +  +A+ +      +     ++G  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 193 -VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----VGSAYYVAPEVLH 247
             +HRDL   N L+   E ++ +K  DFGL+  +   K Y  +        ++ APE L 
Sbjct: 134 RCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 248 QR-YGKEIDVWSAGVILYILLS 268
              + ++ DVWS GV+LY L +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +LG+G FG   LC     G    A  ++ + +        D +REI IL+ L     IV+
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD-FIVK 76
Query: 137 FEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           + G      +Q+L LVME    G L D +  +   +  +A+ +      +     ++G  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 193 -VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----VGSAYYVAPEVLH 247
             +HRDL   N L+   E ++ +K  DFGL+  +   K Y  +        ++ APE L 
Sbjct: 135 RCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 248 QR-YGKEIDVWSAGVILYILLS 268
              + ++ DVWS GV+LY L +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +LG+G FG   LC     G    A  ++ + +        D +REI IL+ L     IV+
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD-FIVK 88
Query: 137 FEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           + G      +Q+L LVME    G L D +  +   +  +A+ +      +     ++G  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 193 -VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI----VGSAYYVAPEVLH 247
             +HRDL   N L+   E ++ +K  DFGL+  +   K Y  +        ++ APE L 
Sbjct: 147 RCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 248 QR-YGKEIDVWSAGVILYILLS 268
              + ++ DVWS GV+LY L +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 11  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 62
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI + 
Sbjct: 63  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG  +    G+ +   + 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWT 177
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           APE L + ++  + DVW+ GV+L+ I   G+ P+       ++E +LE +  ++      
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE-LLEKDYRMERP--EG 234
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAE 324
              +  +L+R     +P  R + AE
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAE 259

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQFG  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 11  TDIT----MKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 62
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI + 
Sbjct: 63  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG       G+ +   + 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWT 177
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
           APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACK----SISRRKLVYDKDMEDVRREILILQHL 128
           + L +++G G FG  YL T   T  + A K         +L+Y+  +        ILQ  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI------YRILQGG 62
Query: 129 TGQPNIVEF--EGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNV 184
           TG PN+  F  EG Y       LVM+L   S  +LF+    K   S +    +  Q++N 
Sbjct: 63  TGIPNVRWFGVEGDYN-----VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--------KEIVG 236
           V   H    +HRD+KP+NFL+      + +   DFGL+        +        K + G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 237 SAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFEAILE 287
           +A Y +    L     +  D+ S G +L   L G  P+    A T+K  +E I E
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 14  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 65
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   ++++E  + G L D +        R+  N      +  Q
Sbjct: 66  EIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 120
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG       G+ + 
Sbjct: 121 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTXTAHAGAKFP 176
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 11  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 62
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNV 184
            +   PN+V+  G    +   ++++E  + G L D  R   +   S      +  QI + 
Sbjct: 63  EIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YV 241
           +        IHRDL   N L+    E+  +K  DFGLS  + TG       G+ +   + 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWT 177
Query: 242 APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           APE L + ++  + DVW+ GV+L+ I   G+ P+       ++E +LE +  ++      
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE-LLEKDYRMERP--EG 234
Query: 300 ISGQAKDLIRKMLTKDPKKRITAAE 324
              +  +L+R     +P  R + AE
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAE 259

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +   
Sbjct: 70  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL 127
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 128 ESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 241
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 18/225 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--- 131
           ++K +G G  G       +  G++    +I   K  Y    E  RR+ L    + GQ   
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDH 109
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHACH 189
           PNI+  EG     +   +V E    G L  F R    G ++  +   + R +   +    
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--KVYKEIVGSA--YYVAPEV 245
            +G +HRDL   N L+ S   +   K +DFGLS  +E      Y    G     + APE 
Sbjct: 169 DLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 246 LHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
           +  R +    DVWS GV+++ +L  G  P+W  T + +  ++ EG
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            DIT    +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +++
Sbjct: 18  TDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 69
Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN------ICRQ 180
            +   PN+V+  G    +   +++ E  + G L D +        R+  N      +  Q
Sbjct: 70  EIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQ 124
Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY- 239
           I + +        IHRDL   N L+    E+  +K  DFGLS  + TG       G+ + 
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTXTAHAGAKFP 180
Query: 240 --YVAPEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPF 273
             + APE L + ++  + DVW+ GV+L+ I   G+ P+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 96/219 (43%), Gaps = 47/219 (21%)
Query: 77  KELGRGQFGVTYL----CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            ++G G FGV Y      T  A  +  A   I+  +L    D E   + +   QH     
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQE--IKVMAKCQH----E 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------IAKGIYSEREAAN 176
           N+VE  G   D  +L LV      G L DR+                IA+G      AAN
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG------AAN 144
Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS----VFIETGKVYK 232
                +N +H  H    IHRD+K  N LL   +E    K +DFGL+     F +T  +  
Sbjct: 145 G----INFLHENHH---IHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT-VMXS 193
Query: 233 EIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVP 271
            IVG+  Y+APE L      + D++S GV+L  +++G+P
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 74
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +   
Sbjct: 75  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL 132
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 133 ESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 246
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 247 YSLMTKCWAYDPSRR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 41  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 97
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +   
Sbjct: 98  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL 155
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 156 ESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 212
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 269
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 270 YSLMTKCWAYDPSRR 284

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 75  LDKELGRGQFGVTYLC-------TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 89
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-------------YSE 171
           +    NI+   GA      L++++E  S G L + + A+   G+              S 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
           ++  +   Q+   +        IHRDL   N L+    ED+ +K  DFGL+  I      
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDXX 206
Query: 232 KEIVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
           K+         ++APE L  R Y  + DVWS GV+L+ I   G  P+     + +F+ + 
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266
Query: 287 EGN 289
           EG+
Sbjct: 267 EGH 269

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +   
Sbjct: 70  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL 127
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 128 ESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 241
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G +        ++     D  D   E+ +L  L   PNI+   
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 139 GAYEDKQNLHLVMELCSGGELFDRI-------------IAKGIYSEREAANICRQIVNVV 185
           GA E +  L+L +E    G L D +             IA    S   +  +     +V 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHRDL   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 196
Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G    +    
Sbjct: 197 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 253
Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            +   +  DL+R+   + P +R + A+ L
Sbjct: 254 LNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 15  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 71
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +   
Sbjct: 72  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL 129
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 130 ESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 186
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 243
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 244 YSLMTKCWAYDPSRR 258

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 96/219 (43%), Gaps = 47/219 (21%)
Query: 77  KELGRGQFGVTYL----CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            ++G G FGV Y      T  A  +  A   I+  +L    D E   + +   QH     
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQE--IKVMAKCQH----E 90
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------IAKGIYSEREAAN 176
           N+VE  G   D  +L LV      G L DR+                IA+G      AAN
Sbjct: 91  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG------AAN 144
Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS----VFIETGKVYK 232
                +N +H  H    IHRD+K  N LL   +E    K +DFGL+     F +T  +  
Sbjct: 145 G----INFLHENHH---IHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT-VMXX 193
Query: 233 EIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVP 271
            IVG+  Y+APE L      + D++S GV+L  +++G+P
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 16/253 (6%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSI-SRRKLVYDKDMEDVRREILILQHLTGQP 132
           +L + +G GQFG  +     +        +I + +    D   E   +E L ++     P
Sbjct: 16  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHACHF 190
           +IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +     
Sbjct: 75  HIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES 132
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVLH- 247
              +HRD+   N L++S +    +K  DFGLS ++E    YK   G     ++APE ++ 
Sbjct: 133 KRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 248 QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+       
Sbjct: 190 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTLYS 246
Query: 307 LIRKMLTKDPKKR 319
           L+ K    DP +R
Sbjct: 247 LMTKCWAYDPSRR 259

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 16/253 (6%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSI-SRRKLVYDKDMEDVRREILILQHLTGQP 132
           +L + +G GQFG  +     +        +I + +    D   E   +E L ++     P
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHACHF 190
           +IV+  G   +   + ++MELC+ GEL   +  +  YS   A+ I    Q+   +     
Sbjct: 69  HIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES 126
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVLH- 247
              +HRD+   N L++S   +  +K  DFGLS ++E    YK   G     ++APE ++ 
Sbjct: 127 KRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 248 QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+       
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTLYS 240
Query: 307 LIRKMLTKDPKKR 319
           L+ K    DP +R
Sbjct: 241 LMTKCWAYDPSRR 253

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 28/238 (11%)
Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L +ELG G FG  +L  C      +     ++   K   D   +D  RE  +L +L  + 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE- 75
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-------------YSEREAANICR 179
           +IV+F G   +   L +V E    G+L   + A G               ++ +  +I +
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           QI   +        +HRDL   N L+    E+  +K  DFG+S  + +   Y+  VG   
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYR--VGGHT 190
Query: 240 -----YVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNL 290
                ++ PE ++++++  E DVWS GV+L+ I   G  P++  +   + E I +G +
Sbjct: 191 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 147 LHLVMELCSGGELFDRIIAKGIYSEREAA---NICRQIVNVVHACHFMGVIHRDLKPENF 203
           L++ M+LC    L D +  +    +RE     +I  QI   V   H  G++HRDLKP N 
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 204 LLASKEEDSPIKATDFGLSVFIETGKVYKEI-------------VGSAYYVAPEVLH-QR 249
                  D  +K  DFGL   ++  +  + +             VG+  Y++PE +H   
Sbjct: 196 FFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG----QAK 305
           Y  ++D++S G+IL+ LL     F  + E+      +    D+++  +P +      Q  
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMER------VRIITDVRNLKFPLLFTQKYPQEH 303
Query: 306 DLIRKMLTKDPKKRITAAEALEH 328
            +++ ML+  P +R  A + +E+
Sbjct: 304 MMVQDMLSPSPTERPEATDIIEN 326

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G +        ++     D  D   E+ +L  L   PNI+   
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 139 GAYEDKQNLHLVMELCSGGELFDRI-------------IAKGIYSEREAANICRQIVNVV 185
           GA E +  L+L +E    G L D +             IA    S   +  +     +V 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHRDL   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 206
Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G    +    
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 263
Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            +   +  DL+R+   + P +R + A+ L
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 40/278 (14%)
Query: 75  LDKELGRGQFGVTYL--CTKKATGRK---YACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG G FG  +L  C   +  +     A K++    L   KD +     +  LQH  
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-- 76
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELF--------DRII--------AKGIYSERE 173
              +IV+F G   D   L +V E    G+L         D +I        AKG     +
Sbjct: 77  --EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
             +I  QI + +        +HRDL   N L+ +   +  +K  DFG+S  + +   Y+ 
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDVYSTDYYR- 190
Query: 234 IVGSAY-----YVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAIL 286
            VG        ++ PE ++++++  E DVWS GVIL+ I   G  P++  +   + E I 
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
           +G +  +    P    +  D++     ++P++R+   E
Sbjct: 250 QGRVLERPRVCPK---EVYDVMLGCWQREPQQRLNIKE 284

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED----VRREILILQHLTGQPNI 134
           +G+G+FG  Y       GR +    ++ R +  ++D ED     +RE++  +  T   N+
Sbjct: 41  IGKGRFGQVY------HGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQ-TRHENV 91
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGV 193
           V F GA     +L ++  LC G  L+  +  AK +    +   I ++IV  +   H  G+
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGL---SVFIETGKVYKEI---VGSAYYVAPEVLH 247
           +H+DLK +N       ++  +  TDFGL   S  ++ G+   ++    G   ++APE++ 
Sbjct: 152 LHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 248 QR----------YGKEIDVWSAGVILYILLSGVPPF 273
           Q           + K  DV++ G I Y L +   PF
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 63/277 (22%)
Query: 32  RRTQQDFRPTSSRP-PALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLC 90
           R+     +PT+S P P    QIP                   Y++   +G G +G     
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQIPDR-----------------YEIRHLIGTGSYGHVCEA 72
Query: 91  TKKATGRKYACKSISRRKLVYDK--DMEDVRREILILQHLTGQPNI----VEFEGAYEDK 144
             K   R  A K I R   V++   D + + REI IL  L     +    +      E  
Sbjct: 73  YDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129
Query: 145 QNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHACHFMGVIHRDLKPENF 203
             L++V+E+      F ++    +Y +E     +   ++  V   H  G++HRDLKP N 
Sbjct: 130 DELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC 187
Query: 204 LLASKEEDSPIKATDFGLS-------------------------VFIETGKVYKEIVG-- 236
           L+    +D  +K  DFGL+                          F  T  + +++ G  
Sbjct: 188 LV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 237 -SAYYVAPE--VLHQRYGKEIDVWSAGVILYILLSGV 270
            + +Y APE  +L + Y + IDVWS G I   LL+ +
Sbjct: 245 VTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 77  KELGRGQFGVTYL----CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            ++G G FGV Y      T  A  +  A   I+  +L    D E   + +   QH     
Sbjct: 31  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQE--IKVMAKCQH----E 84
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------IAKGIYSEREAAN 176
           N+VE  G   D  +L LV      G L DR+                IA+G      AAN
Sbjct: 85  NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG------AAN 138
Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKE 233
                +N +H  H    IHRD+K  N LL   +E    K +DFGL+   E      +   
Sbjct: 139 G----INFLHENHH---IHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 234 IVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVP 271
           IVG+  Y+APE L      + D++S GV+L  +++G+P
Sbjct: 189 IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 261
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 289 N 289
           +
Sbjct: 322 H 322

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 116/249 (46%), Gaps = 19/249 (7%)
Query: 46  PALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSIS 105
           P  SK  P T+ +G   G   +D   +  L KELG GQFGV      +      A K I 
Sbjct: 2   PLGSKNAPSTAGLG--YGSWEIDPKDLTFL-KELGTGQFGVVKYGKWRGQ-YDVAIKMIK 57
Query: 106 RRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII- 164
              +  D+ +E+ +    ++ +L+ +  +V+  G    ++ + ++ E  + G L + +  
Sbjct: 58  EGSMSEDEFIEEAK----VMMNLSHE-KLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 165 AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
            +  +  ++   +C+ +   +        +HRDL   N L+    +   +K +DFGLS +
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169
Query: 225 IETGKVYKEIVGSAY---YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEK 279
           +   + Y   VGS +   +  PEVL + ++  + D+W+ GV+++ + S G  P+   T  
Sbjct: 170 VLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 280 GIFEAILEG 288
              E I +G
Sbjct: 229 ETAEHIAQG 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK 
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKN 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 51/215 (23%)
Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFL-LASKEEDSPIKATDFGLSVFIETG----KV 230
           ++  QI++ +H  H   V+HRDLKP N L +    E   +K  D G +    +       
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 231 YKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWA-----ETEKGIFE 283
              +V + +Y APE+L   + Y K ID+W+ G I   LL+  P F       +T      
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 284 AILEGNLDLQSSP----WPSI----------------------------------SGQAK 305
             L+   ++   P    W  I                                    +A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDG-ATSD 339
            L++K+LT DP KRIT+ +A++ P+  ED   TSD
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSD 346

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   ++LG G F    L      G  YA K I   +    +D E+ +RE   +  L   P
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREA-DMHRLFNHP 86
Query: 133 NIVEF-------EGAYEDKQNLHLVMELCSGGELFD---RIIAKGIY-SEREAANICRQI 181
           NI+          GA   K    L++     G L++   R+  KG + +E +   +   I
Sbjct: 87  NILRLVAYCLRERGA---KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG----LSVFIETGKVYKEIVGS 237
              + A H  G  HRDLKP N LL   +E  P+   D G      + +E  +    +   
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG--DEGQPV-LMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 238 A------YYVAPEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI-L 286
           A       Y APE+     H    +  DVWS G +LY ++ G  P+    +KG   A+ +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR------ITAAEALEHP 329
           +  L +  S  P  S     L+  M+T DP +R      ++  EAL+ P
Sbjct: 261 QNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--- 131
           ++K +G G  G       +  G++    +I   K  Y    E  RR+ L    + GQ   
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDH 109
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGEL--FDRIIAKGIYSEREAANICRQIVNVVHACH 189
           PNI+  EG     +   +V E    G L  F R    G ++  +   + R +   +    
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA----YYVAPEV 245
            +G +HRDL   N L+ S   +   K +DFGLS  +E                 + APE 
Sbjct: 169 DLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 246 LHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
           +  R +    DVWS GV+++ +L  G  P+W  T + +  ++ EG
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 75  LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L++ LG G FG  Y       K      A K+  +   + +K  E    E +I+++L   
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL-DH 84
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--------CRQIVN 183
           P+IV+  G  E++    ++MEL   GEL       G Y ER   ++          QI  
Sbjct: 85  PHIVKLIGIIEEEPTW-IIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICK 136
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYV 241
            +     +  +HRD+   N L+AS E    +K  DFGLS +IE    YK  V      ++
Sbjct: 137 AMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLS--GVPPFWAETEKGI 281
           +PE ++ +R+    DVW   V ++ +LS    P FW E +  I
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 75  LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L++ LG G FG  Y       K      A K+  +   + +K  E    E +I+++L   
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL-DH 68
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--------CRQIVN 183
           P+IV+  G  E++    ++MEL   GEL       G Y ER   ++          QI  
Sbjct: 69  PHIVKLIGIIEEEPTW-IIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICK 120
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYV 241
            +     +  +HRD+   N L+AS E    +K  DFGLS +IE    YK  V      ++
Sbjct: 121 AMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLS--GVPPFWAETEKGI 281
           +PE ++ +R+    DVW   V ++ +LS    P FW E +  I
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 56  SQIGPILGKPYVDITTIYDLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYD 112
           S  GP  G    D+     L++ LG G FG  Y       K      A K+  +   + +
Sbjct: 1   SMGGPQYGIAREDVV----LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN 56
Query: 113 KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER 172
           K  E    E +I+++L   P+IV+  G  E++    ++MEL   GEL       G Y ER
Sbjct: 57  K--EKFMSEAVIMKNL-DHPHIVKLIGIIEEEPTW-IIMELYPYGEL-------GHYLER 105
Query: 173 EAANI--------CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
              ++          QI   +     +  +HRD+   N L+AS E    +K  DFGLS +
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRY 162
Query: 225 IETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS--GVPPFWAETEK 279
           IE    YK  V      +++PE ++ +R+    DVW   V ++ +LS    P FW E + 
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
Query: 280 GI 281
            I
Sbjct: 223 VI 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 7/192 (3%)
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           +P++V      E    L++   L +G +L   +  +G  +   A  I RQI + + A H 
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQ 248
            G  HRD+KPEN L+++   D      DFG++      K+ +    VG+ YY APE   +
Sbjct: 153 AGATHRDVKPENILVSA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 249 RYGK-EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
            +     D+++   +LY  L+G PP+  + +  +  A +   +   S+  P I      +
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGD-QLSVXGAHINQAIPRPSTVRPGIPVAFDAV 268
Query: 308 IRKMLTKDPKKR 319
           I +   K+P+ R
Sbjct: 269 IARGXAKNPEDR 280

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 85
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNIDYYKK 202
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262
Query: 289 N 289
           +
Sbjct: 263 H 263

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 127/324 (39%), Gaps = 72/324 (22%)
Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           Y++   LG G FG    C   +  G + A K I       +K  E  R EI +L+ +  +
Sbjct: 35  YEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKN----VEKYKEAARLEINVLEKINEK 90
Query: 132 -PN----IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNV 184
            P+     V+    ++   ++ +  EL  G   FD +       Y   +  ++  Q+   
Sbjct: 91  DPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQA 149
Query: 185 VHACHFMGVIHRDLKPENFL-----------LASKEEDSPIKAT-----DFGLSVFIETG 228
           V   H   + H DLKPEN L           L  K ++  +K+T     DFG + F    
Sbjct: 150 VKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DH 207
Query: 229 KVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEA 284
           + +  IV + +Y APEV L   + +  DVWS G I++    G   F     +    + E 
Sbjct: 208 EHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMER 267
Query: 285 IL------------------EGNLDLQSSPWPS-------------ISGQAK------DL 307
           IL                   G LD   +                 ++ +A+      DL
Sbjct: 268 ILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDL 327
Query: 308 IRKMLTKDPKKRITAAEALEHPWL 331
           I  ML  +P KR+T  EAL+HP+ 
Sbjct: 328 IESMLEYEPAKRLTLGEALQHPFF 351

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 78  ELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +LG+G FG   LC     G    A  ++ + +        D +REI IL+ L     IV+
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD-FIVK 72
Query: 137 FEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG-- 192
           + G      +  L LVME    G L D    +   +  +A+ +      +     ++G  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 193 -VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSA-YYVAPEVLH 247
             +HRDL   N L+   E ++ +K  DFGL+  +   K   V +E   S  ++ APE L 
Sbjct: 131 RCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 248 QR-YGKEIDVWSAGVILYILLS 268
              + ++ DVWS GV+LY L +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ ++  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 87
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 204
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264
Query: 289 N 289
           +
Sbjct: 265 H 265

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 22/256 (8%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 449
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  +S   A+ I    Q+   +   
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL 507
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L++S   +  +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 508 ESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN-LDLQSSPWPSISGQ 303
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  L +  +  P++   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS- 623
Query: 304 AKDLIRKMLTKDPKKR 319
              L+ K    DP +R
Sbjct: 624 ---LMTKCWAYDPSRR 636

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 207
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267
Query: 289 N 289
           +
Sbjct: 268 H 268

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 86/337 (25%), Positives = 134/337 (39%), Gaps = 76/337 (22%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI 122
           G+PY D   I  L ++LG G F   +L  K      +    I R   VY +  ED   EI
Sbjct: 13  GEPYKDARYI--LVRKLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAED---EI 66
Query: 123 LILQHLT----------GQPNIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYS 170
            +LQ +           G  +I++    +  K    +H+VM     GE    +I K  Y 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YE 124
Query: 171 ERE-----AANICRQIVNVVHACHF-MGVIHRDLKPENFLLA---SKEEDSPIKATDFGL 221
            R         I +Q++  +   H   G+IH D+KPEN L+    S E    IK  D G 
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 222 SVFIETGKVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPF------- 273
           + + +  + Y   + +  Y +PEV L   +G   D+WS   +++ L++G   F       
Sbjct: 185 ACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 274 WAETEKGIFEAI-LEGNL---------------------------------DLQSSPWPS 299
           + + +  I + I L G L                                 D+ +  +  
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 300 ISGQAK---DLIRKMLTKDPKKRITAAEALEHPWLKE 333
              +AK   D +  ML  DP+KR  A   + HPWLK+
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           +G G FG       K  G +        ++     D  D   E+ +L  L   PNI+   
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 139 GAYEDKQNLHLVMELCSGGELFDRI-------------IAKGIYSEREAANICRQIVNVV 185
           GA E +  L+L +E    G L D +             IA    S   +  +     +V 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 186 HACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-KEIVGS--AY 239
               ++     IHR+L   N L+    E+   K  DFGLS      +VY K+ +G     
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 203
Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G    +    
Sbjct: 204 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 260
Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
            +   +  DL+R+   + P +R + A+ L
Sbjct: 261 LNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 86/337 (25%), Positives = 134/337 (39%), Gaps = 76/337 (22%)
Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI 122
           G+PY D   I  L ++LG G F   +L  K      +    I R   VY +  ED   EI
Sbjct: 13  GEPYKDARYI--LVRKLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAED---EI 66
Query: 123 LILQHLT----------GQPNIVEFEGAYEDK--QNLHLVMELCSGGELFDRIIAKGIYS 170
            +LQ +           G  +I++    +  K    +H+VM     GE    +I K  Y 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YE 124
Query: 171 ER-----EAANICRQIVNVVHACHF-MGVIHRDLKPENFLLA---SKEEDSPIKATDFGL 221
            R         I +Q++  +   H   G+IH D+KPEN L+    S E    IK  D G 
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 222 SVFIETGKVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPF------- 273
           + + +  + Y   + +  Y +PEV L   +G   D+WS   +++ L++G   F       
Sbjct: 185 ACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 274 WAETEKGIFEAI-LEGNL---------------------------------DLQSSPWPS 299
           + + +  I + I L G L                                 D+ +  +  
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 300 ISGQAK---DLIRKMLTKDPKKRITAAEALEHPWLKE 333
              +AK   D +  ML  DP+KR  A   + HPWLK+
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRI--------------IAKGIYSEREAANICR 179
           IV   GA      + ++ E C  G+L + +              IA    S R+  +   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q+   +        IHRD+   N LL +       K  DFGL+  I     Y  + G+A 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNAR 227
Query: 240 ----YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
               ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           +ELG  +FG  Y       A G +    +I   K   +  + +  R   +L+     PN+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--- 191
           V   G     Q L ++   CS G+L + ++ +  +S+  + +  R + + +    F+   
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 192 -------------GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
                         V+H+DL   N L+  K     +K +D GL   +     YK +  S 
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFREVYAADYYKLLGNSL 208
Query: 239 Y---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
               ++APE +++ ++  + D+WS GV+L+ + S G+ P+   + + + E I
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    +D+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 20/255 (7%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 69
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  +S   A+ I    Q+   +   
Sbjct: 70  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL 127
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L+++ +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 128 ESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA 304
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  +    P P+     
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--ERLPMP-PNCPPTL 241
Query: 305 KDLIRKMLTKDPKKR 319
             L+ K    DP +R
Sbjct: 242 YSLMTKCWAYDPSRR 256

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           +ELG  +FG  Y       A G +    +I   K   +  + +  R   +L+     PN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--- 191
           V   G     Q L ++   CS G+L + ++ +  +S+  + +  R + + +    F+   
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 192 -------------GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
                         V+H+DL   N L+  K     +K +D GL   +     YK +  S 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFREVYAADYYKLLGNSL 191
Query: 239 Y---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
               ++APE +++ ++  + D+WS GV+L+ + S G+ P+   + + + E I
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRI--------------IAKGIYSEREAANICR 179
           IV   GA      + ++ E C  G+L + +              IA    S R+  +   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q+   +        IHRD+   N LL +       K  DFGL+  I     Y  + G+A 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNAR 227
Query: 240 ----YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
               ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++VME  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I      K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++   S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 22/256 (8%)
Query: 74  DLDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L + +G GQFG  +     + +      A K+   +    D   E   +E L ++    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-D 449
Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI--CRQIVNVVHAC 188
            P+IV+  G   +   + ++MELC+ GEL   +  +  +S   A+ I    Q+   +   
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL 507
Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAPEVL 246
                +HRD+   N L+++ +    +K  DFGLS ++E    YK   G     ++APE +
Sbjct: 508 ESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 247 H-QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN-LDLQSSPWPSISGQ 303
           + +R+    DVW  GV ++ IL+ GV PF       +   I  G  L +  +  P++   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS- 623
Query: 304 AKDLIRKMLTKDPKKR 319
              L+ K    DP +R
Sbjct: 624 ---LMTKCWAYDPSRR 636

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V+E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++   S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I     YK+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRR-KLVYD----KDMEDVRREILILQHLT 129
           L K LG G FG   +       +    ++++   K++ D    KD+ D+  E+ +++ + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR---------- 179
              NI+   GA      L++++E  S G L + + A+       + +I R          
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 180 ------QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
                 Q+   +        IHRDL   N L+    E++ +K  DFGL+  I      K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDXXKK 215
Query: 234 IVGS---AYYVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                    ++APE L  R Y  + DVWS GV+++ I   G  P+     + +F+ + EG
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 289 N 289
           +
Sbjct: 276 H 276

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 77  KELGRGQFGVTYLCTKKATG----RKYACKSISRRKLVYDKDME-DVRREILILQHLTGQ 131
           +++G G FG  +    +A G      +   ++   K     DM+ D +RE  ++      
Sbjct: 53  RDIGEGAFGRVF--QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-N 109
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFD----------------------RIIAKGIY 169
           PNIV+  G     + + L+ E  + G+L +                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 170 SEREAANIC--RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET 227
               A  +C  RQ+   +        +HRDL   N L+    E+  +K  DFGLS  I +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYS 226
Query: 228 GKVYKEIVGSAY---YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF 282
              YK     A    ++ PE + + RY  E DVW+ GV+L+ + S G+ P++    + + 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286
Query: 283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR 319
             + +GN+       P    +  +L+R   +K P  R
Sbjct: 287 YYVRDGNILACPENCPL---ELYNLMRLCWSKLPADR 320

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 11  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 65
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 66  QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 124 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 179
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 236
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 237 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 267

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 85/202 (42%), Gaps = 19/202 (9%)
Query: 80  GRGQFGVTYL----CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           G G FGV Y      T  A  +  A   I+  +L    D E   +     QH     N+V
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQE--IKVXAKCQH----ENLV 84
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGI--YSEREAANICRQIVNVVHACHFMG 192
           E  G   D  +L LV      G L DR+    G    S      I +   N ++  H   
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLHQR 249
            IHRD+K  N LL   +E    K +DFGL+   E          IVG+  Y APE L   
Sbjct: 145 HIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE 201
Query: 250 YGKEIDVWSAGVILYILLSGVP 271
              + D++S GV+L  +++G+P
Sbjct: 202 ITPKSDIYSFGVVLLEIITGLP 223

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 79/347 (22%), Positives = 133/347 (38%), Gaps = 89/347 (25%)
Query: 69  ITTIYDLDKELGRGQFGVTYLCTKK-ATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           ++ ++ ++ ++G G F   YL T +   G +   + I+ + L+       +  E+  L  
Sbjct: 19  LSNVFKIEDKIGEGTFSSVYLATAQLQVGPE---EKIALKHLIPTSHPIRIAAELQCLTV 75
Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE-AANICRQIVNVVH 186
             GQ N++  +  +    ++ + M         D + +      RE   N+ + +  +  
Sbjct: 76  AGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRI-- 133
Query: 187 ACHFMGVIHRDLKPENFL--------------LASKEEDSPIKATDF------------- 219
             H  G++HRD+KP NFL              LA    D+ I+   F             
Sbjct: 134 --HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQN 191
Query: 220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAET 277
             S+ +   +      G+  + APEVL +       ID+WSAGVI   LLSG  PF+  +
Sbjct: 192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251
Query: 278 E-----------KGIFEAILEGNL--------------DLQ-----------SSP----- 296
           +           +G  E I                   DL+           S+P     
Sbjct: 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311
Query: 297 ----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                     W  +  +A DL+ K+L  +P  RITA EAL HP+ K+
Sbjct: 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 13  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 67
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 68  QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 126 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 181
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 238
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 239 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 269

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 116/253 (45%), Gaps = 27/253 (10%)
Query: 46  PALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSIS 105
           P  SK  P T+ +G   G   +D   +  L KELG GQFGV      +      A K I 
Sbjct: 2   PLGSKNAPSTAGLG--YGSWEIDPKDLTFL-KELGTGQFGVVKYGKWRGQ-YDVAIKMIK 57
Query: 106 RRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII- 164
              +  D+ +E+ +    ++ +L+ +  +V+  G    ++ + ++ E  + G L + +  
Sbjct: 58  EGSMSEDEFIEEAK----VMMNLSHE-KLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 165 AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
            +  +  ++   +C+ +   +        +HRDL   N L+    +   +K +DFGLS +
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169
Query: 225 I----ETGKVYKEIVGSAY---YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWA 275
           +    ET       VGS +   +  PEVL + ++  + D+W+ GV+++ + S G  P+  
Sbjct: 170 VLDDEETSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
Query: 276 ETEKGIFEAILEG 288
            T     E I +G
Sbjct: 225 FTNSETAEHIAQG 237

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 36/280 (12%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD------KDMEDVRREILILQHL 128
           L+ +LG+G FG  ++ T   T R  A K++    +  +      + M+ +R E L+  + 
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLY- 79
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVH 186
                      A   ++ +++V E  S G L D +  + G Y    +  ++  QI + + 
Sbjct: 80  -----------AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 128
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAP 243
               M  +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + AP
Sbjct: 129 YVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 184
Query: 244 EV-LHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS 301
           E  L+ R+  + DVWS G++L  L + G  P+     + + + +  G       P P   
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECP 241
Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
               DL+ +   KDP++R T  E L+     ED  TS +P
Sbjct: 242 ESLHDLMCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    N+
Sbjct: 25  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNL 76
Query: 135 VEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-- 191
           V+  G   E+K  L++V E  + G L D + ++G  S      + +  ++V  A  ++  
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 192 -GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAPEVL 246
              +HRDL   N L++   ED+  K +DFGL    S   +TGK+         + APE L
Sbjct: 136 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEAL 186
Query: 247 HQR-YGKEIDVWSAGVILYILLS-GVPPF 273
            ++ +  + DVWS G++L+ + S G  P+
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV     K       A K I    +  D+ +E+ +    ++ +L+ +  +V+
Sbjct: 10  KELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHE-KLVQ 63
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +        +H
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    +   +K +DFGLS ++   + Y   VGS +   +  PEVL + ++ 
Sbjct: 124 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + D+W+ GV+++ + S G  P+   T     E I +G
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    N+
Sbjct: 10  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNL 61
Query: 135 VEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-- 191
           V+  G   E+K  L++V E  + G L D + ++G  S      + +  ++V  A  ++  
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 192 -GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAPEVL 246
              +HRDL   N L++   ED+  K +DFGL    S   +TGK+         + APE L
Sbjct: 121 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEAL 171
Query: 247 HQR-YGKEIDVWSAGVILYILLS-GVPPF 273
            ++ +  + DVWS G++L+ + S G  P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    N+
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNL 248
Query: 135 VEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-- 191
           V+  G   E+K  L++V E  + G L D + ++G  S      + +  ++V  A  ++  
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 192 -GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAPEVL 246
              +HRDL   N L++   ED+  K +DFGL    S   +TGK+         + APE L
Sbjct: 308 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEAL 358
Query: 247 HQR-YGKEIDVWSAGVILYILLS 268
            ++ +  + DVWS G++L+ + S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 189 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNM----SPEAFLQEAQVMKKLRHEKLV 243
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 244 QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL   IE  + Y    G+ +   + APE  L+ 
Sbjct: 302 YVHRDLRAANILVG---ENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAALYG 357
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 414
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 415 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 445

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV     K       A K I    +  D+ +E+ +    ++ +L+ +  +V+
Sbjct: 14  KELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHE-KLVQ 67
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +        +H
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    +   +K +DFGLS ++   + Y   VGS +   +  PEVL + ++ 
Sbjct: 128 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + D+W+ GV+++ + S G  P+   T     E I +G
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 221

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV     K       A K I    +  D+ +E+ +    ++ +L+ +  +V+
Sbjct: 15  KELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHE-KLVQ 68
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +        +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    +   +K +DFGLS ++   + Y   VGS +   +  PEVL + ++ 
Sbjct: 129 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + D+W+ GV+++ + S G  P+   T     E I +G
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV      +      A K I    +  D+ +E+ +    ++ +L+    +V+
Sbjct: 21  KELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAK----VMMNLS-HEKLVQ 74
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +        +H
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 134
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    +   +K +DFGLS ++   + Y   VGS +   +  PEVL + ++ 
Sbjct: 135 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + D+W+ GV+++ + S G  P+   T     E I +G
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           D ELG G FG       +   ++        ++     D E++ RE  I+  L   P IV
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIV 73
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---G 192
              G  +  + L LVME+  GG L   ++ K    E   +N+   +  V     ++    
Sbjct: 74  RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA----YYVAPEVLH- 247
            +HRDL   N LL ++      K +DFGLS  +     Y     +      + APE ++ 
Sbjct: 131 FVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           +++    DVWS GV ++  LS G  P+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 28/267 (10%)
Query: 73  YDLDKELGRGQFGVT---YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           + L + LG+G+FG      L  +  +  K A K + +  ++   D+E+  RE   ++   
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD 83
Query: 130 GQPNIVEFEGAY---EDKQNL---HLVMELCSGGELFDRIIAKGIYSE---REAANICRQ 180
             P++ +  G       K  L    +++     G+L   ++A  I           + R 
Sbjct: 84  -HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 181 IVNVVHACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
           +V++     ++     IHRDL   N +LA   ED  +   DFGLS  I +G  Y++   S
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 238 AY---YVAPEVLHQR-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDL 292
                ++A E L    Y    DVW+ GV ++ I+  G  P+       I+  ++ GN   
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKR 319
           Q    P    +  DL+ +  + DPK+R
Sbjct: 260 QP---PECMEEVYDLMYQCWSADPKQR 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL   N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 135 YVHRDLAAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 28/241 (11%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + +G G FGV +  T     ++ A K   RR       + D  R   +L   TG P
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 69
Query: 133 NIVEFEGAYEDKQNLH--LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACH 189
           N+  F      ++ LH  LV++L  G  L D +   G  +S +  A   +Q++  V + H
Sbjct: 70  NVYYF-----GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 190 FMGVIHRDLKPENFLLA--SKEEDSPIKATDFGLSVFIETG--------KVYKEIVGSAY 239
              +++RD+KP+NFL+   + +  + I   DFG+  F            +  K + G+A 
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 240 YVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFEAILEGNLDLQSS 295
           Y++    L +   +  D+ + G +    L G  P+    A T K  +E I E     QS+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---QST 240
Query: 296 P 296
           P
Sbjct: 241 P 241

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 28/241 (11%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + +G G FGV +  T     ++ A K   RR       + D  R   +L   TG P
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 68
Query: 133 NIVEFEGAYEDKQNLH--LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACH 189
           N+  F      ++ LH  LV++L  G  L D +   G  +S +  A   +Q++  V + H
Sbjct: 69  NVYYF-----GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 122
Query: 190 FMGVIHRDLKPENFLLA--SKEEDSPIKATDFGLSVFIETG--------KVYKEIVGSAY 239
              +++RD+KP+NFL+   + +  + I   DFG+  F            +  K + G+A 
Sbjct: 123 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 182
Query: 240 YVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFEAILEGNLDLQSS 295
           Y++    L +   +  D+ + G +    L G  P+    A T K  +E I E     QS+
Sbjct: 183 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---QST 239
Query: 296 P 296
           P
Sbjct: 240 P 240

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 76  DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV 135
           D ELG G FG       +   ++        ++     D E++ RE  I+  L   P IV
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIV 399
Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---G 192
              G  +  + L LVME+  GG L   ++ K    E   +N+   +  V     ++    
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA----YYVAPEVLH- 247
            +HR+L   N LL ++      K +DFGLS  +     Y     +      + APE ++ 
Sbjct: 457 FVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           +++    DVWS GV ++  LS G  P+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 76
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V+E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 77  QLY--AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  +      G+ +   + APE  L+ 
Sbjct: 135 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYG 190
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 247
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   KDP++R T  E L+     ED  TS +P
Sbjct: 248 MCQCWRKDPEERPT-FEYLQA--FLEDYFTSTEP 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    N+
Sbjct: 16  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNL 67
Query: 135 VEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-- 191
           V+  G   E+K  L++V E  + G L D + ++G  S      + +  ++V  A  ++  
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 192 -GVIHRDLKPENFLLASKEEDSPIKATDFGL----SVFIETGKVYKEIVGSAYYVAPEVL 246
              +HRDL   N L++   ED+  K +DFGL    S   +TGK+         + APE L
Sbjct: 127 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEAL 177
Query: 247 HQR-YGKEIDVWSAGVILYILLS 268
            +  +  + DVWS G++L+ + S
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYS 200

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 15  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 69
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 70  QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 128 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 183
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 240
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 241 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 271

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 242
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 243 QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 356
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 413
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 414 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 444

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 242
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 243 QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 356
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 413
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 414 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 444

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 21/254 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 325
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 326 QLY--AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 384 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 439
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 496
Query: 308 IRKMLTKDPKKRIT 321
           + +   K+P++R T
Sbjct: 497 MCQCWRKEPEERPT 510

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L +++E C  G L              ++  + +Y +       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 151 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDXVR 206
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 207 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAK--GIYSEREAAN------------ 176
            N+V   GA       L +++E C  G L   + +K       +EA              
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 153 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVR 208
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 209 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 74  DLDKELGRGQFGVT-----YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +L K LGRG FG       +   K AT R  A K +  ++     +   +  E+ IL H+
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 129 TGQPNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAK--------GIYSEREAAN--I 177
               N+V   GA       L +++E C  G L   + +K         +Y +       I
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 178 CRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYK 232
           C     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V K
Sbjct: 148 CYSF-QVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVRK 203
Query: 233 EIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
              G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 204 ---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 74  DLDKELGRGQFGVT-----YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +L K LGRG FG       +   K AT R  A K +  ++     +   +  E+ IL H+
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 129 TGQPNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAK--------GIYSE-REAANIC 178
               N+V   GA       L +++E C  G L   + +K         +Y +     ++ 
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 179 RQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKE 233
                V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V K 
Sbjct: 148 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKIXDFGLARDIYKDPDYVRK- 203
Query: 234 IVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
             G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 204 --GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           KELG GQFGV     K       A K I    +  D+ +E+ +    ++ +L+ +  +V+
Sbjct: 15  KELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHE-KLVQ 68
Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFMGVIH 195
             G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +        +H
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVL-HQRYG 251
           RDL   N L+    +   +K +DFGLS ++   + Y    GS +   +  PEVL + ++ 
Sbjct: 129 RDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 252 KEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + D+W+ GV+++ + S G  P+   T     E I +G
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 242
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 243 QLY--AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 301 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 356
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 413
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 414 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 444

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTG 130
           +L K LGRG FG           +   C++++ + L       +   +  E+ IL H+  
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 131 QPNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVH- 186
             N+V   GA       L +++E C  G L   + +K       +   ++ +  + + H 
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 187 ACHFMGV------------IHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYK 232
            C+   V            IHRDL   N LL+ K   + +K  DFGL+  +  +   V K
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKDPDXVRK 207
Query: 233 EIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
              G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 208 ---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 73
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  + G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 74  QLY--AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + Y    G+ +   + APE  L+ 
Sbjct: 132 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 187
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 244
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 245 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 275

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L +++E C  G L              ++  + +Y +       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 151 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVR 206
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 207 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L +++E C  G L              ++  + +Y +       
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 188 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVR 243
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 244 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK---GI-------------YSEREAANI 177
           IV   GA      + ++ E C  G+L + +  K   G+              S R+  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q+   +        IHRD+   N LL +       K  DFGL+  I     Y  + G+
Sbjct: 172 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGN 227
Query: 238 AY----YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
           A     ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANICRQIVN 183
           IV   GA      + ++ E C  G+L + +  K               R+  +   Q+  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---- 239
            +        IHRD+   N LL +       K  DFGL+  I     Y  + G+A     
Sbjct: 164 GMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARLPVK 219
Query: 240 YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
           ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANICRQIVN 183
           IV   GA      + ++ E C  G+L + +  K               R+  +   Q+  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---- 239
            +        IHRD+   N LL +       K  DFGL+  I     Y  + G+A     
Sbjct: 172 GMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARLPVK 227
Query: 240 YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
           ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L ++ E C  G L              ++  + +Y +       
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 142 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVR 197
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 198 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L ++ E C  G L              ++  + +Y +       
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  ++ +   V 
Sbjct: 142 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVR 197
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 198 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 76  DKELGRGQFGVTYL--CTKKATGR-KYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           D+ +G+G FGV Y      +A  R + A KS+SR  +   + +E   RE L+++ L   P
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLN-HP 82
Query: 133 NIVEFEGAYEDKQNL-HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF 190
           N++   G     + L H+++     G+L   I + +   + ++  +   Q+   +     
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR- 249
              +HRDL   N +L   +E   +K  DFGL+         ++I+   YY   +  H R 
Sbjct: 143 QKFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSVQQHRHARL 190
Query: 250 --------------YGKEIDVWSAGVILYILLS-GVPPF 273
                         +  + DVWS GV+L+ LL+ G PP+
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L +++E C  G L              ++  + +Y +       
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  +  +   V 
Sbjct: 151 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKDPDXVR 206
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 207 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 19  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 73
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ +++V E  + G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 74  QLY--AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  + +    G+ +   + APE  L+ 
Sbjct: 132 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPEAALYG 187
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 244
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 245 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 275

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L +++E C  G L              ++  + +Y +       
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  +  +   V 
Sbjct: 142 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKDPDXVR 197
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 198 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---TGQPN 133
           K LG G FG  Y       G     K     K++ +       +EIL   ++    G P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 80
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMG 192
           +    G       + LV +L   G L D +   +G    ++  N C QI   +     + 
Sbjct: 81  VSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS----AYYVAPEVLHQ 248
           ++HRDL   N L+ S      +K TDFGL+  ++  +      G      +     +L +
Sbjct: 140 LVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPF 273
           R+  + DVWS GV ++ L++ G  P+
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 75  LDKELGRGQFGVT-----YLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L K LGRG FG       +   K AT R  A K +  ++     +   +  E+ IL H+ 
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHRALMSELKILIHIG 90
Query: 130 GQPNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVH- 186
              N+V   GA       L +++E C  G L   + +K   +   +  ++ +  + + H 
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 187 ---------ACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYK 232
                       F+     IHRDL   N LL+ K   + +K  DFGL+  +  +   V K
Sbjct: 151 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK---NVVKICDFGLARDIXKDPDXVRK 207
Query: 233 EIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
              G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 208 ---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQ 131
           L K LGRG FG           +   C++++ + L       +   +  E+ IL H+   
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 132 PNIVEFEGAYEDKQN-LHLVMELCSGGELFD------------RIIAKGIYSEREAAN-- 176
            N+V   GA       L ++ E C  G L              ++  + +Y +       
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 177 ICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVY 231
           IC     V     F+     IHRDL   N LL+ K   + +K  DFGL+  +  +   V 
Sbjct: 142 ICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIXKDPDXVR 197
Query: 232 KEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
           K   G A     ++APE +  R Y  + DVWS GV+L+ + S G  P+
Sbjct: 198 K---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 74  DLDKELGRGQFG-----VTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           +  K LG G FG       Y  +K     + A K +  +      + E +  E+ ++  L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--------------GIYSEREA 174
               NIV   GA      ++L+ E C  G+L + + +K                  E E 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 175 ANI---------CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI 225
            N+           Q+   +    F   +HRDL   N L+        +K  DFGL+  I
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 222
Query: 226 ETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPF 273
            +   Y  + G+A     ++APE L +  Y  + DVWS G++L+ + S GV P+
Sbjct: 223 MSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 24/274 (8%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L  +  +
Sbjct: 12  LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLV 66
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSER-EAANICRQIVNVVHACHFMG 192
             +  A   ++ + +V E  S G L D +  + G Y    +  ++  QI + +     M 
Sbjct: 67  QLY--AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LHQ 248
            +HRDL+  N L+    E+   K  DFGL+  IE  +      G+ +   + APE  L+ 
Sbjct: 125 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYG 180
Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           R+  + DVWS G++L  L + G  P+     + + + +  G       P P       DL
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCP-PECPESLHDL 237
Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           + +   K+P++R T  E L+     ED  TS +P
Sbjct: 238 MCQCWRKEPEERPT-FEYLQA--FLEDYFTSTEP 268

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 30/239 (12%)
Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L  ELG G FG  +L  C      +     ++   K   +   +D +RE  +L  L  Q 
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ- 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGEL--FDRI-------------IAKGIYSEREAANI 177
           +IV F G   + + L +V E    G+L  F R              +A G     +   +
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q+   +     +  +HRDL   N L+    +   +K  DFG+S  I +   Y+  VG 
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYR--VGG 189
Query: 238 -----AYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
                  ++ PE +L++++  E DVWS GV+L+ I   G  P++  +     + I +G 
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 248

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 30/239 (12%)
Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L  ELG G FG  +L  C      +     ++   K   +   +D +RE  +L  L  Q 
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ- 80
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGEL--FDRI-------------IAKGIYSEREAANI 177
           +IV F G   + + L +V E    G+L  F R              +A G     +   +
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q+   +     +  +HRDL   N L+    +   +K  DFG+S  I +   Y+  VG 
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYR--VGG 195
Query: 238 -----AYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
                  ++ PE +L++++  E DVWS GV+L+ I   G  P++  +     + I +G 
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 254

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 75  LDKELGRGQFGVTYL--CTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L  ELG G FG  +L  C      +     ++   K   +   +D +RE  +L  L  Q 
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ- 103
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGEL--FDRI-------------IAKGIYSEREAANI 177
           +IV F G   + + L +V E    G+L  F R              +A G     +   +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             Q+   +     +  +HRDL   N L+    +   +K  DFG+S  I +   Y+  VG 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYR--VGG 218
Query: 238 -----AYYVAPE-VLHQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                  ++ PE +L++++  E DVWS GV+L+ I   G  P++  +     + I +G
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 36/229 (15%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKL---VYDKDMEDVRREILILQHLTGQPN 133
           K LG G FG     T    G++ A   ++ + L    +  + E +  E+ I+ HL    N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----------------GIYSE------ 171
           IV   GA      + ++ E C  G+L + +  K                G+  E      
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 172 -REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
            R+  +   Q+   +        IHRD+   N LL +       K  DFGL+  I     
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSN 213
Query: 231 YKEIVGSAY----YVAPE-VLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
           Y  + G+A     ++APE +    Y  + DVWS G++L+ + S G+ P+
Sbjct: 214 YI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 33/235 (14%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYA----CKSISRRKLVYDKDMEDVRREILILQHL 128
           Y L +++G G FG  YL T  A G + A    C      +L  +  +        ++Q  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK------MMQGG 64
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            G P I  + GA E   N+ +VMEL   S  +LF+    K  +S +    +  Q+++ + 
Sbjct: 65  VGIPTI-RWCGA-EGDYNV-MVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIE 119
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--------KEIVGSA 238
             H    IHRD+KP+NFL+   ++ + +   DFGL+      + +        K + G+A
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 239 YYVAPEV-LHQRYGKEIDVWSAG-VILYILLSGVPPFW----AETEKGIFEAILE 287
            Y +    L     +  D+ S G V++Y  L  +P  W    A T++  +E I E
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISE 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 32  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 87
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         ++MEL +GG+L   +       
Sbjct: 88  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 146
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 207 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 266 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 33/235 (14%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYA----CKSISRRKLVYDKDMEDVRREILILQHL 128
           Y L +++G G FG  YL T  A G + A    C      +L  +  +        ++Q  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK------MMQGG 62
Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            G P I  + GA E   N+ +VMEL   S  +LF+    K  +S +    +  Q+++ + 
Sbjct: 63  VGIPTI-RWCGA-EGDYNV-MVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIE 117
Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--------KEIVGSA 238
             H    IHRD+KP+NFL+   ++ + +   DFGL+      + +        K + G+A
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 239 YYVAPEV-LHQRYGKEIDVWSAG-VILYILLSGVPPFW----AETEKGIFEAILE 287
            Y +    L     +  D+ S G V++Y  L  +P  W    A T++  +E I E
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISE 230

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL----TGQP 132
           +++G G FG   LC      + YA K +   K    K     + E  IL+ +        
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNN 96
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI---CRQIVNVVHACH 189
           NIV++ G +    ++ L+ E   G  L++ II +  Y+     +I   C +I+  ++   
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPL-GPSLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 190 FMGVIHRDLKPENFLLAS----------------------KEEDSPIKATDFGLSVFIET 227
            M + H DLKPEN LL                        + + + IK  DFG + F   
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--K 212
Query: 228 GKVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPF 273
              +  I+ +  Y APEV L+  +    D+WS G +L  L +G   F
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 18  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+  L  Q NIV   G         +++EL +GG+L   +       
Sbjct: 74  SEQDELDFLMEALIISKLNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 132
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 133 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 193 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 252 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 32  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 87
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+  L  Q NIV   G         +++EL +GG+L   +       
Sbjct: 88  SEQDELDFLMEALIISKLNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 207 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 266 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 17  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         ++MEL +GG+L      K    
Sbjct: 73  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILMELMAGGDL------KSFLR 125
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 186 DFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 245 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 65  PYVDI---TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           P VD+   T  +D    +G G FG  Y    K   R  A  ++ RR     + +E+   E
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVY----KGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI----YSEREAANI 177
           I  L      P++V   G  +++  + L+ +    G L   +    +     S  +   I
Sbjct: 86  IETLS-FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIV- 235
           C      +H  H   +IHRD+K  N LL   +E+   K TDFG+S    E G+ +   V 
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 236 -GSAYYVAPE-VLHQRYGKEIDVWSAGVILYILL 267
            G+  Y+ PE  +  R  ++ DV+S GV+L+ +L
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 25/231 (10%)
Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L +++G G FG  YL    A+G + A K    +       +E   +   ++Q   G P
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIES--KFYKMMQGGVGIP 68
Query: 133 NIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           +I ++ GA E   N+ +VMEL   S  +LF+    K  +S +    +  Q+++ +   H 
Sbjct: 69  SI-KWCGA-EGDYNV-MVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--------KEIVGSAYYVA 242
              IHRD+KP+NFL+   ++ + +   DFGL+      + +        K + G+A Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 243 PEV-LHQRYGKEIDVWSAG-VILYILLSGVPPFW----AETEKGIFEAILE 287
               L     +  D+ S G V++Y  L  +P  W    A T++  +E I E
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISE 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL--VY 111
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L  VY
Sbjct: 32  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVY 87
Query: 112 -DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L      K    
Sbjct: 88  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDL------KSFLR 140
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 141 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 200
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 201 DFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 260 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K LG GQFG  ++ T      K A K++    +  +  +E+ +    I++ L     +
Sbjct: 13  LIKRLGNGQFGEVWMGTWNGN-TKVAIKTLKPGTMSPESFLEEAQ----IMKKLKHDKLV 67
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF---M 191
             +  A   ++ +++V E  + G L D  +  G     +  N+      V     +   M
Sbjct: 68  QLY--AVVSEEPIYIVTEYMNKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEV-LH 247
             IHRDL+  N L+ +       K  DFGL+  IE  +      G+ +   + APE  L+
Sbjct: 125 NYIHRDLRSANILVGN---GLICKIADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALY 180
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            R+  + DVWS G++L  L++ G  P+     + + E +  G
Sbjct: 181 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 24  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 79
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L      K    
Sbjct: 80  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDL------KSFLR 132
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 133 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 192
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 193 DFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 251
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 252 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 65  PYVDI---TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           P VD+   T  +D    +G G FG  Y    K   R  A  ++ RR     + +E+   E
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVY----KGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI----YSEREAANI 177
           I  L      P++V   G  +++  + L+ +    G L   +    +     S  +   I
Sbjct: 86  IETLS-FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS---VFIETGKVYKEI 234
           C      +H  H   +IHRD+K  N LL   +E+   K TDFG+S     ++   +   +
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 235 VGSAYYVAPE-VLHQRYGKEIDVWSAGVILYILL 267
            G+  Y+ PE  +  R  ++ DV+S GV+L+ +L
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 9   KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 64
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L   +       
Sbjct: 65  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 123
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 184 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 242
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 243 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 44  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 99
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L   +       
Sbjct: 100 SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 158
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 159 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 219 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 277
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 278 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 18  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L      K    
Sbjct: 74  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDL------KSFLR 126
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 127 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 186
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 187 DFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 245
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 246 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K LG GQFG  ++        K A K++    +     +E+    +  LQH      +
Sbjct: 17  LVKRLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANL-MKTLQH----DKL 70
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMG 192
           V        ++ ++++ E  + G L D + +   G     +  +   QI   +       
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLH-Q 248
            IHRDL+  N L++   E    K  DFGL+  IE  + Y    G+ +   + APE ++  
Sbjct: 131 YIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFG 186
Query: 249 RYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
            +  + DVWS G++LY I+  G  P+   T   +  A+ +G
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 122/289 (42%), Gaps = 49/289 (16%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 79  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           +I + +   +    +HRDL   N ++A    D  +K  DFG++         ++I  +AY
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RDIYETAY 185
Query: 240 Y------------VAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
           Y            +APE L    +    D+WS GV+L+ + S    P+   + + + + +
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           ++G    Q    P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 246 MDGGYLDQPDNCPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 289

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 78
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 79  HVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 138 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 195 RIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 18  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 73
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L      K    
Sbjct: 74  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDL------KSFLR 126
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 127 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 186
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 187 DFGMAQDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 245
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 246 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 34  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 89
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L   +       
Sbjct: 90  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 148
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 209 DIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 267
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 268 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 17  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L      K    
Sbjct: 73  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDL------KSFLR 125
Query: 171 E---REAANICRQIVNVVH-------ACHFM---GVIHRDLKPENFLLASKEEDSPIKAT 217
           E   R +      +++++H        C ++     IHRD+   N LL         K  
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 218 DFGLSVFIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVP 271
           DFG++  I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  
Sbjct: 186 DFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           P+ +++ + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 245 PYPSKSNQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 77
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 78  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EIVG 236
           +I + +   +    +HRDL   N ++A    D  +K  DFG++  I     Y+   + + 
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 253
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 254 DNCPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 288

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 17/221 (7%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L K+LG GQFG  ++        K A K++    +     +E+    +  LQH      +
Sbjct: 16  LVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANL-MKTLQH----DKL 69
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMG 192
           V        ++ ++++ E  + G L D + +   G     +  +   QI   +       
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY---YVAPEVLH-Q 248
            IHRDL+  N L++   E    K  DFGL+  IE  + Y    G+ +   + APE ++  
Sbjct: 130 YIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFG 185
Query: 249 RYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
            +  + +VWS G++LY I+  G  P+   T   +  A+ +G
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG 226

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 35  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 90
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L   +       
Sbjct: 91  SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 149
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 210 DIYRAGYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 268
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 269 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 75
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 76  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVG-- 236
           +I + +   +    +HRDL   N ++A    D  +K  DFG++  I ET    K   G  
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 251
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 252 DNCPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 79  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EIVG 236
           +I + +   +    +HRDL   N ++A    D  +K  DFG++  I     Y+   + + 
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 255 DNCPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 289

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 79  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVG-- 236
           +I + +   +    +HRDL   N ++A    D  +K  DFG++  I ET    K   G  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +PK R T  E +    LK+D
Sbjct: 255 DNCPE---RVTDLMRMCWQFNPKMRPTFLEIVN--LLKDD 289

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 25/290 (8%)
Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL---V 110
           +TS I  +   P  +IT I    + LG G FG  Y           +   ++ + L    
Sbjct: 58  KTSSISDLKEVPRKNITLI----RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
            ++D  D   E LI+     Q NIV   G         +++EL +GG+L   +       
Sbjct: 114 SEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 171 EREAANICRQIVNVVH----ACHFM---GVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
            + ++     +++V       C ++     IHRD+   N LL         K  DFG++ 
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 224 FIETGKVYKEIVGSAY----YVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAET 277
            I     Y++  G A     ++ PE   +  +  + D WS GV+L+ + S G  P+ +++
Sbjct: 233 DIYRAGYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            + + E +  G    +  P  +  G    ++ +     P+ R   A  LE
Sbjct: 292 NQEVLEFVTSGG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 82  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 141 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 79
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 80
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 81  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 191
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           K LG G FG  Y  L   +    K        R+    K  +++  E  ++  +   P++
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHV 80
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGV 193
               G       + L+M+L   G L D +   K     +   N C QI   ++      +
Sbjct: 81  CRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 139
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLHQR 249
           +HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH+ 
Sbjct: 140 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 250 YGKEIDVWSAGVILYILLS-GVPPF 273
           Y  + DVWS GV ++ L++ G  P+
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 423
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 424 MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 481
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY---- 240
           +        +HRDL   N LL ++      K +DFGLS  +   + Y +      +    
Sbjct: 482 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 539 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           K LG G FG  Y  L   +    K        R+    K  +++  E  ++  +   P++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHV 79
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGV 193
               G       + L+M+L   G L D +   K     +   N C QI   ++      +
Sbjct: 80  CRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLHQR 249
           +HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH+ 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 250 YGKEIDVWSAGVILYILLS-GVPPF 273
           Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 365 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 424
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 425 MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 482
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY---- 240
           +        +HRDL   N LL ++      K +DFGLS  +   + Y +      +    
Sbjct: 483 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 540 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           K LG G FG  Y  L   +    K     +  R+    K  +++  E  ++  +   P++
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN-PHV 113
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGV 193
               G       + L+ +L   G L D +   K     +   N C QI   ++      +
Sbjct: 114 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 172
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLHQR 249
           +HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH+ 
Sbjct: 173 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 250 YGKEIDVWSAGVILYILLS-GVPPF 273
           Y  + DVWS GV ++ L++ G  P+
Sbjct: 230 YTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 79  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVG-- 236
           +I + +   +    +HRDL   N ++A    D  +K  DFG++  I ET    K   G  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +P  R T  E +    LK+D
Sbjct: 255 DNCPE---RVTDLMRMCWQFNPNMRPTFLEIVN--LLKDD 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 70  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 121
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 122 VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 178
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 235
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 296 PYPDVNTFDITVYLLQGRRLLQPEYCP 322

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 77
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 11  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 62
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 63  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 119
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 176
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 237 PYPDVNTFDITVYLLQGRRLLQPEYCP 263

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 20  YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 79
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 80  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 137
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 138 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 194
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 195 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 16  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 67
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 68  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 124
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 125 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 181
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 182 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 242 PYPDVNTFDITVYLLQGRRLLQPEYCP 268

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 11  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 62
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 63  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 119
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 176
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 237 PYPDVNTFDITVYLLQGRRLLQPEYCP 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 12  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 63
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 64  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 120
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 177
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 238 PYPDVNTFDITVYLLQGRRLLQPEYCP 264

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 9   ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 60
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 61  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 117
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 118 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 174
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 235 PYPDVNTFDITVYLLQGRRLLQPEYCP 261

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 12  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 63
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 64  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 120
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     F+     +HRDL   N +L   +E   +K  D
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVAD 177
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 238 PYPDVNTFDITVYLLQGRRLLQPEYCP 264

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 22  YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 82  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 22  YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 81
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 82  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 139
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 140 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 146 NLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL 204
            + L+M+L   G L D +   K     +   N C QI   ++      ++HRDL   N L
Sbjct: 97  TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 156
Query: 205 LASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVAPEVLHQRYGKEID 255
           + + +    +K TDFGL+  +         E GKV        +     +LH+ Y  + D
Sbjct: 157 VKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMALESILHRIYTHQSD 208
Query: 256 VWSAGVILYILLS-GVPPF 273
           VWS GV ++ L++ G  P+
Sbjct: 209 VWSYGVTVWELMTFGSKPY 227

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 29  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 80
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 81  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 137
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 138 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 194
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 195 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 255 PYPDVNTFDITVYLLQGRRLLQPEYCP 281

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 10  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 61
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 62  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 118
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 119 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 175
Query: 219 FGLSVFI---ETGKVYKEIVGS--AYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   E   V+ +        ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 176 FGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 236 PYPDVNTFDITVYLLQGRRLLQPEYCP 262

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 6   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 66  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 124 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENXYKAQTHGKWPVKW 180
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 11  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 62
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 63  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 119
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 176
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 237 PYPDVNTFDITVYLLQGRRLLQPEYCP 263

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 87
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 88  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 147 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 204 RIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 39/283 (13%)
Query: 60  PILGKPYVDITTI---------YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV 110
           P  G PY  +  +         Y++   +  G  G  YL    A  R    + +  + LV
Sbjct: 60  PYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYL----ALDRNVNGRPVVLKGLV 115
Query: 111 YDKDMEDVRREILILQHLTG--QPNIVEFEGAYEDKQNL-----HLVMELCSGGELFDRI 163
           +  D E     +   Q L     P+IV+     E          ++VME   GG+   R 
Sbjct: 116 HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRS 174
Query: 164 IAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
             + +    EA     +I+  +   H +G+++ DLKPEN +L  ++    +K  D G   
Sbjct: 175 KGQKL-PVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVS 229
Query: 224 FIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
            I +   +  + G+  + APE++        D+++ G  L  L   +P     T  G + 
Sbjct: 230 RINS---FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLP-----TRNGRYV 281
Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
             L      +  P          L+R+ +  DP++R T AE +
Sbjct: 282 DGLP-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 6   ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 57
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 58  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 114
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 115 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 171
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 232 PYPDVNTFDITVYLLQGRRLLQPEYCP 258

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 80
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 8   ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 59
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 116
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 117 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 173
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 174 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 234 PYPDVNTFDITVYLLQGRRLLQPEYCP 260

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 30  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 81
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 82  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 138
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 139 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 195
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 196 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 256 PYPDVNTFDITVYLLQGRRLLQPEYCP 282

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 3   ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 54
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 55  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 111
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 112 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 168
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 169 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 229 PYPDVNTFDITVYLLQGRRLLQPEYCP 255

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 12  YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 71
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 72  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 80
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 197 RIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 6   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 65
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 66  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 123
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 124 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 180
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 181 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 9   ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 60
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 61  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 117
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 118 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 174
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 175 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 235 PYPDVNTFDITVYLLQGRRLLQPEYCP 261

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 80
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 81  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 140 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 191
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 81
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 82  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFG +  +  E  + + E   V   +     +LH
Sbjct: 141 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 198 RIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 79
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 80  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 83
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 84  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 143 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 200 RIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 79
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFG +  +  E  + + E   V   +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 79
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+M+L   G L D +   K     +   N C QI   ++     
Sbjct: 80  HVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFG +  +  E  + + E   V   +     +LH
Sbjct: 139 RLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 RIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 11  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 62
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 63  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 119
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 176
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 237 PYPDVNTFDITVYLLQGRRLLQPEYCP 263

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 13/205 (6%)
Query: 77  KELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           K LG G FG  Y  L   +    K        R+    K  +++  E  ++  +   P++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHV 79
Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGV 193
               G       + L+ +L   G L D +   K     +   N C QI   ++      +
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLHQR 249
           +HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH+ 
Sbjct: 139 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 250 YGKEIDVWSAGVILYILLS-GVPPF 273
           Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 102
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 103 HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKE--IVGSAYYVAPEVLH 247
            ++HRDL   N L+ + +    +K TDFGL+  +  E  + + E   V   +     +LH
Sbjct: 162 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPF 273
           + Y  + DVWS GV ++ L++ G  P+
Sbjct: 219 RIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 84
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 85  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 144 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 195
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 47  ALSKQIPQTSQ---IGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACK 102
           AL+ ++ Q  Q   IGP         + I   ++ +GRG FG  Y  T     G+K  C 
Sbjct: 10  ALNPELVQAVQHVVIGPS--------SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 61
Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG-AYEDKQNLHLVMELCSGGELFD 161
             S  ++    ++     E +I++  +  PN++   G     + +  +V+     G+L  
Sbjct: 62  VKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL-- 118
Query: 162 RIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKEEDSPIKATD 218
           R   +         ++    + V     ++     +HRDL   N +L   +E   +K  D
Sbjct: 119 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVAD 175
Query: 219 FGLSVFIETGKVYK--EIVGSAY---YVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVP 271
           FGL+  +   + Y      G+     ++A E L  Q++  + DVWS GV+L+ L++ G P
Sbjct: 176 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
Query: 272 PFWAETEKGIFEAILEGNLDLQSSPWP 298
           P+       I   +L+G   LQ    P
Sbjct: 236 PYPDVNTFDITVYLLQGRRLLQPEYCP 262

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 79
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 80  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EIVG 236
           +I + +   +    +HR+L   N ++A    D  +K  DFG++  I     Y+   + + 
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 255
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +P  R T  E +    LK+D
Sbjct: 256 DNCPE---RVTDLMRMCWQFNPNMRPTFLEIVN--LLKDD 290

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 74
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 75  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 134 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 185
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 12/215 (5%)
Query: 66  YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILI 124
           Y+D   +   DKELG G FG       +             +    D  ++D +  E  +
Sbjct: 2   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           +Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+   
Sbjct: 62  MQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAY---Y 240
           +        +HRDL   N LL ++      K +DFGLS  +   +  YK      +   +
Sbjct: 120 MKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPF 273
            APE + + ++  + DVWS GV+++   S G  P+
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 31/280 (11%)
Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L +ELG+G FG+ Y        K     + A K+++    + ++   +   E  +++  T
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE----------REAANICR 179
              ++V   G     Q   +VMEL + G+L   + +    +E          +E   +  
Sbjct: 79  CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EIVG 236
           +I + +   +    +HR+L   N ++A    D  +K  DFG++  I     Y+   + + 
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 237 SAYYVAPEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++APE L    +    D+WS GV+L+ + S    P+   + + + + +++G    Q 
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              P    +  DL+R     +P  R T  E +    LK+D
Sbjct: 255 DNCPE---RVTDLMRMCWQFNPNMRPTFLEIVN--LLKDD 289

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 71
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 72  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 131 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 182
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 77  KELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           K LG G FG  Y       G K     A K +  R+    K  +++  E  ++  +   P
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD-NP 77
Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM 191
           ++    G       + L+ +L   G L D +   K     +   N C QI   ++     
Sbjct: 78  HVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---------ETGKVYKEIVGSAYYVA 242
            ++HRDL   N L+ + +    +K TDFGL+  +         E GKV        +   
Sbjct: 137 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMAL 188
Query: 243 PEVLHQRYGKEIDVWSAGVILYILLS-GVPPF 273
             +LH+ Y  + DVWS GV ++ L++ G  P+
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 42/236 (17%)
Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---KDMEDVRREILILQHLTGQ 131
           L K LG G+FG     T      +    +++ + L  +    ++ D+  E  +L+ +   
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-H 85
Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELF-----DRIIAKGIY--------------SER 172
           P++++  GA      L L++E    G L       R +  G                 ER
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 173 -----EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS--VFI 225
                +  +   QI   +     M ++HRDL   N L+A   E   +K +DFGLS  V+ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKISDFGLSRDVYE 202
Query: 226 ETGKVYKEI--VGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLS-------GVPP 272
           E   V +    +   +     +    Y  + DVWS GV+L+ +++       G+PP
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	366
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	0.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	0.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	0.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	0.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	0.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-179
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-177
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-177
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-177
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-177
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-177
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-174
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-174
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-174
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-172
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-172
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-170
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-169
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-168
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-168
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-164
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-164
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-164
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-164
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-162
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-162
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-159
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-153
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-152
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-111
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-108
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-93
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-89
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-89
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-87
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-87
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-85
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-85
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-84
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-84
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-84
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-84
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-83
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-83
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-83
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-83
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-82
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-82
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-79
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-77
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-76
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-72
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-70
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-70
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-66
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-64
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-64
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-62
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-62
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-61
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-60
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-59
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-58
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-58
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-58
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-58
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-57
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-57
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-56
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-56
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-56
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-56
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-56
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-55
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-54
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-54
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-53
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-53
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-53
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-52
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-51
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-51
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-50
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-50
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-49
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-48
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-47
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-46
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-45
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-45
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-44
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-44
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-43
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-43
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-43
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-40
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-40
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-39
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-39
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-39
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-39
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-38
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-38
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-35
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-33
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-33
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-33
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-32
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-30
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-30
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-21
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-16
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	1e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	9e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	7e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-08
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	9e-08
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	6e-07
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-06
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  528 bits (1363), Expect = 0.0
 Identities = 116/315 (36%), Positives = 180/315 (57%), Gaps = 3/315 (0%)

Query: 53  PQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD 112
            Q  +    +       +  YD+ +ELG+G F V   C  K TG ++A K I+ +KL   
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-A 69

Query: 113 KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSER 172
           +D + + RE  I + L   PNIV    + +++   +LV +L +GGELF+ I+A+  YSE 
Sbjct: 70  RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
           +A++  +QI+  +  CH  G++HR+LKPEN LLASK + + +K  DFGL++ +   + + 
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188

Query: 233 EIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD 291
              G+  Y++PEVL +  Y K +D+W+ GVILYILL G PPFW E +  ++  I  G  D
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248

Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMK 351
             S  W +++ +AK LI  MLT +PKKRITA +AL+ PW+      +        +  +K
Sbjct: 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLK 308

Query: 352 QFRAMNKMKKLALKV 366
           +F A  K+K   L  
Sbjct: 309 KFNARRKLKGAILTT 323

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  522 bits (1346), Expect = 0.0
 Identities = 124/301 (41%), Positives = 183/301 (60%), Gaps = 4/301 (1%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
             T  Y L +ELG+G F V   C K   G++YA   I+ +KL   +D + + RE  I + 
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRL 66

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNIV    +  ++ + +L+ +L +GGELF+ I+A+  YSE +A++  +QI+  V  
Sbjct: 67  L-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVL 246
           CH MGV+HR+LKPEN LLASK + + +K  DFGL++ +E   + +    G+  Y++PEVL
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            +  YGK +D+W+ GVILYILL G PPFW E +  +++ I  G  D  S  W +++ +AK
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALK 365
           DLI KMLT +P KRITAAEAL+HPW+      +        +  +K+F A  K+K   L 
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILT 305

Query: 366 V 366
           V
Sbjct: 306 V 306

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  523 bits (1350), Expect = 0.0
 Identities = 128/303 (42%), Positives = 179/303 (59%), Gaps = 6/303 (1%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
                Y++   LG+G FG    C  + T ++YA K I++     +KD   + RE+ +L+ 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKK 77

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNI++     ED  + ++V EL +GGELFD II +  +SE +AA I +Q+ + +  
Sbjct: 78  L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H   ++HRDLKPEN LL SKE+D  IK  DFGLS   +     K+ +G+AYY+APEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             Y ++ DVWSAGVILYILLSG PPF+ + E  I + +  G        W +IS  AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 308 IRKMLTKDPKKRITAAEALEHPWLK----EDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           IRKMLT  P  RITA + LEHPW++    E    SD P   + +T ++QF+A  K+ + A
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316

Query: 364 LKV 366
           L  
Sbjct: 317 LLY 319

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  523 bits (1348), Expect = 0.0
 Identities = 130/325 (40%), Positives = 190/325 (58%), Gaps = 6/325 (1%)

Query: 45  PPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI 104
           P ++   +  T   G  +       +  Y   + LG+G FG   LC  K TG++ A K I
Sbjct: 2   PGSMMDHLHATP--GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59

Query: 105 SRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII 164
           S+R++    D E + RE+ +L+ L   PNI++    +EDK   +LV E+ +GGELFD II
Sbjct: 60  SKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118

Query: 165 AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
           ++  +SE +AA I RQ+++ +   H   ++HRDLKPEN LL SK +D+ I+  DFGLS  
Sbjct: 119 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178

Query: 225 IETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
            E  K  K+ +G+AYY+APEVLH  Y ++ DVWS GVILYILLSG PPF    E  I + 
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238

Query: 285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK---EDGATSDKP 341
           + +G    +   W  +S  AKDLIRKMLT  P  RI+A +AL+H W++   ++  + D P
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

Query: 342 IDSAVLTRMKQFRAMNKMKKLALKV 366
                +  ++QF+   K+ + AL  
Sbjct: 299 SLDNAILNIRQFQGTQKLAQAALLY 323

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  517 bits (1333), Expect = 0.0
 Identities = 127/349 (36%), Positives = 190/349 (54%), Gaps = 13/349 (3%)

Query: 23  PHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGP---ILGKPYVDITTIYDLDKEL 79
            HH +         +     S     +   P T+ + P   I G     ++  ++++ EL
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 80  GRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG 139
           GRG   + Y C +K T + YA K + +       D + VR EI +L  L+  PNI++ + 
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKE 115

Query: 140 AYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLK 199
            +E    + LV+EL +GGELFDRI+ KG YSER+AA+  +QI+  V   H  G++HRDLK
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175

Query: 200 PENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWS 258
           PEN L A+   D+P+K  DFGLS  +E   + K + G+  Y APE+L    YG E+D+WS
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235

Query: 259 AGVILYILLSGVPPFWAET-EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPK 317
            G+I YILL G  PF+ E  ++ +F  IL       S  W  +S  AKDL+RK++  DPK
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295

Query: 318 KRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           KR+T  +AL+HPW+   G  ++         ++++F A  K+K     V
Sbjct: 296 KRLTTFQALQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAV 342

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  515 bits (1329), Expect = 0.0
 Identities = 119/322 (36%), Positives = 175/322 (54%), Gaps = 12/322 (3%)

Query: 55  TSQIGPILGKPYVD--ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-- 110
           +   G IL     D     +Y+L + +G+G F V   C  + TG+++A K +   K    
Sbjct: 6   SGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65

Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG--- 167
                ED++RE  I   L   P+IVE    Y     L++V E   G +L   I+ +    
Sbjct: 66  PGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124

Query: 168 -IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FI 225
            +YSE  A++  RQI+  +  CH   +IHRD+KP   LLASKE  +P+K   FG+++   
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

Query: 226 ETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA 284
           E+G V    VG+ +++APEV+ +  YGK +DVW  GVIL+ILLSG  PF+   E+ +FE 
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEG 243

Query: 285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDS 344
           I++G   +    W  IS  AKDL+R+ML  DP +RIT  EAL HPWLKE    + K    
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP 303

Query: 345 AVLTRMKQFRAMNKMKKLALKV 366
             + ++++F A  K+K   L  
Sbjct: 304 ETVEQLRKFNARRKLKGAVLAA 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  520 bits (1340), Expect = 0.0
 Identities = 118/345 (34%), Positives = 183/345 (53%), Gaps = 16/345 (4%)

Query: 35  QQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKA 94
                 +S R     + I     +   + K    I   Y   ++LG G +G   LC +K 
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59

Query: 95  TGRKYACKSISRRKLV----------YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK 144
              + A K I + +             +K  E++  EI +L+ L   PNI++    +EDK
Sbjct: 60  GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDK 118

Query: 145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL 204
           +  +LV E   GGELF++II +  + E +AANI +QI++ +   H   ++HRD+KPEN L
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178

Query: 205 LASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILY 264
           L +K     IK  DFGLS F       ++ +G+AYY+APEVL ++Y ++ DVWS GVI+Y
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMY 238

Query: 265 ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAE 324
           ILL G PPF  + ++ I + + +G      + W +IS +AK+LI+ MLT D  KR TA E
Sbjct: 239 ILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE 298

Query: 325 ALEHPWLKE---DGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           AL   W+K+   +   SD+      L+ M++F    K+ + A+  
Sbjct: 299 ALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  516 bits (1330), Expect = 0.0
 Identities = 124/345 (35%), Positives = 191/345 (55%), Gaps = 16/345 (4%)

Query: 26  RYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFG 85
            +       +++                  +  G  +      ++ +Y   K+LG G +G
Sbjct: 2   HHHHHHSSGRENLYFQGD----------LQATPGMFITSKKGHLSEMYQRVKKLGSGAYG 51

Query: 86  VTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ 145
              LC  K T  + A K I +  +        +  E+ +L+ L   PNI++    +EDK+
Sbjct: 52  EVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKR 109

Query: 146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL 205
           N +LVME   GGELFD II +  ++E +AA I +Q+++ V   H   ++HRDLKPEN LL
Sbjct: 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL 169

Query: 206 ASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYI 265
            SKE+D+ IK  DFGLS   E  K  KE +G+AYY+APEVL ++Y ++ DVWS GVIL+I
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFI 229

Query: 266 LLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEA 325
           LL+G PPF  +T++ I   + +G     S  W ++S  AKDLI++ML  D ++RI+A +A
Sbjct: 230 LLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

Query: 326 LEHPWLKEDGATS----DKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           LEHPW+KE  +      + P  +  +  M++F+   K+ + AL  
Sbjct: 290 LEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY 334

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  506 bits (1306), Expect = 0.0
 Identities = 92/319 (28%), Positives = 158/319 (49%), Gaps = 6/319 (1%)

Query: 50  KQIPQTSQIGPILGKPYVDITTIYDL-DKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
                      +  +   +    Y L  KELGRG+F V   C  K+TG++YA K + +R+
Sbjct: 7   HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-- 166
                   ++  EI +L+     P ++     YE+   + L++E  +GGE+F   + +  
Sbjct: 67  RG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125

Query: 167 GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE 226
            + SE +   + +QI+  V+  H   ++H DLKP+N LL+S      IK  DFG+S  I 
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 227 TGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI 285
                +EI+G+  Y+APE+L+        D+W+ G+I Y+LL+   PF  E  +  +  I
Sbjct: 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245

Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE-DGATSDKPIDS 344
            + N+D     + S+S  A D I+ +L K+P+KR TA   L H WL++ D      P ++
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305

Query: 345 AVLTRMKQFRAMNKMKKLA 363
           +  ++ +     +   K +
Sbjct: 306 SSSSQTQDHSVRSSEDKTS 324

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  496 bits (1280), Expect = e-179
 Identities = 115/280 (41%), Positives = 175/280 (62%), Gaps = 4/280 (1%)

Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI 122
           G    DI   Y L+  +GRG +G   +  +K T  + A K I +  +   +D++  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
            I++ L   PNI+     +ED  +++LVMELC+GGELF+R++ K ++ E +AA I + ++
Sbjct: 58  EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
           + V  CH + V HRDLKPENFL  +   DSP+K  DFGL+   + GK+ +  VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 243 PEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           P+VL   YG E D WSAGV++Y+LL G PPF A T+  +   I EG        W ++S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           QA+ LIR++LTK PK+RIT+ +ALEH W ++  ++S + +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  494 bits (1275), Expect = e-177
 Identities = 87/301 (28%), Positives = 155/301 (51%), Gaps = 12/301 (3%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           ++   Y + ++LGRG+FG+ + C + ++ + Y  K +  +      D   V++EI IL  
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNI 57

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVH 186
                NI+    ++E  + L ++ E  SG ++F+RI       +ERE  +   Q+   + 
Sbjct: 58  A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
             H   + H D++PEN +  ++   S IK  +FG +  ++ G  ++ +  +  Y APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
                    D+WS G ++Y+LLSG+ PF AET + I E I+          +  IS +A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALK 365
           D + ++L K+ K R+TA+EAL+HPWLK+      + + + V+  +K  R  + + K  L 
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQK----IERVSTKVIRTLKHRRYYHTLIKKDLN 291

Query: 366 V 366
           +
Sbjct: 292 M 292

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  494 bits (1273), Expect = e-177
 Identities = 112/321 (34%), Positives = 165/321 (51%), Gaps = 28/321 (8%)

Query: 68  DITTIYDLD---KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI 124
                YDLD   K LG G F +   C  K + + +A K IS+R         + ++EI  
Sbjct: 5   PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITA 58

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+   G PNIV+    + D+ +  LVMEL +GGELF+RI  K  +SE EA+ I R++V+ 
Sbjct: 59  LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA 118

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAP 243
           V   H +GV+HRDLKPEN L   + ++  IK  DFG +       +  K    + +Y AP
Sbjct: 119 VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-------GIFEAILEGNLDLQSS 295
           E+L    Y +  D+WS GVILY +LSG  PF +            I + I +G+   +  
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI---------DSAV 346
            W ++S +AKDLI+ +LT DP KR+  +    + WL++    S  P+          +AV
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAV 298

Query: 347 LTRMK-QFRAMNKMKKLALKV 366
            T +K  F A NK K+    +
Sbjct: 299 HTCVKATFHAFNKYKREGFCL 319

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  494 bits (1273), Expect = e-177
 Identities = 115/304 (37%), Positives = 171/304 (56%), Gaps = 13/304 (4%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 68  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E+++    G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL 362
            AKD IR++L KDPKKR+T  ++L+HPW+K              L+R      M K KK 
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKKF 299

Query: 363 ALKV 366
           A + 
Sbjct: 300 AARK 303

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  496 bits (1279), Expect = e-177
 Identities = 108/365 (29%), Positives = 165/365 (45%), Gaps = 22/365 (6%)

Query: 16  SSSSDESPHHRYQPLPRR---TQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTI 72
           +S     P     P P     T     P +  PP   +Q PQ      +  K    I   
Sbjct: 4   NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
               + LG G  G       K T  K+A K +         D    RRE+ +    +  P
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQCP 115

Query: 133 NIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVH 186
           +IV     YE+    ++ L +VME   GGELF RI  +G   ++EREA+ I + I   + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
             H + + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPSIS 301
               Y K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            + K LIR +L  +P +R+T  E + HPW+ +       P+ ++ + +  + R  +  ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 355

Query: 362 LALKV 366
           +   +
Sbjct: 356 MTSAL 360

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  485 bits (1252), Expect = e-174
 Identities = 117/269 (43%), Positives = 163/269 (60%), Gaps = 2/269 (0%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
                Y++   LG+G FG    C  + T ++YA K I++     +KD   + RE+ +L+ 
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKK 77

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNI++     ED  + ++V EL +GGELFD II +  +SE +AA I +Q+ + +  
Sbjct: 78  LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
            H   ++HRDLKPEN LL SKE+D  IK  DFGLS   +     K+ +G+AYY+APEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             Y ++ DVWSAGVILYILLSG PPF+ + E  I + +  G        W +IS  AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGA 336
           IRKMLT  P  RITA + LEHPW+++  +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  487 bits (1256), Expect = e-174
 Identities = 105/328 (32%), Positives = 158/328 (48%), Gaps = 19/328 (5%)

Query: 51  QIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV 110
           Q      I   L +  +  T  Y++ +++G G + V   C  KAT  ++A K I + K  
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-- 59

Query: 111 YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS 170
                 D   EI IL      PNI+  +  Y+D + +++V EL  GGEL D+I+ +  +S
Sbjct: 60  -----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114

Query: 171 EREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED-SPIKATDFGLSVFIE-TG 228
           EREA+ +   I   V   H  GV+HRDLKP N L   +  +   I+  DFG +  +    
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 229 KVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFEA 284
            +      +A +VAPEVL  Q Y    D+WS GV+LY +L+G  PF     +T + I   
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234

Query: 285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDS 344
           I  G   L    W S+S  AKDL+ KML  DP +R+TAA  L HPW+          ++ 
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNR 294

Query: 345 AVLTRMKQ------FRAMNKMKKLALKV 366
                + +      + A+N+ +   L+ 
Sbjct: 295 QDAPHLVKGAMAATYSALNRNQSPVLEP 322

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  485 bits (1250), Expect = e-174
 Identities = 109/274 (39%), Positives = 167/274 (60%), Gaps = 3/274 (1%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
             +  YD+ +ELG+G F V   C  K TG ++A K I+ +KL   +D + + RE  I + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRK 61

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PNIV    + +++   +LV +L +GGELF+ I+A+  YSE +A++  +QI+  +  
Sbjct: 62  LQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
           CH  G++HR+LKPEN LLASK + + +K  DFGL++ +   + +    G+  Y++PEVL 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180

Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +  Y K +D+W+ GVILYILL G PPFW E +  ++  I  G  D  S  W +++ +AK 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
           LI  MLT +PKKRITA +AL+ PW+      +  
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASA 274

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  480 bits (1239), Expect = e-172
 Identities = 112/283 (39%), Positives = 164/283 (57%), Gaps = 6/283 (2%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---KDMEDVRREILI 124
            +   Y++ +ELG GQF +   C +K TG++YA K I +R+L         E++ RE+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PNI+     +E+K ++ L++EL SGGELFD +  K   +E EA    +QI++ 
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 185 VHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           VH  H   + H DLKPEN +L  K   +  IK  DFG++  IE G  +K I G+  +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E+++    G E D+WS GVI YILLSG  PF  ET++     I   N D     + + S 
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA 345
            AKD IR++L KDPK+R+T A++LEH W+K     + +  DS 
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  480 bits (1237), Expect = e-172
 Identities = 109/301 (36%), Positives = 164/301 (54%), Gaps = 8/301 (2%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILI 124
            +   YD+ +ELG GQF +   C +K+TG +YA K I +R+    +     E++ RE+ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +    N++     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ 
Sbjct: 69  LRQVLH-HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E+++    G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLK--EDGATSDKPIDSAVLTRMKQFRAMNKMK 360
            AKD IRK+L K+ +KR+T  EAL HPW+   ++     +      L   ++     + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWK 307

Query: 361 K 361
            
Sbjct: 308 L 308

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  478 bits (1233), Expect = e-170
 Identities = 108/337 (32%), Positives = 163/337 (48%), Gaps = 18/337 (5%)

Query: 8   SRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYV 67
                  I S  D+           +   D +P  +         P+         K   
Sbjct: 34  REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK--- 90

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL-----VYDKDMEDVRREI 122
           +    YD    +GRG   V   C  +ATG ++A K +            ++  E  RRE 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
            IL+ + G P+I+    +YE    + LV +L   GELFD +  K   SE+E  +I R ++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
             V   H   ++HRDLKPEN LL   +++  I+ +DFG S  +E G+  +E+ G+  Y+A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 243 PEVL-------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
           PE+L       H  YGKE+D+W+ GVIL+ LL+G PPFW   +  +   I+EG     S 
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327

Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            W   S   KDLI ++L  DP+ R+TA +AL+HP+ +
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  475 bits (1224), Expect = e-169
 Identities = 112/301 (37%), Positives = 162/301 (53%), Gaps = 8/301 (2%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV---YDKDMEDVRREILI 124
            +   YD+ +ELG GQF +   C +K+TG +YA K I +R+          E++ RE+ I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PNI+     YE++ ++ L++EL SGGELFD +  K   SE EA +  +QI++ 
Sbjct: 69  LRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H   + H DLKPEN +L  K    P IK  DFGL+  IE G  +K I G+  +VAP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 244 EVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E+++    G E D+WS GVI YILLSG  PF  +T++     I   + D     +   S 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS--DKPIDSAVLTRMKQFRAMNKMK 360
            AKD IRK+L K+ +KR+T  EAL HPW+          +      L   K+     + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307

Query: 361 K 361
            
Sbjct: 308 L 308

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  470 bits (1211), Expect = e-168
 Identities = 92/270 (34%), Positives = 152/270 (56%), Gaps = 8/270 (2%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
            I  ++   ++LG G FG  +L  ++++G +   K+I++ +      ME +  EI +L+ 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVN 183
           L   PNI++    +ED  N+++VME C GGEL +RI++        SE   A + +Q++N
Sbjct: 77  L-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   V+H+DLKPEN L       SPIK  DFGL+   ++ +      G+A Y+AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

Query: 244 EVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
           EV  +    + D+WSAGV++Y LL+G  PF   + + + +       +      P ++ Q
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQ 254

Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           A DL+++MLTKDP++R +AA+ L H W K+
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  470 bits (1211), Expect = e-168
 Identities = 104/287 (36%), Positives = 156/287 (54%), Gaps = 16/287 (5%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK--LVYDKDMEDVR----RE 121
                Y+  + LGRG   V   C  K T ++YA K I          ++++++R    +E
Sbjct: 14  GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           + IL+ ++G PNI++ +  YE      LV +L   GELFD +  K   SE+E   I R +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV 241
           + V+ A H + ++HRDLKPEN LL   ++D  IK TDFG S  ++ G+  +E+ G+  Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190

Query: 242 APEVL-------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS 294
           APE++       H  YGKE+D+WS GVI+Y LL+G PPFW   +  +   I+ GN    S
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250

Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
             W   S   KDL+ + L   P+KR TA EAL HP+ ++      + 
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  462 bits (1190), Expect = e-164
 Identities = 101/313 (32%), Positives = 149/313 (47%), Gaps = 36/313 (11%)

Query: 68  DITTIYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
               +Y L ++ LG G       C    T ++YA K I ++          V RE+ +L 
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLY 65

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
              G  N++E    +E++   +LV E   GG +   I  +  ++E EA+ + + + + + 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--------VGSA 238
             H  G+ HRDLKPEN L     + SP+K  DF L   I+       I         GSA
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 239 YYVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAE---------------T 277
            Y+APEV+         Y K  D+WS GVILYILLSG PPF                   
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 278 EKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT 337
           +  +FE+I EG  +     W  IS  AKDLI K+L +D K+R++AA+ L+HPW++  G  
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCA 303

Query: 338 SDKPIDSA-VLTR 349
            +  + +  VL R
Sbjct: 304 PENTLPTPMVLQR 316

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  464 bits (1195), Expect = e-164
 Identities = 110/366 (30%), Positives = 177/366 (48%), Gaps = 29/366 (7%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQ 83
           HH +    +   +   P  +      + I +     P+  K    +   YD+ +ELG G 
Sbjct: 5   HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGA 63

Query: 84  FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED 143
           FGV + C +KATGR +  K I+        D   V+ EI I+  L   P ++    A+ED
Sbjct: 64  FGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFED 119

Query: 144 KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPEN 202
           K  + L++E  SGGELFDRI A+    SE E  N  RQ    +   H   ++H D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179

Query: 203 FLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGV 261
            +  +K+  S +K  DFGL+  +   ++ K    +A + APE++ +   G   D+W+ GV
Sbjct: 180 IMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 262 ILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT 321
           + Y+LLSG+ PF  E +    + +   + +     + S+S +AKD I+ +L K+P+KR+T
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298

Query: 322 AAEALEHPWLKEDGATSDKPIDSAVL---------------------TRMKQFRAMNKMK 360
             +ALEHPWLK D +     I S+                        R+  F ++ K +
Sbjct: 299 VHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 358

Query: 361 KLALKV 366
               ++
Sbjct: 359 PQEYQI 364

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  460 bits (1186), Expect = e-164
 Identities = 104/309 (33%), Positives = 157/309 (50%), Gaps = 18/309 (5%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREI 122
            +   Y + K LG G  G   L  ++ T +K A K IS+RK             +V  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
            IL+ L   P I++ +  ++ + + ++V+EL  GGELFD+++      E        Q++
Sbjct: 67  EILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
             V   H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 243 PEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPW 297
           PEVL       Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMN 357
             +S +A DL++K+L  DPK R T  EAL HPWL+      D+ +       + +     
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENEST 298

Query: 358 KMKKLALKV 366
            + ++  + 
Sbjct: 299 ALPQVLAQP 307

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  460 bits (1185), Expect = e-164
 Identities = 109/312 (34%), Positives = 156/312 (50%), Gaps = 24/312 (7%)

Query: 68  DITTIYDLDKE-LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
            +T  Y L K+ LG G  G    C  + TG+K A K +              R+E+    
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHW 76

Query: 127 HLTGQPNIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQ 180
             +G P+IV     YE+    K+ L ++ME   GGELF RI  +G   ++EREAA I R 
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY 240
           I   +   H   + HRD+KPEN L  SKE+D+ +K TDFG +       + +    + YY
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYY 195

Query: 241 VAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLDLQSS 295
           VAPEVL    Y K  D+WS GVI+YILL G PPF++ T +    G+   I  G     + 
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA-VLTRMKQFR 354
            W  +S  AK LIR +L  DP +R+T  + + HPW+ +       P+ +A VL   K   
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH- 314

Query: 355 AMNKMKKLALKV 366
             +++K+     
Sbjct: 315 -WDEVKEEMTSA 325

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  466 bits (1200), Expect = e-162
 Identities = 108/359 (30%), Positives = 161/359 (44%), Gaps = 11/359 (3%)

Query: 8   SRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYV 67
                  +    +      Y    +      + T S                  +   + 
Sbjct: 94  CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
            +   YD+ +ELG G FGV +  T++ATG  +A K +         D E VR+EI  +  
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSV 210

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVH 186
           L   P +V    A+ED   + ++ E  SGGELF+++  +    SE EA    RQ+   + 
Sbjct: 211 LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
             H    +H DLKPEN +  +K  +  +K  DFGL+  ++  +  K   G+A + APEV 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
             +  G   D+WS GV+ YILLSG+ PF  E +      +   + ++  S +  IS   K
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGA-TSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           D IRK+L  DP  R+T  +ALEHPWL    A   D  I S+   R  + R   K K  A
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS---RYTKIRDSIKTKYDA 444

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  457 bits (1178), Expect = e-162
 Identities = 109/352 (30%), Positives = 170/352 (48%), Gaps = 15/352 (4%)

Query: 16  SSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDL 75
           S S        +       +   +   +   A+    P       I+      + + Y +
Sbjct: 32  SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTV 91

Query: 76  DK--ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
            K   LG G+FG  + C + ATG K A K I  R +   KD E+V+ EI ++  L    N
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQL-DHAN 147

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMG 192
           +++   A+E K ++ LVME   GGELFDRII +    +E +     +QI   +   H M 
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           ++H DLKPEN L  +++    IK  DFGL+   +  +  K   G+  ++APEV++     
Sbjct: 208 ILHLDLKPENILCVNRD-AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
              D+WS GVI Y+LLSG+ PF  + +      IL    DL+   +  IS +AK+ I K+
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326

Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
           L K+   RI+A+EAL+HPWL       D  + S +  + K+ R  +    + 
Sbjct: 327 LIKEKSWRISASEALKHPWLS------DHKLHSRLSAQKKKNRGSDAQDFVT 372

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  447 bits (1152), Expect = e-159
 Identities = 92/313 (29%), Positives = 141/313 (45%), Gaps = 39/313 (12%)

Query: 64  KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL 123
           K    I       + LG G  G       K T  K+A K +         D    RRE+ 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVE 62

Query: 124 ILQHLTGQPNIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGI--YSEREAANI 177
           +    +  P+IV     YE+    ++ L +VME   GGELF RI  +G   ++EREA+ I
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
            + I   +   H + + HRD+KPEN L  SK  ++ +K TDFG                 
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166

Query: 238 AYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQ 293
               A E   ++Y K  D+WS GVI+YILL G PPF++        G+   I  G  +  
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222

Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF 353
           +  W  +S + K LIR +L  +P +R+T  E + HPW+ +       P+ ++ + +  + 
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282

Query: 354 RAMNKMKKLALKV 366
           R    +K+     
Sbjct: 283 R-WEDVKEEMTSA 294

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  435 bits (1121), Expect = e-153
 Identities = 102/282 (36%), Positives = 150/282 (53%), Gaps = 12/282 (4%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----DKDMEDVRREI 122
            +   Y + K LG G  G   L  ++ T +K A + IS+RK             +V  EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
            IL+ L   P I++ +  ++ + + ++V+EL  GGELFD+++      E        Q++
Sbjct: 192 EILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
             V   H  G+IHRDLKPEN LL+S+EED  IK TDFG S  +    + + + G+  Y+A
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 243 PEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPW 297
           PEVL       Y + +D WS GVIL+I LSG PPF    T+  + + I  G  +     W
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
             +S +A DL++K+L  DPK R T  EAL HPWL+++     
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  430 bits (1108), Expect = e-152
 Identities = 95/335 (28%), Positives = 153/335 (45%), Gaps = 52/335 (15%)

Query: 56  SQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL--VYDK 113
            +     G   +++   Y L   +G+G +GV  +  +  T    A K +++ K+  +  K
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 114 DMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG------ 167
           D+E ++ E+ +++ L   PNI      YED+Q + LVMELC GG L D++          
Sbjct: 71  DVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 168 ----------------------------------IYSEREAANICRQIVNVVHACHFMGV 193
                                             +  E+  +NI RQI + +H  H  G+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-----VYKEIVGSAYYVAPEVLH- 247
            HRD+KPENFL ++ +    IK  DFGLS                  G+ Y+VAPEVL+ 
Sbjct: 190 CHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248

Query: 248 --QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
             + YG + D WSAGV+L++LL G  PF    +      +L   L  ++  +  +S  A+
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK 340
           DL+  +L ++  +R  A  AL+HPW+ +      K
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  329 bits (846), Expect = e-111
 Identities = 73/305 (23%), Positives = 133/305 (43%), Gaps = 32/305 (10%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +     LG G  G T +       R  A K I        +      RE+ +L+     P
Sbjct: 26  FCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFM 191
           N++ +    +D+Q  ++ +ELC    L + +  K   +   E   + +Q  + +   H +
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 192 GVIHRDLKPENFLLASKEEDSPIKA--TDFGLSVFIETGKVY----KEIVGSAYYVAPEV 245
            ++HRDLKP N L++       IKA  +DFGL   +  G+        + G+  ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 246 L----HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           L     +     +D++SAG + Y ++S G  PF    ++     +   +LD    P    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPEKHE 256

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG-------ATSDK----PIDSAVLTR 349
              A++LI KM+  DP+KR +A   L+HP+              SD+     +D  ++ +
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ 316

Query: 350 MKQFR 354
           +++  
Sbjct: 317 LERGG 321

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  324 bits (831), Expect = e-108
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 42/300 (14%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
            +  +   +K LG G  G          GR  A K +           +    EI +L  
Sbjct: 12  SLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDF------CDIALMEIKLLTE 64

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYS-------EREAANICRQ 180
               PN++ +  +    + L++ +ELC    L D + +K +         E    ++ RQ
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKE----------EDSPIKATDFGLSVFIETGKV 230
           I + V   H + +IHRDLKP+N L+++            E+  I  +DFGL   +++G+ 
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 231 Y-----KEIVGSAYYVAPEVL--------HQRYGKEIDVWSAGVILYILLS-GVPPFWA- 275
                     G++ + APE+L         +R  + ID++S G + Y +LS G  PF   
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 276 -ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
              E  I   I   + +++     S+  +A DLI +M+  DP KR TA + L HP     
Sbjct: 244 YSRESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  282 bits (723), Expect = 5e-94
 Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 43/299 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L   LG+G     +    K TG  +A K  +       + ++   RE  +L+ L    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67

Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHA 187
           NIV+     E+   ++  L+ME C  G L+  +          E E   + R +V  ++ 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 188 CHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
               G++HR++KP N +    E   S  K TDFG +  +E  + +  + G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 247 ---------HQRYGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFEAILEG----- 288
                     ++YG  +D+WS GV  Y   +G  PF         K +   I+ G     
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 289 ------------NLDLQSSPWPSISGQAKD----LIRKMLTKDPKKRITAAEALEHPWL 331
                       +         S+S   +     ++  +L  D +K     +       
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  281 bits (721), Expect = 9e-94
 Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 41/291 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++    LG+G FG           R YA K I   +    + +  +  E+++L  L    
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN-HQ 62

Query: 133 NIVEFEGAYEDKQN-------------LHLVMELCSGGELFDRIIAKGIYSER-EAANIC 178
            +V +  A+ +++N             L + ME C  G L+D I ++ +  +R E   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI---- 234
           RQI+  +   H  G+IHRDLKP N  +   +E   +K  DFGL+  +       ++    
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 235 -----------VGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGI 281
                      +G+A YVA EVL     Y ++ID++S G+I + ++   P         I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237

Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            + +   +++       +     K +IR ++  DP KR  A   L   WL 
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  282 bits (723), Expect = 1e-93
 Identities = 96/309 (31%), Positives = 137/309 (44%), Gaps = 15/309 (4%)

Query: 29  PLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTY 88
           P P    +   P  + P A +   P   +I  +L  P       Y   + LG+G F   +
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAA-PPAKEIPEVLVDP--RSRRRYVRGRFLGKGGFAKCF 58

Query: 89  LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH 148
             +   T   +A K + +  L+     E +  EI I + L    ++V F G +ED   + 
Sbjct: 59  EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117

Query: 149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK 208
           +V+ELC    L +    +   +E EA    RQIV      H   VIHRDLK  N  L   
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED 177

Query: 209 EEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYIL 266
            E   +K  DFGL+  +E  G+  K + G+  Y+APEVL ++ +  E+DVWS G I+Y L
Sbjct: 178 LE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234

Query: 267 LSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIRKMLTKDPKKRITAAEA 325
           L G PPF     K  +  I +          P  I+  A  LI+KML  DP  R T  E 
Sbjct: 235 LVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPVAASLIQKMLQTDPTARPTINEL 289

Query: 326 LEHPWLKED 334
           L   +    
Sbjct: 290 LNDEFFTSG 298

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  276 bits (708), Expect = 6e-92
 Identities = 90/289 (31%), Positives = 130/289 (44%), Gaps = 20/289 (6%)

Query: 49  SKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK 108
           +K+IP+         +        Y   + LG+G F   +  +   T   +A K + +  
Sbjct: 1   AKEIPEVLVDPRSRRR--------YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 52

Query: 109 LVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI 168
           L+     E +  EI I + L    ++V F G +ED   + +V+ELC    L +    +  
Sbjct: 53  LLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 111

Query: 169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET- 227
            +E EA    RQIV      H   VIHRDLK  N  L    E   +K  DFGL+  +E  
Sbjct: 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYD 168

Query: 228 GKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL 286
           G+  K + G+  Y+APEVL ++ +  E+DVWS G I+Y LL G PPF     K  +  I 
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228

Query: 287 EGNLDLQSSPWPS-ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           +          P  I+  A  LI+KML  DP  R T  E L   +    
Sbjct: 229 KNEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  269 bits (691), Expect = 1e-89
 Identities = 81/263 (30%), Positives = 138/263 (52%), Gaps = 10/263 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN LL S  E   +K  DFG SV   + +   ++ G+  Y+ PE++  R + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHD 185

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I     +     +  ++  A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLISRL 241

Query: 312 LTKDPKKRITAAEALEHPWLKED 334
           L  +P +R    E LEHPW+  +
Sbjct: 242 LKHNPSQRPMLREVLEHPWITAN 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  271 bits (696), Expect = 2e-89
 Identities = 75/317 (23%), Positives = 134/317 (42%), Gaps = 32/317 (10%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ- 131
           Y + K++G G     +    +   + YA K ++  +   ++ ++  R EI  L  L    
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHS 68

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
             I+         Q +++VME C   +L   +  K      E  +  + ++  VH  H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVL-- 246
           G++H DLKP NFL+     D  +K  DFG++  +    T  V    VG+  Y+ PE +  
Sbjct: 128 GIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 247 ----------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSS 295
                       +   + DVWS G ILY +  G  PF     +     AI++ N +++  
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF- 242

Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA------VLTR 349
                    +D+++  L +DPK+RI+  E L HP+++      ++           VL +
Sbjct: 243 -PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 301

Query: 350 MKQFRAMNKMKKLALKV 366
           +    + N + K A  +
Sbjct: 302 LVGLNSPNSILKAAKTL 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  270 bits (692), Expect = 3e-89
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 26/291 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ- 131
           Y + K++G G     +    +   + YA K ++  +   ++ ++  R EI  L  L    
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHS 87

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
             I+         Q +++VME C   +L   +  K      E  +  + ++  VH  H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVL-- 246
           G++H DLKP NFL+     D  +K  DFG++  +    T  V    VG+  Y+ PE +  
Sbjct: 147 GIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 247 ----------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSS 295
                       +   + DVWS G ILY +  G  PF     +     AI++ N +++  
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF- 261

Query: 296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
                    +D+++  L +DPK+RI+  E L HP+++      ++      
Sbjct: 262 -PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  268 bits (688), Expect = 4e-89
 Identities = 79/265 (29%), Positives = 137/265 (51%), Gaps = 11/265 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + +   LG+G F   Y      TG + A K I ++ +     ++ V+ E+ I   L   P
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFM 191
           +I+E    +ED   ++LV+E+C  GE+   +  +   +SE EA +   QI+  +   H  
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GKVYKEIVGSAYYVAPEVL-HQR 249
           G++HRDL   N LL        IK  DFGL+  ++   + +  + G+  Y++PE+     
Sbjct: 132 GILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           +G E DVWS G + Y LL G PPF  +T K     ++  + ++   P   +S +AKDLI 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLIH 244

Query: 310 KMLTKDPKKRITAAEALEHPWLKED 334
           ++L ++P  R++ +  L+HP++  +
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRN 269

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  266 bits (683), Expect = 3e-88
 Identities = 86/275 (31%), Positives = 148/275 (53%), Gaps = 10/275 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D+ + LG+G+FG  YL  +K      A K + + +L  +     +RREI I  HL   P
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+     + D++ ++L++E    GEL+  +   G + E+ +A    ++ + +H CH   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           VIHRD+KPEN L+  K E   +K  DFG SV   + +  + + G+  Y+ PE++  + + 
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHD 190

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+W AGV+ Y  L G+PPF + +       I+    DL+  P+  +S  +KDLI K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLISKL 246

Query: 312 LTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
           L   P +R+     +EHPW+K +      P+  + 
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  270 bits (691), Expect = 4e-88
 Identities = 78/370 (21%), Positives = 142/370 (38%), Gaps = 39/370 (10%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTI-------YDLD 76
           HH +       +      ++      + +           K               Y + 
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIV 135
           K++G G     +    +   + YA K ++  +   ++ ++  R EI  L  L      I+
Sbjct: 62  KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 136 EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIH 195
                    Q +++VME C   +L   +  K      E  +  + ++  VH  H  G++H
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVL------ 246
            DLKP NFL+     D  +K  DFG++  +    T  V    VG+  Y+ PE +      
Sbjct: 179 SDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 247 ------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPS 299
                   +   + DVWS G ILY +  G  PF     +     AI++ N +++      
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--PDI 292

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSA------VLTRMKQF 353
                +D+++  L +DPK+RI+  E L HP+++      ++           VL ++   
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 352

Query: 354 RAMNKMKKLA 363
            + N + K A
Sbjct: 353 NSPNSILKAA 362

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  269 bits (688), Expect = 1e-87
 Identities = 61/298 (20%), Positives = 111/298 (37%), Gaps = 43/298 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L   LG+G     +    K TG  +A K  +       + ++   RE  +L+ L    
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67

Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHA 187
           NIV+     E+   ++  L+ME C  G L+  +          E E   + R +V  ++ 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 188 CHFMGVIHRDLKPENFLL-ASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
               G++HR++KP N +    ++  S  K TDFG +  +E  + +  + G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 247 ---------HQRYGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFEAILEGNLDLQ 293
                     ++YG  +D+WS GV  Y   +G  PF         K +   I+ G     
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 294 SSPW---------------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            S                         +      ++  +L  D +K     +      
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  267 bits (683), Expect = 2e-87
 Identities = 49/348 (14%), Positives = 99/348 (28%), Gaps = 51/348 (14%)

Query: 28  QPLPRRTQQDFRPTSSRPPALSKQI---PQTSQIGPILGKPYVDITTIYDLDKELGRGQF 84
           + +    ++  +  ++   A++  +      + +  +L +          L + L  G  
Sbjct: 20  ELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERK----LKLVEPLRVGDR 75

Query: 85  GVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---------------- 128
            V +L         +A K  +        ++E +         L                
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 129 -------TGQPNIVEFEGAYEDK--QNLHLVMELCSG------GELFDRIIAKGIYSERE 173
                    QP   +     +D    N  L+M   S         L    + +G      
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195

Query: 174 AANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
              +  Q++ +       G++H    P+N  +     D  +   D       + G     
Sbjct: 196 LHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGTRGPA 250

Query: 234 IVGSAYYVAPEVLHQR---YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--- 287
                 Y   E L+     +   ++ W  G+ +Y +     PF   T             
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310

Query: 288 --GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             G   L       +    K LI + L  D ++R+   EA+E P   +
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  264 bits (677), Expect = 8e-87
 Identities = 98/292 (33%), Positives = 150/292 (51%), Gaps = 11/292 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L K +G+G F    L     TGR+ A K I + +L     ++ + RE+ I++ L   P
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILN-HP 74

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+     E ++ L+L+ME  SGGE+FD ++A G   E+EA +  RQIV+ V  CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY- 250
           ++HRDLK EN LL   + D  IK  DFG S     G       G+  Y APE+   ++Y 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G E+DVWS GVILY L+SG  PF  +  K + E +L G   +   P   +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---P-FYMSTDCENLLKR 247

Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL 362
            L  +P KR T  + ++  W+       +          +   + ++ M  +
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  262 bits (672), Expect = 1e-85
 Identities = 102/298 (34%), Positives = 137/298 (45%), Gaps = 24/298 (8%)

Query: 43  SRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACK 102
            R P  +   P    I     +        YD  K++G G FGV  L   K T    A K
Sbjct: 2   DRAPVTTG--PLDMPIMHDSDR--------YDFVKDIGSGNFGVARLMRDKLTKELVAVK 51

Query: 103 SISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR 162
            I R   + +     V+REI+  + L   PNIV F+       +L ++ME  SGGEL++R
Sbjct: 52  YIERGAAIDEN----VQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYER 106

Query: 163 IIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS 222
           I   G +SE EA    +Q+++ V  CH M + HRDLK EN LL        +K  DFG S
Sbjct: 107 ICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYS 165

Query: 223 VFIETGKVYKEIVGSAYYVAPEVL-HQRY-GKEIDVWSAGVILYILLSGVPPFWAETEKG 280
                    K  VG+  Y+APEVL  Q Y GK  DVWS GV LY++L G  PF    E  
Sbjct: 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

Query: 281 IF----EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
            +    + IL     +       IS +   LI ++   DP  RI+  E   H W  ++
Sbjct: 226 DYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  261 bits (669), Expect = 2e-85
 Identities = 69/365 (18%), Positives = 136/365 (37%), Gaps = 60/365 (16%)

Query: 31  PRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLC 90
           P  + +D     S    L+K + +  +    +          Y + + L +G+F    LC
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKY---IND--------YRIIRTLNQGKFNKIILC 50

Query: 91  TKKATGRKYACKSISRRKLVYDKD--------------MEDVRREILILQHLTGQPNIVE 136
            K    + YA K   +  L   +D               +D + E+ I+  +      + 
Sbjct: 51  EK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLT 107

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--------YSEREAANICRQIVNVVHAC 188
            EG   +   ++++ E      +        +           +    I + ++N     
Sbjct: 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167

Query: 189 H-FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH 247
           H    + HRD+KP N L+        +K +DFG S ++   K+     G+  ++ PE   
Sbjct: 168 HNEKNICHRDVKPSNILMDKNGR---VKLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFS 223

Query: 248 QR---YGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNL------------- 290
                 G ++D+WS G+ LY++   V PF  + +   +F  I   N+             
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPL 283

Query: 291 --DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLT 348
                +     +S +  D ++  L K+P +RIT+ +AL+H WL +      +     +  
Sbjct: 284 TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343

Query: 349 RMKQF 353
           + K+ 
Sbjct: 344 KRKKL 348

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  260 bits (666), Expect = 3e-85
 Identities = 76/320 (23%), Positives = 137/320 (42%), Gaps = 30/320 (9%)

Query: 22  SPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGR 81
           S HH +       +      +      + ++    +  P+  +        Y +   LG 
Sbjct: 4   SHHHHHHSSGLVPRG--SHMAPCNDLHATKLAPGKEKEPLESQ--------YQVGPLLGS 53

Query: 82  GQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED---VRREILILQHLT-GQPNIVEF 137
           G FG  Y   + +     A K + + ++    ++ +   V  E+++L+ ++ G   ++  
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113

Query: 138 EGAYEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              +E   +  L++E      +LFD I  +G   E  A +   Q++  V  CH  GV+HR
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 173

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY-GKEI 254
           D+K EN L+     +  +K  DFG    ++    Y +  G+  Y  PE + + RY G+  
Sbjct: 174 DIKDENILIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSA 230

Query: 255 DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK 314
            VWS G++LY ++ G  PF  + E      I+ G +         +S + + LIR  L  
Sbjct: 231 AVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF---R-QRVSSECQHLIRWCLAL 280

Query: 315 DPKKRITAAEALEHPWLKED 334
            P  R T  E   HPW+++ 
Sbjct: 281 RPSDRPTFEEIQNHPWMQDV 300

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  257 bits (659), Expect = 8e-85
 Identities = 99/265 (37%), Positives = 135/265 (50%), Gaps = 12/265 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L   LG G FG   +   + TG K A K ++R+K+     +  ++REI  L+     P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HP 71

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++         +  +VME  SGGELFD I   G   E EA  + +QI++ V  CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY- 250
           V+HRDLKPEN LL   +     K  DFGLS  +  G+  +   GS  Y APEV+  + Y 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIR 309
           G E+D+WS GVILY LL G  PF  E    +F+ I  G   +     P  ++     L+ 
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI-----PEYLNRSVATLLM 243

Query: 310 KMLTKDPKKRITAAEALEHPWLKED 334
            ML  DP KR T  +  EH W K+D
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  258 bits (661), Expect = 1e-84
 Identities = 80/299 (26%), Positives = 121/299 (40%), Gaps = 22/299 (7%)

Query: 45  PPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI 104
            P      P  +   P  GK        Y L   LG+G FG  +   +     + A K I
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64

Query: 105 SRRKLVYDKDMED---VRREILILQHLTGQ---PNIVEFEGAYEDKQNLHLVMEL-CSGG 157
            R +++    + D      E+ +L  +      P ++     +E ++   LV+E      
Sbjct: 65  PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124

Query: 158 ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT 217
           +LFD I  KG   E  +     Q+V  +  CH  GV+HRD+K EN L+  +      K  
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLI 182

Query: 218 DFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY-GKEIDVWSAGVILYILLSGVPPFWA 275
           DFG    +     Y +  G+  Y  PE +   +Y      VWS G++LY ++ G  PF  
Sbjct: 183 DFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

Query: 276 ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
           + E      ILE  L     P   +S     LIR+ L   P  R +  E L  PW++  
Sbjct: 242 DQE------ILEAELHF---P-AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  257 bits (658), Expect = 1e-84
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 14/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVL-HQ 248
           + HRD+KPEN LL   +E   +K +DFGL+             ++ G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 249 RY-GKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISGQAKD 306
            +  + +DVWS G++L  +L+G  P+   ++    +    E       +PW  I      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKED 334
           L+ K+L ++P  RIT  +  +  W  + 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKP 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  259 bits (663), Expect = 4e-84
 Identities = 47/353 (13%), Positives = 100/353 (28%), Gaps = 65/353 (18%)

Query: 28  QPLPRRTQQDFRPTSSRPPALSKQI---PQTSQIGPILGKPYVDITTIYDLDKELGRGQF 84
            P            S+    +S  +    Q  ++   LG+              LG+   
Sbjct: 31  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT----LVRGTVLGQEDP 86

Query: 85  GVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---------------- 128
                 T + TG  +        +      ++ ++ E+L L+ L                
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 129 --------TGQPNIVEFEGAYEDKQ--NLHLVMELCS------GGELFDRIIAKGIYSER 172
                     +  ++       D    +   +           G  L             
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
               +  Q++ ++ + H  G++H  L+P + +L   ++   +  T F   V         
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA---RV 260

Query: 233 EIVGSAYYVAPEVLHQR------------YGKEIDVWSAGVILYILLSGVPPFWAETEKG 280
               S  +  PE+  +R                 D W+ G+++Y +     P   +   G
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320

Query: 281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             E I             +I    + L+   L    + R+   +A+E P  ++
Sbjct: 321 GSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  256 bits (656), Expect = 6e-84
 Identities = 78/316 (24%), Positives = 116/316 (36%), Gaps = 17/316 (5%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTI----YDLDKEL 79
           HH            F+      P       + S+     G       +     +     L
Sbjct: 6   HHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRL 65

Query: 80  GRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG 139
           G G +G  +    K  GR YA K  S       KD      E+   + +   P  V  E 
Sbjct: 66  GHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 140 AYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHACHFMGVIHRDL 198
           A+E+   L+L  ELC G  L     A G    E +     R  +  +   H  G++H D+
Sbjct: 125 AWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183

Query: 199 KPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWS 258
           KP N  L         K  DFGL V + T    +   G   Y+APE+L   YG   DV+S
Sbjct: 184 KPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFS 240

Query: 259 AGVILYILLSGVP-PFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPK 317
            G+ +  +   +  P   E  + + +  L             +S + + ++  ML  DPK
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVMMLEPDPK 294

Query: 318 KRITAAEALEHPWLKE 333
            R TA   L  P L++
Sbjct: 295 LRATAEALLALPVLRQ 310

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  255 bits (654), Expect = 8e-84
 Identities = 88/293 (30%), Positives = 137/293 (46%), Gaps = 43/293 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD------------------ 114
           Y L  E+G+G +GV  L   +     YA K +S++KL+                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 115 -----MEDVRREILILQHLTGQPNIVEFEGAYE-----DKQNLHLVMELCSGGELFDRII 164
                +E V +EI IL+ L   PN+V+     E     ++ +L++V EL + G + + + 
Sbjct: 75  QPRGPIEQVYQEIAILKKLD-HPNVVKL---VEVLDDPNEDHLYMVFELVNQGPVME-VP 129

Query: 165 AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-V 223
                SE +A    + ++  +   H+  +IHRD+KP N L+    ED  IK  DFG+S  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNE 186

Query: 224 FIETGKVYKEIVGSAYYVAPEVL---HQRY-GKEIDVWSAGVILYILLSGVPPFWAETEK 279
           F  +  +    VG+  ++APE L    + + GK +DVW+ GV LY  + G  PF  E   
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
            +   I    L+      P I+   KDLI +ML K+P+ RI   E   HPW+ 
Sbjct: 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  256 bits (655), Expect = 1e-83
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 14/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI---VGSAYYVAPEVL-HQ 248
           + HRD+KPEN LL   +E   +K +DFGL+         + +    G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 249 RY-GKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISGQAKD 306
            +  + +DVWS G++L  +L+G  P+   ++    +    E       +PW  I      
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKED 334
           L+ K+L ++P  RIT  +  +  W  + 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKP 268

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  256 bits (655), Expect = 2e-83
 Identities = 90/309 (29%), Positives = 138/309 (44%), Gaps = 30/309 (9%)

Query: 44  RPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKS 103
            PP   +     +  G    K        Y     LG G FG  +    K   ++   K 
Sbjct: 5   EPPKAVELEGLAACEGEYSQK--------YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF 56

Query: 104 ISRRKLVYDKDMED-----VRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL-CSGG 157
           I + K++ D  +ED     V  EI IL  +    NI++    +E++    LVME   SG 
Sbjct: 57  IKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGL 115

Query: 158 ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT 217
           +LF  I       E  A+ I RQ+V+ V       +IHRD+K EN ++A   ED  IK  
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLI 172

Query: 218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY-GKEIDVWSAGVILYILLSGVPPFWA 275
           DFG + ++E GK++    G+  Y APEVL    Y G E+++WS GV LY L+    PF  
Sbjct: 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232

Query: 276 ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG 335
                  E  +E  +     P+  +S +   L+  +L   P++R T  + +  PW+ +  
Sbjct: 233 ------LEETVEAAIHP---PYL-VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282

Query: 336 ATSDKPIDS 344
             +D   + 
Sbjct: 283 NLADYTWEE 291

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  258 bits (662), Expect = 8e-83
 Identities = 106/320 (33%), Positives = 153/320 (47%), Gaps = 33/320 (10%)

Query: 45  PPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI 104
           P A  ++     +IG             Y L   LG G FG   +   + TG K A K +
Sbjct: 2   PMAEKQKHDGRVKIGH------------YILGDTLGVGTFGKVKVGKHELTGHKVAVKIL 49

Query: 105 SRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII 164
           +R+K+     +  +RREI  L+     P+I++         ++ +VME  SGGELFD I 
Sbjct: 50  NRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC 108

Query: 165 AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
             G   E+E+  + +QI++ V  CH   V+HRDLKPEN LL   +     K  DFGLS  
Sbjct: 109 KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 165

Query: 225 IETGKVYKEIVGSAYYVAPEVL-HQRY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIF 282
           +  G+  +   GS  Y APEV+  + Y G E+D+WS+GVILY LL G  PF  +    +F
Sbjct: 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF 225

Query: 283 EAILEGNLDLQSSPWPS-ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG------ 335
           + I +G         P  ++     L++ ML  DP KR T  +  EH W K+D       
Sbjct: 226 KKICDGIFYT-----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280

Query: 336 ---ATSDKPIDSAVLTRMKQ 352
              + S   ID   L  + +
Sbjct: 281 EDPSYSSTMIDDEALKEVCE 300

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  264 bits (675), Expect = 9e-83
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 33/291 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG G FG       + TG + A K   +      K+ E    EI I++ L   P
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLN-HP 72

Query: 133 NIVEFEGAYEDKQNLH------LVMELCSGGELFDRIIAKG---IYSEREAANICRQIVN 183
           N+V      +  Q L       L ME C GG+L   +          E     +   I +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   +IHRDLKPEN +L    +    K  D G +  ++ G++  E VG+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E+L  ++Y   +D WS G + +  ++G  PF    +   +   +    +     +  ++G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 303 --------------------QAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                               + +  ++ ML    ++R T  +       + 
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  253 bits (649), Expect = 2e-82
 Identities = 99/291 (34%), Positives = 147/291 (50%), Gaps = 21/291 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + LG G FG   L T   T +K A K ISR+ L        V REI  L+ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHP 69

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           +I++         ++ +V+E   GGELFD I+ K   +E E     +QI+  +  CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY- 250
           ++HRDLKPEN LL   +++  +K  DFGLS  +  G   K   GS  Y APEV+  + Y 
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDLIR 309
           G E+DVWS G++LY++L G  PF  E    +F+ +      +     P  +S  A+ LIR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM-----PDFLSPGAQSLIR 240

Query: 310 KMLTKDPKKRITAAEALEHPWLKEDGATSDKP--------IDSAVLTRMKQ 352
           +M+  DP +RIT  E    PW   +     +P         DS +++++ +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  243 bits (622), Expect = 3e-79
 Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 23/275 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   +G G +G      +K+ G+    K +    +  + + + +  E+ +L+ L   P
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 65

Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRI---IAKGIY-SEREAANICRQIVNVVH 186
           NIV +     D+ N  L++VME C GG+L   I     +  Y  E     +  Q+   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 187 ACH-----FMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYY 240
            CH        V+HRDLKP N  L   +    +K  DFGL+ +        K  VG+ YY
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 241 VAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           ++PE +    Y ++ D+WS G +LY L + +PPF A ++K +   I EG         P 
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----RIPY 238

Query: 300 I-SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             S +  ++I +ML      R +  E LE+P + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  238 bits (609), Expect = 6e-77
 Identities = 71/273 (26%), Positives = 129/273 (47%), Gaps = 20/273 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-VRREILILQHLTGQ 131
           Y +   LG G +G         T  + A K + ++KL    + E  V++EI +L+ L   
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65

Query: 132 PNIVE-FE-GAYEDKQNLHLVMELCSGG--ELFDRIIAKGIYSEREAANICRQIVNVVHA 187
            N+++  +    E+KQ +++VME C  G  E+ D +  K      +A     Q+++ +  
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF-PVCQAHGYFCQLIDGLEY 124

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET---GKVYKEIVGSAYYVAPE 244
            H  G++H+D+KP N LL        +K +  G++  +         +   GS  +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 245 VL--HQRY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS 301
           +      + G ++D+WSAGV LY + +G+ PF  +    +FE I +G+  +   P     
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI---P-GDCG 237

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
               DL++ ML  +P KR +  +  +H W ++ 
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  238 bits (609), Expect = 2e-76
 Identities = 74/266 (27%), Positives = 140/266 (52%), Gaps = 14/266 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   +++G G FG   L      GR+Y  K I+  ++   K+ E+ RRE+ +L ++   P
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK-HP 83

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIY-SEREAANICRQIVNVVHACHF 190
           NIV++  ++E+  +L++VM+ C GG+LF RI   KG+   E +  +   QI   +   H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQ 248
             ++HRD+K +N  L    +D  ++  DFG++ V   T ++ +  +G+ YY++PE+  ++
Sbjct: 144 RKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQAKDL 307
            Y  + D+W+ G +LY L +    F A + K +   I+ G+      P     S   + L
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYDLRSL 256

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKE 333
           + ++  ++P+ R +    LE  ++ +
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAK 282

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  225 bits (575), Expect = 5e-72
 Identities = 68/280 (24%), Positives = 112/280 (40%), Gaps = 38/280 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   + +G G FG  +    +  G+ Y  K +         + E   RE+  L  L    
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLD-HV 64

Query: 133 NIVEFEGAYED----------------KQNLHLVMELCSGGELFDRI-IAKGIY-SEREA 174
           NIV + G ++                  + L + ME C  G L   I   +G    +  A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 175 ANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI 234
             +  QI   V   H   +I+RDLKP N  L    +   +K  DFGL   ++        
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 235 VGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
            G+  Y++PE +  Q YGKE+D+++ G+IL  LL              F  + +G +   
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS-- 237

Query: 294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                    + K L++K+L+K P+ R   +E L    + +
Sbjct: 238 ----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  222 bits (568), Expect = 1e-70
 Identities = 72/307 (23%), Positives = 132/307 (42%), Gaps = 22/307 (7%)

Query: 37  DFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATG 96
           D +    + P + +  PQ +    +      +    + ++K++GRGQF   Y       G
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDG 57

Query: 97  RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG 156
              A K +    L+  K   D  +EI +L+ L   PN++++  ++ +   L++V+EL   
Sbjct: 58  VPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADA 116

Query: 157 GELFDRI---IAKGIY-SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS 212
           G+L   I     +     ER       Q+ + +   H   V+HRD+KP N  + +     
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TG 173

Query: 213 PIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGV 270
            +K  D GL   F         +VG+ YY++PE +H+  Y  + D+WS G +LY + +  
Sbjct: 174 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

Query: 271 PPFWAETE--KGIFEAILEGNLDLQSSPWPS--ISGQAKDLIRKMLTKDPKKRITAAEAL 326
            PF+ +      + + I + +      P PS   S + + L+   +  DP+KR       
Sbjct: 234 SPFYGDKMNLYSLCKKIEQCDYP----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289

Query: 327 EHPWLKE 333
           +      
Sbjct: 290 DVAKRMH 296

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  223 bits (570), Expect = 8e-70
 Identities = 44/352 (12%), Positives = 97/352 (27%), Gaps = 59/352 (16%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQ 83
                 +   ++       S          Q  ++   LG+    +         LG+  
Sbjct: 35  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLV----RGTVLGQED 90

Query: 84  FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL--------------- 128
                  T + TG  +        +      ++ ++ E+L L+ L               
Sbjct: 91  PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150

Query: 129 ---------TGQPNIVEFEGAYEDK--QNLHLVMELCSG------GELFDRIIAKGIYSE 171
                      +  ++       D    +   +              L            
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
                +  Q++ ++ + H  G++H  L+P + +L   ++   +  T F   V    G   
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLV--RDGASA 265

Query: 232 KEIVGSAY----YVAPEVL------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 281
              +G  +      A  +L              D W+ G+ +Y +     P   +   G 
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325

Query: 282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            E I             +I    + L+   L    + R+   +A+E P  ++
Sbjct: 326 SEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  215 bits (550), Expect = 6e-68
 Identities = 65/281 (23%), Positives = 102/281 (36%), Gaps = 32/281 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   ++LG G F    L      G  YA K I   +    +D E+ +RE  + +     P
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLF-NHP 86

Query: 133 NIVEFEGAYEDKQN----LHLVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNV 184
           NI+        ++       L++     G L++ I          +E +   +   I   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF----------IETGKVYKEI 234
           + A H  G  HRDLKP N LL  + +       D G                T + +   
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 235 VGSAYYVAPEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGN 289
             +  Y APE+     H    +  DVWS G +LY ++ G  P+    +KG      ++  
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263

Query: 290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           L +     P  S     L+  M+T DP +R      L    
Sbjct: 264 LSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  211 bits (539), Expect = 1e-66
 Identities = 74/291 (25%), Positives = 120/291 (41%), Gaps = 42/291 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++  + LGRG FGV +    K     YA K I       +   E V RE+  L  L   P
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE-HP 63

Query: 133 NIVEFEGAYEDKQN------------LHLVMELCSGGELFDRIIAKGIYSERE---AANI 177
            IV +  A+ +K              L++ M+LC    L D +  +    ERE     +I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI--- 234
             QI   V   H  G++HRDLKP N        D  +K  DFGL   ++  +  + +   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 235 ----------VGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IF 282
                     VG+  Y++PE +H   Y  ++D++S G+IL+ LL    PF  + E+    
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237

Query: 283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             +           +         +++ ML+  P +R  A   +E+   ++
Sbjct: 238 TDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  211 bits (540), Expect = 2e-66
 Identities = 94/309 (30%), Positives = 137/309 (44%), Gaps = 28/309 (9%)

Query: 37  DFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLD--KELGRGQFGVTYLCTKKA 94
           D      RP A S Q  Q          P        D    K LG G F    L  + A
Sbjct: 2   DGTAAEPRPGAGSLQHAQPP--------PQPRKKRPEDFKFGKILGEGSFSTVVLARELA 53

Query: 95  TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC 154
           T R+YA K + +R ++ +  +  V RE  ++  L   P  V+    ++D + L+  +   
Sbjct: 54  TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYA 112

Query: 155 SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI 214
             GEL   I   G + E        +IV+ +   H  G+IHRDLKPEN LL    ED  I
Sbjct: 113 KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHI 169

Query: 215 KATDFGLS---VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGV 270
           + TDFG +               VG+A YV+PE+L  +   K  D+W+ G I+Y L++G+
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

Query: 271 PPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT------AAE 324
           PPF A  E  IF+ I++   D    P      +A+DL+ K+L  D  KR+          
Sbjct: 230 PPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 285

Query: 325 ALEHPWLKE 333
              HP+ + 
Sbjct: 286 LKAHPFFES 294

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  206 bits (525), Expect = 2e-64
 Identities = 60/283 (21%), Positives = 117/283 (41%), Gaps = 34/283 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   +++G G+FG  + C K+  G  YA K  S++ L    D ++  RE+     L    
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI----IAKGIYSEREAANICRQIVNVVHAC 188
           ++V +  A+ +  ++ +  E C+GG L D I         + E E  ++  Q+   +   
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 189 HFMGVIHRDLKPENFLL----------------ASKEEDSPIKATDFGLSVFIETGKVYK 232
           H M ++H D+KP N  +                         K  D G    I + +V  
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190

Query: 233 EIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
              G + ++A EVL +   +  + D+++  + +       P      +   +  I +G L
Sbjct: 191 --EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRL 245

Query: 291 DLQSSPWPS-ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
                  P  +S +  +L++ M+  DP++R +A   ++H  L 
Sbjct: 246 ----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  206 bits (527), Expect = 3e-64
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 41/287 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             + + L  G F   Y      +GR+YA K +   +   ++    + +E+  ++ L+G P
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHP 86

Query: 133 NIVEFEGAY-------EDKQNLHLVMELCSGGELFDRII---AKGIYSEREAANICRQIV 182
           NIV+F  A        +  Q   L++     G+L + +    ++G  S      I  Q  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 183 NVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK-------- 232
             V   H     +IHRDLK EN LL++      IK  DFG +  I     Y         
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 233 -----EIVGSAYYVAPEVL----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
                    +  Y  PE++    +   G++ D+W+ G ILY+L     PF    E G   
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKL 259

Query: 284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
            I+ G   +   P  +       LIR ML  +P++R++ AE +    
Sbjct: 260 RIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  202 bits (517), Expect = 1e-62
 Identities = 90/275 (32%), Positives = 138/275 (50%), Gaps = 32/275 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY-------YVAPEV 245
           +I+RDLKPEN L+   ++   I+ TDFG +         K + G  +        +APE+
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFA---------KRVKGRTWTLCGTPEALAPEI 209

Query: 246 LHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQ 303
           +  + Y K +D W+ GV++Y + +G PPF+A+    I+E I+ G +      +PS  S  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSD 264

Query: 304 AKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
            KDL+R +L  D  KR         +   H W   
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  200 bits (512), Expect = 3e-62
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 32/275 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + + + LG G FG  +L   +  GR YA K + +  +V  K +E    E L+L  +T  P
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I+   G ++D Q + ++M+   GGELF  +     +    A     ++   +   H   
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY-------YVAPEV 245
           +I+RDLKPEN LL   +++  IK TDFG +         K +    Y       Y+APEV
Sbjct: 127 IIYRDLKPENILL---DKNGHIKITDFGFA---------KYVPDVTYTLCGTPDYIAPEV 174

Query: 246 LH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISGQ 303
           +  + Y K ID WS G+++Y +L+G  PF+       +E IL   L      +P   +  
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-----FPPFFNED 229

Query: 304 AKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
            KDL+ +++T+D  +R+        +   HPW KE
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  201 bits (514), Expect = 2e-61
 Identities = 88/271 (32%), Positives = 136/271 (50%), Gaps = 16/271 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++ K +GRG FG   L   K+T + YA K +S+ +++   D      E  I+      P
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SP 129

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+   A++D + L++VME   GG+L   +++     E+ A     ++V  + A H MG
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVY-KEIVGSAYYVAPEVL---- 246
            IHRD+KP+N LL   ++   +K  DFG  +   + G V     VG+  Y++PEVL    
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
               YG+E D WS GV LY +L G  PF+A++  G +  I+     L       IS +AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305

Query: 306 DLIRKMLTKDPKKRITAAEALE---HPWLKE 333
           +LI   LT D + R+      E   H + K 
Sbjct: 306 NLICAFLT-DREVRLGRNGVEEIKRHLFFKN 335

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  205 bits (523), Expect = 2e-60
 Identities = 86/341 (25%), Positives = 148/341 (43%), Gaps = 21/341 (6%)

Query: 5   FTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGK 64
           F++S    +       + P   +QP      Q+ R    +    S +  +  Q   +   
Sbjct: 124 FSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELN 183

Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REI 122
            ++ +   + + + +GRG FG  Y C K  TG+ YA K + ++++   +        R +
Sbjct: 184 IHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
           L L      P IV    A+     L  +++L +GG+L   +   G++SE +      +I+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVA 242
             +   H   V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+A
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMA 358

Query: 243 PEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFEAILEGNLDLQSSPW 297
           PEVL     Y    D +S G +L+ LL G  PF     K    I    L   ++L   P 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---P- 414

Query: 298 PSISGQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
            S S + + L+  +L +D  +R+      A E  E P+ + 
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  196 bits (499), Expect = 1e-59
 Identities = 66/268 (24%), Positives = 129/268 (48%), Gaps = 16/268 (5%)

Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           ++ + +G+G FG   +  K  T + YA K ++++K V   ++ +V +E+ I+Q L   P 
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPF 76

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           +V    +++D++++ +V++L  GG+L   +     + E        ++V  +       +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR---- 249
           IHRD+KP+N LL   +E   +  TDF ++  +        + G+  Y+APE+   R    
Sbjct: 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193

Query: 250 YGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           Y   +D WS GV  Y LL G  P+    + + K I        +     P  + S +   
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMVS 249

Query: 307 LIRKMLTKDPKKRITAAEAL-EHPWLKE 333
           L++K+L  +P +R +    +   P++ +
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  195 bits (497), Expect = 1e-58
 Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 18/274 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG FG   +   K   + +A K +++ +++   +    R E  +L +     
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SK 134

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFM 191
            I     A++D  NL+LVM+   GG+L   +   +    E  A     ++V  + + H +
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVY-KEIVGSAYYVAPEVL--- 246
             +HRD+KP+N L+   + +  I+  DFG     +E G V     VG+  Y++PE+L   
Sbjct: 195 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-ISG 302
                RYG E D WS GV +Y +L G  PF+AE+    +  I+      Q     + +S 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311

Query: 303 QAKDLIRKMLTKDPKKRITAAEALE---HPWLKE 333
            AKDLIR+++    + R+      +   HP+   
Sbjct: 312 NAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  191 bits (488), Expect = 3e-58
 Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 10/264 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L K LG+G FG  +L   K T + +A K++ +  ++ D D+E    E  +L      P
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +      ++ K+NL  VME  +GG+L   I +   +    A     +I+  +   H  G
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
           +++RDLK +N LL   ++D  IK  DFG+    +          G+  Y+APE+L  Q+Y
Sbjct: 139 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 195

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
              +D WS GV+LY +L G  PF  + E+ +F +I   N          +  +AKDL+ K
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVK 251

Query: 311 MLTKDPKKRITAAEAL-EHPWLKE 333
           +  ++P+KR+     + +HP  +E
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFRE 275

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  192 bits (490), Expect = 6e-58
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 20/276 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ K +GRG F    +   K TG+ YA K +++  ++   ++   R E  +L +   + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RR 121

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFM 191
            I +   A++D+  L+LVME   GG+L   +   G       A     +IV  + + H +
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVY-KEIVGSAYYVAPEVL--- 246
           G +HRD+KP+N LL   +    I+  DFG  +     G V     VG+  Y++PE+L   
Sbjct: 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238

Query: 247 -----HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS-I 300
                   YG E D W+ GV  Y +  G  PF+A++    +  I+     L        +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298

Query: 301 SGQAKDLIRKMLTKDPKKRITAAEALE---HPWLKE 333
             +A+D I+++L   P+ R+    A +   HP+   
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  190 bits (486), Expect = 6e-58
 Identities = 82/269 (30%), Positives = 125/269 (46%), Gaps = 15/269 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++  + LG+G FG   L   K TG  YA K + +  ++ D D+E    E  IL      P
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            + +    ++    L  VME  +GG+L   I     + E  A     +I++ +   H  G
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
           +I+RDLK +N LL   + +   K  DFG+    I  G       G+  Y+APE+L    Y
Sbjct: 145 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G  +D W+ GV+LY +L G  PF AE E  +FEAIL   +         +   A  +++ 
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGILKS 257

Query: 311 MLTKDPKKRI------TAAEALEHPWLKE 333
            +TK+P  R+           L HP+ KE
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  190 bits (484), Expect = 2e-57
 Identities = 87/308 (28%), Positives = 143/308 (46%), Gaps = 19/308 (6%)

Query: 31  PRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLC 90
             +  +      + PPA S+QI            P+   +  +   K +G+G FG   L 
Sbjct: 4   QPQEPELMNANPAPPPAPSQQINLGPS-----SNPHAKPSD-FHFLKVIGKGSFGKVLLA 57

Query: 91  TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV 150
             KA    YA K + ++ ++  K+ + +  E  +L      P +V    +++    L+ V
Sbjct: 58  RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117

Query: 151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE 210
           ++  +GGELF  +  +  + E  A     +I + +   H + +++RDLKPEN LL S   
Sbjct: 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--- 174

Query: 211 DSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS 268
              I  TDFGL    IE         G+  Y+APEVLH Q Y + +D W  G +LY +L 
Sbjct: 175 QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234

Query: 269 GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI----TAAE 324
           G+PPF++     +++ IL   L L+    P+I+  A+ L+  +L KD  KR+       E
Sbjct: 235 GLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFME 290

Query: 325 ALEHPWLK 332
              H +  
Sbjct: 291 IKSHVFFS 298

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  189 bits (482), Expect = 3e-57
 Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 14/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++    LG+G FG   L  +K T   YA K + +  ++ D D+E    E  +L      P
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            + +    ++    L+ VME  +GG+L   I   G + E  A     +I   +      G
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
           +I+RDLK +N +L   + +  IK  DFG+    I  G   K   G+  Y+APE++ +Q Y
Sbjct: 142 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           GK +D W+ GV+LY +L+G  PF  E E  +F++I+E N+     P  S+S +A  + + 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKG 254

Query: 311 MLTKDPKKRI-----TAAEALEHPWLKE 333
           ++TK P KR+        +  EH + + 
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  193 bits (492), Expect = 1e-56
 Identities = 93/319 (29%), Positives = 149/319 (46%), Gaps = 22/319 (6%)

Query: 27  YQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGV 86
           +Q L R T +            S    +  Q   +  +P V   T +   + LG+G FG 
Sbjct: 142 FQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQP-VTKNT-FRQYRVLGKGGFGE 199

Query: 87  TYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN 146
              C  +ATG+ YACK + ++++   K       E  IL+       +V    AYE K  
Sbjct: 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDA 258

Query: 147 LHLVMELCSGGELFDRI--IAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL 204
           L LV+ L +GG+L   I  + +  + E  A     +I   +   H   +++RDLKPEN L
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318

Query: 205 LASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVIL 263
           L   ++   I+ +D GL+V +  G+  K  VG+  Y+APEV+ ++RY    D W+ G +L
Sbjct: 319 L---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLL 375

Query: 264 YILLSGVPPFWAETEKG----IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKR 319
           Y +++G  PF    +K     +   + E   +         S QA+ L  ++L KDP +R
Sbjct: 376 YEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAER 431

Query: 320 I-----TAAEALEHPWLKE 333
           +     +A E  EHP  K+
Sbjct: 432 LGCRGGSAREVKEHPLFKK 450

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  187 bits (477), Expect = 1e-56
 Identities = 46/287 (16%), Positives = 93/287 (32%), Gaps = 37/287 (12%)

Query: 72  IYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +  +   LG G F   Y  T+         +K+  K           +     + +  L+
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLK 122

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-----SEREAANICRQI 181
               Q   ++F  A+  +    LV EL S G L + I            +    +   ++
Sbjct: 123 PSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSP--------IKATDFGLSV---FIETGKV 230
           + ++   H   +IH D+KP+NF+L +   +          +   D G S+       G +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 231 YKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN 289
           +     ++ +   E+L  + +  +ID +     +Y +L G                L   
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP---WLKE 333
           L      W        +    ML       + + + L        ++
Sbjct: 302 LP-HLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  194 bits (494), Expect = 2e-56
 Identities = 89/340 (26%), Positives = 149/340 (43%), Gaps = 20/340 (5%)

Query: 1   MGLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGP 60
             L        ++P+     E      Q   R      +          K     S+   
Sbjct: 277 KLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA-----KIGQGTKAPEEKTANTISKFDN 331

Query: 61  ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRR 120
              +  + +T  ++    LG+G FG   L  +K T   YA K + +  ++ D D+E    
Sbjct: 332 NGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 390

Query: 121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
           E  +L      P + +    ++    L+ VME  +GG+L   I   G + E  A     +
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAY 239
           I   +      G+I+RDLK +N +L   + +  IK  DFG+    I  G   K   G+  
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           Y+APE++ +Q YGK +D W+ GV+LY +L+G  PF  E E  +F++I+E N+     P  
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-K 563

Query: 299 SISGQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
           S+S +A  + + ++TK P KR+        +  EH + + 
Sbjct: 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  186 bits (474), Expect = 3e-56
 Identities = 89/268 (33%), Positives = 141/268 (52%), Gaps = 15/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+ T  P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP 65

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
           V++RD+K EN +L   ++D  IK TDFGL    I  G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL   +        ++S +AK L+  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 238

Query: 311 MLTKDPKKRI-----TAAEALEHPWLKE 333
           +L KDPK+R+      A E +EH +   
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  191 bits (486), Expect = 4e-56
 Identities = 91/336 (27%), Positives = 148/336 (44%), Gaps = 29/336 (8%)

Query: 15  ISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYD 74
           ++ +   +    +QPL R           +    S    +  Q   +  +P         
Sbjct: 131 VARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPM----GEDW 186

Query: 75  LD--KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
               + LGRG FG  + C  KATG+ YACK +++++L   K  +    E  IL       
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA-KVHSR 245

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHAC 188
            IV    A+E K +L LVM + +GG++   I         + E  A     QIV+ +   
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGKVYKEIVGSAYYVAPEVL- 246
           H   +I+RDLKPEN LL   ++D  ++ +D GL+V         K   G+  ++APE+L 
Sbjct: 306 HQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLDLQSSPWPSISG 302
            + Y   +D ++ GV LY +++   PF A  EK     + + +LE  +     P    S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY---P-DKFSP 418

Query: 303 QAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
            +KD    +L KDP+KR+     +      HP  ++
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  187 bits (476), Expect = 5e-56
 Identities = 83/328 (25%), Positives = 150/328 (45%), Gaps = 27/328 (8%)

Query: 23  PHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRG 82
            HH    +P      F+          K+   T + G       + +   +DL + +GRG
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGK--ASSSLGLQD-FDLLRVIGRG 63

Query: 83  QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE 142
            +    L   K T R YA + + +  +  D+D++ V+ E  + +  +  P +V     ++
Sbjct: 64  SYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123

Query: 143 DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPEN 202
            +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G+I+RDLK +N
Sbjct: 124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183

Query: 203 FLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAG 260
            LL   + +  IK TD+G+    +  G       G+  Y+APE+L  + YG  +D W+ G
Sbjct: 184 VLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240

Query: 261 VILYILLSGVPPFW---------AETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           V+++ +++G  PF            TE  +F+ ILE  + +   P  S+S +A  +++  
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKAASVLKSF 296

Query: 312 LTKDPKKRI------TAAEALEHPWLKE 333
           L KDPK+R+        A+   HP+ + 
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRN 324

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  184 bits (469), Expect = 2e-55
 Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 24/278 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + +GRG +    L   K T R YA K + +  +  D+D++ V+ E  + +  +  P
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V     ++ +  L  V+E  +GG+L   +  +    E  A     +I   ++  H  G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
           +I+RDLK +N LL   + +  IK TD+G+    +  G       G+  Y+APE+L  + Y
Sbjct: 131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187

Query: 251 GKEIDVWSAGVILYILLSGVPPFW---------AETEKGIFEAILEGNLDLQSSPWPSIS 301
           G  +D W+ GV+++ +++G  PF            TE  +F+ ILE  + +   P  S+S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLS 243

Query: 302 GQAKDLIRKMLTKDPKKRI------TAAEALEHPWLKE 333
            +A  +++  L KDPK+R+        A+   HP+ + 
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  184 bits (468), Expect = 2e-55
 Identities = 71/326 (21%), Positives = 124/326 (38%), Gaps = 22/326 (6%)

Query: 16  SSSSDESPHHRYQPLPRRTQQD-FRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYD 74
           S S      H    L +       +     P     +    ++    +   Y +      
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-REILILQHLTGQPN 133
               +GRG FG  +    K TG + A K +          +E  R  E++    L+  P 
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RLEVFRVEELVACAGLS-SPR 111

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGV 193
           IV   GA  +   +++ MEL  GG L   I   G   E  A     Q +  +   H   +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171

Query: 194 IHRDLKPENFLLASKEEDSPIKATDFGLSVFIE------TGKVYKEIVGSAYYVAPEVLH 247
           +H D+K +N LL+S    S     DFG ++ ++      +      I G+  ++APEV+ 
Sbjct: 172 LHGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 248 QR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            +    ++D+WS+  ++  +L+G  P+       +   I      ++  P PS +     
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQ 288

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLK 332
            I++ L K+P  R +A E        
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKA 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  180 bits (458), Expect = 2e-54
 Identities = 64/268 (23%), Positives = 123/268 (45%), Gaps = 16/268 (5%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
            D E+GRG F   Y      T  + A   +  RKL    + +  + E  +L+ L   PNI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87

Query: 135 VEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           V F  ++E     K+ + LV EL + G L   +    +   +   + CRQI+  +   H 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 191 MG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ 248
               +IHRDLK +N  +        +K  D GL+  ++     K ++G+  ++APE+  +
Sbjct: 148 RTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE 204

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +Y + +DV++ G+ +  + +   P ++E +    I+  +  G      S       + K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVKE 261

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKED 334
           +I   + ++  +R +  + L H + +E+
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  183 bits (467), Expect = 4e-54
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 16/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++  K LG+G FG   L  +KATGR YA K + +  +V   ++     E  +LQ+ +  P
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH-FM 191
            +   + +++    L  VME  +GGELF  +  + ++SE  A     +IV+ +   H   
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-QR 249
            V++RDLK EN +L   ++D  IK TDFGL    I+ G   K   G+  Y+APEVL    
Sbjct: 269 NVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
           YG+ +D W  GV++Y ++ G  PF+ +  + +FE IL   +        ++  +AK L+ 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLS 381

Query: 310 KMLTKDPKKRI-----TAAEALEHPWLK 332
            +L KDPK+R+      A E ++H +  
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  179 bits (457), Expect = 1e-53
 Identities = 92/331 (27%), Positives = 158/331 (47%), Gaps = 27/331 (8%)

Query: 23  PHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLD--KELG 80
            HH ++     +      ++       + +    ++       + +   I + +  K LG
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLG 63

Query: 81  RGQFGVTYLCTK---KATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNIVE 136
            G +G  +L  K     TG+ YA K + +  +V   K  E  R E  +L+H+   P +V 
Sbjct: 64  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
              A++ +  LHL+++  +GGELF  +  +  ++E E      +IV  +   H +G+I+R
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 183

Query: 197 DLKPENFLLASKEEDSPIKATDFGLS--VFIETGKVYKEIVGSAYYVAPEVLHQR---YG 251
           D+K EN LL   + +  +  TDFGLS     +  +   +  G+  Y+AP+++      + 
Sbjct: 184 DIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLDLQSSPWPSISGQAKDL 307
           K +D WS GV++Y LL+G  PF  + EK     I   IL+        P   +S  AKDL
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALAKDL 296

Query: 308 IRKMLTKDPKKRI-----TAAEALEHPWLKE 333
           I+++L KDPKKR+      A E  EH + ++
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  178 bits (454), Expect = 2e-53
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 19/271 (7%)

Query: 74  DLDKELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYD-KDMEDVRREILILQHLT 129
           +L + LG+G +G  +   K     TG+ +A K + +  +V + KD    + E  IL+ + 
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             P IV+   A++    L+L++E  SGGELF ++  +GI+ E  A     +I   +   H
Sbjct: 80  -HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-H 247
             G+I+RDLKPEN +L        +K TDFGL    I  G V     G+  Y+APE+L  
Sbjct: 139 QKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
             + + +D WS G ++Y +L+G PPF  E  K   + IL+  L+L   P P ++ +A+DL
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDL 251

Query: 308 IRKMLTKDPKKRI-----TAAEALEHPWLKE 333
           ++K+L ++   R+      A E   HP+ + 
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  177 bits (451), Expect = 5e-53
 Identities = 78/270 (28%), Positives = 135/270 (50%), Gaps = 19/270 (7%)

Query: 74  DLDKELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG 130
           +L K LG+G FG  +L  K       + YA K + ++  +  +D    + E  IL     
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE-VN 84

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV+   A++ +  L+L+++   GG+LF R+  + +++E +      ++   +   H 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLH-Q 248
           +G+I+RDLKPEN LL     +  IK TDFGLS   I+  K      G+  Y+APEV++ +
Sbjct: 145 LGIIYRDLKPENILLDE---EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            + +  D WS GV+++ +L+G  PF  +  K     IL+  L +   P   +S +A+ L+
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLL 257

Query: 309 RKMLTKDPKKRI-----TAAEALEHPWLKE 333
           R +  ++P  R+        E   H +   
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  174 bits (444), Expect = 4e-52
 Identities = 82/280 (29%), Positives = 146/280 (52%), Gaps = 25/280 (8%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   + D   ++G G  G+  L  +K +GR+ A K +    L   +  E +  E++I++ 
Sbjct: 42  DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRD 98

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
                N+VE   +Y   + L ++ME   GG L D I+++   +E + A +C  ++  +  
Sbjct: 99  YQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAY 156

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVL 246
            H  GVIHRD+K ++ LL     D  +K +DFG    I +     K +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQA 304
            +  Y  E+D+WS G+++  ++ G PP+++++  + +          L+ SP P +    
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR--------LRDSPPPKLKNSH 265

Query: 305 K------DLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           K      D + +ML +DP++R TA E L+HP+L + G   
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  174 bits (442), Expect = 4e-52
 Identities = 80/280 (28%), Positives = 135/280 (48%), Gaps = 25/280 (8%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D    Y   +++G+G  G  Y     ATG++ A + +    L      E +  EIL+++ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +  
Sbjct: 74  NK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVL 246
            H   VIHRD+K +N LL     D  +K TDFG    I         +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 247 HQR-YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQA 304
            ++ YG ++D+WS G++   ++ G PP+  E   + ++         + ++  P +    
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--------IATNGTPELQNPE 240

Query: 305 K------DLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           K      D + + L  D +KR +A E L+H +LK     S
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  172 bits (437), Expect = 2e-51
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 22/271 (8%)

Query: 79  LGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE 138
           LG+G +G+ Y     +   + A K I        +  + +  EI + +HL    NIV++ 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIVQYL 85

Query: 139 GAYEDKQNLHLVMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIH 195
           G++ +   + + ME   GG L   + +K      +E+      +QI+  +   H   ++H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145

Query: 196 RDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVLHQR---YG 251
           RD+K +N L+ +      +K +DFG S  +       +   G+  Y+APE++ +    YG
Sbjct: 146 RDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKG---IFEAILEGNLDLQSSPWP-SISGQAKDL 307
           K  D+WS G  +  + +G PP + E  +    +F  +            P S+S +AK  
Sbjct: 204 KAADIWSLGCTIIEMATGKPP-FYELGEPQAAMF-KVGMFK---VHPEIPESMSAEAKAF 258

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           I K    DP KR  A + L   +LK      
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  172 bits (439), Expect = 5e-51
 Identities = 79/329 (24%), Positives = 130/329 (39%), Gaps = 22/329 (6%)

Query: 18  SSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQT-SQIGPILGKPYVDITTIYDLD 76
           S     HH    +P      F+      PA  +        +  +  K   D   ++   
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDL 59

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           +E+G G FG  Y           A K +S      ++  +D+ +E+  LQ L   PN ++
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118

Query: 137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
           + G Y  +    LVME C G       + K    E E A +    +  +   H   +IHR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVLHQR----Y 250
           D+K  N LL+   E   +K  DFG +       +      VG+ Y++APEV+       Y
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMDEGQY 230

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAKDLIR 309
             ++DVWS G+    L    PP +       ++      +  LQS  W   S   ++ + 
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 287

Query: 310 KMLTKDPKKRITAAEALEHPWLKEDGATS 338
             L K P+ R T+   L+H ++  +   +
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  170 bits (433), Expect = 2e-50
 Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 43/303 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTG 130
           Y+   ++G G +GV + C  + TG+  A K         D  +      REI +L+ L  
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLK- 60

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
            PN+V     +  K+ LHLV E C        DR   +    E    +I  Q +  V+ C
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFC 118

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL- 246
           H    IHRD+KPEN L+        IK  DFG + +       Y + V + +Y +PE+L 
Sbjct: 119 HKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIF-------EAILEGNLDLQ- 293
              +YG  +DVW+ G +   LLSGVP +  +++      I            +     Q 
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235

Query: 294 ---------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
                             +P+IS  A  L++  L  DP +R+T  + L HP+ +      
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

Query: 339 DKP 341
           D  
Sbjct: 296 DLA 298

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  168 bits (428), Expect = 6e-50
 Identities = 79/298 (26%), Positives = 142/298 (47%), Gaps = 24/298 (8%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   ++   +++G+G FG  +      T +  A K I   +   + ++ED+++EI +L  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 76

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               P + ++ G+Y     L ++ME   GG   D ++  G   E + A I R+I+  +  
Sbjct: 77  CD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDY 134

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVL 246
            H    IHRD+K  N LL+   E   +K  DFG++  + +T       VG+ +++APEV+
Sbjct: 135 LHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 247 HQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQ- 303
            Q  Y  + D+WS G+    L  G PP       K +F       L  +++P P++ G  
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------LIPKNNP-PTLEGNY 243

Query: 304 ---AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNK 358
               K+ +   L K+P  R TA E L+H ++  +   +    +  ++ R K+++A   
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE--LIDRYKRWKAEQS 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  167 bits (426), Expect = 2e-49
 Identities = 76/276 (27%), Positives = 134/276 (48%), Gaps = 17/276 (6%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
               ++D+ ++LG G +G  Y    K TG+  A K +       + D++++ +EI I+Q 
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQQ 80

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVH 186
               P++V++ G+Y    +L +VME C  G + D I +     +E E A I +  +  + 
Sbjct: 81  CD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEV 245
             HFM  IHRD+K  N LL     +   K  DFG++  + +T      ++G+ +++APEV
Sbjct: 140 YLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196

Query: 246 LHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQ-SSPWPSISG 302
           + +  Y    D+WS G+    +  G PP+      + IF          +    W   S 
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SD 253

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
              D +++ L K P++R TA + L+HP+++     S
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  167 bits (424), Expect = 5e-49
 Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 47/303 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR----REILILQHL 128
           Y+    +G G +G+   C  K TGR  A K     K +   D + V+    REI +L+ L
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQL 81

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVH 186
               N+V      + K+  +LV E       +  +          +       QI+N + 
Sbjct: 82  R-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIG 138

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   +IHRD+KPEN L++       +K  DFG +      G+VY + V + +Y APE+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIF-------EAILEGNLDL 292
           L    +YGK +DVW+ G ++  +  G P F  +++      I            E     
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 293 Q----------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
                               +P +S    DL +K L  DP KR   AE L H + + DG 
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315

Query: 337 TSD 339
              
Sbjct: 316 AER 318

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  166 bits (422), Expect = 5e-49
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 30/287 (10%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           +D   ++++  ELG G FG  Y    K TG   A K I       ++++ED   EI IL 
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVV 185
                P IV+  GAY     L +++E C GG +   +       +E +   +CRQ++  +
Sbjct: 72  TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPE 244
           +  H   +IHRDLK  N L+     +  I+  DFG+S    +T +     +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 245 VLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPW 297
           V+         Y  + D+WS G+ L  +    PP       + + +        +  S  
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--------IAKSDP 239

Query: 298 PSI------SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           P++      S + +D ++  L K+P+ R +AA+ LEHP++    +  
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  164 bits (416), Expect = 3e-48
 Identities = 87/300 (29%), Positives = 129/300 (43%), Gaps = 44/300 (14%)

Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI 122
             P+      Y+L + +G G   V           K A K I+  K      M+++ +EI
Sbjct: 7   ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEI 64

Query: 123 LILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--------RIIAKGIYSEREA 174
             +      PNIV +  ++  K  L LVM+L SGG + D             G+  E   
Sbjct: 65  QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123

Query: 175 ANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE- 233
           A I R+++  +   H  G IHRD+K  N LL    ED  ++  DFG+S F+ TG      
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRN 180

Query: 234 -----IVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAI 285
                 VG+  ++APEV+ Q   Y  + D+WS G+    L +G  P+      K +    
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--- 237

Query: 286 LEGNLDLQSSPWPSISGQA-------------KDLIRKMLTKDPKKRITAAEALEHPWLK 332
               L LQ+ P PS+                 + +I   L KDP+KR TAAE L H + +
Sbjct: 238 ----LTLQNDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  164 bits (416), Expect = 6e-48
 Identities = 79/306 (25%), Positives = 135/306 (44%), Gaps = 29/306 (9%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   I++L + +G G +G  Y      TG+  A K +     V   + E++++EI +L+ 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKK 76

Query: 128 LTGQPNIVEFEGAY------EDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICR 179
            +   NI  + GA+           L LVME C  G + D  +        E   A ICR
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSA 238
           +I+  +   H   VIHRD+K +N LL    E++ +K  DFG+S  +  T       +G+ 
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193

Query: 239 YYVAPEVLHQR------YGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAILEGNL 290
           Y++APEV+         Y  + D+WS G+    +  G PP   +    + +F        
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPMRALFLIPRNPAP 252

Query: 291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD-KPIDSAVLTR 349
            L+S  W   S + +  I   L K+  +R    + ++HP++++       +      + R
Sbjct: 253 RLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDR 309

Query: 350 MKQFRA 355
            K+ R 
Sbjct: 310 TKKKRG 315

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  161 bits (408), Expect = 8e-47
 Identities = 65/333 (19%), Positives = 118/333 (35%), Gaps = 83/333 (24%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGR-------KYACKSISRRKLV--------------- 110
           ++  + +GRG FGV +    K           +   + ++R K++               
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 111 ---------------------------------YDKDMEDVRREILILQHLTGQPNIVEF 137
                                                M+    +I  +   +   N V  
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQ 126

Query: 138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSERE---AANICRQIVNVVHACHFMGVI 194
                 K  L++ M+LC    L D +  +    +RE     +I  QI   V   H  G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-------------VGSAYYV 241
           HRDLKP N        D  +K  DFGL   ++  +  + +             VG+  Y+
Sbjct: 187 HRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQSSPWPS 299
           +PE +H   Y  ++D++S G+IL+ LL     F  + E+  I   +           +  
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKF---PLLFTQ 297

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK 332
              Q   +++ ML+  P +R  A + +E+   +
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  156 bits (397), Expect = 3e-45
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 24/274 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            +   E+G G  G  +    + TG   A K +  R+    ++ + +  ++ ++      P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-M 191
            IV+  G +    ++ + MEL        +   +G   ER    +   IV  ++      
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----- 246
           GVIHRD+KP N LL  + +   IK  DFG+S  +   K      G A Y+APE +     
Sbjct: 145 GVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE---AILEGN---LDLQSSPWPS 299
               Y    DVWS G+ L  L +G  P+  +  K  FE    +L+     L      +  
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLP-GHMGF-- 256

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            SG  +  ++  LTKD +KR    + LEH ++K 
Sbjct: 257 -SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  156 bits (396), Expect = 5e-45
 Identities = 83/330 (25%), Positives = 128/330 (38%), Gaps = 45/330 (13%)

Query: 40  PTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKY 99
                      Q P +  +        +D    Y    +LG G +G  Y      T    
Sbjct: 6   HHHMGTLEAQTQGPGSMSVSAAPSATSIDR---YRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 100 ACKSISRRKLVYDKDMEDV----RREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS 155
           A K I   +L  + + E V     RE+ +L+ L    NI+E +        LHL+ E   
Sbjct: 63  AIKRI---RL--EHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAE 116

Query: 156 GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL--ASKEEDSP 213
             +L   +      S R   +   Q++N V+ CH    +HRDLKP+N LL  +   E   
Sbjct: 117 N-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 214 IKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGV 270
           +K  DFGL+  F    + +   + + +Y  PE+L   + Y   +D+WS   I   +L   
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

Query: 271 PPFWAETEKG----IF-------EAILEG---------------NLDLQSSPWPSISGQA 304
           P F  ++E      IF       +    G                  L+      +  + 
Sbjct: 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEG 295

Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLKED 334
            DL+  ML  DP KRI+A  ALEHP+   +
Sbjct: 296 LDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  155 bits (395), Expect = 8e-45
 Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 25/277 (9%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
                E+GRG +G       K +G+  A K I  R  V +K+ + +  ++ ++   +  P
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK------GIYSEREAANICRQIVNVVH 186
            IV+F GA   + +  + MEL S    FD+           +  E     I    V  ++
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 187 ACHFMG-VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV 245
                  +IHRD+KP N LL        IK  DFG+S  +          G   Y+APE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 196

Query: 246 LHQR-----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEA---ILEGNL-DLQSSP 296
           +        Y    DVWS G+ LY L +G  P+       +F+    +++G+   L +S 
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSE 254

Query: 297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
               S    + +   LTKD  KR    E L+HP++  
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  153 bits (390), Expect = 2e-44
 Identities = 89/296 (30%), Positives = 132/296 (44%), Gaps = 46/296 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV----RREILILQHL 128
           Y   +++G G +GV Y       G  +A K I   +L  +K+ E +     REI IL+ L
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RL--EKEDEGIPSTTIREISILKEL 57

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVH 186
               NIV+       K+ L LV E       +L D    +G      A +   Q++N + 
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIA 114

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   V+HRDLKP+N L+  + E   +K  DFGL+  F    + Y   + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILEGNLDL 292
           L   ++Y   ID+WS G I   +++G P F   +E      IF               +L
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 293 Q--------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                           S    +     DL+ KML  DP +RITA +ALEH + KE+
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  154 bits (391), Expect = 3e-44
 Identities = 76/312 (24%), Positives = 120/312 (38%), Gaps = 54/312 (17%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-----VRREILILQH 127
           +   ++LG G +   Y    K TG   A K +   KL    D E+       REI +++ 
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KL----DSEEGTPSTAIREISLMKE 59

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGG-----ELFDRIIAKGIYSEREAANICRQIV 182
           L    NIV        +  L LV E          +                     Q++
Sbjct: 60  LK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYV 241
             +  CH   ++HRDLKP+N L+  + +   +K  DFGL+  F      +   V + +Y 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYR 175

Query: 242 APEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILEG 288
           AP+VL   + Y   ID+WS G IL  +++G P F    ++     IF       E++   
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 289 -----------------NLD--LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
                            +L   LQ      + G   D +  +L  +P  R++A +AL HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 330 WLKEDGATSDKP 341
           W  E    +   
Sbjct: 296 WFAEYYHHASMG 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  152 bits (387), Expect = 5e-44
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 23/274 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            +   ELGRG +GV        +G+  A K I  R  V  ++ + +  ++ I       P
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGG--ELFDRIIAK-GIYSEREAANICRQIVNVVHACH 189
             V F GA   + ++ + MEL      + + ++I K     E     I   IV  +   H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 190 F-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH- 247
             + VIHRD+KP N L+ +  +   +K  DFG+S ++          G   Y+APE ++ 
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 248 ----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE---AILEGN-LDLQSSPWPS 299
               + Y  + D+WS G+ +  L     P+  ++    F+    ++E     L +  +  
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF-- 239

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            S +  D   + L K+ K+R T  E ++HP+   
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  153 bits (388), Expect = 8e-44
 Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 50/313 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-----VRREILILQH 127
           Y    +LG G +   Y    K T    A K I   +L    + E+       RE+ +L+ 
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RL----EHEEGAPCTAIREVSLLKD 56

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVV 185
           L    NIV        +++L LV E       +  D      I +         Q++  +
Sbjct: 57  LK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLLRGL 113

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPE 244
             CH   V+HRDLKP+N L+  + E   +K  DFGL+       K Y   V + +Y  P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILEGNLD 291
           +L     Y  +ID+W  G I Y + +G P F   T +     IF       E    G L 
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 292 LQ---------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA 336
            +                S  P +     DL+ K+L  + + RI+A +A++HP+    G 
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

Query: 337 TSDK-PIDSAVLT 348
              K P  +++  
Sbjct: 291 RIHKLPDTTSIFA 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  150 bits (382), Expect = 3e-43
 Identities = 80/298 (26%), Positives = 124/298 (41%), Gaps = 48/298 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV----RREILILQHL 128
           Y+  +++G G +G  +    + T    A K +   +L  D D E V     REI +L+ L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RL--DDDDEGVPSSALREICLLKEL 58

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVH 186
               NIV         + L LV E C     + FD     G        +   Q++  + 
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   V+HRDLKP+N L+    E   +K  +FGL+  F    + Y   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 246 L--HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG----IFEAI------------- 285
           L   + Y   ID+WSAG I   L + G P F           IF  +             
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 286 ---------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                          L +   P ++   +DL++ +L  +P +RI+A EAL+HP+  + 
Sbjct: 233 LPDYKPYPMYPATTSLVNV-VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  152 bits (386), Expect = 5e-43
 Identities = 58/353 (16%), Positives = 120/353 (33%), Gaps = 63/353 (17%)

Query: 66  YVDITTIYDLDKELGRGQ--FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL 123
           ++     Y+L   +G+G        L   K TG     + I+      ++ +  ++ E+ 
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELH 78

Query: 124 ILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQI 181
           + +     PNIV +   +     L +V    + G   D          +E   A I + +
Sbjct: 79  VSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137

Query: 182 VNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV-FIETGK-------VYKE 233
           +  +   H MG +HR +K  + L++    D  +  +    ++  I  G+         K 
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 234 IVGSAYYVAPEVLHQR---YGKEIDVWSAGVILYILLSGVPPF----------------- 273
            V    +++PEVL Q    Y  + D++S G+    L +G  PF                 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 274 -------------------WAETEKGIFEAILEGNLDLQSSPWPSI------SGQAKDLI 308
                               +    G+ +++        +   PS       S      +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            + L ++P  R +A+  L H + K+    + + +   +L  +         + 
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE-LLRPVTPITNFEGSQS 366

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  150 bits (382), Expect = 5e-43
 Identities = 76/300 (25%), Positives = 118/300 (39%), Gaps = 45/300 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR-----REILILQH 127
           Y+   E+G G +G  Y      +G   A KS+   ++               RE+ +L+ 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRR 67

Query: 128 LTGQ--PNIVE-----FEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANIC 178
           L     PN+V           + +  + LV E          D+    G+       ++ 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL-PAETIKDLM 126

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
           RQ +  +   H   ++HRDLKPEN L+ S      +K  DFGL+           +V + 
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVVTL 183

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAIL 286
           +Y APEVL    Y   +D+WS G I   +    P F   +E      IF       E   
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243

Query: 287 EGNLDLQSS---PW---------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
             ++ L      P          P +      L+ +MLT +P KRI+A  AL+H +L +D
Sbjct: 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  150 bits (380), Expect = 9e-43
 Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 33/284 (11%)

Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN 133
           ++++ +GRG FGV      +   +  A K     ++  + + +    E+  L  +   PN
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQLSRVN-HPN 62

Query: 134 IVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQI---VNVVHA 187
           IV+  GA      + LVME   GG L++ +        Y+   A + C Q    V  +H+
Sbjct: 63  IVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
                +IHRDLKP N LL      + +K  DFG +  I+T        GSA ++APEV  
Sbjct: 121 MQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFE 176

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFW--AETEKGIFEAILEGN-LDLQSSPWPSISGQ 303
              Y ++ DV+S G+IL+ +++   PF         I  A+  G    L  +    I   
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--- 233

Query: 304 AKDLIRKMLTKDPKKRITAAE---ALEHPWLKEDGATSDKPIDS 344
            + L+ +  +KDP +R +  E    + H  L      +D+P+  
Sbjct: 234 -ESLMTRCWSKDPSQRPSMEEIVKIMTH--LMRYFPGADEPLQY 274

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  150 bits (382), Expect = 9e-43
 Identities = 82/326 (25%), Positives = 129/326 (39%), Gaps = 46/326 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED-----VRREILILQH 127
           Y+    LG GQF   Y    K T +  A K I   KL +  + +D       REI +LQ 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQE 68

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVV 185
           L+  PNI+    A+  K N+ LV +        +        + +           +  +
Sbjct: 69  LS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGL 125

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPE 244
              H   ++HRDLKP N LL        +K  DFGL+  F    + Y   V + +Y APE
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 245 VL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAI------------- 285
           +L   + YG  +D+W+ G IL  LL  VP    +++      IFE +             
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242

Query: 286 LEGNLDLQSSP-------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS 338
           L   +  +S P       + +      DLI+ +   +P  RITA +AL+  +       +
Sbjct: 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302

Query: 339 DK---PIDSAVLTRMKQFRAMNKMKK 361
                P  +  +  +K+        K
Sbjct: 303 PGCQLPRPNCPVETLKEQSNPALAIK 328

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  150 bits (381), Expect = 1e-42
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 63/306 (20%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L ++LGRG++   +         K   K +   K V  K    ++REI IL++L G P
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKK---IKREIKILENLRGGP 91

Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANIC---RQIVNVVHA 187
           NI+      +D   +   LV E  +  +       K +Y      +I     +I+  +  
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDY 145

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH MG++HRD+KP N ++  +     ++  D+GL+ F   G+ Y   V S Y+  PE+L 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG---------IFEAI----LEGNLDL 292
            +Q Y   +D+WS G +L  ++    PF+     G         I + +    L   +D 
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFF----HGHDNYDQLVRIAKVLGTEDLYDYIDK 259

Query: 293 QSS----------------PW---------PSISGQAKDLIRKMLTKDPKKRITAAEALE 327
            +                  W           +S +A D + K+L  D + R+TA EA+E
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319

Query: 328 HPWLKE 333
           HP+   
Sbjct: 320 HPYFYT 325

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  149 bits (378), Expect = 2e-42
 Identities = 85/296 (28%), Positives = 128/296 (43%), Gaps = 47/296 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDV----RREILILQHL 128
           Y   +++G G +GV Y       GR  A K I   +L  D + E +     REI +L+ L
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI---RL--DAEDEGIPSTAIREISLLKEL 76

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANICRQIVNVVH 186
              PNIV        ++ L LV E       ++ D    K    + +      Q++  V 
Sbjct: 77  H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVA 133

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEV 245
            CH   ++HRDLKP+N L+ S      +K  DFGL+  F    + Y   V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 246 L--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAILEGNLDL 292
           L   ++Y   +D+WS G I   +++G P F   T+      IF               +L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 293 Q---------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                           SS  P    +  DL+  ML  DP KRI+A +A+ HP+ K+
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  148 bits (376), Expect = 7e-42
 Identities = 72/326 (22%), Positives = 118/326 (36%), Gaps = 49/326 (15%)

Query: 50  KQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL 109
           +Q  +         K        ++   ELG G  GV +  + K +G   A K I     
Sbjct: 12  QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLE 69

Query: 110 VYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY 169
           +       + RE+ +L H    P IV F GA+     + + ME   GG L   +   G  
Sbjct: 70  IKPAIRNQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 128

Query: 170 SEREAANICRQIVNVVHACHFMG-VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
            E+    +   ++  +        ++HRD+KP N L+ S+ E   IK  DFG+S  +   
Sbjct: 129 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS 185

Query: 229 KVYKEIVGSAYYVAPEVLHQR-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
                 VG+  Y++PE L    Y  + D+WS G+ L  +  G  P      K +      
Sbjct: 186 MA-NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244

Query: 288 --------------------GNLDLQSSPWPSI--------------------SGQAKDL 307
                                   + S P  +I                    S + +D 
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKE 333
           + K L K+P +R    + + H ++K 
Sbjct: 305 VNKCLIKNPAERADLKQLMVHAFIKR 330

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  145 bits (367), Expect = 1e-40
 Identities = 77/314 (24%), Positives = 124/314 (39%), Gaps = 51/314 (16%)

Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDV----RREILILQH 127
           Y+   E+G G +G  +     K  GR  A K +   ++      E +     RE+ +L+H
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RV--QTGEEGMPLSTIREVAVLRH 67

Query: 128 LTGQ--PNIVE-----FEGAYEDKQNLHLVMELCSG--GELFDRIIAKGIYSEREAANIC 178
           L     PN+V           + +  L LV E          D++   G+       ++ 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV-PTETIKDMM 126

Query: 179 RQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA 238
            Q++  +   H   V+HRDLKP+N L+ S  +   IK  DFGL+           +V + 
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTL 183

Query: 239 YYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IF-------EAIL 286
           +Y APEVL    Y   +D+WS G I   +    P F   ++      I        E   
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 287 EGNLDLQ------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
             ++ L                   I    KDL+ K LT +P KRI+A  AL HP+ ++ 
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

Query: 335 GATSDKPIDSAVLT 348
               ++  ++    
Sbjct: 304 ----ERCKENLDSH 313

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  146 bits (371), Expect = 2e-40
 Identities = 83/306 (27%), Positives = 121/306 (39%), Gaps = 56/306 (18%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI---SRRKLVYDKDMEDVRREILIL 125
               Y   K +G G FGV Y      +G   A K +    R K           RE+ I+
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----------RELQIM 101

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRII-----AKGIYSEREA 174
           + L    NIV         G  +D+  L+LV++     E   R+      AK        
Sbjct: 102 RKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYV 158

Query: 175 ANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI 234
                Q+   +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 216

Query: 235 VGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIF------ 282
           + S YY APE++     Y   IDVWSAG +L  LL G P F  ++       I       
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276

Query: 283 --EAILEGNLD--------LQSSPW-----PSISGQAKDLIRKMLTKDPKKRITAAEALE 327
             E I E N +        +++ PW     P    +A  L  ++L   P  R+T  EA  
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

Query: 328 HPWLKE 333
           H +  E
Sbjct: 337 HSFFDE 342

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  144 bits (365), Expect = 2e-40
 Identities = 82/323 (25%), Positives = 135/323 (41%), Gaps = 58/323 (17%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           D+ + Y   K LG G  G+ +        ++ A K     K+V           REI I+
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKII 62

Query: 126 QHLTGQPNIVE--------------FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSE 171
           + L    NIV+                G+  +  ++++V E     +L   ++ +G   E
Sbjct: 63  RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLE 119

Query: 172 REAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY 231
             A     Q++  +   H   V+HRDLKP N  + +  ED  +K  DFGL+  ++    +
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSH 177

Query: 232 K----EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI 285
           K    E + + +Y +P +L     Y K ID+W+AG I   +L+G   F    E    + I
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 286 LE--GNLD--------------LQSSPW----------PSISGQAKDLIRKMLTKDPKKR 319
           LE    +               +++             P IS +A D + ++LT  P  R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 320 ITAAEALEHPWLKEDGATSDKPI 342
           +TA EAL HP++       D+PI
Sbjct: 298 LTAEEALSHPYMSIYSFPMDEPI 320

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  139 bits (352), Expect = 5e-39
 Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 27/272 (9%)

Query: 74  DLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL----VYDKDMEDVRREILILQHLT 129
           + +K++G+G FG+ +           A KS+            +  ++ +RE+ I+ +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQI---VNVV 185
             PNIV+  G         +VME    G+L+ R++ K           +   I   +  +
Sbjct: 82  -HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSP--IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
              +   ++HRDL+  N  L S +E++P   K  DFGLS           ++G+  ++AP
Sbjct: 139 QNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMAP 195

Query: 244 EVL---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI 300
           E +    + Y ++ D +S  +ILY +L+G  PF   +   I    +     L+    P+I
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR----PTI 251

Query: 301 SGQA----KDLIRKMLTKDPKKRITAAEALEH 328
                   +++I    + DPKKR   +  ++ 
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  141 bits (357), Expect = 5e-39
 Identities = 78/303 (25%), Positives = 125/303 (41%), Gaps = 48/303 (15%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           ++   Y     +G G +G         TG + A K +SR    +   +   R  RE+ +L
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLL 82

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           +H+    N++          + E+  +++LV  L  G +L + I+     ++     +  
Sbjct: 83  KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIY 139

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           QI+  +   H   +IHRDLKP N  +    ED  +K  DFGL+    T       V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTADEMTGYVATRW 194

Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD---- 291
           Y APE++     Y + +D+WS G I+  LL+G   F         + IL   G       
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254

Query: 292 -----------LQSSPW----------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                      +QS                +  A DL+ KML  D  KRITAA+AL H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

Query: 331 LKE 333
             +
Sbjct: 315 FAQ 317

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  143 bits (362), Expect = 6e-39
 Identities = 74/313 (23%), Positives = 123/313 (39%), Gaps = 57/313 (18%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
            +   Y   K +G G  G+          R  A K +SR    +       R  RE++++
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLM 115

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           + +    NI+        +   E+ Q+++LVMEL        ++I   +      + +  
Sbjct: 116 KCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMEL-DHERMSYLLY 171

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q++  +   H  G+IHRDLKP N ++   + D  +K  DFGL+    T  +    V + Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228

Query: 240 YVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPF------------------------- 273
           Y APEV L   Y + +D+WS G I+  ++     F                         
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288

Query: 274 ------------WAETEKGIFEAILEG-NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRI 320
                         +     F  +         S      + QA+DL+ KML  DP KRI
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348

Query: 321 TAAEALEHPWLKE 333
           +  +AL+HP++  
Sbjct: 349 SVDDALQHPYINV 361

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  141 bits (358), Expect = 9e-39
 Identities = 86/337 (25%), Positives = 130/337 (38%), Gaps = 56/337 (16%)

Query: 40  PTSSRPPALSKQIPQTSQIGPI-----LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKA 94
             S+ P    K  P       I      GK        Y   K +G G FGV +      
Sbjct: 4   TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63

Query: 95  TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEF------EGAYEDKQNLH 148
           +  + A K + +       D     RE+ I++ +   PN+V+        G  +D+  L+
Sbjct: 64  SD-EVAIKKVLQ-------DKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 149 LVMELCSGGELFDRII-----AKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF 203
           LV+E     E   R        K             Q++  +   H +G+ HRD+KP+N 
Sbjct: 115 LVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN- 171

Query: 204 LLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGV 261
           LL        +K  DFG +  +  G+     + S YY APE++     Y   ID+WS G 
Sbjct: 172 LLLDPPSGV-LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGC 230

Query: 262 ILYILLSGVPPFWAETE----KGIF--------EAILEGNLD--------LQSSPW---- 297
           ++  L+ G P F  E+       I         E I   N +        ++  P+    
Sbjct: 231 VMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290

Query: 298 -PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            P     A DLI ++L   P  R+TA EAL HP+  E
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  140 bits (355), Expect = 1e-38
 Identities = 86/318 (27%), Positives = 138/318 (43%), Gaps = 54/318 (16%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           ++   Y     +G G +G       K +G K A K +SR    +  ++   R  RE+L+L
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLL 77

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           +H+    N++          +  +  + +LVM      +L  +I+     SE +   +  
Sbjct: 78  KHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKF-SEEKIQYLVY 133

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q++  +   H  GV+HRDLKP N  +    ED  +K  DFGL+   +        V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEM--TGYVVTRW 188

Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--GNLD---- 291
           Y APEV+     Y + +D+WS G I+  +L+G   F  +        IL+  G       
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248

Query: 292 -----------LQSSPW----------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                      +QS P           P  S QA DL+ KML  D  KR+TAA+AL HP+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

Query: 331 LK-----EDGATSDKPID 343
            +     E+   + +P D
Sbjct: 309 FEPFRDPEEETEAQQPFD 326

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  140 bits (355), Expect = 1e-38
 Identities = 81/313 (25%), Positives = 131/313 (41%), Gaps = 57/313 (18%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
            +   Y   K +G G  G+          R  A K +SR    +       R  RE++++
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLM 78

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           + +    NI+        + + E+ Q++++VMEL     L  ++I   +  ER  + +  
Sbjct: 79  KCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHER-MSYLLY 134

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q++  +   H  G+IHRDLKP N ++   + D  +K  DFGL+    T  +    V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191

Query: 240 YVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPF-------------------WAETEK 279
           Y APEV L   Y + +D+WS G I+  ++ G   F                     E  K
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 280 GI------------------FEAILEGNLDLQSSP-WPSISGQAKDLIRKMLTKDPKKRI 320
            +                  FE +    L    S      + QA+DL+ KML  D  KRI
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

Query: 321 TAAEALEHPWLKE 333
           +  EAL+HP++  
Sbjct: 312 SVDEALQHPYINV 324

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  140 bits (354), Expect = 2e-38
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 48/303 (15%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           ++  +Y   + +G G +G         TG K A K + R    +  ++   R  RE+ +L
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLL 78

Query: 126 QHLTGQPNIVEF------EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           +H+    N++        +   +D  + +LVM    G +L  +++      E     +  
Sbjct: 79  KHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVY 135

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
           Q++  +   H  G+IHRDLKP N  +    ED  +K  DFGL+   ++       V + +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEM--TGYVVTRW 190

Query: 240 YVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE-----GNLDL 292
           Y APEV+    RY + +D+WS G I+  +++G   F         + I++         +
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250

Query: 293 QS------------------SPW----PSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
           Q                     +     + S  A +L+ KML  D ++R+TA EAL HP+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310

Query: 331 LKE 333
            + 
Sbjct: 311 FES 313

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (347), Expect = 2e-38
 Identities = 73/260 (28%), Positives = 109/260 (41%), Gaps = 25/260 (9%)

Query: 74  DLDKELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKD-MEDVRREILILQHLTG 130
            L++ +G G FG  Y    +A   G + A K+            +E+VR+E  +   L  
Sbjct: 10  TLEEIIGIGGFGKVY----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK- 64

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI---VNVVHA 187
            PNI+   G    + NL LVME   GG L   +++          N   QI   +N +H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSP-----IKATDFGLSVFIETGKVYKEIVGSAYYVA 242
              + +IHRDLK  N L+  K E+       +K TDFGL+             G+  ++A
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMA 182

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN--LDLQSSPWPS 299
           PEV+    + K  DVWS GV+L+ LL+G  PF       +   +      L + S+    
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242

Query: 300 ISGQAKDLIRKMLTKDPKKR 319
                  L+      DP  R
Sbjct: 243 F----AKLMEDCWNPDPHSR 258

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  138 bits (351), Expect = 5e-38
 Identities = 84/307 (27%), Positives = 124/307 (40%), Gaps = 52/307 (16%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISR-RKLVYDKDMEDVR--REILI 124
           D+   Y     +G G +G+           + A K IS      Y +     R  REI I
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-----RTLREIKI 78

Query: 125 LQHLTGQPNIVEFE-----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICR 179
           L       NI+           E  +++++V +L    +L  +++     S         
Sbjct: 79  LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLY 135

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK----EIV 235
           QI+  +   H   V+HRDLKP N LL        +K  DFGL+   +    +     E V
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 236 GSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE------ 287
            + +Y APE++   + Y K ID+WS G IL  +LS  P F  +        IL       
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 288 -------GNLD----LQSSPW----------PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
                   NL     L S P           P+   +A DL+ KMLT +P KRI   +AL
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 327 EHPWLKE 333
            HP+L++
Sbjct: 313 AHPYLEQ 319

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  137 bits (348), Expect = 1e-37
 Identities = 77/336 (22%), Positives = 129/336 (38%), Gaps = 67/336 (19%)

Query: 48  LSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRR 107
           ++KQ             P+ D  + Y+   ++G+G FG  +    + TG+K A K     
Sbjct: 1   MAKQYDSVEC-------PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----- 48

Query: 108 KLVYDKDMEDVR----REILILQHLTGQPNIVEFEG--------AYEDKQNLHLVMELCS 155
           K++ + + E       REI ILQ L    N+V                K +++LV + C 
Sbjct: 49  KVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE 107

Query: 156 G--GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP 213
                L   ++ K  ++  E   + + ++N ++  H   ++HRD+K  N L+        
Sbjct: 108 HDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--- 162

Query: 214 IKATDFGLSVFI-----ETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYIL 266
           +K  DFGL+             Y   V + +Y  PE+L   + YG  ID+W AG I+  +
Sbjct: 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

Query: 267 LSGVPPFWAETEKG----IF-------EAILEGNLDL-----------------QSSPWP 298
            +  P     TE+     I          +     +                        
Sbjct: 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 282

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                A DLI K+L  DP +RI + +AL H +   D
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  136 bits (344), Expect = 2e-37
 Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 31/293 (10%)

Query: 43  SRPPALSKQIPQTSQIGPILGKPY----VDITTIYDLDKELGRGQFGVTYLCTKKAT--G 96
              P     IP T  +            +    + ++ +++G G FG  +    +A   G
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDL-NIKEKIGAGSFGTVH----RAEWHG 60

Query: 97  RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG 156
              A K +  +     + + +  RE+ I++ L   PNIV F GA     NL +V E  S 
Sbjct: 61  SDVAVKILMEQDFH-AERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 157 GELFDRIIAKGI---YSEREAANICRQI---VNVVHACHFMGVIHRDLKPENFLLASKEE 210
           G L+  +   G      ER   ++   +   +N +H  +   ++HR+LK  N L+   ++
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLV---DK 174

Query: 211 DSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS 268
              +K  DFGLS +   T    K   G+  ++APEVL  +   ++ DV+S GVIL+ L +
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 269 GVPPFWAETEKGIFEAILEGNL--DLQSSPWPSISGQAKDLIRKMLTKDPKKR 319
              P+       +  A+       ++  +  P +      +I    T +P KR
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV----AAIIEGCWTNEPWKR 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 2e-37
 Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 36/272 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD-MEDVRREILI---LQHL 128
           Y +  +LG G     YL        K A K          ++ ++   RE+     L H 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSH- 70

Query: 129 TGQPNIVEFEGAY---EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVV 185
               NIV         E+    +LVME   G  L + I + G  S   A N   QI++ +
Sbjct: 71  ---QNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI------ETGKVYKEIVGSAY 239
              H M ++HRD+KP+N L+     +  +K  DFG++  +      +T  V    +G+  
Sbjct: 125 KHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHV----LGTVQ 177

Query: 240 YVAPEVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQS 294
           Y +PE   Q  G+      D++S G++LY +L G PPF  ET   I  + I +   ++ +
Sbjct: 178 YFSPE---QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234

Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
                I     ++I +   KD   R    + +
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  136 bits (345), Expect = 2e-37
 Identities = 93/319 (29%), Positives = 137/319 (42%), Gaps = 68/319 (21%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
           +I++ + L   LG G +GV    T K TG   A K I      +DK +  +R  REI IL
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE----PFDKPLFALRTLREIKIL 63

Query: 126 QHLTGQPNIVEFE-----GAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
           +H     NI+         ++E+   ++++ EL    +L  R+I+  + S+        Q
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQ 120

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA-- 238
            +  V   H   VIHRDLKP N L+     +  +K  DFGL+  I+              
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 239 ---------YYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG------- 280
                    +Y APEV+    +Y + +DVWS G IL  L    P F      G       
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-----PGRDYRHQL 232

Query: 281 --IFEAI----LEGNLDLQSSP--------------------WPSISGQAKDLIRKMLTK 314
             IF  I     + +L    SP                    +P ++ +  DL+++ML  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 315 DPKKRITAAEALEHPWLKE 333
           DP KRITA EALEHP+L+ 
Sbjct: 293 DPAKRITAKEALEHPYLQT 311

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (333), Expect = 5e-36
 Identities = 73/305 (23%), Positives = 116/305 (38%), Gaps = 38/305 (12%)

Query: 36  QDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKAT 95
                +   P          S+ G   G         Y L + +GRG  G  Y       
Sbjct: 7   HHHHSSGLVPRGSHMDGTAESREGTQFGP--------YRLRRLVGRGGMGDVYEAEDTVR 58

Query: 96  GRKYACKSISRRKLVYDKD-MEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLHLVM 151
            R  A K +    L  D      ++RE      LQ     P++V      E    L++ M
Sbjct: 59  ERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQE----PHVVPIHDFGEIDGQLYVDM 113

Query: 152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED 211
            L +G +L   +  +G  +   A  I RQI + + A H  G  HRD+KPEN L++    D
Sbjct: 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---AD 170

Query: 212 SPIKATDFGLSVFI------ETGKVYKEIVGSAYYVAPEVLHQRYGKEI----DVWSAGV 261
                 DFG++         + G      VG+ YY+APE   +          D+++   
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNT----VGTLYYMAPE---RFSESHATYRADIYALTC 223

Query: 262 ILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT 321
           +LY  L+G PP+  +    +  A +   +   S+  P I      +I + + K+P+ R  
Sbjct: 224 VLYECLTGSPPYQGDQL-SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV 282

Query: 322 AAEAL 326
               L
Sbjct: 283 TCGDL 287

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  133 bits (336), Expect = 6e-36
 Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 52/311 (16%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL------VYDKDMEDVR-- 119
            + + Y + + +  G +G          G   A K +           +        R  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 120 REILILQHLTGQPNIVEFE-----GAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSER 172
           REI +L H    PNI+                L+LV EL    +L  ++I     + S +
Sbjct: 78  REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQ 134

Query: 173 EAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
                   I+  +H  H  GV+HRDL P N LLA    ++ I   DF L+          
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTADANKT 191

Query: 233 EIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE--- 287
             V   +Y APE++   + + K +D+WSAG ++  + +    F   T       I+E   
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251

Query: 288 --GNLDLQS-------------------SPW----PSISGQAKDLIRKMLTKDPKKRITA 322
                D+                       W    P+    A DLI KML  +P++RI+ 
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311

Query: 323 AEALEHPWLKE 333
            +AL HP+ + 
Sbjct: 312 EQALRHPYFES 322

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  129 bits (326), Expect = 5e-35
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 49/274 (17%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
             + LG+G FG     T + TG     K + R     ++      +E+ +   L+H    
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH---- 66

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHAC-- 188
           PN+++F G     + L+ + E   GG L   I +    Y   +  +  + I     A   
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI-----ASGM 121

Query: 189 ---HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE---------------TGKV 230
              H M +IHRDL   N L+    E+  +   DFGL+  +                  K 
Sbjct: 122 AYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 231 YKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFEAILE 287
              +VG+ Y++APE++  + Y +++DV+S G++L  ++  V     +       F   + 
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-DFGLNVR 237

Query: 288 GNLDLQSSPW--PSISGQAKDLIRKMLTKDPKKR 319
           G LD    P   PS       +  +    DP+KR
Sbjct: 238 GFLDRYCPPNCPPSFF----PITVRCCDLDPEKR 267

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  129 bits (326), Expect = 6e-35
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 39/276 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD-MEDVRREILI---LQHL 128
           Y+L + LG G     +L       R  A K + R  L  D       RRE      L H 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNH- 71

Query: 129 TGQPNIV------EFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
              P IV      E E         ++VME   G  L D +  +G  + + A  +     
Sbjct: 72  ---PAIVAVYDTGEAETPAGPLP--YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--------ETGKVYKEI 234
             ++  H  G+IHRD+KP N +++     + +K  DFG++  I        +T  V    
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAV---- 179

Query: 235 VGSAYYVAPEVLHQRYGKEI----DVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL 290
           +G+A Y++PE   Q  G  +    DV+S G +LY +L+G PPF  ++   +    +  + 
Sbjct: 180 IGTAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236

Query: 291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL 326
              S+    +S     ++ K L K+P+ R   A  +
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (326), Expect = 8e-35
 Identities = 53/264 (20%), Positives = 106/264 (40%), Gaps = 30/264 (11%)

Query: 74  DLDKELGRGQFGVTYLCTKKATGRKY-ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++ + +G+G+FG  Y            A + I   +   +  ++  +RE++  +      
Sbjct: 36  EIGELIGKGRFGQVY----HGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HE 89

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFM 191
           N+V F GA     +L ++  LC G  L+  +  AK +    +   I ++IV  +   H  
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS------VFIETGKVYKEIVGSAYYVAPEV 245
           G++H+DLK +N       ++  +  TDFGL                +   G   ++APE+
Sbjct: 150 GILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 246 L----------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS 295
           +             + K  DV++ G I Y L +   PF  +  + I   +  G     + 
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM--KPNL 263

Query: 296 PWPSISGQAKDLIRKMLTKDPKKR 319
               +  +  D++      + ++R
Sbjct: 264 SQIGMGKEISDILLFCWAFEQEER 287

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  130 bits (328), Expect = 9e-35
 Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 57/326 (17%)

Query: 54  QTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK 113
            +        +        + +++  G+G FG   L  +K+TG   A K +        +
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-------Q 58

Query: 114 DMEDVRREILILQHLTGQ--PNIVE----FEGAYEDKQN---LHLVMELCSGGELFDRII 164
           D     RE+ I+Q L     PNIV+    F    E  +    L++VME     +   R  
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCC 116

Query: 165 AKGIYSEREAANI-CR----QIVNVVHACHF--MGVIHRDLKPENFLLASKEEDSPIKAT 217
                 +     I  +    Q++  +   H   + V HRD+KP N L+   E D  +K  
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLC 174

Query: 218 DFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWA 275
           DFG +  +   +     + S YY APE++  +Q Y   +D+WS G I   ++ G P F  
Sbjct: 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234

Query: 276 ETE----KGIF--------EAILEGNLD--------LQSSPW--------PSISGQAKDL 307
           +        I         E + + N           +  PW           + +A DL
Sbjct: 235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL 294

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKE 333
           +  +L   P++R+   EAL HP+  E
Sbjct: 295 LSALLQYLPEERMKPYEALCHPYFDE 320

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  130 bits (329), Expect = 9e-35
 Identities = 86/351 (24%), Positives = 139/351 (39%), Gaps = 89/351 (25%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
            +   Y+L K+LG+G +G+ +    + TG   A K I      +    +  R  REI+IL
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMIL 62

Query: 126 QHLTGQPNIVEFEGAY--EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN 183
             L+G  NIV        ++ ++++LV +     +L   +I   I        +  Q++ 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIK 120

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA----- 238
           V+   H  G++HRD+KP N LL     +  +K  DFGLS      +     +  +     
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 239 -----------------YYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEK 279
                            +Y APE+L    +Y K ID+WS G IL  +L G P F      
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-----P 232

Query: 280 G---------IFEAI---------------------------------------LEGNLD 291
           G         I   I                                          NL 
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292

Query: 292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
           L+ +P    + +A DL+ K+L  +P KRI+A +AL+HP++      +++P 
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  129 bits (326), Expect = 2e-34
 Identities = 75/344 (21%), Positives = 125/344 (36%), Gaps = 90/344 (26%)

Query: 63  GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSI---SRRKLVYDKDMEDVR 119
           G         Y L K LG G FG+        +G+++A K +    R K           
Sbjct: 1   GLETSSKK--YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---------- 48

Query: 120 REILILQHLTGQPNIVE--------------------------------------FEGAY 141
           RE+ I++ L    NI++                                           
Sbjct: 49  RELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107

Query: 142 EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANI-CR----QIVNVVHACHFMGVIHR 196
              + L+++ME     +   +++   I S R            Q+   V   H +G+ HR
Sbjct: 108 SQNKYLNVIMEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEI 254
           D+KP+N L+ S  +D+ +K  DFG +  +   +     + S +Y APE++     Y   I
Sbjct: 166 DIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223

Query: 255 DVWSAGVILYILLSGVPPFWAETE----KGIF--------EAILEGNLDLQSSPWPSISG 302
           D+WS G +   L+ G P F  ET       I         E ++  N       +P++  
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283

Query: 303 Q-------------AKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
           +             A DL+ ++L  +P  RI   EA+ HP+   
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  129 bits (327), Expect = 2e-34
 Identities = 74/323 (22%), Positives = 122/323 (37%), Gaps = 70/323 (21%)

Query: 75  LDKELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
              ++GRG +G  Y   +K     + YA K I          M   R EI +L+ L   P
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG----TGISMSACR-EIALLRELK-HP 78

Query: 133 NIVEFEGAYEDKQN--LHLVMELCS--------GGELFDRIIAKGIYSEREAANICRQIV 182
           N++  +  +    +  + L+ +                               ++  QI+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDS-PIKATDFGLS-VFIETGKVY----KEIVG 236
           + +H  H   V+HRDLKP N L+  +  +   +K  D G + +F    K        +V 
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 237 SAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-------------I 281
           + +Y APE+L   + Y K ID+W+ G I   LL+  P F    E               I
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 282 F-------EAILEG----------NLDLQSSPW-------------PSISGQAKDLIRKM 311
           F       +   E             D + + +                  +A  L++K+
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 312 LTKDPKKRITAAEALEHPWLKED 334
           LT DP KRIT+ +A++ P+  ED
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLED 340

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  124 bits (313), Expect = 2e-33
 Identities = 46/260 (17%), Positives = 94/260 (36%), Gaps = 31/260 (11%)

Query: 74  DLDKELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           +   +L     G  +    K    G     K +  R     +   D   E   L+  +  
Sbjct: 13  NFLTKLNENHSGELW----KGRWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFS-H 66

Query: 132 PNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQI---VNV 184
           PN++   GA +     +  L+      G L++ +      +  + +A      +   +  
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAP 243
           +H    + +    L   + ++   +ED   + +   +   F   G+     + +  +VAP
Sbjct: 127 LHTLEPL-IPRHALNSRSVMI---DEDMTARISMADVKFSFQSPGR-----MYAPAWVAP 177

Query: 244 EVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           E L ++      +  D+WS  V+L+ L++   PF   +   I   +    L       P 
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PG 235

Query: 300 ISGQAKDLIRKMLTKDPKKR 319
           IS     L++  + +DP KR
Sbjct: 236 ISPHVSKLMKICMNEDPAKR 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  125 bits (317), Expect = 3e-33
 Identities = 78/333 (23%), Positives = 119/333 (35%), Gaps = 74/333 (22%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--- 129
           Y L ++LG G F   +L          A K I R   VY    E    EI +LQ +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVY---TEAAEDEIKLLQRVNDAD 76

Query: 130 -------GQPNIVEFEGA--YEDKQNLH--LVMELCSGGELFDRIIA---KGIYSEREAA 175
                  G  +I++      ++    +H  +V E+  G  L   I     +GI       
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-PLIYVK 134

Query: 176 NICRQIVNVVHACH-FMGVIHRDLKPENFLLA---SKEEDSPIKATDFGLSVFIETGKVY 231
            I +Q++  +   H   G+IH D+KPEN L+    S E    IK  D G + +       
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-YDEHYT 193

Query: 232 KEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI--------- 281
             I  +  Y +PEV L   +G   D+WS   +++ L++G   F  +              
Sbjct: 194 NSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 282 FEAIL--------------------EGNLDLQSS--PWP-------------SISGQAKD 306
              +L                     G L   S    WP               + +  D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSD 339
            +  ML  DP+KR  A   + HPWLK+     +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 345

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  125 bits (316), Expect = 3e-33
 Identities = 75/325 (23%), Positives = 111/325 (34%), Gaps = 70/325 (21%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---- 128
           Y++   LG G FG    C   A G+      I R    Y    E  R EI +L+ +    
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY---REAARLEINVLKKIKEKD 77

Query: 129 -TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVV 185
              +   V     +    ++ +  EL  G   F+ +       Y      ++  Q+ + +
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 186 HACHFMGVIHRDLKPENFLLASKE----------------EDSPIKATDFGLSVFIETGK 229
              H   + H DLKPEN L  + E                +++ I+  DFG + F +   
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF-DHEH 195

Query: 230 VYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETE---------- 278
               IV + +Y  PEV L   + +  DVWS G IL+    G   F               
Sbjct: 196 HT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254

Query: 279 KGIF------EAILEGNLDLQSSPWPSIS------------------------GQAKDLI 308
            G            +         W   S                         Q  DL+
Sbjct: 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314

Query: 309 RKMLTKDPKKRITAAEALEHPWLKE 333
           R+ML  DP +RIT AEAL HP+   
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAG 339

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  125 bits (317), Expect = 4e-33
 Identities = 76/335 (22%), Positives = 120/335 (35%), Gaps = 78/335 (23%)

Query: 69  ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
               Y++D  +G+G FG       +      A K I  +K   ++       E+ +L+ +
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELM 107

Query: 129 -----TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQI 181
                  +  IV  +  +  + +L LV E+ S   L+D +        S        +Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 182 VNVVHACHF--MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
              +       + +IH DLKPEN LL +  + S IK  DFG S      ++Y+ I  S +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQ-LGQRIYQYIQ-SRF 223

Query: 240 YVAPEV-LHQRYGKEIDVWSA---------GVILY------------ILLSGVPPFW--- 274
           Y +PEV L   Y   ID+WS          G  L+            + + G+PP     
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283

Query: 275 -------------------------AETEKGIFEAILEGNLDLQSSPWPSISGQA----- 304
                                        K      L   L +++               
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343

Query: 305 ------KDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                 KDLI +ML  DPK RI    AL+H + K+
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (323), Expect = 7e-33
 Identities = 60/267 (22%), Positives = 96/267 (35%), Gaps = 42/267 (15%)

Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDV---RREILI---L 125
           Y++   +  G  G  YL   +   GR    K      LV+  D E       E      +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136

Query: 126 QHLTGQPNIVE-----FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQ 180
            H    P+IV+                ++VME   G  L             EA     +
Sbjct: 137 VH----PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLE 190

Query: 181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAY 239
           I+  +   H +G+++ DLKPEN +L     +  +K  D G    I   G +Y    G+  
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGYLY----GTPG 242

Query: 240 YVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           + APE++        D+++ G  L  L   +P        G+ E            P   
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLK 292

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEAL 326
                  L+R+ +  DP++R T AE +
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEEM 319

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  123 bits (311), Expect = 2e-32
 Identities = 69/331 (20%), Positives = 116/331 (35%), Gaps = 78/331 (23%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + + +++G G FG   LC      + YA K + R    Y       + E  IL+ +    
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKY---TRSAKIEADILKKIQNDD 92

Query: 133 ----NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVH 186
               NIV++ G +    ++ L+ E   G  L++ I       +   +    C +I+  ++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 187 ACHFMGVIHRDLKPENFLLASKE----------------------EDSPIKATDFGLSVF 224
               M + H DLKPEN LL                          + + IK  DFG + F
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211

Query: 225 IETGKVYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE 283
            ++      I+ +  Y APEV L+  +    D+WS G +L  L +G   F          
Sbjct: 212 -KSDYHG-SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269

Query: 284 AILE--GNLD---LQSSP----------------WPSISGQAK----------------- 305
            +      +    L  +                 WP  +                     
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329

Query: 306 ----DLIRKMLTKDPKKRITAAEALEHPWLK 332
               D +  +L  DP  R + AE L+H +L+
Sbjct: 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  122 bits (308), Expect = 4e-32
 Identities = 79/324 (24%), Positives = 111/324 (34%), Gaps = 70/324 (21%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---- 128
           Y++   LG G FG    C     G ++    I +    Y    E  R EI +L+HL    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---CEAARSEIQVLEHLNTTD 72

Query: 129 -TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVV 185
                  V+    +E   ++ +V EL  G   +D I   G   +       +  QI   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 186 HACHFMGVIHRDLKPENFLLASKE----------------EDSPIKATDFGLSVFIETGK 229
           +  H   + H DLKPEN L    +                 +  IK  DFG + + +   
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-DDEH 190

Query: 230 VYKEIVGSAYYVAPEV-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETE---------- 278
               +V + +Y APEV L   + +  DVWS G IL     G   F               
Sbjct: 191 HS-TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249

Query: 279 KGIF------EAILEGNLDLQSSPWPSISGQAK------------------------DLI 308
            G        +             W   S   +                        DLI
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309

Query: 309 RKMLTKDPKKRITAAEALEHPWLK 332
           +KML  DP KRIT  EAL+HP+  
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFD 333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  120 bits (302), Expect = 1e-31
 Identities = 62/258 (24%), Positives = 113/258 (43%), Gaps = 25/258 (9%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           + + +G G FG  Y           A K ++       + ++  + E+ +    +H    
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRH---- 79

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHF 190
            NI+ F G       L +V + C G  L+  +  ++  +  ++  +I RQ    +   H 
Sbjct: 80  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS---VFIETGKVYKEIVGSAYYVAPEVL- 246
             +IHRDLK  N  L    ED+ +K  DFGL+           ++++ GS  ++APEV+ 
Sbjct: 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQSSPWP-SIS 301
                 Y  + DV++ G++LY L++G  P+     +  I E +  G+L    S    +  
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 302 GQAKDLIRKMLTKDPKKR 319
            + K L+ + L K   +R
Sbjct: 256 KRMKRLMAECLKKKRDER 273

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  121 bits (304), Expect = 7e-31
 Identities = 80/405 (19%), Positives = 130/405 (32%), Gaps = 121/405 (29%)

Query: 33  RTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK 92
            TQ     +        +                  I   Y++   +G G +G       
Sbjct: 15  GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYD 74

Query: 93  KATGRKYACKSISRRKLVYDKDMEDVR--REILILQHLTGQPNIVEFE-----GAYEDKQ 145
           K   R  A K I R   V++  ++  R  REI IL  L    ++V+          E   
Sbjct: 75  KLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130

Query: 146 NLHLVMELC---------SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHR 196
            L++V+E+          +   L +  I   +Y           ++  V   H  G++HR
Sbjct: 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NLLVGVKYVHSAGILHR 180

Query: 197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA------------------ 238
           DLKP N L+    +D  +K  DFGL+  ++  +     +  +                  
Sbjct: 181 DLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237

Query: 239 ----------YYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG--IF-- 282
                     +Y APE++   + Y + IDVWS G I   LL+ +    A       +F  
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297

Query: 283 ------------------EAILEGN-----LDLQSSP----WPSI-SGQAKDLIR----- 309
                                   +      ++  +P      ++    AK  IR     
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357

Query: 310 ---------------------KMLTKDPKKRITAAEALEHPWLKE 333
                                +ML  +P KRIT  E L HP+ KE
Sbjct: 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (294), Expect = 3e-30
 Identities = 64/334 (19%), Positives = 117/334 (35%), Gaps = 56/334 (16%)

Query: 39  RPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYD---LDKELGRGQFGVTYLCTKKAT 95
           RP  S    L   I   +  G   G P +   TI     L + +G+G+FG  +    +  
Sbjct: 7   RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-- 64

Query: 96  GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH----LVM 151
           G + A K  S R    ++       EI     L    NI+ F  A            LV 
Sbjct: 65  GEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVS 119

Query: 152 ELCSGGELFDRIIAKGIYSEREAANICRQIVN--------VVHACHFMGVIHRDLKPENF 203
           +    G LFD  + +   +      +     +        +V       + HRDLK +N 
Sbjct: 120 DYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 204 LLASKEEDSPIKATDFGLSVFIETGKVYKEI-----VGSAYYVAPEVL-------HQRYG 251
           L+   +++      D GL+V  ++     +I     VG+  Y+APEVL       H    
Sbjct: 179 LV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQS---------------S 295
           K  D+++ G++ + +           +  + +  ++  +  ++                +
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295

Query: 296 PWPSISGQA--KDLIRKMLTKDPKKRITAAEALE 327
            W S         ++R+    +   R+TA    +
Sbjct: 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  118 bits (298), Expect = 4e-30
 Identities = 72/224 (32%), Positives = 103/224 (45%), Gaps = 18/224 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---- 128
           Y++ K +G+G FG           +  A K +   K  + +  E    EI IL+HL    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQD 154

Query: 129 -TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY---SEREAANICRQIVNV 184
                N++     +  + ++ +  EL S   L++ +I K  +   S          I+  
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE 244
           + A H   +IH DLKPEN LL   +  S IK  DFG S + E  +VY  I  S +Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSCY-EHQRVYTYIQ-SRFYRAPE 269

Query: 245 V-LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
           V L  RYG  ID+WS G IL  LL+G P    E E      ++E
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 13/42 (30%), Positives = 21/42 (50%)

Query: 305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAV 346
            D +++ L  DP  R+T  +AL HPWL+           ++V
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSV 427

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  117 bits (294), Expect = 1e-29
 Identities = 78/354 (22%), Positives = 128/354 (36%), Gaps = 97/354 (27%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVR--REILIL 125
            +   Y +   +GRG +G  YL   K T +  A K ++R   +++  ++  R  REI IL
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITIL 79

Query: 126 QHLTGQPNIVEFE-----GAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICR 179
             L     I+                L++V+E+    +L  ++    I+ +E     I  
Sbjct: 80  NRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILY 136

Query: 180 QIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSA- 238
            ++   +  H  G+IHRDLKP N LL    +D  +K  DFGL+  I + K    +     
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 239 ----------------------YYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFW 274
                                 +Y APE++   + Y K ID+WS G I   LL+ +    
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 275 AETE------KGIFEAILEGNLDLQSSPW----------------PS-------ISGQAK 305
            +         G     L  + + +                    P+          +  
Sbjct: 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313

Query: 306 DLIR--------------------------KMLTKDPKKRITAAEALEHPWLKE 333
             I+                           ML  +P KRIT  +AL+HP+LK+
Sbjct: 314 KYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  114 bits (286), Expect = 5e-29
 Identities = 64/330 (19%), Positives = 115/330 (34%), Gaps = 66/330 (20%)

Query: 48  LSKQIPQTSQIGPILGKPYVDITTIYD---LDKELGRGQFGVTYLCTKKAT--GRKYACK 102
           L   I Q+   G   G P +   TI     + K++G+G++G  +         G K A K
Sbjct: 11  LRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVW----MGKWRGEKVAVK 66

Query: 103 SISRRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGA----YEDKQNLHLVMELCS 155
                    ++       EI     ++H     NI+ F  A          L+L+ +   
Sbjct: 67  VFFTT----EEASWFRETEIYQTVLMRH----ENILGFIAADIKGTGSWTQLYLITDYHE 118

Query: 156 GGELFDRIIAKGIYSEREAANICRQIVN--------VVHACHFMGVIHRDLKPENFLLAS 207
            G L+D  +       +    +    V+        +        + HRDLK +N L+  
Sbjct: 119 NGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV-- 175

Query: 208 KEEDSPIKATDFGLSVFIETGKVYKEI-----VGSAYYVAPEVL-------HQRYGKEID 255
            +++      D GL+V   +     +I     VG+  Y+ PEVL       H +     D
Sbjct: 176 -KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234

Query: 256 VWSAGVILYILLSGV----------PPFWAE-----TEKGIFEAILEGNLDLQ-SSPWPS 299
           ++S G+IL+ +               P+        + + + E +    L     + W S
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSS 294

Query: 300 ISGQA--KDLIRKMLTKDPKKRITAAEALE 327
                    L+ +    +P  R+TA    +
Sbjct: 295 DECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  112 bits (281), Expect = 1e-28
 Identities = 53/297 (17%), Positives = 104/297 (35%), Gaps = 57/297 (19%)

Query: 75  LDKELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           L + +G+G++G  +    + +  G   A K  S R    D+       E+     L    
Sbjct: 12  LLECVGKGRYGEVW----RGSWQGENVAVKIFSSR----DEKSWFRETELYNTVMLR-HE 62

Query: 133 NIVEFEGAYEDKQNLH----LVMELCSGGELFDRIIAKGIYSEREAANICRQIVN----- 183
           NI+ F  +    ++      L+      G L+D  +            I   I +     
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHL 121

Query: 184 ---VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI-----V 235
              +        + HRDLK +N L+   +++      D GL+V         ++     V
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 236 GSAYYVAPEVL-------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI-FEAILE 287
           G+  Y+APEVL            K +D+W+ G++L+ +   +       +    F  ++ 
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 288 GNLDLQS---------------SPWPSISGQA--KDLIRKMLTKDPKKRITAAEALE 327
            +   +                + W S         L+++   ++P  R+TA    +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (269), Expect = 9e-27
 Identities = 68/325 (20%), Positives = 119/325 (36%), Gaps = 62/325 (19%)

Query: 49  SKQIPQTSQIGPILGKPYVDITTI-YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRR 107
                 +S  G  LG   +   ++   L +   RG+FG  +           A K    +
Sbjct: 3   HHHHHHSS--GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ 58

Query: 108 KLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLH----LVMELCSGGELF 160
               DK       E+     ++H     NI++F GA +   ++     L+      G L 
Sbjct: 59  ----DKQSWQNEYEVYSLPGMKH----ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS 110

Query: 161 DRIIAKGIYSEREAANICRQI----------VNVVHACHFMGVIHRDLKPENFLLASKEE 210
           D  +   + S  E  +I   +          +  +   H   + HRD+K +N LL   + 
Sbjct: 111 D-FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KN 166

Query: 211 DSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVL------HQRYGKEIDVWSAGV 261
           +      DFGL++  E GK        VG+  Y+APEVL       +     ID+++ G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 262 ILYILLSG-----------VPPFWAE-----TEKGIFEAILEGNLDLQ-SSPWPSISGQA 304
           +L+ L S            + PF  E     + + + E ++           W   +G A
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286

Query: 305 K--DLIRKMLTKDPKKRITAAEALE 327
              + I +    D + R++A    E
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGE 311

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (266), Expect = 1e-26
 Identities = 43/314 (13%), Positives = 74/314 (23%), Gaps = 49/314 (15%)

Query: 40  PTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKY 99
               R  +      Q      I    Y        L    G       +     A  R+ 
Sbjct: 7   REPDRESSAPPDDVQLVPGARIANGRYR-------LLIFHGGVPPLQFWQALDTALDRQV 59

Query: 100 ACKSISRRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSG 156
           A   +  + ++ D  +++     L    +      P +         +    +V E   G
Sbjct: 60  ALTFVDPQGVLPDDVLQETLSRTLRLSRIDK----PGVARVLDVVHTRAGGLVVAEWIRG 115

Query: 157 GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA 216
           G L +  +A    S   A    + +     A H  GV      P    ++    D  +  
Sbjct: 116 GSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVL 170

Query: 217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAE 276
                                   +           + D+   G  LY LL    P    
Sbjct: 171 AYPA-------------------TMPDA------NPQDDIRGIGASLYALLVNRWPLPEA 205

Query: 277 TEKGIFEAILEGNLDLQSSPW---PSISGQAKDLIRKMLTKDPKKRITAA--EALEHPWL 331
             +                P      I  Q   +  + +  D   R  +     ++    
Sbjct: 206 GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATA 265

Query: 332 KEDGATSDKPIDSA 345
             D      PID A
Sbjct: 266 VADRTEVLGPIDEA 279

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  100 bits (251), Expect = 6e-24
 Identities = 68/369 (18%), Positives = 115/369 (31%), Gaps = 120/369 (32%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--- 129
           Y + ++LG G F   +L       +  A K + +    Y    E    EI +L+ +    
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLKSVRNSD 94

Query: 130 ----GQPNIV------EFEGAYEDKQNLH--LVMEL--CSGGELFDRIIAKGIYSEREAA 175
                +  +V      +  G        H  +V E+      +   +   +G+       
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGT----HICMVFEVLGHHLLKWIIKSNYQGL-PLPCVK 149

Query: 176 NICRQIVNVVHACHF-MGVIHRDLKPENFLLASKE------------------------- 209
            I +Q++  +   H    +IH D+KPEN LL+  E                         
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 210 ---------------------EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEV-LH 247
                                E   +K  D G + +    K + E + +  Y + EV + 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIG 267

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF---------EAIL------------ 286
             Y    D+WS   + + L +G   F   + +              +L            
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327

Query: 287 --------EGNLDLQSSPWPS-----------ISGQAK----DLIRKMLTKDPKKRITAA 323
                   +G+L   +   P             S +      D +  ML   P+KR TAA
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387

Query: 324 EALEHPWLK 332
           E L HPWL 
Sbjct: 388 ECLRHPWLN 396

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 29/230 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILI---LQH 127
             K LG G FG  Y       G K     A K +  R+    K  +++  E  +   + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDN 76

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVH 186
               P++    G       + L+ +L   G L D +   K     +   N C QI     
Sbjct: 77  ----PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK--- 128

Query: 187 ACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV-- 241
             ++     ++HRDL   N L+ + +    +K TDFGL+  +   +      G    +  
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 242 -APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            A E + H+ Y  + DVWS GV ++ L++ G  P+       I   + +G
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 63/266 (23%), Positives = 114/266 (42%), Gaps = 23/266 (8%)

Query: 33  RTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTK 92
            T  D   T+   PA  +  P    + P   K  ++ T I  +  +LG GQ+G  Y    
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDI-TMKHKLGGGQYGEVYEGVW 241

Query: 93  KATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLHL 149
           K      A K++         ++E+  +E  +   ++H    PN+V+  G    +   ++
Sbjct: 242 KKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKH----PNLVQLLGVCTREPPFYI 293

Query: 150 VMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS 207
           + E  + G L D  R   +   S      +  QI + +        IHR+L   N L+  
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG- 352

Query: 208 KEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVIL 263
             E+  +K  DFGLS  +  G  Y    G+ + +   APE L + ++  + DVW+ GV+L
Sbjct: 353 --ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409

Query: 264 YILLS-GVPPFWAETEKGIFEAILEG 288
           + + + G+ P+       ++E + + 
Sbjct: 410 WEIATYGMSPYPGIDLSQVYELLEKD 435

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 60/314 (19%), Positives = 106/314 (33%), Gaps = 78/314 (24%)

Query: 74  DLDKELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKDMEDVRREILI-----LQ 126
            L + +GRG++G  Y    K +   R  A K  S        + ++   E  I     ++
Sbjct: 16  KLLELIGRGRYGAVY----KGSLDERPVAVKVFSFA------NRQNFINEKNIYRVPLME 65

Query: 127 HLTGQPNIVEFEGA-----YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQI 181
           H     NI  F         + +    LVME    G L    ++        +  +   +
Sbjct: 66  H----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSV 120

Query: 182 VN---------VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
                           +   + HRDL   N L+   + D     +DFGLS+ +   ++ +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVR 177

Query: 233 E---------IVGSAYYVAPEVL--------HQRYGKEIDVWSAGVILYILLSGV----- 270
                      VG+  Y+APEVL         +   K++D+++ G+I + +         
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 271 --------PPFWAE-----TEKGIFEAILEGNLDLQ-SSPWPSISGQA---KDLIRKMLT 313
                     F  E     T + +   +       +    W   S      K+ I     
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 314 KDPKKRITAAEALE 327
           +D + R+TA  A E
Sbjct: 298 QDAEARLTAQXAEE 311

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 62/233 (26%), Positives = 96/233 (41%), Gaps = 29/233 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L +++G G FG  YL T   T  + A K  +            +  E  I + L G  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGGT 63

Query: 133 NIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            I        +     LVM+L   S  +LF+        S +    +  Q++N V   H 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 121

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKV--YKE---IVGSAYYVA 242
              +HRD+KP+NFL+      + +   DFGL+       T +   Y+E   + G+A Y +
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 243 PEVLHQRYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFEAILE 287
              ++   G E     D+ S G +L   L G  P W    A T+K  +E I E
Sbjct: 182 ---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISE 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 28/227 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           +  +LG GQ+G  Y    K      A K++    +    ++E+  +E  +   ++H    
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH---- 68

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACH 189
           PN+V+  G    +   +++ E  + G L D  R   +   S      +  QI +   A  
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS---AME 125

Query: 190 F---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---AP 243
           +      IHRDL   N L+    E+  +K  DFGLS  +     Y    G+ + +   AP
Sbjct: 126 YLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAP 181

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           E L + ++  + DVW+ GV+L+ + + G+ P+       ++E + + 
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L +++G G FG  YL T  A G + A K               +  E  I + + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 65

Query: 133 NIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            I        +     +VMEL   S  +LF+       +S +    +  Q+++ +   H 
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFI--ETGKV--YKE---IVGSAYYVA 242
              IHRD+KP+NFL+   ++ + +   DFGL+  +    T +   Y+E   + G+A Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 243 PEVLHQRYGKEI----DVWSAG-VILYILLSGVPPFW----AETEKGIFEAILE 287
              ++   G E     D+ S G V++Y  L  +P  W    A T++  +E I E
Sbjct: 184 ---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISE 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 31/235 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + +G G FGV +  T     ++ A K   R       D   +R E    + L G  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 66

Query: 133 NIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            I       ++  +  LV++L   S  +L D       +S +  A   +Q++  V + H 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 191 MGVIHRDLKPENFLL--ASKEEDSPIKATDFGLS-VFI--ETGKV--YKE---IVGSAYY 240
             +++RD+KP+NFL+   + +  + I   DFG+   +    T +   Y+E   + G+A Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 241 VAPEVLHQRYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFEAILE 287
           ++   ++   G+E     D+ + G +    L G  P W    A T K  +E I E
Sbjct: 185 MS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKYERIGE 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 20/224 (8%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L +++GRG FG  +    +A     A KS   R+ +         +E  I     H    
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSH---- 171

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHACHF 190
           PNIV   G    KQ +++VMEL  GG+    +  +G     +    +       +     
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY----VAPEVL 246
              IHRDL   N L+    E + +K +DFG+S     G VY    G         APE L
Sbjct: 232 KCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEAL 287

Query: 247 HQ-RYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
           +  RY  E DVWS G++L+     G  P+   + +   E + +G
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 29/230 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILI---LQH 127
             K LG G FG  +       G         K I        +  + V   +L    L H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDH 74

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVH 186
                +IV   G       L LV +    G L D +   +G    +   N   QI     
Sbjct: 75  ----AHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK--- 126

Query: 187 ACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV-- 241
             ++    G++HR+L   N LL      S ++  DFG++  +           +   +  
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 242 -APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            A E +   +Y  + DVWS GV ++ L++ G  P+       + + + +G
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 29/230 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILI---LQH 127
             K LG G FG  Y       G K     A K +  R+    K  +++  E  +   + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDN 76

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVH 186
               P++    G       + L+ +L   G L D +   K     +   N C QI     
Sbjct: 77  ----PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK--- 128

Query: 187 ACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV-- 241
             ++     ++HRDL   N L+ + +    +K TDFGL+  +   +      G    +  
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 242 -APEVLHQR-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            A E +  R Y  + DVWS GV ++ L++ G  P+       I   + +G
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 46/238 (19%), Positives = 83/238 (34%), Gaps = 39/238 (16%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY-------ACKSISRRKLVYDKDMEDVRREILI--- 124
            ++ LG+G F   +   ++  G            K +      +    E       +   
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSK 68

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVN 183
           L H     ++V   G         LV E    G L   +   K   +      + +Q+  
Sbjct: 69  LSH----KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 184 VVHACHF---MGVIHRDLKPENFLLASKEEDSP-----IKATDFGLSVFIETGKVYKEIV 235
              A HF     +IH ++  +N LL  +E+        IK +D G+S+ +    + +E +
Sbjct: 125 ---AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181

Query: 236 GSAYYVAPEVLHQRYGKEI----DVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
               +V PE +     K +    D WS G  L+ + S G  P  A   +   +   + 
Sbjct: 182 P---WVPPECIE--NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 28/226 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
             +E+G GQFG+ +L        K A K+I           ED   E  +   L H    
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR----EGAMSEEDFIEEAEVMMKLSH---- 62

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF 190
           P +V+  G   ++  + LV E    G L D +   +G+++      +C  +        +
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE---GMAY 119

Query: 191 ---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APE 244
                VIHRDL   N L+    E+  IK +DFG++ F+     Y    G+ + V   +PE
Sbjct: 120 LEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPE 175

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           V    RY  + DVWS GV+++ + S G  P+   +   + E I  G
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 55/227 (24%), Positives = 82/227 (36%), Gaps = 27/227 (11%)

Query: 75  LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHL 128
           L ++LG G FGV                A K +    L   + M+D  RE+     L H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH- 80

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHA 187
               N++   G       + +V EL   G L DR+   +G +     +    Q+      
Sbjct: 81  ---RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE---G 133

Query: 188 CHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYV-- 241
             +      IHRDL   N LLA+++    +K  DFGL   +      Y            
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 242 -APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI 285
            APE L  + +    D W  GV L+ + + G  P+       I   I
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 63/256 (24%), Positives = 96/256 (37%), Gaps = 57/256 (22%)

Query: 75  LDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
             ++LG+G FG   +C     +  TG   A K +   +   ++ + D  REI I   LQH
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQH 101

Query: 128 LTGQPNIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNV 184
                NIV+++G      ++NL L+ME    G L D +   K      +      QI   
Sbjct: 102 ----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI--- 154

Query: 185 VHAC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                         IHRDL   N L+     ++ +K  DFGL+  +   K Y       Y
Sbjct: 155 --CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEY-------Y 202

Query: 240 YV-----------APEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
            V           APE L   ++    DVWS GV+LY L + +    +           E
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------E 254

Query: 288 GNLDLQSSPWPSISGQ 303
               + +     +   
Sbjct: 255 FMRMIGNDKQGQMIVF 270

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 35/257 (13%)

Query: 46  PALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSIS 105
           P  SK  P T+ +G   G   +D   +    KELG GQFGV      +      A K I 
Sbjct: 2   PLGSKNAPSTAGLGY--GSWEIDPKDL-TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIK 57

Query: 106 RRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDR 162
              +      ++   E  +   L H      +V+  G    ++ + ++ E  + G L + 
Sbjct: 58  EGSM----SEDEFIEEAKVMMNLSH----EKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109

Query: 163 IIA-KGIYSEREAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATD 218
           +   +  +  ++   +C+ +     A  +      +HRDL   N L+    +   +K +D
Sbjct: 110 LREMRHRFQTQQLLEMCKDVCE---AMEYLESKQFLHRDLAARNCLVN---DQGVVKVSD 163

Query: 219 FGLSVFIETGKVYKEIVGSAYYV---APEVLHQRYGK---EIDVWSAGVILYILLS-GVP 271
           FGLS ++     Y   VGS + V    PEVL   Y K   + D+W+ GV+++ + S G  
Sbjct: 164 FGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKM 220

Query: 272 PFWAETEKGIFEAILEG 288
           P+   T     E I +G
Sbjct: 221 PYERFTNSETAEHIAQG 237

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 36/228 (15%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L + +G+G+FG   L   +  G K A K I       D   +    E  +   L+H    
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLRH---- 245

Query: 132 PNIVEFEGA-YEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHAC 188
            N+V+  G   E+K  L++V E  + G L D  R   + +            +     A 
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE---AM 302

Query: 189 HF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---A 242
            +      +HRDL   N L++   ED+  K +DFGL+      +           V   A
Sbjct: 303 EYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTA 354

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           PE L  +++  + DVWS G++L+ + S G  P+     K +   + +G
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 31/235 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + + K++G G FG   L     T    A K +   K         +  E    + L    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQLGSGD 65

Query: 133 NIVEFEGAYEDKQNLHLVMELC--SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            I +        +   +V+EL   S  +LFD       +S +    I  Q+++ +   H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 191 MGVIHRDLKPENFLL--ASKEEDSPIKATDFGLS-VFI--ETGKV--YKE---IVGSAYY 240
             +I+RD+KPENFL+     +    I   DF L+  +I  ET K   Y+E   + G+A Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 241 VAPEVLHQRYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFEAILE 287
           ++   ++   GKE     D+ + G +    L G  P W    A+T K  ++ I +
Sbjct: 184 MS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGD 234

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 24/230 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
            ++ +GRG FG  Y  T      K    A KS+   ++    ++     E +I++  +  
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS-H 85

Query: 132 PNIVEFEGA-YEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACH 189
           PN++   G     + +  +V+     G+L + I       + ++      Q+        
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK---GMK 142

Query: 190 F---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV----- 241
           +      +HRDL   N +L    E   +K  DFGL+  +   + Y     +   +     
Sbjct: 143 YLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
           A E L  Q++  + DVWS GV+L+ L++ G PP+       I   +L+G 
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 62/247 (25%), Positives = 85/247 (34%), Gaps = 50/247 (20%)

Query: 75  LDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
              +LG+G FG   LC        TG   A K +   +        D +REI I   L  
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHS 83

Query: 128 LTGQPNIVEFEG--AYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNV 184
                 IV++ G      +Q+L LVME    G L D +   +             QI   
Sbjct: 84  ----DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI--- 136

Query: 185 VHAC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                         +HRDL   N L+   E ++ +K  DFGL+  +   K Y       Y
Sbjct: 137 --CKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDY-------Y 184

Query: 240 YV-----------APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL 286
            V           APE L    + ++ DVWS GV+LY L +          E        
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 287 EGNLDLQ 293
                L 
Sbjct: 245 RDVPALS 251

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 61/256 (23%), Positives = 96/256 (37%), Gaps = 57/256 (22%)

Query: 75  LDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
             ++LG+G FG   +C     +  TG   A K +   +   ++ + D  REI I   LQH
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQH 70

Query: 128 LTGQPNIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNV 184
                NIV+++G      ++NL L+ME    G L D +   K      +      QI   
Sbjct: 71  ----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI--- 123

Query: 185 VHAC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                         IHRDL   N L+     ++ +K  DFGL+  +   K +       +
Sbjct: 124 --CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEF-------F 171

Query: 240 YV-----------APEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILE 287
            V           APE L   ++    DVWS GV+LY L + +    +           E
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------E 223

Query: 288 GNLDLQSSPWPSISGQ 303
               + +     +   
Sbjct: 224 FMRMIGNDKQGQMIVF 239

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 48/221 (21%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILI---LQH 127
             ++LG G FG   LC     G       A KS+  +       + D+++EI I   L H
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLYH 82

Query: 128 LTGQPNIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNV 184
                NIV+++G    +    + L+ME    G L + +   K   + ++      QI   
Sbjct: 83  ----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI--- 135

Query: 185 VHAC-----HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                         +HRDL   N L+     +  +K  DFGL+  IET K Y       Y
Sbjct: 136 --CKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEY-------Y 183

Query: 240 YV-----------APEVL-HQRYGKEIDVWSAGVILYILLS 268
            V           APE L   ++    DVWS GV L+ LL+
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 39/287 (13%)

Query: 31  PRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYD---------------- 74
           P++  +   P+  +     KQ  ++  +       Y +I    D                
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391

Query: 75  --LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             L + +G GQFG  +     + +      A K+   +    D   E   +E L ++   
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD 449

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHAC 188
             P+IV+  G    +  + ++MELC+ GEL   +   K             Q+     A 
Sbjct: 450 -HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST---AL 504

Query: 189 HF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS--AYYVAP 243
            +      +HRD+   N L++    +  +K  DFGLS ++E    YK   G     ++AP
Sbjct: 505 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           E +  +R+    DVW  GV ++ +L  GV PF       +   I  G
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 53/239 (22%), Positives = 92/239 (38%), Gaps = 46/239 (19%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILI---LQHL 128
           ++K +G G  G       +  G++    A K++  +    ++   D   E  I     H 
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDH- 109

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHA 187
              PNI+  EG     +   +V E    G L   +    G ++  +   + R +      
Sbjct: 110 ---PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA---G 163

Query: 188 CHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV--- 241
             +   +G +HRDL   N L+     +   K +DFGLS  +E             Y    
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDA-------AYTTTG 213

Query: 242 --------APEVLHQRYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
                   APE +   +       DVWS GV+++ +L+ G  P+W  T + +  ++ EG
Sbjct: 214 GKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 42/237 (17%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILI---LQHL 128
           +DK +G G+FG       K   +K    A K++  +    +K   D   E  I     H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDH- 105

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHA 187
              PNI+  EG     + + +V E    G L   +      ++  +   + R I +    
Sbjct: 106 ---PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS---G 159

Query: 188 CHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV--- 241
             +   MG +HRDL   N L+     +   K +DFGL   +E           A Y    
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 242 --------APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
                   +PE + ++++    DVWS G++L+ ++S G  P+W  + + + +A+ EG
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 64/218 (29%), Positives = 89/218 (40%), Gaps = 44/218 (20%)

Query: 75  LDKELGRGQFGVTYLC----TKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQH 127
             ++LG G FG   L     T   TG   A K++  +     +     ++EI I   L H
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYH 92

Query: 128 LTGQPNIVEFEGA--YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN-- 183
                +I++++G        +L LVME    G L D +    I    +     +QI    
Sbjct: 93  ----EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI-GLAQLLLFAQQICEGM 147

Query: 184 -VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV- 241
             +HA H+   IHRDL   N LL     D  +K  DFGL+  +  G  Y       Y V 
Sbjct: 148 AYLHAQHY---IHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEY-------YRVR 194

Query: 242 ----------APEVL-HQRYGKEIDVWSAGVILYILLS 268
                     APE L   ++    DVWS GV LY LL+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 36/228 (15%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L + +G+G+FG   L      G K A K I       D   +    E  +   L+H    
Sbjct: 25  LLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN-----DATAQAFLAEASVMTQLRH---- 73

Query: 132 PNIVEFEGA-YEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHAC 188
            N+V+  G   E+K  L++V E  + G L D  R   + +            +     A 
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE---AM 130

Query: 189 HF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---A 242
            +      +HRDL   N L++   ED+  K +DFGL+      +           V   A
Sbjct: 131 EYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTA 182

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           PE L  +++  + DVWS G++L+ + S G  P+     K +   + +G
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 60/324 (18%), Positives = 109/324 (33%), Gaps = 58/324 (17%)

Query: 3   LCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPIL 62
           + +     H      +++            ++ +           ++   P     G   
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60

Query: 63  GKPYV------DITTIYDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVY 111
               +      +IT    L + LG G FG  Y           +  + A K++   ++  
Sbjct: 61  SISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCS 114

Query: 112 DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-------RII 164
           ++D  D   E LI+       NIV   G         +++EL +GG+L         R  
Sbjct: 115 EQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 173

Query: 165 AKGIYSEREAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGL 221
                +  +  ++ R I      C +      IHRD+   N LL         K  DFG+
Sbjct: 174 QPSSLAMLDLLHVARDIAC---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

Query: 222 SVFIETGKVYKEIVGSAYYV------------APEVLHQRYGK---EIDVWSAGVILYIL 266
           +         ++I  + YY              PE      G    + D WS GV+L+ +
Sbjct: 231 A---------RDIYRAGYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEI 279

Query: 267 LS-GVPPFWAETEKGIFEAILEGN 289
            S G  P+ +++ + + E +  G 
Sbjct: 280 FSLGYMPYPSKSNQEVLEFVTSGG 303

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 24/224 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++           E   +E  +++ L     +
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG----TMSPEAFLQEAQVMKKLR-HEKL 241

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHF-- 190
           V+       ++ +++V E  S G L D  +          +  ++  QI +      +  
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS---GMAYVE 297

Query: 191 -MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL 246
            M  +HRDL+  N L+    E+   K  DFGL+  IE    Y    G+ + +   APE  
Sbjct: 298 RMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353

Query: 247 -HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + R+  + DVWS G++L  L + G  P+     + + + +  G
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 60/237 (25%), Positives = 91/237 (38%), Gaps = 45/237 (18%)

Query: 75  LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHL 128
           L++ LG G FG  Y       K      A K+   +K     + E    E +I   L H 
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDH- 72

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHA 187
              P+IV+  G  E ++   ++MEL   GEL   +   K             QI     A
Sbjct: 73  ---PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK---A 125

Query: 188 CHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV--- 241
             +   +  +HRD+   N L+A       +K  DFGLS         + I    YY    
Sbjct: 126 MAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---------RYIEDEDYYKASV 173

Query: 242 --------APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
                   +PE +  +R+    DVW   V ++ +LS G  PF+    K +   + +G
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 57/303 (18%), Positives = 107/303 (35%), Gaps = 41/303 (13%)

Query: 13  IPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTI 72
           +    S         + L     +     +      +      S + P L +    +   
Sbjct: 26  LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85

Query: 73  YD-----LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILI 124
                   ++ +GRG FG  Y  T      K    A KS+   ++    ++     E +I
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGII 143

Query: 125 LQHLTGQPNIVEFEGA-YEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIV 182
           ++  +  PN++   G     + +  +V+     G+L + I       + ++      Q+ 
Sbjct: 144 MKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202

Query: 183 NVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                  F      +HRDL   N +L    E   +K  DFGL+  +   +        + 
Sbjct: 203 K---GMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFD------SV 250

Query: 240 YV-----------APEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL 286
           +            A E L  Q++  + DVWS GV+L+ L++ G PP+       I   +L
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

Query: 287 EGN 289
           +G 
Sbjct: 311 QGR 313

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 32/238 (13%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L + LG G FG  Y           +  + A K++   ++  ++D  D   E LI+    
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFN 91

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-------RIIAKGIYSEREAANICRQIV 182
              NIV   G         ++MEL +GG+L         R       +  +  ++ R I 
Sbjct: 92  -HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 183 NVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAY 239
                C +      IHRD+   N LL         K  DFG++  I     Y+   G A 
Sbjct: 151 C---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-KGGCAM 206

Query: 240 Y----VAPEVLHQRYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
                + PE      G    + D WS GV+L+ + S G  P+ +++ + + E +  G 
Sbjct: 207 LPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 18/221 (8%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+K+LG GQFG  ++ T     +  A K++          +E    E  +++ L     +
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKL 245

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           V+       K+ ++++ E  + G L D  +          +  +   QI   +       
Sbjct: 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL-HQ 248
            IHRDL+  N L++        K  DFGL+  IE    Y    G+ + +   APE +   
Sbjct: 305 YIHRDLRAANILVS---ASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFG 360

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            +  + DVWS G++L  +++ G  P+   +   +  A+  G
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 82.2 bits (204), Expect = 4e-18
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 28/226 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L KELG GQFGV  L   K      A K I    +      ++  +E      L H    
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMMKLSH---- 62

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVHACHF 190
           P +V+F G    +  +++V E  S G L + + + G      +   +C  +        F
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE---GMAF 119

Query: 191 ---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APE 244
                 IHRDL   N L+     D  +K +DFG++ ++     Y   VG+ + V   APE
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPE 175

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           V  + +Y  + DVW+ G++++ + S G  P+   T   +   + +G
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 61/241 (25%), Positives = 89/241 (36%), Gaps = 37/241 (15%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY--ACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
               +G G FG       K  G +   A K +  ++     D  D   E+ +L  L   P
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFD-----RIIAKGIYSEREAAN----------- 176
           NI+   GA E +  L+L +E    G L D     R++          +            
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 177 ICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE 233
               +        +      IHRDL   N L+    E+   K  DFGLS   E   VY +
Sbjct: 147 FAADVAR---GMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQE---VYVK 197

Query: 234 IVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEG 288
                  V   A E L +  Y    DVWS GV+L+ I+  G  P+   T   ++E + +G
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257

Query: 289 N 289
            
Sbjct: 258 Y 258

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 84.2 bits (208), Expect = 6e-18
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 24/224 (10%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
           L+ +LG+G FG  ++ T   T R  A K++           E   +E  +++ L     +
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPG----TMSPEAFLQEAQVMKKLR-HEKL 324

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACHF-- 190
           V+       ++ +++V E  S G L D  +          +  ++  QI +      +  
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS---GMAYVE 380

Query: 191 -MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVL 246
            M  +HRDL+  N L+    E+   K  DFGL+  IE    Y    G+ + +   APE  
Sbjct: 381 RMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436

Query: 247 -HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            + R+  + DVWS G++L  L + G  P+     + + + +  G
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 59/276 (21%)

Query: 54  QTSQIGPILGKPYVDITTIYD------------------LDKELGRGQFGVTYLCTKKAT 95
                 P     Y       D                    K +G G+FG  Y    K +
Sbjct: 9   HHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTS 68

Query: 96  GRKY----ACKSISRRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLH 148
             K     A K++  +    +K   D   E  I     H     NI+  EG     + + 
Sbjct: 69  SGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSH----HNIIRLEGVISKYKPMM 122

Query: 149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF---MGVIHRDLKPENFL 204
           ++ E    G L   +    G +S  +   + R I        +   M  +HRDL   N L
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA---GMKYLANMNYVHRDLAARNIL 179

Query: 205 LASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV----------APEVL-HQRYGKE 253
           +     +   K +DFGLS  +E      +   + Y            APE + ++++   
Sbjct: 180 VN---SNLVCKVSDFGLSRVLE------DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230

Query: 254 IDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
            DVWS G++++ +++ G  P+W  +   + +AI +G
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 7e-18
 Identities = 65/302 (21%), Positives = 110/302 (36%), Gaps = 25/302 (8%)

Query: 2   GLCFTRSRSHDIPISSSSDESPHHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGP- 60
           G       +H   ++                   +   P   RP  +   + ++    P 
Sbjct: 264 GAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPE 323

Query: 61  --ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKY--ACKSISRRKLVYDKDME 116
                K ++    +   D ELG G FG       +   ++   A K +  ++     D E
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTE 381

Query: 117 DVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY-SEREAA 175
           ++ RE  I+  L   P IV   G  + +  L LVME+  GG L   ++ K         A
Sbjct: 382 EMMREAQIMHQLD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439

Query: 176 NICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VY 231
            +  Q+        +      +HR+L   N LL ++      K +DFGLS  +      Y
Sbjct: 440 ELLHQVSM---GMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSYY 493

Query: 232 KEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL 286
                  + +   APE +  +++    DVWS GV ++  LS G  P+       +   I 
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

Query: 287 EG 288
           +G
Sbjct: 554 QG 555

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 26/228 (11%)

Query: 75  LDKELGRGQFGVTY--LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLT 129
            DKELG G FG         K   +  A K + + +       +++  E  +   L +  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDN-- 77

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH 189
             P IV   G  E  ++  LVME+   G L   +       ++    +  Q+        
Sbjct: 78  --PYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM---GMK 131

Query: 190 F---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYV---A 242
           +      +HRDL   N LL ++      K +DFGLS  +   +  YK      + V   A
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           PE + + ++  + DVWS GV+++   S G  P+       +   + +G
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 31/238 (13%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L + LG+G+FG       K     +   A K + +  ++   D+E+  RE   ++     
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD-H 84

Query: 132 PNIVEFEGA------YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREA------ANICR 179
           P++ +  G               +++     G+L   ++A  I                 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 180 QIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG 236
            I        +      IHRDL   N +LA   ED  +   DFGLS  I +G  Y++   
Sbjct: 145 DIAC---GMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCA 198

Query: 237 SAYYV---APEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
           S   V   A E L    Y    DVW+ GV ++ +++ G  P+       I+  ++ GN
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.5 bits (202), Expect = 8e-18
 Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 39/234 (16%)

Query: 75  LDKELGRGQFGVTY---LCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L + +G GQFG  +     + +      A K+   +    D   E   +E L ++     
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFD-H 75

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHF 190
           P+IV+  G    +  + ++MELC+ GEL   +   K             Q+     A  +
Sbjct: 76  PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST---ALAY 131

Query: 191 ---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV------ 241
                 +HRD+   N L++    +  +K  DFGLS         + +  S YY       
Sbjct: 132 LESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---------RYMEDSTYYKASKGKL 179

Query: 242 -----APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
                APE +  +R+    DVW  GV ++ +L  GV PF       +   I  G
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 81.5 bits (202), Expect = 8e-18
 Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 28/229 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY--ACKSISRRKLVYDKDMEDVRREILI---LQHLT 129
            D ELG G FG       +   ++   A K +  ++     D E++ RE  I   L +  
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDN-- 69

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHAC 188
             P IV   G  +  + L LVME+  GG L   ++  +        A +  Q+       
Sbjct: 70  --PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM---GM 123

Query: 189 HF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYV--- 241
            +      +HRDL   N LL ++      K +DFGLS  +      Y       + +   
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWY 180

Query: 242 APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           APE +  +++    DVWS GV ++  LS G  P+       +   I +G
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 56/216 (25%), Positives = 80/216 (37%), Gaps = 34/216 (15%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             K LG G FG     T     K+    K A K +  +   +  + E +  E+ I+ HL 
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLG 107

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD--------------RIIAKGIYSEREAA 175
              NIV   GA      + ++ E C  G+L +                IA    S R+  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 176 NICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK 232
           +   Q+        F      IHRD+   N LL         K  DFGL+  I     Y 
Sbjct: 168 HFSSQVAQ---GMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYI 221

Query: 233 EIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY 264
               +   V   APE +    Y  + DVWS G++L+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 52/220 (23%), Positives = 75/220 (34%), Gaps = 38/220 (17%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             K LG G FG     T     K       A K +  +   +  + E +  E+ +L +L 
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLG 84

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD------------------RIIAKGIYSE 171
              NIV   GA        ++ E C  G+L +                      +     
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 172 REAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
            +  +   Q+        F      IHRDL   N LL         K  DFGL+  I+  
Sbjct: 145 EDLLSFSYQVAK---GMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 198

Query: 229 KVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY 264
             Y     +   V   APE + +  Y  E DVWS G+ L+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 30/233 (12%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY---ACKSISRRKLVYDKDMEDVRREILI---LQHL 128
            D+ +G+G FGV Y        +     A KS+   ++   + +E   RE L+   L H 
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH- 81

Query: 129 TGQPNIVEFEGAYEDKQNLHL-VMELCSGGELFDRIIAKGIY-SEREAANICRQIVNVVH 186
              PN++   G     + L   ++     G+L   I +     + ++  +   Q+     
Sbjct: 82  ---PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR--- 135

Query: 187 ACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV-- 241
              +      +HRDL   N +L    E   +K  DFGL+  I   + Y         +  
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192

Query: 242 ---APEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
              A E L   R+  + DVWS GV+L+ LL+ G PP+       +   + +G 
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 39/246 (15%)

Query: 75  LDKELGRGQFGVTYLCT-------KKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   L         K     K A K +  +    +KD+ D+  E+ +++ 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 130

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD----------------RIIAKGIYSE 171
           +    NI+   GA      L++++E  S G L +                    +   S 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 172 REAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           ++  +   Q+        +      IHRDL   N L+    ED+ +K  DFGL+  I   
Sbjct: 191 KDLVSCAYQVAR---GMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHI 244

Query: 229 KVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFE 283
             YK+       V   APE L  + Y  + DVWS GV+L+ I   G  P+     + +F+
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 284 AILEGN 289
            + EG+
Sbjct: 305 LLKEGH 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 50/238 (21%), Positives = 93/238 (39%), Gaps = 32/238 (13%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           + +ELG+G FG+ Y        K     + A K++   +    ++  +   E  +++   
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF- 85

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGEL----------FDRIIAKGIYSEREAANICR 179
              ++V   G     Q   ++MEL + G+L                    S  +   +  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 180 QIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG 236
           +I +      +      +HRDL   N ++A   ED  +K  DFG++  I     Y++   
Sbjct: 146 EIAD---GMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGK 199

Query: 237 SAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGN 289
               V   +PE L    +    DVWS GV+L+ I      P+   + + +   ++EG 
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 48/237 (20%), Positives = 95/237 (40%), Gaps = 30/237 (12%)

Query: 75  LDKELGRGQFGVTYLCT---KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           L K LG G+FG         +  T  K A K++ +      +++E+   E   ++  +  
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFS-H 95

Query: 132 PNIVEFEGA-----YEDKQNLHLVMELCSGGELFDRIIAKGIYSEREA------ANICRQ 180
           PN++   G       +      +++     G+L   ++   + +  +             
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 181 IVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
           I        +      +HRDL   N +L    +D  +   DFGLS  I +G  Y++   +
Sbjct: 156 IAL---GMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQGRIA 209

Query: 238 AYYV---APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
              V   A E L  + Y  + DVW+ GV ++ + + G+ P+       +++ +L G+
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 39/246 (15%)

Query: 75  LDKELGRGQFGVTYLCT-------KKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   +         K       A K +  +    +KD+ D+  E+ +++ 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKM 96

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD----------------RIIAKGIYSE 171
           +    NI+   GA      L++++E  S G L +                  + +   + 
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 172 REAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           ++  +   Q+        +      IHRDL   N L+    E++ +K  DFGL+  I   
Sbjct: 157 KDLVSCTYQLAR---GMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNI 210

Query: 229 KVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFE 283
             YK+       V   APE L  + Y  + DVWS GV+++ I   G  P+     + +F+
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

Query: 284 AILEGN 289
            + EG+
Sbjct: 271 LLKEGH 276

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 39/246 (15%)

Query: 75  LDKELGRGQFGVTYLCT-------KKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           L K LG G FG   +         K       A K +  +    +KD+ D+  E+ +++ 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKM 142

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD----------------RIIAKGIYSE 171
           +    NI+   GA      L++++E  S G L +                  + +   + 
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 172 REAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG 228
           ++  +   Q+        +      IHRDL   N L+    E++ +K  DFGL+  I   
Sbjct: 203 KDLVSCTYQLAR---GMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNI 256

Query: 229 KVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFE 283
             YK+       V   APE L  + Y  + DVWS GV+++ I   G  P+     + +F+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

Query: 284 AILEGN 289
            + EG+
Sbjct: 317 LLKEGH 322

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.2 bits (196), Expect = 6e-17
 Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 30/227 (13%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI---LQHLTGQ 131
           L + LG GQFG  ++        K A KS+ +         +    E  +   LQH    
Sbjct: 17  LVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQG----SMSPDAFLAEANLMKQLQH---- 67

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFD--RIIAKGIYSEREAANICRQIVNVVHACH 189
             +V        ++ ++++ E    G L D  +  +    +  +  ++  QI        
Sbjct: 68  QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE---GMA 123

Query: 190 F---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---AP 243
           F      IHRDL+  N L++   +    K  DFGL+  IE    Y    G+ + +   AP
Sbjct: 124 FIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG 288
           E + +  +  + DVWS G++L  +++ G  P+   T   + + +  G
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.2 bits (196), Expect = 6e-17
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 44/247 (17%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY-----ACKSISRRKLVYDKDMEDVRREILI---LQ 126
             +ELG  +FG  Y                A K++  +        E+ R E ++   LQ
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQ 70

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGEL----------------FDRIIAKGIYS 170
           H    PN+V   G     Q L ++   CS G+L                 D    K    
Sbjct: 71  H----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 171 EREAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET 227
             +  ++  QI        +     V+H+DL   N L+    +   +K +D GL   +  
Sbjct: 127 PPDFVHLVAQIAA---GMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFREVYA 180

Query: 228 GKVYKEIVGSAYYV---APE-VLHQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF 282
              YK +  S   +   APE +++ ++  + D+WS GV+L+ + S G+ P+   + + + 
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240

Query: 283 EAILEGN 289
           E I    
Sbjct: 241 EMIRNRQ 247

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 64/285 (22%), Positives = 106/285 (37%), Gaps = 49/285 (17%)

Query: 38  FRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGR 97
             PT  +   L   I +  Q        ++    I  L  ELG G FG  +L        
Sbjct: 9   LSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI-VLKWELGEGAFGKVFLAECHNLLP 67

Query: 98  KY-----ACKSISRRKLVYDKDMEDVRREILI---LQHLTGQPNIVEFEGAYEDKQNLHL 149
           +      A K++   K   +   +D +RE  +   LQH     +IV F G   + + L +
Sbjct: 68  EQDKMLVAVKAL---KEASESARQDFQREAELLTMLQH----QHIVRFFGVCTEGRPLLM 120

Query: 150 VMELCSGGEL---------------FDRIIAKGIYSEREAANICRQIVNVVHACHF---M 191
           V E    G+L                   +A G     +   +  Q+        +   +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA---GMVYLAGL 177

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYV---APEVLHQ 248
             +HRDL   N L+    +   +K  DFG+S  I +   Y+    +   +    PE +  
Sbjct: 178 HFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL- 233

Query: 249 RYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN 289
            Y K   E DVWS GV+L+ + + G  P++  +     + I +G 
Sbjct: 234 -YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 38/201 (18%), Positives = 72/201 (35%), Gaps = 35/201 (17%)

Query: 42  SSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYAC 101
           +      S   P+   +  + G  +V       L K++G G FG+ YL        K A 
Sbjct: 15  TENLYFQSMPFPEGKVLDDMEGNQWV-------LGKKIGSGGFGLIYLAFPTNKPEKDAR 67

Query: 102 KSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE----------------GAYEDKQ 145
             +        ++   +  E+   Q +  +  I ++                 G  E K 
Sbjct: 68  HVVKVEY----QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123

Query: 146 NLH--LVMEL--CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPE 201
             +  +VME       ++  +    G + +     +  ++++V+   H    +H D+K  
Sbjct: 124 RSYRFMVMERLGIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA 180

Query: 202 NFLLASKEEDSPIKATDFGLS 222
           N LL  K  D  +   D+GLS
Sbjct: 181 NLLLGYKNPDQ-VYLADYGLS 200

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 55/278 (19%), Positives = 93/278 (33%), Gaps = 51/278 (18%)

Query: 25  HRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGK---PYVDITTIYDLDKELGR 81
           H+Y+   R  +   +       + ++      +      K   P  ++       K LG 
Sbjct: 1   HKYKKQFRY-ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLE----FGKVLGS 55

Query: 82  GQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE 136
           G FG     T     K     + A K +  ++     + E +  E+ ++  L    NIV 
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSHENIVN 113

Query: 137 FEGAYEDKQNLHLVMELCSGGEL-----------------------FDRIIAKGIYSERE 173
             GA      ++L+ E C  G+L                        +      + +  +
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173

Query: 174 AANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV 230
                 Q+        F      +HRDL   N L+        +K  DFGL+  I +   
Sbjct: 174 LLCFAYQVAK---GMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSN 227

Query: 231 YKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY 264
           Y     +   V   APE L    Y  + DVWS G++L+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 57/219 (26%), Positives = 83/219 (37%), Gaps = 37/219 (16%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L K LGRG FG           K AT R  A K +  ++     +   +  E+ IL H+ 
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIG 88

Query: 130 GQPNIVEFEGA-YEDKQNLHLVMELCSGGELFD----------------RIIAKGIYSER 172
              N+V   GA  +    L +++E C  G L                    + K   +  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 173 EAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK 229
                  Q+        F      IHRDL   N LL+   E + +K  DFGL+  I    
Sbjct: 149 HLICYSFQVAK---GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202

Query: 230 VYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY 264
            Y     +   +   APE +  + Y  + DVWS GV+L+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 61/249 (24%), Positives = 95/249 (38%), Gaps = 49/249 (19%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKY-----ACKSISRRKLVYDKDMEDVRREILI---LQ 126
           L +ELG G FG  +L               A K++   K       +D +RE  +   LQ
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 75

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-----RIIAKGIYSEREAAN----- 176
           H     +IV+F G   D   L +V E    G+L          A  +   +         
Sbjct: 76  H----EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 177 ------ICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET 227
                 I  QI +      +      +HRDL   N L+     +  +K  DFG+S  + +
Sbjct: 132 LSQMLHIASQIAS---GMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDVYS 185

Query: 228 GKVYKEIVGSAYYV---APEVLHQRYGK---EIDVWSAGVILYILLS-GVPPFWAETEKG 280
              Y+    +   +    PE +   Y K   E DVWS GVIL+ + + G  P++  +   
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 281 IFEAILEGN 289
           + E I +G 
Sbjct: 244 VIECITQGR 252

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 9/41 (21%), Positives = 16/41 (39%)

Query: 326 LEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           + H      G  +       VL   K +  + K +KLA+ +
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTI 41

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 60/252 (23%), Positives = 96/252 (38%), Gaps = 46/252 (18%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L K LG G+FG     T      +A     A K +  ++     ++ D+  E  +L+ + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQV- 83

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-----RIIAKGIYSEREAAN-------- 176
             P++++  GA      L L++E    G L       R +  G      + N        
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 177 -----------ICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLS 222
                         QI        +   M ++HRDL   N L+A   E   +K +DFGLS
Sbjct: 144 ERALTMGDLISFAWQISQ---GMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLS 197

Query: 223 VFIETGKVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPPFWAET 277
             +     Y +       V   A E L    Y  + DVWS GV+L+ I+  G  P+    
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257

Query: 278 EKGIFEAILEGN 289
            + +F  +  G+
Sbjct: 258 PERLFNLLKTGH 269

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score = 71.1 bits (175), Expect = 9e-15
 Identities = 11/44 (25%), Positives = 21/44 (47%), Gaps = 1/44 (2%)

Query: 324 EALEHPWLKED-GATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
               H   +E+        + S +L  +K F+  N++KK+AL +
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTI 46

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 46/252 (18%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             +++G G FG  +                A K +  ++        D +RE  ++    
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF- 107

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFD-----RIIAKGIYSEREAA--------- 175
             PNIV+  G     + + L+ E  + G+L +             S  + +         
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 176 ----------NICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSPIKATDFGLS 222
                      I RQ+        +      +HRDL   N L+    E+  +K  DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAA---GMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 221

Query: 223 VFIETGKVYKEIVGSAYYV---APEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAET 277
             I +   YK     A  +    PE + + RY  E DVW+ GV+L+ + S G+ P++   
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281

Query: 278 EKGIFEAILEGN 289
            + +   + +GN
Sbjct: 282 HEEVIYYVRDGN 293

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 48/300 (16%), Positives = 99/300 (33%), Gaps = 55/300 (18%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQ 83
           HH    +   T+  +  + +        +P  + +    G+ +        L     R  
Sbjct: 5   HHHSSGVDLGTENLYFQSMTTSLE---ALPTGTVLTDKSGRQWK-------LKSFQTRDN 54

Query: 84  FGVTYLCTKKATGR--------KYACK---------SISRRKLVYDKDMEDVRREILILQ 126
            G+ Y     +T          K++ K         +         K ++  + + L   
Sbjct: 55  QGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST 114

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMEL--CSGGELFDRIIAKGIYSEREAANICRQIVNV 184
            L   P  + F G ++DK    LV+     S     D    K + SER    +  ++++ 
Sbjct: 115 PLLAIPTCMGF-GVHQDKYRF-LVLPSLGRSLQSALDVS-PKHVLSERSVLQVACRLLDA 171

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGK--VYKE-----IVG 236
           +   H    +H ++  EN  +  +++   +    +G +  +  +GK   Y E       G
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG 230

Query: 237 SAYYVAPEVLHQRYGKEI----DVWSAG-VILYILLSGVPPFW----AETEKGIFEAILE 287
              +++   +    G       D+ S G  +L  L   +P  W      TE  + +    
Sbjct: 231 DLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP--WTNCLPNTEDIMKQKQKF 285

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 31/205 (15%), Positives = 71/205 (34%), Gaps = 30/205 (14%)

Query: 39  RPTSSRPPALSKQIPQTSQIGPILGKPYVDITTI-YDLDKELGRGQFGVTYLC-----TK 92
              + R  +  + + +   +G I+     D+    + +   +G+G FG  YL        
Sbjct: 6   AAQAGRQSSAKRHLAEQFAVGEIIT----DMAAAAWKVGLPIGQGGFGCIYLADMNSSES 61

Query: 93  KATGRKYACKSISRR-----------KLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY 141
             +      K                +     +          L++L G P      G +
Sbjct: 62  VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL-GVPKYWGS-GLH 119

Query: 142 EDKQNLH--LVMEL--CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRD 197
           +     +  ++M+       ++++       +S +    +  +I++++   H    +H D
Sbjct: 120 DKNGKSYRFMIMDRFGSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177

Query: 198 LKPENFLLASKEEDSPIKATDFGLS 222
           +K  N LL  K  D  +   D+GL+
Sbjct: 178 IKASNLLLNYKNPDQ-VYLVDYGLA 201

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.8 bits (149), Expect = 7e-11
 Identities = 45/325 (13%), Positives = 94/325 (28%), Gaps = 68/325 (20%)

Query: 70  TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRK-----LVYDKDMEDVRREILI 124
           T      +++G G FG  +           A K I+          + K  E++  EI+I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 125 LQHLTGQ--------PNIVEFEGAY------------------------------EDKQN 146
            + L+             +     +                                   
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN-VVHACHFMGVIHRDLKPENFL- 204
           L +V+E   GG   +++  K + S   A +I  Q+   +  A   +   HRDL   N L 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 205 -------LASKEEDSPIKATDFGLSVFIET-----GKVYKEIVGSAYYVAPEVLHQRYGK 252
                  L              GL V I        +    +V     +  ++       
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255

Query: 253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKML 312
           + D++   ++     +    +   +       + +  L   +      +   K + RK+ 
Sbjct: 256 QFDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI- 312

Query: 313 TKDPKKRI----TAAEALEHPWLKE 333
            ++  + +    +A + L    L +
Sbjct: 313 -QEFHRTMLNFSSATDLLCQHSLFK 336

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 35/141 (24%), Positives = 53/141 (37%), Gaps = 12/141 (8%)

Query: 75  LDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
           L K LGRG FG           K AT R  A K +  ++     +   +  E+ IL H+ 
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIG 83

Query: 130 GQPNIVEFEGAYEDKQN-LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              N+V   GA       L +++E C  G L   + +K      E      +        
Sbjct: 84  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKTKGARFRQGK 139

Query: 189 HFMGVIHRDLKPENFLLASKE 209
            ++G I  DLK     + S +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQ 160

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 8/102 (7%)

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
               Q+   +        IHRDL   N LL+   E + +K  DFGL+  I     Y    
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 236 GSAYYV---APEVL-HQRYGKEIDVWSAGVILY-ILLSGVPP 272
            +   +   APE +  + Y  + DVWS GV+L+ I   G  P
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 54.2 bits (131), Expect = 7e-09
 Identities = 7/27 (25%), Positives = 14/27 (51%)

Query: 340 KPIDSAVLTRMKQFRAMNKMKKLALKV 366
           K   +  L  MK+F++  K+ + A+  
Sbjct: 2   KHALTGALGNMKKFQSSQKLAQAAMLF 28

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 55.3 bits (134), Expect = 7e-09
 Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 37/151 (24%)

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLHQR 249
            IHRD+K  N LL   +E    K +DFGL+   E      +   IVG+  Y+APE L   
Sbjct: 154 HIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210

Query: 250 YGKEIDVWSAGVILYILLSGVPPF-----------WAE---TEKGIFEAILEGNLDLQSS 295
              + D++S GV+L  +++G+P               E    E+   E      +D    
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY----ID---- 262

Query: 296 PWPSISGQAKDLIRKM-------LTKDPKKR 319
               ++      +  M       L +   KR
Sbjct: 263 --KKMNDADSTSVEAMYSVASQCLHEKKNKR 291

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 52/292 (17%)

Query: 41  TSSRPPALSKQIPQTSQIGPILGK--PYVDITTI---YDLDKELGRGQFGVTYLCTKKAT 95
             S+          +S + P      P VD+      +D    +G G FG  Y    K  
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVY----KGV 59

Query: 96  ---GRKYACKSISRRKLVYDKDMEDVRREILIL---QHLTGQPNIVEFEGAYEDKQNLHL 149
              G K A K  +       ++      EI  L   +H    P++V   G  +++  + L
Sbjct: 60  LRDGAKVALKRRTPESSQGIEEF---ETEIETLSFCRH----PHLVSLIGFCDERNEMIL 112

Query: 150 VMELCSGGELFDRIIAKGIYSE----REAANICRQIVNVVHACHFMGVIHRDLKPENFLL 205
           + +    G L   +    + +      +   IC      +H  H   +IHRD+K  N LL
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL 172

Query: 206 ASKEEDSPIKATDFGLS-VFIETGK--VYKEIVGSAYYVAPE-VLHQRYGKEIDVWSAGV 261
              +E+   K TDFG+S    E  +  +   + G+  Y+ PE  +  R  ++ DV+S GV
Sbjct: 173 ---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 262 ILYILLSGVPPF-------------WAET--EKGIFEAI----LEGNLDLQS 294
           +L+ +L                   WA      G  E I    L   +  +S
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES 281

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score = 51.6 bits (123), Expect = 9e-08
 Identities = 13/92 (14%), Positives = 22/92 (23%), Gaps = 10/92 (10%)

Query: 274 WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
             E  K       +GNL       P    ++    R   T+    R          W+  
Sbjct: 4   TKEAVKAS-----DGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53

Query: 334 DGATSDKPIDSAVLTRMKQFRAMNKMKKLALK 365
             A        + L           + +L  +
Sbjct: 54  SAAPQGSDSSDSELELSTVRHQPEGLDQLQAQ 85

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 48.1 bits (115), Expect = 6e-07
 Identities = 5/25 (20%), Positives = 12/25 (48%)

Query: 342 IDSAVLTRMKQFRAMNKMKKLALKV 366
           I   VL  MK +   + ++ + + +
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINI 26

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 11/71 (15%), Positives = 23/71 (32%), Gaps = 4/71 (5%)

Query: 297 WPSISGQAKDLIRKMLTKDPK--KRITAAEALEHPW--LKEDGATSDKPIDSAVLTRMKQ 352
              I+ + ++   K+   D K      A E  E      + D A   + + S +      
Sbjct: 43  EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDD 102

Query: 353 FRAMNKMKKLA 363
               N+++   
Sbjct: 103 ASGYNRLRPSK 113

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 46.8 bits (112), Expect = 5e-06
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 6/84 (7%)

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK--VYKEIVGSAYYVAPE-VLHQR 249
           +IHRD+K  N LL   +E+      DFGL+  ++     V   + G+  ++APE +   +
Sbjct: 155 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211

Query: 250 YGKEIDVWSAGVILYILLSGVPPF 273
             ++ DV+  GV+L  L++G   F
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAF 235

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 3/39 (7%), Positives = 12/39 (30%)

Query: 328 HPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
            P +      + +PI  + +     ++    ++      
Sbjct: 2   QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFP 40

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 55/403 (13%), Positives = 118/403 (29%), Gaps = 112/403 (27%)

Query: 24  HHRYQPLPRRTQQDFRPTSSRPPALSKQIPQTSQIGPILGKPYVDITTIYDLDKELGRGQ 83
            ++Y+ +    +  F           K +    +   IL K  +D   I      +    
Sbjct: 15  QYQYKDILSVFEDAFVDNFD-----CKDVQDMPK--SILSKEEIDH--IIMSKDAVSGTL 65

Query: 84  FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED 143
                L +K+    +   + + R    Y   M  ++ E         QP+++     Y +
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRIN--YKFLMSPIKTE-------QRQPSMMTRM--YIE 114

Query: 144 KQNLHLVMELCSGGELFD-----RI-----IAKGIYSEREAANICRQIVNVVHACHFMG- 192
           +++      L +  ++F      R+     + + +   R A N+      ++     +  
Sbjct: 115 QRD-----RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV------LIDG---VLG 160

Query: 193 ---------VIHRDLKPEN------FLLASKEEDSP----------IKATDFGLSVFIET 227
                    V     K +       F L  K  +SP          +   D   +   + 
Sbjct: 161 SGKTWVALDVC-LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 228 GKVYKEIVGSAYYVAPEVLHQRYGKE---I--DVWSAGVILY------ILLSGVPPFWAE 276
               K  + S       +L  +  +    +  +V +A           ILL+        
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT-------- 271

Query: 277 T-EKGIFEAILEGN---LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE-HPW- 330
           T  K + + +       + L          + K L+ K L   P+      E L  +P  
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD--LPREVLTTNPRR 329

Query: 331 -------LKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
                  +++  AT D         +      +  + + +L V
Sbjct: 330 LSIIAESIRDGLATWDN-------WKHVNCDKLTTIIESSLNV 365

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	366
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.21
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.89
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.63
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.58
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.23
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.13
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.04
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.92
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.71
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.7
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.46
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.37
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.84
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.5
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	90.14
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.33
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.13
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.6

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-65  Score=463.90  Aligned_cols=259  Identities=33%  Similarity=0.540  Sum_probs=235.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++++++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999998765555566788999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC--
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG--  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~--  228 (366)
                      ||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999   67788999999999876432  


Q ss_pred             -CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       ....+.+||+.|||||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.++...++.    .+++++.+
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence             23456789999999999874 5899999999999999999999999999999999999988776543    57999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCCCcccCCCC
Q 017768          307 LIRKMLTKDPKKRITAAE------ALEHPWLKEDGAT  337 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~------~l~hp~f~~~~~~  337 (366)
                      ||.+||+.||++|||++|      +++||||++.+..
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence            999999999999999987      6899999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-65  Score=468.30  Aligned_cols=261  Identities=30%  Similarity=0.554  Sum_probs=231.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.++||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|+.++ |||||++++++.+++.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CSSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            3567999999999999999999999999999999997543   234566889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||||+||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence            99999999999998875 569999999999999999999999999999999999999   67788999999999876543


Q ss_pred             -CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       ....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+.+..+..... .....+..+++++.+
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence             3456679999999999986 4699999999999999999999999999988888887776532 233344578999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ||.+||+.||++|||++|+|+||||++...++
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~  334 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPA  334 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCCCCc
Confidence            99999999999999999999999999876543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-65  Score=452.86  Aligned_cols=255  Identities=39%  Similarity=0.650  Sum_probs=214.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++..|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999998766555556778999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||| +|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 67999999999999999999999999999999999999999999999999   6678899999999988766666


Q ss_pred             eecccCCCCCCcccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQR-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ..+.+||+.|||||++.+. + +.++|||||||++|+|++|+.||.+.+.......+..+...++.    .+++++.+||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            6678999999999998754 4 68999999999999999999999999988888888887765543    5799999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .+||+.||++|||++|+++||||+..
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHHcCcccccC
Confidence            99999999999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-63  Score=468.31  Aligned_cols=261  Identities=30%  Similarity=0.554  Sum_probs=231.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.++||+|+||.||+|+++.+|+.||||++....   ....+.+.+|+.+|+.++ |||||++++++.+++.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence            3567999999999999999999999999999999997543   344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||||+||+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCC
Confidence            99999999999998865 569999999999999999999999999999999999999   67788999999999876543


Q ss_pred             -CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       ....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+.+..+..... .....+..+++++.+
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             3456678999999999986 4699999999999999999999999999988888888776532 233445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ||.+||+.||++|||+.|+|+||||++...++
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~  411 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPA  411 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCCCCc
Confidence            99999999999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-64  Score=460.29  Aligned_cols=257  Identities=27%  Similarity=0.561  Sum_probs=224.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      -++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|++++ ||||+++++++.+++.+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            3679999999999999999999999999999999976543 3445778999999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||+||+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecC
Confidence            999999999999997654  47999999999999999999999999999999999999   6778899999999987654


Q ss_pred             CC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. .....+||+.|||||++.+ .++.++|||||||+||+|++|+.||.+.+..+.+..+..+.....   +..+++++.
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~  254 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLR  254 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHH
Confidence            32 2345689999999999875 589999999999999999999999999999999988888765432   346899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +||.+||+.||++|||++|+|+||||++.
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999999763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-63  Score=445.22  Aligned_cols=255  Identities=24%  Similarity=0.428  Sum_probs=218.9

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----CCeEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----KQNLH  148 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~~~~  148 (366)
                      |++.++||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.++++++ |||||++++++.+    ++.+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence            4788899999999999999999999999999976543 3345678999999999997 9999999999865    35689


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ||||||+||+|.+++.....+++.++..++.||+.||.|||+++  |+||||||+|||++  +.++.+||+|||+|+...
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCC
Confidence            99999999999999999999999999999999999999999999  99999999999995  246789999999998654


Q ss_pred             CCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      . ....+.+||+.|||||++.++++.++|||||||+||||++|+.||.+... ......+..+.....  .....++++.
T Consensus       184 ~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~  260 (290)
T 3fpq_A          184 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK  260 (290)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCHHHH
T ss_pred             C-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC--CCccCCHHHH
Confidence            3 34456789999999999988899999999999999999999999976544 444455544432221  2235688999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +||.+||+.||++|||+.|+|+||||++.
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-63  Score=447.70  Aligned_cols=256  Identities=30%  Similarity=0.529  Sum_probs=221.7

Q ss_pred             cceeeeceecccCceEEEEEEEc---cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ++|++.+.||+|+||+||+|++.   .+++.||+|++.+.... ......+.+|+.+|++++ ||||+++++++.+++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            56999999999999999999874   46789999999765432 234456889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||||+||+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999999999999999999999999999999999999999999999   6778899999999986543


Q ss_pred             -CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 -GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                       .....+.+||+.|||||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.++...++.    .+++++.
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHH
Confidence             33445678999999999986 46899999999999999999999999999999999999887765543    5899999


Q ss_pred             HHHHHhcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          306 DLIRKMLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      +||.+||+.||++|||     ++|+++||||++.+
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            9999999999999998     58999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-61  Score=441.90  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=221.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++.....        ..+|+.+++.++ |||||++++++.+++.+||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            3568999999999999999999999999999999975432        246999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC-CEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS-PIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~-~vkl~Dfg~a~~~~~~  228 (366)
                      |||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++   .++ .+||+|||+|+.....
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC---
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCC
Confidence            999999999999999989999999999999999999999999999999999999994   454 6999999999876543


Q ss_pred             Cc------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          229 KV------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~~------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ..      ....+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.+.......+..+..... ..++.++
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s  283 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCA  283 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSC
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCC
Confidence            21      223579999999999864 599999999999999999999999988877777777776654322 2345789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHH-------------hcCCCcccCCCCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEA-------------LEHPWLKEDGATS  338 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~-------------l~hp~f~~~~~~~  338 (366)
                      +++.++|.+||+.||++|||+.|+             |+|||+.+...+-
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            999999999999999999999997             6799998765543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-60  Score=446.98  Aligned_cols=265  Identities=27%  Similarity=0.422  Sum_probs=225.4

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----  143 (366)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|+.++ ||||+++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            46678999999999999999999999999999999996543 23345667889999999997 9999999998754    


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 --KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                        .+.+|||||||+ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence              367999999996 6899999888889999999999999999999999999999999999999   6778899999999


Q ss_pred             cccccCC-----CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          222 SVFIETG-----KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       222 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                      |+.....     ....+.+||+.|+|||++.+  .++.++||||+||++|||++|..||.+.+..+.+..+......+..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9865322     23456789999999998754  4799999999999999999999999999888888777543322211


Q ss_pred             C---------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          295 S---------------------------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       295 ~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      .                           .++.+++++.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence            1                           1245789999999999999999999999999999999865433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-58  Score=429.41  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=210.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEc---cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+.++|++.+.||+|+||+||+|+++   .+++.||+|.+...     ....++.+|+.+|+.+.+||||+++++++.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            46778999999999999999999875   35789999988543     34567889999999998899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +..|||||||+|++|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++  .+.+.+||+|||+|+.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcc
Confidence            99999999999999999883   589999999999999999999999999999999999995  3346799999999975


Q ss_pred             ccCCC-----------------------------ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCC
Q 017768          225 IETGK-----------------------------VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       225 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                      .....                             .....+||+.|+|||++.+  .++.++||||+||++|+|++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            43221                             1234579999999998764  4899999999999999999999999


Q ss_pred             CCCC-hHHHHHHHHcC--------------------------------------C------------CCCCCCCCCCCCH
Q 017768          274 WAET-EKGIFEAILEG--------------------------------------N------------LDLQSSPWPSISG  302 (366)
Q Consensus       274 ~~~~-~~~~~~~~~~~--------------------------------------~------------~~~~~~~~~~~~~  302 (366)
                      .... ..+.+..+...                                      .            .......+..+++
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            6543 33333322110                                      0            0011223557899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ++.+||.+||+.||++|+|++|+|+||||++.+
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999998754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-58  Score=452.10  Aligned_cols=267  Identities=36%  Similarity=0.642  Sum_probs=242.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++....   ....+.+.+|+.+|+.++ ||||+++++++.+.+.+
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            35578999999999999999999999999999999986543   345677899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |||||||+||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+|+...
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEcc
Confidence            9999999999999998643 56999999999999999999999999999999999999963 234789999999999887


Q ss_pred             CCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ........+||+.|||||++.+ .++.++|||||||+||+|++|..||.+.+..+.+..+......+....++.+++++.
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            7777778899999999999864 589999999999999999999999999999999999999888887777788999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      +||.+||+.||++|||+.|+|+||||+....+..
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence            9999999999999999999999999998776543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.7e-59  Score=419.56  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=199.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-----
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-----  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-----  145 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|++++ ||||+++++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            45999999999999999999999999999999986543  2345567899999999997 999999999987654     


Q ss_pred             -------eEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          146 -------NLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       146 -------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                             .+|||||||++|+|.+++.....   .++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   37999999999999999987654   4456789999999999999999999999999999999   5677899


Q ss_pred             EeecCCcccccCCCc-------------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-H
Q 017768          216 ATDFGLSVFIETGKV-------------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK-G  280 (366)
Q Consensus       216 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~  280 (366)
                      |+|||+|+.......             ..+.+||+.|||||++.+ .++.++|||||||++|||++   ||...... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987644321             234579999999999874 69999999999999999996   88654322 2


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      .+..+......   ..++..++.+.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus       236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            22333333221   11223467788999999999999999999999999999876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-58  Score=414.46  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=215.6

Q ss_pred             ccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|.+.+.||+|+||+||+|++.     .++..||||++...   .....+.+.+|+.+|++++ |||||++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence            356999999999999999999865     35789999998643   2345678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          145 QNLHLVMELCSGGELFDRIIAK-------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      +..+||||||++|+|.+++...             ..+++.++..++.||+.||.|||+++|+||||||+|||+   +.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence            9999999999999999999764             259999999999999999999999999999999999999   567


Q ss_pred             CCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017768          212 SPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAIL  286 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~  286 (366)
                      +.+||+|||+|+........   ....||+.|||||++. +.++.++|||||||+||||+| |+.||.+.+..+....+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            78999999999876443322   2246899999999886 579999999999999999998 899999999999988888


Q ss_pred             cCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          287 EGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+......   ..+++++.+|+.+||+.||++|||+.++++  |+++
T Consensus       245 ~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~  286 (299)
T 4asz_A          245 QGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQN  286 (299)
T ss_dssp             HTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             cCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            87643322   357899999999999999999999999954  5543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4e-57  Score=442.14  Aligned_cols=257  Identities=29%  Similarity=0.499  Sum_probs=220.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEeeCCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~~~~~~  148 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..++..+.  +||||+++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56999999999999999999999999999999997655443444455555554444332  4999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++++||+|||+|+.....
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCCC
Confidence            999999999999999999999999999999999999999999999999999999999   67889999999999877544


Q ss_pred             CceecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      . ..+.+||+.|||||++. + .++.++|||||||+||+|++|..||.+.+   .......+......++    ..++++
T Consensus       346 ~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~  420 (689)
T 3v5w_A          346 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPE  420 (689)
T ss_dssp             C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             C-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHH
Confidence            3 45678999999999985 3 58999999999999999999999997643   3344555555554443    368999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          304 AKDLIRKMLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      +.+||.+||+.||++|++     ++|+++||||++.+
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            999999999999999998     79999999998743

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-57  Score=411.25  Aligned_cols=249  Identities=20%  Similarity=0.352  Sum_probs=215.1

Q ss_pred             cceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +.+++.++||+|+||+||+|.+.     .+++.||||.+....  .....+.+.+|+.++++++ |||||++++++..++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            45788999999999999999864     357899999986442  3445678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          146 NLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                      ..+||||||++|+|.+++...                ..+++.++..++.||+.||+|||+++||||||||+|||+   +
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence            999999999999999999653                348999999999999999999999999999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 017768          210 EDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA  284 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~  284 (366)
                      +++.+||+|||+++......   ......||+.|||||++. +.++.++|||||||+||||+| |..||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            67789999999998764332   234457999999999875 679999999999999999998 8999999999999888


Q ss_pred             HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +..+......   ..+++++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877543322   3678999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-57  Score=414.08  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             cceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ++|.+.++||+|+||+||+|++.     .++..||||++...   .....+.+.+|+.+|++++ |||||++++++.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            56889999999999999999865     35789999999643   2345678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC
Q 017768          146 NLHLVMELCSGGELFDRIIAK---------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE  210 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~  210 (366)
                      ..+||||||++|+|.+++...               ..+++.++..++.||+.||.|||+++|+||||||+|||+   +.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence            999999999999999998753               358999999999999999999999999999999999999   56


Q ss_pred             CCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017768          211 DSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAI  285 (366)
Q Consensus       211 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~  285 (366)
                      ++.+||+|||+++......   ......||+.|||||++. ..++.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            7789999999998764332   223457999999999876 469999999999999999999 89999999988888888


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+.....   ...+++++.+|+.+||+.||++|||+.|++++
T Consensus       274 ~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            77653222   23578999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-57  Score=409.20  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.+++.++||+|+||+||+|++.   ..||||+++... ......+.+.+|+.++++++ ||||+++++++.+ +..+|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEE
Confidence            356788999999999999999865   359999986433 23345678999999999997 9999999998765 56899


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||||+||+|.+++... ..+++.++..|+.||+.||+|||+++||||||||+|||+   ++++.+||+|||+|+.....
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccC
Confidence            99999999999999764 469999999999999999999999999999999999999   56778999999999875432


Q ss_pred             ---CceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-cCCCCCC-CCCCCC
Q 017768          229 ---KVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL-EGNLDLQ-SSPWPS  299 (366)
Q Consensus       229 ---~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~-~~~~~~  299 (366)
                         ......+||+.|||||++.    +.++.++|||||||+||||++|+.||.+.+....+..+. .+...+. ....+.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence               2334568999999999874    248899999999999999999999998876655444443 3333222 233456


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++++.+||.+||+.||++|||+.|+++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            8999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9e-56  Score=422.21  Aligned_cols=296  Identities=42%  Similarity=0.748  Sum_probs=261.6

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.+|+|++..... .......+.+|+.+++.++ ||||+++++++.+++.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH   84 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence            4567889999999999999999999999999999999976543 2345667899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .|+||||++|++|.+.+.....+++.++..++.||+.||.|||++||+||||||+|||++...+++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999999999998899999999999999999999999999999999999999765567889999999998765


Q ss_pred             CCC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+..+...+....++.+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            433 3345689999999999875 68999999999999999999999999999999999999999888888888999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHhhh
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL  364 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (366)
                      .++|.+||+.||++|||+.|+|+||||+.................++.+...+++++..+
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~  304 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL  304 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999876544444445567788899999999887654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-55  Score=411.67  Aligned_cols=295  Identities=39%  Similarity=0.728  Sum_probs=258.4

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            34567889999999999999999999999999999999976543 2345677899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999999988888999999999999999999999999999999999999976556678999999999887


Q ss_pred             cCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+..+...++...|..+++++
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            66555566789999999999865 68999999999999999999999999999888999998888887777777899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHh
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL  362 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (366)
                      .++|.+||+.||++|||+.++|+||||+.................++.+...+++++.
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  319 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGA  319 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998654333333344556677777777777654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.9e-56  Score=409.88  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=211.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCC-----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATG-----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .-.++|++.+.||+|+||+||+|.+...+     +.||||.+....  .......+.+|+.+|.++.+|||||++++++.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            34578999999999999999999976543     579999986543  23456779999999999997899999999986


Q ss_pred             e-CCeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          143 D-KQNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       143 ~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      . ++.++||||||++|+|.++++..                ..+++.++..++.||+.||+|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            6 45789999999999999999763                248999999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCh-H
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETE-K  279 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~-~  279 (366)
                         ++++.+||+|||+|+.......   .....||+.|||||++. +.++.++|||||||+||||+| |..||.+... .
T Consensus       219 ---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          219 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             ---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence               5677899999999987644332   23457899999999876 569999999999999999998 9999988654 4


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .....+..+......   ..+++++.++|.+||+.||++|||+.++++|
T Consensus       296 ~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            444555554322221   3578999999999999999999999999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-54  Score=402.89  Aligned_cols=290  Identities=41%  Similarity=0.732  Sum_probs=232.2

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++...     ...+.+.+|+.+++++. ||||+++++++...
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  120 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLS-HPNIIKLKEIFETP  120 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-----hhHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence            3456778899999999999999999999999999999998643     23456788999999998 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999999998888899999999999999999999999999999999999997545578899999999987


Q ss_pred             ccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCH
Q 017768          225 IETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ...........||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+...........++.++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            765554556689999999998764 58999999999999999999999997765544 6667777766666666678999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHh
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL  362 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (366)
                      ++.++|.+||+.||++|||+.++|+||||++.......  .......++.+...+++++.
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  338 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH--MDTAQKKLQEFNARRKLKAA  338 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSC--CHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhh--hcchHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999987654432  34555667777777776553

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.7e-55  Score=423.22  Aligned_cols=297  Identities=43%  Similarity=0.721  Sum_probs=266.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++++. ||||+++++++...+.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence            457788999999999999999999999999999999997765544567788999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++||||+.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++....
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999999888889999999999999999999999999999999999999766677889999999998876


Q ss_pred             CCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+...+....|..+++++.+
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            66655667899999999999888999999999999999999999999999999999999998888777777789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCC---CCCCCCchHHHHHHHHHHHHhHHHHhhh
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGA---TSDKPIDSAVLTRMKQFRAMNKMKKLAL  364 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (366)
                      +|.+||+.||++|||+.++|+||||+....   ....+........++++...+++++..+
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l  321 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL  321 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHH
Confidence            999999999999999999999999987554   2345555667778888888888876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.8e-55  Score=422.26  Aligned_cols=295  Identities=42%  Similarity=0.718  Sum_probs=259.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence            467889999999999999999999999999999999865432 2345678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+.+++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999888999999999999999999999999999999999999997666777899999999987766


Q ss_pred             CCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ........||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+....+..+...+....|..+++++.++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence            66566678999999999998889999999999999999999999999999999999999988888777777899999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC----chHHHHHHHHHHHHhHHHHhhh
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI----DSAVLTRMKQFRAMNKMKKLAL  364 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  364 (366)
                      |.+||+.||++|||+.++|+||||+..........    .......+++++..+++++.++
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  317 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAAL  317 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999998766553322    2334567778888787776554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8e-54  Score=393.93  Aligned_cols=259  Identities=37%  Similarity=0.624  Sum_probs=233.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++...+..|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence            34569999999999999999999999999999999976542 3345677889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence            999999999999999998899999999999999999999999999999999999999   66778999999999887666


Q ss_pred             CceecccCCCCCCccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ......+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+..+....+..+....+.    .+++++.+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  243 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCEN  243 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence            66677789999999998864 34 57899999999999999999999999999988888888766543    47899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +|.+||+.||.+|||++|+++||||+....
T Consensus       244 li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            999999999999999999999999987543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.8e-54  Score=401.73  Aligned_cols=268  Identities=40%  Similarity=0.671  Sum_probs=238.5

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc---ccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---KDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..+.+.|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence            3467789999999999999999999999999999999976543221   24578999999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a  222 (366)
                      .+..++||||++|++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999999999988888999999999999999999999999999999999999953221 127999999999


Q ss_pred             ccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      .............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...+....+..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            88766655666789999999999864 68999999999999999999999999999999999998887777665566789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +++.+||.+||..||++|||+.|+|+||||+...
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            9999999999999999999999999999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-55  Score=401.60  Aligned_cols=287  Identities=30%  Similarity=0.562  Sum_probs=249.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+++.+|+|.+...    ......+.+|+.+++.+. ||||+++++++.+.+..
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            3567899999999999999999999999999999998643    244567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||++|++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECC
Confidence            99999999999999997654 6999999999999999999999999999999999999953 126789999999998877


Q ss_pred             CCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...+....++.+++++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            6666667789999999999865 478999999999999999999999999999999999988887777666678899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHhhh
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLAL  364 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (366)
                      ++|.+||+.||++|||+.|+|+||||++.......    ..+..++.++.++++.+..+
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  290 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVST----KVIRTLKHRRYYHTLIKKDL  290 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCC----CCCCCHHHHHHHHHHHCCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCcccccH----HHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999876543322    23445566666777665443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1e-54  Score=421.69  Aligned_cols=296  Identities=41%  Similarity=0.695  Sum_probs=253.1

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+.++|++.+.||+|+||+||+|+++.++..||+|++..... .......+.+|+.+++.+. ||||+++++++.+..
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  109 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKR  109 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            34577789999999999999999999999999999999976542 2334677899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..|+|||||++++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999999999998888999999999999999999999999999999999999976666778999999999887


Q ss_pred             cCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ..........||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+....+..+...+....|..+++.+.
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            76666667789999999999988899999999999999999999999999999999999999988888777888999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCC----CCCCCchHHHHHHHHHHHHhHHHHhh
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGAT----SDKPIDSAVLTRMKQFRAMNKMKKLA  363 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (366)
                      ++|.+||+.||++|||+.++|+||||++....    ...+........+++++..+++++.+
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~  331 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAA  331 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHH
Confidence            99999999999999999999999999763211    22233334555666666655555543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-54  Score=407.17  Aligned_cols=265  Identities=35%  Similarity=0.628  Sum_probs=219.1

Q ss_pred             ccccceeee-ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee---
Q 017768           68 DITTIYDLD-KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED---  143 (366)
Q Consensus        68 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---  143 (366)
                      .+.+.|.+. +.||+|+||+||+|.++.+|+.||||++..        ...+.+|+.++.++.+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            455667776 789999999999999999999999999852        24577899998777779999999999875   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       .+..||||||++|++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             567899999999999999997643  59999999999999999999999999999999999999754447889999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCCCCCCC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFEAILEGNLDLQSS  295 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~~  295 (366)
                      ++............+||+.|+|||++. ..++.++|||||||++|+|++|..||......    .....+..+...+...
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            998776555556678999999999986 46899999999999999999999999765432    2455666777777766


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       296 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      .+..+++++.+||.+||+.||++|||+.++++||||.+.......
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~  334 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT  334 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCC
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCC
Confidence            777899999999999999999999999999999999876554333

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5e-54  Score=398.95  Aligned_cols=259  Identities=31%  Similarity=0.539  Sum_probs=228.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..+++.+.+||||+++++++...+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            35699999999999999999999999999999999765444455677888999999999779999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||++|++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ..
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence            99999999999999998899999999999999999999999999999999999999   677889999999998643 23


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++.    .+++++.++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence            33455689999999998864 5899999999999999999999999999999999999888766553    478999999


Q ss_pred             HHHhcccCcCCCCCH------HHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRITA------AEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~------~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++||++      .++++||||++..
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            999999999999998      8999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-54  Score=400.77  Aligned_cols=294  Identities=38%  Similarity=0.672  Sum_probs=241.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc--cccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--DKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.......  ....+.+.+|+.+++.++ ||||+++++++..+
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence            346778999999999999999999999999999999986543221  224678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 QNLHLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      +..|+||||+++++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998887653    248999999999999999999999999999999999999765556679999999


Q ss_pred             CcccccCCCc-eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          221 LSVFIETGKV-YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       221 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+. .......+..+........++
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9987654432 34567999999999886 45899999999999999999999999875 455666777776665555556


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHHHhHHHHh
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKL  362 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (366)
                      .+++++.++|.+||+.||++|||+.++|+||||+................+++.+...+++++.
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  321 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA  321 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999998754322222223445666666666666543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-53  Score=392.42  Aligned_cols=291  Identities=37%  Similarity=0.643  Sum_probs=228.5

Q ss_pred             cccceeee---ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           69 ITTIYDLD---KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        69 ~~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +.++|++.   +.||+|+||.||+|.++.+|+.||+|++...      ....+.+|+.+++.+.+||||+++++++.+++
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            44567765   7899999999999999999999999998542      34677899999999988999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999999999888999999999999999999999999999999999999976555557999999999865


Q ss_pred             cCCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHcCCCCCCCCC
Q 017768          226 ETGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET-------EKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       226 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  296 (366)
                      .... ......||+.|+|||++. ..++.++||||||+++|+|++|..||....       ..+....+..+...+....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            4332 334567899999999886 458999999999999999999999997643       3456677777776666655


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHH---------HHH-HHHHHHhHHHHhhhc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVL---------TRM-KQFRAMNKMKKLALK  365 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~---------~~~-~~~~~~~~~~~~~~~  365 (366)
                      +..+++++.+||.+||+.||++|||+.++++||||++.......+......         +.. .++.++++.++.|.+
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFC  318 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCCcccccchHHHHHHHHHHHHHHHhhhcccee
Confidence            567899999999999999999999999999999999988777666644321         222 368888999998865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-53  Score=415.67  Aligned_cols=295  Identities=38%  Similarity=0.648  Sum_probs=250.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc----------cccHHHHHHHHHHHHHhcCCCceeE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY----------DKDMEDVRREILILQHLTGQPNIVE  136 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~h~~i~~  136 (366)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||+|++.......          ....+.+.+|+.+++.+. ||||++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  110 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIK  110 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCC
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCe
Confidence            457788999999999999999999999999999999997644321          134677899999999997 999999


Q ss_pred             eceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      +++++.+....++|||||++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+....+||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99999999999999999999999999998889999999999999999999999999999999999999975444457999


Q ss_pred             eecCCcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      +|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+...+....
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            99999988776666667789999999999988899999999999999999999999999999999999999888777666


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCc---hHHHHHHHHHHHHhHHHHh
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPID---SAVLTRMKQFRAMNKMKKL  362 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  362 (366)
                      |..+++++.+||.+||+.||.+|||+.|+|+||||++..........   ...+.+++++...+++++.
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a  339 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQA  339 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHH
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence            77899999999999999999999999999999999987655432221   1223344444444444443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.5e-53  Score=390.12  Aligned_cols=256  Identities=34%  Similarity=0.589  Sum_probs=230.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997654434456778899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CCC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~~  229 (366)
                      |||++|++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence            9999999999999988889999999999999999999999999999999999999   667889999999998643 333


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      .....+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......++.    .+++++.++|
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            445678999999999986 45899999999999999999999999998888888888877655443    5799999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          309 RKMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      .+||+.||++||     ++.++++||||+..
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999     99999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-53  Score=391.47  Aligned_cols=268  Identities=40%  Similarity=0.710  Sum_probs=235.9

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---cccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---DKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..+.+.|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++.++ ||||+++++++..
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            346778999999999999999999999999999999997654322   124678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a  222 (366)
                      .+..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998878899999999999999999999999999999999999995432 2237999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      .............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+...........++.++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            8876555556678999999999886 468999999999999999999999999988888888887776665554456789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ..+.++|.+||+.||++|||+.++|+||||+...
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-53  Score=381.89  Aligned_cols=268  Identities=43%  Similarity=0.794  Sum_probs=242.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..++..+|+|.+....   ....+.+.+|+.++++++ ||||+++++++...+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD   80 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence            457788999999999999999999999999999999986543   245678999999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++||||+++++|.+++.....+++.+++.++.|++.||.|||++||+||||||+|||+..++.++.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999998889999999999999999999999999999999999999665667889999999998876


Q ss_pred             CCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+....+...+..+++.+.+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            66666667899999999999888999999999999999999999999999988888888888777666555678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +|.+||+.||++|||+.++|+||||++.....
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            99999999999999999999999998754433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-52  Score=377.24  Aligned_cols=269  Identities=41%  Similarity=0.779  Sum_probs=243.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++..++..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            456789999999999999999999999999999999976543 3345677889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +++|||+++++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+||+++.++..+.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999999999888899999999999999999999999999999999999997655666799999999987766


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+........+..+++++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            665566789999999998764 5899999999999999999999999999999999999888888777777789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +|.+||+.||++|||+.|+|+||||+......
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            99999999999999999999999998765533

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-52  Score=394.73  Aligned_cols=259  Identities=29%  Similarity=0.528  Sum_probs=224.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|..++.++.+||||+++++++...+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            45799999999999999999999999999999999876554455566788999999998779999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc-cCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~-~~~  228 (366)
                      ||||++|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.. ...
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCC
Confidence            99999999999999998899999999999999999999999999999999999999   67788999999999863 334


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCCCCCCCCCC
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAE---------TEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...         ......+.+......++.    
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----  283 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----  283 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----
Confidence            44566789999999998764 5899999999999999999999999532         233455566666555443    


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcccCC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITA------AEALEHPWLKEDG  335 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~------~~~l~hp~f~~~~  335 (366)
                      .++.++.+||.+||+.||++||++      +|+++||||++..
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            579999999999999999999984      8999999998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.2e-53  Score=389.84  Aligned_cols=259  Identities=30%  Similarity=0.493  Sum_probs=231.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.............+..|..++..+.+||||+++++++.+.+..|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            35699999999999999999999999999999999765443345667788999999988669999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-C
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-G  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~  228 (366)
                      ||||++|++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.... .
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCC
Confidence            99999999999999988889999999999999999999999999999999999999   6678899999999986432 2


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..+...++.    .+++++.++
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  248 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL  248 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHH
Confidence            33456789999999998764 5899999999999999999999999999988888888877655432    478999999


Q ss_pred             HHHhcccCcCCCCCHH-HHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRITAA-EALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~-~~l~hp~f~~~~  335 (366)
                      |.+||+.||++||++. ++++||||++..
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            9999999999999998 999999998754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-52  Score=377.15  Aligned_cols=262  Identities=35%  Similarity=0.632  Sum_probs=224.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|.+.+.||+|+||.||+|.+..++..+|+|++....  .....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence            46778999999999999999999999999999999987643  2345678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          148 HLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999999988653    569999999999999999999999999999999999999765566789999999998


Q ss_pred             cccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+............... ...++++
T Consensus       176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  254 (285)
T 3is5_A          176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ  254 (285)
T ss_dssp             C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred             ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence            766555555668999999999998889999999999999999999999999988877776666554443332 2347899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      +.++|.+||+.||++|||+.|+|+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-52  Score=392.85  Aligned_cols=270  Identities=37%  Similarity=0.649  Sum_probs=238.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.+.|++.+.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence            45678999999999999999999999999999999986532   234567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecC
Confidence            99999999999999887654 6999999999999999999999999999999999999953 234679999999998876


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+......+....+..+++++.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            665556668999999999886 4588999999999999999999999999988888888888777777666778999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      ++|.+||+.||++|||+.++|+||||+..........
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  319 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  319 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCcccccccC
Confidence            9999999999999999999999999998765544333

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-52  Score=389.24  Aligned_cols=259  Identities=31%  Similarity=0.515  Sum_probs=231.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|..++..+.+||+|+++++++...+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            35699999999999999999999989999999999765444445677888999999988779999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence            99999999999999988889999999999999999999999999999999999999   677889999999998643 23


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+......++.    .+++++.++
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence            3445678999999999876 46899999999999999999999999999988888888887665543    579999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++||     +++++++||||+...
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9999999999999     479999999998643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-52  Score=381.61  Aligned_cols=255  Identities=32%  Similarity=0.600  Sum_probs=229.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.+. ||||+++++++.+.+..|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence            56999999999999999999999999999999997654434456778889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc--
Confidence            9999999999999988889999999999999999999999999999999999999   67788999999999875432  


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      ....+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+..+...++    +.+++++.++|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            34568999999999876 4589999999999999999999999999888888888888765544    257899999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +||+.||++||     +++++++||||++..
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            99999999999     999999999998743

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.7e-52  Score=383.74  Aligned_cols=259  Identities=29%  Similarity=0.527  Sum_probs=225.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++++.+||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            35699999999999999999999999999999999876554455667788999999998679999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ..
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence            99999999999999988889999999999999999999999999999999999999   667889999999998642 33


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC---------CChHHHHHHHHcCCCCCCCCCCC
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWA---------ETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~---------~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||..         .........+......++    .
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence            34456689999999998764 589999999999999999999999965         233445555666555443    2


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcccCC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITA------AEALEHPWLKEDG  335 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~------~~~l~hp~f~~~~  335 (366)
                      .++.++.++|.+||+.||++||++      .++++||||+...
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            578999999999999999999995      8999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-52  Score=396.68  Aligned_cols=263  Identities=33%  Similarity=0.502  Sum_probs=230.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++..|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            3467999999999999999999999999999999997644333344556889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence            99999999999998865 468999999999999999999999999999999999999   67788999999999876544


Q ss_pred             Cc--eecccCCCCCCccccccc-c----CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          229 KV--YKEIVGSAYYVAPEVLHQ-R----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       229 ~~--~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ..  ....+||+.|+|||++.+ .    ++.++|||||||++|+|++|..||.+.+..+....+..+......+.+..++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  235689999999998753 2    7889999999999999999999999999888888887765444444455789


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCCC
Q 017768          302 GQAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDGA  336 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~~  336 (366)
                      +++.+||.+||+.+|.+  |++++|+++||||+....
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            99999999999999988  999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7e-53  Score=382.71  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=191.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC----
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ----  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~----  145 (366)
                      ..+|.+.+.||+|+||+||+|++.  |+.||||++....    ........|+..+.+++ ||||+++++++..++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            346899999999999999999874  8999999986432    12223344666666776 999999999998654    


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--------GVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      .+|||||||++|+|.+++... .+++.++..++.|++.||.|||++        +|+||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            589999999999999999764 589999999999999999999987        99999999999999   677889999


Q ss_pred             ecCCcccccCCCc-----eecccCCCCCCccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCC---------
Q 017768          218 DFGLSVFIETGKV-----YKEIVGSAYYVAPEVLHQ-------RYGKEIDVWSAGVILYILLSGVPPFWAE---------  276 (366)
Q Consensus       218 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~vl~~ll~g~~pf~~~---------  276 (366)
                      |||+|+.......     ....+||+.|||||++.+       .++.++|||||||+||||++|..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654332     223579999999998854       3577999999999999999997665321         


Q ss_pred             ------ChHHHHHHHHcCCCCCCCCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          277 ------TEKGIFEAILEGNLDLQSSPW---PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       277 ------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                            ........+......+..+..   ...++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                  122333334333332222110   113357889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-52  Score=387.68  Aligned_cols=261  Identities=38%  Similarity=0.652  Sum_probs=229.2

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.....       ...+|+.++.++.+||||+++++++.+++.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            4577889999999999999999999999999999999965432       235688899998779999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a~~~  225 (366)
                      .|+||||++|++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999999998888899999999999999999999999999999999999985322 2245999999999876


Q ss_pred             cCC-CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETG-KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||..   .+..+....+..+........++.+
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            443 23445688999999999864 488999999999999999999999975   4566778888888888777777889


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ++++.+||.+||+.||++|||+.++++||||...
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999999653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.3e-52  Score=385.02  Aligned_cols=256  Identities=34%  Similarity=0.592  Sum_probs=230.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+..|+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence            457999999999999999999999999999999997655444456778899999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||++|++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC-
Confidence            99999999999999988889999999999999999999999999999999999999   66788999999999876443 


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                       ....+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+..+...++.    .+++++.++|
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  269 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLL  269 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence             34567999999999876 45899999999999999999999999999888888888887665543    5799999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCcccCC
Q 017768          309 RKMLTKDPKKRIT-----AAEALEHPWLKEDG  335 (366)
Q Consensus       309 ~~~l~~dp~~Rpt-----~~~~l~hp~f~~~~  335 (366)
                      .+||+.||++||+     ++++++||||+...
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            9999999999998     99999999998743

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-52  Score=389.64  Aligned_cols=261  Identities=38%  Similarity=0.640  Sum_probs=226.0

Q ss_pred             cccceee--eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           69 ITTIYDL--DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        69 ~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.+.|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.++++++ ||||+++++++...+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            3445655  668999999999999999999999999997543   245678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+|||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence            99999999999999988765 35999999999999999999999999999999999999953 34567999999999887


Q ss_pred             cCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+.+..+...........++.+++++
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            6665556668999999999876 458899999999999999999999999999888888888877766666667889999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      .+||.+||+.||++|||+.|+|+||||++.
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.2e-52  Score=387.47  Aligned_cols=258  Identities=25%  Similarity=0.491  Sum_probs=227.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++.+.+..|+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEE
Confidence            467999999999999999999999999999999997655444566778999999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||+.|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCCC
Confidence            99999999999999988889999999999999999999999999999999999999   677889999999998876666


Q ss_pred             ceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .....+||+.|+|||++..    .++.++|||||||++|+|++|..||...   ........+.......+    ..+++
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~  245 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQ  245 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCH
Confidence            6677889999999998852    4789999999999999999999999743   33445555555444433    25789


Q ss_pred             HHHHHHHHhcccCcCCCCC-HHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKKRIT-AAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt-~~~~l~hp~f~~~~  335 (366)
                      ++.+||.+||+.||++||+ ++++++||||++..
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            9999999999999999998 99999999998743

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.6e-53  Score=389.78  Aligned_cols=257  Identities=37%  Similarity=0.602  Sum_probs=222.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ ||||+++++++...+..+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            3456999999999999999999999999999999997654333444567899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+ +++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence            999999 67999999988899999999999999999999999999999999999999   56778999999999887666


Q ss_pred             CceecccCCCCCCcccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQR-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ......+||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.........+..+...    ....+++++.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV----MPDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC----CCTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC----CcccCCHHHHH
Confidence            666677899999999998754 3 78999999999999999999999876544333222222222    12357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +|.+||+.||.+|||+.|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.2e-52  Score=378.99  Aligned_cols=267  Identities=36%  Similarity=0.618  Sum_probs=220.5

Q ss_pred             cccceeee-ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           69 ITTIYDLD-KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        69 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      +.+.|++. +.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++.++.+||||+++++++..++..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            56679985 78999999999999999999999999986542   345678899999999977799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999999999888899999999999999999999999999999999999996544445699999999876532


Q ss_pred             CC--------ceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------h
Q 017768          228 GK--------VYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAET---------------E  278 (366)
Q Consensus       228 ~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~---------------~  278 (366)
                      ..        ......||+.|+|||++.      ..++.++||||||+++|+|++|..||....               .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            11        122346999999999875      347899999999999999999999997654               2


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ......+..+...++...+..+++++.+||.+||+.||++|||+.|+|+||||++.....
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  306 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN  306 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC------
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcc
Confidence            345566666666555444456899999999999999999999999999999999765433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-51  Score=373.07  Aligned_cols=260  Identities=30%  Similarity=0.507  Sum_probs=224.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|.+....   ....+.+.+|+.+++.+. ||||+++++++..++..
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence            35667999999999999999999999999999999986543   344677899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence            9999999999999998765 58999999999999999999999999999999999999   5677899999999887644


Q ss_pred             CC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+....... ......+++.+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHH
Confidence            33 334567999999999875 468999999999999999999999998887766655554432221 112235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ++|.+||+.||++|||+.|+|+||||+....
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999999999987654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.5e-52  Score=386.48  Aligned_cols=259  Identities=30%  Similarity=0.532  Sum_probs=218.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|..++.+..+||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            45799999999999999999999999999999999876554445556677777774333349999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||+++... ..
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccCC
Confidence            99999999999999998889999999999999999999999999999999999999   667889999999998643 33


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......+.    +.++.++.++
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~l  269 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHL  269 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHH
Confidence            34456789999999998764 589999999999999999999999999988888888888765543    3579999999


Q ss_pred             HHHhcccCcCCCCCH----HHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRITA----AEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~----~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++||++    .++++||||+...
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            999999999999986    6999999998743

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-52  Score=396.69  Aligned_cols=264  Identities=27%  Similarity=0.457  Sum_probs=227.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++..+. ||||+++++++.+++..|
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEE
Confidence            3567999999999999999999999999999999997644333334445889999999986 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence            99999999999999987 4679999999999999999999999999999999999999   6778899999999977644


Q ss_pred             CCc--eecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC-CCC
Q 017768          228 GKV--YKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS-PWP  298 (366)
Q Consensus       228 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  298 (366)
                      ...  ....+||+.|+|||++.      +.++.++|||||||++|||++|..||.+.+..+....+.........+ .+.
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            332  23368999999999874      358999999999999999999999999998888888876543222222 224


Q ss_pred             CCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccCCC
Q 017768          299 SISGQAKDLIRKMLTKDPKK--RITAAEALEHPWLKEDGA  336 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~--Rpt~~~~l~hp~f~~~~~  336 (366)
                      .+++++.+||++||+.+|++  |++++|+++||||++...
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence            68999999999999999888  999999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.7e-52  Score=380.24  Aligned_cols=274  Identities=32%  Similarity=0.564  Sum_probs=237.0

Q ss_pred             Cccccccceeee-ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           65 PYVDITTIYDLD-KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        65 ~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ....+.++|.+. +.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+.+||||+++++++..
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            345677789887 899999999999999999999999999976442 334567899999999999889999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      .+..++||||+++++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||++....++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999999988543  5699999999999999999999999999999999999996544478899999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      +.............||+.|+|||++. ..++.++||||||+++|+|++|..||...+..+....+...........+..+
T Consensus       181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  260 (327)
T 3lm5_A          181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV  260 (327)
T ss_dssp             CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence            98876655555678999999999876 46899999999999999999999999999888888888887777777777789


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ++.+.++|.+||+.||++|||++++|+||||++......
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            999999999999999999999999999999998766443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-51  Score=385.30  Aligned_cols=263  Identities=38%  Similarity=0.715  Sum_probs=233.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----cccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----DKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.......     ....+.+.+|+.+++++.+||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            35577999999999999999999999899999999986543111     1224567899999999967999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ..+..++||||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||+   +.++.++|+|||++
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS  247 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence            999999999999999999999988889999999999999999999999999999999999999   67788999999999


Q ss_pred             ccccCCCceecccCCCCCCccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLHQ-------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS  295 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (366)
                      .............||+.|+|||++.+       .++.++||||||+++|+|++|..||...........+..+.......
T Consensus       248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  327 (365)
T 2y7j_A          248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP  327 (365)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            88766655666789999999998742       47889999999999999999999999988888888888877766655


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       296 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+..++..+.++|.+||+.||++|||+.++|+||||++
T Consensus       328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            55678999999999999999999999999999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.6e-51  Score=377.70  Aligned_cols=268  Identities=40%  Similarity=0.667  Sum_probs=234.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---cccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---DKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++.+. ||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            346778999999999999999999999999999999997644322   124678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a  222 (366)
                      .+..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999999999988888999999999999999999999999999999999999953221 117999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      .............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+...........+..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            8876655555667999999999876 468999999999999999999999999998888888887776655443345688


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +.+.++|.+||+.||++|||+.++++||||+...
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999997644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=373.48  Aligned_cols=265  Identities=27%  Similarity=0.400  Sum_probs=217.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhc--CCCceeEeceEEee
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLT--GQPNIVEFEGAYED  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~  143 (366)
                      .+.++|++.+.||+|+||+||+|++..+|+.||+|++......  .......+.+|+.+++.+.  +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567899999999999999999999999999999998643321  1223456777888887775  49999999999987


Q ss_pred             CC-----eEEEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          144 KQ-----NLHLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       144 ~~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      ..     ..+++|||+. ++|.+++.....  +++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence            65     5899999997 499999987654  9999999999999999999999999999999999999   56778999


Q ss_pred             eecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS  295 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (366)
                      +|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+..........
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999998776655556678999999999875 568999999999999999999999999988887777765432211111


Q ss_pred             C-----------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          296 P-----------------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       296 ~-----------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .                       .+.+++++.++|.+||+.||++|||+.|+|+||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            1                       1357899999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-51  Score=381.10  Aligned_cols=259  Identities=37%  Similarity=0.561  Sum_probs=208.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||+||++++..+++.||+|++....    ...+.+.+|+.+++.++ ||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEE
Confidence            4567999999999999999999999999999999996533    23466889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCcccccccc
Confidence            99999999999999998888999999999999999999999999999999999999953 22335999999999865444


Q ss_pred             CceecccCCCCCCccccccc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYG-KEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~-~~~Di~slG~vl~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .......||+.|+|||++.+ .+. .++||||||+++|+|++|..||.+...    ......+.......+.  ...+++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~  249 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISP  249 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCH
Confidence            44455689999999998754 454 448999999999999999999976433    3445555554443332  235789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            999999999999999999999999999996643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-51  Score=369.46  Aligned_cols=267  Identities=39%  Similarity=0.693  Sum_probs=235.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc------ccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV------YDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++......      .....+.+.+|+.+++++.+||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3567799999999999999999999999999999998654311      1123456789999999998899999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      ...+..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.+||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  170 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF  170 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence            9999999999999999999999988889999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                      +.............||+.|+|||++.       ..++.++||||||+++|+|++|..||...........+..+......
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            98776655556678999999999874       34788999999999999999999999998888888888888777766


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ..+..+++.+.++|.+||+.||++|||+.++++||||++...+
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            6666789999999999999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=390.12  Aligned_cols=264  Identities=27%  Similarity=0.452  Sum_probs=225.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..+. ||||+++++++.+.+..|
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEE
Confidence            3567999999999999999999999999999999997644333344556889999999986 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||++|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||++.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence            9999999999999998754 79999999999999999999999999999999999999   6778899999999987654


Q ss_pred             CCce--ecccCCCCCCcccccc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC-C
Q 017768          228 GKVY--KEIVGSAYYVAPEVLH--------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS-P  296 (366)
Q Consensus       228 ~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~  296 (366)
                      ....  ...+||+.|+|||++.        +.++.++|||||||++|||++|..||.+.+..+....+.........+ .
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            4332  3458999999999875        358999999999999999999999999988888777776533211111 1


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcccCCCC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKR---ITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~R---pt~~~~l~hp~f~~~~~~  337 (366)
                      ...+++++.+||.+||+ +|.+|   ++++|+++||||++....
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            23689999999999999 99998   599999999999886543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2e-51  Score=371.07  Aligned_cols=267  Identities=44%  Similarity=0.751  Sum_probs=239.6

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++...+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence            3466789999999999999999999998999999999875432 2445778999999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+++|||+++++|.+++.....+++.+++.++.||+.||.+||++||+|+||||+||+++..+.+..+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999765556689999999998776


Q ss_pred             CCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .........+|+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+........+..+++++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55544555789999999999888999999999999999999999999999888888888888776666666678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +|.+||+.||++|||+.++|+||||++..
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999998654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4e-51  Score=370.08  Aligned_cols=259  Identities=26%  Similarity=0.455  Sum_probs=214.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.++++++ ||||+++++++.+++..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            46999999999999999999999999999999997554 23344577889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          151 MELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      |||+++ ++.+.+.. ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999976 66665555 5679999999999999999999999999999999999999   56778999999999876432 


Q ss_pred             CceecccCCCCCCccccccc-c-CCCchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHcCCCCCCC-----------
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-R-YGKEIDVWSAGVILYILLSGVPPF-WAETEKGIFEAILEGNLDLQS-----------  294 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~vl~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~-----------  294 (366)
                      .......||+.|+|||++.+ . ++.++||||||+++|+|++|..|| .+.+..+....+.........           
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            23345578999999998753 3 799999999999999999887774 555555555555432111111           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          295 --------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       295 --------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                    ...+.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                          11235789999999999999999999999999999998743

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-51  Score=395.58  Aligned_cols=259  Identities=37%  Similarity=0.608  Sum_probs=232.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++ ||||+++++++...+..+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            3456999999999999999999999999999999997654433445678999999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence            999999999999999887889999999999999999999999999999999999999   56778999999999887666


Q ss_pred             CceecccCCCCCCcccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ......+||+.|+|||++.+.  .+.++||||||+++|+|++|..||.+.........+..+....+.    .+++++.+
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  245 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVIS  245 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCHHHHH
Confidence            656677899999999998754  368999999999999999999999998888888888877654432    47899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +|.+||+.||++|||+.++++||||++..
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            99999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.8e-51  Score=374.57  Aligned_cols=263  Identities=29%  Similarity=0.469  Sum_probs=216.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.++++++ ||||+++++++.+++.
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERC   93 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSC
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCE
Confidence            446778999999999999999999986 59999999986543 22334567889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++ +|.+.+.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEET
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceec
Confidence            9999999975 8888776643 49999999999999999999999999999999999999   56778999999999876


Q ss_pred             cCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCC-------
Q 017768          226 ETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSS-------  295 (366)
Q Consensus       226 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------  295 (366)
                      ... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+..........       
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            432 23344578999999998753  58999999999999999999999998877666555554311111110       


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          296 -------------------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       296 -------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                         ..+.+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                               12346789999999999999999999999999999998653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-51  Score=394.32  Aligned_cols=259  Identities=33%  Similarity=0.570  Sum_probs=219.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ ||||+++++++...+..+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence            3467999999999999999999999999999999997654434455667888999999987 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-  226 (366)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||++.... 
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence            999999999999999988899999999999999999999998 999999999999999   567789999999998643 


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ........+||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......++.    .+++++.
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~  377 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAK  377 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHH
Confidence            233345578999999999875 56899999999999999999999999999988888888877665443    5789999


Q ss_pred             HHHHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          306 DLIRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       306 ~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +||.+||+.||++||     +++|+++||||++..
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            999999999999999     999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.2e-51  Score=367.42  Aligned_cols=265  Identities=29%  Similarity=0.561  Sum_probs=228.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence            3467999999999999999999999999999999987654433445677899999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++......
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence            999999999999999988889999999999999999999999999999999999999   56778999999998655433


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      . .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+.    .+++.+.++
T Consensus       163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l  237 (279)
T 3fdn_A          163 R-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHH
T ss_pred             c-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHH
Confidence            2 344578999999998764 5788999999999999999999999998888888877776555443    478999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      |.+||+.||++|||+.|+++||||+..........
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~  272 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ  272 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCCCC-
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccCccccc
Confidence            99999999999999999999999988766554433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-51  Score=377.79  Aligned_cols=266  Identities=29%  Similarity=0.451  Sum_probs=214.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++ ||||+++++++..++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEE
Confidence            34567999999999999999999999999999999986543 22334556789999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCcccc
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLSVFI  225 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a~~~  225 (366)
                      ++||||+++ +|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+  ..+.+||+|||++...
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999975 9999999988899999999999999999999999999999999999996432  3455999999999876


Q ss_pred             cCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC----
Q 017768          226 ETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP----  298 (366)
Q Consensus       226 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  298 (366)
                      ... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+...........++    
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            432 23344578999999998764  48999999999999999999999999888777666665432211111111    


Q ss_pred             ----------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          299 ----------------------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       299 ----------------------~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                            .+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                  16789999999999999999999999999999998654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-51  Score=394.95  Aligned_cols=263  Identities=29%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----  143 (366)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+|++++ |+||+++++++..    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence            4567899999999999999999999999999999998643 233445678899999999997 9999999999843    


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                       .+..|+||||+ +++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla  203 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA  203 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence             35799999998 56999999888889999999999999999999999999999999999999   66778999999999


Q ss_pred             ccccCCC----------------------------ceecccCCCCCCccccc-c-ccCCCchhHHHHHHHHHHHHh----
Q 017768          223 VFIETGK----------------------------VYKEIVGSAYYVAPEVL-H-QRYGKEIDVWSAGVILYILLS----  268 (366)
Q Consensus       223 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~vl~~ll~----  268 (366)
                      +......                            .....+||+.|+|||++ . ..++.++|||||||+||||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            8754221                            23445789999999975 3 458999999999999999998    


Q ss_pred             -------CCCCCCCCCh--------------------HHHHHHHHc-----------------------C----CCCCCC
Q 017768          269 -------GVPPFWAETE--------------------KGIFEAILE-----------------------G----NLDLQS  294 (366)
Q Consensus       269 -------g~~pf~~~~~--------------------~~~~~~~~~-----------------------~----~~~~~~  294 (366)
                             |..+|.+...                    .+.+..+..                       .    ......
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   6666655431                    111111111                       0    000011


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..++..++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            123567999999999999999999999999999999988644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-50  Score=372.11  Aligned_cols=258  Identities=33%  Similarity=0.590  Sum_probs=216.3

Q ss_pred             ccceeeeceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .++|++.+.||+|+||.||+|++.   .+|+.||+|++...... .......+.+|+.+++.+. ||||+++++++..++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            467999999999999999999985   57999999999764322 1234556788999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccccc
Confidence            999999999999999999988889999999999999999999999999999999999999   56778999999999764


Q ss_pred             cC-CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          226 ET-GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       226 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      .. ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+.......+    +.++++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~  247 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE  247 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence            32 22344567999999999875 4589999999999999999999999999988888888887765544    357899


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          304 AKDLIRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +.++|.+||+.||++||     ++.++++||||+...
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            99999999999999999     899999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-50  Score=373.56  Aligned_cols=265  Identities=33%  Similarity=0.481  Sum_probs=233.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            4567999999999999999999999999999999997665444456778899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccC
Confidence            999999999999999988889999999999999999999999999999999999999   56778999999999876432


Q ss_pred             -CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       .......||..|+|||++.+ .++.++||||||+++|+|++|..||......+....+.........    .+++.+.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  270 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS  270 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHH
Confidence             23344679999999998764 5889999999999999999999999988877777777766554432    57899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP  341 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~  341 (366)
                      +|.+||+.||++|||+.++++||||.....+...+
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~  305 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP  305 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCCccccCC
Confidence            99999999999999999999999998876655443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-50  Score=368.11  Aligned_cols=264  Identities=43%  Similarity=0.757  Sum_probs=233.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|.+....   ......+.+|+.+++.+. ||||+++++++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHY   81 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEE
Confidence            46778999999999999999999999999999999997543   233456889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+||++...+.++.++|+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999999999999888899999999999999999999999999999999999996555678899999999876543


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      . ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+........+..+++++.+
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (304)
T 2jam_A          162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD  240 (304)
T ss_dssp             B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred             C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence            2 2334568999999998864 5889999999999999999999999999888888888888777766666788999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +|.+||+.||++|||+.++|+||||++...
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          241 FICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.6e-51  Score=406.97  Aligned_cols=259  Identities=31%  Similarity=0.516  Sum_probs=234.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+.+|++|+.+++++.+.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            45699999999999999999999999999999999865444456677889999999998889999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc-CC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~-~~  228 (366)
                      ||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence            99999999999999998899999999999999999999999999999999999999   677889999999998643 33


Q ss_pred             CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++. ..++.++||||||++||||++|..||.+.+..+....+......++.    .+++++.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence            3455678999999999886 56899999999999999999999999999999999999988766553    589999999


Q ss_pred             HHHhcccCcCCCCCH-----HHHhcCCCcccCC
Q 017768          308 IRKMLTKDPKKRITA-----AEALEHPWLKEDG  335 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~-----~~~l~hp~f~~~~  335 (366)
                      |.+||+.||++||++     +|+++||||+...
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            999999999999997     9999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-51  Score=385.90  Aligned_cols=263  Identities=32%  Similarity=0.507  Sum_probs=210.8

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--  145 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.+.+||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            4567899999999999999999999999999999998643 2334556778899999999988999999999997544  


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..|+||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSF  159 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEES
T ss_pred             EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccc
Confidence            7899999997 589888876 468999999999999999999999999999999999999   66778999999999765


Q ss_pred             cC----------------------CCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017768          226 ET----------------------GKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGI  281 (366)
Q Consensus       226 ~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~  281 (366)
                      ..                      .......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            32                      112344689999999998753  589999999999999999999999999887777


Q ss_pred             HHHHHcCCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHhcccCcCC
Q 017768          282 FEAILEGNLDLQ------------------------------S-------------SPWPSISGQAKDLIRKMLTKDPKK  318 (366)
Q Consensus       282 ~~~~~~~~~~~~------------------------------~-------------~~~~~~~~~~~~li~~~l~~dp~~  318 (366)
                      +..+......+.                              .             .....+++++.+||.+||+.||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            666643111000                              0             011256889999999999999999


Q ss_pred             CCCHHHHhcCCCcccCCC
Q 017768          319 RITAAEALEHPWLKEDGA  336 (366)
Q Consensus       319 Rpt~~~~l~hp~f~~~~~  336 (366)
                      |||++|+|+||||+....
T Consensus       320 R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          320 RISANDALKHPFVSIFHN  337 (388)
T ss_dssp             SCCHHHHTTSTTTTTTCC
T ss_pred             CCCHHHHhCCHHHHHhcC
Confidence            999999999999976543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-50  Score=381.25  Aligned_cols=269  Identities=20%  Similarity=0.326  Sum_probs=219.2

Q ss_pred             Cccccccceeeeceeccc--CceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           65 PYVDITTIYDLDKELGRG--QFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      ++....++|++.+.||+|  +||.||+|+++.+|+.||||++..... .......+.+|+.+++.++ ||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~   96 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFI   96 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE
Confidence            344456789999999999  999999999999999999999976542 2345677889999999998 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      .++..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg  173 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLR  173 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGG
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccc
Confidence            999999999999999999999876  569999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCC--------ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 017768          221 LSVFIETGK--------VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN  289 (366)
Q Consensus       221 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~  289 (366)
                      .+.......        ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.........+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            986542211        1223478999999998764   58999999999999999999999998765554443333221


Q ss_pred             CCC------------------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          290 LDL------------------------------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       290 ~~~------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...                                          .......+++++.+||.+||+.||++|||+.|+|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            110                                          00122357889999999999999999999999999


Q ss_pred             CCCcccCCCCC
Q 017768          328 HPWLKEDGATS  338 (366)
Q Consensus       328 hp~f~~~~~~~  338 (366)
                      ||||++.....
T Consensus       334 hp~f~~~~~~~  344 (389)
T 3gni_B          334 HSFFKQIKRRA  344 (389)
T ss_dssp             SGGGGGC---C
T ss_pred             CHHHHHHhhcc
Confidence            99999866543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=368.31  Aligned_cols=257  Identities=27%  Similarity=0.355  Sum_probs=213.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++.... ...........|+..+..+.+|+||+++++++.+++.
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            345678999999999999999999999999999999875432 2234455666777777777679999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence            99999999 668988887654 59999999999999999999999999999999999999   56677999999999877


Q ss_pred             cCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|..++....   ....+..+....  .....+++++.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPP--EFTAGLSSELR  282 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCH--HHHTTSCHHHH
T ss_pred             ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCc--ccccCCCHHHH
Confidence            6655555667999999999998889999999999999999999977775532   233333332211  11235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ++|.+||+.||++|||+.++|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9.7e-51  Score=371.96  Aligned_cols=263  Identities=25%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|.+....  .......+.+|+.+++.+. ||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence            356999999999999999999999999999999987543  2344567889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          150 VMELCSGGELFDRIIAK------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ||||+++ +|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence            9999985 999988764      358999999999999999999999999999999999999   567789999999998


Q ss_pred             cccCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC------
Q 017768          224 FIETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS------  294 (366)
Q Consensus       224 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------  294 (366)
                      ..... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+.........      
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            76432 23345578999999998754  5899999999999999999999999988887776666432111100      


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          295 ------------------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       295 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                              .....++.++.+||.+||+.||++|||+.|+|+||||++...++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence                                    011246889999999999999999999999999999998766544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.6e-51  Score=367.57  Aligned_cols=257  Identities=32%  Similarity=0.481  Sum_probs=212.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            4699999999999999999998 5799999999865432 2334567889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      |||+++ +|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999976 898888764 569999999999999999999999999999999999999   56778999999999876432 


Q ss_pred             CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC------------
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS------------  294 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  294 (366)
                      .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+.........            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            22344578999999998753  4899999999999999999999999988777666655431110000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          295 -------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       295 -------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                                   .....+++++.++|.+||+.||++|||+.|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         0123578999999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5e-51  Score=374.78  Aligned_cols=259  Identities=31%  Similarity=0.542  Sum_probs=216.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+++..+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            45679999999999999999999999999999999865432  233456889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence            999999999999999877789999999999999999999999999999999999999   56778999999999865432


Q ss_pred             C---ceecccCCCCCCccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQ-R-YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .   ......||+.|+|||++.+ . .+.++||||||+++|+|++|..||...... ............  ...+..+++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCH
Confidence            2   2345679999999998764 3 477899999999999999999999776543 223333332222  222346899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      .+.+||.+||+.||++|||+.|+++||||+...
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999998644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-51  Score=390.85  Aligned_cols=265  Identities=38%  Similarity=0.660  Sum_probs=218.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----cccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----DKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++.......     ......+.+|+.+|+++. ||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            35678999999999999999999999999999999997654321     122235789999999997 999999999975


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                       .+..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence             4568999999999999999988888999999999999999999999999999999999999976666678999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  297 (366)
                      .............||+.|+|||++.    ..++.++||||||+++|+|++|..||..... ......+..+........+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            8876665556678999999999874    3578899999999999999999999976543 3445556666665555555


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ..+++.+.++|.+||+.||++|||+.++|+||||++.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            6789999999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.8e-51  Score=365.88  Aligned_cols=266  Identities=41%  Similarity=0.722  Sum_probs=228.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++++. ||||+++++++...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            4578999999999999999999999999999999987654322   224678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a~~  224 (366)
                      ..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+||+++..+ ....++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999999888899999999999999999999999999999999999995422 223799999999987


Q ss_pred             ccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          225 IETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ...........||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+...........++.+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            76555555667999999999876 46899999999999999999999999998888888877776665544444568899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +.++|.+||+.||++|||+.++++||||+...
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999999999999999998643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4e-51  Score=398.35  Aligned_cols=258  Identities=33%  Similarity=0.541  Sum_probs=226.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+..|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence            3466999999999999999999999999999999997655444455677899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +||||++|++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence            99999999999999976543  9999999999999999999999999999999999999   677889999999998876


Q ss_pred             CCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||....    .......+......++    ..++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s  413 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS  413 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence            6665666789999999998764 68999999999999999999999997753    3445555555443332    3689


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          302 GQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      +++.+||.+||+.||++||     +++|+++||||+..
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999999999     89999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.9e-51  Score=368.85  Aligned_cols=257  Identities=34%  Similarity=0.594  Sum_probs=215.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----------------------cccHHHHHHHHHHHH
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----------------------DKDMEDVRREILILQ  126 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~  126 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            457999999999999999999999999999999997543211                       112456889999999


Q ss_pred             HhcCCCceeEeceEEee--CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEE
Q 017768          127 HLTGQPNIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL  204 (366)
Q Consensus       127 ~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  204 (366)
                      .+. ||||+++++++.+  ++..++||||+++++|.+++. ...+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus        92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            997 9999999999986  568999999999999977543 346999999999999999999999999999999999999


Q ss_pred             eeecCCCCCEEEeecCCcccccCCC-ceecccCCCCCCcccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 017768          205 LASKEEDSPIKATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLHQR----YGKEIDVWSAGVILYILLSGVPPFWAETEK  279 (366)
Q Consensus       205 l~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~vl~~ll~g~~pf~~~~~~  279 (366)
                      +   +.++.+||+|||++....... ......||+.|+|||++.+.    .+.++||||||+++|+|++|..||......
T Consensus       170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9   567789999999998765433 33456799999999998643    377899999999999999999999988877


Q ss_pred             HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .....+.......+.  .+.+++++.++|.+||+.||++|||+.|+++||||++
T Consensus       247 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            777777665544332  3468999999999999999999999999999999964

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-52  Score=381.29  Aligned_cols=277  Identities=27%  Similarity=0.424  Sum_probs=220.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++..++..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            469999999999999999999999999999999864321  112223457999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      |||+++ +|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            999975 8988887754 58999999999999999999999999999999999999   56778999999999765432 


Q ss_pred             CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC----------
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP----------  296 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  296 (366)
                      .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+...........          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23344578999999998753  589999999999999999999999999888777766654322221111          


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHH
Q 017768          297 ----------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFR  354 (366)
Q Consensus       297 ----------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  354 (366)
                                      .+.+++++.+||.+||+.||++|||++|+|+||||.+...............++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  308 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ  308 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCC
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHH
Confidence                            1346889999999999999999999999999999998877665444444444444333

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-50  Score=362.47  Aligned_cols=260  Identities=38%  Similarity=0.599  Sum_probs=220.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ ||||+++++++...+..+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence            4567999999999999999999999899999999997654333455678899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCCC
Confidence            999999999999999988889999999999999999999999999999999999999   56778999999999877655


Q ss_pred             CceecccCCCCCCcccccccc--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      .......+|+.|+|||++.+.  .+.++||||||+++|+|++|..||...........+..+....+    ..++..+.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  240 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVAT  240 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHH
Confidence            544556789999999998754  36799999999999999999999998888887777777654433    247899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +|.+||+.||++|||+.++++||||++...
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            999999999999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.1e-50  Score=362.57  Aligned_cols=266  Identities=33%  Similarity=0.485  Sum_probs=233.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.+. |+||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence            4567999999999999999999999999999999997655444456678899999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ++|||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+|||+   +.++.+||+|||++......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999   56778999999999876432


Q ss_pred             -CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 -KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                       .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+.    .+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  244 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS  244 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHHH
Confidence             23344578999999998764 5889999999999999999999999988887777777666544332    57899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      +|.+||+.||++|||+.++++||||.+...+...+.
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~  280 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI  280 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCG
T ss_pred             HHHHHcccChhhCcCHHHHhhChheecCCcCCCCCc
Confidence            999999999999999999999999998777665543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-51  Score=379.62  Aligned_cols=273  Identities=34%  Similarity=0.622  Sum_probs=230.9

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc--ccccHHHHHHHHHHHHHhcCCCceeEeceE
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV--YDKDMEDVRREILILQHLTGQPNIVEFEGA  140 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~  140 (366)
                      |.....+.++|++.+.||+|+||.||+|.+..++..||+|++......  .....+.+.+|+.+++.++ ||||++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~   96 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEV   96 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehh
Confidence            445567889999999999999999999999999999999998754321  2345678999999999997 9999999999


Q ss_pred             EeeCCeEEEEEeccCCCchHHHHHH----------------------------------------hCCCCHHHHHHHHHH
Q 017768          141 YEDKQNLHLVMELCSGGELFDRIIA----------------------------------------KGIYSEREAANICRQ  180 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~q  180 (366)
                      +.+.+..++||||+++++|.+++..                                        ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            9999999999999999999998741                                        011367789999999


Q ss_pred             HHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-----ceecccCCCCCCcccccc---ccCCC
Q 017768          181 IVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-----VYKEIVGSAYYVAPEVLH---QRYGK  252 (366)
Q Consensus       181 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~  252 (366)
                      |+.||.|||++||+||||||+|||++. +....+||+|||++.......     ......||+.|+|||++.   ..++.
T Consensus       177 i~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          177 IFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            999999999999999999999999953 222379999999998653321     234457999999999875   45889


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          253 EIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       253 ~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ++||||||+++|+|++|..||.+....+....+...........+..+++++.++|.+||+.||++|||+.++|+||||+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS  335 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence            99999999999999999999999998888888888877776666667899999999999999999999999999999998


Q ss_pred             cCCCC
Q 017768          333 EDGAT  337 (366)
Q Consensus       333 ~~~~~  337 (366)
                      +....
T Consensus       336 ~~~~~  340 (345)
T 3hko_A          336 QFSDK  340 (345)
T ss_dssp             TTSSC
T ss_pred             cChHh
Confidence            86654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=369.03  Aligned_cols=265  Identities=30%  Similarity=0.506  Sum_probs=215.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++ ||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence            357999999999999999999999999999999986543 22334567889999999998 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999999988877889999999999999999999999999999999999999   56778999999999876532 


Q ss_pred             CceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC----------------
Q 017768          229 KVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL----------------  290 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------  290 (366)
                      .......||+.|+|||++.  ..++.++||||||+++|+|++|..||.+....+....+.....                
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            2334557899999999875  3579999999999999999999999988877665554432110                


Q ss_pred             ---CCCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          291 ---DLQSS--------PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       291 ---~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                         .....        ..+.+++.+.++|.+||+.||++|||++|+|+||||++......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence               00000        12467889999999999999999999999999999998665443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-50  Score=362.35  Aligned_cols=264  Identities=31%  Similarity=0.613  Sum_probs=231.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEE
Confidence            457999999999999999999999999999999997654333445677899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +|||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSSC
T ss_pred             EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCcccc
Confidence            99999999999999988889999999999999999999999999999999999999   567789999999987654322


Q ss_pred             ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                       .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......+    +.++..+.++|
T Consensus       169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  243 (284)
T 2vgo_A          169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI  243 (284)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred             -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHH
Confidence             344578999999998764 588999999999999999999999998888877777776655433    35789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      .+||+.||++|||+.++++||||+........+.
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~  277 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV  277 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred             HHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence            9999999999999999999999998776665543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.9e-51  Score=374.11  Aligned_cols=264  Identities=39%  Similarity=0.659  Sum_probs=220.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc-----ccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-----YDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.+. ||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence            4667899999999999999999999999999999998654321     1123345789999999997 999999999987


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      .++ .++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            665 8999999999999999988888999999999999999999999999999999999999976555667999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  297 (366)
                      .............||+.|+|||++.    ..++.++||||||+++|+|++|..||...... .....+..+........+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8776554445567999999999863    45889999999999999999999999765433 344455555554433334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ..+++.+.++|.+||+.||++|||+.++|+||||++
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            568999999999999999999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-50  Score=389.60  Aligned_cols=261  Identities=28%  Similarity=0.431  Sum_probs=211.1

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-  144 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-  144 (366)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++... 
T Consensus        57 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK  134 (464)
T ss_dssp             EEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred             ceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence            3456788999999999999999999999999999999997542 23455678889999999997 99999999999654 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          145 -----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       145 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                           ...|+||||+++ +|.+.+.  ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DF  208 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDF  208 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEE
Confidence                 467999999976 5666664  348999999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL------  292 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  292 (366)
                      |+++...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......      
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             EeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9998876665566778999999999876 468999999999999999999999999888776666654321110      


Q ss_pred             ----------------CCCCC----CC------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          293 ----------------QSSPW----PS------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       293 ----------------~~~~~----~~------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                                      ....+    +.            .++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                            00000    00            14678999999999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.3e-50  Score=372.16  Aligned_cols=265  Identities=28%  Similarity=0.434  Sum_probs=221.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----  143 (366)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++..     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   92 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence            45679999999999999999999999999999999865432 2344567889999999998 9999999999877     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          144 ---KQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       144 ---~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                         .+..++||||+++ +|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df  168 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF  168 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccc
Confidence               4568999999976 777776654 569999999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccC-----CCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC
Q 017768          220 GLSVFIET-----GKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       220 g~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      |++.....     ........||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.........+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99986542     222344578999999998753  47999999999999999999999999988887777765543333


Q ss_pred             CCCCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          293 QSSPWPS----------------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       293 ~~~~~~~----------------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ....++.                            .++.+.+||.+||+.||++|||+.|+|+||||+....+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            3333322                            2678999999999999999999999999999998776654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-50  Score=375.25  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=220.5

Q ss_pred             CCCCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc----CCCceeE
Q 017768           61 ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT----GQPNIVE  136 (366)
Q Consensus        61 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~  136 (366)
                      +.......+.++|++.+.||+|+||.||+|++..+++.||||++...    ......+..|+.+++.+.    +||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            33444556788899999999999999999999999999999998632    244566788999999997    5999999


Q ss_pred             eceEEeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec------
Q 017768          137 FEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK------  208 (366)
Q Consensus       137 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~------  208 (366)
                      +++++...+..++||||+ +++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++..      
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence            999999999999999999 889999998765  48999999999999999999999999999999999999531      


Q ss_pred             ----------------CCCCCEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCC
Q 017768          209 ----------------EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVP  271 (366)
Q Consensus       209 ----------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~  271 (366)
                                      ..++.+||+|||++......  .....||+.|+|||++. ..++.++||||||+++|+|++|..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence                            12678999999999865432  34567899999999876 468999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHcCCCCCCC---------------------CCCC---------------------CCCHHHHHHHH
Q 017768          272 PFWAETEKGIFEAILEGNLDLQS---------------------SPWP---------------------SISGQAKDLIR  309 (366)
Q Consensus       272 pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~---------------------~~~~~~~~li~  309 (366)
                      ||......+....+.......+.                     ..++                     ..++.+.+||.
T Consensus       258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            99888777666655442221110                     0000                     12367889999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcc
Q 017768          310 KMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      +||+.||++|||+.|+|+||||+
T Consensus       338 ~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.1e-50  Score=376.72  Aligned_cols=260  Identities=27%  Similarity=0.469  Sum_probs=215.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-CCceeEeceEEeeCCeE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-QPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~  147 (366)
                      ....|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++++.+ |+||+++++++..++..
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34569999999999999999999864 89999999975432 33456788999999999984 79999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |+||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC--
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccC
Confidence            99999 55789999999888899999999999999999999999999999999999993    36799999999987643


Q ss_pred             CC---ceecccCCCCCCccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCC
Q 017768          228 GK---VYKEIVGSAYYVAPEVLHQ------------RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLD  291 (366)
Q Consensus       228 ~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~  291 (366)
                      ..   .....+||+.|+|||++.+            .++.++|||||||++|+|++|..||..... ...+..+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345679999999998753            578899999999999999999999987543 3445555554443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .....  ..+.++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus       287 ~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          287 IEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             CCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             CCCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            33332  347899999999999999999999999999999865543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-50  Score=374.37  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=214.9

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            3456788999999999999999999999999999999985432 23345667889999999998 999999999997653


Q ss_pred             ------eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 ------NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 ------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                            ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df  172 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  172 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEee
Confidence                  469999999 7899998876 568999999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-----
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-----  292 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (366)
                      |+++.....  .....+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.......     
T Consensus       173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999875432  345678999999998754  68999999999999999999999999888776665554311110     


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          293 ----------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       293 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                            ....++.+++++.+||.+||+.||++|||+.++|+||||++.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence                                  0112346789999999999999999999999999999998865543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-49  Score=363.30  Aligned_cols=258  Identities=30%  Similarity=0.557  Sum_probs=222.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|+..+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.++ ||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence            34788889999999999999999899999999986543   345677899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      |||+++++|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence            999999999998754 468999999999999999999999999999999999999   567789999999988764432 


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+....... ......+++.+.++|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence            334567999999999876 458999999999999999999999999888777776666543322 122235789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          309 RKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .+||+.||++|||+.++++||||.+...+
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCCCc
Confidence            99999999999999999999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-49  Score=357.77  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=218.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----CC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----KQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~  145 (366)
                      ...|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++ ||||+++++++..    ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence            4458999999999999999999999999999999875443 3345677899999999997 9999999998865    45


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++  +.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence            68999999999999999998888999999999999999999999999  99999999999994  256789999999997


Q ss_pred             cccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ...... .....||+.|+|||++.+.++.++||||||+++|+|++|..||...... .....+..+.....  .....++
T Consensus       181 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  257 (290)
T 1t4h_A          181 LKRASF-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIP  257 (290)
T ss_dssp             GCCTTS-BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCH
T ss_pred             cccccc-cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc--cCCCCCH
Confidence            654432 3455799999999999888999999999999999999999999875443 44444443322211  1224678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ++.++|.+||+.||++|||+.++|+||||++.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-49  Score=378.72  Aligned_cols=266  Identities=31%  Similarity=0.481  Sum_probs=212.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++ |+||+++++++...  
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence            45677899999999999999999999999999999999643 233445678899999999997 99999999999776  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          145 ---QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                         +..|+||||++ ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGl  175 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGL  175 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCC
Confidence               57999999996 5999999888889999999999999999999999999999999999999   6677899999999


Q ss_pred             cccccCCC-----------------------ceecccCCCCCCccccc-c-ccCCCchhHHHHHHHHHHHHhCCCC----
Q 017768          222 SVFIETGK-----------------------VYKEIVGSAYYVAPEVL-H-QRYGKEIDVWSAGVILYILLSGVPP----  272 (366)
Q Consensus       222 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~vl~~ll~g~~p----  272 (366)
                      ++......                       .....+||+.|+|||++ . ..++.++|||||||++|+|++|..|    
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98764322                       23556899999999985 3 4589999999999999999985443    


Q ss_pred             -------CCCCC-----------------hHHHHHHHHc------------------------CCCCCC---CCCCCCCC
Q 017768          273 -------FWAET-----------------EKGIFEAILE------------------------GNLDLQ---SSPWPSIS  301 (366)
Q Consensus       273 -------f~~~~-----------------~~~~~~~~~~------------------------~~~~~~---~~~~~~~~  301 (366)
                             |.+.+                 ..+.+..+..                        ......   ...++.++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence                   33322                 0111111111                        000000   00124689


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      +++.+||.+||+.||++|||++|+|+||||++.....
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            9999999999999999999999999999999865543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-49  Score=369.35  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=222.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...+.|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.++++++ ||||+++++++..++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence            34567999999999999999999999999999999997654333445567899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+. |+|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSS
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecC
Confidence            99999997 578887754 4569999999999999999999999999999999999999   466789999999997654


Q ss_pred             CCCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ..   ....||+.|+|||++.    +.++.++||||||+++|+|++|..||...+.......+........  ....+++
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  280 (348)
T 1u5q_A          206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSE  280 (348)
T ss_dssp             SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCH
T ss_pred             CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCH
Confidence            32   3457999999999873    4689999999999999999999999988877766666655443222  2235789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .+.++|.+||+.||++|||++++++||||.....+
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999999999876544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-49  Score=386.42  Aligned_cols=257  Identities=32%  Similarity=0.523  Sum_probs=224.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+..|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence            467999999999999999999999999999999997655444455678899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          150 VMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeec
Confidence            99999999999998764    359999999999999999999999999999999999999   67788999999999876


Q ss_pred             cCCCc-eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKV-YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...    ........+......++    ..
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~  415 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK  415 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence            54432 334589999999998764 5899999999999999999999999765    33556666666554443    35


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRIT-----AAEALEHPWLKED  334 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt-----~~~~l~hp~f~~~  334 (366)
                      +++++.++|.+||+.||++||+     ++++++||||+..
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            7999999999999999999996     5899999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-50  Score=370.46  Aligned_cols=265  Identities=29%  Similarity=0.448  Sum_probs=218.0

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKK   96 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecC
Confidence            34455678999999999999999999999999999999986543 22334556789999999998 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFART  173 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCcee
Confidence            9999999999998888887777789999999999999999999999999999999999999   5677899999999976


Q ss_pred             ccCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC-----------
Q 017768          225 IETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL-----------  290 (366)
Q Consensus       225 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------  290 (366)
                      .... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||......+....+.....           
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            5432 23345678999999998764  588999999999999999999999988877665554432100           


Q ss_pred             --------CCCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          291 --------DLQS--------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       291 --------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                              ..+.        ...+.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                    0000        0123578999999999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-50  Score=375.82  Aligned_cols=259  Identities=34%  Similarity=0.573  Sum_probs=217.4

Q ss_pred             ccceeeeceecccCceEEEEEEEc---cCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .++|++.+.||+|+||.||+|++.   .+|+.||||++...... .....+.+.+|+.+++++.+||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            467999999999999999999984   47999999998654321 12334567789999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          146 NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeec
Confidence            999999999999999999988889999999999999999999999999999999999999   56778999999999765


Q ss_pred             cCCC--ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCCCCCCCC
Q 017768          226 ETGK--VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       226 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~  296 (366)
                      ....  ......||+.|+|||++.+   .++.++||||||+++|+|++|..||....    .......+.......+   
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  286 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---  286 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence            3322  2334579999999999863   37899999999999999999999996432    3344444444433322   


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                       ..++..+.+||.+||..||++||     ++.++++||||+...
T Consensus       287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence             35789999999999999999999     999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=371.62  Aligned_cols=254  Identities=32%  Similarity=0.532  Sum_probs=217.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++........     .....+.+|+.+++.++ ||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~   99 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE   99 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            467789999999999999999999999999999999976543211     23445778999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCC-chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          143 DKQNLHLVMELCSGG-ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      ..+..++||||+.++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~  176 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS  176 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence            999999999998766 999999888889999999999999999999999999999999999999   5678899999999


Q ss_pred             cccccCCCceecccCCCCCCccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLHQ-RY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      +.............||+.|+|||++.+ .+ +.++||||||+++|+|++|..||......      ...    .......
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~----~~~~~~~  246 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEA----AIHPPYL  246 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTT----CCCCSSC
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhh----ccCCCcc
Confidence            988766665666789999999998764 34 78899999999999999999999763221      111    1112234


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +++++.++|.+||+.||++|||+.++++||||++..
T Consensus       247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            789999999999999999999999999999998743

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-50  Score=359.31  Aligned_cols=259  Identities=30%  Similarity=0.535  Sum_probs=198.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEE
Confidence            457999999999999999999998899999999997554333345678899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|||+++++|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence            99999999999999865 568999999999999999999999999999999999999   56778999999999876432


Q ss_pred             C-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      . ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......    ....++.++.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  241 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKD  241 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHH
Confidence            2 2234578999999998764 5789999999999999999999999876655444433332222    12357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      +|.+||+.||++|||+.++++||||.+...
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            999999999999999999999999987543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.5e-50  Score=361.84  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=217.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++ ||||+++++++..++.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence            346778999999999999999999999999999999987655444556678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccccc
Confidence            99999999999999999998889999999999999999999999999999999999999   567789999999998764


Q ss_pred             CCC--ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCCCCH
Q 017768          227 TGK--VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL-QSSPWPSISG  302 (366)
Q Consensus       227 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  302 (366)
                      ...  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+............... .....+.+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            332  2234579999999998764 58899999999999999999999999888766655555443322 1223456899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      .+.++|.+||+.||++||+..+.+.+.|.
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999999999965555555554

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7e-51  Score=371.86  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=221.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence            446778999999999999999999999999999999997654444455667899999999997 999999999987654 


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          146 ---NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                         ..|+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  163 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCc
Confidence               349999999999999999988889999999999999999999999999999999999999   45677999999999


Q ss_pred             ccccCCC----ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          223 VFIETGK----VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       223 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      .......    ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......................
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  243 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence            8654322    2233568999999998764 5889999999999999999999999988887777776666554444344


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ..+++++.++|.+||+.||++||++.++|.|+|++..
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            5689999999999999999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-49  Score=362.77  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=213.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQN  146 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~  146 (366)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..      .....+.+|+.+++.+.+|+||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            45779999999999999999999999999999999853      3356789999999999889999999999987  667


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+++|||+++++|.+++.   .+++.+++.++.||+.||.|||++||+||||||+|||++  .++..+||+|||++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcC
Confidence            899999999999988874   389999999999999999999999999999999999995  233479999999998776


Q ss_pred             CCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHH-------------HcCCC
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFEAI-------------LEGNL  290 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~-~~~~~~~~-------------~~~~~  290 (366)
                      .........||..|+|||++.+  .++.++||||||+++|+|++|..||.... ..+.+..+             .....
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            6665666789999999998753  58999999999999999999999995432 22222211             11111


Q ss_pred             CC--------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          291 DL--------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       291 ~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..                    .......+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            10                    01111237899999999999999999999999999999997643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.2e-49  Score=354.66  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=213.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+..+..+.+||||+++++++.+.+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            356789999999999999999999999999999999875432 2345667889999999996699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--------------
Q 017768          148 HLVMELCSGGELFDRIIAK----GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--------------  209 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------------  209 (366)
                      ++||||+++++|.+++...    ..+++.+++.++.||+.||.|||++||+||||||+|||++..+              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999765    6699999999999999999999999999999999999996433              


Q ss_pred             --CCCCEEEeecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017768          210 --EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI  285 (366)
Q Consensus       210 --~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~  285 (366)
                        ....++|+|||++.......   ...||+.|+|||++.+  .++.++||||||+++|+|++|..++....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              45579999999998765433   2358999999999864  35679999999999999999988775442   23444


Q ss_pred             HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ..+.....   ...+++++.++|.+||+.||++|||+.++++||||++..
T Consensus       241 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            44433222   235789999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-49  Score=363.80  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=212.4

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEeceEEeeCCe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEGAYEDKQN  146 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~~~~~~~~  146 (366)
                      ...++|++.+.||+|+||.||++.+. +++.||+|++.... ........+.+|+.+++.+.+| +||+++++++..++.
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            34667999999999999999999875 68999999987543 2334567789999999999843 999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++|||+ .+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++....
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence            9999995 5789999999988899999999999999999999999999999999999994    4569999999998764


Q ss_pred             CCC---ceecccCCCCCCcccccc------------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCC
Q 017768          227 TGK---VYKEIVGSAYYVAPEVLH------------QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNL  290 (366)
Q Consensus       227 ~~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~  290 (366)
                      ...   ......||+.|+|||++.            ..++.++||||||+++|+|++|..||...... .....+.....
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            332   223457999999999874            35788999999999999999999999765433 33444443333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      .....  ...+.++.++|.+||+.||++|||+.++|+||||+....+.
T Consensus       239 ~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  284 (343)
T 3dbq_A          239 EIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  284 (343)
T ss_dssp             CCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC--
T ss_pred             ccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcc
Confidence            22222  24578999999999999999999999999999998655443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-49  Score=365.89  Aligned_cols=267  Identities=39%  Similarity=0.671  Sum_probs=196.1

Q ss_pred             cccccceeeec-eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--
Q 017768           67 VDITTIYDLDK-ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--  143 (366)
Q Consensus        67 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--  143 (366)
                      ..+.++|.+.+ .||+|+||.||+|.++.+|+.||+|++...        ....+|+..+.+..+|+||+++++++..  
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            34677899855 699999999999999999999999998532        2334455555555569999999999876  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          144 --KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       144 --~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                        +...++||||+++++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998654  5999999999999999999999999999999999999976566778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHcCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI----FEAILEGNLDLQS  294 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~  294 (366)
                      |++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........    ...+.........
T Consensus       176 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          176 GFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            999865433 234457899999999875 4588999999999999999999999976654433    2233334444455


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      ..+..+++++.++|.+||+.||++|||+.++|+||||++.......+.
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  302 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL  302 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence            555678999999999999999999999999999999988665555444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-49  Score=366.93  Aligned_cols=265  Identities=28%  Similarity=0.412  Sum_probs=214.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc--cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.+. ||||+++++++...+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence            3467999999999999999999999999999999986533211  112346789999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++ +|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence            9999999976 8888886643 58999999999999999999999999999999999999   56778999999999876


Q ss_pred             cCC-CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC------
Q 017768          226 ETG-KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP------  296 (366)
Q Consensus       226 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  296 (366)
                      ... .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+.+..+...........      
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            433 23445678999999998753  478999999999999999999999998887777766654321111111      


Q ss_pred             ------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          297 ------------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       297 ------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                        +..+++++.++|.+||+.||++|||+.|+|+||||+....+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                              134678999999999999999999999999999998865543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=356.45  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=216.3

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--  143 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--  143 (366)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++++.+||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3445678999999999999999999999899999999986432    3456789999999999779999999999987  


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          144 ----KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       144 ----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                          .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.+||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEe
Confidence                56899999999999999999874  468999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCC-ceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          218 DFGLSVFIETGK-VYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       218 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      |||++....... ......||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            999987654322 233457899999999874      3588999999999999999999999988877666555554432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ..  .....+++.+.++|.+||..||++|||+.++++||||++..
T Consensus       252 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          252 PR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            22  12245789999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.2e-50  Score=372.46  Aligned_cols=266  Identities=27%  Similarity=0.417  Sum_probs=204.4

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++..
T Consensus        22 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~   99 (367)
T 2fst_X           22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP   99 (367)
T ss_dssp             TEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred             CcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec
Confidence            334567788999999999999999999999999999999986432 23345667889999999998 9999999999865


Q ss_pred             C------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          144 K------QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       144 ~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      .      ...|+++|++ +++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus       100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~  174 (367)
T 2fst_X          100 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL  174 (367)
T ss_dssp             CSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             CCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEe
Confidence            4      5689999999 6799988865 569999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC----
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD----  291 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  291 (366)
                      |||+++.....  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+......    
T Consensus       175 DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99999875432  345679999999998754  5899999999999999999999999988877666655431110    


Q ss_pred             -------------------CCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          292 -------------------LQSS----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       292 -------------------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                         ....    ..+..++.+.+||.+||+.||++|||+.++|+||||++...+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                               0000    1235688999999999999999999999999999998765543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.4e-49  Score=373.41  Aligned_cols=261  Identities=29%  Similarity=0.425  Sum_probs=214.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc-----CCCceeEeceE
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-----GQPNIVEFEGA  140 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~  140 (366)
                      ...+..+|++.+.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.+.     +|+||++++++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            445677899999999999999999999999999999998643    234567788999998885     47799999999


Q ss_pred             EeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC--EEE
Q 017768          141 YEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP--IKA  216 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~--vkl  216 (366)
                      +...+..++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++   .++.  +||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL  243 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKV  243 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEE
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEE
Confidence            999999999999996 59999998764  489999999999999999999999999999999999994   4444  999


Q ss_pred             eecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC--
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ--  293 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--  293 (366)
                      +|||++......  .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+........  
T Consensus       244 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          244 IDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            999999765432  34567999999999876 4689999999999999999999999998887766655542100000  


Q ss_pred             ------------------------------------------------CC-----CCCCCCHHHHHHHHHhcccCcCCCC
Q 017768          294 ------------------------------------------------SS-----PWPSISGQAKDLIRKMLTKDPKKRI  320 (366)
Q Consensus       294 ------------------------------------------------~~-----~~~~~~~~~~~li~~~l~~dp~~Rp  320 (366)
                                                                      ..     .....++++.+||.+||+.||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                                                            00     0012378899999999999999999


Q ss_pred             CHHHHhcCCCcccCCC
Q 017768          321 TAAEALEHPWLKEDGA  336 (366)
Q Consensus       321 t~~~~l~hp~f~~~~~  336 (366)
                      |+.|+|+||||++...
T Consensus       402 ta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          402 TPGQALRHPWLRRRLP  417 (429)
T ss_dssp             CHHHHHTSTTTC----
T ss_pred             CHHHHhCChhhccCCC
Confidence            9999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-49  Score=365.37  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=206.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      +.++|++.+.||+|+||.||+|+++.+|+.||||++....  .....+.+.+|+.++++++ ||||+++++++.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            4567999999999999999999999999999999996543  2345678999999999997 999999999986543   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCchHHHHHHhCC---
Q 017768          146 ------------------------------------------------------NLHLVMELCSGGELFDRIIAKGI---  168 (366)
Q Consensus       146 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---  168 (366)
                                                                            ..+++|||+++++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-------------ceeccc
Q 017768          169 YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-------------VYKEIV  235 (366)
Q Consensus       169 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~  235 (366)
                      .++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            5666799999999999999999999999999999999   567789999999998765432             223457


Q ss_pred             CCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          236 GSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       236 gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      ||+.|+|||++. ..++.++||||||+++|+|++|..|+..  .......+.......   .....++++.++|.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccC
Confidence            999999999876 4689999999999999999998776522  122223333332211   1123567889999999999


Q ss_pred             CcCCCCCHHHHhcCCCccc
Q 017768          315 DPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       315 dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ||++|||+.|+|+||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-49  Score=369.82  Aligned_cols=259  Identities=27%  Similarity=0.439  Sum_probs=206.2

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+ 
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           21 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCS
T ss_pred             cchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccc
Confidence            346678999999999999999999999999999999987532 23345667889999999997 999999999997665 


Q ss_pred             -----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          146 -----NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       146 -----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                           ..++||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg  172 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  172 (371)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCC
T ss_pred             cccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEee
Confidence                 78999999975 7888775  458999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-----
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-----  294 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  294 (366)
                      ++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+.........     
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            998776554455668999999999876 45899999999999999999999999988877776666543221100     


Q ss_pred             ------------CC--------------CC-------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          295 ------------SP--------------WP-------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       295 ------------~~--------------~~-------~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                  ..              .+       ..+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                        00              00       01467899999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-50  Score=377.63  Aligned_cols=250  Identities=16%  Similarity=0.203  Sum_probs=203.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEec-------e
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFE-------G  139 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~-------~  139 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.  +||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4578999999999999999999998899999999997654444556788999996666554  499999998       6


Q ss_pred             EEeeCC-----------------eEEEEEeccCCCchHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHHHcCCEE
Q 017768          140 AYEDKQ-----------------NLHLVMELCSGGELFDRIIAKGIYSE-------REAANICRQIVNVVHACHFMGVIH  195 (366)
Q Consensus       140 ~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~qi~~~l~~LH~~~ivH  195 (366)
                      ++...+                 ..|++|||+ +|+|.+++.....+++       ..++.++.||+.||.|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            666553                 288999999 6799999987655555       788899999999999999999999


Q ss_pred             eccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccc------------cCCCchhHHHHHHHH
Q 017768          196 RDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ------------RYGKEIDVWSAGVIL  263 (366)
Q Consensus       196 ~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~vl  263 (366)
                      |||||+|||+   +.++.+||+|||++.....  ......| +.|+|||++.+            .++.++||||||+++
T Consensus       230 rDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999   5667899999999986432  3455677 99999998763            589999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          264 YILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       264 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      |+|++|..||.+.........+.        ..++.+++++.++|.+||+.||++|||+.++++||||++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999997654332222221        223468999999999999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.1e-49  Score=351.65  Aligned_cols=261  Identities=31%  Similarity=0.538  Sum_probs=220.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++..++..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            45679999999999999999999999999999999865432  344678899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999998877779999999999999999999999999999999999999   56778999999999765432


Q ss_pred             C---ceecccCCCCCCccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQ-R-YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .   ......||+.|+|||++.+ . .+.++||||||+++|+|++|..||...... .....+......  ...+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence            2   2344578999999999864 3 367899999999999999999999776543 233333333222  222346799


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .+.++|.+||+.||++|||+.++++||||++....
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            99999999999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.1e-49  Score=365.67  Aligned_cols=264  Identities=29%  Similarity=0.421  Sum_probs=218.7

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-  144 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-  144 (366)
                      ...+.++|++.+.||+|+||.||+|.+..++..||+|++....  .......+.+|+.++++++ ||||+++++++... 
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   98 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence            3456678999999999999999999999999999999986432  2344577889999999997 99999999998765 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          145 ----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       145 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                          ...++||||+++ +|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg  173 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG  173 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCc
Confidence                468999999974 99998865 458999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCc----eecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC--
Q 017768          221 LSVFIETGKV----YKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL--  292 (366)
Q Consensus       221 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--  292 (366)
                      ++........    .....||+.|+|||++. . .++.++||||||+++|+|++|..||.+....+....+.......  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987643321    23457999999999864 3 48999999999999999999999998887666555553211100  


Q ss_pred             ---------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          293 ---------------------QS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       293 ---------------------~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                           ..    ...+.+++++.+||.+||+.||++|||+.|+|+||||++...+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                                 00    0124578999999999999999999999999999999886443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.6e-49  Score=373.72  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=209.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK----  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----  144 (366)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++ |+||+++++++...    
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence            4557999999999999999999999999999999986432       12347999999997 99999999988532    


Q ss_pred             --CeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          145 --QNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       145 --~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                        ...++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++  .+.+.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEecc
Confidence              246799999976 66665543    45699999999999999999999999999999999999995  2345689999


Q ss_pred             cCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC--------
Q 017768          219 FGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG--------  288 (366)
Q Consensus       219 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~--------  288 (366)
                      ||+++............||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.+..+.+..+...        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987765555556789999999998753  5899999999999999999999999988776655554331        


Q ss_pred             ---------CCCCCC---C-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          289 ---------NLDLQS---S-----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       289 ---------~~~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                               ...++.   .     ..+.+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                     001110   0     11356899999999999999999999999999999987543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.2e-48  Score=352.01  Aligned_cols=276  Identities=27%  Similarity=0.465  Sum_probs=231.8

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++...+..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence            455679999999999999999999999999999999975432  345678999999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++||||+++++|.+++.. ..+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCc
Confidence            999999999999998864 568999999999999999999999999999999999999   5677899999999977654


Q ss_pred             CC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+........   ...++..+.
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~  248 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLK  248 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHHHH
Confidence            33 234457899999999876 4588999999999999999999999988877776666655443222   235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHHHH
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRA  355 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  355 (366)
                      ++|.+||+.||++|||+.++++||||.........  -.....+++.+.+
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~--~~~~~~~~~~~~~  296 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY--LTELIDRYKRWKA  296 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGG--GHHHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHH--HHHHHHHHHHhhh
Confidence            99999999999999999999999999876554432  2344444444433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-49  Score=369.43  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=210.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----  143 (366)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++.....       ...+|+.+++.++ ||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            45679999999999999999999999999999999864321       1237999999997 9999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHH
Q 017768          144 ---------------------------------KQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVH  186 (366)
Q Consensus       144 ---------------------------------~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~  186 (366)
                                                       ....++||||+++ +|.+.+..    ...+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3348899999975 77776653    467999999999999999999


Q ss_pred             HHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHH
Q 017768          187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILY  264 (366)
Q Consensus       187 ~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~  264 (366)
                      |||++||+||||||+|||++  ..++.+||+|||++.............+|+.|+|||++.+  .++.++||||||+++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99999999999999999995  2566799999999987766665666789999999998754  4899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHcCCC-----------------CCCC---C-----CCCCCCHHHHHHHHHhcccCcCCC
Q 017768          265 ILLSGVPPFWAETEKGIFEAILEGNL-----------------DLQS---S-----PWPSISGQAKDLIRKMLTKDPKKR  319 (366)
Q Consensus       265 ~ll~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~R  319 (366)
                      +|++|..||.+.+..+.+..+.....                 .++.   .     ....+++++.+||.+||+.||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999998887776666543110                 0000   0     112478899999999999999999


Q ss_pred             CCHHHHhcCCCcccC
Q 017768          320 ITAAEALEHPWLKED  334 (366)
Q Consensus       320 pt~~~~l~hp~f~~~  334 (366)
                      ||+.|+|+||||++.
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=371.97  Aligned_cols=264  Identities=27%  Similarity=0.485  Sum_probs=199.0

Q ss_pred             ccccceee-eceecccCceEEEEEEEc--cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-
Q 017768           68 DITTIYDL-DKELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-  143 (366)
Q Consensus        68 ~~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-  143 (366)
                      .+.+.|++ .++||+|+||.||+|+++  .+++.||+|++...     .....+.+|+.+|+.++ ||||+++++++.. 
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   90 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELK-HPNVISLQKVFLSH   90 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-----SCCHHHHHHHHHHHHCC-CTTBCCCCEEEEET
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-----CCCHHHHHHHHHHHhcC-CCCeeeEeeEEecC
Confidence            45667887 458999999999999966  46889999998643     23456889999999998 9999999999954 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKG---------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDS  212 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~  212 (366)
                       +...++||||+++ +|.+++....         .+++.+++.++.||+.||.|||++||+||||||+|||+... +.++
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred             CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence             6789999999965 8888775321         48999999999999999999999999999999999999643 4567


Q ss_pred             CEEEeecCCcccccCC----CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------
Q 017768          213 PIKATDFGLSVFIETG----KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK-------  279 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-------  279 (366)
                      .+||+|||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....       
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            8999999999876432    22344678999999998764  4899999999999999999999999765432       


Q ss_pred             --HHHHHHHcCCCCCCCCCCC----------------------------------CCCHHHHHHHHHhcccCcCCCCCHH
Q 017768          280 --GIFEAILEGNLDLQSSPWP----------------------------------SISGQAKDLIRKMLTKDPKKRITAA  323 (366)
Q Consensus       280 --~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~dp~~Rpt~~  323 (366)
                        +.+..+...........|.                                  ..++.+.+||.+||+.||++|||++
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              3333333221111111111                                  1267899999999999999999999


Q ss_pred             HHhcCCCcccCCCCC
Q 017768          324 EALEHPWLKEDGATS  338 (366)
Q Consensus       324 ~~l~hp~f~~~~~~~  338 (366)
                      |+|+||||++...+.
T Consensus       330 e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          330 QAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHTSGGGTSSSCCC
T ss_pred             HHhcChhhccCCCCc
Confidence            999999998876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6e-49  Score=360.27  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=214.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--  145 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.++++++ ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence            456789999999999999999999999999999999865432  344677889999999998 999999999988765  


Q ss_pred             eEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee-cCCCCCEEEeecCC
Q 017768          146 NLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS-KEEDSPIKATDFGL  221 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~vkl~Dfg~  221 (366)
                      ..++||||+++++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+|||+.. .+..+.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999986543   899999999999999999999999999999999999843 23455699999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHcC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH---------QRYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEG  288 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~vl~~ll~g~~pf~~~----~~~~~~~~~~~~  288 (366)
                      +.............||+.|+|||++.         ..++.++||||||+++|+|++|..||...    ...+....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            98876666666678999999999874         46889999999999999999999999643    234445555443


Q ss_pred             CCCC---------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017768          289 NLDL---------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP  329 (366)
Q Consensus       289 ~~~~---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp  329 (366)
                      ....                     .......+++.+.++|.+||+.||++|||+.|+|+||
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3211                     0111123456889999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-48  Score=352.52  Aligned_cols=262  Identities=29%  Similarity=0.494  Sum_probs=218.7

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+..++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.+. ||||+++++++..++.
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence            356778999999999999999999999999999999986542   345678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccc
Confidence            9999999999999998876 4569999999999999999999999999999999999999   56778999999987643


Q ss_pred             cCC-CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          226 ETG-KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       226 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ... .......||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+........ ....
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  246 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPS  246 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGG
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCcc
Confidence            211 1223457899999999872      4578899999999999999999999998887776666655543221 1123


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .++..+.++|.+||+.||++|||+.++++||||+....
T Consensus       247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            57889999999999999999999999999999987654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-48  Score=363.90  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=218.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++....  .......+.+|+.+++.+. ||||+++++++..++..+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEE
Confidence            4567999999999999999999999999999999987542  2345677899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+||||||+|||+   +.++.++|+|||++.....
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccccc
Confidence            9999999999999999988899999999999999999999996 99999999999999   5677899999999976533


Q ss_pred             CCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------------
Q 017768          228 GKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI---------------------  285 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~---------------------  285 (366)
                      . ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+                     
T Consensus       185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             H-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             c-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence            2 233457999999999876 45899999999999999999999999876654432221                     


Q ss_pred             ---------------------HcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          286 ---------------------LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       286 ---------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                           .....  .......++.++.+||.+||+.||++|||+.++|+||||++.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             ccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence                                 11111  1111234788999999999999999999999999999998755433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.4e-48  Score=362.39  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=215.2

Q ss_pred             cccceeeeceecccCceEEEEEEEc-------cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-------ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++.+.+||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4578999999999999999999874       245679999986542  2345678999999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ...+..|+||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999998753                37899999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence               6678899999999986543321   22345678899999875 468999999999999999999 999999888887


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....+..+.....   ...+++++.++|.+||+.||++|||+.|++++
T Consensus       314 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7777766643222   23578999999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-48  Score=350.77  Aligned_cols=260  Identities=25%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....  .........|...+.+..+||||+++++++..++..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            45679999999999999999999999999999999865421  2233334444444334345999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      +||||+++ +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++.
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC----
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence            99999975 88777654    45699999999999999999999998 99999999999999   567789999999998


Q ss_pred             cccCCCceecccCCCCCCcccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLH-----QRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ............||+.|+|||++.     ..++.++||||||+++|+|++|..||... .................  ..
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  236 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--PA  236 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--CT
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--cc
Confidence            776555555567999999999862     35788999999999999999999999753 33333333333322211  12


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..+++++.++|.+||+.||++|||+.++++||||+....
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence            357899999999999999999999999999999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.7e-48  Score=354.56  Aligned_cols=265  Identities=27%  Similarity=0.385  Sum_probs=219.1

Q ss_pred             ccccceeeeceecccCceEEEEEEEc-cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEe--
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKK-ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYE--  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~--  142 (366)
                      ...++|++.+.||+|+||.||+|.+. .+|+.||+|++..... .......+.+|+.+++.+.  +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            45678999999999999999999985 6788999999875432 1222345667888888774  5999999999987  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          143 ---DKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       143 ---~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                         .....++||||++ ++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEe
Confidence               5567899999997 59999998754  38999999999999999999999999999999999999   567789999


Q ss_pred             ecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC----
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL----  292 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (366)
                      |||++.............||..|+|||++. ..++.++||||||+++|+|++|..||.+.........+.......    
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            999998765544455567899999999875 468999999999999999999999999888777666654321100    


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          293 -------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       293 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                         .....+.+++.+.++|.+||+.||++|||+.++|+||||++....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                               011224678999999999999999999999999999999876553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-48  Score=367.16  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=210.0

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ......+|++.+.||+|+||+||+|.+..++. +|+|++.....       ...+|+.+++.++ ||||+++++++...+
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSNG  105 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEES
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEecC
Confidence            34456789999999999999999999886554 88888754321       1236999999997 999999999985543


Q ss_pred             ------eEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEE
Q 017768          146 ------NLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       146 ------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                            ..++||||++++ +...+..    ...+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+|
T Consensus       106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~k  182 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLK  182 (394)
T ss_dssp             SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEE
T ss_pred             CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEE
Confidence                  388999999774 4443332    45699999999999999999999999999999999999995  2567899


Q ss_pred             EeecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC---
Q 017768          216 ATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL---  290 (366)
Q Consensus       216 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~---  290 (366)
                      |+|||+++............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.....   
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999988766555566789999999998753  589999999999999999999999998887766655543100   


Q ss_pred             --------------CCCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          291 --------------DLQS--------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       291 --------------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                    .++.        ...+.+++++.+||.+||+.||++|||+.|+++||||++....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                          0000        0112478999999999999999999999999999999976553

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-48  Score=351.91  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=208.3

Q ss_pred             CCCCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceE
Q 017768           61 ILGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGA  140 (366)
Q Consensus        61 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~  140 (366)
                      ..+.......++|++.+.||+|+||+||+|++.  |..||+|++..... .......+.+|+.++++++ ||||++++++
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~  102 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGA  102 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence            344445556778999999999999999999874  88999999865432 2344667899999999997 9999999999


Q ss_pred             EeeCCeEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEE
Q 017768          141 YEDKQNLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIK  215 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vk  215 (366)
                      +...+..++||||+++++|.+++.....   +++..++.++.||+.||.|||++|  |+||||||+|||+   +.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~k  179 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVK  179 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEE
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEE
Confidence            9999999999999999999999976543   899999999999999999999999  9999999999999   6677899


Q ss_pred             EeecCCcccccCCC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC
Q 017768          216 ATDFGLSVFIETGK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       216 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  293 (366)
                      |+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+........
T Consensus       180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE  259 (309)
T ss_dssp             ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            99999997654332 2334579999999998764 589999999999999999999999998888777766654333222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .  ...+++++.++|.+||+.||++|||+.++++
T Consensus       260 ~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          260 I--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2  2367999999999999999999999999988

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=352.61  Aligned_cols=262  Identities=25%  Similarity=0.478  Sum_probs=219.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-cccHHHHHHHHHHHHHhcCCCceeEeceEE--eeCC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNIVEFEGAY--EDKQ  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--~~~~  145 (366)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++ |+||+++++++  ...+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            4467999999999999999999999999999999997543221 244677899999999997 99999999998  4456


Q ss_pred             eEEEEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..++||||++++ |.+++..  ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            789999999875 7777766  3469999999999999999999999999999999999999   567789999999998


Q ss_pred             cccC---CCceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          224 FIET---GKVYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       224 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ....   ........||+.|+|||++.+   .++.++||||||+++|+|++|..||......+....+..+.....    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            7542   222344578999999998764   247799999999999999999999999888888888877655443    


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ..+++.+.++|.+||+.||++|||+.++++||||++......
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence            257899999999999999999999999999999987665443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-48  Score=364.67  Aligned_cols=262  Identities=28%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-----ceeEeceE
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-----NIVEFEGA  140 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----~i~~~~~~  140 (366)
                      ...+.++|++.+.||+|+||+||+|.+..+++.||||++...    ......+..|+.+++.+.+|+     +|+.++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            345678899999999999999999999999999999998643    234567788999999887566     49999999


Q ss_pred             EeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--HcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          141 YEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACH--FMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      +...+..++||||+++ +|.+++....  .+++..+..++.||+.||.|||  +.||+||||||+|||++. +.++.+||
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL  202 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKI  202 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEE
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEE
Confidence            9999999999999965 9999998763  5899999999999999999999  579999999999999953 24567999


Q ss_pred             eecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC--
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ--  293 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--  293 (366)
                      +|||++......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+  
T Consensus       203 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          203 VDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             EeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999999876432  345679999999998764 689999999999999999999999998887776666543211000  


Q ss_pred             ---------------------------------CCCCCC-------------------------CCHHHHHHHHHhcccC
Q 017768          294 ---------------------------------SSPWPS-------------------------ISGQAKDLIRKMLTKD  315 (366)
Q Consensus       294 ---------------------------------~~~~~~-------------------------~~~~~~~li~~~l~~d  315 (366)
                                                       ......                         ..+++.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                                             000000                         0137899999999999


Q ss_pred             cCCCCCHHHHhcCCCcccCC
Q 017768          316 PKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       316 p~~Rpt~~~~l~hp~f~~~~  335 (366)
                      |++|||+.|+|+||||++..
T Consensus       361 P~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC--
T ss_pred             hhhCCCHHHHhcCcccccCC
Confidence            99999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.6e-49  Score=369.32  Aligned_cols=259  Identities=18%  Similarity=0.211  Sum_probs=197.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc-CCCceeEec-------eEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-GQPNIVEFE-------GAY  141 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~-------~~~  141 (366)
                      ...|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+. +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999998765434455667888876666665 499988754       444


Q ss_pred             eeC-----------------CeEEEEEeccCCCchHHHHHHh-CCCCHHHH------HHHHHHHHHHHHHHHHcCCEEec
Q 017768          142 EDK-----------------QNLHLVMELCSGGELFDRIIAK-GIYSEREA------ANICRQIVNVVHACHFMGVIHRD  197 (366)
Q Consensus       142 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~qi~~~l~~LH~~~ivH~D  197 (366)
                      ...                 ...||||||++ ++|.+++... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            332                 34899999998 7999999874 33455555      67779999999999999999999


Q ss_pred             cCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCC
Q 017768          198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFW  274 (366)
Q Consensus       198 lkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~  274 (366)
                      |||+|||+   +.++.+||+|||++......  .....+|+.|+|||++.+   .++.++||||||+++|+|++|..||.
T Consensus       220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999   56778999999999865432  224567799999998763   58999999999999999999999997


Q ss_pred             CCChHHHH--HH---HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          275 AETEKGIF--EA---ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       275 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ........  ..   ............++.+++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            76432100  00   01111222333345789999999999999999999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.1e-48  Score=347.75  Aligned_cols=260  Identities=28%  Similarity=0.504  Sum_probs=221.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe--eCCeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE--DKQNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~~~~~  147 (366)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.++++++ ||||+++++++.  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence            4579999999999999999999999999999999975432 2345677899999999997 999999999874  46789


Q ss_pred             EEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHcC-----CEEeccCCCcEEeeecCCCCCEEEee
Q 017768          148 HLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACHFMG-----VIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      ++||||+++++|.+++....    .+++.+++.++.||+.||.|||+.+     |+|+||||+|||+   +.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            99999999999999997642    3899999999999999999999999     9999999999999   5677899999


Q ss_pred             cCCcccccCCCc-eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          219 FGLSVFIETGKV-YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       219 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      ||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--  237 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--  237 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC--
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC--
Confidence            999987644322 234578999999998764 5889999999999999999999999988888877777776553222  


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                       ..+++++.++|.+||+.||++|||+.++++|+|+.+...+
T Consensus       238 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          238 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             -cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence             2578999999999999999999999999999999886554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-47  Score=355.37  Aligned_cols=264  Identities=32%  Similarity=0.467  Sum_probs=216.3

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--  144 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||.+....  .......+.+|+.+++.++ ||||+++++++...  
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCS
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccccc
Confidence            346778999999999999999999999999999999985432  2344567889999999997 99999999987654  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          145 ---QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                         ...+++|||+. ++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL  158 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccc
Confidence               67899999996 589888876 568999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCC-----------ceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          222 SVFIETGK-----------VYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       222 a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                      +.......           ......||+.|+|||++.  ..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            98654321           122347899999999864  45889999999999999999999999988766555444321


Q ss_pred             CCC------------------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          289 NLD------------------------LQS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       289 ~~~------------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ...                        ...    ..++.+++++.++|.+||+.||++|||+.++|+||||+....+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            000                        000    01246789999999999999999999999999999998865543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-48  Score=354.04  Aligned_cols=263  Identities=32%  Similarity=0.488  Sum_probs=197.6

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCc
Confidence            345679999999999999999999988899999998864322  234567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          148 HLVMELCSGGELFDRIIA--------KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      ++||||+++++|.+++..        ...+++.+++.++.||+.||.|||++||+|+||||+||++   +.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEec
Confidence            999999999999999875        3458999999999999999999999999999999999999   56778999999


Q ss_pred             CCcccccCCC------ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC
Q 017768          220 GLSVFIETGK------VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       220 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      |++.......      ......||+.|+|||++.+  .++.++||||||+++|+|++|..||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987654321      1234578999999998753  5899999999999999999999999887766555544443322


Q ss_pred             CC------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          292 LQ------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       292 ~~------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..      ......+++++.++|.+||+.||++|||+.++++||||++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            11      1123467899999999999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=353.39  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=213.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..++|++.+.||+|+||.||+|.+..+++   .||||.+....  .......+.+|+.+++.++ ||||+++++++.+++
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            45679999999999999999999986555   49999986432  2345677899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence            999999999999999999754 469999999999999999999999999999999999999   6678899999999987


Q ss_pred             ccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          225 IETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       225 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ......    .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   ..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CC
Confidence            643321    12234577899999886 568999999999999999999 9999999998888888877643222   23


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+++.+.++|.+||..||++|||+.++++
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            67899999999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-48  Score=359.63  Aligned_cols=260  Identities=24%  Similarity=0.474  Sum_probs=221.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccccc--------------HHHHHHHHHHHHHhcCCCce
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD--------------MEDVRREILILQHLTGQPNI  134 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~~h~~i  134 (366)
                      ..++|++.+.||+|+||.||+|.+  +|+.||+|.+..........              ...+.+|+.+++.++ ||||
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i  105 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYC  105 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTB
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCc
Confidence            456799999999999999999998  79999999997544322221              278999999999997 9999


Q ss_pred             eEeceEEeeCCeEEEEEeccCCCchHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEe
Q 017768          135 VEFEGAYEDKQNLHLVMELCSGGELFDR------IIA--KGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLL  205 (366)
Q Consensus       135 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll  205 (366)
                      +++++++...+..++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+|+||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999988      655  4569999999999999999999999 999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCceecccCCCCCCcccccccc--CCC-chhHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR--YGK-EIDVWSAGVILYILLSGVPPFWAETE-KGI  281 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~Di~slG~vl~~ll~g~~pf~~~~~-~~~  281 (366)
                         +.++.++|+|||++...... ......||..|+|||++.+.  ++. ++||||||+++|+|++|..||..... .+.
T Consensus       186 ---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 ---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             ---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             ---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence               56778999999999876443 34556799999999998643  445 89999999999999999999988776 677


Q ss_pred             HHHHHcCCCCCCCCC---------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          282 FEAILEGNLDLQSSP---------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       282 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ...+..+....+...               ...++.++.++|.+||+.||++|||+.++++||||++..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            777766655444211               145789999999999999999999999999999998753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.8e-48  Score=361.14  Aligned_cols=262  Identities=30%  Similarity=0.459  Sum_probs=214.6

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++ ||||+++++++..
T Consensus        35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  112 (371)
T 4exu_A           35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTP  112 (371)
T ss_dssp             TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred             cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheec
Confidence            334557788999999999999999999999999999999986543 23344677889999999998 9999999999987


Q ss_pred             CCeE------EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          144 KQNL------HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       144 ~~~~------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      .+..      ++||||+. ++|.+.+.  ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus       113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~  186 (371)
T 4exu_A          113 ASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL  186 (371)
T ss_dssp             CSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred             cCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence            7654      99999997 58877763  348999999999999999999999999999999999999   667789999


Q ss_pred             ecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC----
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD----  291 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~----  291 (366)
                      |||++......  .....||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+......    
T Consensus       187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            99999865432  344578999999998764  5899999999999999999999999988776666555331100    


Q ss_pred             -------------------CCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          292 -------------------LQS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       292 -------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                         ...    ..++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                               000    01235789999999999999999999999999999998643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=348.57  Aligned_cols=260  Identities=28%  Similarity=0.501  Sum_probs=215.8

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|.+...     .....+.+|+.+++.+. ||||+++++++...+..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            3456799999999999999999999999999999998643     34567899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++.. ...+++.+++.++.||+.||.|||+.||+|+||||+||++   +.++.++|+|||++....
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence            999999999999999874 4569999999999999999999999999999999999999   567789999999997664


Q ss_pred             CCC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......++..+
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  255 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNF  255 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHH
Confidence            432 2334578999999998764 5899999999999999999999999887766555544443221 111223468999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      .++|.+||..||++|||+.++++||||+.....
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            999999999999999999999999999876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=355.61  Aligned_cols=268  Identities=29%  Similarity=0.427  Sum_probs=212.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe---
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE---  142 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---  142 (366)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|.+....   ......+.+|+.+++.+. ||||+++++++.   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            3456788999999999999999999999999999999986432   345678899999999997 999999998873   


Q ss_pred             -----------eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          143 -----------DKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       143 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                                 ..+..++||||++ ++|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++  .++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~  157 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED  157 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence                       4468899999997 599988854 5689999999999999999999999999999999999995  345


Q ss_pred             CCEEEeecCCcccccCC----CceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 017768          212 SPIKATDFGLSVFIETG----KVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI  285 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~  285 (366)
                      +.+||+|||++......    .......+|..|+|||++.  ..++.++||||||+++|+|++|..||.+....+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67999999999875432    1223446799999999864  45889999999999999999999999988776666555


Q ss_pred             HcCCCCC----------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          286 LEGNLDL----------------------QS----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       286 ~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      .......                      ..    ...+.++.++.++|.+||+.||++|||+.++|+||||+....+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            4332110                      00    012457899999999999999999999999999999998777665


Q ss_pred             CC
Q 017768          340 KP  341 (366)
Q Consensus       340 ~~  341 (366)
                      .+
T Consensus       318 ~~  319 (320)
T 2i6l_A          318 EP  319 (320)
T ss_dssp             --
T ss_pred             CC
Confidence            43

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=361.24  Aligned_cols=258  Identities=22%  Similarity=0.295  Sum_probs=218.9

Q ss_pred             cccceeeeceecccCceEEEEEE-----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||.||+|.     +..++..||||++...  ........+.+|+.++++++ ||||+++++++..
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            35679999999999999999999     4456789999998543  22345567889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG-------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      .+..++||||+++++|.+++....       .+++.+++.++.||+.||.|||++||+||||||+|||++..+.+..+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999998763       4899999999999999999999999999999999999975556667999


Q ss_pred             eecCCcccccCC---CceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCC
Q 017768          217 TDFGLSVFIETG---KVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       217 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      +|||+++.....   .......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999999754321   2233456789999999875 568999999999999999998 99999999888888888776533


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ...   ..+++.+.++|.+||+.||++|||+.+++++.++-
T Consensus       306 ~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 DPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            322   35789999999999999999999999999987664

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-47  Score=352.70  Aligned_cols=263  Identities=31%  Similarity=0.429  Sum_probs=214.9

Q ss_pred             cccccceeeeceecccCceEEEEEEE-ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-----CCceeEeceE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTK-KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-----QPNIVEFEGA  140 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~i~~~~~~  140 (366)
                      ..+.++|++.+.||+|+||.||+|.+ ..+++.||+|++...    ....+.+.+|+.+++.+.+     ++++++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            44667899999999999999999998 557899999998532    2445678899999998862     3359999999


Q ss_pred             EeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC--------
Q 017768          141 YEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE--------  210 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--------  210 (366)
                      +...+..++||||+ +++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++..+.        
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999999 889999998765  5899999999999999999999999999999999999964221        


Q ss_pred             --------CCCEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 017768          211 --------DSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGI  281 (366)
Q Consensus       211 --------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~  281 (366)
                              ++.+||+|||++......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    567999999999875432  344578999999998764 689999999999999999999999988877665


Q ss_pred             HHHHHcCCCCCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCC
Q 017768          282 FEAILEGNLDLQS----------------------------------------SPWPSISGQAKDLIRKMLTKDPKKRIT  321 (366)
Q Consensus       282 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt  321 (366)
                      ...+.......+.                                        ......++++.+||.+||+.||++|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            5444321111000                                        000123467889999999999999999


Q ss_pred             HHHHhcCCCcccCCC
Q 017768          322 AAEALEHPWLKEDGA  336 (366)
Q Consensus       322 ~~~~l~hp~f~~~~~  336 (366)
                      +.|+++||||+....
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999987543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.6e-48  Score=359.53  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe-
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN-  146 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-  146 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....    .......+|+..+..+. ||||+++++++...+. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSS
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcC-CCCcccHHHhhhccccc
Confidence            34567999999999999999999999999999999885432    23345667888888887 9999999999865433 


Q ss_pred             ------EEEEEeccCCCchHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH--HcCCEEeccCCCcEEeeecCCCCCE
Q 017768          147 ------LHLVMELCSGGELFDRII----AKGIYSEREAANICRQIVNVVHACH--FMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       147 ------~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                            .++||||+++ +|...+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++  ..++.+
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcE
Confidence                  8899999987 5544443    3456899999999999999999999  99999999999999995  236789


Q ss_pred             EEeecCCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC
Q 017768          215 KATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL  292 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  292 (366)
                      ||+|||++.............||+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+.......+.......
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            9999999988766665566789999999998743  48999999999999999999999999888777666654311100


Q ss_pred             ----------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          293 ----------------------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       293 ----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                                                  ........++++.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                        0001122568999999999999999999999999999998865433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-48  Score=354.42  Aligned_cols=259  Identities=27%  Similarity=0.493  Sum_probs=216.2

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc---ccHHHHHHHHHHHHHhc-CCCceeEeceE
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---KDMEDVRREILILQHLT-GQPNIVEFEGA  140 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~-~h~~i~~~~~~  140 (366)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++. +|+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344567789999999999999999999999999999999976543221   12345678999999997 37999999999


Q ss_pred             EeeCCeEEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          141 YEDKQNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       141 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      +...+..+++||++.+ ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++  .+++.+||+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df  194 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF  194 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence            9999999999999976 89999999888899999999999999999999999999999999999995  25677999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ-R-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      |++....... .....||+.|+|||++.+ . .+.++||||||+++|+|++|..||....      .+........    
T Consensus       195 g~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----  263 (320)
T 3a99_A          195 GSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----  263 (320)
T ss_dssp             TTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----
T ss_pred             cccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----
Confidence            9998765432 344579999999998763 3 3678999999999999999999996532      1222222222    


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ..+++++.++|.+||+.||++|||++++++||||++...
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            357899999999999999999999999999999987543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-47  Score=346.41  Aligned_cols=255  Identities=28%  Similarity=0.500  Sum_probs=209.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-----
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-----  143 (366)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|.+...    ......+.+|+.+++.+. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            567899999999999999999999999999999998542    245677889999999997 9999999998765     


Q ss_pred             --------CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCE
Q 017768          144 --------KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       144 --------~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                              .+..++||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+|+||||+|||+   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    457899999999999999998654 47889999999999999999999999999999999999   567789


Q ss_pred             EEeecCCcccccCC---------------CceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 017768          215 KATDFGLSVFIETG---------------KVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAE-  276 (366)
Q Consensus       215 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~-  276 (366)
                      ||+|||++......               .......||+.|+|||++.+  .++.++||||||+++|+|++   ||... 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               12234578999999999763  58999999999999999998   55432 


Q ss_pred             ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          277 TEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ........+.......+.......++.+.++|.+||+.||++|||+.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            3344555555555555544445678899999999999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-47  Score=356.35  Aligned_cols=264  Identities=27%  Similarity=0.384  Sum_probs=207.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc--------cccHHHHHHHHHHHHHhcCCCceeEec
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--------DKDMEDVRREILILQHLTGQPNIVEFE  138 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~i~~~~  138 (366)
                      ..+.++|++.+.||+|+||.||+|.+. +|..||||++.......        ....+.+.+|+.++++++ ||||++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   95 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR   95 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence            346778999999999999999999986 49999999986433211        122478899999999997 99999999


Q ss_pred             eEEee-----CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          139 GAYED-----KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       139 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      +++..     ....++||||++ ++|.+.+.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~  171 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNN  171 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTC
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCC
Confidence            99843     346899999997 58888877543 59999999999999999999999999999999999999   5677


Q ss_pred             CEEEeecCCcccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          213 PIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      .+||+|||++.............||+.|+|||++.  ..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  251 (362)
T 3pg1_A          172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG  251 (362)
T ss_dssp             CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            89999999998765555555668999999999875  4589999999999999999999999998877666655532110


Q ss_pred             ------------------------CCCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          291 ------------------------DLQSS----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       291 ------------------------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                              .....    ..+.+++.+.+||.+||+.||++|||+.++|+||||++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                                    00110    12356889999999999999999999999999999987543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-47  Score=350.46  Aligned_cols=262  Identities=23%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ...++|++.+.||+|+||.||+|.+..++.   .||+|++..... .....+.+.+|+.++++++ ||||+++++++...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   97 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRS   97 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence            345679999999999999999999877665   899999865432 3445778999999999996 99999999999877


Q ss_pred             CeE------EEEEeccCCCchHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          145 QNL------HLVMELCSGGELFDRIIAKG------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       145 ~~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      +..      +++|||+++++|.+++....      .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence            655      99999999999999997643      58999999999999999999999999999999999999   5677


Q ss_pred             CEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 017768          213 PIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE  287 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~  287 (366)
                      .+||+|||++........   .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            899999999987644332   22335677899999876 458999999999999999999 9999998888887777776


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCC-------HHHHhcCCCcccCCCC
Q 017768          288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRIT-------AAEALEHPWLKEDGAT  337 (366)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt-------~~~~l~hp~f~~~~~~  337 (366)
                      +.....   .+.+++++.++|.+||+.||++|||       ++++++|||+....+.
T Consensus       255 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          255 GNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            553322   2367899999999999999999999       8889999999886654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=352.97  Aligned_cols=260  Identities=30%  Similarity=0.460  Sum_probs=213.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+.
T Consensus        20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred             cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccc
Confidence            346678999999999999999999999999999999986532 22344667889999999997 9999999999987654


Q ss_pred             ------EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          147 ------LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       147 ------~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                            .+++|||++ ++|.+++.  ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg  171 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFG  171 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecc
Confidence                  499999997 58877764  358999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC---------
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN---------  289 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~---------  289 (366)
                      ++......  .....+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+....         
T Consensus       172 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          172 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             cccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99865432  334578999999998754  58899999999999999999999999887666555543210         


Q ss_pred             ------------------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          290 ------------------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       290 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                        .......++.+++++.++|.+||+.||++|||+.++|+||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                              00111223467899999999999999999999999999999986543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.2e-48  Score=358.27  Aligned_cols=256  Identities=26%  Similarity=0.338  Sum_probs=211.0

Q ss_pred             CccccccceeeeceecccCceEEEEEE-----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEece
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG  139 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~  139 (366)
                      .+....++|++.+.||+|+||.||+|.     ...+++.||||++....  .......+.+|+.++.++.+||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            344567889999999999999999998     45567899999996532  23445679999999999977999999999


Q ss_pred             EEeeCC-eEEEEEeccCCCchHHHHHHhCC--------------------------------------------------
Q 017768          140 AYEDKQ-NLHLVMELCSGGELFDRIIAKGI--------------------------------------------------  168 (366)
Q Consensus       140 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------  168 (366)
                      ++...+ ..++||||+++++|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            988755 48999999999999999976532                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC---
Q 017768          169 ----------------YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK---  229 (366)
Q Consensus       169 ----------------l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---  229 (366)
                                      +++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......   
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccch
Confidence                            8999999999999999999999999999999999999   566779999999998654332   


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF-EAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+.. ..+..+... ..  ...+++++.+
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~  327 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RA--PDYTTPEMYQ  327 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CC--CTTCCHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CC--CCCCCHHHHH
Confidence            223456788999999875 568999999999999999998 99999877644433 333333222 11  2357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 017768          307 LIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +|.+||+.||++|||+.++++|
T Consensus       328 li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHH
Confidence            9999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-47  Score=346.36  Aligned_cols=265  Identities=26%  Similarity=0.454  Sum_probs=212.3

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-CCceeEeceEEeeC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-QPNIVEFEGAYEDK  144 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~  144 (366)
                      .....++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++++.+ |+||+++++++..+
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3445667999999999999999999986 589999999865432 23456788999999999985 79999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +..+++|| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++..
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ  175 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccccc
Confidence            99999999 55789999999888899999999999999999999999999999999999994    36799999999987


Q ss_pred             ccCCCc---eecccCCCCCCccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcC
Q 017768          225 IETGKV---YKEIVGSAYYVAPEVLHQ------------RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEG  288 (366)
Q Consensus       225 ~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~  288 (366)
                      ......   .....||+.|+|||++..            .++.++||||||+++|+|++|..||..... ......+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            643321   234578999999998753            578899999999999999999999976543 2333444443


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      .......  ...++++.++|.+||+.||++|||+.++|+||||+....+..
T Consensus       256 ~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          256 NHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             TSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             ccccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence            3322222  245789999999999999999999999999999987655443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-47  Score=361.78  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=206.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-------CCceeEece
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-------QPNIVEFEG  139 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-------h~~i~~~~~  139 (366)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||+|++...    ....+.+.+|+.+++.+.+       |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            34567899999999999999999999999999999998643    2446678899999999862       788999999


Q ss_pred             EEe----eCCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecC---
Q 017768          140 AYE----DKQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKE---  209 (366)
Q Consensus       140 ~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~---  209 (366)
                      ++.    .....++||||+ +++|.+.+...  ..+++.+++.++.||+.||.|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            987    556899999999 55777777665  4599999999999999999999998 999999999999995321   


Q ss_pred             -------------------------------------------CCCCEEEeecCCcccccCCCceecccCCCCCCccccc
Q 017768          210 -------------------------------------------EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL  246 (366)
Q Consensus       210 -------------------------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  246 (366)
                                                                 ....+||+|||++......  .....||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence                                                       1137999999999876433  3445799999999987


Q ss_pred             cc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHc--C----------CCCC-----------CC--
Q 017768          247 HQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE------KGIFEAILE--G----------NLDL-----------QS--  294 (366)
Q Consensus       247 ~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~------~~~~~~~~~--~----------~~~~-----------~~--  294 (366)
                      .+ .++.++|||||||++|+|++|..||.....      ......+..  +          ....           ..  
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            64 589999999999999999999999975442      222222211  0          0000           00  


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          295 -------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       295 -------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                   ......++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                         000123467889999999999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-47  Score=352.01  Aligned_cols=264  Identities=27%  Similarity=0.375  Sum_probs=213.7

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCC-cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC------ceeEe
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATG-RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP------NIVEF  137 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~------~i~~~  137 (366)
                      ....+.++|++.+.||+|+||.||+|.+..++ ..||+|++...    ......+.+|+.+++.+. |+      +++.+
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~   87 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCVLM   87 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence            34456788999999999999999999998777 68999998642    244567888999999987 33      38999


Q ss_pred             ceEEeeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-------
Q 017768          138 EGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-------  208 (366)
Q Consensus       138 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-------  208 (366)
                      ++++...+..++||||+ +++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||+...       
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            99999999999999999 567777777654  59999999999999999999999999999999999999532       


Q ss_pred             ---------CCCCCEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 017768          209 ---------EEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE  278 (366)
Q Consensus       209 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~  278 (366)
                               +.++.+||+|||++......  .....||+.|+|||++. ..++.++||||||+++|+|++|..||.....
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     24678999999999865432  34457999999999875 4689999999999999999999999988877


Q ss_pred             HHHHHHHHcCCCCCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCcCC
Q 017768          279 KGIFEAILEGNLDLQS----------------------------------------SPWPSISGQAKDLIRKMLTKDPKK  318 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~  318 (366)
                      .+....+.......+.                                        ......+.++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            6655444321111000                                        000112457889999999999999


Q ss_pred             CCCHHHHhcCCCcccCCC
Q 017768          319 RITAAEALEHPWLKEDGA  336 (366)
Q Consensus       319 Rpt~~~~l~hp~f~~~~~  336 (366)
                      |||+.|+|+||||++...
T Consensus       325 Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCH
T ss_pred             CcCHHHHhcChhhcCCCh
Confidence            999999999999997643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-48  Score=351.13  Aligned_cols=260  Identities=28%  Similarity=0.503  Sum_probs=204.3

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc---ccHHHHHHHHHHHHHhc---CCCceeEece
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---KDMEDVRREILILQHLT---GQPNIVEFEG  139 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~---~h~~i~~~~~  139 (366)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.++.++.   +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34567789999999999999999999998999999999865432211   12334567999999984   4999999999


Q ss_pred             EEeeCCeEEEEEec-cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          140 AYEDKQNLHLVMEL-CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       140 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      ++...+..+++||+ +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++  ..++.+||+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d  183 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID  183 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence            99999999999999 78899999999888899999999999999999999999999999999999995  2567799999


Q ss_pred             cCCcccccCCCceecccCCCCCCccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          219 FGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       219 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      ||++....... .....||..|+|||++.+ .+ +.++||||||+++|+|++|..||....      .+........   
T Consensus       184 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~---  253 (312)
T 2iwi_A          184 FGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP---  253 (312)
T ss_dssp             CSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC---
T ss_pred             cchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc---
Confidence            99998765433 345678999999998754 33 458999999999999999999996532      1222222222   


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                       ..++..+.++|.+||+.||++|||+.++++||||+......
T Consensus       254 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             -ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence             35789999999999999999999999999999999865543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-46  Score=335.70  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=214.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++....    .....+.+|+.++++++ ||||+++++++..++..+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceE
Confidence            3567999999999999999999876 57789999986543    34567899999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||+++++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecch
Confidence            9999999999999998764 49999999999999999999999999999999999999   5677899999999987654


Q ss_pred             CCce--ecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GKVY--KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....  ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+......   ..+++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            4322  22345678999998764 68999999999999999999 99999988888887777766543333   246899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.++|.+||+.||++|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=352.67  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=217.9

Q ss_pred             cccccceeeeceecccCceEEEEEEEccC-------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEece
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKAT-------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEG  139 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~  139 (366)
                      ....++|.+.+.||+|+||.||+|.+...       +..||+|++....  .......+.+|+.+++.+.+||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            34567899999999999999999997533       3579999986542  34456788999999999966999999999


Q ss_pred             EEeeCCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcE
Q 017768          140 AYEDKQNLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF  203 (366)
Q Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  203 (366)
                      ++..++..++||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             EeeecCCCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017768          204 LLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETE  278 (366)
Q Consensus       204 ll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~  278 (366)
                      |+   +.++.+||+|||++.......   ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus       223 ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          223 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99   567789999999998664432   223345788999999875 458999999999999999999 9999999888


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+....+..+......   ..+++++.++|.+||+.||++|||+.+++++
T Consensus       300 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8888777766433222   3578999999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=345.47  Aligned_cols=265  Identities=28%  Similarity=0.410  Sum_probs=198.2

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHH-HHHHHhcCCCceeEeceEE
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREI-LILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~h~~i~~~~~~~  141 (366)
                      +..+....++|++.+.||+|+||.||+|.+..+|+.||||++.....  .........|. .+++.+ +||||+++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~   93 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSH-DCPYIVQCFGTF   93 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEE
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhc-CCCceeeEEEEE
Confidence            34445556789999999999999999999999999999999875432  22233344444 445555 599999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      ...+..++||||+ ++.+..+... ...+++..++.++.||+.||.|||+. ||+|+||||+|||+   +.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~df  169 (318)
T 2dyl_A           94 ITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDF  169 (318)
T ss_dssp             ECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCC
T ss_pred             ecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEEC
Confidence            9999999999999 5556555544 45699999999999999999999995 99999999999999   56778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDL  292 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~  292 (366)
                      |++.............||+.|+|||++.      ..++.++||||||+++|+|++|..||... ........+.......
T Consensus       170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL  249 (318)
T ss_dssp             TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred             CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence            9998765555455567999999999873      35788999999999999999999999874 4445555555544322


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      . .....+++++.++|.+||+.||++|||+.++++||||++..
T Consensus       250 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          250 L-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             C-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            2 22335789999999999999999999999999999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=342.18  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=206.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      |.....||+|+||.||+|.+..++..||+|.+....   ......+.+|+.+++.+. ||||+++++++...+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            333448999999999999999999999999986542   345677899999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          153 LCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |+++++|.+++....   .+++..++.++.||+.||.|||++||+|+||||+||+++  ..++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCC
Confidence            999999999998753   467899999999999999999999999999999999995  236789999999998764322


Q ss_pred             -ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCCCHHH
Q 017768          230 -VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       230 -~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                       ......||+.|+|||++.+   .++.++||||||+++|+|++|..||........ ........  ........+++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccCCHHH
Confidence             2334578999999998753   378899999999999999999999976543322 11111111  1112223678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      .++|.+||+.||++|||+.++|+||||+....
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            99999999999999999999999999987654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.7e-47  Score=344.15  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=206.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++..++..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence            356999999999999999999999999999999987554333344578899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      +|||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+|||+   +.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence            99999999999999988889999999999999999999999999999999999999   566789999999987664432


Q ss_pred             --ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          230 --VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                        ......||+.|+|||++. ..++.++||||||+++|+|++|..||........... ............+.+++++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-HHSCCCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-hccCCCCccccCCCCCHHHHH
Confidence              223457899999999876 4588999999999999999999999987765544333 333333333344578999999


Q ss_pred             HHHHhcccCcCCCC-CHHHHhc
Q 017768          307 LIRKMLTKDPKKRI-TAAEALE  327 (366)
Q Consensus       307 li~~~l~~dp~~Rp-t~~~~l~  327 (366)
                      +|.+||+.||++|| +++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 8888876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-46  Score=336.63  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=214.0

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      -.++|++.+.||+|+||.||+|.+. +++.||+|++....    ...+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceE
Confidence            3567999999999999999999987 57889999986543    34567899999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccc
Confidence            999999999999999764 458999999999999999999999999999999999999   5567799999999986543


Q ss_pred             CC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ..  ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+......   ..+++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTH  235 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHH
Confidence            22  122335677899999876 568999999999999999999 99999998888888887776433322   346899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-46  Score=338.02  Aligned_cols=249  Identities=20%  Similarity=0.333  Sum_probs=212.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++....    .....+.+|+.+++.+. |+||+++++++...+..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCe
Confidence            34567999999999999999999887 57889999997543    34567899999999998 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBC
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccc
Confidence            999999999999999976 4569999999999999999999999999999999999999   567789999999998654


Q ss_pred             CCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....  .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+......   ..+++
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  248 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE  248 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCH
Confidence            3221  12235677899999876 568999999999999999998 99999998888888877776433332   24689


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+.++|.+||+.||++|||+.++++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-47  Score=350.92  Aligned_cols=253  Identities=19%  Similarity=0.190  Sum_probs=206.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+.+|+.+++.+.+|+||+++++++..++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            35677999999999999999999999999999999986432     2335789999999996699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCC--CCCEEEeecCCccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEE--DSPIKATDFGLSVF  224 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--~~~vkl~Dfg~a~~  224 (366)
                      ++||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++..+.  ...+||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 89999999874 57999999999999999999999999999999999999953221  12399999999987


Q ss_pred             ccCCCc--------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCC
Q 017768          225 IETGKV--------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDL  292 (366)
Q Consensus       225 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~  292 (366)
                      ......        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...   .+....+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            643322        245679999999998764 589999999999999999999999987433   33334433322222


Q ss_pred             CCC-CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          293 QSS-PWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       293 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ... ....++ ++.++|..||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111 111234 9999999999999999999999877

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=341.63  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+...   .......+.+|+.+++.++ ||||+++++++.+++..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence            46799999999999999999999999999999988542   2456678999999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||+++++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence            9999999999999987 4569999999999999999999999999999999999999   66778999999999875432


Q ss_pred             Cce---------------ecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHc
Q 017768          229 KVY---------------KEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKG-----IFEAILE  287 (366)
Q Consensus       229 ~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~-----~~~~~~~  287 (366)
                      ...               ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               14579999999998764 58999999999999999999999986432110     0111111


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ..      ..+.+++.+.++|.+||+.||++|||+.++++  +++.
T Consensus       242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence            11      11356788999999999999999999999987  4544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=348.63  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=215.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++ ||||+++++++.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCA  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc
Confidence            35678999999999999999999987     345899999986542  2344677899999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEecc
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAK------------------------GIYSEREAANICRQIVNVVHACHFMGVIHRDL  198 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  198 (366)
                      .++..++||||+++++|.+++...                        ..+++.+++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999874                        46899999999999999999999999999999


Q ss_pred             CCCcEEeeecCCCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCC
Q 017768          199 KPENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPF  273 (366)
Q Consensus       199 kp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf  273 (366)
                      ||+|||+   +.++.+||+|||++.......   ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||
T Consensus       201 kp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          201 ATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999   566789999999997654322   223346788999999875 568999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          274 WAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+....+....+..+......   ..+++++.++|.+||+.||++|||+.+++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            999888888887776543322   3578999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.6e-47  Score=354.69  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=214.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ....+.|.+.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+. ||||+++++++...+.
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence            344567999999999999999999999899999999986432  2234456889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence            999999999999999998754 59999999999999999999999999999999999999   56778999999999865


Q ss_pred             cCCCcee---cccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGKVYK---EIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .......   ...++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+..+......   ..+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  340 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP---ELC  340 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCC
Confidence            4332111   123467799999876 568999999999999999998 99999998888777777665432222   357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++++.++|.+||+.||++|||+.++++
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            899999999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-46  Score=340.72  Aligned_cols=254  Identities=26%  Similarity=0.483  Sum_probs=201.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ |+||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence            4457999999999999999999999899999999997654444456778899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      +||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence            99999999999998875    3458999999999999999999999999999999999999   5677899999999876


Q ss_pred             ccCCC-ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCC
Q 017768          225 IETGK-VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       225 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ..... ......|++.|+|||++. ..++.++||||||+++|+|++|..||.+..  .......+......  ......+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCccccc
Confidence            54332 223457899999999876 458899999999999999999999997653  23344444444332  2223467


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++++.++|.+||+.||++|||+.+++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-46  Score=343.65  Aligned_cols=267  Identities=21%  Similarity=0.308  Sum_probs=223.4

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEec
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFE  138 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~  138 (366)
                      ..+....++|++.+.||+|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.+++.+. |+||++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~   94 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLL   94 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeE
Confidence            334556778999999999999999999876     357899999986432  2344567889999999997 99999999


Q ss_pred             eEEeeCCeEEEEEeccCCCchHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec
Q 017768          139 GAYEDKQNLHLVMELCSGGELFDRIIAK----------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK  208 (366)
Q Consensus       139 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~  208 (366)
                      +++...+..++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||+   
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---
Confidence            9999999999999999999999998763          346899999999999999999999999999999999999   


Q ss_pred             CCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 017768          209 EEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFE  283 (366)
Q Consensus       209 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~  283 (366)
                      +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||..........
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            5677899999999986543322   12335688899999876 468999999999999999999 899999988888877


Q ss_pred             HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC------CCcccCCCCCC
Q 017768          284 AILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH------PWLKEDGATSD  339 (366)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h------p~f~~~~~~~~  339 (366)
                      .+..+......   ..+++.+.++|.+||+.||++|||+.+++++      ++|++......
T Consensus       252 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~  310 (322)
T 1p4o_A          252 FVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS  310 (322)
T ss_dssp             HHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred             HHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccc
Confidence            77766543222   3578999999999999999999999999997      67766554443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.3e-47  Score=349.12  Aligned_cols=264  Identities=27%  Similarity=0.359  Sum_probs=192.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+..|+..+.+..+||||+++++++...+..+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            3467999999999999999999999999999999996542  23344556677775555445999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          149 LVMELCSGGELFDRIIA-----KGIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      +||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+|||+   +.++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCc
Confidence            99999975 88777764     45689999999999999999999999 99999999999999   45677999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCC-CCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH-----QRYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILEGN-LDLQSS  295 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~  295 (366)
                      .............||+.|+|||++.     ..++.++||||||+++|+|++|..||...... +....+..+. ......
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            8765554444557999999999872     35889999999999999999999999764321 1111111111 112222


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCC
Q 017768          296 PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATS  338 (366)
Q Consensus       296 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~  338 (366)
                      ....+++.+.++|.+||+.||++|||+.++++||||.......
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA  296 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence            2346899999999999999999999999999999998655443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-46  Score=333.99  Aligned_cols=252  Identities=28%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .++|++.+.||+|+||.||+|.+.  |+.||+|++....... ....+.+.+|+.+++.++ ||||+++++++..++..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence            356999999999999999999975  8999999986543221 234577899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC---CEEeccCCCcEEeeecC-----CCCCEEEeecC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG---VIHRDLKPENFLLASKE-----EDSPIKATDFG  220 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~-----~~~~vkl~Dfg  220 (366)
                      +||||+++++|.+++. ...+++.+++.++.|++.||.|||++|   |+||||||+|||++...     .++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999988875 456999999999999999999999999   99999999999996422     26779999999


Q ss_pred             CcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ++........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+.........  ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence            9986654332 3457899999999876 45899999999999999999999999988877777666665544332  236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+.++|.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            78999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-46  Score=340.57  Aligned_cols=255  Identities=22%  Similarity=0.268  Sum_probs=210.3

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+.+|+.+++.+.+|++++.+++++..+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            35667999999999999999999999999999999985432     3345788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLSVF  224 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a~~  224 (366)
                      ++||||+ +++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||++..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 899999998754 599999999999999999999999999999999999995432  233499999999987


Q ss_pred             ccCCCc--------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHcCCCCC
Q 017768          225 IETGKV--------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFEAILEGNLDL  292 (366)
Q Consensus       225 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~  292 (366)
                      ......        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...   ........+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            654321        234579999999998764 5899999999999999999999999874   3333333333222111


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          293 Q-SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       293 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      . ....+.+++++.++|.+||+.||++|||+.++++.
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1 11123578999999999999999999999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=346.99  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=209.6

Q ss_pred             ccccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      ...++|++.+.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3457899999999999999999997     3356789999986432  23456789999999999966999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccC
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKG-----------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLK  199 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  199 (366)
                      ..+..++||||+++++|.+++....                       .+++.+++.++.||+.||.|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997643                       27899999999999999999999999999999


Q ss_pred             CCcEEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 017768          200 PENFLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFW  274 (366)
Q Consensus       200 p~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~  274 (366)
                      |+|||+   +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus       200 p~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          200 ARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             GGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            999999   4567899999999986644332   22345788999999875 568999999999999999998 999998


Q ss_pred             CCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          275 AETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +...................  ...+++++.++|.+||+.||++|||+.+++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            87655544444443332222  23578999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.6e-46  Score=341.58  Aligned_cols=253  Identities=24%  Similarity=0.320  Sum_probs=215.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ....++|.+.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.++ ||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   95 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGAC   95 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEE
Confidence            334678999999999999999999873     456899999986432  2345678899999999997 99999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCEEec
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKGI------------------------YSEREAANICRQIVNVVHACHFMGVIHRD  197 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  197 (366)
                      ...+..++||||+++++|.+++.....                        +++.+++.++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999987543                        89999999999999999999999999999


Q ss_pred             cCCCcEEeeecCCCCCEEEeecCCcccccCCCce---ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCC
Q 017768          198 LKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPP  272 (366)
Q Consensus       198 lkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~p  272 (366)
                      |||+|||+   +.++.+||+|||++.........   ....+|+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus       176 ikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          176 LAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999   45677999999999866443322   2335678899999875 458999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          273 FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       273 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      |.+.........+..+.....   ...+++++.++|.+||+.||++|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            998888777777766543222   23678999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.3e-47  Score=352.87  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC----------CCceeEece
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG----------QPNIVEFEG  139 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------h~~i~~~~~  139 (366)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++++.+          |+||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            45799999999999999999999999999999998643    2345678889999998863          789999999


Q ss_pred             EEeeCC----eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeccCCCcEEeeecC---
Q 017768          140 AYEDKQ----NLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFM-GVIHRDLKPENFLLASKE---  209 (366)
Q Consensus       140 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~---  209 (366)
                      ++...+    ..+++|||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++..+   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            988654    789999999 88999999874  3599999999999999999999998 999999999999996432   


Q ss_pred             CCCCEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHH
Q 017768          210 EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE------KGIF  282 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~------~~~~  282 (366)
                      ..+.+||+|||++......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....      ...+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            3346999999999876432  334578999999998764 589999999999999999999999976542      2222


Q ss_pred             HHHHcCCCCCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHH
Q 017768          283 EAILEGNLDLQ--------------------------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAE  324 (366)
Q Consensus       283 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  324 (366)
                      ..+.......+                                      ......+++++.+||.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            22211000000                                      0001134578899999999999999999999


Q ss_pred             HhcCCCcccCCCC
Q 017768          325 ALEHPWLKEDGAT  337 (366)
Q Consensus       325 ~l~hp~f~~~~~~  337 (366)
                      +|+||||++....
T Consensus       331 ll~hp~f~~~~~~  343 (373)
T 1q8y_A          331 LVNHPWLKDTLGM  343 (373)
T ss_dssp             HHTCGGGTTCTTC
T ss_pred             HhhChhhhcccCc
Confidence            9999999986443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.7e-46  Score=335.77  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccc----cHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK----DMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.........    ....+.+|+.++++++ ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            345799999999999999999999999999999998654332221    1267899999999997 99999999998776


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCC--CCCEEEeec
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEE--DSPIKATDF  219 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~--~~~vkl~Df  219 (366)
                      .  ++||||+++++|.+.+.... .+++..++.++.|++.||.|||++|  |+||||||+|||++..+.  ...+||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6  69999999999988886543 6999999999999999999999999  999999999999953221  123999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHcCCCCCCC
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH---QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI--FEAILEGNLDLQS  294 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~  294 (366)
                      |++.....  ......||+.|+|||++.   ..++.++||||||+++|+|++|..||........  ...+.......  
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  249 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP--  249 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC--
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC--
Confidence            99975433  344567999999999983   3478899999999999999999999976654333  33333333222  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .....+++++.++|.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            223467999999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.2e-46  Score=335.07  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=217.0

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +....++|++.+.||+|+||.||+|.+..++..||+|.+...    ....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP   82 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            344667899999999999999999999999999999998643    345678899999999998 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccce
Confidence            9999999999999999998743  48999999999999999999999999999999999999   566779999999998


Q ss_pred             cccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          224 FIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       224 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .......  .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.......   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  236 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEG  236 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---CCCC
Confidence            7654332  22345678899999876 568999999999999999999 999998888777777666553322   2236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++.+.++|.+||+.||++|||+.++++
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            7899999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-46  Score=345.16  Aligned_cols=259  Identities=22%  Similarity=0.281  Sum_probs=215.4

Q ss_pred             cccceeeeceecccCceEEEEEE-----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||.||+|.     ...++..||+|.+....  .......+.+|+.+++++. ||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence            45679999999999999999998     55678899999985332  2345667889999999996 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEE
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG-------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      .+..++||||+++++|.+++....       .+++.+++.++.||+.||.|||++||+||||||+|||++..+.+..++|
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998763       3899999999999999999999999999999999999975556677999


Q ss_pred             eecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCC
Q 017768          217 TDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLD  291 (366)
Q Consensus       217 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  291 (366)
                      +|||++.......   ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999997653322   123346788999999875 568999999999999999998 99999988888877777766433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          292 LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       292 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ..   ...++..+.++|.+||+.||++|||+.+++++.|+-.
T Consensus       265 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          265 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            22   2357899999999999999999999999999977643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-46  Score=336.62  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      +....++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence            344567899999999999999999998654   4569999875432  2345677899999999997 999999999984


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                       ++..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccc
Confidence             456889999999999999998764 589999999999999999999999999999999999995   456799999999


Q ss_pred             cccccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          222 SVFIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       222 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      +........  .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+....   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~  239 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MP  239 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CC
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CC
Confidence            987654332  22335678899999876 568899999999999999997 999999888887777777654322   22


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +.+++.+.++|.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4678999999999999999999999999873

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-46  Score=340.95  Aligned_cols=255  Identities=24%  Similarity=0.302  Sum_probs=212.6

Q ss_pred             cccccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34457899999999999999999985     4467899999986542  2344678899999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcE
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKG------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF  203 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  203 (366)
                      ..++..++||||+++++|.+++....                  .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998754                  389999999999999999999999999999999999


Q ss_pred             EeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 017768          204 LLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETE  278 (366)
Q Consensus       204 ll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~  278 (366)
                      |+   +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.....
T Consensus       177 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99   4567799999999987654432   22345678899999875 568999999999999999999 9999987765


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ................  ...+++.+.++|.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5444444333322221  23578999999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.9e-46  Score=341.40  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=214.1

Q ss_pred             cccceeeeceecccCceEEEEEEEc-------cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-------ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++.+.+||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            4567999999999999999999975       357789999986432  2345677899999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      ...+..++||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999997653                38999999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+
T Consensus       191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence               5677899999999987654332   22335678899999875 458899999999999999999 999999888888


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....+..+.....   ...++.++.++|.+||+.||++|||+.+++++
T Consensus       268 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7777766543222   23578999999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.3e-46  Score=337.15  Aligned_cols=248  Identities=34%  Similarity=0.625  Sum_probs=200.0

Q ss_pred             ccccceeee-ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee---
Q 017768           68 DITTIYDLD-KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED---  143 (366)
Q Consensus        68 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---  143 (366)
                      .+.++|.+. +.||+|+||.||+|.+..+++.||+|++..        .....+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            355667776 789999999999999999999999999842        24577899999777779999999999887   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                       ....++||||+++++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             678899999999999999998764  59999999999999999999999999999999999999754447889999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC----CCCCCCCC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG----NLDLQSSP  296 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~  296 (366)
                      ++.....                    ..++.++||||||+++|+|++|..||...............    ........
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9865321                    34678999999999999999999999766543322111111    11111111


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPID  343 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~  343 (366)
                      +..+++++.++|.+||+.||++|||+.|+|+||||++.......+..
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~  272 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH  272 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCS
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCc
Confidence            24679999999999999999999999999999999887766555543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.9e-46  Score=368.33  Aligned_cols=243  Identities=24%  Similarity=0.305  Sum_probs=204.8

Q ss_pred             eceecccCceEEEEEEE--ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEec
Q 017768           76 DKELGRGQFGVTYLCTK--KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      .+.||+|+||.||+|.+  +.+++.||||++.... ......+.+.+|+.++++++ ||||+++++++.. +..++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEc
Confidence            34799999999999954  4567899999986543 23345678999999999997 9999999999865 558899999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc---
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV---  230 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---  230 (366)
                      +++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.......   
T Consensus       451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC------
T ss_pred             cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCccccc
Confidence            99999999999888899999999999999999999999999999999999995   556799999999987644321   


Q ss_pred             -eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          231 -YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       231 -~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                       .....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.+....+....+..+......   ..+++++.++
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~l  604 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREMYDL  604 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHH
Confidence             222346788999999864 68999999999999999998 99999999988888888776543222   3578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhc
Q 017768          308 IRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~  327 (366)
                      |..||+.||++|||+.++++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999976

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-46  Score=342.63  Aligned_cols=251  Identities=26%  Similarity=0.332  Sum_probs=210.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEE--EEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKY--ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .++|++.+.||+|+||.||+|.+..+|..+  |+|.+...  ........+.+|+.+++++.+||||+++++++...+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            367999999999999999999998888865  88888642  22345567899999999996699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC
Q 017768          148 HLVMELCSGGELFDRIIAKG----------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED  211 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~  211 (366)
                      ++||||+++++|.+++....                .+++.+++.++.||+.||.|||++||+||||||+|||+   +.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCC
Confidence            99999999999999997654                68999999999999999999999999999999999999   556


Q ss_pred             CCEEEeecCCcccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 017768          212 SPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGN  289 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~  289 (366)
                      +.+||+|||++.............+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+.
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            7799999999875433333334467889999998764 57899999999999999998 999999988887777766553


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          290 LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       290 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ...   ....+++.+.++|.+||+.||++|||+.+++++
T Consensus       259 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          259 RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            221   223678999999999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-46  Score=337.91  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=208.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||+|++....     ....+.+|+.+++.+.+++++..+..+...++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            346778999999999999999999999999999999986432     234688999999999966667777666678889


Q ss_pred             EEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+++|||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 8899999975 446999999999999999999999999999999999999964456778999999999876


Q ss_pred             cCCCc--------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCCC
Q 017768          226 ETGKV--------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDLQ  293 (366)
Q Consensus       226 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~  293 (366)
                      .....        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....   ......+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54332        234579999999998764 588999999999999999999999976322   222233222221111


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          294 -SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       294 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                       ......+++++.++|.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence             11123578999999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=354.10  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=211.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC--
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ--  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--  145 (366)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.++++++ ||||+++++++...+  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence            456789999999999999999999999999999999965432  344677889999999997 999999999998765  


Q ss_pred             eEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec-CCCCCEEEeecCC
Q 017768          146 NLHLVMELCSGGELFDRIIAKGI---YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK-EEDSPIKATDFGL  221 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~vkl~Dfg~  221 (366)
                      ..++||||+++++|.+++.....   +++.+++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999999876433   8999999999999999999999999999999999998432 3445699999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc---------ccCCCchhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHcC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH---------QRYGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFEAILEG  288 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~vl~~ll~g~~pf~~----~~~~~~~~~~~~~  288 (366)
                      +.............||+.|+|||++.         ..++.++||||||+++|+|++|..||..    ....+....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            98876655556678999999999874         3577899999999999999999999964    2334555555554


Q ss_pred             CCCCC---------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          289 NLDLQ---------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       289 ~~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .....                     ......++..+.++|.+||+.||++||++.+++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            33210                     00112245678899999999999999999998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.6e-46  Score=341.81  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEE----EEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .++|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .......+.+|+.++++++ ||||+++++++..+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            467999999999999999999988777754    777664322  2345678999999999997 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                       .++++||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence             77899999999999999874 5699999999999999999999999999999999999994   566799999999987


Q ss_pred             ccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          225 IETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       225 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......   .....+|..|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.....   .+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            644332   22335678999999876 568999999999999999999 9999998887777666666543222   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.++.+++.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            78999999999999999999999999976

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-45  Score=353.58  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=213.4

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+....+.|++.+.||+|+||.||+|.+. ++..||||.+....    ...+.+.+|+.+++.++ ||||+++++++. .
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K  254 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence            34455678999999999999999999986 47889999986532    35778999999999997 999999999986 5


Q ss_pred             CeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          145 QNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      +..++||||+++++|.+++...  ..+++.+++.++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence            6789999999999999999743  368999999999999999999999999999999999999   56788999999999


Q ss_pred             ccccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          223 VFIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       223 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      +.......  .....++..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+..+.....   ..
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~  408 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PE  408 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence            87643221  12234677899999886 568999999999999999999 9999999888888887776543222   23


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+++++.++|.+||+.||++|||+.++++
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            57899999999999999999999999976

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-46  Score=337.31  Aligned_cols=257  Identities=18%  Similarity=0.226  Sum_probs=206.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCC-------cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATG-------RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      .++|++.+.||+|+||.||+|.+..++       ..||+|.+....   ....+.+.+|+.+++.++ ||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence            567999999999999999999988777       479999986432   355678999999999998 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC-----CCEEE
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED-----SPIKA  216 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~-----~~vkl  216 (366)
                      .++..++||||+++++|.+++..... +++.+++.++.||+.||.|||++||+||||||+|||++..+..     +.+||
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999999987654 9999999999999999999999999999999999999643221     12999


Q ss_pred             eecCCcccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHcCCCCCC
Q 017768          217 TDFGLSVFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQ  293 (366)
Q Consensus       217 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~  293 (366)
                      +|||++......   ....+|..|+|||++.  ..++.++||||||+++|+|++|..| |......... .........+
T Consensus       163 ~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~  238 (289)
T 4fvq_A          163 SDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQLP  238 (289)
T ss_dssp             CCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCC
T ss_pred             ccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCCC
Confidence            999998765332   2345788999999876  4589999999999999999995544 4444444433 3333333222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                      .    ..++++.++|.+||+.||++|||+.+++++  +++...+...
T Consensus       239 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~~~  279 (289)
T 4fvq_A          239 A----PKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLV  279 (289)
T ss_dssp             C----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-----
T ss_pred             C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCC
Confidence            2    357789999999999999999999999997  5554444443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-46  Score=349.40  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             ccceeeeceecccCceEEEEEEEc---cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKK---ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .++|++.+.||+|+||.||+|++.   .++..||||.+....  .......+.+|+.+++++. ||||+++++++...+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            457999999999999999999876   457789999986532  2345677999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence            999999999999999997654 59999999999999999999999999999999999999   66788999999999876


Q ss_pred             cCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .....    .....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   ...
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            44321    11223567899999876 568999999999999999998 9999999988888777766533222   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++..+.++|.+||+.||++||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7899999999999999999999999887

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.5e-46  Score=336.71  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             cccceeeeceecccCceEEEEEE----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-  143 (366)
                      ..++|++.+.||+|+||+||+|+    +..+++.||+|++...   .......+.+|+.++++++ ||||+++++++.. 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            45679999999999999999998    5667999999998643   2345677899999999997 9999999999854 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                       ....++||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCcc
Confidence             356899999999999999998754 499999999999999999999999999999999999995   456799999999


Q ss_pred             cccccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 017768          222 SVFIETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------G  280 (366)
Q Consensus       222 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----------------~  280 (366)
                      +........    .....++..|+|||++. ..++.++||||||+++|+|++|..||......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987644321    22345677899999876 56899999999999999999999998543211                1


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ....+..+..   ......+++++.++|.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCc---CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2222222221   1122367899999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.7e-46  Score=343.59  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=207.3

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcE----EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRK----YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+....  .......+.+|+.+++.+. ||||+++++++. ++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence            45699999999999999999999888876    6777664332  2233456778999999997 999999999886 45


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence            689999999999999999764 468999999999999999999999999999999999999   5677899999999987


Q ss_pred             ccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          225 IETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       225 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .....   ......+|..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.......   .
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---I  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT---T
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC---c
Confidence            64432   223456788999999876 568999999999999999999 999999888777777777654333222   4


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.++.++|.+||..||++|||+.+++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67789999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.9e-45  Score=351.20  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=208.5

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-eE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-NL  147 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~  147 (366)
                      ..+.|++.+.||+|+||.||+|.+.  |+.||||.+...     ...+.+.+|+.++++++ ||||+++++++...+ ..
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCce
Confidence            4567999999999999999999886  789999998643     24577899999999997 999999999987665 79


Q ss_pred             EEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          148 HLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ++||||+++++|.+++...+.  +++..++.++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++..
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccc
Confidence            999999999999999987654  7999999999999999999999999999999999999   56778999999999865


Q ss_pred             cCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....  ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   ...++++
T Consensus       340 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---p~~~~~~  414 (450)
T 1k9a_A          340 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPA  414 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCHH
T ss_pred             cccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHH
Confidence            3322  2235788999999875 568999999999999999998 9999998887777777776643222   2367899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.++|.+||+.||++|||+.++++
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-45  Score=352.73  Aligned_cols=256  Identities=30%  Similarity=0.470  Sum_probs=199.5

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+...      ..+.+.+|+.+++++.+||||+++++++..++..
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            355668888999999999998754 457999999988542      2456789999999886799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCC-------CHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec----------CC
Q 017768          148 HLVMELCSGGELFDRIIAKGIY-------SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK----------EE  210 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~----------~~  210 (366)
                      +||||||+ ++|.+++......       ++..++.++.||+.||.|||++||+||||||+|||++..          +.
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            99999996 5999999765432       233467899999999999999999999999999999643          24


Q ss_pred             CCCEEEeecCCcccccCCCc-----eecccCCCCCCcccccc--------ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 017768          211 DSPIKATDFGLSVFIETGKV-----YKEIVGSAYYVAPEVLH--------QRYGKEIDVWSAGVILYILLS-GVPPFWAE  276 (366)
Q Consensus       211 ~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~vl~~ll~-g~~pf~~~  276 (366)
                      +..+||+|||++........     .....||+.|+|||++.        ..++.++|||||||++|+|++ |..||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            45799999999987654321     23457999999999874        347899999999999999999 99999766


Q ss_pred             ChHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          277 TEKGIFEAILEGNLDLQSSP---WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ....  ..+..+........   ...+++++.++|.+||+.||++|||+.++++||||..
T Consensus       244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            5443  33444433332221   1134578999999999999999999999999999964

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2e-45  Score=332.45  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=209.1

Q ss_pred             ccceeeec-eecccCceEEEEEEE--ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDK-ELGRGQFGVTYLCTK--KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .++|++.+ .||+|+||.||+|.+  ..+++.||+|++.... ......+.+.+|+.+++.+. ||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence            45799888 999999999999954  5567899999986543 22344678999999999997 99999999998 5677


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceeec
Confidence            899999999999999999888899999999999999999999999999999999999995   45679999999998764


Q ss_pred             CCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          227 TGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       227 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....    ....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   ...+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence            43321    1234678899999876 458899999999999999999 9999999888887777766543222   2367


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+.++|.+||+.||++||++.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-45  Score=327.57  Aligned_cols=247  Identities=25%  Similarity=0.406  Sum_probs=212.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....    ...+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence            467999999999999999999986 67899999997543    23467899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|||+++++|.+++... ..+++..++.++.|++.||.+||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence            99999999999999875 458999999999999999999999999999999999999   55677999999999865432


Q ss_pred             C--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          229 K--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       229 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      .  ......++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+......   ..++..+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHHH
Confidence            1  112345677899999876 568899999999999999999 89999988888888777766433222   2568999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++.+||+.||++|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-45  Score=357.49  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=215.3

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...+.|++.+.||+|+||.||+|.++.++..||||.+....    ...+.+.+|+.++++++ ||||+++++++...+..
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcE
Confidence            34567999999999999999999999889999999986432    34678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          148 HLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      +|||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceec
Confidence            9999999999999999874  348999999999999999999999999999999999999   56678999999999876


Q ss_pred             cCCCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          226 ETGKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       226 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ......  ....++..|+|||++. +.++.++||||||++||+|++ |..||.+.+..+..+.+..+....   ....++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  445 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEGCP  445 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTTCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            443221  2234567899999876 568999999999999999999 999999888777777666543222   223678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+||.+||+.||++|||+.++++.
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            999999999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-45  Score=328.26  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=213.5

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      ...+....++|++.+.||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.+. ||||+++++++.
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   78 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT   78 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEc
Confidence            3445566788999999999999999999976 57789999986432    34678899999999997 999999999986


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          143 DKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       143 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      . +..++||||+++++|.+++....  .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        79 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg  154 (279)
T 1qpc_A           79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFG  154 (279)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred             C-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCc
Confidence            4 46899999999999999986543  68999999999999999999999999999999999999   567789999999


Q ss_pred             CcccccCCCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          221 LSVFIETGKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       221 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      ++.........  ....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---  231 (279)
T 1qpc_A          155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---  231 (279)
T ss_dssp             TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred             ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC---
Confidence            99876543321  2335678899999886 568899999999999999999 9999998888887777766533222   


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...+++++.++|.+||..||++|||+.++++
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2357899999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.6e-46  Score=335.21  Aligned_cols=255  Identities=21%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.+.+++++..+..++..++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            346678999999999999999999999999999999875432     223578899999999966677777777788889


Q ss_pred             EEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .+++|||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999999 8899999985 456999999999999999999999999999999999999965556778999999999876


Q ss_pred             cCCCc--------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCCCCC
Q 017768          226 ETGKV--------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEAILEGNLDLQ  293 (366)
Q Consensus       226 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~  293 (366)
                      .....        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....   .....+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            54322        234578999999998764 6889999999999999999999999764321   22222222211111


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          294 -SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       294 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                       ......+++++.++|.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             1111357899999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.9e-46  Score=347.86  Aligned_cols=250  Identities=15%  Similarity=0.208  Sum_probs=193.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccC-----CcEEEEEEeecccccccccHHHHHHHHHHHHHhcC-------------
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT-----GRKYACKSISRRKLVYDKDMEDVRREILILQHLTG-------------  130 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-------------  130 (366)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||+|++....       ..+.+|+.+++.+.+             
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~~~~~~~~~~~~e~~~~~~l  105 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFYQRAAKPEQIQKWIRTRKL  105 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-------HHHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-------hhHHHHHHHHHhhhhhHHHHHHHHHhhc
Confidence            455899999999999999999998764     5789999986432       233444444444332             


Q ss_pred             -CCceeEeceEEeeC----CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEE
Q 017768          131 -QPNIVEFEGAYEDK----QNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL  204 (366)
Q Consensus       131 -h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  204 (366)
                       |+||+++++++...    ...+|||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus       106 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nil  184 (364)
T 3op5_A          106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL  184 (364)
T ss_dssp             SCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEE
Confidence             99999999998764    4589999999 99999999876 56999999999999999999999999999999999999


Q ss_pred             eeecCCCCCEEEeecCCcccccCCCc--------eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017768          205 LASKEEDSPIKATDFGLSVFIETGKV--------YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWA  275 (366)
Q Consensus       205 l~~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~  275 (366)
                      ++. +.++.+||+|||+++.......        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus       185 l~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          185 LNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             Eec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            953 2567899999999976543221        123459999999998864 589999999999999999999999986


Q ss_pred             CChHHH-HHHHHcC---CCC-CC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          276 ETEKGI-FEAILEG---NLD-LQ--SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       276 ~~~~~~-~~~~~~~---~~~-~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...... .......   ... ..  ......+++++.+++..||+.||++||++.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             GTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            432221 1111100   000 00  0001357899999999999999999999999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.4e-46  Score=338.88  Aligned_cols=254  Identities=26%  Similarity=0.318  Sum_probs=209.6

Q ss_pred             cccccceeeeceecccCceEEEEEEE-----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTK-----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.+++++.+||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            34567899999999999999999985     3467899999986542  2344567899999999997799999999998


Q ss_pred             eeCC-eEEEEEeccCCCchHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEE
Q 017768          142 EDKQ-NLHLVMELCSGGELFDRIIAKGI----------------YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFL  204 (366)
Q Consensus       142 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  204 (366)
                      ...+ ..+++|||+++++|.+++.....                +++.+++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7754 58999999999999999987543                889999999999999999999999999999999999


Q ss_pred             eeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 017768          205 LASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEK  279 (366)
Q Consensus       205 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~  279 (366)
                      +   +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......
T Consensus       181 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          181 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             E---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             E---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            9   5567799999999986543322   22346788999999875 468999999999999999998 99999876543


Q ss_pred             -HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          280 -GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       280 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                       .....+..+.....   ...+++.+.++|.+||+.||++|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             33344444332211   23478999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.1e-46  Score=333.36  Aligned_cols=249  Identities=27%  Similarity=0.456  Sum_probs=210.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----  143 (366)
                      .+..+|++.+.||+|+||.||+|.+..+|+.||+|.+....       +.+.+|+.+++.+. ||||+++++++..    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence            46678999999999999999999999899999999986432       34678999999997 9999999998864    


Q ss_pred             ------------CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC
Q 017768          144 ------------KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE  209 (366)
Q Consensus       144 ------------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~  209 (366)
                                  ....++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+|||++   
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---  156 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---  156 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---
Confidence                        44589999999999999999765  5699999999999999999999999999999999999995   


Q ss_pred             CCCCEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 017768          210 EDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~  288 (366)
                      .++.+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..|+...  ......+..+
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~  234 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG  234 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT
T ss_pred             CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc
Confidence            45679999999998776555555567999999999876 45899999999999999999999887432  2333333333


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      ..      ...++..+.++|.+||+.||++|||+.+++++.+.-...
T Consensus       235 ~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          235 II------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            22      134789999999999999999999999999997765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.2e-46  Score=340.76  Aligned_cols=248  Identities=25%  Similarity=0.313  Sum_probs=198.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC---
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ---  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---  145 (366)
                      -.++|++.+.||+|+||+||+|++.  ++.||||++...    .........|+.++++++ ||||+++++++....   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSS
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCC
Confidence            3467999999999999999999876  899999998643    234445667898899997 999999999998754   


Q ss_pred             -eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc----------CCEEeccCCCcEEeeecCCCCCE
Q 017768          146 -NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM----------GVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       146 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                       ..++||||+++++|.+++... .+++.+++.++.||+.||.|||+.          +|+||||||+|||+   +.++.+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~  170 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTA  170 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCE
T ss_pred             ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeE
Confidence             479999999999999999764 589999999999999999999999          99999999999999   567789


Q ss_pred             EEeecCCcccccCCCc---eecccCCCCCCccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCC--------
Q 017768          215 KATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLHQ------RYGKEIDVWSAGVILYILLSGVPPFWAET--------  277 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~vl~~ll~g~~pf~~~~--------  277 (366)
                      ||+|||++........   .....||+.|+|||++.+      .++.++||||||+++|+|++|..||.+..        
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999977644332   233578999999998764      45678999999999999999999996532        


Q ss_pred             --------hHHHHHHHHcCCCCCCCCC-C--CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          278 --------EKGIFEAILEGNLDLQSSP-W--PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       278 --------~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                              .......+........... +  ...++++.++|.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    1222222322222211111 0  112356999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-45  Score=328.86  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=207.9

Q ss_pred             cccccceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ....++|++.+.||+|+||.||+|.+...   +..||+|.+....  .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC
Confidence            33567899999999999999999986542   3469999986542  2345678899999999997 9999999999865


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      + ..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS  160 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCC
Confidence            4 5689999999999999997754 599999999999999999999999999999999999995   4567999999999


Q ss_pred             ccccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          223 VFIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       223 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ........  .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+......   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  237 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP---D  237 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---T
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---C
Confidence            87644322  22345678899999876 568899999999999999998 99999887777777666655432222   3


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++.+.++|.+||+.||++|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            578999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-45  Score=338.29  Aligned_cols=255  Identities=23%  Similarity=0.324  Sum_probs=211.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCc-----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGR-----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      ....++|++.+.||+|+||.||+|.+..++.     .||+|.+....  .......+.+|+.+++.+.+||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3345679999999999999999999876664     79999986432  2345677899999999996699999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAK--------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS  207 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~  207 (366)
                      ..++..++||||+++++|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-  198 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-  198 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE-
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC-
Confidence            9999999999999999999999753              3579999999999999999999999999999999999994 


Q ss_pred             cCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 017768          208 KEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF  282 (366)
Q Consensus       208 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~  282 (366)
                        .++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.......
T Consensus       199 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 --NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             --GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             --CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence              556799999999986543322   22345678899999875 568999999999999999998 99999877655544


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+.........  ....++.+.++|.+||+.||++|||+.+++++
T Consensus       277 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            444443332222  23468999999999999999999999999873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-46  Score=344.09  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=206.1

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ....++|++.+.||+|+||.||+|.+. +|+.||+|.+....   ....+.+.+|+.+++.++ ||||+++++++...+.
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence            345678999999999999999999965 68999999876532   345678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          147 LHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      .++||||+++++|.+++....    .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence            999999999999999886543    48999999999999999999999999999999999999   66788999999999


Q ss_pred             ccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHcCCCC
Q 017768          223 VFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGI-------FEAILEGNLD  291 (366)
Q Consensus       223 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~  291 (366)
                      .......   ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+.       ......+...
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            7643221   223346899999999875 5689999999999999999999999975432211       1111111111


Q ss_pred             C------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          292 L------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       292 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .      .....+..+..+.+++.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0      011112345778999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-45  Score=336.61  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=206.7

Q ss_pred             cccceeeeceecccCceEEEEEEEccCC----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..++|++.+.||+|+||.||+|.+..++    ..||+|.+....  .......+.+|+.+++.+. ||||+++++++...
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            3457999999999999999999887553    359999986432  2344567889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 QNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      +..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence            9999999999999999999875 569999999999999999999999999999999999999   567789999999998


Q ss_pred             cccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          224 FIETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       224 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      .......    .....+|..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   .
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~  272 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---P  272 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---C
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---c
Confidence            7643321    12234577899999876 568899999999999999999 9999998888888777776533222   2


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+++.+.++|.+||+.||++||++.+++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3578999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=339.12  Aligned_cols=254  Identities=29%  Similarity=0.471  Sum_probs=190.4

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      +........+|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++++.+||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            3344445568999999999999999999999999999999885432   3456678899999999988999999999984


Q ss_pred             --------eCCeEEEEEeccCCCchHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecC
Q 017768          143 --------DKQNLHLVMELCSGGELFDRIIA---KGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKE  209 (366)
Q Consensus       143 --------~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~  209 (366)
                              .....+++|||++ ++|.+++..   ...+++.+++.++.||+.||.|||++|  |+||||||+|||+   +
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~  172 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---S  172 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---C
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---C
Confidence                    3446899999996 689888865   456999999999999999999999999  9999999999999   5


Q ss_pred             CCCCEEEeecCCcccccCCCce-------------ecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCC
Q 017768          210 EDSPIKATDFGLSVFIETGKVY-------------KEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPP  272 (366)
Q Consensus       210 ~~~~vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~p  272 (366)
                      .++.+||+|||++.........             ....||+.|+|||++.    ..++.++||||||+++|+|++|..|
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            6778999999999876543221             1346899999999872    3578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017768          273 FWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP  329 (366)
Q Consensus       273 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp  329 (366)
                      |..........    +....  ......+..+.++|.+||+.||++|||+.+++++.
T Consensus       253 ~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          253 FEDGAKLRIVN----GKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             C----------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CcchhHHHhhc----CcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            97654433222    22221  12235678899999999999999999999999973

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=353.05  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=197.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ..|++.+.||+|+||+||.. ...+|+.||||++.....      ..+.+|+.+|+.+.+||||+++++++.+.+..|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            46999999999999997643 345799999999864322      23568999999996799999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC--CCCCEEEeecCCcccccC
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE--EDSPIKATDFGLSVFIET  227 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||. ++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||++.....
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            99996 59999987654 356667889999999999999999999999999999996432  234588999999987653


Q ss_pred             CC----ceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          228 GK----VYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       228 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ..    ......||+.|+|||++.    ..++.++|||||||++|+|++ |..||.......... +.............
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~  254 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLHPEK  254 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSCTTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccCccc
Confidence            32    234467999999999885    346789999999999999999 999996655443322 22221111111112


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ..+..+.+||.+||+.||++|||+.++++||||..
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            34566899999999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.9e-45  Score=331.39  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=202.2

Q ss_pred             ccceeeeceecccCceEEEEEE----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-
Q 017768           70 TTIYDLDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-  144 (366)
                      ...|++.+.||+|+||.||+|+    +..+++.||+|++....  .......+.+|+.+++.++ ||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            4569999999999999999999    56689999999986543  2345678999999999997 99999999999876 


Q ss_pred             -CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          145 -QNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                       ...++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.++|+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECccccc
Confidence             6789999999999999999554 5699999999999999999999999999999999999995   4567999999999


Q ss_pred             ccccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--------------C-hHHHH
Q 017768          223 VFIETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE--------------T-EKGIF  282 (366)
Q Consensus       223 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~--------------~-~~~~~  282 (366)
                      ........    .....+|..|+|||++. ..++.++||||||+++|+|++|..|+...              . .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654432    22346788899999875 45889999999999999999998876321              1 11222


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+..+..   ....+.+++++.++|.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGKR---LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCC---CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22222221   1223467899999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=360.58  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=204.9

Q ss_pred             ccceeeec-eecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDK-ELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~-~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+.+.+.+ .||+|+||.||+|.++.  ++..||||++....  .....+.+.+|+.++++++ ||||+++++++.. +.
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence            34455555 89999999999998753  45679999986542  2346778999999999997 9999999999876 56


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++..
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence            89999999999999998754 3599999999999999999999999999999999999995   5667999999999876


Q ss_pred             cCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......    ....+++.|+|||++. +.++.++||||||++||||++ |..||.+.+..+....+..+......   +.
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---PE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC---TT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---Cc
Confidence            433211    1224568899999886 568999999999999999998 99999999888888888776533222   35


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++++.++|.+||+.||++||++.++++
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7899999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=337.83  Aligned_cols=256  Identities=25%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             CCCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           63 GKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        63 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      |.......++|++.+.||+|+||.||++.+..+|+.||+|++...   .....+.+.+|+.+++.+. ||||+++++++.
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   96 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCL   96 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEE
Confidence            333344567899999999999999999999999999999988643   2345678899999999997 999999999986


Q ss_pred             ----eCCeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCE
Q 017768          143 ----DKQNLHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       143 ----~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                          .....++||||+++++|.+++..    ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~  173 (317)
T 2buj_A           97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQP  173 (317)
T ss_dssp             EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCE
T ss_pred             eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCE
Confidence                34478999999999999999976    3569999999999999999999999999999999999999   567789


Q ss_pred             EEeecCCcccccCCC----------ceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCC--h
Q 017768          215 KATDFGLSVFIETGK----------VYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAET--E  278 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~--~  278 (366)
                      ||+|||++.......          ......||+.|+|||++.+    .++.++||||||+++|+|++|..||....  .
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            999999987543211          0123457999999998753    36899999999999999999999995321  1


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ......+.. ...  ....+.++.++.++|.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          254 DSVALAVQN-QLS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             SCHHHHHHC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhhHHhhc-cCC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            112222222 222  22234678999999999999999999999999996

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-45  Score=327.31  Aligned_cols=245  Identities=18%  Similarity=0.267  Sum_probs=208.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC--CeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK--QNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~  147 (366)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.++++++ ||||+++++++...  +..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence            457999999999999999999985  89999999875432 2345567899999999997 99999999999887  788


Q ss_pred             EEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          148 HLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ++||||+++++|.+++....  .+++.+++.++.||+.||.|||+++  |+||||||+|||+   +.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecccee
Confidence            99999999999999998765  4899999999999999999999999  9999999999999   567789999888876


Q ss_pred             cccCCCceecccCCCCCCcccccccc-C---CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQR-Y---GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ....    ....||+.|+|||++.+. +   +.++||||||+++|+|++|..||...........+.........  ...
T Consensus       162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  235 (271)
T 3kmu_A          162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--PPG  235 (271)
T ss_dssp             TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--CTT
T ss_pred             eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--CCC
Confidence            5332    234689999999987642 3   33799999999999999999999988887776666655443332  236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +++++.++|.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7999999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.9e-45  Score=331.08  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=203.1

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-CCc--EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-TGR--KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..++|++.+.||+|+||.||+|.+.. ++.  .||+|++...........+.+.+|+.+++.+. ||||+++++++....
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC
Confidence            45679999999999999999998643 333  68999887654444456778999999999997 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                       .+++|||+++++|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+|||++   .++.+||+|||++..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA  170 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence             88999999999999999875 4689999999999999999999999999999999999995   456799999999987


Q ss_pred             ccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          225 IETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       225 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      ......    .....+|..|+|||++. ..++.++||||||+++|+|++ |..||......+....+.........  ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  248 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE  248 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--Cc
Confidence            644332    12345777899999876 457899999999999999999 99999998888887777665443332  24


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++++.++|.+||..||++|||+.+++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            689999999999999999999999999973

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-44  Score=347.42  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=210.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +....+.|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.++++++ ||||+++++++.. +
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence            34456789999999999999999999874 5679999986543    34567899999999997 9999999999876 6


Q ss_pred             eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..++||||+++++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR  328 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence            789999999999999999753  568999999999999999999999999999999999999   566789999999998


Q ss_pred             cccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          224 FIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       224 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      .......  .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.....   .+.
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~  405 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPE  405 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence            7643321  12335678899999875 568999999999999999999 9999999988888888776643222   236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC--CCccc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH--PWLKE  333 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h--p~f~~  333 (366)
                      +++.+.++|.+||+.||++|||++++++.  .+|..
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            78999999999999999999999999873  55544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-45  Score=327.56  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=209.4

Q ss_pred             ccceeeec-eecccCceEEEEEEEc--cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDK-ELGRGQFGVTYLCTKK--ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.+. ||||+++++++ ..+.
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCC
Confidence            45677766 9999999999999854  457889999986542  2345678999999999996 99999999999 5567


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++... ..+++.+++.++.||+.||.+||++||+||||||+|||++   .++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence            89999999999999998654 4599999999999999999999999999999999999995   4567999999999876


Q ss_pred             cCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......    ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+.....   .+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCC
Confidence            443321    2234678899999876 568899999999999999998 9999998888877777776543222   236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++++.++|.+||..||++||++.+++++
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            79999999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-45  Score=350.86  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=209.7

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....     ....+..|+.+++.+.++++|..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            35678999999999999999999999999999999876433     2235788999999999788888888888899999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +|||||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+..+.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999986 4569999999999999999999999999999999999999655567889999999998765


Q ss_pred             CCCc--------eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCCC-
Q 017768          227 TGKV--------YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDLQ-  293 (366)
Q Consensus       227 ~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~-  293 (366)
                      ....        .....||+.|+|||++. ..++.++||||||++||+|++|..||.+...   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4332        12567999999999876 4689999999999999999999999977543   233333322211111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ......+++++.++|..||+.||++||++.++++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1111357899999999999999999999998876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.5e-45  Score=333.54  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=202.8

Q ss_pred             ccccceeeeceecccCceEEEEEEEcc---CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ...++|.+.+.||+|+||.||+|.+..   ++..||+|.+..... .......+.+|+.++++++ ||||+++++++...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  108 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEM  108 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeec
Confidence            345679999999999999999998765   455899999865432 2344677899999999997 99999999998875


Q ss_pred             C-----eEEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          145 Q-----NLHLVMELCSGGELFDRIIAK------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       145 ~-----~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      +     ..+++|||+++++|.+++...      ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCc
Confidence            5     359999999999999998542      459999999999999999999999999999999999999   56778


Q ss_pred             EEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 017768          214 IKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~  288 (366)
                      +||+|||++.......   ......+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            9999999998664332   122345788899999876 458899999999999999999 99999888887777777665


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .....   ...+++.+.++|.+||..||++|||+.+++++
T Consensus       266 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          266 HRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43222   23678999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.6e-45  Score=330.52  Aligned_cols=251  Identities=25%  Similarity=0.430  Sum_probs=197.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||.||+|.+.   ..+|+|++.... ........+.+|+.+++.++ |+||++++++. .....
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSSC
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCcc
Confidence            34567999999999999999999864   359999986543 23445677899999999998 99999999965 55668


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.++|+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccccc
Confidence            9999999999999998543 4589999999999999999999999999999999999994   56779999999997654


Q ss_pred             C---CCceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCCCCCC-CCC
Q 017768          227 T---GKVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFEAILEGNLDLQS-SPW  297 (366)
Q Consensus       227 ~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~-~~~  297 (366)
                      .   ........||+.|+|||++.    ..++.++||||||+++|+|++|..||....... ....+..+...... ...
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence            2   22233457899999999874    347889999999999999999999998765544 44444444433322 223


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+++.+.++|.+||+.||++|||+.++++
T Consensus       252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          252 SNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            468899999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=334.28  Aligned_cols=249  Identities=23%  Similarity=0.309  Sum_probs=203.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEE----EEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKY----ACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      .++|++.+.||+|+||.||+|.+..+++.+    |+|.+...  ........+.+|+.+++.++ ||||+++++++..+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            456999999999999999999998888765    55655432  23456778999999999997 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                       .++++||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence             78899999999999999874 4699999999999999999999999999999999999994   456799999999987


Q ss_pred             ccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          225 IETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       225 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.....   .+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            643322   22335677899999876 468999999999999999999 9999998888777777666543322   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.++.++|.+||+.||++|||+.++++.
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            78999999999999999999999999974

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.2e-45  Score=335.28  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             ccceeeeceecccCceEEEEEE----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe--e
Q 017768           70 TTIYDLDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE--D  143 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~  143 (366)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++....   ......+.+|+.++++++ |+||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence            4579999999999999999999    46678999999986532   345567899999999996 999999999886  4


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ....++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence            56789999999999999999874 4599999999999999999999999999999999999994   5667999999999


Q ss_pred             ccccCCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHH
Q 017768          223 VFIETGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK---------------GIF  282 (366)
Q Consensus       223 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------------~~~  282 (366)
                      ........    .....+|..|+|||++. ..++.++||||||+++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    12345788899999876 45789999999999999999999998544321               222


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+..+..   ....+.+++++.++|.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22222221   12234689999999999999999999999999664

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-44  Score=325.57  Aligned_cols=243  Identities=22%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC-CeE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK-QNL  147 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-~~~  147 (366)
                      ..++|++.+.||+|+||.||+|.+.  |+.||+|.+...     ...+.+.+|+.++++++ ||||+++++++... +..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCce
Confidence            3567999999999999999999875  899999998542     35677899999999997 99999999987544 478


Q ss_pred             EEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          148 HLVMELCSGGELFDRIIAKGI--YSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      ++||||+++++|.+++.....  +++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence            999999999999999977543  8999999999999999999999999999999999999   56778999999998765


Q ss_pred             cCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          226 ETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       226 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ....  ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...   .....+++.
T Consensus       168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  242 (278)
T 1byg_A          168 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPA  242 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHH
T ss_pred             cccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCcccCCHH
Confidence            4332  2335788999999876 468899999999999999998 99999888877777766554322   222467899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      +.++|.+||+.||++|||+.++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.6e-45  Score=329.52  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHh-cCCCceeEeceEEee---
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQPNIVEFEGAYED---  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~h~~i~~~~~~~~~---  143 (366)
                      .+.++|++.+.||+|+||.||+|.+  +|+.||||++..      .....+..|.+++... -+||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3567899999999999999999987  489999999853      2345566777777773 249999999998654   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEeccCCCcEEeeecCCCCCE
Q 017768          144 -KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH--------FMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       144 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                       ....++||||+++++|.+++. ...+++..++.++.||+.||.|||        +++|+||||||+|||+   +.++.+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~  152 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC  152 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred             CCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence             346899999999999999995 446899999999999999999999        9999999999999999   567789


Q ss_pred             EEeecCCcccccCCCce-----ecccCCCCCCccccccc-------cCCCchhHHHHHHHHHHHHhC----------CCC
Q 017768          215 KATDFGLSVFIETGKVY-----KEIVGSAYYVAPEVLHQ-------RYGKEIDVWSAGVILYILLSG----------VPP  272 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~vl~~ll~g----------~~p  272 (366)
                      ||+|||++.........     ....||+.|+|||++.+       .++.++||||||+++|+|++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99999999766443322     23479999999998764       344689999999999999999          888


Q ss_pred             CCCCC----hHHHHHHHHcCCCCCCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          273 FWAET----EKGIFEAILEGNLDLQSSP----WPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       273 f~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      |....    ...................    ....++++.++|.+||+.||++|||+.++++
T Consensus       233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            85432    1222222222111111110    0124578999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-45  Score=337.06  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=205.3

Q ss_pred             CCccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           64 KPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        64 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .......++|++.+.||+|+||.||+|.+. +|+.||+|++.....  ......+.+|+.+++.+. ||||+++++++..
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   98 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMT   98 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECC
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEec
Confidence            344556778999999999999999999854 689999999865432  222336889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHc---CCEEeccCCCcEEeeecCCCCCEEE
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG----IYSEREAANICRQIVNVVHACHFM---GVIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      .+..++||||+++++|.+++....    .+++..++.++.||+.||.|||++   ||+||||||+|||+   +.++.+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl  175 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVV  175 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEE
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEe
Confidence            999999999999999999997643    389999999999999999999999   99999999999999   56778999


Q ss_pred             eecCCcccccCCC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHcCC
Q 017768          217 TDFGLSVFIETGK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFEAILEGN  289 (366)
Q Consensus       217 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~----~~~~~~~~~~~~~  289 (366)
                      +|||++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|..||...    .............
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999998764332  233456999999999875 56899999999999999999999999421    1111111111111


Q ss_pred             CCC-----------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017768          290 LDL-----------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW  330 (366)
Q Consensus       290 ~~~-----------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~  330 (366)
                      ...           ........++.+.+++.+||+.||++|||+.++++|..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            100           00011123468999999999999999999999999843

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=342.76  Aligned_cols=257  Identities=17%  Similarity=0.168  Sum_probs=195.6

Q ss_pred             cccceeeeceecccCceEEEEEEEcc---CCcEEEEEEeeccccccc--------ccHHHHHHHHHHHHHhcCCCceeEe
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA---TGRKYACKSISRRKLVYD--------KDMEDVRREILILQHLTGQPNIVEF  137 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~~h~~i~~~  137 (366)
                      ..++|++.+.||+|+||.||+|.+..   ++..+|+|++........        .....+.+|+..++.+. |+||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            34679999999999999999999987   788999999865421100        11233557778888886 9999999


Q ss_pred             ceEEee----CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          138 EGAYED----KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       138 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      ++++..    ....++||||+ +++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~  191 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ  191 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence            999988    67899999999 999999998777899999999999999999999999999999999999996422 238


Q ss_pred             EEEeecCCcccccCCC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 017768          214 IKATDFGLSVFIETGK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFE  283 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~  283 (366)
                      +||+|||+++......        ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .....
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999997653221        1134579999999998765 589999999999999999999999965322 11111


Q ss_pred             HHHcC-CCCCCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          284 AILEG-NLDLQS-----SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       284 ~~~~~-~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..... ....+.     .....+++++.++|.+||+.||++|||+.++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            11111 000100     0111578999999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=324.61  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             ceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE-
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL-  147 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-  147 (366)
                      .|++.+.||+|+||.||+|.+..++.   .+|+|.+...  ......+.+.+|+.+++.++ ||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCc
Confidence            47788999999999999999765554   7999988642  22345678899999999997 99999999999876655 


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +++|||+.+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccccc
Confidence            999999999999999976 3458999999999999999999999999999999999999   567789999999997653


Q ss_pred             CCC-----ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          227 TGK-----VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       227 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ...     ......+++.|+|||.+.+ .++.++||||||+++|+|++|. .||...+.......+..+.....   ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Ccc
Confidence            321     2233467889999998764 5899999999999999999954 55555555566666555543222   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+.++|.+||+.||++|||+.++++.
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.1e-44  Score=326.75  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCC---cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE-eeCC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATG---RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY-EDKQ  145 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-~~~~  145 (366)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+...  ........+.+|+.++++++ ||||+++++++ ..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence            446999999999999999999875433   35889987642  23345677899999999997 99999999985 4566


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          146 NLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      ..+++|||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence            789999999999999999764 458999999999999999999999999999999999999   6677899999999986


Q ss_pred             ccCCC-----ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          225 IETGK-----VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       225 ~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      .....     ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+......   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence            54322     123346778899999876 468999999999999999999 66777777666666666666544333   


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+++.+.++|.+||+.||++|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            246899999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=350.98  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=214.3

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      +....+.|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.+|++++ |+||+++++++.+ +
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence            34456789999999999999999999874 5679999987543    34567899999999997 9999999999876 6


Q ss_pred             eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          146 NLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ..+|||||+++++|.+++...  ..+++.+++.++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccce
Confidence            789999999999999999753  568999999999999999999999999999999999999   566789999999998


Q ss_pred             cccCCC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          224 FIETGK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       224 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......  ......++..|+|||++. +.++.++||||||++||||++ |..||.+....+....+..+.....   ...
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~  488 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPE  488 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence            754321  112234677899999875 568999999999999999999 9999999988888888776643222   236


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC--CCcc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH--PWLK  332 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h--p~f~  332 (366)
                      +++++.+||.+||+.||++|||+.++++.  .+|.
T Consensus       489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            78999999999999999999999999874  4443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=336.75  Aligned_cols=246  Identities=14%  Similarity=0.190  Sum_probs=198.8

Q ss_pred             ccceeeeceecccCceEEEEEEEcc--------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeE-----
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA--------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-----  136 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~-----  136 (366)
                      .++|++.+.||+|+||.||+|.+..        +++.||+|.+...        ..+.+|+.+++++. ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            5689999999999999999999987        4889999998643        35788999999997 888877     


Q ss_pred             ----------eceEEee-CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcE
Q 017768          137 ----------FEGAYED-KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENF  203 (366)
Q Consensus       137 ----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  203 (366)
                                +++++.. ++..++||||+ +++|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      5666665 67899999999 99999999886  6799999999999999999999999999999999999


Q ss_pred             EeeecCCCC--CEEEeecCCcccccCCC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCC
Q 017768          204 LLASKEEDS--PIKATDFGLSVFIETGK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPP  272 (366)
Q Consensus       204 ll~~~~~~~--~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~p  272 (366)
                      |++   .++  .+||+|||++.......        ......||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            995   444  79999999997654322        1133479999999998865 689999999999999999999999


Q ss_pred             CCCCC--hHHHHHHH---HcCCCCC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          273 FWAET--EKGIFEAI---LEGNLDL--QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       273 f~~~~--~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      |....  ........   .......  ....+..+++++.++|.+||+.||++|||+.++++.
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            98763  22222222   1111111  111223578999999999999999999999999873

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.2e-46  Score=366.09  Aligned_cols=260  Identities=26%  Similarity=0.415  Sum_probs=209.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee------C
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED------K  144 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~------~  144 (366)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...  ......+.+.+|+.++++++ ||||+++++++..      +
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence            5699999999999999999999999999999988643  23445677899999999997 9999999998765      6


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      +..++||||+++++|.+++....   .+++..++.++.||+.||.|||+.||+||||||+|||++.++....++|+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            77899999999999999998644   589999999999999999999999999999999999997654555699999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHH-----H
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF---------EAI-----L  286 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~---------~~~-----~  286 (366)
                      +.............||+.|+|||++. ..++.++||||||+++|+|++|..||.........         ...     .
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            98876666566678999999999876 56899999999999999999999999765332111         000     0


Q ss_pred             cCCCCC------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          287 EGNLDL------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       287 ~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      .+...+      +......+++.+.++|.+||..||++|||+.++++||||+.
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            011111      11112236789999999999999999999999999999966

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=340.01  Aligned_cols=247  Identities=17%  Similarity=0.234  Sum_probs=196.6

Q ss_pred             cccccceeeeceecccCceEEEEE-----EEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcC--CCceeEece
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLC-----TKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTG--QPNIVEFEG  139 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~i~~~~~  139 (366)
                      ....++|.+.+.||+|+||+||+|     .+..+++.||+|++...      ....+..|+.+++.+..  |+||+.+++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            334567999999999999999999     46678999999998542      34567788888888763  799999999


Q ss_pred             EEeeCCeEEEEEeccCCCchHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee-------
Q 017768          140 AYEDKQNLHLVMELCSGGELFDRIIA-----KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS-------  207 (366)
Q Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-------  207 (366)
                      ++...+..++||||+++++|.+++..     ...+++.+++.++.||+.||+|||++||+||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999975     346999999999999999999999999999999999999954       


Q ss_pred             -cCCCCCEEEeecCCccccc---CCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 017768          208 -KEEDSPIKATDFGLSVFIE---TGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF  282 (366)
Q Consensus       208 -~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~  282 (366)
                       .+.++.+||+|||+++...   ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ 
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-  293 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-  293 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence             1226789999999997543   3334556689999999998864 589999999999999999999999965432110 


Q ss_pred             HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          283 EAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                            ......... ..++.+.+++..||+.+|.+|++..+.+.
T Consensus       294 ------~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 ------KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ------EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ------eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                  000111111 24678999999999999999965544444

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=325.34  Aligned_cols=241  Identities=29%  Similarity=0.456  Sum_probs=194.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|.+..     ....+.+.+|+.++++++ ||||+++++++.+  ..++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEE
Confidence            356999999999999999999875  78999998853     245678899999999997 9999999998763  4789


Q ss_pred             EEeccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---cCCEEeccCCCcEEeeecCCCCC-EEEeecCCc
Q 017768          150 VMELCSGGELFDRIIAKG---IYSEREAANICRQIVNVVHACHF---MGVIHRDLKPENFLLASKEEDSP-IKATDFGLS  222 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~-vkl~Dfg~a  222 (366)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+   +||+||||||+|||++   .++. +||+|||++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccc
Confidence            999999999999998654   37899999999999999999999   8999999999999995   4444 799999999


Q ss_pred             ccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCC
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....  ......+..+...   .....
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  228 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLIKN  228 (307)
T ss_dssp             -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC---CCBTT
T ss_pred             cccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC---Ccccc
Confidence            765432  233468999999998764 689999999999999999999999975433  2233333333222   22246


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+.++|.+||+.||++|||+.+++++
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            78999999999999999999999999883

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=338.93  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=198.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCC---cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe-eCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATG---RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE-DKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~~  146 (366)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.+...  ........+.+|+.++++++ ||||+++++++. .++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence            35888999999999999999876433   36899987542  23455678999999999997 999999999865 4567


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence            899999999999999997653 48899999999999999999999999999999999999   56778999999999865


Q ss_pred             cCCCc-----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          226 ETGKV-----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       226 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      .....     .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...+..+....+..+......   .
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---T
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence            43221     12345678899999876 568999999999999999999 78888777666666666665443322   3


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+++.+.++|.+||+.||++|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-44  Score=329.16  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=201.8

Q ss_pred             cccce-eeeceecccCceEEEEEEE----ccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIY-DLDKELGRGQFGVTYLCTK----KATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      +.++| ++.+.||+|+||.||++.+    ..+++.||+|++....  .......+.+|+.+++.++ ||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence            44455 9999999999999988754    3468899999996542  2345677899999999998 9999999999987


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 --KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                        ....++||||+++++|.+++... .+++.+++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL  180 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence              46789999999999999998654 48999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCCc----eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------------HH
Q 017768          222 SVFIETGKV----YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEK---------------GI  281 (366)
Q Consensus       222 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~---------------~~  281 (366)
                      +........    .....+|..|+|||++.+ .++.++||||||+++|+|++|..||......               ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            987654432    223467888999998764 6889999999999999999999998653221               11


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ...+..+..   ......+++++.++|.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            122222221   1222467899999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-44  Score=329.01  Aligned_cols=250  Identities=25%  Similarity=0.316  Sum_probs=202.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccc-cccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKL-VYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVM  151 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  151 (366)
                      |...+.||+|+||.||+|.+  +++.||+|++..... ........+.+|+.+++.++ ||||+++++++...+..+++|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence            44558999999999999986  488999999865332 22344678899999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          152 ELCSGGELFDRIIAK---GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       152 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            999999999998742   458999999999999999999999999999999999999   56778999999999865432


Q ss_pred             C---ceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHcCCCC-------CCC
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFEAILEGNLD-------LQS  294 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~----~~~~~~~~~~~-------~~~  294 (366)
                      .   ......||+.|+|||++.+.++.++||||||+++|+|++|..||.......    ....+......       ...
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            2   123357899999999988889999999999999999999999997653322    22222221110       001


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       295 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ......++.+.+++.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112345678999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=331.16  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=206.9

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++..... .....+.+.+|+.+++.++ |+||+++++++...+..
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCce
Confidence            345679999999999999999998853   599999865432 2334456778999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +++|||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++    ++.++|+|||++....
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC---
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccc
Confidence            99999999999999997654 589999999999999999999999999999999999994    4679999999987543


Q ss_pred             C------CCceecccCCCCCCccccccc----------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC
Q 017768          227 T------GKVYKEIVGSAYYVAPEVLHQ----------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       227 ~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~  290 (366)
                      .      ........||+.|+|||++..          .++.++||||||+++|+|++|..||...........+..+..
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence            1      122233468999999998753          368899999999999999999999999888877777766543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ....  ...++.++.++|.+||..||++|||+.++++.
T Consensus       261 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          261 PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            3222  22578899999999999999999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=325.87  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=194.7

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc-CCCceeEeceEEeeC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT-GQPNIVEFEGAYEDK-  144 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~-  144 (366)
                      ..+.++|++.+.||+|+||.||+|.+.  |+.||||++...      .......|.+++..+. +||||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            346678999999999999999999886  899999998532      2344555666665542 599999999999887 


Q ss_pred             ---CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeccCCCcEEeeecCCCCC
Q 017768          145 ---QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--------GVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       145 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                         ...++||||+++++|.+++... .+++.+++.++.|++.||.|||++        ||+||||||+|||+   +.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCC
Confidence               7899999999999999999654 689999999999999999999999        99999999999999   56778


Q ss_pred             EEEeecCCcccccCCCc-----eecccCCCCCCcccccccc-CCC------chhHHHHHHHHHHHHhC----------CC
Q 017768          214 IKATDFGLSVFIETGKV-----YKEIVGSAYYVAPEVLHQR-YGK------EIDVWSAGVILYILLSG----------VP  271 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~------~~Di~slG~vl~~ll~g----------~~  271 (366)
                      +||+|||++........     .....||+.|+|||++.+. ...      ++||||||+++|+|++|          ..
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            99999999976543322     1245799999999998643 333      38999999999999999          77


Q ss_pred             CCCCCC-----hHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          272 PFWAET-----EKGIFEAILEGNLDLQSSP---WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       272 pf~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ||....     .......+...........   ...+++++.++|.+||+.||++|||+.+++++
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            775431     1222222222222211111   11356779999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.2e-43  Score=327.81  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=201.6

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHh-cCCCceeEeceEEeeCC-
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL-TGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~h~~i~~~~~~~~~~~-  145 (366)
                      .+.++|++.+.||+|+||.||+|.+.  |+.||+|++..      .....+.+|.+++..+ .+||||+++++++...+ 
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             cccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            45678999999999999999999984  89999999853      2345678899999884 25999999999998876 


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEeccCCCcEEeeecCCCCCE
Q 017768          146 ---NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACH--------FMGVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                         ..++||||+++++|.+++.. ..+++.+++.++.||+.||.|||        +.+|+||||||+|||+   +.++.+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~  186 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC  186 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCE
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCE
Confidence               79999999999999999976 46899999999999999999999        8999999999999999   567789


Q ss_pred             EEeecCCcccccCCCc-----eecccCCCCCCcccccccc-------CCCchhHHHHHHHHHHHHhC----------CCC
Q 017768          215 KATDFGLSVFIETGKV-----YKEIVGSAYYVAPEVLHQR-------YGKEIDVWSAGVILYILLSG----------VPP  272 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~vl~~ll~g----------~~p  272 (366)
                      ||+|||++........     .....||+.|+|||++.+.       ++.++||||||+++|+|++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999987654432     2345799999999988643       33689999999999999999          788


Q ss_pred             CCCCC-----hHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          273 FWAET-----EKGIFEAILEGNLDLQSSP---WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       273 f~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      |....     .......+...........   ....++.+.++|.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            86542     2333343433332222111   11234678999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=324.65  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=202.2

Q ss_pred             cccceeeeceecccCceEEEEEE----EccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCT----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      ..++|++.+.||+|+||.||+|.    ...+|+.||+|++...   .......+.+|+.+++.++ ||||+++++++...
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA  114 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence            45679999999999999999998    4567999999998653   2355678999999999997 99999999988665


Q ss_pred             C--eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          145 Q--NLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       145 ~--~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      +  ..++||||+++++|.+++.... .+++.+++.++.||+.||.+||++||+||||||+|||++   .++.+||+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence            4  6899999999999999998764 599999999999999999999999999999999999995   456799999999


Q ss_pred             cccccCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 017768          222 SVFIETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------G  280 (366)
Q Consensus       222 a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~----------------~  280 (366)
                      +.........    ....++..|+|||++. ..++.++||||||+++|+|++|..||......                .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9876544321    2235677899999876 45889999999999999999999988532110                1


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ..+.+..+.. .  .....+++++.++|.+||+.||++|||+.++++
T Consensus       272 ~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNGR-L--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTCC-C--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCC-C--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1122222211 1  122467899999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-45  Score=344.82  Aligned_cols=249  Identities=17%  Similarity=0.208  Sum_probs=192.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeE-------------
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVE-------------  136 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~-------------  136 (366)
                      ...|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+.+..+...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3458889999999999999999999999999999875444444557789999999998874232111             


Q ss_pred             --------eceEEee-----CCeEEEEEeccCCCchHHHHHH-------hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEe
Q 017768          137 --------FEGAYED-----KQNLHLVMELCSGGELFDRIIA-------KGIYSEREAANICRQIVNVVHACHFMGVIHR  196 (366)
Q Consensus       137 --------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  196 (366)
                              +..++..     ....+++|+++ +++|.+++..       ...+++..++.++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     12467778876 5799888852       1237788999999999999999999999999


Q ss_pred             ccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccc----------cc-cCCCchhHHHHHHHHHH
Q 017768          197 DLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL----------HQ-RYGKEIDVWSAGVILYI  265 (366)
Q Consensus       197 Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~Di~slG~vl~~  265 (366)
                      ||||+|||+   +.++.+||+|||+++.....  .....| +.|+|||++          .. .++.++|||||||++|+
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   56777999999998765432  445577 999999987          32 37789999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          266 LLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       266 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      |++|+.||...+.......+        ...+..+++++.+||.+||+.||++|||+.++++||||++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            99999999776544322222        2223467899999999999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.6e-46  Score=341.79  Aligned_cols=251  Identities=18%  Similarity=0.231  Sum_probs=195.2

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccc-----ccccHHHHHHHHHHHHHhc--------CCCceeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV-----YDKDMEDVRREILILQHLT--------GQPNIVE  136 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~--------~h~~i~~  136 (366)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.++        +|+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  5899999999765321     2344578999999999987        4666666


Q ss_pred             eceEE-----------------ee-------------CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHH
Q 017768          137 FEGAY-----------------ED-------------KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH  186 (366)
Q Consensus       137 ~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~  186 (366)
                      +.+++                 ..             .+..||||||+++|++.+.+.. ..+++.+++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            66553                 32             6789999999999977666643 56899999999999999999


Q ss_pred             HHH-HcCCEEeccCCCcEEeeecCC-----------------CCCEEEeecCCcccccCCCceecccCCCCCCccccccc
Q 017768          187 ACH-FMGVIHRDLKPENFLLASKEE-----------------DSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQ  248 (366)
Q Consensus       187 ~LH-~~~ivH~Dlkp~NIll~~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  248 (366)
                      ||| ++||+||||||+|||++..+.                 ...+||+|||+|+.....    ...||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 999999999999999975431                 127999999999876543    3479999999999987


Q ss_pred             cCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHcCC-CCC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHH
Q 017768          249 RYGKEIDVWSAGVI-LYILLSGVPPFWAETE-KGIFEAILEGN-LDL--QSSPWPSISGQAKDLIRKMLTKDPKKRITAA  323 (366)
Q Consensus       249 ~~~~~~Di~slG~v-l~~ll~g~~pf~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  323 (366)
                      ..+.++|||||+++ .++++.|..||..... ......+.... ...  ....++.+++++.+||.+||+.|     |++
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            67889999998777 6778889999844211 11222333221 111  11112346789999999999987     999


Q ss_pred             HHh-cCCCcc
Q 017768          324 EAL-EHPWLK  332 (366)
Q Consensus       324 ~~l-~hp~f~  332 (366)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=331.73  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=187.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHH--HhcCCCceeEeceEEee-----
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ--HLTGQPNIVEFEGAYED-----  143 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~--~l~~h~~i~~~~~~~~~-----  143 (366)
                      ++|++.+.||+|+||.||+|++  +++.||||++...      ....+..|..++.  .+. |+||+++++.+..     
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhcc-CcchhhheecccccccCC
Confidence            5699999999999999999976  5899999998643      2333444444433  354 9999999975532     


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEEeccCCCcEEeeecCCCCCE
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM---------GVIHRDLKPENFLLASKEEDSPI  214 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~ivH~Dlkp~NIll~~~~~~~~v  214 (366)
                      ....++||||+++++|.+++.... +++..++.++.||+.||.|||+.         ||+||||||+|||+   +.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcE
Confidence            336789999999999999997654 58999999999999999999999         99999999999999   567789


Q ss_pred             EEeecCCcccccCCC---------ceecccCCCCCCccccccc--------cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 017768          215 KATDFGLSVFIETGK---------VYKEIVGSAYYVAPEVLHQ--------RYGKEIDVWSAGVILYILLSGVPPFWAET  277 (366)
Q Consensus       215 kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~vl~~ll~g~~pf~~~~  277 (366)
                      ||+|||++.......         ......||+.|+|||++.+        .++.++||||||+++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998664321         1224579999999998764        35678999999999999999977763321


Q ss_pred             h------------------HHHHHHHHcCCCCCC-CCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CC
Q 017768          278 E------------------KGIFEAILEGNLDLQ-SSPW---PSISGQAKDLIRKMLTKDPKKRITAAEALE------HP  329 (366)
Q Consensus       278 ~------------------~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~------hp  329 (366)
                      .                  ......+........ ...+   ..+++++.++|.+||+.||++|||+.|+++      ++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1                  111111111111111 1111   124457999999999999999999999955      56


Q ss_pred             CcccCCCC
Q 017768          330 WLKEDGAT  337 (366)
Q Consensus       330 ~f~~~~~~  337 (366)
                      |-++....
T Consensus       320 ~~~~~~~~  327 (336)
T 3g2f_A          320 WERNKSVS  327 (336)
T ss_dssp             CCC-----
T ss_pred             HHhcccCC
Confidence            66655443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.5e-43  Score=347.75  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=208.8

Q ss_pred             cccccceeeeceecccCceEEEEEEEccC---CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++++. ||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-
Confidence            34567799999999999999999998653   4579999875432  2344578899999999997 999999999985 


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ++..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCC
Confidence            456899999999999999998754 589999999999999999999999999999999999995   4567999999999


Q ss_pred             ccccCCCce--ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          223 VFIETGKVY--KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       223 ~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      .........  ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.....   .+
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~  615 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PP  615 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence            876443322  2335678899999876 468999999999999999997 9999999888888888776643322   23


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+++.+.++|.+||..||++|||+.++++
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            67899999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-43  Score=318.17  Aligned_cols=228  Identities=16%  Similarity=0.100  Sum_probs=187.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..+. ||||+++++++..++..|
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcEE
Confidence            4567999999999999999999999999999999997654433445678999999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +||||++|++|.+++...  ....++..++.||+.||.|||++||+||||||+|||+   +.++.+||+++|        
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC--------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc--------
Confidence            999999999999998542  4677899999999999999999999999999999999   466779998554        


Q ss_pred             CceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHcCCCCCCCCCCCCCCHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFE---AILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                                 |++      .++.++||||||+++|+|++|+.||.+.+....+.   ....+.........+.+++++.
T Consensus       175 -----------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 -----------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             -----------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             -----------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                       333      26789999999999999999999998765432110   0001111111112346899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++|.+||+.||++| |+.++++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999 99999884

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-43  Score=352.08  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             cccccceeeeceecccCceEEEEEEEcc-CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKA-TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ..+.++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.++++++ ||||+++++++...+
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC
Confidence            3456889999999999999999999976 78999999886432  2344567889999999997 999999999998766


Q ss_pred             e-----EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecC
Q 017768          146 N-----LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFG  220 (366)
Q Consensus       146 ~-----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg  220 (366)
                      .     .||||||++|++|.+++..  .+++.+++.++.||+.+|.|||++||+||||||+|||++   . +.+||+|||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG  226 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLG  226 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCT
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecc
Confidence            5     7999999999999887654  699999999999999999999999999999999999995   2 379999999


Q ss_pred             CcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          221 LSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       221 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ++......   ....||+.|+|||++.+..+.++||||||+++|+|++|..||.+.....         .. ........
T Consensus       227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~-~~~~~~~~  293 (681)
T 2pzi_A          227 AVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP-EDDPVLKT  293 (681)
T ss_dssp             TCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC-TTCHHHHH
T ss_pred             cchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------cc-cccccccc
Confidence            99876543   4457999999999988777899999999999999999988886432110         00 00001123


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ++.+.++|.+||+.||++||+..+.+.|+|+.
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            57899999999999999999988888887763

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.7e-35  Score=290.12  Aligned_cols=187  Identities=19%  Similarity=0.142  Sum_probs=137.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccc-------cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-------DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ..++.|++|.+..++....|+.+++|.+.......       +.+.+++.+|+++|+++.+|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            35778888888888877789999999997543221       23456799999999999889999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      ||||++|++|.+++...+.+++.   .|+.||+.||+|+|++|||||||||+|||+   ++++.+||+|||+|+..... 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence            99999999999999988888775   478999999999999999999999999999   67788999999999876433 


Q ss_pred             CceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhC
Q 017768          229 KVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSG  269 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g  269 (366)
                      ....+.+||+.|+|||++.+.+..++|+|++|++++++.++
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-----------------CCCCTT
T ss_pred             ccccCceechhhccHHHhCCCCCCcccccccccchhhhccc
Confidence            33455689999999999998888899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.4e-29  Score=246.78  Aligned_cols=183  Identities=19%  Similarity=0.159  Sum_probs=143.4

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeeccccccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ..+.||+|+||.||+|..  .+..+++|..........     ...+.+.+|+.++++++ ||||+.+..+....+..||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccEE
Confidence            456899999999999954  488999998754332211     12445789999999997 9999966666667777899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||++|++|.+++..        +..++.||+.+|.|||++||+||||||+|||++   .  .+||+|||+++......
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCcc
Confidence            9999999999998865        678999999999999999999999999999994   3  79999999998875432


Q ss_pred             c--------eecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCC
Q 017768          230 V--------YKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       230 ~--------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                      .        .....||+.|+|||++..   .|+..+|+|+..+-.++.+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1        135689999999999864   4788899999998888887776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2e-26  Score=206.69  Aligned_cols=146  Identities=21%  Similarity=0.263  Sum_probs=115.2

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc---------------ccHHHHHHHHHHHHHhcCCCceeEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD---------------KDMEDVRREILILQHLTGQPNIVEF  137 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~i~~~  137 (366)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|.+........               .....+.+|+.+++++. |   +.+
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCc
Confidence            55669999999999999999 7899999999864322111               13456889999999998 3   455


Q ss_pred             ceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       138 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      .+++.. +..++||||++|++|.+ +      ...+...++.|++.||.+||++||+||||||+|||++    ++.+||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEEE
Confidence            554443 45699999999999987 3      2234567999999999999999999999999999995    6779999


Q ss_pred             ecCCcccccCCCceecccCCCCCCcccccc
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVAPEVLH  247 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  247 (366)
                      |||+++.            +..++|||.+.
T Consensus       235 DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHH
Confidence            9999863            44578899774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3.4e-22  Score=176.92  Aligned_cols=141  Identities=17%  Similarity=0.177  Sum_probs=107.0

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcE--EEEEEeeccccccc---------------------ccHHHHHHHHHHHHHh
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRK--YACKSISRRKLVYD---------------------KDMEDVRREILILQHL  128 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~l  128 (366)
                      .|.+.+.||+|+||.||+|.+..+|+.  ||||++........                     .....+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378899999999999999998668999  99998754321110                     0123678899999999


Q ss_pred             cCCCce--eEeceEEeeCCeEEEEEeccCC-C----chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEeccCC
Q 017768          129 TGQPNI--VEFEGAYEDKQNLHLVMELCSG-G----ELFDRIIAKGIYSEREAANICRQIVNVVHACH-FMGVIHRDLKP  200 (366)
Q Consensus       129 ~~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp  200 (366)
                      . |+++  +.+++.    +..+|||||+.+ |    +|.+....   .++..+..++.||+.+|.+|| ++||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            7 5543  344432    345899999932 3    66655322   235578899999999999999 99999999999


Q ss_pred             CcEEeeecCCCCCEEEeecCCcccc
Q 017768          201 ENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       201 ~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      +|||++   +  .++|+|||+|...
T Consensus       200 ~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES---S--SEEECCCTTCEET
T ss_pred             HHEEEc---C--cEEEEECcccccC
Confidence            999994   3  7999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=1.6e-19  Score=166.42  Aligned_cols=145  Identities=14%  Similarity=0.238  Sum_probs=103.4

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc-----------cccH--------HHHHHHHHHHHHhcCCC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY-----------DKDM--------EDVRREILILQHLTGQP  132 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~--------~~~~~e~~~l~~l~~h~  132 (366)
                      .|.+.+.||.|+||.||+|.+. +|+.||||++.......           ....        .....|...|.++. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            4899999999999999999975 69999999875422110           0001        11345788888875 34


Q ss_pred             ceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCC-
Q 017768          133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEED-  211 (366)
Q Consensus       133 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~-  211 (366)
                      ++....-+....  .+|||||++|.+|..+.      .......++.||+.+|.+||++|||||||||.|||++.+++. 
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            433222222222  37999999998885432      234567889999999999999999999999999999754321 


Q ss_pred             ------CCEEEeecCCccccc
Q 017768          212 ------SPIKATDFGLSVFIE  226 (366)
Q Consensus       212 ------~~vkl~Dfg~a~~~~  226 (366)
                            ..+.|+||+.+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                  138999999887654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=5e-14  Score=124.45  Aligned_cols=141  Identities=17%  Similarity=0.109  Sum_probs=112.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++...++.|+.+.||++...  +..+++|.......   .....+.+|+.+++.+.++..+++++++....+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            45888888999999999998754  78999998854211   22345889999999997677888999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF----------------------------------------  190 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~----------------------------------------  190 (366)
                      |||++|.+|.+.+     .+......++.++..+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999887652     1233445788999999999998                                        


Q ss_pred             -------------------cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 -------------------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 -------------------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                                         ..++|+|++|.|||++   ++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                               4589999999999994   334457999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=1.5e-12  Score=114.57  Aligned_cols=135  Identities=13%  Similarity=0.081  Sum_probs=97.6

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc-eeEeceEEeeCCeEEEE
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN-IVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-i~~~~~~~~~~~~~~lv  150 (366)
                      .|.+....+.|..+.||++.. .+|..+++|.....      ....+..|+.+++.+.++.- +++++++...++..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            355544444666799999864 46788999986432      22457889999999985532 67788888888889999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--------------------------------------  192 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------  192 (366)
                      |||++|.+|.  .   ....   ...++.+++..|..||+..                                      
T Consensus        94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999998883  1   1112   2356677777777777643                                      


Q ss_pred             --------------------CEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          193 --------------------VIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       193 --------------------ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                                          ++|+|++|+|||++   ++..+.|+|||.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                99999999999994   334456999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=1.7e-11  Score=113.22  Aligned_cols=143  Identities=22%  Similarity=0.352  Sum_probs=103.6

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEee--cccccccccHHHHHHHHHHHHHhcC-CCceeEeceEEeeC---CeEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSIS--RRKLVYDKDMEDVRREILILQHLTG-QPNIVEFEGAYEDK---QNLHL  149 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~---~~~~l  149 (366)
                      .+.|+.|.++.||++...  +..+++|+..  ....  ......+.+|+.+++.+.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            467899999999998764  5788898764  2211  1224467889999999974 23578888887766   45899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF---------------------------------------  190 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------  190 (366)
                      ||||++|..+.+..  -..++..+...++.+++..|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999998774311  1236788889999999999999997                                       


Q ss_pred             -------------------cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          191 -------------------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       191 -------------------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                                         ..++|+|++++|||++.++ ...+.|+||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECccccccC
Confidence                               3589999999999995311 123589999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.21  E-value=2e-11  Score=110.11  Aligned_cols=181  Identities=15%  Similarity=0.194  Sum_probs=122.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc--eeEeceEEeeCC---eEEEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN--IVEFEGAYEDKQ---NLHLVM  151 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--i~~~~~~~~~~~---~~~lv~  151 (366)
                      +.++.|....||++.     ..+++|+...     ......+.+|..+|+.+..+..  +++++......+   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999853     5689997532     1345678999999999864433  344544433333   347899


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 017768          152 ELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-----------------------------------------  190 (366)
Q Consensus       152 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-----------------------------------------  190 (366)
                      ++++|.+|......  .++..+...++.+++..|..||+                                         
T Consensus        96 ~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99999888654332  36788888899999999999986                                         


Q ss_pred             -----------------cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCC---Ccccccc---
Q 017768          191 -----------------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYY---VAPEVLH---  247 (366)
Q Consensus       191 -----------------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~~~---  247 (366)
                                       ..++|+|++|.||+++.+ +...+.|+||+.+..........   ....+   ..|+...   
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~---~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFI---SLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHH---TTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHH---HHHhhccccCHHHHHHHH
Confidence                             136999999999999531 14457899999987543221111   11111   2232211   


Q ss_pred             ccC------------CCchhHHHHHHHHHHHHhCCCCC
Q 017768          248 QRY------------GKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       248 ~~~------------~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                      ..|            ..-.+.|+++.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111            12268999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.93  E-value=1e-08  Score=90.50  Aligned_cols=133  Identities=20%  Similarity=0.201  Sum_probs=99.2

Q ss_pred             ecccCce-EEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCC
Q 017768           79 LGRGQFG-VTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGG  157 (366)
Q Consensus        79 lG~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  157 (366)
                      +..|..| .||+......+..+++|.-..      .....+..|...|+.+..+--+++++.+..+.+..++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445444 689887776678899997643      235568899999999986555788999999999999999999998


Q ss_pred             chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 017768          158 ELFDRIIAKGIYSEREAANICRQIVNVVHACHFM----------------------------------------------  191 (366)
Q Consensus       158 ~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------------------------  191 (366)
                      ++.+....    .......+..++...|..||..                                              
T Consensus       106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            88776543    2233445667777777777742                                              


Q ss_pred             ------------CCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          192 ------------GVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       192 ------------~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                                  .++|+|+.+.|||++   +++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                        169999999999994   444567999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.89  E-value=2.3e-08  Score=90.10  Aligned_cols=137  Identities=19%  Similarity=0.312  Sum_probs=94.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC--ceeEeceEEe-eCCeEEEEEec
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP--NIVEFEGAYE-DKQNLHLVMEL  153 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~i~~~~~~~~-~~~~~~lv~e~  153 (366)
                      +.++.|....||+.     |..+++|+-..     ......+..|..+|+.+.++-  .+++++.+.. ..+..+++||+
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            45788998999986     56789987421     234567899999999998542  3566666664 44567899999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 017768          154 CSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM------------------------------------------  191 (366)
Q Consensus       154 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------------------  191 (366)
                      ++|.++.....  ..++..+...++.++...|..||+.                                          
T Consensus        95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            99988866321  2245555555556666655555542                                          


Q ss_pred             ------------------CCEEeccCCCcEEeeecCCCCCE-EEeecCCcccc
Q 017768          192 ------------------GVIHRDLKPENFLLASKEEDSPI-KATDFGLSVFI  225 (366)
Q Consensus       192 ------------------~ivH~Dlkp~NIll~~~~~~~~v-kl~Dfg~a~~~  225 (366)
                                        .++|+|++|.|||++..+.++.+ .|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              35999999999999532223454 89999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.58  E-value=3.2e-07  Score=85.70  Aligned_cols=80  Identities=19%  Similarity=0.107  Sum_probs=51.4

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccc-cc---cccHHHHHHHHHHHHHhcCC-C-ceeEeceEEeeCCeEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKL-VY---DKDMEDVRREILILQHLTGQ-P-NIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~e~~~l~~l~~h-~-~i~~~~~~~~~~~~~~l  149 (366)
                      .+.||.|.++.||++....+++.+++|....... ..   ......+..|..+|+.+... + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            3578999999999997655678999997643211 00   12345677899999988643 2 34566544  3445689


Q ss_pred             EEeccCCC
Q 017768          150 VMELCSGG  157 (366)
Q Consensus       150 v~e~~~~~  157 (366)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=1.9e-07  Score=85.90  Aligned_cols=84  Identities=8%  Similarity=0.033  Sum_probs=55.4

Q ss_pred             ecee-cccCceEEEEEEEc--c----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC--CceeEeceEEeeC--
Q 017768           76 DKEL-GRGQFGVTYLCTKK--A----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--PNIVEFEGAYEDK--  144 (366)
Q Consensus        76 ~~~l-G~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~--  144 (366)
                      .+.| +.|....+|+....  .    ++..+++|+..............+.+|+.+++.+..+  -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999987653  1    1568999976432200000124577888998888754  3577788776655  


Q ss_pred             -CeEEEEEeccCCCch
Q 017768          145 -QNLHLVMELCSGGEL  159 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L  159 (366)
                       +..++||||++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             356899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=5.3e-06  Score=75.38  Aligned_cols=74  Identities=14%  Similarity=0.125  Sum_probs=43.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC-CceeEece------EEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ-PNIVEFEG------AYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~i~~~~~------~~~~~~~~~l  149 (366)
                      +.|+.|..+.||++...  +..+++|+....       ...+..|..+++.+..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            35666778899998764  446999987531       23444566666666421 13444443      1234677899


Q ss_pred             EEeccCCCch
Q 017768          150 VMELCSGGEL  159 (366)
Q Consensus       150 v~e~~~~~~L  159 (366)
                      +|+|++|..+
T Consensus       109 l~~~i~G~~~  118 (346)
T 2q83_A          109 VYDWIEGRPF  118 (346)
T ss_dssp             EEECCCCBCC
T ss_pred             EEEeecCccC
Confidence            9999998643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.23  E-value=7.6e-06  Score=76.90  Aligned_cols=77  Identities=12%  Similarity=0.063  Sum_probs=46.1

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccc-ccc-----ccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKL-VYD-----KDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.||.|..+.||++..  ++..++||....... ...     .....+..|+..+..-.....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            35689999999999864  477899994332111 011     12233444444333222234567777664  456789


Q ss_pred             EEecc-CC
Q 017768          150 VMELC-SG  156 (366)
Q Consensus       150 v~e~~-~~  156 (366)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.13  E-value=1.9e-05  Score=70.93  Aligned_cols=76  Identities=17%  Similarity=0.107  Sum_probs=60.5

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC--CceeEeceEEeeCCeEEEEEec
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--PNIVEFEGAYEDKQNLHLVMEL  153 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~lv~e~  153 (366)
                      .+.|+.|....+|+...  ++..+++|....      .....+..|...|+.+...  ..+++++.+....+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINER------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEG------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCc------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            35689999999999875  477899997643      2356788999999998643  5688888888888889999999


Q ss_pred             cCCCch
Q 017768          154 CSGGEL  159 (366)
Q Consensus       154 ~~~~~L  159 (366)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.04  E-value=1.5e-05  Score=71.27  Aligned_cols=72  Identities=8%  Similarity=0.011  Sum_probs=46.1

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEecc-
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC-  154 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-  154 (366)
                      .+.|+.|....+|++      ..+++|+.....    .......+|+.+++.+..+.-.++++..  +.+.-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            467889999999998      568999875421    1111235688888887644333566554  333447899999 


Q ss_pred             CCCch
Q 017768          155 SGGEL  159 (366)
Q Consensus       155 ~~~~L  159 (366)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66555

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.92  E-value=0.00012  Score=61.16  Aligned_cols=135  Identities=16%  Similarity=0.057  Sum_probs=89.1

Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCceecc
Q 017768          157 GELFDRIIAK-GIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEI  234 (366)
Q Consensus       157 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~  234 (366)
                      .+|.+.|... .+++++++|.++.|.+..|..+-. ..-..+=+.|..|++   ..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            4899999875 579999999999999999877622 122233345688888   5667776653 1110           


Q ss_pred             cCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 017768          235 VGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTK  314 (366)
Q Consensus       235 ~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  314 (366)
                      .....+.|||......+.+.=|||||+++|..+--..|-                     ..-..+++.+.+||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHhc
Confidence            122346788876555667889999999999888633331                     11125799999999999865


Q ss_pred             C-------------------------cCCCCCHHHHhc
Q 017768          315 D-------------------------PKKRITAAEALE  327 (366)
Q Consensus       315 d-------------------------p~~Rpt~~~~l~  327 (366)
                      +                         +..|.++.+|++
T Consensus       157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             CC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            2                         357888988886

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.89  E-value=2.4e-05  Score=70.48  Aligned_cols=139  Identities=17%  Similarity=0.096  Sum_probs=78.0

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceE------EeeCCeEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGA------YEDKQNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~------~~~~~~~~  148 (366)
                      .+.|+.|....+|+....  +..+++|+....     .....+..|+.+++.+..+. .+++++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            345778888999998764  347889987542     12335667888888876431 13444421      12346678


Q ss_pred             EEEeccCCCchH----H----------HHHHh-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH
Q 017768          149 LVMELCSGGELF----D----------RIIAK-GIY--------SEREAANI---------------CRQIVNVVHACHF  190 (366)
Q Consensus       149 lv~e~~~~~~L~----~----------~l~~~-~~l--------~~~~~~~i---------------~~qi~~~l~~LH~  190 (366)
                      ++++|++|..+.    .          .++.. ..+        ........               -..+...+..++.
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999886431    0          11111 011        11100000               0113344555553


Q ss_pred             -------cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 -------MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 -------~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                             .+++|+|++++|||++   ++..+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence                   3699999999999995   333357999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=0.00017  Score=63.84  Aligned_cols=78  Identities=19%  Similarity=0.094  Sum_probs=54.6

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCc--eeEeceEEeeCCeEEEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPN--IVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--i~~~~~~~~~~~~~~lv  150 (366)
                      ..-++.+|.|..+.||+.+.. +|+.|++|+.....   ......+..|...|+.+.....  +++++.+  +.  .+++
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv   88 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLA   88 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEE
Confidence            344577999999999999865 78999999764322   2233467889999999864322  4455543  33  3789


Q ss_pred             EeccCCCc
Q 017768          151 MELCSGGE  158 (366)
Q Consensus       151 ~e~~~~~~  158 (366)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.75  E-value=5.6e-05  Score=68.53  Aligned_cols=140  Identities=15%  Similarity=0.079  Sum_probs=71.6

Q ss_pred             eecccCceE-EEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceEEeeCCeEEEEEeccC
Q 017768           78 ELGRGQFGV-TYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        78 ~lG~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .|+.|+... +|+... .+|..+++|......      ...+..|+.+++.+..+. .+++++.+....+  +++||++.
T Consensus        25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             C--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             ECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            455555444 556543 236778887543221      123456777777776432 3556666533333  78999997


Q ss_pred             CCchHHHHHHhC--------------------------CCCHHHHH-------HHH-------------HHHHHHHHHH-
Q 017768          156 GGELFDRIIAKG--------------------------IYSEREAA-------NIC-------------RQIVNVVHAC-  188 (366)
Q Consensus       156 ~~~L~~~l~~~~--------------------------~l~~~~~~-------~i~-------------~qi~~~l~~L-  188 (366)
                      +..+.+++....                          .+......       .+.             ..+...+..+ 
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            766654432210                          01121110       000             0111122233 


Q ss_pred             -----HHcCCEEeccCCCcEEeeecCC-CCCEEEeecCCccccc
Q 017768          189 -----HFMGVIHRDLKPENFLLASKEE-DSPIKATDFGLSVFIE  226 (366)
Q Consensus       189 -----H~~~ivH~Dlkp~NIll~~~~~-~~~vkl~Dfg~a~~~~  226 (366)
                           +...++|+|+.+.|||++.+.. .+.+.|+||+.+....
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence                 1236999999999999953111 1568999999887643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.71  E-value=5.5e-05  Score=69.77  Aligned_cols=140  Identities=14%  Similarity=0.165  Sum_probs=82.9

Q ss_pred             ceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +.|..|....+|++....       ++..+++|+....    ........+|..+++.+..+.-.+++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            457778888899987642       3578999985321    12355667899999998765555677766543    28


Q ss_pred             EEeccCCCchHH--------------HHH---HhC-----CCC--HHHHHHHHHHHHH-------------------HHH
Q 017768          150 VMELCSGGELFD--------------RII---AKG-----IYS--EREAANICRQIVN-------------------VVH  186 (366)
Q Consensus       150 v~e~~~~~~L~~--------------~l~---~~~-----~l~--~~~~~~i~~qi~~-------------------~l~  186 (366)
                      ||||++|..|..              .+.   ...     ...  ..++..++.++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998754421              111   100     111  3455555544422                   233


Q ss_pred             HHH----H----cCCEEeccCCCcEEeeec-CCCCCEEEeecCCccc
Q 017768          187 ACH----F----MGVIHRDLKPENFLLASK-EEDSPIKATDFGLSVF  224 (366)
Q Consensus       187 ~LH----~----~~ivH~Dlkp~NIll~~~-~~~~~vkl~Dfg~a~~  224 (366)
                      .|.    .    ..++|+|+.++|||++.. +..+.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    2    249999999999999643 1235799999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.70  E-value=8.9e-05  Score=69.75  Aligned_cols=74  Identities=12%  Similarity=0.119  Sum_probs=50.7

Q ss_pred             eceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           76 DKELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      .+.|+.|....||++....       ++..+++|+....     .....+..|..+++.+..+.-.+++++.+.  +  .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence            3568888889999998652       2578999987321     112455689999999875544567776543  2  2


Q ss_pred             EEEeccCCCc
Q 017768          149 LVMELCSGGE  158 (366)
Q Consensus       149 lv~e~~~~~~  158 (366)
                      +|+||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.67  E-value=0.00016  Score=65.17  Aligned_cols=75  Identities=11%  Similarity=0.111  Sum_probs=49.3

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceE-----EeeCCeEEEEE
Q 017768           78 ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGA-----YEDKQNLHLVM  151 (366)
Q Consensus        78 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~-----~~~~~~~~lv~  151 (366)
                      .|+ |....||++... +|+.+++|......    .....+..|..+++.+..+. .+++++..     ...++..+++|
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            466 778899987643 46789999875321    23456777888888886332 24444442     22355678899


Q ss_pred             eccCCCc
Q 017768          152 ELCSGGE  158 (366)
Q Consensus       152 e~~~~~~  158 (366)
                      ++++|..
T Consensus       107 ~~i~G~~  113 (328)
T 1zyl_A          107 PSVGGRQ  113 (328)
T ss_dssp             ECCCCEE
T ss_pred             EecCCCC
Confidence            9998754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.55  E-value=0.00016  Score=66.48  Aligned_cols=76  Identities=9%  Similarity=0.096  Sum_probs=45.7

Q ss_pred             eceecccCceEEEEEEEcc--------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           76 DKELGRGQFGVTYLCTKKA--------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .+.|+.|....+|++....        .+..+++|+.....    ........|..+++.+..+.-++++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            3467888888999987653        13688999764321    11112467888888887443355666543  22  


Q ss_pred             EEEEeccCCCch
Q 017768          148 HLVMELCSGGEL  159 (366)
Q Consensus       148 ~lv~e~~~~~~L  159 (366)
                      ++||||++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.46  E-value=0.00047  Score=65.23  Aligned_cols=76  Identities=13%  Similarity=0.089  Sum_probs=49.3

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccC
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCS  155 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  155 (366)
                      .+.|+.|....+|++.....+..+++|+.....    ...-....|..+++.+..+.-.+++++.+.  +  .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            346788888999999876435789999874321    111112589999999985554567777663  3  25999998


Q ss_pred             CCch
Q 017768          156 GGEL  159 (366)
Q Consensus       156 ~~~L  159 (366)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.37  E-value=0.0012  Score=59.81  Aligned_cols=69  Identities=12%  Similarity=0.034  Sum_probs=43.9

Q ss_pred             cccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCC--CceeEeceE------EeeCCeEEEEE
Q 017768           80 GRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ--PNIVEFEGA------YEDKQNLHLVM  151 (366)
Q Consensus        80 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~------~~~~~~~~lv~  151 (366)
                      |.|....||+.... +| .+++|+.....         ...|+.+++.|..+  +.+++++..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~---------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYH---------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSS---------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCcc---------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            44446889998754 45 89999875432         13566667666522  334555432      23456789999


Q ss_pred             eccCCCch
Q 017768          152 ELCSGGEL  159 (366)
Q Consensus       152 e~~~~~~L  159 (366)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.84  E-value=0.0019  Score=60.42  Aligned_cols=76  Identities=11%  Similarity=0.127  Sum_probs=49.7

Q ss_pred             eceecccCceEEEEEEEccC-------CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           76 DKELGRGQFGVTYLCTKKAT-------GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ++.|..|....+|++.....       +..+++++.....    ...-...+|..+++.+..+.-.+++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            34577788889999886521       5789999864321    11123457888888887555556666543  23  7


Q ss_pred             EEEeccCCCch
Q 017768          149 LVMELCSGGEL  159 (366)
Q Consensus       149 lv~e~~~~~~L  159 (366)
                      +||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.50  E-value=0.0035  Score=58.21  Aligned_cols=32  Identities=28%  Similarity=0.419  Sum_probs=26.1

Q ss_pred             CEEeccCCCcEEeeec---CCCCCEEEeecCCccc
Q 017768          193 VIHRDLKPENFLLASK---EEDSPIKATDFGLSVF  224 (366)
Q Consensus       193 ivH~Dlkp~NIll~~~---~~~~~vkl~Dfg~a~~  224 (366)
                      ++|+|+.+.|||+...   ++...+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999542   3456799999998865

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=90.14  E-value=4.5  Score=35.89  Aligned_cols=74  Identities=14%  Similarity=0.128  Sum_probs=42.2

Q ss_pred             eEEEEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHH--HHHHHHHHHcC-----CEEeccCCCcEEeeecCCCCCEEE
Q 017768          146 NLHLVMELCSGGELFDRIIA--KGIYSEREAANICRQI--VNVVHACHFMG-----VIHRDLKPENFLLASKEEDSPIKA  216 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi--~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~vkl  216 (366)
                      ...++|+|.+|..|.+.-..  ...+.++    .+.++  +-++..+..+.     +-+.--+++|||+..  +++.+.+
T Consensus       156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~--~n~~~~~  229 (342)
T 1cja_A          156 ANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSE--RGATVVP  229 (342)
T ss_dssp             SEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEES--BTTCEEE
T ss_pred             cceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcccccCCCChhheEEeC--CCCeEEE
Confidence            56799999987665431100  0112222    23332  23455555543     112235899999974  3447999


Q ss_pred             eecCCcccc
Q 017768          217 TDFGLSVFI  225 (366)
Q Consensus       217 ~Dfg~a~~~  225 (366)
                      +|-+++...
T Consensus       230 IDhn~af~~  238 (342)
T 1cja_A          230 IDSKIIPLD  238 (342)
T ss_dssp             CSCCCCCCC
T ss_pred             EcCCccccC
Confidence            999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.33  E-value=3.2  Score=34.43  Aligned_cols=121  Identities=12%  Similarity=0.163  Sum_probs=77.5

Q ss_pred             HHHHHHHhcCCCceeEeceEEeeCCeEEEEEeccCCC-chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccC
Q 017768          121 EILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGG-ELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLK  199 (366)
Q Consensus       121 e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  199 (366)
                      |+..|..  .+|+++.. .+-..++.+.|.++.-+.+ ++.. +.   .++..+.+.++.+|+....++  ..=+|--|+
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~  106 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLA  106 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCS
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEe
Confidence            4444444  47888866 4666677777777665422 3322 32   368889999999998877443  445788899


Q ss_pred             CCcEEeeecCCCCCEEEeecCCcccccCCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCC
Q 017768          200 PENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPF  273 (366)
Q Consensus       200 p~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf  273 (366)
                      |+||++   +.++.+++.-.|+-..+.                |.-    ++...=+-.+=+++..+++++..|
T Consensus       107 P~NL~f---~~~~~p~i~~RGik~~l~----------------P~~----~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          107 PDELFF---TRDGLPIAKTRGLQNVVD----------------PLP----VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGGEEE---CTTSCEEESCCEETTTBS----------------CCC----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             cceEEE---cCCCCEEEEEccCccCCC----------------CCC----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999   678889998877643322                211    111112224456777888887776

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.13  E-value=4.3  Score=33.76  Aligned_cols=84  Identities=14%  Similarity=0.075  Sum_probs=60.2

Q ss_pred             CCCceeEeceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHHHcCCEEeccCCCcEEeeec
Q 017768          130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH-ACHFMGVIHRDLKPENFLLASK  208 (366)
Q Consensus       130 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~ivH~Dlkp~NIll~~~  208 (366)
                      .+|++  -..+-..++.+.|.++.-+++.=+..++   .++..+.++++.+|+.... ++  ..-+|--|+|+||++   
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f---  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF---  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE---
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE---
Confidence            46888  4444567777777777664443334443   3688999999999887655 33  556788899999999   


Q ss_pred             CCCCCEEEeecCCcc
Q 017768          209 EEDSPIKATDFGLSV  223 (366)
Q Consensus       209 ~~~~~vkl~Dfg~a~  223 (366)
                      +.++.+++.-.|+-.
T Consensus       118 ~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          118 NRALEPFFLHVGVKE  132 (219)
T ss_dssp             CTTCCEEESCCEETT
T ss_pred             eCCCcEEEEEcCCcc
Confidence            678889998877643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.60  E-value=0.18  Score=47.63  Aligned_cols=63  Identities=10%  Similarity=0.064  Sum_probs=17.7

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEE------EEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEe
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYAC------KSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYE  142 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~  142 (366)
                      +.+.||   ||.||+|.+.....+||+      |...... ........+.+|..+.+.+. |+|+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc-cccccccccccccccccccc-ccccCCCcceEE
Confidence            345676   999999998755568888      6554322 12233456777888888776 999999888764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	366
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-96
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-90
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-90
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-89
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-88
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-85
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-83
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-82
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-82
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-81
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-81
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-81
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-80
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-79
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-78
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-74
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-74
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-72
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-72
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-69
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-68
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-66
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-65
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-64
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-64
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-64
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-63
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-63
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-62
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-58
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-55
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-44
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-22
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	2e-04

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  288 bits (737), Expect = 1e-96
 Identities = 128/295 (43%), Positives = 175/295 (59%), Gaps = 5/295 (1%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           DI  IYD    LG G F    L   K T +  A K I+++ L  +     +  EI +L  
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHK 63

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           +   PNIV  +  YE   +L+L+M+L SGGELFDRI+ KG Y+ER+A+ +  Q+++ V  
Sbjct: 64  IK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H +G++HRDLKPEN L  S +EDS I  +DFGLS   + G V     G+  YVAPEVL 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            + Y K +D WS GVI YILL G PPF+ E +  +FE IL+   +  S  W  IS  AKD
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKK 361
            IR ++ KDP+KR T  +AL+HPW+  D A  DK I  +V  ++K+  A +K K+
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTA-LDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  270 bits (692), Expect = 8e-90
 Identities = 88/296 (29%), Positives = 154/296 (52%), Gaps = 12/296 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + ++LGRG+FG+ + C + ++ + Y  K +  +      D   V++EI IL       
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHR 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFM 191
           NI+    ++E  + L ++ E  SG ++F+RI       +ERE  +   Q+   +   H  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRY 250
            + H D++PEN +  ++   S IK  +FG +  ++ G  ++ +  +  Y APEV  H   
Sbjct: 122 NIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
               D+WS G ++Y+LLSG+ PF AET + I E I+          +  IS +A D + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLALKV 366
           +L K+ K R+TA+EAL+HPWLK+      + + + V+  +K  R  + + K  L +
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKI----ERVSTKVIRTLKHRRYYHTLIKKDLNM 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  271 bits (695), Expect = 9e-90
 Identities = 101/283 (35%), Positives = 157/283 (55%), Gaps = 7/283 (2%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG G FGV + C +KATGR +  K I+        D   V+ EI I+  L   P
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HP 86

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGI-YSEREAANICRQIVNVVHACHFM 191
            ++    A+EDK  + L++E  SGGELFDRI A+    SE E  N  RQ    +   H  
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
            ++H D+KPEN +    ++ S +K  DFGL+  +   ++ K    +A + APE++  +  
Sbjct: 147 SIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G   D+W+ GV+ Y+LLSG+ PF  E +    + +   + +     + S+S +AKD I+ 
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265

Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF 353
           +L K+P+KR+T  +ALEHPWLK D +     I S+   +++Q 
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  269 bits (688), Expect = 1e-89
 Identities = 104/274 (37%), Positives = 149/274 (54%), Gaps = 16/274 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLV------YDKDMEDVRREILILQ 126
           Y+  + LGRG   V   C  K T ++YA K I              +  E   +E+ IL+
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
            ++G PNI++ +  YE      LV +L   GELFD +  K   SE+E   I R ++ V+ 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           A H + ++HRDLKPEN LL    +D  IK TDFG S  ++ G+  +E+ G+  Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 247 -------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
                  H  YGKE+D+WS GVI+Y LL+G PPFW   +  +   I+ GN    S  W  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            S   KDL+ + L   P+KR TA EAL HP+ ++
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  267 bits (684), Expect = 3e-88
 Identities = 97/271 (35%), Positives = 142/271 (52%), Gaps = 7/271 (2%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           YD+ +ELG G FGV +  T++ATG  +A K +       + D E VR+EI  +  L   P
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HP 83

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFM 191
            +V    A+ED   + ++ E  SGGELF+++  +    SE EA    RQ+   +   H  
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
             +H DLKPEN +  +K   + +K  DFGL+  ++  +  K   G+A + APEV   +  
Sbjct: 144 NYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G   D+WS GV+ YILLSG+ PF  E +      +   + ++  S +  IS   KD IRK
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262

Query: 311 MLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           +L  DP  R+T  +ALEHPWL    A     
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (657), Expect = 3e-85
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 10/265 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +++ + LG+G+FG  YL  +K +    A K + + +L        +RRE+ I  HL   P
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHP 66

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NI+   G + D   ++L++E    G ++  +     + E+  A    ++ N +  CH   
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYG 251
           VIHRD+KPEN LL S      +K  DFG SV   + +    + G+  Y+ PE++  + + 
Sbjct: 127 VIHRDIKPENLLLGS---AGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 182

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           +++D+WS GV+ Y  L G PPF A T +  ++ I              ++  A+DLI ++
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISRL 238

Query: 312 LTKDPKKRITAAEALEHPWLKEDGA 336
           L  +P +R    E LEHPW+  + +
Sbjct: 239 LKHNPSQRPMLREVLEHPWITANSS 263

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 4e-83
 Identities = 108/271 (39%), Positives = 163/271 (60%), Gaps = 6/271 (2%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKD---MEDVRREILI 124
           ++   YD  +ELG GQF V   C +K+TG +YA K I +R+    +     ED+ RE+ I
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 125 LQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNV 184
           L+ +   PN++     YE+K ++ L++EL +GGELFD +  K   +E EA    +QI+N 
Sbjct: 67  LKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 185 VHACHFMGVIHRDLKPENFLLASKEEDSP-IKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
           V+  H + + H DLKPEN +L  +    P IK  DFGL+  I+ G  +K I G+  +VAP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
           E++ ++  G E D+WS GVI YILLSG  PF  +T++     +   N + +   + + S 
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
            AKD IR++L KDPKKR+T  ++L+HPW+K 
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (640), Expect = 2e-82
 Identities = 82/285 (28%), Positives = 135/285 (47%), Gaps = 19/285 (6%)

Query: 67  VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQ 126
           ++    +++  ELG G FG  Y    K T    A K I  +    ++++ED   EI IL 
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILA 64

Query: 127 HLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVV 185
                PNIV+   A+  + NL +++E C+GG +   ++  +   +E +   +C+Q ++ +
Sbjct: 65  SCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 186 HACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPE 244
           +  H   +IHRDLK  N L      D  IK  DFG+S     T +     +G+ Y++APE
Sbjct: 124 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 245 VLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP 298
           V+       + Y  + DVWS G+ L  +    PP        +   I +      + P  
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-S 239

Query: 299 SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPID 343
             S   KD ++K L K+   R T ++ L+HP++  D   S+KPI 
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPIR 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  251 bits (642), Expect = 2e-82
 Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 16/302 (5%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D   ++   +E+G G FG  Y           A K +S      ++  +D+ +E+  LQ 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
           L   PN +++ G Y  +    LVME C G       + K    E E A +    +  +  
Sbjct: 72  LR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
            H   +IHRD+K  N LL+   E   +K  DFG +  +     +   VG+ Y++APEV+ 
Sbjct: 131 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 184

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
                +Y  ++DVWS G+    L    PP +          I +   +  +      S  
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEY 242

Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD-KPIDSAVLTRMKQFRAMN--KMK 360
            ++ +   L K P+ R T+   L+H ++  +   +    +       +++   +   KMK
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMK 302

Query: 361 KL 362
           K+
Sbjct: 303 KI 304

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 2e-81
 Identities = 85/265 (32%), Positives = 129/265 (48%), Gaps = 12/265 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   K LG G F    L  + AT R+YA K + +R ++ +  +  V RE  ++  L   P
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             V+    ++D + L+  +     GEL   I   G + E        +IV+ +   H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVL-HQ 248
           +IHRDLKPEN LL    ED  I+ TDFG +  +            VG+A YV+PE+L  +
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
              K  D+W+ G I+Y L++G+PPF A  E  IF+ I++   D           +A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD----FPEKFFPKARDLV 241

Query: 309 RKMLTKDPKKRITAAEALEHPWLKE 333
            K+L  D  KR+   E   +  LK 
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKA 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 2e-81
 Identities = 95/303 (31%), Positives = 151/303 (49%), Gaps = 19/303 (6%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNI 134
             + LG G  G       K T  K+A K +        +D    RRE+ +    +  P+I
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHI 67

Query: 135 VEFEGAYED----KQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHAC 188
           V     YE+    ++ L +VME   GGELF RI  +G   ++EREA+ I + I   +   
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-H 247
           H + + HRD+KPEN L  SK  ++ +K TDFG +    +         + YYVAPEVL  
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFEAILEGNLDLQSSPWPSISGQ 303
           ++Y K  D+WS GVI+YILL G PPF++        G+   I  G  +  +  W  +S +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247

Query: 304 AKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQFRAMNKMKKLA 363
            K LIR +L  +P +R+T  E + HPW+ +       P+ ++ + +  + R  +  +++ 
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 307

Query: 364 LKV 366
             +
Sbjct: 308 SAL 310

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (633), Expect = 3e-81
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 11/276 (3%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D    Y   +++G+G  G  Y     ATG++ A + ++ ++       E +  EIL+++ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRE 73

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHA 187
               PNIV +  +Y     L +VME  +GG L D ++ +    E + A +CR+ +  +  
Sbjct: 74  N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE-TGKVYKEIVGSAYYVAPEVL 246
            H   VIHRD+K +N LL     D  +K TDFG    I         +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
             + YG ++D+WS G++   ++ G PP+  E        I       +      +S   +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKP 341
           D + + L  D +KR +A E L+H +LK     S   
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 2e-80
 Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 12/267 (4%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +DL + LG G +G   L   + T    A K +  ++ V     E++++EI I + L    
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 63

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           N+V+F G   +    +L +E CSGGELFDRI       E +A     Q++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVL--H 247
           + HRD+KPEN LL   +E   +K +DFGL+         ++  ++ G+  YVAPE+L   
Sbjct: 124 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 248 QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           + + + +DVWS G++L  +L+G  P+   ++     +  +       +PW  I      L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLAL 239

Query: 308 IRKMLTKDPKKRITAAEALEHPWLKED 334
           + K+L ++P  RIT  +  +  W  + 
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKP 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 6e-79
 Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 14/267 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
              D E+GRG F   Y      T  + A   +  RKL    + +  + E  +L+ L   P
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ-HP 68

Query: 133 NIVEFEGAYED----KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
           NIV F  ++E     K+ + LV EL + G L   +    +   +   + CRQI+  +   
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 189 HFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL 246
           H     +IHRDLK +N  +        +K  D GL+         K ++G+  ++APE+ 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY 185

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            ++Y + +DV++ G+ +  + +   P+   +    I+  +  G      S       + K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVK 243

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLK 332
           ++I   + ++  +R +  + L H + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 6e-78
 Identities = 79/264 (29%), Positives = 131/264 (49%), Gaps = 10/264 (3%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + L K LG+G FG  +L   K T + +A K++ +  ++ D D+E    E  +L      P
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +      ++ K+NL  VME  +GG+L   I +   +    A     +I+  +   H  G
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-KVYKEIVGSAYYVAPEVL-HQRY 250
           +++RDLK +N L    ++D  IK  DFG+      G        G+  Y+APE+L  Q+Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
              +D WS GV+LY +L G  PF  + E+ +F +I   N          +  +AKDL+ K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLVK 236

Query: 311 MLTKDPKKRITAA-EALEHPWLKE 333
           +  ++P+KR+    +  +HP  +E
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (598), Expect = 2e-76
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 21/272 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y++   +G G +G      +K+ G+    K +    +  + + + +  E+ +L+ L   P
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 63

Query: 133 NIVEFEGAYEDKQN--LHLVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVH 186
           NIV +     D+ N  L++VME C GG+L   I      +    E     +  Q+   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 187 ACHFMG-----VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYY 240
            CH        V+HRDLKP N  L  K+    +K  DFGL+  +       K  VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 241 VAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           ++PE ++   Y ++ D+WS G +LY L + +PPF A ++K +   I EG           
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIPYR 237

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEHPWL 331
            S +  ++I +ML      R +  E LE+P +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 1e-74
 Identities = 71/303 (23%), Positives = 114/303 (37%), Gaps = 49/303 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           ++   ELG G  GV +  + K +G   A K I     +       + RE+ +L      P
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECN-SP 64

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM- 191
            IV F GA+     + + ME   GG L   +   G   E+    +   ++  +       
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRY 250
            ++HRD+KP N L+ S+ E   IK  DFG+S  +         VG+  Y++PE L    Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHY 180

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEK---GIFEAILEG------------------- 288
             + D+WS G+ L  +  G  P      K    +F   +EG                   
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 289 ------------------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPW 330
                             N      P    S + +D + K L K+P +R    + + H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 331 LKE 333
           +K 
Sbjct: 301 IKR 303

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  230 bits (587), Expect = 5e-74
 Identities = 82/267 (30%), Positives = 133/267 (49%), Gaps = 16/267 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           + + + LG G FG  +L   +  GR YA K + +  +V  K +E    E L+L  +T  P
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 64

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I+   G ++D Q + ++M+   GGELF  +     +    A     ++   +   H   
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLHQR-YG 251
           +I+RDLKPEN LL    ++  IK TDFG + ++    V   + G+  Y+APEV+  + Y 
Sbjct: 125 IIYRDLKPENILLD---KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYN 179

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K ID WS G+++Y +L+G  PF+       +E IL   L       P  +   KDL+ ++
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRL 235

Query: 312 LTKDPKKRI-----TAAEALEHPWLKE 333
           +T+D  +R+        +   HPW KE
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 5e-72
 Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 20/268 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMED---VRREILILQHLT 129
           Y +   LG G FG  Y   + +     A K + + ++    ++ +   V  E+++L+ ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 130 GQ-PNIVEFEGAYEDKQNLHLVMELCSGG-ELFDRIIAKGIYSEREAANICRQIVNVVHA 187
                ++     +E   +  L++E      +LFD I  +G   E  A +   Q++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL- 246
           CH  GV+HRD+K EN L+        +K  DFG    ++   VY +  G+  Y  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIR 182

Query: 247 -HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            H+ +G+   VWS G++LY ++ G  PF  + E      I+ G +         +S + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVSSECQ 232

Query: 306 DLIRKMLTKDPKKRITAAEALEHPWLKE 333
            LIR  L   P  R T  E   HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  226 bits (577), Expect = 5e-72
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 14/270 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT--G 130
           + + + +GRG FG  Y C K  TG+ YA K + ++++   +       E ++L  ++   
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P IV    A+     L  +++L +GG+L   +   G++SE +      +I+  +   H 
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH--Q 248
             V++RDLKP N LL   +E   ++ +D GL+      K +   VG+  Y+APEVL    
Sbjct: 126 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGV 181

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI 308
            Y    D +S G +L+ LL G  PF     K   E I    L +      S S + + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLL 240

Query: 309 RKMLTKDPKKRIT-----AAEALEHPWLKE 333
             +L +D  +R+      A E  E P+ + 
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  223 bits (569), Expect = 6e-72
 Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 7/266 (2%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+L + LG G     +L       R  A K +              RRE      L   P
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 67

Query: 133 NIVEFEGAYEDKQN----LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
            IV      E +       ++VME   G  L D +  +G  + + A  +       ++  
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFG-LSVFIETGKVYKEIVGSAYYVAPEVL- 246
           H  G+IHRD+KP N ++++      +       ++    +      ++G+A Y++PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 247 HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
                   DV+S G +LY +L+G PPF  ++   +    +  +    S+    +S     
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 307 LIRKMLTKDPKKRITAAEALEHPWLK 332
           ++ K L K+P+ R   A  +    ++
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLVR 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 2e-70
 Identities = 87/268 (32%), Positives = 138/268 (51%), Gaps = 15/268 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG+G FG   L  +KATGR YA K + +  ++   ++     E  +LQ+    P
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HP 65

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +   + A++    L  VME  +GGELF  +  + +++E  A     +IV+ +   H   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVLH-QRY 250
           V++RD+K EN +L    +D  IK TDFGL       G   K   G+  Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 251 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRK 310
           G+ +D W  GV++Y ++ G  PF+ +  + +FE IL   +        ++S +AK L+  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAG 238

Query: 311 MLTKDPKKRI-----TAAEALEHPWLKE 333
           +L KDPK+R+      A E +EH +   
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 6e-69
 Identities = 75/287 (26%), Positives = 110/287 (38%), Gaps = 33/287 (11%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDM--EDVRREILILQHLTGQPNI 134
             LG GQF   Y    K T +  A K I        KD       REI +LQ L+  PNI
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62

Query: 135 VEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVI 194
           +    A+  K N+ LV +               + +           +  +   H   ++
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 195 HRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVL--HQRYG 251
           HRDLKP N LL   +E+  +K  DFGL+       + Y   V + +Y APE+L   + YG
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP------------- 298
             +D+W+ G IL  LL  VP    +++      I E         WP             
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 299 -----------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED 334
                      +      DLI+ +   +P  RITA +AL+  +    
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 2e-68
 Identities = 77/318 (24%), Positives = 125/318 (39%), Gaps = 48/318 (15%)

Query: 65  PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILI 124
           P+ D  + Y+   ++G+G FG  +    + TG+K A K +       +       REI I
Sbjct: 4   PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKI 62

Query: 125 LQHLTGQPNIVEFEGAYED--------KQNLHLVMELCSGGELFDRIIAKGIYSEREAAN 176
           LQ L    N+V                K +++LV + C              ++  E   
Sbjct: 63  LQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-----VY 231
           + + ++N ++  H   ++HRD+K  N L+     D  +K  DFGL+      K      Y
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 232 KEIVGSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN 289
              V + +Y  PE+L   + YG  ID+W AG I+  + +  P     TE+     I +  
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 290 LDLQSSPWPSI----------------------------SGQAKDLIRKMLTKDPKKRIT 321
             +    WP++                               A DLI K+L  DP +RI 
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 322 AAEALEHPWLKEDGATSD 339
           + +AL H +   D   SD
Sbjct: 299 SDDALNHDFFWSDPMPSD 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 1e-67
 Identities = 88/275 (32%), Positives = 142/275 (51%), Gaps = 17/275 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTK---KATGRKYACKSISRRKLVYD-KDMEDVRREILILQHL 128
           ++L K LG G +G  +L  K     TG+ YA K + +  +V   K  E  R E  +L+H+
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHAC 188
              P +V    A++ +  LHL+++  +GGELF  +  +  ++E E      +IV  +   
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE--TGKVYKEIVGSAYYVAPEVL 246
           H +G+I+RD+K EN LL   + +  +  TDFGLS        +   +  G+  Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 247 ---HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQ 303
                 + K +D WS GV++Y LL+G  PF  + EK     I    L  +      +S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 304 AKDLIRKMLTKDPKKRI-----TAAEALEHPWLKE 333
           AKDLI+++L KDPKKR+      A E  EH + ++
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-66
 Identities = 61/266 (22%), Positives = 110/266 (41%), Gaps = 19/266 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             + + +G G FG  Y           A K ++       + ++  + E+ +L+      
Sbjct: 10  ITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HV 64

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI-IAKGIYSEREAANICRQIVNVVHACHFM 191
           NI+ F G Y     L +V + C G  L+  + I +  +   +  +I RQ    +   H  
Sbjct: 65  NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ETGKVYKEIVGSAYYVAPEVLHQ 248
            +IHRDLK  N  L    ED  +K  DFGL+           ++++ GS  ++APEV+  
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 249 R----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ--SSPWPSISG 302
           +    Y  + DV++ G++LY L++G  P+     +     ++         S    +   
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEH 328
             K L+ + L K   +R    + L  
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-66
 Identities = 86/338 (25%), Positives = 130/338 (38%), Gaps = 48/338 (14%)

Query: 68  DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
           D+   Y     +G G +G+           + A K IS  +       +   REI IL  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 62

Query: 128 LTGQPNIVEF-----EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV 182
                NI+           E  ++++LV  L        +++     S         QI+
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQIL 119

Query: 183 NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK----VYKEIVGSA 238
             +   H   V+HRDLKP N LL        +K  DFGL+   +          E V + 
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 239 YYVAPEVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG-------- 288
           +Y APE++     Y K ID+WS G IL  +LS  P F  +        IL          
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 289 -------------------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHP 329
                              N    +  +P+   +A DL+ KMLT +P KRI   +AL HP
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296

Query: 330 WLKEDGATSDKPIDSAVLTRMKQFRAMNK--MKKLALK 365
           +L++    SD+PI  A      +   + K  +K+L  +
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  207 bits (528), Expect = 5e-65
 Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 49/299 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L ++LGRG++   +         K   K +   K       + ++REI IL++L G P
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGP 90

Query: 133 NIVEFEGAYED--KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
           NI+      +D   +   LV E  +  +           ++ +      +I+  +  CH 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 147

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL--HQ 248
           MG++HRD+KP N ++    E   ++  D+GL+ F   G+ Y   V S Y+  PE+L  +Q
Sbjct: 148 MGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFEAILEGNLDLQ- 293
            Y   +D+WS G +L  ++    PF+   +              + +++ I + N++L  
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 294 -------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                              S     +S +A D + K+L  D + R+TA EA+EHP+   
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 83/289 (28%), Positives = 122/289 (42%), Gaps = 34/289 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   +++G G +GV Y       G  +A K I   K   +       REI IL+ L    
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV+       K+ L LV E           + +G      A +   Q++N +  CH   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFI-ETGKVYKEIVGSAYYVAPEVL--HQR 249
           V+HRDLKP+N L+     +  +K  DFGL+       + Y   + + +Y AP+VL   ++
Sbjct: 121 VLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 250 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI--------- 300
           Y   ID+WS G I   +++G P F   +E      I        S  WP++         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 301 ----------------SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                DL+ KML  DP +RITA +ALEH + KE
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 3e-64
 Identities = 87/267 (32%), Positives = 136/267 (50%), Gaps = 16/267 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +D  K LG G FG   L   K +G  YA K + ++K+V  K +E    E  ILQ +   P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            +V+ E +++D  NL++VME  +GGE+F  +   G +SE  A     QIV      H + 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQRYG 251
           +I+RDLKPEN L+   ++   I+ TDFG +  ++       + G+   +APE++  + Y 
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYN 216

Query: 252 KEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKM 311
           K +D W+ GV++Y + +G PPF+A+    I+E I+ G +          S   KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----FPSHFSSDLKDLLRNL 272

Query: 312 LTKDPKKRI-----TAAEALEHPWLKE 333
           L  D  KR         +   H W   
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 9e-64
 Identities = 73/297 (24%), Positives = 110/297 (37%), Gaps = 46/297 (15%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G FGV Y      +G   A K +        +D     RE+ I++ L    
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-------QDKRFKNRELQIMRKL-DHC 73

Query: 133 NIVEFEGAY------EDKQNLHLVMELCSGG---ELFDRIIAKGIYSEREAANICRQIVN 183
           NIV     +      +D+  L+LV++               AK             Q+  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H  G+ HRD+KP+N LL    + + +K  DFG +  +  G+     + S YY AP
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

Query: 244 EVLHQR--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEG------------- 288
           E++     Y   IDVWSAG +L  LL G P F  ++       I++              
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 289 ------------NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                                P    +A  L  ++L   P  R+T  EA  H +  E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-63
 Identities = 73/316 (23%), Positives = 129/316 (40%), Gaps = 44/316 (13%)

Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           + K   ++  +Y   + +G G +G         TG K A K +  R    +   +   RE
Sbjct: 9   VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRE 67

Query: 122 ILILQHLTGQPNIVEFEGAYEDKQ------NLHLVMELCSGGELFDRIIAKGIYSEREAA 175
           + +L+H+    N++     +   +      + +LVM     G    +++      E    
Sbjct: 68  LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124

Query: 176 NICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIV 235
            +  Q++  +   H  G+IHRDLKP N  +    ED  +K  DFGL+   ++       V
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYV 179

Query: 236 GSAYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ 293
            + +Y APEV+    RY + +D+WS G I+  +++G   F         + I++      
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 294 SSPW---------------------------PSISGQAKDLIRKMLTKDPKKRITAAEAL 326
           +                               + S  A +L+ KML  D ++R+TA EAL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 327 EHPWLKEDGATSDKPI 342
            HP+ +    T D+P 
Sbjct: 300 AHPYFESLHDTEDEPQ 315

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-63
 Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 34/290 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y+  +++G G +G  +    + T    A K +       +       REI +L+ L    
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH-K 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
           NIV         + L LV E C            G        +   Q++  +  CH   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVLHQR-- 249
           V+HRDLKP+N L+     +  +K  +FGL+  F    + Y   V + +Y  P+VL     
Sbjct: 122 VLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 250 YGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFEAILEGNLDLQSSPWPS--------- 299
           Y   ID+WSAG I   L +   P F         + I           WPS         
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 300 ----------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                           ++   +DL++ +L  +P +RI+A EAL+HP+  +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 5e-63
 Identities = 76/294 (25%), Positives = 116/294 (39%), Gaps = 37/294 (12%)

Query: 73  YDLDKELGRGQFGVTYLCT-KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQ 131
           Y+   E+G G +G  +     K  GR  A K + R +   +       RE+ +L+HL   
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 132 --PNIVEF-----EGAYEDKQNLHLVMELCSGGEL-FDRIIAKGIYSEREAANICRQIVN 183
             PN+V           + +  L LV E        +   + +         ++  Q++ 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAP 243
            +   H   V+HRDLKP+N L+ S      IK  DFGL+           +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWP---- 298
           EVL    Y   +D+WS G I   +    P F   ++      IL+         WP    
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 299 -------------------SISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                               I    KDL+ K LT +P KRI+A  AL HP+ ++
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 8e-62
 Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 34/290 (11%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           +   +++G G +GV Y    K TG   A K I R     +       REI +L+ L   P
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-NHP 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCS-GGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM 191
           NIV+       +  L+LV E      + F    A          +   Q++  +  CH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLS-VFIETGKVYKEIVGSAYYVAPEVL--HQ 248
            V+HRDLKP+N L+     +  IK  DFGL+  F    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 249 RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPS--------- 299
            Y   +D+WS G I   +++    F  ++E      I           WP          
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 300 ----------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
                           +    + L+ +ML  DP KRI+A  AL HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 4e-61
 Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 22/287 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y L +++G G FG  YL T  A G + A K    +          +  E  I + + G  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGV 63

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I        +     +VMEL               +S +    +  Q+++ +   H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 193 VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY--------KEIVGSAYYVAPE 244
            IHRD+KP+NFL+   ++ + +   DFGL+      + +        K + G+A Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 245 VL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP----WPS 299
                   +  D+ S G +L     G  P+         +     +    S+P       
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 300 ISGQAKDLIRKMLTKDPKKRITAA---EALEHPWLKEDGATSDKPID 343
              +    +    +     +   +   +   + + ++ G + D   D
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ-GFSYDYVFD 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 5e-60
 Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 20/278 (7%)

Query: 66  YVDITTIYDLDKELGRGQFGVTYLCT--KKATGRKYACKSISRRKLVYDKDMEDVRREIL 123
           Y+D   +   DKELG G FG         K   +  A K + + +       +++  E  
Sbjct: 2   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEAN 60

Query: 124 ILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVN 183
           ++Q L   P IV   G  E  ++  LVME+   G L   +       ++    +  Q+  
Sbjct: 61  VMQQLD-NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 184 VVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE----IVGSAY 239
            +        +HRDL   N LL +       K +DFGLS  +   + Y +          
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 240 YVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW 297
           + APE + + ++  + DVWS GV+++   S G  P+       +   + +G    +    
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCP 232

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAE---ALEHPWLK 332
                +  DL+    T D + R   A     L + +  
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 7e-60
 Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 21/261 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             L + +G+G+FG   L   +  G K A K I       D   +    E  ++  L    
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HS 60

Query: 133 NIVEFEGA-YEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACH 189
           N+V+  G   E+K  L++V E  + G L D + ++G  +            +   +    
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 190 FMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVL-HQ 248
               +HRDL   N L++   ED+  K +DFGL+    + +          + APE L  +
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK 175

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           ++  + DVWS G++L+ + S G  P+     K +   + +G    +            ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYEV 232

Query: 308 IRKMLTKDPKKRITAAEALEH 328
           ++     D   R +  +  E 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-59
 Identities = 73/314 (23%), Positives = 121/314 (38%), Gaps = 40/314 (12%)

Query: 62  LGKPYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRRE 121
           L K   ++   Y     +G G +G         TG + A K +  R        +   RE
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 67

Query: 122 ILILQHLTGQPNIVEFEGAYEDKQNL----HLVMELCSGGELFDRIIAKGIYSEREAANI 177
           + +L+H+    N++     +   ++L     + +     G   + I+     ++     +
Sbjct: 68  LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGS 237
             QI+  +   H   +IHRDLKP N       ED  +K  DFGL+    T       V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARH--TDDEMTGYVAT 181

Query: 238 AYYVAPEVL--HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ-- 293
            +Y APE++     Y + +D+WS G I+  LL+G   F         + IL         
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241

Query: 294 -------------------------SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
                                    ++ +   +  A DL+ KML  D  KRITAA+AL H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301

Query: 329 PWLKEDGATSDKPI 342
            +  +     D+P+
Sbjct: 302 AYFAQYHDPDDEPV 315

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 3e-59
 Identities = 63/274 (22%), Positives = 102/274 (37%), Gaps = 24/274 (8%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
                 +G G FG       K  G +        ++     D  D   E+ +L  L   P
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------IAKGIYSEREAAN 176
           NI+   GA E +  L+L +E    G L D +                      S ++  +
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG 236
               +   +        IHRDL   N L+    E+   K  DFGLS   E          
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 237 SAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQS 294
              ++A E L +  Y    DVWS GV+L+ ++S G  P+   T   ++E + +G    + 
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245

Query: 295 SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
               +   +  DL+R+   + P +R + A+ L  
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-59
 Identities = 52/261 (19%), Positives = 106/261 (40%), Gaps = 17/261 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
               KELG GQFGV      +      A K I    +      ++   E  ++ +L+   
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HE 59

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRII-AKGIYSEREAANICRQIVNVVHACHFM 191
            +V+  G    ++ + ++ E  + G L + +   +  +  ++   +C+ +   +      
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE--IVGSAYYVAPEVL-HQ 248
             +HRDL   N L+    +   +K +DFGLS ++   +            +  PEVL + 
Sbjct: 120 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           ++  + D+W+ GV+++ + S G  P+   T     E I +G   L+       S +   +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTI 233

Query: 308 IRKMLTKDPKKRITAAEALEH 328
           +     +   +R T    L +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-59
 Identities = 62/270 (22%), Positives = 98/270 (36%), Gaps = 22/270 (8%)

Query: 75  LDKELGRGQFGVTYLCTKKATGRK--YACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
            D ELG G FG       +   ++   A K +  ++     D E++ RE  I+  L   P
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NP 69

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFM 191
            IV   G  +  + L LVME+  GG L   ++ K         A +  Q+   +      
Sbjct: 70  YIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE----IVGSAYYVAPEVL- 246
             +HRDL   N LL         K +DFGLS  +     Y            + APE + 
Sbjct: 129 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
            +++    DVWS GV ++  LS G  P+       +   I +G    +    P    +  
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELY 242

Query: 306 DLIRKMLTKDPKKRITAAE---ALEHPWLK 332
            L+        + R         +   +  
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-58
 Identities = 57/289 (19%), Positives = 104/289 (35%), Gaps = 40/289 (13%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGR-----KYACKSISRRKLVYDKDMEDVRREILILQH 127
            +  K LG G FG     T     +     + A K +  +      + E +  E+ ++  
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQ 96

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK--------------------- 166
           L    NIV   GA      ++L+ E C  G+L + + +K                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 167 --GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF 224
              + +  +      Q+   +    F   +HRDL   N L+        +K  DFGL+  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213

Query: 225 IETGK---VYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEK 279
           I +     V         ++APE L    Y  + DVWS G++L+ + S GV P+      
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 280 GIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
             F  +++    +    +   + +   +++     D +KR +       
Sbjct: 274 ANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 17/266 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISR-RKLVYDKDMEDVRREILILQHLTGQ 131
             +++ +G G+FG       K  G++    +I   +    +K   D   E  I+      
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-H 86

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHF 190
           PN++  EG       + ++ E    G L   +    G ++  +   + R I   +     
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE------IVGSAYYVAPE 244
           M  +HRDL   N L+     +   K +DFGLS F+E                   + APE
Sbjct: 147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
            + ++++    DVWS G++++ ++S G  P+W  T + +  AI +   D +  P      
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPS 260

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEH 328
               L+     KD   R    + +  
Sbjct: 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 53/315 (16%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y   K +G G  G+          R  A K +  R        +   RE+++++ +    
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCV-NHK 76

Query: 133 NIVEFEGAY------EDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVH 186
           NI+     +      E+ Q+++LVMEL            +        + +  Q++  + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIK 133

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVGSAYYVAPE-V 245
             H  G+IHRDLKP N ++   + D  +K  DFGL+    T  +    V + YY APE +
Sbjct: 134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 246 LHQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN---------------- 289
           L   Y + +D+WS G I+  ++     F        +  ++E                  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 290 ----------------------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
                                     S      + QA+DL+ KML  DP KRI+  +AL+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 328 HPWLKEDGATSDKPI 342
           HP++      ++   
Sbjct: 311 HPYINVWYDPAEVEA 325

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-57
 Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 17/261 (6%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
               +E+G GQFG+ +L        K A K+I    +      ED   E  ++  L+  P
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HP 60

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFM 191
            +V+  G   ++  + LV E    G L D +  +  +++      +C  +   +      
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 192 GVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE--IVGSAYYVAPEVL-HQ 248
            VIHRDL   N L+    E+  IK +DFG++ F+   +            + +PEV    
Sbjct: 121 CVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 249 RYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL 307
           RY  + DVWS GV+++ + S G  P+   +   + E I  G    +       S     +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQI 234

Query: 308 IRKMLTKDPKKRITAAEALEH 328
           +     + P+ R   +  L  
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-56
 Identities = 60/271 (22%), Positives = 95/271 (35%), Gaps = 19/271 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKAT---GRKYACKSISRRKLVYDKDMEDVRREILILQHLT 129
             L ++LG G FGV       A        A K +    L   + M+D  RE+  +  L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 130 GQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHAC 188
              N++   G       + +V EL   G L DR+    G +     +    Q+   +   
Sbjct: 70  -HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 189 HFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY----KEIVGSAYYVAPE 244
                IHRDL   N LLA       +K  DFGL   +     +    +       + APE
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 245 VL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG 302
            L  + +    D W  GV L+ + + G  P+       I   I +    L          
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQ 242

Query: 303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKE 333
              +++ +     P+ R T     +  +L E
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD--FLLE 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-56
 Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 14/262 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISR-RKLVYDKDMEDVRREILILQHLTGQ 131
            +L + +G GQFG  +     +        +I   +    D   E   +E L ++     
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DH 67

Query: 132 PNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHF 190
           P+IV+  G   +   + ++MELC+ GEL   +  +              Q+   +     
Sbjct: 68  PHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK--EIVGSAYYVAPEVL-H 247
              +HRD+   N L++S +    +K  DFGLS ++E    YK  +      ++APE +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 248 QRYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
           +R+    DVW  GV ++ IL+ GV PF       +   I  G    +    P+       
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYS 240

Query: 307 LIRKMLTKDPKKRITAAEALEH 328
           L+ K    DP +R    E    
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-56
 Identities = 59/269 (21%), Positives = 110/269 (40%), Gaps = 21/269 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             L+ +LG+G FG  ++ T   T R  A K++    +      E   +E  +++ L    
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKL-RHE 72

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHF 190
            +V+      ++  +++V E  S G L D +  +        +  ++  QI + +     
Sbjct: 73  KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE--IVGSAYYVAPEVL-H 247
           M  +HRDL+  N L+    E+   K  DFGL+  IE  +            + APE   +
Sbjct: 132 MNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            R+  + DVWS G++L  L + G  P+     + + + +  G    +    P       D
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHD 245

Query: 307 LIRKMLTKDPKKRITAAEALE--HPWLKE 333
           L+ +   K+P++R T          +   
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 5e-55
 Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 19/269 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             +  +LG GQ+G  Y    K      A K++         ++E+  +E  +++ +   P
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HP 73

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY--SEREAANICRQIVNVVHACHF 190
           N+V+  G    +   +++ E  + G L D +        S      +  QI + +     
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI--ETGKVYKEIVGSAYYVAPEVL-H 247
              IHRDL   N L+    E+  +K  DFGLS  +  +T   +        + APE L +
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
            ++  + DVW+ GV+L+ + + G+ P+       ++E + +   D +         +  +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 247

Query: 307 LIRKMLTKDPKKRITAAEALE--HPWLKE 333
           L+R     +P  R + AE  +      +E
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  180 bits (456), Expect = 8e-55
 Identities = 53/288 (18%), Positives = 98/288 (34%), Gaps = 22/288 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
           Y + + +G G FGV +  T     ++ A K   RR      D   +R E    + L G  
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 61

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
            I       ++  +  LV++L          +    +S +  A   +Q++  V + H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 193 VIHRDLKPENFLLASKE--EDSPIKATDFGLSVFIETG--------KVYKEIVGSAYYVA 242
           +++RD+KP+NFL+        + I   DFG+  F            +  K + G+A Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 243 PEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP----W 297
                 +   +  D+ + G +    L G  P+         +         QS+P     
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 298 PSISGQAKDLIRKMLTKDPKKRITAAEALE--HPWLKEDGATSDKPID 343
                +    +                        L+    T D+  D
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-54
 Identities = 52/261 (19%), Positives = 99/261 (37%), Gaps = 19/261 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             L + LG GQFG  ++        K A KS+ +  +      +    E  +++ L    
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQ 68

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY--SEREAANICRQIVNVVHACHF 190
            +V        +  ++++ E    G L D +        +  +  ++  QI   +     
Sbjct: 69  RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE--IVGSAYYVAPEVL-H 247
              IHRDL+  N L++        K  DFGL+  IE  +            + APE + +
Sbjct: 128 RNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 248 QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD 306
             +  + DVWS G++L  +++ G  P+   T   + + +  G    +     +   +   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQ 241

Query: 307 LIRKMLTKDPKKRITAAEALE 327
           L+R    + P+ R T      
Sbjct: 242 LMRLCWKERPEDRPTFDYLRS 262

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 30/281 (10%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGR-------KYACKSISRRKLVYDKDMEDVRREILIL 125
             L K LG G FG   L       +       K A K +       +KD+ D+  E+ ++
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMM 72

Query: 126 QHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRI----------------IAKGIY 169
           + +    NI+   GA      L++++E  S G L + +                  +   
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 170 SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK 229
           S ++  +   Q+   +        IHRDL   N L+                   I+  K
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 230 VYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILE 287
                     ++APE L  + Y  + DVWS GV+L+ + + G  P+     + +F+ + E
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 288 GNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
           G+   +     + + +   ++R      P +R T  + +E 
Sbjct: 253 GH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 62/283 (21%), Positives = 97/283 (34%), Gaps = 35/283 (12%)

Query: 73  YDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
               K LG G FG     T     K       A K +      +  + E +  E+ +L +
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSY 82

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG------------------IY 169
           L    NIV   GA        ++ E C  G+L + +  K                     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 170 SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK 229
              +  +   Q+   +        IHRDL   N LL         K  DFGL+  I+   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199

Query: 230 VY---KEIVGSAYYVAPEVLHQRY-GKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEA 284
            Y           ++APE +       E DVWS G+ L+ L S G  P+        F  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 285 ILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           +++    + S        +  D+++     DP KR T  + ++
Sbjct: 260 MIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-53
 Identities = 53/263 (20%), Positives = 94/263 (35%), Gaps = 14/263 (5%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISR--RKLVYDKDMEDVRREILILQHLTG 130
           +   K LG G FG  Y       G K       +  R+    K  +++  E  ++  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 131 QPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF 190
            P++    G         +   +  G  L      K     +   N C QI   ++    
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY---KEIVGSAYYVAPEVL- 246
             ++HRDL   N L+        +K TDFGL+  +   +     +       ++A E + 
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 247 HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK 305
           H+ Y  + DVWS GV ++ L++ G  P+       I   + +G    +    P  +    
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDVY 243

Query: 306 DLIRKMLTKDPKKRITAAEALEH 328
            ++ K    D   R    E +  
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (444), Expect = 6e-53
 Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 43/289 (14%)

Query: 73  YDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
            +  +++G G FG  +                A K +            D +RE  ++  
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAE 72

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIY------------------ 169
               PNIV+  G     + + L+ E  + G+L + + +   +                  
Sbjct: 73  F-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 170 ------SEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV 223
                 S  E   I RQ+   +        +HRDL   N L+    E+  +K  DFGLS 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSR 188

Query: 224 FIETGKVYKE---IVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETE 278
            I +   YK          ++ PE + + RY  E DVW+ GV+L+ + S G+ P++    
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 279 KGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
           + +   + +GN+    +   +   +  +L+R   +K P  R +      
Sbjct: 249 EEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 20/266 (7%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKLVYDKDMEDVRREILILQHL 128
               K +G G+FG  Y    K +        A K++       +K   D   E  I+   
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQF 66

Query: 129 TGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHA 187
               NI+  EG     + + ++ E    G L   +  K G +S  +   + R I   +  
Sbjct: 67  -SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 188 CHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY----KEIVGSAYYVAP 243
              M  +HRDL   N L+ S       K +DFGLS  +E                 + AP
Sbjct: 126 LANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 244 EVL-HQRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS 301
           E + ++++    DVWS G++++ +++ G  P+W  +   + +AI +G    +        
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCP 239

Query: 302 GQAKDLIRKMLTKDPKKRITAAEALE 327
                L+ +   ++  +R   A+ + 
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 57/287 (19%), Positives = 115/287 (40%), Gaps = 35/287 (12%)

Query: 73  YDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
             + +ELG+G FG+ Y    K         + A K+++       ++  +   E  +++ 
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKE 79

Query: 128 LTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKG----------IYSEREAANI 177
                ++V   G     Q   ++MEL + G+L   + +              S  +   +
Sbjct: 80  F-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 178 CRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYK---EI 234
             +I + +   +    +HRDL   N ++A   ED  +K  DFG++  I     Y+   + 
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 235 VGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFEAILEGNLDL 292
           +    +++PE L    +    DVWS GV+L+ + +    P+   + + +   ++EG L  
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL- 254

Query: 293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE------HPWLKE 333
                 +      +L+R     +PK R +  E +        P  +E
Sbjct: 255 --DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-48
 Identities = 56/269 (20%), Positives = 107/269 (39%), Gaps = 21/269 (7%)

Query: 72  IYDLDKELGRGQFGVTYLCT---KKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL 128
           I   ++ +GRG FG  Y  T           A KS+   ++    ++     E +I++  
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85

Query: 129 TGQPNIVEFEGA-YEDKQNLHLVMELCSGGELFD-RIIAKGIYSEREAANICRQIVNVVH 186
           +  PN++   G     + +  +V+     G+L +         + ++      Q+   + 
Sbjct: 86  S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144

Query: 187 ACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKE-----IVGSAYYV 241
                  +HRDL   N +L   +E   +K  DFGL+  +   +               ++
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 242 APEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS 299
           A E L  Q++  + DVWS GV+L+ L++ G PP+       I   +L+G   LQ    P 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 261

Query: 300 ISGQAKDLIRKMLTKDPKKRITAAEALEH 328
                 +++ K      + R + +E +  
Sbjct: 262 ---PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-46
 Identities = 65/283 (22%), Positives = 106/283 (37%), Gaps = 34/283 (12%)

Query: 73  YDLDKELGRGQFGVTYLCT-----KKATGRKYACKSISRRKLVYDKDMEDVRREILILQH 127
             L K LGRG FG           K AT R  A K +         +   +  E+ IL H
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIH 72

Query: 128 LTGQPNIVEFEGA-YEDKQNLHLVMELCSGGELFDRI----------------IAKGIYS 170
           +    N+V   GA  +    L +++E C  G L   +                + K   +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 171 EREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI---ET 227
                    Q+   +        IHRDL   N LL+   E + +K  DFGL+  I     
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189

Query: 228 GKVYKEIVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFEAI 285
                +      ++APE +  + Y  + DVWS GV+L+ + S    P+        F   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 286 LEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH 328
           L+    +++  +   + +    +      +P +R T +E +EH
Sbjct: 250 LKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 9e-46
 Identities = 54/297 (18%), Positives = 96/297 (32%), Gaps = 53/297 (17%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP 132
             L + +G+G+FG  +       G + A K  S R    ++       EI     L    
Sbjct: 5   IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HE 57

Query: 133 NIVEFEGAYEDKQN----LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIV------ 182
           NI+ F  A          L LV +    G LFD +    + +      +           
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-TVEGMIKLALSTASGLAHL 116

Query: 183 --NVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVY-----KEIV 235
              +V       + HRDLK +N L+    ++      D GL+V  ++            V
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 236 GSAYYVAPEVL-------HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKG-------- 280
           G+  Y+APEVL       H    K  D+++ G++ + +           +          
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 281 -------IFEAILEGNLDLQ---SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE 327
                  + + + E  L                   ++R+    +   R+TA    +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 6e-44
 Identities = 66/334 (19%), Positives = 114/334 (34%), Gaps = 70/334 (20%)

Query: 73  YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHL---- 128
           Y L ++LG G F   +L          A K +   K+      E    EI +LQ +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 70

Query: 129 ------TGQPNIVE----FEGAYEDKQNLHLVMELCSGGEL-FDRIIAKGIYSEREAANI 177
                  G  +I++    F     +  ++ +V E+     L   +              I
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 178 CRQIVN-VVHACHFMGVIHRDLKPENFLLASK---EEDSPIKATDFGLSVFIETGKVYKE 233
            +Q++  + +     G+IH D+KPEN L+      E    IK  D G + + +    Y  
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTN 188

Query: 234 IVGSAYYVAPEVL-HQRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI------- 285
            + +  Y +PEVL    +G   D+WS   +++ L++G   F  +      +         
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 286 -------------------------------------LEGNLDLQSSPWPSISGQAKDLI 308
                                                LE  L  +       + +  D +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308

Query: 309 RKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI 342
             ML  DP+KR  A   + HPWLK+     +  +
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.2 bits (223), Expect = 5e-22
 Identities = 41/210 (19%), Positives = 71/210 (33%), Gaps = 35/210 (16%)

Query: 72  IYDLDKELGRGQFGVTYLCTKKATGRKYACK-----SISRRKLVYDKDMEDVR------- 119
           +  + K +G G+    + C  +    +   K       S +K+   +D  D+        
Sbjct: 1   VDAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 120 ---REILILQHLTGQPNIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAAN 176
               E   LQ L G   + +      +     ++MEL    EL+                
Sbjct: 60  SARNEFRALQKLQG-LAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDE 107

Query: 177 ICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKVYKEIVG 236
           +   I+  V   +  G++H DL   N L+     +  I   DF  SV +     ++EI+ 
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEG-WREILE 162

Query: 237 SAYYVAPEVLHQRYGKEIDVWSAGVILYIL 266
                      + Y  E D+ S   I  IL
Sbjct: 163 RDVRNIITYFSRTYRTEKDINS--AIDRIL 190

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 18/127 (14%), Positives = 38/127 (29%), Gaps = 4/127 (3%)

Query: 77  KELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK----DMEDVRREILILQHLTGQP 132
           +E+G G     +    +   R    K       V  +     ++  R E   L       
Sbjct: 32  QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91

Query: 133 NIVEFEGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG 192
             +     Y D +    VME  S  ++  + + +G      + +I   +   +       
Sbjct: 92  PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151

Query: 193 VIHRDLK 199
           +  +  K
Sbjct: 152 LEPKVKK 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	366
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.88
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.53
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.84

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-64  Score=455.72  Aligned_cols=283  Identities=44%  Similarity=0.767  Sum_probs=231.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .++.+.|++.+.||+|+||+||+|+++.+|+.||||++.....  ......+.+|+.+|++++ ||||+++++++.+++.
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGH   81 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh--hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            4577889999999999999999999999999999999976543  233456889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .|||||||+|++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||+...++++.+||+|||+++...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999999988889999999999999999999999999999999999999766678899999999998876


Q ss_pred             CCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..+........++.+++++.
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            6666667789999999999864 589999999999999999999999999999999999999888887777788999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCCchHHHHHHHHH
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPIDSAVLTRMKQF  353 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  353 (366)
                      +||.+||+.||++|||++|+|+||||++..... .........++++.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~-~~~~~~~~~~~~~~  288 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD-KNIHQSVSEQIKKN  288 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCC-CCCHHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCCCccc-cccchhHHHHHHHH
Confidence            999999999999999999999999998754333 23333334444443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-63  Score=439.62  Aligned_cols=255  Identities=31%  Similarity=0.584  Sum_probs=231.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++..|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999997655444556778999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||||++|+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|....... 
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc-
Confidence            9999999999999998899999999999999999999999999999999999999   567789999999998765443 


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.+....++.    .+++++.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence            345689999999999875 5899999999999999999999999999988888888887665443    57999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcccC
Q 017768          310 KMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       310 ~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      +||+.||++|||++|+|+||||++.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-62  Score=436.30  Aligned_cols=260  Identities=31%  Similarity=0.550  Sum_probs=218.6

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.....  ....+.+.+|+.++++++ ||||+++++++.+++..|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            34679999999999999999999999999999999975432  234457889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      ||||||++|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999887789999999999999999999999999999999999999   56778999999999876433


Q ss_pred             C---ceecccCCCCCCccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCCCH
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQ-RY-GKEIDVWSAGVILYILLSGVPPFWAETEKGI-FEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .   .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||........ .........  ....++.+++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~  234 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  234 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCH
Confidence            2   2345689999999999864 44 6789999999999999999999976654332 223332222  2233456899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ++.+||.+||+.||++|||++|+|+||||++.-.
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         235 APLALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999999999999999986443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-62  Score=437.37  Aligned_cols=268  Identities=40%  Similarity=0.709  Sum_probs=239.0

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---cccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---DKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+|++++ ||||+++++++.+.
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~   85 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENK   85 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence            46678999999999999999999999999999999997654322   234678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecC-CCCCEEEeecCCcc
Q 017768          145 QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKE-EDSPIKATDFGLSV  223 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~vkl~Dfg~a~  223 (366)
                      +..|||||||++|+|.+++...+.+++.+++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+|||++.
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999999999999988999999999999999999999999999999999999996433 23369999999999


Q ss_pred             cccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......+....++.+++
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            8876666667789999999999874 589999999999999999999999999999999999988877766555567899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                      ++.+||.+||+.||++|||++|+|+||||+....
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            9999999999999999999999999999986543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-61  Score=444.99  Aligned_cols=269  Identities=37%  Similarity=0.651  Sum_probs=241.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.+.|++.+.||+|+||+||+|+++.+|+.||||++....   ......+.+|+.+|+++. ||||+++++++.+++.+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4567999999999999999999999999999999987543   234567889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||||+||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+|.....
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCC
Confidence            9999999999998876544 6999999999999999999999999999999999999953 2457899999999998877


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...++.+++++.+
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            776777889999999999864 5899999999999999999999999999999999999998888887777889999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      ||.+||+.||++|||+.|+|+||||++.........
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~~~  297 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  297 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCcchhcccC
Confidence            999999999999999999999999988655444333

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-61  Score=444.90  Aligned_cols=264  Identities=36%  Similarity=0.647  Sum_probs=238.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +-++|++.+.||+|+||.||+|+++.+|+.||||++....   ....+.+.+|+.+|++++ ||||+++++++.+++..|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4568999999999999999999999999999999996543   345677899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||||+||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+++....
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheeccc
Confidence            99999999999999854 456999999999999999999999999999999999999953 2357899999999998877


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                      ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...........++.+++++.+
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            777777899999999999864 5889999999999999999999999999999999999988887777666788999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          307 LIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                      ||.+||+.||++|||++|+|+||||+....+
T Consensus       259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999999876553

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=434.48  Aligned_cols=258  Identities=33%  Similarity=0.544  Sum_probs=230.0

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++ ||||+++++++.+++..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999997665444566778999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      ||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+...... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   677889999999998764322 


Q ss_pred             --ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 017768          230 --VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKD  306 (366)
Q Consensus       230 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (366)
                        .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.++...++.    .+++++.+
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHH
Confidence              2345689999999999864 5899999999999999999999999999988888888887765543    57999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCCCcccCCC
Q 017768          307 LIRKMLTKDPKKRITAAE------ALEHPWLKEDGA  336 (366)
Q Consensus       307 li~~~l~~dp~~Rpt~~~------~l~hp~f~~~~~  336 (366)
                      ||.+||+.||++|||++|      +++||||++...
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence            999999999999999987      688999988653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-61  Score=431.97  Aligned_cols=256  Identities=30%  Similarity=0.516  Sum_probs=223.9

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.++++++ ||||+++++++.+++..||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEEE
Confidence            457999999999999999999999999999999987543   345678999999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-  228 (366)
                      |||||+||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+..... 
T Consensus        95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTT
T ss_pred             EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccc
Confidence            9999999999987765 569999999999999999999999999999999999999   56778999999999876443 


Q ss_pred             CceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDL  307 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  307 (366)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+...... ....++.+++++.+|
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDF  249 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHH
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHH
Confidence            34455689999999999864 5899999999999999999999999988877766665544321 122234689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          308 IRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       308 i~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      |.+||+.||++|||+.|+|+||||+..
T Consensus       250 i~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         250 LNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.5e-61  Score=426.42  Aligned_cols=261  Identities=39%  Similarity=0.705  Sum_probs=237.4

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeeccccccc------ccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYD------KDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+......      ...+.+.+|+.+++++.+||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4689999999999999999999999999999999976543221      1234688999999999889999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      ++..|||||||++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence            99999999999999999999999999999999999999999999999999999999999999   677889999999999


Q ss_pred             cccCCCceecccCCCCCCccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQ-------RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP  296 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  296 (366)
                      ............||+.|+|||++..       .++.++||||+||++|+|++|..||.+.+.......+..+........
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            8776666666789999999998742       367899999999999999999999999999998888998888777777


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                      ++.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            7789999999999999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=424.15  Aligned_cols=253  Identities=24%  Similarity=0.423  Sum_probs=218.0

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----CCeEE
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----KQNLH  148 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----~~~~~  148 (366)
                      |++.++||+|+||+||+|.++.++..||+|.+..... .....+.+.+|+++|++++ ||||+++++++.+    +..+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence            4788899999999999999999999999999876543 3345677899999999998 9999999999865    35689


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMG--VIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +||||+++++|.+++.....+++.+++.++.||+.||.|||+++  |+||||||+|||++  ++++.+||+|||+|+...
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc
Confidence            99999999999999999889999999999999999999999999  99999999999995  346789999999998654


Q ss_pred             CCCceecccCCCCCCccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLHQRYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. .....+||+.|+|||++.++++.++|||||||++|+|++|+.||.+... ......+..+.....  .....++++.
T Consensus       167 ~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~  243 (270)
T d1t4ha_         167 AS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK  243 (270)
T ss_dssp             TT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCHHHH
T ss_pred             CC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--cCccCCHHHH
Confidence            33 3456789999999999988899999999999999999999999976544 444555554433222  2235688999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLK  332 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~  332 (366)
                      ++|.+||+.||++|||++|+|+||||+
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-61  Score=429.48  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=225.3

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+.+|++++ ||||+++++++.+++..|
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEE
Confidence            3467999999999999999999999999999999997543   345677889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||||++|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCC
Confidence            999999999999987764 569999999999999999999999999999999999999   5677899999999976533


Q ss_pred             C-CceecccCCCCCCcccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          228 G-KVYKEIVGSAYYVAPEVLH------QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       228 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      . .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.+..+.+..+..+..... ...+.+
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  241 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRW  241 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGS
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccC
Confidence            2 2234568999999999873      3478999999999999999999999999888888888777654322 223468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEHPWLKED  334 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~  334 (366)
                      ++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-61  Score=433.74  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=227.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..+.|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++++ ||||+++++++.+++..|
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence            3456999999999999999999999999999999997665444555678999999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      +|||||++++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC
Confidence            999999999998888888889999999999999999999999999999999999999   56778999999999875432


Q ss_pred             CceecccCCCCCCcccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          229 KVYKEIVGSAYYVAPEVLH----QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       229 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                         ....||+.|+|||++.    +.++.++|||||||++|+|++|..||.+.+..+.+..+..+......  ...+++++
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~  243 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYF  243 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHH
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence               3457999999999874    35889999999999999999999999988888777777766543322  23579999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      .+||.+||+.||++|||++|+|+||||.+..
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            9999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=433.51  Aligned_cols=256  Identities=34%  Similarity=0.591  Sum_probs=233.4

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++ ||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            46999999999999999999999999999999998765544556788999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC-CC
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET-GK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~-~~  229 (366)
                      ||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   6678899999999987543 33


Q ss_pred             ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+..+...++.    .+++++.+||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence            455678999999999986 46999999999999999999999999999999999998888766543    5899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          309 RKMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      .+||+.||++|+     +++|+++||||++.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999999     49999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-60  Score=422.04  Aligned_cols=253  Identities=29%  Similarity=0.530  Sum_probs=212.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~  148 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++..... .+...+.+.+|+.++++++ ||||+++++++.+  ++.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            569999999999999999999999999999999976543 3445677899999999997 9999999999865  45689


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          149 LVMELCSGGELFDRIIA----KGIYSEREAANICRQIVNVVHACHFMG-----VIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                      ||||||++|+|.+++..    ...+++.+++.++.||+.||.|||+.+     |+||||||+|||+   +.++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence            99999999999998864    356999999999999999999999976     9999999999999   56788999999


Q ss_pred             CCcccccCCC-ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          220 GLSVFIETGK-VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       220 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      |+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+......   
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~---  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence            9998765433 3345689999999999864 6899999999999999999999999999988888888877654322   


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      ..+++++.+||.+||+.||++|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            3589999999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-60  Score=433.83  Aligned_cols=262  Identities=31%  Similarity=0.590  Sum_probs=237.4

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ++.++|++.+.||+|+||+||+|.++.+|+.||+|++....    .+...+.+|+.+|+.++ ||||+++++++.+++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            46788999999999999999999999999999999996543    34456889999999998 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      |||||||+|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++. ++...+||+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccc
Confidence            99999999999999997665 6999999999999999999999999999999999999953 244579999999999887


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .........+|+.|+|||.+. ..++.++|||||||++|+|++|..||.+.+..+....+..+...++...++.+++++.
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            766667778999999999876 4589999999999999999999999999999999999999888877766778999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +||.+||..||++|||+.|+|+||||++..
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999999997643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-59  Score=427.02  Aligned_cols=254  Identities=32%  Similarity=0.605  Sum_probs=231.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+++..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            46999999999999999999999999999999997655444566788999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      ||||+|++|..++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.....  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence            9999999999999999999999999999999999999999999999999999999   56788999999999876543  


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+..+....+    +.+++++.++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345689999999999875 589999999999999999999999999999999888888766544    357999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccC
Q 017768          310 KMLTKDPKKRI-----TAAEALEHPWLKED  334 (366)
Q Consensus       310 ~~l~~dp~~Rp-----t~~~~l~hp~f~~~  334 (366)
                      +||..||++|+     |++++++||||++.
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     99999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-59  Score=430.04  Aligned_cols=255  Identities=35%  Similarity=0.594  Sum_probs=231.7

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+. ||||+++++++.+.+..++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            57999999999999999999999999999999997655444566778999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV  230 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~  230 (366)
                      |||+.+|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999998899999999999999999999999999999999999999   56788999999999876543  


Q ss_pred             eecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIR  309 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  309 (366)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+....+.    .+++++.++|.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence            345689999999999864 5899999999999999999999999999988888888887665543    58999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          310 KMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       310 ~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +||+.||.+|+     |++++++||||++..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            99999999995     999999999998753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-60  Score=430.30  Aligned_cols=260  Identities=26%  Similarity=0.378  Sum_probs=216.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++....  .......+.+|+.+|++++ ||||+++++++.+.+..|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            3567999999999999999999999999999999987542  2345678899999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          149 LVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||++|++|.+++...+.+++.+++.++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+|+....
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence            999999999999999998899999999999999999999997 599999999999999   6678899999999987643


Q ss_pred             CCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---cCC--------------
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL---EGN--------------  289 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~---~~~--------------  289 (366)
                      .. ..+.+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+.........   .+.              
T Consensus       158 ~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 SM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             Cc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            32 345689999999999864 69999999999999999999999997665332111000   000              


Q ss_pred             -----------------------CCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          290 -----------------------LDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       290 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                             ...+......++.++.+||.+||+.||++|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                                   0000111123688999999999999999999999999999998643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=429.68  Aligned_cols=266  Identities=35%  Similarity=0.620  Sum_probs=223.6

Q ss_pred             cccceeeec-eecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----
Q 017768           69 ITTIYDLDK-ELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----  143 (366)
Q Consensus        69 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----  143 (366)
                      +.++|.+.+ .||+|+||+||+|++..+|+.||||++..        ...+.+|+.++.++.+||||+++++++.+    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            456798875 59999999999999999999999999853        34577899998877679999999999875    


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                      +..+|||||||+||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++..++.+.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46789999999999999999864  3699999999999999999999999999999999999998666678899999999


Q ss_pred             cccccCCCceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HcCCCCCCCCC
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI----LEGNLDLQSSP  296 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~  296 (366)
                      |+............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+    ..+...++...
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            998776666677789999999999875 5899999999999999999999999876654443333    23333344444


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCCCC
Q 017768          297 WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDKPI  342 (366)
Q Consensus       297 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~~~  342 (366)
                      ++.+++++.+||.+||+.||++|||+.|+|+||||++.......+.
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  286 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  286 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence            4568999999999999999999999999999999987665544444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-59  Score=422.26  Aligned_cols=257  Identities=31%  Similarity=0.506  Sum_probs=229.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++.+..+||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999997655444566777888888877644599999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC-C
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG-K  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~-~  229 (366)
                      |||+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+++..... .
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccccc
Confidence            9999999999999999999999999999999999999999999999999999999   67788999999999865433 3


Q ss_pred             ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          230 VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+..+....+.    .+++++.+||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHH
Confidence            3445689999999998864 6899999999999999999999999999999988888877654432    5799999999


Q ss_pred             HHhcccCcCCCCCHH-HHhcCCCcccC
Q 017768          309 RKMLTKDPKKRITAA-EALEHPWLKED  334 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~-~~l~hp~f~~~  334 (366)
                      .+||+.||++|||+. ++++||||++.
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999995 89999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-58  Score=425.51  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=216.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHH---HHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREIL---ILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|..   +++.+. ||||+++++++.+.+..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence            46999999999999999999999999999999997654433334444555544   444444 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      |||||||+|++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999999999999999999999999999999999999999999999   6778899999999987654


Q ss_pred             CCceecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          228 GKVYKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .. .....||+.|+|||++. + .++.++|||||||++|+|++|+.||.+.......... ..........+..+++++.
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHH
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHH
Confidence            43 34568999999999875 3 4899999999999999999999999876544332222 2222223333346899999


Q ss_pred             HHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017768          306 DLIRKMLTKDPKKRIT-----AAEALEHPWLKED  334 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt-----~~~~l~hp~f~~~  334 (366)
                      +||.+||+.||++|||     ++|+++||||++.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-58  Score=414.89  Aligned_cols=261  Identities=28%  Similarity=0.380  Sum_probs=215.8

Q ss_pred             eeceecccCceEEEEEEEccCCcEEEEEEeecccccc--cccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEe
Q 017768           75 LDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY--DKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVME  152 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  152 (366)
                      ..+.||+|+||+||+|+++.+|+.||||++.......  ......+.+|+.++++++ ||||+++++++..++..|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            3578999999999999999999999999986543221  122456889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-ce
Q 017768          153 LCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-VY  231 (366)
Q Consensus       153 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-~~  231 (366)
                      |+.++++..+......+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99988777666656679999999999999999999999999999999999999   677889999999998765433 33


Q ss_pred             ecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC-------------
Q 017768          232 KEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP-------------  296 (366)
Q Consensus       232 ~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------  296 (366)
                      ...+||+.|+|||++. . .++.++|||||||++|+|++|..||.+.+..+.+..+...........             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            4568999999999875 3 479999999999999999999999999888877777654211111100             


Q ss_pred             -----------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          297 -----------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       297 -----------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                 .+.+++++.+||.+||+.||++|||++|+|+||||++...+..
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~  291 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  291 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence                       1346889999999999999999999999999999998776554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=406.49  Aligned_cols=254  Identities=28%  Similarity=0.517  Sum_probs=216.1

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccc---cHHHHHHHHHHHHHhc-CCCceeEeceEEeeC
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDK---DMEDVRREILILQHLT-GQPNIVEFEGAYEDK  144 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~  144 (366)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++.+.......   ...++.+|+.+++++. +||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            456799999999999999999999999999999999765433222   2334678999999986 489999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcc
Q 017768          145 QNLHLVMELCSG-GELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSV  223 (366)
Q Consensus       145 ~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~  223 (366)
                      +..++||||+.+ +++.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++  .+++.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccce
Confidence            999999999976 57888888888999999999999999999999999999999999999995  245679999999998


Q ss_pred             cccCCCceecccCCCCCCccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          224 FIETGKVYKEIVGSAYYVAPEVLHQ-R-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       224 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||....      .+..+...+.    +.++
T Consensus       160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred             ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence            75443 3456789999999998864 3 4678999999999999999999997532      2344443333    3579


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                      +++.+||.+||+.||++|||++|+|+||||++..
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999999998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=404.69  Aligned_cols=263  Identities=28%  Similarity=0.420  Sum_probs=217.6

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|++++ ||||+++++++.+++..|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            57999999999999999999999999999999996543 22345678899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          151 MELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||+.+ .+.+++..  ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999966 55555543  3459999999999999999999999999999999999999   56778999999999876543


Q ss_pred             C-ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCC---------
Q 017768          229 K-VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSP---------  296 (366)
Q Consensus       229 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  296 (366)
                      . ......||+.|+|||++..  .++.++|||||||++|+|++|+.||.+.+..+.+..+...........         
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            3 3445689999999998653  368899999999999999999999998887776666543211111110         


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          297 ----------------WPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       297 ----------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                      .+.+++++.+||.+||+.||++|||+.|+|+||||++...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p  294 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP  294 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence                            1356789999999999999999999999999999998877643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.5e-57  Score=402.34  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=218.8

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      ..+.++|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.+++.++ ||||+++++++...+ 
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   81 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccC
Confidence            346788999999999999999999999999999999997665444555678999999999997 999999999987654 


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          146 ---NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                         ..||||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.++|+|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence               489999999999999999999999999999999999999999999999999999999999   46677999999998


Q ss_pred             ccccCCC----ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          223 VFIETGK----VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       223 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      .......    .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            7553322    3345679999999999864 5899999999999999999999999999888888887777666666666


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWL  331 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f  331 (366)
                      +.+++++.++|.+||+.||++||+..+.|.|+|+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            7899999999999999999999944444445554

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=401.74  Aligned_cols=264  Identities=27%  Similarity=0.367  Sum_probs=216.2

Q ss_pred             cccceeeeceecccCceEEEEEEEccC-CcEEEEEEeecccccccccHHHHHHHHHHHHHhc--CCCceeEeceEEee--
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKAT-GRKYACKSISRRKLVYDKDMEDVRREILILQHLT--GQPNIVEFEGAYED--  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~i~~~~~~~~~--  143 (366)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++..... .......+.+|+.+|+.+.  +||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            346899999999999999999999765 56799999875432 2233445667888888774  59999999999853  


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          144 ---KQNLHLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       144 ---~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                         ....+++|||++++.+...... ...+++..++.++.||+.||+|||+++|+||||||+|||+   +..+.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecch
Confidence               3478999999988766544333 3458999999999999999999999999999999999999   66778999999


Q ss_pred             CCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCC------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDL------  292 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  292 (366)
                      |++.............||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+..+.+..+.......      
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            9998776666667788999999999875 569999999999999999999999999988877776664321100      


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          293 -----------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       293 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                       .......+++.+.+||.+||+.||++|||+.|+|+||||++..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                             01112457899999999999999999999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-55  Score=396.27  Aligned_cols=257  Identities=32%  Similarity=0.459  Sum_probs=215.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++ ||||+++++++..++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            57999999999999999999986 789999999976542 3445678999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      ||++.++.+..+....+.+++.+++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||.+....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999887776666667789999999999999999999999999999999999999   567889999999998765433 


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC-------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS-------------  294 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  294 (366)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+..+....+.........             
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2344568999999998753  4789999999999999999999999988877766665432111110             


Q ss_pred             ------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017768          295 ------------SPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKE  333 (366)
Q Consensus       295 ------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~  333 (366)
                                  ...+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        112357889999999999999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-55  Score=391.71  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=211.4

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      -.++|++.+.||+|+||+||+|.++.+|+.||||++....    ...+.+.+|+.+|++++ ||||+++++++.+++..+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeE
Confidence            3467999999999999999999999999999999986432    35678999999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ||||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecC
Confidence            999999999999999764  458999999999999999999999999999999999999   566789999999998765


Q ss_pred             CCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          227 TGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       227 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      ....  .....|++.|+|||++. +.++.++|||||||++|||++|..||. +.+.....+.+..+.. .  .....+++
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-~--~~~~~~~~  243 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-M--ERPEGCPE  243 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-C--CCCTTCCH
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-C--CCCccchH
Confidence            4432  22345788999999875 579999999999999999999766654 4555555555544422 2  22246899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.+||.+||+.||++|||+.++++
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=400.65  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=211.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCc-----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGR-----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||+||+|++..+++     .||+|.+....  .......+.+|+.++.++.+||||+++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            4679999999999999999999876544     69999886443  2345667899999999997799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCC
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG-----------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPE  201 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  201 (366)
                      +..++|||||++|+|.+++....                       .+++.+++.++.||+.||.|||+++|+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999999999999997542                       4899999999999999999999999999999999


Q ss_pred             cEEeeecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 017768          202 NFLLASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAE  276 (366)
Q Consensus       202 NIll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~  276 (366)
                      |||+   +.++.+||+|||+|+.......   .....||+.|+|||++. +.++.++|||||||++|||++ |..||.+.
T Consensus       194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999   5677899999999987654432   23456799999999875 578999999999999999998 89999887


Q ss_pred             ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          277 TEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .....+..+......+..  ...+++++.+||.+||+.||++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            766655555554443332  23578999999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=392.52  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=204.8

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||+||+|+.+   ..||||++..... .....+.+.+|+.++++++ ||||+++++++.. +..+|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEEEE
Confidence            456999999999999999999864   3699999865432 3456778999999999997 9999999998654 56899


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCC
Q 017768          150 VMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETG  228 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~  228 (366)
                      |||||++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecccc
Confidence            99999999999999765 459999999999999999999999999999999999999   56778999999999876432


Q ss_pred             C---ceecccCCCCCCccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HcCCCCCC-CCCCCC
Q 017768          229 K---VYKEIVGSAYYVAPEVLHQ----RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAI-LEGNLDLQ-SSPWPS  299 (366)
Q Consensus       229 ~---~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~-~~~~~~  299 (366)
                      .   ......||+.|+|||++..    .++.++|||||||+||||++|+.||.+.+....+... ..+..... ......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   3345679999999998742    4788999999999999999999999887665544444 34333222 223346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++++.+||.+||+.||++|||+.|++++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            88999999999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-55  Score=396.53  Aligned_cols=265  Identities=28%  Similarity=0.414  Sum_probs=216.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee------
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED------  143 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~------  143 (366)
                      .++|++++.||+|+||+||+|++..+|+.||||++..... .+.....+.+|+.+|++++ |+||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            4789999999999999999999999999999999865542 3455677899999999997 9999999998755      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 --KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                        .+..|++|||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              34689999999887666555556679999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCC-----ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 017768          222 SVFIETGK-----VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQS  294 (366)
Q Consensus       222 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (366)
                      +.......     .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654322     2334579999999998753  5899999999999999999999999988877776666443322222


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          295 SPWPS----------------------------ISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       295 ~~~~~----------------------------~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                      ..+..                            .++++.+||.+||+.||++|||++|+|+||||+....+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~  316 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  316 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence            11111                            2667889999999999999999999999999998766654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=391.46  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=205.8

Q ss_pred             ceecccCceEEEEEEEcc--CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEEEecc
Q 017768           77 KELGRGQFGVTYLCTKKA--TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLVMELC  154 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  154 (366)
                      ++||+|+||+||+|.+..  +++.||||++.... ......+.+.+|+.+|++++ ||||+++++++.. +..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEcC
Confidence            469999999999998643  45789999986543 23445678999999999997 9999999999865 4578999999


Q ss_pred             CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCCc----
Q 017768          155 SGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGKV----  230 (366)
Q Consensus       155 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~~----  230 (366)
                      ++|+|.+++.....+++.++..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+++.......    
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccccc
Confidence            9999999999988899999999999999999999999999999999999994   567799999999987644322    


Q ss_pred             eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 017768          231 YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAKDLI  308 (366)
Q Consensus       231 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  308 (366)
                      .....||+.|+|||++. +.++.++|||||||++|||++ |..||.+.+..+....+..+......   ..+++++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---cccCHHHHHHH
Confidence            12346899999999875 568999999999999999998 89999999888888888776533222   35789999999


Q ss_pred             HHhcccCcCCCCCHHHHh---cCCCc
Q 017768          309 RKMLTKDPKKRITAAEAL---EHPWL  331 (366)
Q Consensus       309 ~~~l~~dp~~Rpt~~~~l---~hp~f  331 (366)
                      .+||+.||++|||+++++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=389.16  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=214.5

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .+....++|++.+.||+|+||+||+|.++ ++..||||++....    ...+.+.+|+.++++++ ||||+++++++.+ 
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-   79 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-   79 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-
Confidence            33344578999999999999999999986 57889999986432    34567999999999997 9999999998755 


Q ss_pred             CeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          145 QNLHLVMELCSGGELFDRIIAK--GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      +..++||||+++|+|.+++...  ..+++.++..++.||+.||.|||+++|+||||||+|||+   ++++.+||+|||+|
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla  156 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA  156 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccce
Confidence            5678999999999999876433  358999999999999999999999999999999999999   67788999999999


Q ss_pred             ccccCCCc--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 017768          223 VFIETGKV--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFEAILEGNLDLQSSPWP  298 (366)
Q Consensus       223 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  298 (366)
                      +.......  .....||+.|+|||++. +.++.++|||||||++|||+|| ..||......+....+..+......   .
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---~  233 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---D  233 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---T
T ss_pred             EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---c
Confidence            87754432  23456899999999876 5689999999999999999995 5556666777777777765433322   3


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCccc
Q 017768          299 SISGQAKDLIRKMLTKDPKKRITAAEALE--HPWLKE  333 (366)
Q Consensus       299 ~~~~~~~~li~~~l~~dp~~Rpt~~~~l~--hp~f~~  333 (366)
                      .+++++.+||.+||+.||++|||++++++  ++||..
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            57899999999999999999999999998  677753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-55  Score=393.12  Aligned_cols=250  Identities=22%  Similarity=0.374  Sum_probs=203.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+.|++.+.||+|+||+||+|.++.+|+   .||||.+....  .....+.+.+|+.+|++++ ||||+++++++..++.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence            3569999999999999999999887665   58888775432  2345667999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++|||||++|+|.+++... +.+++.++..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence            99999999999999988774 469999999999999999999999999999999999999   67788999999999876


Q ss_pred             cCCCce------ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 017768          226 ETGKVY------KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPW  297 (366)
Q Consensus       226 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  297 (366)
                      ......      ....||+.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+.....   .
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---P  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---C
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            543221      1235789999999876 568999999999999999998 8999999998888888877643322   2


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          298 PSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       298 ~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ..+++++.+||.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3678999999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-55  Score=386.17  Aligned_cols=246  Identities=25%  Similarity=0.411  Sum_probs=203.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||+||+|.+. +++.||||++....    ...+++.+|+.++++++ ||||+++++++..++..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            46999999999999999999986 57889999986432    34567999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999988765 458999999999999999999999999999999999999   567789999999998765433


Q ss_pred             c--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          230 V--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       230 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .  .....||+.|+|||++. +.++.++|||||||++|||++ |..||......+....+..+......   ...++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHH
Confidence            2  23357899999999986 569999999999999999999 57777777777787877776443322   25689999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++|.+||+.||++|||++|+++|
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999885

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=381.41  Aligned_cols=246  Identities=21%  Similarity=0.341  Sum_probs=215.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      +.|++.+.||+|+||+||+|+++ +++.||||++....    ...+.+.+|+.++++++ ||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            46889999999999999999986 68899999997543    34567999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      |||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            9999999999987654 468999999999999999999999999999999999999   677889999999998664433


Q ss_pred             c--eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 017768          230 V--YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQAK  305 (366)
Q Consensus       230 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (366)
                      .  .....||+.|+|||++. ..++.++||||||+++|||++ |+.||.+.+..+....+..+......   ...++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHH
Confidence            2  22356899999999876 568999999999999999998 89999999998888888776543322   35789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 017768          306 DLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       306 ~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +||.+||+.||++|||++++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-55  Score=397.09  Aligned_cols=262  Identities=34%  Similarity=0.557  Sum_probs=219.5

Q ss_pred             cceeeeceecccCceEEEEEEE---ccCCcEEEEEEeeccccc-ccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTK---KATGRKYACKSISRRKLV-YDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      ++|++++.||+|+||+||+|.+   +.+|+.||||++.+.... .....+.+.+|+.+++++++||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999987   446899999998754432 223456788999999999977999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      .+++|||+.+++|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++...
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999   567789999999997654


Q ss_pred             CCC--ceecccCCCCCCccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          227 TGK--VYKEIVGSAYYVAPEVLHQ---RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       227 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ...  ......|++.|++||.+.+   .++.++|||||||+||+|++|..||.+.........+..+...........++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            322  2345679999999998753   47889999999999999999999997765444444443332222222234689


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccCC
Q 017768          302 GQAKDLIRKMLTKDPKKRI-----TAAEALEHPWLKEDG  335 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rp-----t~~~~l~hp~f~~~~  335 (366)
                      +++.+||.+||+.||++||     |++|+++||||++.+
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            9999999999999999999     589999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=396.26  Aligned_cols=254  Identities=28%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             ceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee------CC
Q 017768           72 IYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED------KQ  145 (366)
Q Consensus        72 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~------~~  145 (366)
                      .|+..+.||+|+||+||+|+++.+|+.||||++.....       ...+|+.+|++++ |+||+++++++..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            59999999999999999999999999999999965432       2247999999997 9999999999854      33


Q ss_pred             eEEEEEeccCCCchHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          146 NLHLVMELCSGGELFDRI---IAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       146 ~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                      ++|||||||+++.+..+.   .....+++.+++.++.||+.||+|||++||+||||||+|||++  .++..+||+|||++
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTC
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccch
Confidence            579999999765433322   2345699999999999999999999999999999999999995  23347999999999


Q ss_pred             ccccCCCceecccCCCCCCcccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-----------
Q 017768          223 VFIETGKVYKEIVGSAYYVAPEVLH--QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGN-----------  289 (366)
Q Consensus       223 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~-----------  289 (366)
                      .............||+.|+|||.+.  ..++.++|||||||++|||++|+.||...+..+.+..+....           
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            8877666667778999999999764  358999999999999999999999998888776665553210           


Q ss_pred             ------CCC--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          290 ------LDL--------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       290 ------~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                            ...        .....+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                  000        0111245789999999999999999999999999999998753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=395.03  Aligned_cols=256  Identities=28%  Similarity=0.507  Sum_probs=212.5

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee--CCeE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED--KQNL  147 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~  147 (366)
                      .++|+++++||+|+||+||+|+++.+|+.||||++..      .....+.+|+.+|+.+.+||||+++++++..  ....
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH------HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            4679999999999999999999999999999999854      2356788999999999889999999999874  4569


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          148 HLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ++|||||++++|....   +.+++.+++.++.||+.||.|||++||+||||||+|||++  .++..+||+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999987653   4699999999999999999999999999999999999996  2344699999999998776


Q ss_pred             CCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc-------------CCCC
Q 017768          228 GKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFEAILE-------------GNLD  291 (366)
Q Consensus       228 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~-~~~~~~~~-------------~~~~  291 (366)
                      ........+|+.|+|||++.+  .++.++||||+||++|+|++|..||...... .....+..             ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            666677789999999998653  4799999999999999999999999765432 21111110             0000


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCC
Q 017768          292 --------------------LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGA  336 (366)
Q Consensus       292 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~  336 (366)
                                          ........+++++.+||++||+.||++|||++|+|+||||+...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                                011112347889999999999999999999999999999987643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=397.69  Aligned_cols=263  Identities=28%  Similarity=0.446  Sum_probs=212.8

Q ss_pred             ccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC
Q 017768           66 YVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ  145 (366)
Q Consensus        66 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~  145 (366)
                      ...+.++|++++.||+|+||+||+|.++.+|+.||||++.... ......+.+.+|+.+|++++ ||||+++++++...+
T Consensus        13 ~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          13 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   90 (346)
T ss_dssp             EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             eeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence            3457889999999999999999999999999999999996543 23445678899999999997 999999999997654


Q ss_pred             ------eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          146 ------NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       146 ------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                            .+|+||||+ +.+|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Df  165 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  165 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred             cccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccc
Confidence                  579999999 667766654 5679999999999999999999999999999999999999   67788999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC------
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD------  291 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  291 (366)
                      |+|......  .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+....+..+......      
T Consensus       166 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         166 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            999876443  355689999999998753  4789999999999999999999999888766655444321111      


Q ss_pred             -----------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCC
Q 017768          292 -----------------LQ----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGAT  337 (366)
Q Consensus       292 -----------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~  337 (366)
                                       ..    ....+.+++++.+||.+||+.||++|||+.|+|+||||++....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                             11    11224578999999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=387.64  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=212.1

Q ss_pred             ccceeeec-eecccCceEEEEEEEccC--CcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDK-ELGRGQFGVTYLCTKKAT--GRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~-~lG~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .+.|.+.+ +||+|+||+||+|.++.+  +..||||++....  .....+.+.+|+.+|++++ ||||+++++++.. +.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence            35677777 499999999999987543  4579999986542  3445678999999999997 9999999999865 46


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .|||||||++|+|.+++... ..+++.++..++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence            89999999999999987654 5699999999999999999999999999999999999995   5667999999999876


Q ss_pred             cCCCce----ecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGKVY----KEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ......    ....||+.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+.....   .+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCc
Confidence            543322    2346889999999876 568999999999999999998 9999999888888888877654322   246


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHH---hcCCCcc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEA---LEHPWLK  332 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~---l~hp~f~  332 (366)
                      +++++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            88999999999999999999999988   5567664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=382.82  Aligned_cols=260  Identities=26%  Similarity=0.424  Sum_probs=218.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHLV  150 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  150 (366)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++ ||||+++++++.+.+..+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            47999999999999999999999999999999997554 23456788999999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC-
Q 017768          151 MELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK-  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~-  229 (366)
                      ++++.+++|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||.+....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999998888888889999999999999999999999999999999999999   556779999999998775433 


Q ss_pred             ceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHcCCCC---------------
Q 017768          230 VYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFEAILEGNLD---------------  291 (366)
Q Consensus       230 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~-~~~~~~~~~~~~~~~~~---------------  291 (366)
                      ......+++.|+|||++..  .++.++|||||||++|+|++|..||. +.+..+....+......               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            3334467888999998753  36899999999999999999999864 44445444444321111               


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          292 ----------LQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       292 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                ......+.+++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      11112245788999999999999999999999999999998743

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=394.17  Aligned_cols=266  Identities=29%  Similarity=0.422  Sum_probs=213.0

Q ss_pred             cccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC-
Q 017768           67 VDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ-  145 (366)
Q Consensus        67 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-  145 (366)
                      .+++++|++++.||+|+||+||+|.++.+|+.||||++.+..  .....+.+.+|+.+|++++ ||||+++++++.... 
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccc
Confidence            356778999999999999999999999999999999986532  2445667889999999997 999999999987643 


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCc
Q 017768          146 ---NLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLS  222 (366)
Q Consensus       146 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a  222 (366)
                         ..+++++++.+++|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a  156 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  156 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             cccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCce
Confidence               234444556689999998654 69999999999999999999999999999999999999   56778999999999


Q ss_pred             ccccCCC----ceecccCCCCCCcccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCC-----
Q 017768          223 VFIETGK----VYKEIVGSAYYVAPEVLH-Q-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLD-----  291 (366)
Q Consensus       223 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----  291 (366)
                      .......    .....+||+.|+|||++. . .++.++||||+||++|+|++|+.||.+....+...........     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            7654322    234467999999999874 3 4789999999999999999999999887665544443221000     


Q ss_pred             ------------------CC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCC
Q 017768          292 ------------------LQ----SSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSD  339 (366)
Q Consensus       292 ------------------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~  339 (366)
                                        ..    ...++.++.++.+||.+||+.||++|||++|+|+||||++...+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD  306 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence                              00    0113467889999999999999999999999999999997666443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=375.62  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      .++|++.+.||+|+||.||+|+++. ++.||||++....    ...+.+.+|+.++++++ |+||+++++++.+ +..++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEE
Confidence            4679999999999999999999874 5679999986432    34578999999999998 9999999999854 56789


Q ss_pred             EEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccC
Q 017768          150 VMELCSGGELFDRIIA--KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIET  227 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~  227 (366)
                      ||||+++|+|.+++..  ...+++.+++.++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+++....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccC
Confidence            9999999999988864  3569999999999999999999999999999999999999   5667899999999987643


Q ss_pred             CC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 017768          228 GK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFEAILEGNLDLQSSPWPSISGQ  303 (366)
Q Consensus       228 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (366)
                      ..  ......||+.|+|||++. +.++.++||||||+++|||++|..| +......+.+..+..+....   ..+.++++
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CCcccCHH
Confidence            33  223357899999999876 5689999999999999999996544 55566666777776654322   23468999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc--CCCcccCC
Q 017768          304 AKDLIRKMLTKDPKKRITAAEALE--HPWLKEDG  335 (366)
Q Consensus       304 ~~~li~~~l~~dp~~Rpt~~~~l~--hp~f~~~~  335 (366)
                      +.++|.+||+.||++|||++++++  ++||....
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999998  88997754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=393.21  Aligned_cols=268  Identities=26%  Similarity=0.388  Sum_probs=217.3

Q ss_pred             CccccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           65 PYVDITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        65 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      +...+.++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+|++++ ||||+++++++...
T Consensus        12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA   89 (348)
T ss_dssp             SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeec
Confidence            33456789999999999999999999999999999999997543 23345667889999999997 99999999998643


Q ss_pred             -----CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeec
Q 017768          145 -----QNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDF  219 (366)
Q Consensus       145 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Df  219 (366)
                           ...+++|+++.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.+|++||
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~df  165 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF  165 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC
T ss_pred             cccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---ccccccccccc
Confidence                 344666777789999998854 569999999999999999999999999999999999999   66788999999


Q ss_pred             CCcccccCCCceecccCCCCCCccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCCCCC----
Q 017768          220 GLSVFIETGKVYKEIVGSAYYVAPEVLHQ--RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNLDLQ----  293 (366)
Q Consensus       220 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----  293 (366)
                      |++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+........    
T Consensus       166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            99976533  3345678999999998653  468999999999999999999999998887766666543221111    


Q ss_pred             -------------------CC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCCCCCCC
Q 017768          294 -------------------SS----PWPSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDGATSDK  340 (366)
Q Consensus       294 -------------------~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~~~~~~  340 (366)
                                         ..    .+..+++++.+||.+||+.||++|||+.|+|+||||++...+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~  313 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  313 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence                               00    123578999999999999999999999999999999986655443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=375.83  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             cceeeeceecccCceEEEEEEEccCC----cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATG----RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.|++.+.||+|+||+||+|.++.++    ..||||.+....  .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            35899999999999999999987654    369999986432  2344567899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+.++++.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence            99999999999999888765 469999999999999999999999999999999999999   67788999999999876


Q ss_pred             cCCC----ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 017768          226 ETGK----VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFEAILEGNLDLQSSPWPS  299 (366)
Q Consensus       226 ~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (366)
                      ....    ......||+.|+|||++. +.++.++|||||||++|||++| ..|+......+....+..+.....   ...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC---chh
Confidence            4432    122346899999999876 5689999999999999999995 555566666677777766543222   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          300 ISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       300 ~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++.++.+||.+||+.||++|||+.|+++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            7899999999999999999999999977

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=383.61  Aligned_cols=250  Identities=26%  Similarity=0.329  Sum_probs=209.5

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcE--EEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRK--YACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      +.|++.+.||+|+||+||+|.++.+|..  ||||.+...  ......+.+.+|+.+|+++.+||||+++++++.+++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            5799999999999999999999888875  666766432  223456679999999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCC
Q 017768          149 LVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDS  212 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  212 (366)
                      +||||+++|+|.+++...                ..+++.++..++.||+.||.|||+++|+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999998654                458999999999999999999999999999999999999   5667


Q ss_pred             CEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCC
Q 017768          213 PIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFEAILEGNL  290 (366)
Q Consensus       213 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~-~pf~~~~~~~~~~~~~~~~~  290 (366)
                      .+||+|||+++............||..|+|||.+. +.++.++||||||+++|||++|. .||.+.+..+....+..+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            79999999998765444444567899999999876 56899999999999999999965 67888888888777766533


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          291 DLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       291 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .   .....+++++.+||.+||+.||++|||+.+++++
T Consensus       245 ~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2   2234689999999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=373.54  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             ccceeeeceecccCceEEEEEEEccCC---cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATG---RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      .++|++.+.||+|+||.||+|++..++   ..||||.+...  ......+.+.+|+.++++++ ||||+++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            468999999999999999999986543   46888877433  23445678999999999997 999999999986 467


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+||+++   .++.+||+|||+++..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            89999999999999987664 4589999999999999999999999999999999999995   5567999999999876


Q ss_pred             cCCC--ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 017768          226 ETGK--VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSIS  301 (366)
Q Consensus       226 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (366)
                      ....  ......||+.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+....   .++.++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            5433  223456899999999986 568999999999999999998 899999988888888888765432   234689


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          302 GQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       302 ~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      +++.+||.+||+.||++|||+.|++++
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=387.01  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=202.2

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee----
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED----  143 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----  143 (366)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|++++ ||||+++++++..    
T Consensus        14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence            345789999999999999999999999999999999975432 3445667899999999997 9999999999964    


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCC
Q 017768          144 --KQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGL  221 (366)
Q Consensus       144 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~  221 (366)
                        ....|+|||||.+ ++.+.+  ...+++.+++.++.||+.||.|||++||+||||||+|||+   +.++.++++|||+
T Consensus        92 ~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~  165 (355)
T d2b1pa1          92 EEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred             ccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhh
Confidence              4689999999976 454444  3568999999999999999999999999999999999999   5677899999999


Q ss_pred             cccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCC----------
Q 017768          222 SVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAILEGNL----------  290 (366)
Q Consensus       222 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~~~~~----------  290 (366)
                      +.............+|+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+.....          
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            98877666666778999999999976 4689999999999999999999999988776655554432111          


Q ss_pred             ------------CCCCCCC----------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017768          291 ------------DLQSSPW----------------PSISGQAKDLIRKMLTKDPKKRITAAEALEHPWLKEDG  335 (366)
Q Consensus       291 ------------~~~~~~~----------------~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~hp~f~~~~  335 (366)
                                  ......+                ...++++.+||++||+.||++|||++|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                        1100000                01356789999999999999999999999999998743

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=379.02  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=205.1

Q ss_pred             cceeeeceecccCceEEEEEEEccCCc----EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCe
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGR----KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQN  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~  146 (366)
                      +.|++.+.||+|+||+||+|.+..+|+    +||+|.+...  ......+.+.+|+.++++++ ||||+++++++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence            359999999999999999999988776    5788877543  23445678999999999997 99999999999765 5


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccc
Q 017768          147 LHLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFI  225 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~  225 (366)
                      .++++|++.+++|.+.+... ..+++.+++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++..
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceec
Confidence            67888999899999888775 4699999999999999999999999999999999999994   5667999999999876


Q ss_pred             cCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          226 ETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       226 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      .....   .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+....+..+.....   .+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence            44332   22346899999999875 568999999999999999998 8999988888877777776653322   2367


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++++.+||.+||+.||++|||+.|+++|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=377.80  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             ccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||.||+|.+..     +++.||||++....  .......+.+|..++.++.+|+||+.+++++...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4679999999999999999999754     34689999986432  2345667888999999998899999999987654


Q ss_pred             -CeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeee
Q 017768          145 -QNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLAS  207 (366)
Q Consensus       145 -~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~  207 (366)
                       +..++|||||++|+|.+++...                ..+++.++..++.||+.||.|||+++|+||||||+|||+  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence             4689999999999999999754                248899999999999999999999999999999999999  


Q ss_pred             cCCCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHH-
Q 017768          208 KEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSG-VPPFWAETEKGI-  281 (366)
Q Consensus       208 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g-~~pf~~~~~~~~-  281 (366)
                       +.++.+||+|||+|+......   ......||+.|+|||++. +.++.++|||||||++|||++| ..||.+....+. 
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             567789999999998654332   223457999999999876 5689999999999999999986 567876654443 


Q ss_pred             HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          282 FEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ...+..+... .  ....+++++.++|.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC-C--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3444444322 2  123578999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=372.02  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             cceeeeceecccCceEEEEEEEccC-C--cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKAT-G--RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      ++|++.+.||+|+||.||+|++..+ +  ..||||++.+.........+.+.+|+.+|++++ ||||+++++++.+ ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence            4599999999999999999986543 2  368999987665545556778999999999997 9999999999976 467


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIAK-GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||++++++.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence            8999999999999887664 4599999999999999999999999999999999999995   45679999999998764


Q ss_pred             CCCc----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 017768          227 TGKV----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSI  300 (366)
Q Consensus       227 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (366)
                      ....    .....|+..|+|||++. ..++.++||||||+++|||++ |..||.+.+..+....+......++.  .+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence            4332    22345788999999876 458899999999999999998 89999999999888888776544432  3468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          301 SGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       301 ~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ++++.+||.+||+.||++|||+.++++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-52  Score=374.42  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=213.0

Q ss_pred             ccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeC
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDK  144 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~  144 (366)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....  ......++.+|+.+|++++ ||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            5679999999999999999999753     45789999986542  2344667999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCC
Q 017768          145 QNLHLVMELCSGGELFDRIIAKG------------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKP  200 (366)
Q Consensus       145 ~~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  200 (366)
                      +..+++|||+++++|.+++....                        .+++.++..++.||+.||+|||+++|+||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                        388999999999999999999999999999999


Q ss_pred             CcEEeeecCCCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCC-CCCCC
Q 017768          201 ENFLLASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGV-PPFWA  275 (366)
Q Consensus       201 ~NIll~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~-~pf~~  275 (366)
                      +|||+   +.++.+||+|||+++......   ......||+.|+|||.+. ..++.++|||||||++|||++|. .||.+
T Consensus       169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999   566789999999998654332   233457889999999876 46899999999999999999985 68999


Q ss_pred             CChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          276 ETEKGIFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+..+....+..+.....   ...+++++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            998888888888764322   2367899999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=371.53  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=210.8

Q ss_pred             cccceeeeceecccCceEEEEEEEccCC-------cEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATG-------RKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAY  141 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~  141 (366)
                      -.++|++++.||+|+||.||+|+...++       ..||||++....  .......+.+|...+.++.+||||+++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3568999999999999999999876544       379999986543  2445678899999999997799999999999


Q ss_pred             eeCCeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          142 EDKQNLHLVMELCSGGELFDRIIAK----------------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       142 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      .+++..++||||+++|+|.+++...                ..+++.+++.++.||+.||+|||+++|+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            9999999999999999999999754                248999999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCC---ceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGK---VYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.+||+|||+++......   ......+|+.|+|||.+. +.++.++||||||+|+|||++ |..||.+.+...
T Consensus       169 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         169 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence               667889999999998765433   223457899999999875 679999999999999999998 799999888888


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      ....+..+.....   ...+++++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            8777776543222   2357899999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=366.68  Aligned_cols=243  Identities=23%  Similarity=0.339  Sum_probs=201.6

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-CCeEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-KQNLH  148 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~  148 (366)
                      -++|++.+.||+|+||.||+|+++  |..||||+++..     ...+.+.+|+.++++++ ||||+++++++.+ .+.++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEE
Confidence            346999999999999999999985  889999998542     44577999999999997 9999999998855 45689


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          149 LVMELCSGGELFDRIIAKG--IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      +||||+++|+|.+++....  .+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecC
Confidence            9999999999999997643  48999999999999999999999999999999999999   677889999999998754


Q ss_pred             CCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 017768          227 TGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFEAILEGNLDLQSSPWPSISGQA  304 (366)
Q Consensus       227 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (366)
                      ..  .....+|..|+|||++. +.++.++||||||+++|||++ |+.||...+..+....+.++.....   .+.+++++
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~  229 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPAV  229 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTTCCHHH
T ss_pred             CC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHH
Confidence            33  23446889999999875 579999999999999999998 7999988888888888876543322   23578999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017768          305 KDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       305 ~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      .+||.+||+.||++|||+.+++++
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999774

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-51  Score=371.96  Aligned_cols=260  Identities=19%  Similarity=0.236  Sum_probs=207.3

Q ss_pred             ccccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeE
Q 017768           68 DITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNL  147 (366)
Q Consensus        68 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~  147 (366)
                      .++++|++.+.||+|+||+||+|++..+|+.||||++....     ....+..|+++++.+.+|++|+.+.+++.+++..
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            35678999999999999999999999999999999886532     2235788999999999777888888888999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCccccc
Q 017768          148 HLVMELCSGGELFDRIIA-KGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIE  226 (366)
Q Consensus       148 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~  226 (366)
                      ++||||+. ++|...+.. ...+++.++..++.|++.||+|||++||+||||||+|||++..+.+..++|+|||+|+...
T Consensus        79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99999995 466665554 4579999999999999999999999999999999999999766667789999999998765


Q ss_pred             CCC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---cCCCCC-C
Q 017768          227 TGK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFEAIL---EGNLDL-Q  293 (366)
Q Consensus       227 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~-~  293 (366)
                      ...        ......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+.   ...... .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            432        2234579999999998765 58999999999999999999999997765443322221   111111 1


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHH---HhcCCCccc
Q 017768          294 SSPWPSISGQAKDLIRKMLTKDPKKRITAAE---ALEHPWLKE  333 (366)
Q Consensus       294 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~---~l~hp~f~~  333 (366)
                      ....+.+++++.++|..||+.||++||++.+   +|+|+|.+.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            1123467899999999999999999999874   567776543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=368.10  Aligned_cols=252  Identities=24%  Similarity=0.320  Sum_probs=210.8

Q ss_pred             cccceeeeceecccCceEEEEEEEc-----cCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKK-----ATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      -.++|++.+.||+|+||.||+|++.     .+++.||||++....  .......+.+|+.+++++.+||||+++++++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            3578999999999999999999863     456799999997543  244566789999999999779999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEe
Q 017768          144 KQNLHLVMELCSGGELFDRIIAKG------------------IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLL  205 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll  205 (366)
                      .+..+++||||++++|.+++....                  .+++.++..++.||+.||.|||+++|+||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999999999999997643                  48999999999999999999999999999999999999


Q ss_pred             eecCCCCCEEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 017768          206 ASKEEDSPIKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLS-GVPPFWAETEKG  280 (366)
Q Consensus       206 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~-g~~pf~~~~~~~  280 (366)
                         +.++.++|+|||+++.......   .....||+.|+|||++. +.++.++||||||+++|||++ |..||......+
T Consensus       179 ---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence               4567799999999987654332   23357899999999876 568999999999999999998 566666666555


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          281 IFEAILEGNLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .+..+..........  ...++++.+||.+||+.||++|||++++++
T Consensus       256 ~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            555544433332222  357899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=365.59  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=218.1

Q ss_pred             cccceeeeceecccCceEEEEEEEcc-----CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKA-----TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED  143 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~  143 (366)
                      ..++|++.+.||+|+||+||+|.+..     ++..||||++....  .......+.+|+.++++++ ||||+++++++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEec
Confidence            35789999999999999999998753     35789999986432  3345567899999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCC
Q 017768          144 KQNLHLVMELCSGGELFDRIIAK----------GIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSP  213 (366)
Q Consensus       144 ~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~  213 (366)
                      ++..++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||+   +.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCce
Confidence            99999999999999999988653          236889999999999999999999999999999999999   67788


Q ss_pred             EEEeecCCcccccCCCc---eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcC
Q 017768          214 IKATDFGLSVFIETGKV---YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFEAILEG  288 (366)
Q Consensus       214 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g-~~pf~~~~~~~~~~~~~~~  288 (366)
                      +||+|||+++.......   .....||+.|+|||.+. +.++.++||||||+++|||++| ..||.+.+..+....+.++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            99999999986644332   23346899999999876 5688899999999999999997 5888888888888888776


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCccc
Q 017768          289 NLDLQSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE------HPWLKE  333 (366)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~------hp~f~~  333 (366)
                      ......   +.+++.+.++|.+||+.||++|||+.++++      +|+|++
T Consensus       252 ~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         252 GLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            543322   357899999999999999999999999998      677654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=357.30  Aligned_cols=245  Identities=22%  Similarity=0.316  Sum_probs=199.6

Q ss_pred             eeceecccCceEEEEEEEccCCc---EEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEee-CCeEEEE
Q 017768           75 LDKELGRGQFGVTYLCTKKATGR---KYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYED-KQNLHLV  150 (366)
Q Consensus        75 ~~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  150 (366)
                      ..+.||+|+||+||+|++..++.   .||||.+...  ......+++.+|++++++++ ||||+++++++.. ++..++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEE
Confidence            35789999999999999865432   6899998642  23456788999999999997 9999999999765 5689999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEeecCCcccccCCC
Q 017768          151 MELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKATDFGLSVFIETGK  229 (366)
Q Consensus       151 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~~~~~~  229 (366)
                      ||||++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+   ++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccc
Confidence            99999999999887544 47788999999999999999999999999999999999   667889999999998764332


Q ss_pred             c-----eecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCCCCH
Q 017768          230 V-----YKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFEAILEGNLDLQSSPWPSISG  302 (366)
Q Consensus       230 ~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (366)
                      .     .....||..|+|||.+. +.++.++||||||+++|||++|..||... +..+....+..+......   +.+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p---~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---TTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---ccCcH
Confidence            2     22346899999999875 57899999999999999999977777554 334455555665433322   35789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          303 QAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       303 ~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                      ++.+||.+||+.||++||++.|+++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.3e-49  Score=354.41  Aligned_cols=253  Identities=21%  Similarity=0.268  Sum_probs=206.9

Q ss_pred             cccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEE
Q 017768           69 ITTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLH  148 (366)
Q Consensus        69 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  148 (366)
                      ++++|++++.||+|+||+||+|++..+|+.||||++....     ....+.+|++.++.+.+++|++.+++++..+...+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            4678999999999999999999999999999999885432     23457789999999998899999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeec--CCCCCEEEeecCCcccc
Q 017768          149 LVMELCSGGELFDRIIAKG-IYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASK--EEDSPIKATDFGLSVFI  225 (366)
Q Consensus       149 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~vkl~Dfg~a~~~  225 (366)
                      +||||+ +++|.+++.... .+++.++..++.|++.||+|||++||+||||||+|||++..  ...+.+||+|||+|+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 679999887754 69999999999999999999999999999999999999643  23567999999999876


Q ss_pred             cCCC--------ceecccCCCCCCccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCCCC-
Q 017768          226 ETGK--------VYKEIVGSAYYVAPEVLHQ-RYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFEAILEGNLDL-  292 (366)
Q Consensus       226 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~vl~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~-  292 (366)
                      ....        ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...   ......+....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            4321        2334579999999998765 589999999999999999999999975533   22233332221111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017768          293 QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEALE  327 (366)
Q Consensus       293 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~  327 (366)
                      .....+.+++++.+++..|+..+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            11122457899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=355.40  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=189.8

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCC----e
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQ----N  146 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~----~  146 (366)
                      ..|.+.+.||+|+||.||+|++  +|+.||||++..+.    ........|+..+..++ ||||+++++++...+    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceE
Confidence            4689999999999999999987  48999999985432    12222334555555665 999999999997654    6


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEEeccCCCcEEeeecCCCCCEEEee
Q 017768          147 LHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHF--------MGVIHRDLKPENFLLASKEEDSPIKATD  218 (366)
Q Consensus       147 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~ivH~Dlkp~NIll~~~~~~~~vkl~D  218 (366)
                      .++||||+++|+|.++++.. .+++.+++.++.|++.||.|||+        +||+||||||+|||+   +.++.+||+|
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D  151 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD  151 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred             EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence            89999999999999999765 58999999999999999999996        599999999999999   6778899999


Q ss_pred             cCCcccccCCC-----ceecccCCCCCCcccccccc-------CCCchhHHHHHHHHHHHHhCCCCCCCC----------
Q 017768          219 FGLSVFIETGK-----VYKEIVGSAYYVAPEVLHQR-------YGKEIDVWSAGVILYILLSGVPPFWAE----------  276 (366)
Q Consensus       219 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~vl~~ll~g~~pf~~~----------  276 (366)
                      ||++.......     ......||+.|+|||++...       ++.++|||||||+||||++|..||...          
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            99998765433     22346799999999987542       567899999999999999998776321          


Q ss_pred             -----ChHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017768          277 -----TEKGIFEAILEGNLDLQSSP---WPSISGQAKDLIRKMLTKDPKKRITAAEALEH  328 (366)
Q Consensus       277 -----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l~h  328 (366)
                           ...............+....   .......+.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 22223333333333222111   01123468899999999999999999999873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-46  Score=345.09  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=195.2

Q ss_pred             cceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhc----------CCCceeEeceE
Q 017768           71 TIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLT----------GQPNIVEFEGA  140 (366)
Q Consensus        71 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~i~~~~~~  140 (366)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..+.    ...+.+.+|+.+++.+.          +|+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            35999999999999999999999999999999996532    23456788999998886          25889999988


Q ss_pred             Eee--CCeEEEEEeccCCCchHHH-HHH--hCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeccCCCcEEeeecCCC---
Q 017768          141 YED--KQNLHLVMELCSGGELFDR-IIA--KGIYSEREAANICRQIVNVVHACHF-MGVIHRDLKPENFLLASKEED---  211 (366)
Q Consensus       141 ~~~--~~~~~lv~e~~~~~~L~~~-l~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~---  211 (366)
                      +..  ....+++|+++..+..... ...  ...+++..++.++.||+.||.|||+ .||+||||||+|||++..+..   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            764  3566677777655443333 222  3458999999999999999999998 899999999999999754332   


Q ss_pred             CCEEEeecCCcccccCCCceecccCCCCCCcccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHH
Q 017768          212 SPIKATDFGLSVFIETGKVYKEIVGSAYYVAPEVLH-QRYGKEIDVWSAGVILYILLSGVPPFWAETEK------GIFEA  284 (366)
Q Consensus       212 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~vl~~ll~g~~pf~~~~~~------~~~~~  284 (366)
                      ..++++|||.+......  ....+||+.|+|||++. ..++.++||||+||++++|++|+.||......      .....
T Consensus       169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            24899999999865432  34567999999999875 56899999999999999999999999654321      11111


Q ss_pred             HHc--CC--------------------C--CC--------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017768          285 ILE--GN--------------------L--DL--------------QSSPWPSISGQAKDLIRKMLTKDPKKRITAAEAL  326 (366)
Q Consensus       285 ~~~--~~--------------------~--~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~~l  326 (366)
                      ...  +.                    .  ..              ....+...++++.+||.+||+.||++|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            100  00                    0  00              0000112457899999999999999999999999


Q ss_pred             cCCCcccCCC
Q 017768          327 EHPWLKEDGA  336 (366)
Q Consensus       327 ~hp~f~~~~~  336 (366)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999996543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.1e-27  Score=198.87  Aligned_cols=167  Identities=20%  Similarity=0.203  Sum_probs=122.4

Q ss_pred             eeeeceecccCceEEEEEEEccCCcEEEEEEeecccccc---------------cccHHHHHHHHHHHHHhcCCCceeEe
Q 017768           73 YDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY---------------DKDMEDVRREILILQHLTGQPNIVEF  137 (366)
Q Consensus        73 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~~e~~~l~~l~~h~~i~~~  137 (366)
                      +.++++||+|+||+||+|.+. +|+.||||++.......               .........|+..+.++. +.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            567899999999999999985 79999999875322110               011233456888999987 7888887


Q ss_pred             ceEEeeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeccCCCcEEeeecCCCCCEEEe
Q 017768          138 EGAYEDKQNLHLVMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFMGVIHRDLKPENFLLASKEEDSPIKAT  217 (366)
Q Consensus       138 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~vkl~  217 (366)
                      +++.  .  .+++|||+++..+.+       ++...+..++.|++.+|.+||++||+||||||+|||++   + ..++|+
T Consensus        80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~~~li  144 (191)
T d1zara2          80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EGIWII  144 (191)
T ss_dssp             EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TEEEEC
T ss_pred             EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CCEEEE
Confidence            7653  2  279999998865532       56667788999999999999999999999999999995   2 238999


Q ss_pred             ecCCcccccCCCceecccCCCCCCc------cccccccCCCchhHHHHHHHH
Q 017768          218 DFGLSVFIETGKVYKEIVGSAYYVA------PEVLHQRYGKEIDVWSAGVIL  263 (366)
Q Consensus       218 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Di~slG~vl  263 (366)
                      |||+|+........       .|..      .+.+.+.++.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999776433311       1111      123446688999999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.88  E-value=3.8e-09  Score=90.69  Aligned_cols=142  Identities=17%  Similarity=0.109  Sum_probs=97.1

Q ss_pred             ccceeeeceecccCceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           70 TTIYDLDKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        70 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      ...|++.+..+-++.+.||+...  +++.+++|+.....   ......+.+|...+..+..+--+++++.+...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            34577776655555678998763  47788899875432   22344578899999988766557888888888899999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------
Q 017768          150 VMELCSGGELFDRIIAKGIYSEREAANICRQIVNVVHACHFM--------------------------------------  191 (366)
Q Consensus       150 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------------  191 (366)
                      ||++++|.++.+...     +......++.++...+..||+.                                      
T Consensus        88 v~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999887754331     1112223344444445555421                                      


Q ss_pred             ---------------------CCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          192 ---------------------GVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       192 ---------------------~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                                           .++|+|+.|.|||++   +++.+-|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence                                 279999999999994   444456999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.49  E-value=3.6e-07  Score=82.91  Aligned_cols=82  Identities=17%  Similarity=0.097  Sum_probs=52.5

Q ss_pred             eceecccCceEEEEEEEccCCcEEEEEEeecccccc----cccHHHHHHHHHHHHHhcCC--CceeEeceEEeeCCeEEE
Q 017768           76 DKELGRGQFGVTYLCTKKATGRKYACKSISRRKLVY----DKDMEDVRREILILQHLTGQ--PNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        76 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~~h--~~i~~~~~~~~~~~~~~l  149 (366)
                      .+.||.|....||++....+++.+++|.-.......    .....+...|...|+.+..+  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999999887778899999654211111    12345567788888887643  345666654  4455688


Q ss_pred             EEeccCCCch
Q 017768          150 VMELCSGGEL  159 (366)
Q Consensus       150 v~e~~~~~~L  159 (366)
                      +||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.34  E-value=4.7e-07  Score=76.83  Aligned_cols=74  Identities=11%  Similarity=0.058  Sum_probs=52.4

Q ss_pred             ecccC-ceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCC-ceeEeceEEeeCCeEEEEEeccCC
Q 017768           79 LGRGQ-FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQP-NIVEFEGAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        79 lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~i~~~~~~~~~~~~~~lv~e~~~~  156 (366)
                      +..|. .+.||+.... ++..+++|.....      ....+..|...++.+..+. .+++++.+..+++..+++|++++|
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            34444 3678988754 5677888975432      2234678888888876432 267788888888889999999988


Q ss_pred             Cch
Q 017768          157 GEL  159 (366)
Q Consensus       157 ~~L  159 (366)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            665

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.63  E-value=0.00011  Score=66.11  Aligned_cols=74  Identities=14%  Similarity=0.161  Sum_probs=51.7

Q ss_pred             ceecccCceEEEEEEEcc-------CCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCceeEeceEEeeCCeEEE
Q 017768           77 KELGRGQFGVTYLCTKKA-------TGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIVEFEGAYEDKQNLHL  149 (366)
Q Consensus        77 ~~lG~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  149 (366)
                      +.|+.|-.-.+|++....       .++.|++++... .    ...-...+|..+++.+..+.-.+++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            568888889999988653       245677777642 1    2233566899999998866556678777643    68


Q ss_pred             EEeccCCCch
Q 017768          150 VMELCSGGEL  159 (366)
Q Consensus       150 v~e~~~~~~L  159 (366)
                      |+||++|..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.53  E-value=0.00017  Score=63.04  Aligned_cols=68  Identities=10%  Similarity=0.086  Sum_probs=45.3

Q ss_pred             ceEEEEEEEccCCcEEEEEEeecccccccccHHHHHHHHHHHHHhcCCCcee--Eec-----eEEeeCCeEEEEEeccCC
Q 017768           84 FGVTYLCTKKATGRKYACKSISRRKLVYDKDMEDVRREILILQHLTGQPNIV--EFE-----GAYEDKQNLHLVMELCSG  156 (366)
Q Consensus        84 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~--~~~-----~~~~~~~~~~lv~e~~~~  156 (366)
                      .-.||++... +|..+++|+....    ....+++..|...+..|..+ ++.  ...     ..+..++..+.++++++|
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPE----RWTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            3579998864 6899999987543    23456788899998888632 221  111     123446678889999876


Q ss_pred             C
Q 017768          157 G  157 (366)
Q Consensus       157 ~  157 (366)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.84  E-value=0.0015  Score=56.23  Aligned_cols=31  Identities=32%  Similarity=0.411  Sum_probs=25.0

Q ss_pred             cCCEEeccCCCcEEeeecCCCCCEEEeecCCccc
Q 017768          191 MGVIHRDLKPENFLLASKEEDSPIKATDFGLSVF  224 (366)
Q Consensus       191 ~~ivH~Dlkp~NIll~~~~~~~~vkl~Dfg~a~~  224 (366)
                      .|+||+|+.++||+++   .+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcc---cccceeEeccccccc
Confidence            3699999999999995   344468999998753